Citrus Sinensis ID: 044995
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9M2 | 761 | Wall-associated receptor | yes | no | 0.784 | 0.296 | 0.471 | 3e-65 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.760 | 0.292 | 0.469 | 2e-64 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.760 | 0.291 | 0.465 | 5e-64 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.760 | 0.3 | 0.452 | 1e-63 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.763 | 0.301 | 0.453 | 1e-62 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.760 | 0.299 | 0.448 | 1e-62 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.791 | 0.287 | 0.453 | 3e-62 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.760 | 0.277 | 0.450 | 1e-59 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.767 | 0.287 | 0.427 | 5e-59 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.746 | 0.281 | 0.444 | 6e-58 |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 248 bits (634), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 142/301 (47%), Positives = 179/301 (59%), Gaps = 75/301 (24%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++ +K+F SNELEKATD+FN NR+LGQGGQ VYKGM KVE+F
Sbjct: 406 VEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEF 465
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVV+ +QINH N+VKL+GCCLET K + D+ + TWE++L
Sbjct: 466 INEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLH 525
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G +SYLH +AS PIYHRDIK+TNILLD+KY KVS+FGTSRS +DQTH+TTQV
Sbjct: 526 IAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQV 585
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------- 184
GTFGY++P+ DV SFGVVLVEL+TG P EE
Sbjct: 586 AGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVK 645
Query: 185 ------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGASN 226
D+ + VAK AKRCLN GKKRP M+EV+ EL I++ + S
Sbjct: 646 ENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSE 705
Query: 227 V 227
+
Sbjct: 706 I 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 138/294 (46%), Positives = 179/294 (60%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++ +++F S+ELEKATD+FN NR+LGQGGQ VYKGM +VE+F
Sbjct: 398 VEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEF 457
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVV+ +QINH N+VKL+GCCLET K +HD++ + TWE++L
Sbjct: 458 INEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLH 517
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G +SYLH +AS PIYHRDIK+TNILLD++ AKVS+FGTSRS +DQTH+TTQV
Sbjct: 518 IAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQV 577
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------- 184
GTFGY++P+ DV SFGVVLVELLTG KP EE
Sbjct: 578 AGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVK 637
Query: 185 ------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
D+ ++VA A+RCLN GKKRP M+EV+ EL I++
Sbjct: 638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRS 691
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 137/294 (46%), Positives = 177/294 (60%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++ +K+F S ELEKATD+FN+NR+LGQGGQ VYKGM KVE+F
Sbjct: 403 VQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEF 462
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEV + SQINH N+VKL+GCCLET K +H + + TW+++LR
Sbjct: 463 INEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLR 522
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
IS+E +G ++YLH +AS P+YHRD+K+TNILLD+KY AKVS+FGTSRS VDQTH+TT V
Sbjct: 523 ISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLV 582
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKN---------- 187
GTFGYL+P+ DV SFGVVLVEL+TG KP EE++
Sbjct: 583 AGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMK 642
Query: 188 ---------------------ITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
+ VAK A+RCL+ GKKRP M+EV+ EL I++
Sbjct: 643 QNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 133/294 (45%), Positives = 179/294 (60%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++ +K+F S EL KATD+F+++R+LGQGGQ VYKGM K+E+F
Sbjct: 411 VEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEF 470
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INE+V+ SQINH N+VKL+GCCLET K +HD++ + TWE++LR
Sbjct: 471 INEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLR 530
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G ++Y+H +AS PI+HRDIK+TNILLD+KY AKVS+FGTSRS +DQTH+TT V
Sbjct: 531 IAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLV 590
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------- 188
GTFGY++P+ DV SFGVVLVEL+TG KP+ EE + +
Sbjct: 591 AGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMK 650
Query: 189 ----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
VAK A++CLN GK RP MKEV++EL I++
Sbjct: 651 ENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 133/293 (45%), Positives = 179/293 (61%), Gaps = 73/293 (24%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEK 43
+++ +K+F S ELEKATD+F+++R+LGQGGQ VYK M K+E+
Sbjct: 409 SVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEE 468
Query: 44 FINEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQL 87
FINE+V+ SQINH N+VKL+GCCLET K +HD+ + TWE++L
Sbjct: 469 FINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRL 528
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI++E +G +SY+H +AS PI+HRDIK+TNILLD+KY AK+S+FGTSRS A DQTH+TT
Sbjct: 529 RIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTL 588
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP---------IRFTTF----- 182
V GTFGY++P+ DV SFGVVLVEL+TG KP I T+
Sbjct: 589 VAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAM 648
Query: 183 ---------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
E + + VAK A+RCLN G KRP M+EV+ +L I++
Sbjct: 649 KENRAVDIIDIRIKDESKQVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRS 701
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 132/294 (44%), Positives = 176/294 (59%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
+ ++LF S EL+KATD+F+V R+LG+G Q VYKGM K+EKF
Sbjct: 414 VDMSRLFSSEELKKATDNFSVKRVLGKGSQGTVYKGMMVDGKIIAVKRSKVVDEDKLEKF 473
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INE+++ SQINH N+VKLIGCCLET K +HD++ + TWE++LR
Sbjct: 474 INEIILLSQINHRNIVKLIGCCLETEVPILVYEYIPNGDMFKRLHDESDDYAMTWEVRLR 533
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G ++Y+H +AS PIYHRDIK+TNILLD+KY AKVS+FGTSRS +DQTH+TT V
Sbjct: 534 IAIEIAGALTYMHSAASFPIYHRDIKTTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMV 593
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------- 184
GTFGY++P+ DV SFGVVLVEL+TG KP+ EE
Sbjct: 594 AGTFGYMDPEYFLSSQYTDKSDVYSFGVVLVELITGEKPLSRIRSEEGRGLATHFLEAMK 653
Query: 185 ------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
D+ + VAK A++CL+ G KRP M+E + EL I++
Sbjct: 654 ENRVIDIIDIRIKEESKLDQLMAVAKLARKCLSRKGIKRPNMREASLELERIRS 707
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 138/304 (45%), Positives = 180/304 (59%), Gaps = 76/304 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++KT +F S ELEKAT++F+ NRILGQGGQ VYKGM K+E+F
Sbjct: 429 VEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEF 488
Query: 45 INEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKE-LPFTWEMQL 87
INEVVI SQINH N+VKL+GCCLETK ++HD+ E + TW ++L
Sbjct: 489 INEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRL 548
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+I+ +G +SYLH SAS PIYHRD+KSTNI+LD+KY AKVS+FGTSR+ VD TH+TT
Sbjct: 549 RIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTV 608
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI-------- 188
V GT GY++P+ DV SFGVVLVEL+TG K I F +E++ +
Sbjct: 609 VSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAM 668
Query: 189 -----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225
AK A++CLN G+KRP+M+EV+ EL I+ G
Sbjct: 669 KENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDM 728
Query: 226 NVME 229
+ E
Sbjct: 729 QLQE 732
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 133/295 (45%), Positives = 176/295 (59%), Gaps = 76/295 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++KT++F S ELEKATD+F+ +RILGQGGQ VYKGM K+E+F
Sbjct: 433 VEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEF 492
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVVI SQINH +VVKL+GCCLET +++H+++ + TW M+LR
Sbjct: 493 INEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLR 552
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+++ +G +SYLH +AS PIYHRDIKSTNILLD+KY KVS+FGTSRS +D TH TT +
Sbjct: 553 IAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVI 612
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI-------------------- 177
GT GY++P+ DV SFGVVLVEL+TG KP+
Sbjct: 613 SGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAM 672
Query: 178 ---RFTTFEE---------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
RF + ++ + VA A+RCLN GKKRP M++V ++L I A
Sbjct: 673 KENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILA 727
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 127/297 (42%), Positives = 177/297 (59%), Gaps = 76/297 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
+ T++F S ELEKAT++F++ RILG+GGQ VYKGM K+E+F
Sbjct: 415 VDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEF 474
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFT-WEMQL 87
INEVVI SQINH N+VKL+GCCLET +++HD + + T WE++L
Sbjct: 475 INEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRL 534
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+++ +G +SYLH +AS PIYHRDIKSTNI+LD+K+ AKVS+FGTSR+ VD TH+TT
Sbjct: 535 RIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTV 594
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI-------- 188
V GT GY++P+ DV SFGVVL EL+TG K + F +E + +
Sbjct: 595 VSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAM 654
Query: 189 -----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222
AK A++CLN G+KRP+M++V+ EL I++++
Sbjct: 655 KENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 131/295 (44%), Positives = 170/295 (57%), Gaps = 80/295 (27%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
++KTKLF S ELEKATD+FN NR++GQGGQ VYKGM K+++F
Sbjct: 436 VEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEF 495
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEV+I SQINH +VVKL+GCCLET +++H++ + W +++R
Sbjct: 496 INEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMR 555
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+++ SG SYLH +A PIYHRDIKSTNILLD+KY AKVS+FGTSRS ++D TH TT +
Sbjct: 556 IAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVI 615
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNIT-------- 189
GT GY++P+ DV SFGVVLVEL+TG KP+ T E + IT
Sbjct: 616 SGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPV--ITLSETQEITGLADYFRL 673
Query: 190 --------------------------VAKHAKRCLNPSGKKRPAMKEVASELAGI 218
VA A RCL +GK RP M+EV++ L I
Sbjct: 674 AMRENRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | ||||||
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.756 | 0.265 | 0.518 | 9e-72 | |
| 224108615 | 374 | predicted protein [Populus trichocarpa] | 0.802 | 0.617 | 0.490 | 3e-70 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.875 | 0.339 | 0.468 | 4e-70 | |
| 224053046 | 337 | predicted protein [Populus trichocarpa] | 0.753 | 0.643 | 0.506 | 7e-70 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.791 | 0.552 | 0.488 | 1e-69 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.760 | 0.305 | 0.506 | 1e-69 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.829 | 0.348 | 0.479 | 2e-69 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.777 | 0.310 | 0.498 | 3e-69 | |
| 224053068 | 721 | predicted protein [Populus trichocarpa] | 0.878 | 0.350 | 0.462 | 4e-69 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.760 | 0.212 | 0.506 | 5e-69 |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 9e-72, Method: Compositional matrix adjust.
Identities = 152/293 (51%), Positives = 184/293 (62%), Gaps = 75/293 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEKF 44
+ KTKLF S ELEKATD +N NR++GQGGQ VYKGM KVE+F
Sbjct: 511 VDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQF 570
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVVI SQINH NVVKL+GCCLET +++HDQN+E P TWEM+LR
Sbjct: 571 INEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLR 630
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G +SYLH +AS+PIYHRDIKSTNILLDDKY AKV++FGTS+S A+DQTH+TTQV
Sbjct: 631 IAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQV 690
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------- 188
GTFGYL+P+ DV SFG+VL+ELLTG KPI T EE K++
Sbjct: 691 QGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMN 750
Query: 189 ----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219
+A A+RC+N +GKKRP M EVA EL +K
Sbjct: 751 EDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILK 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108615|ref|XP_002333372.1| predicted protein [Populus trichocarpa] gi|222836354|gb|EEE74761.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 271 bits (693), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 150/306 (49%), Positives = 189/306 (61%), Gaps = 75/306 (24%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEK 43
+++KTK+F SNELEKATD FN NRILG GGQ VYKGM K+E+
Sbjct: 36 SVQKTKIFSSNELEKATDYFNENRILGHGGQGTVYKGMLADGSIVAVKKSTIVDEEKLEE 95
Query: 44 FINEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQL 87
FINEVVI SQI+H NVV+L+GCCLET +Y+H+QN++ +WE +L
Sbjct: 96 FINEVVILSQISHRNVVRLLGCCLETDVPLLVYEFIPNGTLSQYLHEQNEDFTLSWESRL 155
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+ EA+G +SYLH +AS+PIYHRDIKSTNILLD+KY AKVS+FGTSRS ++DQTH+TT+
Sbjct: 156 RIASEAAGAISYLHSTASIPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDQTHLTTK 215
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT---------------- 180
V GTFGYL+P+ DV SFGVVLVELL+G KPI T
Sbjct: 216 VQGTFGYLDPEYFRTSQLTEKSDVYSFGVVLVELLSGKKPIFLTHSLETMSLAKHFIKLM 275
Query: 181 ----TFE-----------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225
F+ E++ I +A AKRCLN +G+ RP M+EVA EL GI
Sbjct: 276 EDGRLFDIIDAQVKGDCTEEEAIVIANLAKRCLNLNGRNRPTMREVAMELEGILLSRNGI 335
Query: 226 NVMEEG 231
N+ + G
Sbjct: 336 NIQQIG 341
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 270 bits (691), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 162/346 (46%), Positives = 198/346 (57%), Gaps = 94/346 (27%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEKF 44
I+KT +F + ELEKATD +N NRILGQGGQ VYKGM +K E+F
Sbjct: 384 IEKTNMFTAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQF 443
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVVI SQINH NVVKL+GCCLET +++HD ++E P TWEM+LR
Sbjct: 444 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLR 503
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +SYLH +ASVPIYHRDIKSTNILLDDKY AKVS+FGTS+S AVDQTH+TT+V
Sbjct: 504 IAIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRV 563
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKN---------- 187
GTFGYL+P+ DV SFGVVLVELLTG KPI E+++
Sbjct: 564 QGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSME 623
Query: 188 ---------------------ITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA------ 220
+ VAK A+RCLN +GKKRP M+ V +E+ I+A
Sbjct: 624 QNRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRASQQGTC 683
Query: 221 -WNGASNVME-----------EGILGRAPTVGGTFKPVPQPRLEVP 254
NG ++ E E G P + GT P PR+ P
Sbjct: 684 FTNGENDYQELDCFAFTRGKRETARGNRPGI-GTLGPNGHPRMSSP 728
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053046|ref|XP_002297680.1| predicted protein [Populus trichocarpa] gi|222844938|gb|EEE82485.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 270 bits (689), Expect = 7e-70, Method: Compositional matrix adjust.
Identities = 148/292 (50%), Positives = 180/292 (61%), Gaps = 75/292 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEKF 44
++KTK++ S ELE ATD FNVNRILGQGGQ VYKGM K+E+F
Sbjct: 46 VQKTKIYSSKELEVATDRFNVNRILGQGGQGTVYKGMLADGRIVAVKKSMVVDEGKLEEF 105
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INEVV+ SQINH NVVKL+GCCLET KY+HD+N++ +WEM+LR
Sbjct: 106 INEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFISNGNLYKYIHDRNEDFLLSWEMRLR 165
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+IE +G +SYLH + S+PIYHRDIKSTNILLD+KY AKVS+FG+SRS ++DQTH+TT V
Sbjct: 166 IAIEVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRAKVSDFGSSRSISIDQTHLTTLV 225
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI-------------RFTTFEE 184
GTFGYL+P+ DV SFGVVLVEL++G KPI F E
Sbjct: 226 QGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQKPIFSVSQTETRSLATHFIMLME 285
Query: 185 DKN------------------ITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218
D I+VA AKRCLN +GK RP M+EV SEL I
Sbjct: 286 DNRLSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKNRPTMREVTSELERI 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 269 bits (687), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 148/303 (48%), Positives = 184/303 (60%), Gaps = 75/303 (24%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEKF 44
+ KTKLF S ELEKATD +N NR++GQGGQ VYKGM K+E+F
Sbjct: 65 VDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKLEQF 124
Query: 45 INEVVIQSQINHINVVKLIGCCLE----------------TKYMHDQNKELPFTWEMQLR 88
INEVVI SQINH NVVKL+GCCLE ++++HDQN+E P TW+M+L+
Sbjct: 125 INEVVILSQINHRNVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIHDQNEEFPITWKMRLQ 184
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I+ E +G +SYLH +AS+PIYHRDIKSTNILLDDKY AKV++FGTS+S A+DQTH+TT+V
Sbjct: 185 IATEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKV 244
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------- 188
GTFGYL+P+ DV SFG+VL+ELLTG KPI E K++
Sbjct: 245 QGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIGSGEGKSLASYFIMSMK 304
Query: 189 ----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGASN 226
+A AKRC+N +GKKRP M EVA EL I+ G N
Sbjct: 305 EDRLSDLLDARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIRKCEGDFN 364
Query: 227 VME 229
E
Sbjct: 365 AQE 367
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 269 bits (687), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 149/294 (50%), Positives = 181/294 (61%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
+KTK+F S+ELEKATD+FN NRILGQGGQ VYKGM ++E F
Sbjct: 369 FEKTKIFTSDELEKATDNFNKNRILGQGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHF 428
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INE+VI SQINH NVV ++GCCLET + +HDQN E P +WEM+LR
Sbjct: 429 INEIVILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLR 488
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I++E SG +SYLH + S+PIYHRDIKSTNILLDDKY AKVS+FGTSRS ++DQTH+TT V
Sbjct: 489 IALEVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIV 548
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------- 188
GTFGYL+P+ DV SFGVVLVELLTG KPI T E+K++
Sbjct: 549 QGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQ 608
Query: 189 ----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
T AK A RCLN +G+KRP MKEV +E+ I+
Sbjct: 609 ESRLFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRV 662
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 268 bits (684), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 153/319 (47%), Positives = 190/319 (59%), Gaps = 80/319 (25%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEK 43
+I+KTK+F S ELEKATD FN NRILGQGGQ VYKGM K+E+
Sbjct: 340 SIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEE 399
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTWEMQL 87
FINEVVI SQ+NH NVVKL+GCCLET+ Y+HDQ +E F+WEM+L
Sbjct: 400 FINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRL 459
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+ E + +SYLH +AS+P+YHRDIKSTNI+LD+K+ AKVS+FGTSRS A+DQTH+TT
Sbjct: 460 RIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTH 519
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------- 183
V GTFGYL+P+ DV SFGVVL ELL+G KPI + E
Sbjct: 520 VQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERPEDRRSLATHFILLM 579
Query: 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225
E++ I VA A+RCLN +G+KRP M+EVA EL I+ GA
Sbjct: 580 EENKIFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRVSKGAP 639
Query: 226 NVME-----EGILGRAPTV 239
+ + E I P V
Sbjct: 640 HAQQSCKDLENIRDEVPNV 658
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 267 bits (683), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 149/299 (49%), Positives = 183/299 (61%), Gaps = 75/299 (25%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEK 43
+I+KTK+F S ELEKATD FN NRILGQGGQ VYKGM K+E+
Sbjct: 370 SIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEE 429
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTWEMQL 87
FINEVVI SQ+NH NVVKL+GCCLET+ Y+HDQ +E F+WEM+L
Sbjct: 430 FINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRL 489
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+ E + +SYLH +AS+P+YHRDIKSTNI+LD+K+ AKVS+FGTSRS A+DQTH+TT
Sbjct: 490 RIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTH 549
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------- 183
V GTFGYL+P+ DV SFGVVL ELL+G KPI + E
Sbjct: 550 VQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERSEERGSLATHFILLV 609
Query: 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224
E++ I VA A+RCLN G+KRP M+EVA EL I+ GA
Sbjct: 610 EENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGRKRPTMREVAIELEQIRLSKGA 668
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053068|ref|XP_002297691.1| predicted protein [Populus trichocarpa] gi|222844949|gb|EEE82496.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 267 bits (683), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 159/344 (46%), Positives = 196/344 (56%), Gaps = 91/344 (26%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEK 43
+I+KTK+F S ELEKATD FN NRILGQGGQ VYKGM K E+
Sbjct: 369 SIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMLADGSIVAVKKSKMMDEEKWEE 428
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTWEMQL 87
FINEVVI SQ+NH NVVKL+GCCLET+ Y+HDQ +E F+WEM+L
Sbjct: 429 FINEVVILSQLNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRL 488
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI+ E + +SYLH +AS+P+YHRDIKSTNILLD+K+ AKVS+FGTSRS A+DQTH+TT
Sbjct: 489 RIATEVARALSYLHSAASIPVYHRDIKSTNILLDEKFKAKVSDFGTSRSIAIDQTHLTTH 548
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKN--------- 187
V GTFGYL+P+ DV SFGVVL ELL+G KPI + EE ++
Sbjct: 549 VQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERPEERRSLATHFILLM 608
Query: 188 ----------------------ITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225
I VA A+RCLN +G+KRP M+EVA EL I+ GA
Sbjct: 609 EENKIFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRLSKGAL 668
Query: 226 NVME-----EGILGRAPTVG-----------GTFKPVPQPRLEV 253
+ + E I P V G F+ P L+V
Sbjct: 669 HAQQSSKELENIWEEVPNVWEIAGPTTSVTIGDFRNGTAPSLDV 712
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 267 bits (682), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 149/294 (50%), Positives = 181/294 (61%), Gaps = 75/294 (25%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKF 44
+KTK+F S+ELEKATD+FN NRILGQGGQ VYKGM ++E F
Sbjct: 249 FEKTKIFTSDELEKATDNFNKNRILGQGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHF 308
Query: 45 INEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTWEMQLR 88
INE+VI SQINH NVV ++GCCLET + +HDQN E P +WEM+LR
Sbjct: 309 INEIVILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLR 368
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I++E SG +SYLH + S+PIYHRDIKSTNILLDDKY AKVS+FGTSRS ++DQTH+TT V
Sbjct: 369 IALEVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIV 428
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------- 188
GTFGYL+P+ DV SFGVVLVELLTG KPI T E+K++
Sbjct: 429 QGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQ 488
Query: 189 ----------------------TVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
T AK A RCLN +G+KRP MKEV +E+ I+
Sbjct: 489 ESRLFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRV 542
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | ||||||
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.517 | 0.204 | 0.528 | 1.1e-48 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.517 | 0.199 | 0.539 | 1.4e-48 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.413 | 0.150 | 0.526 | 1.9e-48 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.527 | 0.202 | 0.535 | 1.1e-47 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.517 | 0.344 | 0.454 | 1.4e-46 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.520 | 0.204 | 0.468 | 1.6e-46 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.413 | 0.154 | 0.503 | 1.8e-46 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.427 | 0.155 | 0.492 | 4.6e-46 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.520 | 0.203 | 0.463 | 8e-46 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.479 | 0.175 | 0.539 | 3.4e-44 |
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 1.1e-48, Sum P(2) = 1.1e-48
Identities = 93/176 (52%), Positives = 124/176 (70%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTW 83
K+E+FINE+V+ SQINH N+VKL+GCCLET K +HD++ + TW
Sbjct: 466 KMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTW 525
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
E++LRI+IE +G ++Y+H +AS PI+HRDIK+TNILLD+KY AKVS+FGTSRS +DQTH
Sbjct: 526 EVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTH 585
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+TT V GTFGY++P+ DV SFGVVLVEL+TG KP+ EE + +
Sbjct: 586 LTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGL 641
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 444 (161.4 bits), Expect = 1.4e-48, Sum P(2) = 1.4e-48
Identities = 95/176 (53%), Positives = 123/176 (69%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLET----------------KYMHDQNKELPFTW 83
+VE+FINEVV+ +QINH N+VKL+GCCLET K +HD++ + TW
Sbjct: 453 RVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTW 512
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
E++L I+IE +G +SYLH +AS PIYHRDIK+TNILLD++ AKVS+FGTSRS +DQTH
Sbjct: 513 EVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTH 572
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+TTQV GTFGY++P+ DV SFGVVLVELLTG KP EE++ +
Sbjct: 573 LTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGL 628
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 342 (125.4 bits), Expect = 1.9e-48, Sum P(3) = 1.9e-48
Identities = 69/131 (52%), Positives = 96/131 (73%)
Query: 70 KYMHDQ-NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
+++HD+ ++ + TW ++LRI+I+ +G +SYLH SAS PIYHRD+KSTNI+LD+KY AKV
Sbjct: 530 EHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKV 589
Query: 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
S+FGTSR+ VD TH+TT V GT GY++P+ DV SFGVVLVEL+TG K I
Sbjct: 590 SDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSI 649
Query: 178 RFTTFEEDKNI 188
F +E++ +
Sbjct: 650 SFLRSQENRTL 660
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 1.1e-47, Sum P(2) = 1.1e-47
Identities = 97/181 (53%), Positives = 124/181 (68%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLETK-----YMHDQNKEL-----------PFTW 83
KVE+FINEV + SQINH N+VKL+GCCLET+ Y H N +L TW
Sbjct: 458 KVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTW 517
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
+++LRIS+E +G ++YLH +AS P+YHRD+K+TNILLD+KY AKVS+FGTSRS VDQTH
Sbjct: 518 DVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTH 577
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAK 192
+TT V GTFGYL+P+ DV SFGVVLVEL+TG KP F+ ++N +
Sbjct: 578 LTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKP--FSVMRPEENRGLVS 635
Query: 193 H 193
H
Sbjct: 636 H 636
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 358 (131.1 bits), Expect = 1.4e-46, Sum P(3) = 1.4e-46
Identities = 80/176 (45%), Positives = 111/176 (63%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTW 83
+VE+FINEV++ SQINH NVVKL+GCCLET+ ++H TW
Sbjct: 145 QVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTW 204
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
E +L I+IE +G ++YLH AS+PI HRDIK+ NILLD+ AKV++FG S+ + +D+
Sbjct: 205 EHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQ 264
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+TT V GT GYL+P+ DV SFGVVL+EL++G K + F E K++
Sbjct: 265 LTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPETSKHL 320
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 374 (136.7 bits), Expect = 1.6e-46, Sum P(3) = 1.6e-46
Identities = 83/177 (46%), Positives = 114/177 (64%)
Query: 39 AKVEKFINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFT 82
++VE+FINEV++ SQINH NVVKL+GCCLET+ ++H + T
Sbjct: 444 SQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLT 503
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
WE +LRI+IE +GT++YLH AS+PI HRD+K+ NILLD+ AKV++FG SR +DQ
Sbjct: 504 WEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQE 563
Query: 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+TT V GT GYL+P+ DV SFGVVL+ELL+G K + F + K++
Sbjct: 564 QLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHL 620
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 1.8e-46, Sum P(3) = 1.8e-46
Identities = 66/131 (50%), Positives = 93/131 (70%)
Query: 70 KYMHDQNKELPFT-WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
+++HD + + T WE++LRI+++ +G +SYLH +AS PIYHRDIKSTNI+LD+K+ AKV
Sbjct: 516 EHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKV 575
Query: 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
S+FGTSR+ VD TH+TT V GT GY++P+ DV SFGVVL EL+TG K +
Sbjct: 576 SDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSV 635
Query: 178 RFTTFEEDKNI 188
F +E + +
Sbjct: 636 SFLRSQEYRTL 646
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 4.6e-46, Sum P(3) = 4.6e-46
Identities = 67/136 (49%), Positives = 94/136 (69%)
Query: 70 KYMHDQNKE-LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
K++H++ + W M+LRI+++ +G +SYLH SAS PIYHRDIKSTNILLD+KY AKV
Sbjct: 536 KHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKV 595
Query: 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
++FGTSRS +DQTH TT + GT GY++P+ DV SFGV+L EL+TG KP+
Sbjct: 596 ADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPV 655
Query: 178 RFTTFEEDKNITVAKH 193
++ + +A+H
Sbjct: 656 IMVQNTQEI-VALAEH 670
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 8.0e-46, Sum P(3) = 8.0e-46
Identities = 82/177 (46%), Positives = 114/177 (64%)
Query: 39 AKVEKFINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFT 82
++VE+FINEV++ SQINH NVVKL+GCCLET+ ++H + T
Sbjct: 446 SQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLT 505
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
WE +LR+++E +GT++YLH SAS+PI HRDIK+ NILLD+ AKV++FG SR +D+
Sbjct: 506 WEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKE 565
Query: 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+ T V GT GYL+P+ DV SFGVVL+ELL+G K + F + K+I
Sbjct: 566 DLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHI 622
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 3.4e-44, Sum P(2) = 3.4e-44
Identities = 89/165 (53%), Positives = 116/165 (70%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTW 83
K+E+FINEVVI SQINH +VVKL+GCCLET+ ++H+++ + TW
Sbjct: 488 KLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTW 547
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
M+LRI+++ +G +SYLH +AS PIYHRDIKSTNILLD+KY KVS+FGTSRS +D TH
Sbjct: 548 GMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTH 607
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
TT + GT GY++P+ DV SFGVVLVEL+TG KP+
Sbjct: 608 WTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPV 652
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005799001 | SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (970 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 288 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.001 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.002 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.002 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.003 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.004 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.004 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.004 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 67/232 (28%)
Query: 26 LGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGC- 65
LG+GG VY K +E+ + E+ I ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 66 ------CLETKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRD 112
L +Y + E + + LRI ++ + YLH S I HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 113 IKSTNILLD-DKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------D 159
+K NILLD D K+++FG S+ + + GT Y+ P+ D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 160 VCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEV 211
+ S GV+L EL E K++ ++ L +KRP+ KE+
Sbjct: 177 IWSLGVILYEL------------PELKDL-----IRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-25
Identities = 59/262 (22%), Positives = 94/262 (35%), Gaps = 77/262 (29%)
Query: 23 NRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINV 59
+ LG+G VYKG K +E+F+ E I +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 60 VKLIGCCLETK-------YM-----HD--QNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
VKL+G C E + YM + + L +++ + M YL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------- 158
HRD+ + N L+ + K+S+FG SR D + ++ P+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 159 ----DVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKH-------------------- 193
DV SFGV+L E+ T G +P + N V ++
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235
Query: 194 AKRCLNPSGKKRPAMKEVASEL 215
+C + RP E+ L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-24
Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 78/263 (29%)
Query: 23 NRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINV 59
+ LG+G VYKG K +E+F+ E I +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 60 VKLIGCCLETK-------YM-----HD---QNKELPFTWEMQLRISIEASGTMSYLHLSA 104
VKL+G C E + YM D +N+ + L +++ + M YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------ 158
S HRD+ + N L+ + K+S+FG SR D + ++ P+
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 159 -----DVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKHAK----------------- 195
DV SFGV+L E+ T G +P + N V ++ K
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235
Query: 196 ---RCLNPSGKKRPAMKEVASEL 215
+C + RP E+ L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-21
Identities = 62/275 (22%), Positives = 94/275 (34%), Gaps = 95/275 (34%)
Query: 24 RILGQG--GQDIVYKGMAK----------------------VEKFINEVVIQSQINHINV 59
+ LG+G G+ VYKG K + F+ E + ++ H NV
Sbjct: 1 KKLGEGAFGE--VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 60 VKLIGCCLE-------TKYM---------------HDQNKELPFTWEMQLRISIE-ASGT 96
V+L+G C E +YM ++ + + L +I+ A G
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG- 117
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ--------- 147
M YL S HRD+ + N L+ + K+S+FG SR D +
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 148 -----VHGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKH-------- 193
G F + DV SFGV+L E+ T GA P + N V ++
Sbjct: 175 APESLKDGIFTSKS--DVWSFGVLLWEIFTLGATP-----YPGLSNEEVLEYLRKGYRLP 227
Query: 194 ------------AKRCLNPSGKKRPAMKEVASELA 216
C + RP E+ L
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 70/258 (27%)
Query: 20 FNVNRILGQGGQDIVYKG--------------------MAKVEKFINEVVIQSQINHINV 59
+ + R LG G VYK K + E+ I +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 60 VKLIGCCLETKYMH-------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASV 106
V+LI + +++ ++ P + + +I+++ + YLH S
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SN 117
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP--------- 157
I HRD+K NILLD+ K+++FG ++ + +TT V GT Y+ P
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176
Query: 158 ---DDVCSFGVVLVELLTG--------------------AKPIRFTTFEEDKNITVAKH- 193
DV S GV+L ELLTG P+ F + AK
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 194 AKRCLNPSGKKRPAMKEV 211
K+CLN KRP +E+
Sbjct: 237 IKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 6e-21
Identities = 63/268 (23%), Positives = 101/268 (37%), Gaps = 88/268 (32%)
Query: 23 NRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQSQINHI 57
+ LG+G G+ VYKG K E+F+ E I +++H
Sbjct: 4 GKKLGEGAFGE--VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 58 NVVKLIGCCLE-------TKYM-----HD--QNKELPFTWEMQLRISIE-ASGTMSYLHL 102
N+V+L+G C + T+YM D + T + L+++++ A G M YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG-MEYLE- 119
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ--------------V 148
S HRD+ + N L+ + K+S+FG SR D +
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 149 HGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKHAK------------ 195
G F + DV SFGV+L E+ T G +P + N V + +
Sbjct: 178 DGKFTSKS--DVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 196 --------RCLNPSGKKRPAMKEVASEL 215
+C + RP E+ +L
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 6e-20
Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 61/242 (25%)
Query: 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVV 60
+ + LG+G VY K E+ + E+ I ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 61 KLIGCCLETKYMH---------------DQNKELPFTWEMQLR-ISIEASGTMSYLHLSA 104
+L + ++ + L E + R + + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS---EDEARFYLRQILSALEYLH--- 114
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------ 158
S I HRD+K NILLD+ K+++FG +R +D T GT Y+ P+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGL--ARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 159 -----DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVAS 213
D+ S GV+L ELLTG P F D + K+ P P +++
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLEL--FKKIGKPKPPFPPPEWDISP 225
Query: 214 EL 215
E
Sbjct: 226 EA 227
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 60/205 (29%)
Query: 24 RILGQGGQDIVYKGM--------------------AKVEKFINEVVIQSQINHINVVKLI 63
+LG+G VY + ++E E+ I S + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 64 GCCLETKYMH-----------------DQNKELPFTWEMQLRI---SIEASGTMSYLHLS 103
G + + + +LP E +R I G ++YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP---EPVIRKYTRQI-LEG-LAYLH-- 118
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA-VDQTHITTQVHGTFGYLNPD---- 158
S I HRDIK NIL+D K+++FG ++ ++ T V GT ++ P+
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 159 -------DVCSFGVVLVELLTGAKP 176
D+ S G ++E+ TG P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 56/218 (25%), Positives = 83/218 (38%), Gaps = 57/218 (26%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE----------------TKYMHDQNKE-LPFTWE 84
E +NEV I ++NH N++K E ++ + Q KE PF E
Sbjct: 44 EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE 103
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144
L ++ + YLH S I HRDIK NI L K+ +FG S+ +
Sbjct: 104 QILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160
Query: 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED------KN 187
T V GT YL+P+ D+ S G VL EL T P FE +
Sbjct: 161 KTVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP-----FEGENLLELALK 214
Query: 188 ITVAKHA--------------KRCLNPSGKKRPAMKEV 211
I ++ L ++RP++ ++
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 56/244 (22%), Positives = 84/244 (34%), Gaps = 71/244 (29%)
Query: 26 LGQGGQDIVYKGMAKVEKF------------------INEVVIQSQINHINVVKLIGC-- 65
+G+GG VYK K INE+ I + H N+VK G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 66 -------CLETKYMHD-------QNKELPFTWEMQLR-ISIEASGTMSYLHLSASVPIYH 110
+E + ++ T E Q+ + E + YLH S I H
Sbjct: 68 KKDELWIVME--FCSGGSLKDLLKSTNQTLT-ESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 111 RDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------D 159
RDIK+ NILL K+ +FG S + + T GT ++ P+ D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKAD 179
Query: 160 VCSFGVVLVELLTGAKPIR---------------FTTFEEDKNITVAKHA--KRCLNPSG 202
+ S G+ +EL G P + + K+CL +
Sbjct: 180 IWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239
Query: 203 KKRP 206
+KRP
Sbjct: 240 EKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 41/169 (24%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLETKYM-----------HD---QNKELPFT----W 83
++F+ E + +Q++H +V+LIG C M + +E+P +
Sbjct: 41 KEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL 100
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
Q+ A G M+YL V HRD+ + N+LL +++ AK+S+FG SR+ +
Sbjct: 101 AHQV-----AMG-MAYLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
Query: 144 ITTQVHGT-------------FGYLNPDDVCSFGVVLVELLT-GAKPIR 178
G + + DV S+GV L E + GAKP
Sbjct: 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 48/200 (24%)
Query: 24 RILGQGGQDIVYKGMAKV------------------EKFINEVVIQSQINHINVVKLIGC 65
+G+G VYKG+ K KF+ E I Q +H N+VKLIG
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 66 CLET-------KYM-------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHR 111
C++ + + + K+ T + L++S++A+ M YL S HR
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117
Query: 112 DIKSTNILLDDKYCAKVSNFGTSR---------SRAVDQTHI--TTQVHGTFG-YLNPDD 159
D+ + N L+ + K+S+FG SR S + Q I T +G Y + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 160 VCSFGVVLVELLT-GAKPIR 178
V S+G++L E + G P
Sbjct: 178 VWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 56/247 (22%), Positives = 90/247 (36%), Gaps = 69/247 (27%)
Query: 26 LGQGGQDIVYKGMAKV-----------------EKFINEVVIQSQINHINVVKLIGCCLE 68
+G+G VYK + E INE++I H N+V L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 69 -------TKYMH--------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDI 113
+YM QN + + E + YLH S + HRDI
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQN-FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 114 KSTNILLDDKYCAKVSNFG--TSRSRAVDQTHITTQVHGTFGYLNPD-----------DV 160
KS NILL K+++FG ++ + + + V GT ++ P+ D+
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRN--SVV-GTPYWMAPEVIKRKDYGPKVDI 199
Query: 161 CSFGVVLVELLTGA------KPIRFTTFEEDKNITVAKHAKR-----------CLNPSGK 203
S G++ +E+ G P+R K I K+ ++ CL +
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 204 KRPAMKE 210
KRP+ +E
Sbjct: 260 KRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-12
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 58/231 (25%)
Query: 38 MAKVEKFINEVVIQSQINHINVVKLIGCCLETK--------YMHD-------QNKELPFT 82
+ +VE+F+ E +I +H NV+ L+G CL ++ YM +++ T
Sbjct: 37 LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT 96
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
+ + ++ + M YL AS HRD+ + N +LD+ + KV++FG +R D+
Sbjct: 97 VKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARD-IYDKE 152
Query: 143 HITTQVHG---------------TFGYLNPDDVCSFGVVLVELLT-GAKPIR-FTTFEED 185
+ + H T + DV SFGV+L EL+T GA P +F+
Sbjct: 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-- 210
Query: 186 KNITVAKHAKR------------------CLNPSGKKRPAMKEVASELAGI 218
ITV R C +P + RP E+ S + I
Sbjct: 211 --ITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE-------TKYMHD--------QNKELPFTWEMQ 86
+ FI E + +++H N+V+L G C + T+YM + + K E
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWL 102
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
L + + M YL + + HRD+ + N L+ + KVS+FG +R DQ T
Sbjct: 103 LDMCSDVCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YT 156
Query: 147 QVHGT-------------FG-YLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAK 192
GT + + + DV SFGV++ E+ + K +E N V +
Sbjct: 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK----MPYERFSNSEVVE 212
Query: 193 HAKR--------------------CLNPSGKKRPAMKEVASELA 216
C + + RPA K++ S+L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 60/232 (25%), Positives = 88/232 (37%), Gaps = 58/232 (25%)
Query: 20 FNVNRILGQGG-----------------------QDIVYKGMAKVEKFINEVVIQSQINH 56
F + R++G+G Q V KG V +NE I ++NH
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG--SVRNVLNERRILQELNH 59
Query: 57 INVVKLIGCCLETKYM--------------HDQNKELPFTWEMQLRISI-EASGTMSYLH 101
+V L + + M H K F+ E Q++ I E + YLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV-KFS-EEQVKFWICEIVLALEYLH 117
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPDDVC 161
S I HRDIK NILLD++ +++F + D +TT GT GY+ P+ +C
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLC 172
Query: 162 -----------SFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSG 202
S GV E L G +P R + I + L P+
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 63.6 bits (153), Expect = 2e-11
Identities = 58/257 (22%), Positives = 90/257 (35%), Gaps = 63/257 (24%)
Query: 19 SFNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQSQINHIN-- 58
S+ + R LG+G VY +VE+F+ E+ I + +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 59 ---------------VVKLIGCCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLS 103
V++ + + ++ P + L I + + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118
Query: 104 ASVPIYHRDIKSTNILLDDKYC-AKVSNFGTSRSRAVDQTHITTQ-----VHGTFGYLNP 157
S I HRDIK NILLD K+ +FG ++ + + GT GY+ P
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 158 D--------------DVCSFGVVLVELLTGAKP-----IRFTTFEEDKNITVAKHAKRCL 198
+ D+ S G+ L ELLTG P T + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 199 NPSGKKRPAMKEVASEL 215
S + + AS+L
Sbjct: 238 PLSPSNPELISKAASDL 254
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 52/204 (25%)
Query: 20 FNVNRILGQGGQDIVYKGMAKVEK--------------------FINEVVIQSQINHINV 59
F + +G+G +V+K + K +K I+E + ++++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 60 VKLIGCCLET----------------KYMHDQNKELPFTWEMQLRISIEASGTMSYLHLS 103
++ L+ K + Q P + R I+ +++LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLH-- 118
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S I HRDIKS N+ LD K+ + G ++ + D T+ + GT YL+P+
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 159 ------DVCSFGVVLVELLTGAKP 176
DV + GVVL E TG P
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 62/207 (29%)
Query: 23 NRILGQGGQDIVYKGM----------------------AKVEKFINEVVIQSQINHINVV 60
R +G+G VY+G+ + EKF+ E I Q +H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 61 KLIGCCLET---------------KYMHDQNKELPFTWEMQLRI----SIEASGTMSYLH 101
KLIG E Y+ NK + L S + S ++YL
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYL-QVNKY-----SLDLASLILYSYQLSTALAYLE 124
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--- 158
S HRDI + N+L+ C K+ +FG SR + + ++ ++ P+
Sbjct: 125 ---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 159 --------DVCSFGVVLVELLT-GAKP 176
DV FGV + E+L G KP
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 55/223 (24%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLE-------TKYMHDQN--------KELPFTWEM 85
+ F+ E + + + H N+V+L+G L+ T+YM + T
Sbjct: 44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ 103
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
QL +++ M YL HRD+ + N+L+ + AKVS+FG ++ + Q
Sbjct: 104 QLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160
Query: 146 TQV---------HGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKHAK 195
V F DV SFG++L E+ + G P ++ V H +
Sbjct: 161 LPVKWTAPEALREKKFS--TKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVE 213
Query: 196 R--------------------CLNPSGKKRPAMKEVASELAGI 218
+ C KRP K++ +LA I
Sbjct: 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 50/204 (24%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKVE------KFIN---EVVIQSQI----------NHIN 58
++LGQG +VYK K K I+ + + Q+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 59 VVKLIGC-------CLETKYM-----HDQNKELPFTWEMQL-RISIEASGTMSYLHLSAS 105
VVK G + +YM D K++ E L I+ + + YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSR--SRAVDQTHITTQVHGTFGYLNPD----- 158
I HRDIK +N+L++ K K+++FG S+ +DQ + T V GT Y++P+
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGE 175
Query: 159 ------DVCSFGVVLVELLTGAKP 176
D+ S G+ L+E G P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 61/214 (28%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGMAKVEKFI--------------------NEVVIQ 51
E EK +NRI G+G IVY+ I E+ +
Sbjct: 8 EFEK------LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLL 60
Query: 52 SQINHINVVKL----IGCCLETKYM------HD-----QNKELPFTWEMQLR-ISIEASG 95
+ H N+V+L +G L++ ++ D N PF+ E Q++ + ++
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS-ESQVKCLMLQLLR 119
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
+ YLH + I HRD+K +N+LL DK C K+++FG +R+ + +T +V T Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175
Query: 156 NPD------------DVCSFGVVLVELLTGAKPI 177
P+ D+ + G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 54/213 (25%)
Query: 20 FNVNRILGQGGQDIVYK------------------GMAKVEKF--INEVVIQSQINHINV 59
F V + LG+G VYK M++ E+ +NE+ I + +NH N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 60 VK-----LIGC--CLETKYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHL 102
+ L G C+ +Y + K + RI I+ + LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158
I HRD+KS NILL K+ + G S+ + + TQ+ GT Y+ P+
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGI--SKVLKKNMAKTQI-GTPHYMAPEVWKG 175
Query: 159 -------DVCSFGVVLVELLTGAKPIRFTTFEE 184
D+ S G +L E+ T A P + ++
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 62/253 (24%), Positives = 104/253 (41%), Gaps = 66/253 (26%)
Query: 25 ILGQGGQDIVYKGMAKVE------------------KFINEVVIQSQINHINVVKLIGCC 66
+LG+G V+KG K + KF++E I Q +H N+VKLIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 67 LETK----------------YMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYH 110
+ + ++ + EL + ++ +++A+ M+YL + H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI---H 116
Query: 111 RDIKSTNILLDDKYCAKVSNFGTSR--------SRAVDQTHI--TTQVHGTFG-YLNPDD 159
RD+ + N L+ + K+S+FG SR S + Q I T +G Y + D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 160 VCSFGVVLVELLT-GAKPIRFTTFEEDKNIT---------------VAKHAKRCLNPSGK 203
V S+G++L E + G P T ++ + V K +RC + +
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236
Query: 204 KRPAMKEVASELA 216
RP E+ ELA
Sbjct: 237 NRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 38/167 (22%), Positives = 61/167 (36%), Gaps = 37/167 (22%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETKYM---------------HDQNKELPFTWEM 85
++ F+ E I ++H N+++L G L M F
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALG-HFLIST 98
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
+++ + M YL HRD+ + NILL K+ +FG R+ ++ H
Sbjct: 99 LCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155
Query: 146 TQVH---------------GTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+ H TF + DV FGV L E+ T G +P
Sbjct: 156 MEEHLKVPFAWCAPESLRTRTFS--HASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 1e-10
Identities = 58/202 (28%), Positives = 84/202 (41%), Gaps = 42/202 (20%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCCLETK---YM---HDQNKELPFTWEMQLRISIEA 93
+VE + E I S+INH +VKL +T+ Y+ + EL + R S E
Sbjct: 36 EVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER 94
Query: 94 SG--------TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
+ + YLH S+ I +RD+K NILLD K+++FG ++ + + +
Sbjct: 95 ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151
Query: 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA 194
T GT YL P+ D S GV+L E+LTG P F ED+ K
Sbjct: 152 TFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP--FYA--EDRKEIYEKIL 206
Query: 195 KRCLNPSGKKRPAMKEVASELA 216
K E S A
Sbjct: 207 --------KDPLRFPEFLSPEA 220
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 62/273 (22%), Positives = 95/273 (34%), Gaps = 83/273 (30%)
Query: 11 NELEKATDSFNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQS 52
E E D +LG+G IVY V+ E+ + S
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 53 QINHINVVKLIGCCLETKY-----------------------MHDQNKELPFTWEMQLRI 89
+ H N+V+ +G E + + D + + F + L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTSRSRA----VDQTH 143
+ YLH I HRDIK N+L++ Y K+S+FGTS+ A +T
Sbjct: 120 ------GLKYLH---DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETF 169
Query: 144 ITT------QV--HGTFGYLNPDDVCSFGVVLVELLTGAKP-----------IRFTTFEE 184
T +V G GY P D+ S G +VE+ TG P + F+
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229
Query: 185 DKNITVAKHAK------RCLNPSGKKRPAMKEV 211
I + A+ RC P KR + ++
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 9e-10
Identities = 56/209 (26%), Positives = 81/209 (38%), Gaps = 67/209 (32%)
Query: 24 RILGQG--GQDIVYKGMAKV--------------EK------FINEVVIQSQINHINVVK 61
+G+G GQ VYK K EK I E+ + ++ H N+V+
Sbjct: 5 AQIGEGTYGQ--VYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 62 LIGCCLETK---------YM-HD-----QNKELPFT------WEMQLRISIEASGTMSYL 100
L YM HD + E+ FT + QL G + YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL-----LEG-LQYL 116
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-- 158
H + I HRDIK +NIL+++ K+++FG +R + T T Y P+
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 159 ----------DVCSFGVVLVELLTGAKPI 177
D+ S G +L EL G KPI
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 38/164 (23%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRI 89
F+ E I Q +H N+++L G + T+YM + + + FT + +
Sbjct: 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 90 --SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHIT- 145
I ASG M YL V HRD+ + NIL++ KVS+FG SR + T+ T
Sbjct: 112 LRGI-ASG-MKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 146 ------------TQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+ F + DV SFG+V+ E+++ G +P
Sbjct: 167 GGKIPIRWTAPEAIAYRKFT--SASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (139), Expect = 2e-09
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 44/165 (26%)
Query: 45 INEVVIQSQINHINVVKLIG-CCLETK--------------YMHDQNKELP------FTW 83
+ E+ + ++ H N+VKL+ E K Y+ + L +
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMY 105
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
QL + ++Y H S I HRD+K NIL++ K+++FG +R+ +
Sbjct: 106 --QL---LRG---LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154
Query: 144 ITTQVH-----------GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
T +V G+ Y D+ S G + E++TG KP+
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 54/204 (26%)
Query: 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINV 59
+ + ++G+G +VYKG+ ++ + E+ + + H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 60 VKLIGCCLETKYMHDQNKELPFTWEMQLRISIEASGTMS----------------YLHLS 103
VK IG + ++ L + LR I+ G YLH
Sbjct: 62 VKYIGSIETSDSLY---IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
+ HRDIK+ NIL K+++FG + ++ D + V GT ++ P+
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 159 ------DVCSFGVVLVELLTGAKP 176
D+ S G ++ELLTG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 30 GQDIVYKGM---AKVEKFINEVVIQSQINHINVVKLIGCCLE---------------TKY 71
GQ + K + + F+ E + ++++H N+V+L+G L +
Sbjct: 29 GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNF 88
Query: 72 MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131
+ + + L ++ L+ S++ + M YL S + HRD+ + NIL+ + AKVS+F
Sbjct: 89 LRTRGRALVSVIQL-LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF 144
Query: 132 GTSR--SRAVDQTHITTQ-------VHGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTT 181
G +R S VD + + + H F + DV S+GV+L E+ + G P +
Sbjct: 145 GLARVGSMGVDNSKLPVKWTAPEALKHKKFS--SKSDVWSYGVLLWEVFSYGRAPYPKMS 202
Query: 182 FEEDKNI---------------TVAKHAKRCLNPSGKKRPAMKEVASELA 216
+E K V C KKRP+ ++ +L
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 59/207 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVK 61
+ F++ LG+G VYK + K +++ I E+ I Q + +VK
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 62 LIGCCLETKYMHDQNKELPFTWE----------MQLR--------ISIEASGT---MSYL 100
G Y +N +L E M++ I+ T + YL
Sbjct: 63 YYGS-----YF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT--------- 151
H S HRDIK+ NILL+++ AK+++FG S + D V GT
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 152 --FGYLNPDDVCSFGVVLVELLTGAKP 176
GY N D+ S G+ +E+ G P
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 50/228 (21%)
Query: 32 DIVYKGMAKVEK--FINEVVIQSQINHINVVKLIGCCLETK------YM----------- 72
+I Y M + EK ++EV I ++ H N+V+ ++ M
Sbjct: 32 EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL 91
Query: 73 --HDQNKELPFTWEMQLRISIEASGTMSYLH--LSASVPIYHRDIKSTNILLDDKYCAKV 128
+ + E RI + + H + HRD+K NI LD K+
Sbjct: 92 IQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151
Query: 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
+FG ++ D + T V GT Y++P+ D+ S G ++ EL + P
Sbjct: 152 GDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
Query: 178 RFTTFEE-DKNITVAKHA--------------KRCLNPSGKKRPAMKE 210
+ I K K LN KRP+ +E
Sbjct: 211 TARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 30/154 (19%)
Query: 45 INEVVIQSQINHINVVKLIGCCL-------ETKY--------MHDQNKELPFTWEMQLRI 89
+NE+VI S + H N++ + E +Y + K F EM L
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
+ +SY+H I HRDIK+ NI L K+ +FG S+ + + T V
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV- 162
Query: 150 GTFGYLNPD-----------DVCSFGVVLVELLT 172
GT Y++P+ D+ + G VL ELLT
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 15/112 (13%)
Query: 76 NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
+KE+ FT E E + + +LH S+ I +RD+K NILLD++ K+++FG S+
Sbjct: 90 SKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
Query: 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
++D GT Y+ P+ D SFGV++ E+LTG+ P
Sbjct: 147 -ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 40/182 (21%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE-------TKYMH--DQNKELP-------------- 80
F+ E+ I S++ + N+++L+G C+ T+YM D N+ L
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 81 --FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-- 136
+ L ++++ + M YL AS+ HRD+ + N L+ + Y K+++FG SR+
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 137 ---------RAVDQTHITTQVHGTFG-YLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDK 186
RAV G + DV +FGV L E+ T K ++ +++
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 187 NI 188
I
Sbjct: 241 VI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 47/163 (28%), Positives = 68/163 (41%), Gaps = 45/163 (27%)
Query: 47 EVVIQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEMQLRISIEA------------- 93
E+ I +NH NVVK C + M D N E+ E S+E
Sbjct: 122 EIEILRDVNHPNVVK----CHD---MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA 174
Query: 94 ----SGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
SG ++YLH I HRDIK +N+L++ K+++FG SR A + V
Sbjct: 175 RQILSG-IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 150 GTFGYLNPD----------------DVCSFGVVLVELLTGAKP 176
GT Y++P+ D+ S GV ++E G P
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 59/222 (26%)
Query: 43 KFINEVVIQSQINHINVVKLIGCC---------------------LETKYMHDQNKELPF 81
KF+ E I Q +H N+V+LIG C L T+ + KEL
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-- 96
Query: 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA--- 138
+++ A+ M YL + HRD+ + N L+ +K K+S+FG SR
Sbjct: 97 -----IQMVENAAAGMEYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148
Query: 139 ------VDQTHI--TTQVHGTFG-YLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKNI 188
+ Q + T +G Y + DV SFG++L E + GA P + ++ +
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 189 T---------------VAKHAKRCLNPSGKKRPAMKEVASEL 215
V + +RC +RP+ V EL
Sbjct: 209 IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 38/172 (22%)
Query: 34 VYKGMAKVEKFINEVVIQSQINHINVVKLIGCCLE----------------TKYMHDQNK 77
+ +G E FI E + +++H +V+L G C E + Y+ Q
Sbjct: 36 IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG 95
Query: 78 ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137
+ F+ E L + ++ M+YL S + HRD+ + N L+ + KVS+FG +R
Sbjct: 96 K--FSQETLLGMCLDVCEGMAYLESSNVI---HRDLAARNCLVGENQVVKVSDFGMTRFV 150
Query: 138 AVDQTHITTQVHGT-------------FG-YLNPDDVCSFGVVLVELLTGAK 175
DQ T GT F Y + DV SFGV++ E+ + K
Sbjct: 151 LDDQ---YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 53/177 (29%), Positives = 75/177 (42%), Gaps = 50/177 (28%)
Query: 39 AKVEKFINEVVIQSQINHINVVK------------LI------GCCLE---TKYMHDQNK 77
V++ EV SQ NH NVVK L+ G L+ + Y
Sbjct: 41 TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD 100
Query: 78 ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS--- 134
E L+ ++ + YLH + + HRDIK+ NILL + K+++FG S
Sbjct: 101 E--AIIATVLKEVLKG---LEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASL 152
Query: 135 -----RSRAVDQTHITT----------QVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
R+R V +T + T QVH GY D+ SFG+ +EL TGA P
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVH---GYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 21/122 (17%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I +RDIK NILLD + +++FG S+ ++ GT Y+ P+
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 159 ----DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214
D S GV+ ELLTGA P FT + + + ++ ++R L K +P + S
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP--FTV--DGEQNSQSEISRRIL----KSKPPFPKTMSA 237
Query: 215 LA 216
A
Sbjct: 238 EA 239
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 19/96 (19%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-----GT 151
++YLH + I HRDIK NIL+D+K K+S+FG S+ + T G+
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
++ P+ D+ S G ++VE+LTG P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 68/210 (32%)
Query: 24 RILGQGGQDIVYKGMAKVEK-----------------------FINEVVIQSQINHINVV 60
++LG G VYKG+ E ++E + + ++H +VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 61 KLIGCCLETK---------------YMHDQNKELP----FTWEMQLRISIEASGTMSYLH 101
+L+G CL ++ Y+ + + W +Q+ A G MSYL
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI-----AKG-MSYLE 126
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--------------ITTQ 147
V HRD+ + N+L+ K+++FG ++ VD+ + +
Sbjct: 127 EKRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+H + + + DV S+GV + EL+T GAKP
Sbjct: 184 LHRIYTHKS--DVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 38/168 (22%)
Query: 40 KVEKFINEVVIQSQINHINVVKLIGCC-------LETKYMHDQN----------KELPFT 82
+VE+F+ E + +I H N+V+L+G C + T++M N +E+
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 104
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
+ + I +S M YL + HRD+ + N L+ + + KV++FG SR D
Sbjct: 105 VLLYMATQI-SSA-MEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 158
Query: 143 HITTQVHGTF--GYLNPD-----------DVCSFGVVLVELLT-GAKP 176
T F + P+ DV +FGV+L E+ T G P
Sbjct: 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 53/247 (21%), Positives = 88/247 (35%), Gaps = 70/247 (28%)
Query: 36 KGMAKVE--KFINEVVIQSQINHINVVKLIGCCLET----------KY------------ 71
+ + E ++E + Q+NH +V+KL G C + KY
Sbjct: 40 ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRK 99
Query: 72 ---------------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116
D E T + + + S M YL A + + HRD+ +
Sbjct: 100 VGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAAR 156
Query: 117 NILLDDKYCAKVSNFGTSRSRAVDQTHITTQ----------VHGTFG--YLNPDDVCSFG 164
N+L+ + K+S+FG SR + +++ + F Y DV SFG
Sbjct: 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216
Query: 165 VVLVELLT-------GAKPIRFTTF-------EEDKNITVAKHA--KRCLNPSGKKRPAM 208
V+L E++T G P R E +N + + C KRP
Sbjct: 217 VLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 209 KEVASEL 215
+++ EL
Sbjct: 277 ADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 47/175 (26%), Positives = 68/175 (38%), Gaps = 43/175 (24%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLET-------KYMH--DQNKEL------------- 79
+ F E + + H N+VK G C E +YM D NK L
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 80 -----PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134
T L+I+++ + M YL AS HRD+ + N L+ K+ +FG S
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 135 RS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
R D + ++ P+ DV SFGVVL E+ T G +P
Sbjct: 170 RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 42/163 (25%)
Query: 44 FINEVVIQSQINHINVVKLIGCC---------LETKYM-----------HDQNKELPFTW 83
F E+ I ++H N+VK G C L +Y+ H L
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--- 109
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
L S + M YL S HRD+ + NIL++ + K+S+FG ++ D+ +
Sbjct: 110 -RLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165
Query: 144 ITTQVHG---TFGYLNPD-----------DVCSFGVVLVELLT 172
+ G F Y P+ DV SFGV L EL T
Sbjct: 166 YYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 34/94 (36%), Positives = 45/94 (47%), Gaps = 21/94 (22%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD-QTHITTQVHGTFGYLNPD-------- 158
+ HRD+K +NILLD K+ +FG S R VD + T+ G Y+ P+
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGIS-GRLVDSKAK--TRSAGCAAYMAPERIDPPDPN 192
Query: 159 -------DVCSFGVVLVELLTGAKPIRF--TTFE 183
DV S G+ LVEL TG P + T FE
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 17/94 (18%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR-SRAVDQTHITTQVHGTFGYL 155
++YLH S I HRD+K+ N+L+D K+S+FG S+ S + + G+ ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 156 NPD-------------DVCSFGVVLVELLTGAKP 176
P+ D+ S G V++E+ G +P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 44/211 (20%), Positives = 73/211 (34%), Gaps = 75/211 (35%)
Query: 26 LGQGGQDIVYKGM------------AKVEKF-----------INEVVIQSQINHINVVKL 62
LG+G +VYK K+ + + E+ + ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 63 IGCCLETKYMHDQN------------------KELPFT------WEMQLRISIEASGTMS 98
+ + H N K + T + + +E
Sbjct: 68 LDV-----FGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE------ 116
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YLH + I HRD+K N+L+ K+++FG +RS +T QV T Y P+
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 159 ------------DVCSFGVVLVELLTGAKPI 177
D+ S G + ELL P
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 50/182 (27%), Positives = 73/182 (40%), Gaps = 63/182 (34%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE-------TKYMH--DQN---------------- 76
E F+ EV I S+++ N+ +L+G C +YM D N
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 77 -KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
K L F+ + + I ASG M YL S+ HRD+ + N L+ Y K+++FG SR
Sbjct: 124 SKSLSFSTLLYMATQI-ASG-MRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 136 S-----------RA-----------VDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLTG 173
+ RA V TT+ DV +FGV L E+LT
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK----------SDVWAFGVTLWEILTL 228
Query: 174 AK 175
+
Sbjct: 229 CR 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 54/236 (22%)
Query: 28 QGGQDIVYK----GMAKVEKFINEVVIQSQINHINVVKLIGCCLE-------TKYMHDQN 76
+G D+ K G ++FI E + +++H +V+L G C + T+YM +
Sbjct: 26 RGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN-G 84
Query: 77 KELPFTWEMQ--------LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
L + E L + + M+YL S HRD+ + N L+DD+ C KV
Sbjct: 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKV 141
Query: 129 SNFGTSRSRAVDQTHITTQVHGTF-------------GYLNPDDVCSFGVVLVELLT-GA 174
S+FG SR D+ T+ V F + + DV +FGV++ E+ + G
Sbjct: 142 SDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
Query: 175 KPI-RFTTFEEDKNITVAKHAKR--------------CLNPSGKKRPAMKEVASEL 215
P RF E + ++ R C + ++RP +++ S +
Sbjct: 200 MPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-08
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 34/175 (19%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQL 87
E FI E + +++H +V+L G C + T++M + + ++ + +M L
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL 103
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT- 146
+ + M YL ++ + HRD+ + N L+ KVS+FG +R +D + ++
Sbjct: 104 SMCQDVCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSS 159
Query: 147 -----------QVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITV 190
+V Y + DV SFGV++ E+ T K FE+ N V
Sbjct: 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK----MPFEKKSNYEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 31/164 (18%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQL 87
VE E+ + +++NH ++++++G E + H +K F + +
Sbjct: 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII 106
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQT---H 143
+ + +SYLH + I HRD+K N+L+D ++++FG + A T
Sbjct: 107 NYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
Q+ GT ++ P+ DV S G V++E+ T P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 44/157 (28%), Positives = 66/157 (42%), Gaps = 30/157 (19%)
Query: 46 NEVVIQSQINHINVVKLIGC-------CLETKYM-----HDQNKEL-PFTWEMQLRISIE 92
E+ + + H +V+ GC + +YM DQ K T + + + +
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ 112
Query: 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT--TQVHG 150
+ YLH S I HRDIK NIL D K+ +FG S+ + T V G
Sbjct: 113 ILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 151 TFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
T +++P+ DV S G +VE+LT KP
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 46/146 (31%), Positives = 67/146 (45%), Gaps = 25/146 (17%)
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
E+Q+ E + +LH + I +RDIK NILLD +++FG S+ D+
Sbjct: 106 EVQIYSG-EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 144 ITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITV 190
GT Y+ PD D S GV++ ELLTGA P T + +KN +
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKN-SQ 217
Query: 191 AKHAKRCLNPSGKKRPAMKEVASELA 216
A+ ++R L K P + S LA
Sbjct: 218 AEISRRIL----KSEPPYPQEMSALA 239
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 49/169 (28%)
Query: 46 NEVVIQSQINHINVVKLIGC-------------C--------LETKYMHDQNKELPFTWE 84
+E+ + + H N+VK G C LE + D++ +T
Sbjct: 48 DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT-- 105
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144
+QL + YLH S I HRDIK NI LD K+ +FG + + T +
Sbjct: 106 LQLLEGLA------YLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
Query: 145 TTQVHGTFG---YLNP--------------DDVCSFGVVLVELLTGAKP 176
+V G Y+ P D+ S G V++E+ TG +P
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 57/222 (25%)
Query: 41 VEKFINEV-VIQSQINHINVVK----------------LI-GCCLETKYMHDQNKELPFT 82
+ ++EV +I+ Q+ H N+V+ LI G L + + K+ FT
Sbjct: 52 IGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
E I ++ + YLH I HRD+ NI+L + +++FG ++ + +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVE------------LLTGA----- 174
T V GT Y P+ DV +FG +L + +L+ A
Sbjct: 170 --LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 175 ---KPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVAS 213
+P+ + ED + CL P + RP + +V++
Sbjct: 228 AVYEPLPEGMYSEDVTDVI----TSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 28/159 (17%)
Query: 36 KGMAKVEKFINEVVIQSQINHINVVKLIGCCLETK-----------------YMHDQNKE 78
K A + F+ E + +Q+ H N+V+L+G +E K Y+ + +
Sbjct: 38 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 97
Query: 79 LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138
+ + L+ S++ M YL + V HRD+ + N+L+ + AKVS+FG ++ +
Sbjct: 98 V-LGGDCLLKFSLDVCEAMEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS 153
Query: 139 VDQTHITTQVHGTFG-------YLNPDDVCSFGVVLVEL 170
Q V T + DV SFG++L E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 47/221 (21%), Positives = 76/221 (34%), Gaps = 70/221 (31%)
Query: 20 FNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINH 56
+ +ILG+G V +G +E+F++E +H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 57 INVVKLIGCCLETKYMHDQNKE------LPF----------------------TWEMQLR 88
NV+KLIG C E K LPF + L+
Sbjct: 61 PNVMKLIGVCFE---ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS----RAVDQTHI 144
++ + M YL ++ HRD+ + N +L + V++FG S+ Q I
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 145 TT--------QVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+ Y + DV +FGV + E+ T G P
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 50/201 (24%), Positives = 78/201 (38%), Gaps = 53/201 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGM----------------AKVEKFINEVVIQSQINHINVVK 61
+S + R LG G V+ G E F+ E I ++ H +V+
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 62 LIGCCLE-------TKYM----------HDQNKELPFTWEMQLRISIEASGTMSYLHLSA 104
L C E T+YM + K+L + + I A G M+YL
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI-AEG-MAYLE--- 120
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-------------THITTQVHGT 151
S HRD+ + NIL+ + K+++FG +R D+ T +G
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR 180
Query: 152 FGYLNPDDVCSFGVVLVELLT 172
F DV SFG++L E++T
Sbjct: 181 FTI--KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 36/120 (30%), Positives = 57/120 (47%), Gaps = 16/120 (13%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I +RDIK NILLD + +++FG S+ ++ T GT Y+ P+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215
D S G+++ ELLTGA P T E ++N T ++ ++R L + A +L
Sbjct: 186 KAVDWWSLGILIFELLTGASPF---TLEGERN-TQSEVSRRILKCDPPFPSFIGPEAQDL 241
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 45/177 (25%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLETK------------------YMHDQNKELPFTW 83
++F E + S + H N+V L+G C + + + + ++
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 84 EMQ-----------LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132
+ L I+I+ + M YL +S HRD+ + N L+ + K+S+FG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 133 TSR-----------SRAVDQTHITTQVHGTFGYLNPD-DVCSFGVVLVELLT-GAKP 176
SR S+++ +G + D+ SFGVVL E+ + G +P
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 29/163 (17%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCC--------LETKYMHDQNKELPFTWEMQLRISIE- 92
++ + E + Q+++ +V++IG C +E + NK L + + E
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL 100
Query: 93 ---ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
S M YL + V HRD+ + N+LL ++ AK+S+FG S++ D+ + + H
Sbjct: 101 VHQVSMGMKYLEETNFV---HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157
Query: 150 GT-------------FGYLNPDDVCSFGVVLVELLT-GAKPIR 178
G + + + DV SFGV++ E + G KP +
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 53/223 (23%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE----------------------TKYMHDQNKELPF 81
F E+ + +++H NVV+L+G C E TK ++ K P
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141
+ + ++ + + + M +L ++ HRD+ + N L+ + KVS S+ +
Sbjct: 115 STKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTFEEDKNIT 189
+ +L P+ DV SFGV++ E+ T G P + EE N
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
Query: 190 VAKHAK----------------RCLNPSGKKRPAMKEVASELA 216
A + RC + K RP+ E+ S L
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 64/204 (31%)
Query: 26 LGQGGQDIVYKGMAKV-----------EKF---------INEVVIQSQINHINVVKLI-- 63
+G+G +VYK K+ +F + E+ + ++NH N++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 64 -----GCCLETKYMH--------DQNKELP------FTWEMQLRISIEASGTMSYLHLSA 104
L ++M D+ + LP + +++ L+ +++ H
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCH--- 115
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV-----------HGTFG 153
S I HRD+K N+L++ + K+++FG +RS T V G G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 154 YLNPDDVCSFGVVLVELLTGAKPI 177
Y P D+ S G + ELL+ +P+
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 58/211 (27%)
Query: 26 LGQGGQDIVYKG----------MAKVE----------KFINEVVIQSQINHINVVKLIGC 65
+G+G +VYKG M K+ I E+ + ++ H N+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV----- 62
Query: 66 CLETKYMHDQNKELPFTW-EMQLRI---SIEASGTM------SYLH--LSA-----SVPI 108
CL+ M + L F + M L+ S+ M SYL+ L S +
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV-----------HGTFGYLNP 157
HRD+K N+L+D+K K+++FG +R+ + T +V G+ Y P
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 158 DDVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
D+ S G + E+ T KP+ F D I
Sbjct: 183 VDIWSIGTIFAEMAT-KKPL----FHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 16/90 (17%)
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-- 158
+L + I HRD+K +NILLD K+ +FG S + VD T G Y+ P+
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSIAKTRDA-GCRPYMAPERI 179
Query: 159 ------------DVCSFGVVLVELLTGAKP 176
DV S G+ L E+ TG P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 62/265 (23%), Positives = 100/265 (37%), Gaps = 83/265 (31%)
Query: 24 RILGQGGQDIVYKGM------------------------AKVEKFINEVVIQSQINHINV 59
++LG G VYKG+ A VE F++E +I + ++H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71
Query: 60 VKLIGCCLET---------------KYMHDQN----KELPFTWEMQLRISIEASGTMSYL 100
V+L+G CL Y+H+ +L W +Q+ A G M YL
Sbjct: 72 VRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-----AKGMM-YL 125
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ------------- 147
V HRD+ + N+L+ K+++FG +R D+
Sbjct: 126 EERRLV---HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKN---------------ITVA 191
+H + + DV S+GV + EL+T G KP E + I V
Sbjct: 183 IHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241
Query: 192 KHAKRCLNPSGKKRPAMKEVASELA 216
+C RP KE+A+E +
Sbjct: 242 MVMVKCWMIDADSRPKFKELAAEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 39/147 (26%), Positives = 57/147 (38%), Gaps = 37/147 (25%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR----SRAVDQTHITTQVH---GT 151
YLH S I HRD+K NIL+D K+++FG S+ R ++ + GT
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDK 186
Y+ P+ D S G +L E L G P T + ED
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV 224
Query: 187 NIT-VAKHA-KRCLNPSGKKRPAMKEV 211
++ A + L P +KR K +
Sbjct: 225 EVSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 30/154 (19%)
Query: 47 EVVIQSQINHINVVKLI-------GCCLETKYMHD------QNKELPFTWEMQLR-ISIE 92
E+ H VVKL+ G L +YM +++E P E Q++
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLP-EAQVKSYMRM 107
Query: 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152
++Y+H + I HRD+K N+L+ K+++FG +R + ++ + + T
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 153 GYLNPD------------DVCSFGVVLVELLTGA 174
Y P+ D+ + G + ELL G+
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS--R 137
P E+ +I++ ++YL+ I HRDIK +NIL++ + K+ +FG S
Sbjct: 99 PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156
Query: 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
++ T + GT Y++P+ DV S G+ ++EL G P F D
Sbjct: 157 SIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP--FAFSNIDD 209
Query: 187 NITVA 191
+
Sbjct: 210 DGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 32/165 (19%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE----TKYMH---------DQNKELPFTWEMQLR 88
EK EV + + H+N+V+ +G CL+ + +M N+ P + +
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA-----VDQTH 143
+ + ++YLH + V HRDIK N++L K+ +FG +R A ++
Sbjct: 107 YTKQILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
+ +HGT ++ P+ D+ S G + E+ TG P+
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 33/111 (29%)
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---------SRAVDQTHITTQV 148
YLH S I HRD+K NILLD K+++FGT++ S D T+I +Q+
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 149 H----------GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR 178
GT Y++P+ D+ + G ++ ++LTG P R
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 59/206 (28%)
Query: 24 RILGQGGQDIVYKGMAKV------------------EK----FINEVVIQSQINHINVVK 61
+++G G V++G+ K+ EK F++E I Q +H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 62 LIGCCLETK----------------YMHDQNKEL-PFTWEMQLRISIEASGTMSYLHLSA 104
L G + K Y+ D + E + LR I A M YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAG--MKYL---S 124
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
+ HRD+ + NIL++ KVS+FG SR D T G
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 153 -GYLNPDDVCSFGVVLVELLT-GAKP 176
+ + DV SFG+V+ E+++ G +P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 21/106 (19%)
Query: 91 IEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG 150
+ A YLH + I +RD+K N+LLD K+ +FG ++ Q T G
Sbjct: 103 VLA---FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCG 154
Query: 151 TFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED 185
T Y+ P+ D S G++L ELLTG P F +ED
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP--FGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 38/166 (22%), Positives = 77/166 (46%), Gaps = 34/166 (20%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCC--------LE-------TKYMHDQNKELPFTWEMQ 86
++ + E I Q+++ +V++IG C +E K++ + E+ + ++
Sbjct: 40 DEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVE 99
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
L + S M YL V HRD+ + N+LL +++ AK+S+FG S++ D ++
Sbjct: 100 LMHQV--SMGMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154
Query: 147 QVHGTF-------------GYLNPDDVCSFGVVLVELLT-GAKPIR 178
+ G + + + DV S+G+ + E + G KP +
Sbjct: 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 47/176 (26%), Positives = 67/176 (38%), Gaps = 48/176 (27%)
Query: 37 GMAKVEKFINEVVIQSQINHINVVKLIGCCLET------------------KYMHDQNKE 78
G + E+ I + H N+VK GCC E Y+
Sbjct: 46 GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN 105
Query: 79 LPFTWEMQLRI-SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137
L QL + + + M+YLH S HRD+ + N+LLD+ K+ +FG ++
Sbjct: 106 LA-----QLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL--AK 155
Query: 138 AVDQTHITTQV-----------------HGTFGYLNPDDVCSFGVVLVELLTGAKP 176
AV + H +V F Y + DV SFGV L ELLT
Sbjct: 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS--DVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 17/88 (19%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR-----SRAVDQTHITTQ---- 147
M+YL S+ HRD+ + NIL+ + KV++FG +R I +
Sbjct: 117 MAYLEEQNSI---HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 148 ---VHGTFGYLNPDDVCSFGVVLVELLT 172
HGTF DV SFG++L E+ T
Sbjct: 174 EAASHGTFS--TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 49/214 (22%), Positives = 77/214 (35%), Gaps = 55/214 (25%)
Query: 46 NEVVIQSQINHINVVKLIGC---------CLE-------TKYMHDQNKELPFTWEMQLR- 88
E+ + + H N+V G +E L E+Q+
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAY 105
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS----RSRAVDQTHI 144
+ E ++YLH + + HRDIK NILL + K+++FG S + A ++ I
Sbjct: 106 VCRETLKGLAYLHETGKI---HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI 162
Query: 145 TT---------QVHGTFGYLNPDDVCSFGVVLVELLTGAKP------------IRFTTFE 183
T V GY D+ + G+ +EL P I + F
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP 222
Query: 184 ----EDKNI-TVAKHA--KRCLNPSGKKRPAMKE 210
+DK + H K+CL KKRP +
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 11/75 (14%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH---ITTQVHG------TFGYLNPD 158
I+HRDIK NIL+ D K+++FG+ R + I+T+ + T GY P
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 159 -DVCSFGVVLVELLT 172
D+ + G V E+L+
Sbjct: 180 MDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 41/165 (24%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEM-----------QLRIS 90
E NEVVI H N+V++ L EL E R++
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYL-------VGDELWVVMEFLEGGALTDIVTHTRMN 113
Query: 91 IEASGT--------MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
E T +S+LH + + HRDIKS +ILL K+S+FG + +
Sbjct: 114 EEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170
Query: 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+ V GT ++ P+ D+ S G++++E++ G P
Sbjct: 171 RRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 42/143 (29%), Positives = 58/143 (40%), Gaps = 31/143 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-----------RAVDQTH-- 143
MSYLH S I HRDIK NIL D K+ +FG S+ R+V T
Sbjct: 119 MSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 144 ITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKPIR--------FTTFEEDKNITVAKHAK 195
++ +V GY DV S G +VE+LT P F + N + H
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235
Query: 196 -------RCLNPSGKKRPAMKEV 211
C+ + RP+ +E+
Sbjct: 236 EHARDFLGCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 51/194 (26%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE-------TKYMH--DQNKELP-------------- 80
F+ EV I S++ N+++L+G C++ T+YM D N+ L
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 81 ---------FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131
++ L ++++ + M YL +S+ HRD+ + N L+ + K+++F
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 132 GTSRS-RAVDQTHITTQ-------------VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G SR+ A D I + + G F DV +FGV L E+L K
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF--TTASDVWAFGVTLWEILMLCKEQ 240
Query: 178 RFTTFEEDKNITVA 191
+ +++ I A
Sbjct: 241 PYGELTDEQVIENA 254
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 35/179 (19%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE-------TKYMH--DQNKELPFTWEMQLRISIEAS 94
F+ E+ I S++ N+++L+ C+ T+YM D N+ L E Q
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLS-RHEPQEAAEKADV 124
Query: 95 GTMSYLHLS-------------ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS----- 136
T+SY L +S+ HRD+ + N L+ Y K+++FG SR+
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 137 ------RAVDQTHITTQVHGTFG-YLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
RAV + G + DV +FGV L E+LT K ++ +++ I
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 71/223 (31%)
Query: 55 NHINVVKLIGCCLETKYMHDQNKELPF-----------------------------TWEM 85
+H N++ L+G C Y++ + P+ T +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
L+ + + + M YL + HRD+ + N+L+ + +K+++FG SR V
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV------ 171
Query: 146 TQVHGTFG----------------YLNPDDVCSFGVVLVELLT-GAKPIRFTT------- 181
V T G Y DV SFGV+L E+++ G P T
Sbjct: 172 -YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230
Query: 182 ------FEEDKNI--TVAKHAKRCLNPSGKKRPAMKEVASELA 216
E+ +N V + ++C +RP +++ +L+
Sbjct: 231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 52/207 (25%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGM----AKV------------EKFINEVVIQSQINHI 57
E +S + + LG G V+ G KV E F+ E I ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 58 NVVKLIGCCLE------TKYMHD------------QNKELPFTWEMQLRISIEASGTMSY 99
+V+L E T+YM + +LP +M ++ A+G M+Y
Sbjct: 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV---AAG-MAY 117
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG----------TSRSRAVDQTHITTQVH 149
+ + HRD++S NIL+ D K+++FG T+R A T
Sbjct: 118 IERMNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 150 GTFGYLN-PDDVCSFGVVLVELLTGAK 175
+G DV SFG++L EL+T +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 16/88 (18%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I HRDIK N+L+D K+++FG SR+ ++ + GT YL P+
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDDK 172
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEE 184
D S G V+ E L G P T +
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 20/91 (21%)
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD---QTHITTQVHGTFGYLNP 157
+L I HRD+K +NIL++ + K+ +FG S + V+ +T + GT Y+ P
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKTFV-----GTSSYMAP 168
Query: 158 D-----------DVCSFGVVLVELLTGAKPI 177
+ D+ S G+ L+EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 50/169 (29%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGM------------------------AKVEKFINEVV 49
E DS + R LG G VY+G+ F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 50 IQSQINHINVVKLIGCCLET-------KYM----------HDQNK-ELPFTWEMQ--LRI 89
I S+ NH N+V+LIG E + M ++ + E P + M+ L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSR 135
+ + + YL + + HRDI + N LL K AK+++FG +R
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 42/160 (26%)
Query: 47 EVVIQSQINHINVVKLIGCCLE------------------TKYM-HDQNKELPFTWEMQL 87
E+ I + H N+VK G C E +Y+ ++NK + QL
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQL 112
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ +++ M YL S HRD+ + N+L++ ++ K+ +FG +++ D+ + T +
Sbjct: 113 KYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 148 ---------------VHGTFGYLNPDDVCSFGVVLVELLT 172
+ F Y+ DV SFGV L ELLT
Sbjct: 170 DDLDSPVFWYAPECLIQSKF-YI-ASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 30/121 (24%)
Query: 76 NKELPFTWE----MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131
N ++P W ++ ++++A +M ++H RD+K N+LLD K+++F
Sbjct: 136 NYDIPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADF 186
Query: 132 GTS-RSRAVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAK 175
GT + A T V GT Y++P+ D S GV L E+L G
Sbjct: 187 GTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
Query: 176 P 176
P
Sbjct: 246 P 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 58/209 (27%)
Query: 20 FNVNRILGQGGQDIVYKGM----------------------AKVEKFI-NEVVIQSQINH 56
F ++LG G VYKG+ K K I +E + + +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 57 INVVKLIGCCLETKYMHDQNKELPF------TWEMQLRIS--------IEASGTMSYLHL 102
+V +L+G CL T + + +PF E + I ++ + M+YL
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--------------ITTQV 148
V HRD+ + N+L+ K+++FG ++ D+ + + +
Sbjct: 128 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 149 HGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
H Y + DV S+GV + EL+T G+KP
Sbjct: 185 HRI--YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + + YLH S+ I +RD+K NILLD + +++FG + + Q+ TT GT
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGT 159
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
YL P+ D G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 45/178 (25%)
Query: 39 AKVEKFINEVVIQSQINHINVVKLIGCCLETK-------------YMH------------ 73
+++E F++E V + +H NV++LIG CL+T +M
Sbjct: 42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101
Query: 74 --DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131
D + LP +M ++ + + M YL +S HRD+ + N +L++ V++F
Sbjct: 102 LGDCPQYLPT--QMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADF 156
Query: 132 GTS------------RSRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
G S R + I + Y DV SFGV + E+ T G P
Sbjct: 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 34/162 (20%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCC---------LETKYMHD--------QNKELPFTW 83
+ F E+ I + H N+VK G C L +Y+ +++E
Sbjct: 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR 108
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
++ L S G M YL S HRD+ + NIL++ + K+ +FG ++ D+ +
Sbjct: 109 KLLLYASQICKG-MEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
Query: 144 ITTQVHG---TFGY----LNPD------DVCSFGVVLVELLT 172
+ G F Y L DV SFGVVL EL T
Sbjct: 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 34/167 (20%)
Query: 37 GMAKVEKFINEVVIQSQINHINVVKLIGCCLE------TKYMHDQNKELPF---TWEMQL 87
G E F+ E + ++ H +V+L E T+YM + L F L
Sbjct: 41 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM-SKGSLLDFLKGEMGKYL 99
Query: 88 RI------SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG--------- 132
R+ + + + M+Y+ V HRD+++ NIL+ + KV++FG
Sbjct: 100 RLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNE 156
Query: 133 -TSRSRA---VDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLTGAK 175
T+R A + T ++G F DV SFG++L EL T +
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTI--KSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 20/86 (23%)
Query: 108 IYHRDIKSTNILL---DDKYCAKVSNFGTSR----SRAVDQTHIT--TQVHGTFGYLNPD 158
I HRD+K NI++ + AKV +FG R D +T T+V GT Y P+
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 159 -----------DVCSFGVVLVELLTG 173
D+ ++G++ +E LTG
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 21/97 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD----QTHITTQVHGTF 152
+ Y+H SA+V HRD+K N+L++ K+ +FG +R + + +T V T
Sbjct: 118 LKYIH-SANV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATR 173
Query: 153 GYLNPD------------DVCSFGVVLVELLTGAKPI 177
Y P+ DV S G +L ELL G KP+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 40/168 (23%)
Query: 42 EKFINEVVIQSQI-NHINVVKLIGCC-------LETKY---------MHDQNKELPFTWE 84
E ++E+ I S + NH N+V L+G C + T+Y + + +E T E
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLE 141
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144
L S + + M++L AS HRD+ + N+LL K+ +FG +R D ++
Sbjct: 142 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 145 TTQVHGT----FGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
V G ++ P+ DV S+G++L E+ + G+ P
Sbjct: 199 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 58/205 (28%)
Query: 24 RILGQGGQDIVYKGM-------------AKV----------EKFINEVVIQSQINHINVV 60
++LG G VYKG+ KV ++ ++E + + + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 61 KLIGCCLETKYMHDQNKELPF------TWEMQLRIS--------IEASGTMSYLHLSASV 106
+L+G CL T + + +P+ E + RI ++ + MSYL V
Sbjct: 73 RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--------------ITTQVHGTF 152
+ HRD+ + N+L+ K+++FG +R +D+T + + +H F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 153 GYLNPDDVCSFGVVLVELLT-GAKP 176
+ + DV S+GV + EL+T GAKP
Sbjct: 189 THQS--DVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 30/89 (33%), Positives = 39/89 (43%), Gaps = 13/89 (14%)
Query: 108 IYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------- 158
I HRDIKS NI L + AK+ +FG +R D + GT YL+P+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEE 184
D+ S G VL EL T P +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 40/168 (23%)
Query: 36 KGMAKVEKFINEVVIQSQINHINVVKLIGCCLE------TKYMH----------DQNKEL 79
+G E F+ E + Q+ H +V+L + T+YM + +L
Sbjct: 40 QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKL 99
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
+ + I A G M+++ + HRD+++ NIL+ + C K+++FG +R +
Sbjct: 100 TINKLIDMAAQI-AEG-MAFIERKNYI---HRDLRAANILVSETLCCKIADFGL--ARLI 152
Query: 140 DQTHITTQV---------------HGTFGYLNPDDVCSFGVVLVELLT 172
+ T + +GTF DV SFG++L E++T
Sbjct: 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTI--KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFG----YL 155
+H S + HRDIKS NILL K+ +FG S+ A ++ V TF Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYV 212
Query: 156 NPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA 191
P+ D+ S GV+L ELLT +P EE + T+A
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259
|
Length = 496 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 17/100 (17%)
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
RI++ ++YL S+ I HRD+K +N+L++ + K+ +FG S I
Sbjct: 99 RIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKT 152
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
GT Y+ P+ DV S G+ +EL G P
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 41/147 (27%), Positives = 57/147 (38%), Gaps = 43/147 (29%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+SYLH S I HRDIK +NILL K K+ +FG S V+ T GT Y+
Sbjct: 118 LSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGT--FTGTSFYMA 171
Query: 157 PD-----------DVCSFGVVLVELLTG-----------AKPIRFTTF-----------E 183
P+ DV S G+ L+E+ PI ++ E
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 184 EDKNITVAKHAK----RCLNPSGKKRP 206
I ++ K +CL +RP
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 30/174 (17%)
Query: 30 GQDIVYKGM-----AKVEKFINEVVIQSQINHINVVKLIGC------------CLETKYM 72
G+ + K M + E NEVVI +H NVV + LE +
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 73 HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---------DDK 123
D E + + +SYLH + HRDIKS +ILL D
Sbjct: 107 TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163
Query: 124 YCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
+CA+VS R V + + +V Y D+ S G++++E++ G P
Sbjct: 164 FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 35/163 (21%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK-------YMHD-------QNKELPFTWEMQLRI 89
F++E I Q +H N++ L G ++K YM + + + FT +QL
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT-VIQLVG 110
Query: 90 SIE--ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ ASG M YL + + HRD+ + NIL++ KVS+FG SR D T
Sbjct: 111 MLRGIASG-MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 148 VHGTF-------------GYLNPDDVCSFGVVLVELLT-GAKP 176
G + + DV S+G+V+ E+++ G +P
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 25/157 (15%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCL------------ETKYMHDQNKELPFTWEMQLRI 89
E NEVVI H NVV++ L + + D + E +
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV 122
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILL---------DDKYCAKVSNFGTSRSRAVD 140
+ YLH S + HRDIKS +ILL D +CA++S R V
Sbjct: 123 CESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 141 QTH-ITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
+ + +V Y D+ S G++++E++ G P
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 40/187 (21%), Positives = 76/187 (40%), Gaps = 29/187 (15%)
Query: 19 SFNVNRILGQGGQDIVYKGMAKVE--KFI------------NEVVIQSQINHINVVKLIG 64
S ++ +G + YKG + +F+ +E+ ++ H N+VKLIG
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 65 CCLETK-----YMHDQNKELP-----FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIK 114
C K + + + K L +WE + +I+I + + +LH S + ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 115 STNILLDDKYCAKV-----SNFGTSRSRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVE 169
I++D K + T + ++ + T D+ FG++L+E
Sbjct: 811 PEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIE 870
Query: 170 LLTGAKP 176
LLTG P
Sbjct: 871 LLTGKSP 877
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 27/97 (27%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ-----VHGT 151
+ YLH HRDIK NIL+D K+++FG ++ + G+
Sbjct: 115 LEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGS 164
Query: 152 FGYLNPD------------DVCSFGVVLVELLTGAKP 176
++ P+ D+ S G ++E+ TG P
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 56/231 (24%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETK-------------YMHDQN----------K 77
+E+F+ E + +H NV+KLIG L ++ +M +
Sbjct: 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG 104
Query: 78 ELPFTWEMQ--LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
E PFT +Q +R I+ + M YL +S HRD+ + N +L++ V++FG S+
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
Query: 136 ------------SRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKPIRFTTF 182
+ + + + Y DV +FGV + E++T G P
Sbjct: 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221
Query: 183 EEDKNITVAKH---------------AKRCLNPSGKKRPAMKEVASELAGI 218
E N + + +C +P K RP+ + + +L I
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 36/170 (21%)
Query: 33 IVYKGMAKVEKF--INEVVIQSQINHINVVKLIGCCLETK----------------YMHD 74
I + M K E+ NE + ++H N+++ LE K Y+
Sbjct: 33 IPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK 92
Query: 75 QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGT 133
+ L + L ++ + ++H I HRD+K+ NILLD K K+ +FG
Sbjct: 93 RCNSL-LDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148
Query: 134 SRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT 172
S+ + T V GT Y++P+ D+ + G VL EL +
Sbjct: 149 SKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 43/169 (25%)
Query: 37 GMAKVEKFINEVVIQSQINHINVVKLIGCC-------LETKYMHD-------QNKE---- 78
G + F+ E I ++ H +++L C + T+ M Q
Sbjct: 41 GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL 100
Query: 79 -LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137
LP +M ++ ASG M+YL + HRD+ + N+L+ + KV++FG +R
Sbjct: 101 KLPQLIDMAAQV---ASG-MAYLEAQNYI---HRDLAARNVLVGENNICKVADFGLAR-- 151
Query: 138 AVDQTHITTQVHGT---FGYLNPD-----------DVCSFGVVLVELLT 172
V + I G + P+ DV SFG++L E++T
Sbjct: 152 -VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 16/92 (17%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ Y+H V + HRDIK+ NIL+ + K+ +FG + + + +T V GT ++
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMA 169
Query: 157 PD------------DVCSFGVVLVELLTGAKP 176
P+ D+ S G+ + E+ TG P
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 39/160 (24%)
Query: 56 HINVVKLIGCCLE-------TKYMHDQN------KELPFTWEMQLRISIEASGTMSYLHL 102
H N++ L+G C + +Y N P T++ L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 103 S-------------ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQV 148
AS HRD+ + N+L+ + + K+++FG +R +D TT
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
++ P+ DV SFGV+L E+ T G P
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 44/174 (25%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK-------YMH--DQNKEL--------------- 79
F E + + + H ++V+ G C E + YM D N+ L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 80 ----PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
T L I+ + + M YL AS+ HRD+ + N L+ K+ +FG SR
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
Query: 136 S-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
+ D + + ++ P+ D+ SFGVVL E+ T G +P
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + + YLH S+ I +RD+K NILLD + +++FG + ++ + T+ GT
Sbjct: 104 EIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGT 159
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
YL P+ D G VL E+L G P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 15/99 (15%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ +LH S I +RD+K NILLD K+++FG + + T GT Y+
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIA 164
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTTFEE 184
P+ D SFGV+L E+L G P EE
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 76/228 (33%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEV 48
E + + + R LGQG +VY+G A+ +E F+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60
Query: 49 VIQSQINHINVVKLIGC------------------------CLETKYMHDQNKELPFTWE 84
+ +VV+L+G L + ++ + P E
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-------- 136
M ++++ E + M+YL+ V HRD+ + N ++ + K+ +FG +R
Sbjct: 121 M-IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 137 ---------RAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLTGAK 175
R + + V T D+ SFGVVL E+ + A+
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTS-----SDMWSFGVVLWEITSLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 50/226 (22%)
Query: 38 MAKVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNK-----------EL------- 79
+ + + NE + +++H +++L HDQ EL
Sbjct: 42 LKQEQHVHNEKRVLKEVSHPFIIRLFWT------EHDQRFLYMLMEYVPGGELFSYLRNS 95
Query: 80 -PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138
F+ L + E + YLH S I +RD+K NILLD + K+++FG ++ +
Sbjct: 96 GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-KL 151
Query: 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR-FTTFEEDK 186
D+T + GT YL P+ D + G+++ E+L G P F +
Sbjct: 152 RDRTW---TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
Query: 187 NITVAK-HAKRCLNPSGK---KRPAMKEVASELAGIKAWNGASNVM 228
I K R L+ K K+ + + L +K NGA +V
Sbjct: 209 KILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMK--NGADDVK 252
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 32/175 (18%)
Query: 30 GQDIVYKGM-----AKVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNKELP---- 80
GQ++ K M K E INE+++ + H N+V + L + + L
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 81 --FTWEMQLR------ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132
E + + E + +LH S + HRDIKS NILL K+++FG
Sbjct: 104 TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160
Query: 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+Q+ +T V GT ++ P+ D+ S G++ +E++ G P
Sbjct: 161 FCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 63/213 (29%)
Query: 24 RILGQGGQDIVYKGMAK-VEK-----------------------FINEVVIQSQINHINV 59
R LGQG +VY+G+AK V K F+NE + + N +V
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 60 VKLIGCCLETK-------YM----------------HDQNKELPFTWEMQLRISIEASGT 96
V+L+G + M + P T + ++++ E +
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQVHGTFGYL 155
M+YL A+ HRD+ + N ++ + K+ +FG +R D + ++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 156 NPD-----------DVCSFGVVLVELLT-GAKP 176
P+ DV SFGVVL E+ T +P
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 58/273 (21%), Positives = 99/273 (36%), Gaps = 93/273 (34%)
Query: 17 TDSFNVNRILGQGGQDIVYKGM----------AKVEKF-----------INEVVIQSQIN 55
+F + + +G+G +VYK + KV+ F + E+ + Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 56 HINVVKLIGCCLET-------------------KYMHDQNKELP----FTWEMQLRISIE 92
H NV+K + +E K+ Q + +P + + +QL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----- 115
Query: 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152
S + ++H S I HRDIK N+ + K+ + G R + T + V GT
Sbjct: 116 CSA-LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDK--------NITVAKH 193
Y++P+ D+ S G +L E+ P F DK I +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEKCDY 225
Query: 194 A---------------KRCLNPSGKKRPAMKEV 211
RC+NP +KRP + V
Sbjct: 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 14/106 (13%)
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
EM+ I A T LHL S+ I +RD+K N+LLDD+ ++S+ G + +
Sbjct: 93 EMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE--LKDGK 149
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR 178
TQ GT GY+ P+ D + G + E++ G P +
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 26/114 (22%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETKYM----------------HD-----QNKELPFTW 83
+ E+ I + H NVV LI C HD NK + FT
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118
Query: 84 -EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
E++ + + +G + Y+H + I HRD+K+ NIL+ K+++FG +R+
Sbjct: 119 SEIKKVMKMLLNG-LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 51/189 (26%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLETK-------YMH--DQNKEL--------------- 79
F E + ++ +H N+VKL+G C K YM D N+ L
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 80 -----------PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
P + QL I+ + + M+YL V HRD+ + N L+ + K+
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKI 171
Query: 129 SNFGTSRS-------RAVDQTHITTQ---VHGTF--GYLNPDDVCSFGVVLVELLT-GAK 175
++FG SR+ +A + I + F Y DV ++GVVL E+ + G +
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
Query: 176 PIRFTTFEE 184
P EE
Sbjct: 232 PYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV-------- 148
+SY H I HRD+K N+L+++K K+++FG +R+++V + +V
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
Query: 149 ---HGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEED 185
G+ Y P D+ G +L E+ TG +T +E+
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 14/110 (12%)
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
R + A+ + L S I +RD+K N++LD K+++FG + +T
Sbjct: 97 RATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST- 155
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
GT Y+ P+ D SFGV+L E+L G P F +ED+
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 16/101 (15%)
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ISI ++YL I HRD+K +NIL++ + K+ +FG S + +D +
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANS 157
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
GT Y++P+ D+ S G+ LVE+ G PI
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 15/87 (17%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YLH S I HRDIK N+L++ K+ +FG +R D++ TQ T Y P+
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 159 ------------DVCSFGVVLVELLTG 173
D+ S G + ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 18/89 (20%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YLH S I +RD+K N+LLD+K KV++FG ++ + D+T GT YL P+
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC---GTPEYLAPE 185
Query: 159 -----------DVCSFGVVLVELLTGAKP 176
D + GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 53/216 (24%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKG----------MAKV------EKF----INEVVIQSQ 53
++ D F++ +G+G VYK + KV E F I E+ I Q
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 54 INHINVVKLIGCCLETKYMHDQNKE-----LPFTWEMQLRISIEASGTMSY--------- 99
+NH N+V L + + D K+ L F + + + SG + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 100 ------LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFG 153
L+ HRDIK +NILL++K K+++FG +R +++ T T
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 154 YLNPD------------DVCSFGVVLVELLTGAKPI 177
Y P+ DV S G +L EL T KPI
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 16/104 (15%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
+ HRDIKS NI L K+ +FG++R + T V GT Y+ P+
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNP 200
D+ S G +L EL T P + ++ KN+ + K + P
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSW---KNL-ILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 50/164 (30%)
Query: 56 HINVVKLIGCCLETKYMHDQNKELP-------------FTWEMQLRISIEASGTMS---Y 99
H N++ L+G C Y++ + P + I+ + T+S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 100 LHLSASVP----------IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
LH +A V HRD+ + NIL+ + Y AK+++FG SR + V V
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVK 179
Query: 150 GTFG----------------YLNPDDVCSFGVVLVELLT-GAKP 176
T G Y DV S+GV+L E+++ G P
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 58/169 (34%)
Query: 16 ATDSFNVNRILGQGGQDIVYKG--------------MAKVEK--F----INEVVIQSQIN 55
+ + LG+G VYK + EK F + E+ I ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 56 HINVVKLIGCCLE---------------TKYM-HDQNKEL--PFTWEMQLRISIEASGT- 96
H NVV LI +E T YM HD + L P + + S
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-------SVKLTESQIK 118
Query: 97 ---------MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
++YLH + I HRDIK+ NIL+D++ K+++FG +R
Sbjct: 119 CYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
E+ ++SI ++YL I HRD+K +NIL++ + K+ +FG S + +D
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS-- 157
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
+ GT Y++P+ D+ S G+ LVEL G PI
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 39/166 (23%)
Query: 44 FINEVVIQSQINHINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRI 89
F++E I Q +H N++ L G + T++M + + + FT +QL
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT-VIQLVG 110
Query: 90 SIE--ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---SRAVDQTHI 144
+ A+G M YL + + HRD+ + NIL++ KVS+FG SR D T+
Sbjct: 111 MLRGIAAG-MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY- 165
Query: 145 TTQVHGTF-------------GYLNPDDVCSFGVVLVELLT-GAKP 176
T+ + G + + DV S+G+V+ E+++ G +P
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 42/168 (25%)
Query: 35 YKGMAKVEKF---INEVVIQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEM------ 85
Y G EK+ I EV Q+ H N ++ GC Y+ + L + +
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGC-----YLREHTAWLVMEYCLGSASDI 104
Query: 86 ---------QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
++ I+ G + L S HRDIK+ NILL + K+++FG++
Sbjct: 105 LEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164
Query: 137 RAVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVEL 170
+ + + GT ++ P+ DV S G+ +EL
Sbjct: 165 VSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 15/83 (18%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
+ +RD+K NILLD+ ++S+ G + + + H + GT GY+ P+
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 159 ---DVCSFGVVLVELLTGAKPIR 178
D S G +L +LL G P R
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 36/178 (20%)
Query: 47 EVVIQSQINHINVVKL--------IGCCLETKYMHDQNKELPFTWEMQLRISIEASGT-- 96
E ++ +NH +V+++ I C + Y D L T + + I+ +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL--TKRSR-PLPIDQALIIE 163
Query: 97 ------MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI------ 144
+ YLH + I HRD+K+ NI ++D + + G ++ V +
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 145 ---TTQVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLN 199
+V Y + D+ S G+VL E+L A P +T ED T ++ K C +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML--AYP---STIFEDPPSTPEEYVKSCHS 273
|
Length = 357 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 16/125 (12%)
Query: 74 DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133
D+ + P T E + S + + M +L AS HRD+ + NILL + K+ +FG
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL 219
Query: 134 SRSRAVDQTHITT----------QVHGTFG--YLNPDDVCSFGVVLVELLT-GAKPIRFT 180
+R D ++ F Y DV SFGV+L E+ + GA P
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
Query: 181 TFEED 185
+E+
Sbjct: 280 QIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 16/101 (15%)
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
++SI ++YL I HRD+K +NIL++ + K+ +FG S + +D +
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANS 161
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177
GT Y++P+ D+ S G+ LVE+ G PI
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 19/104 (18%)
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+I++ + YLH SV HRD+K +N+L++ K+ +FG S VD T
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTID 163
Query: 148 VHGTFGYL-----NPD----------DVCSFGVVLVELLTGAKP 176
G Y+ NP+ DV S G+ ++EL TG P
Sbjct: 164 A-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 70/225 (31%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK-VEK-----------------------FINEVV 49
E A + ++R LGQG +VY+G+AK V K F+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 50 IQSQINHINVVKLIGCCLETK-----------------------YMHDQNKELPFTWEMQ 86
+ + N +VV+L+G + + M + + P + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
++++ E + M+YL+ + V HRD+ + N ++ + + K+ +FG +R D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 147 QVHGTFG-----YLNPD-----------DVCSFGVVLVELLTGAK 175
G G +++P+ DV SFGVVL E+ T A+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 15/83 (18%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
+ +RD+K NILLD+ ++S+ G + + + H + GT GY+ P+
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174
Query: 159 ---DVCSFGVVLVELLTGAKPIR 178
D S G +L +LL G P R
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 25/107 (23%)
Query: 110 HRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------- 158
HRDIK N+L+D K+++FG++ ++ + GT Y+ P+
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLN 199
D S GV+ E++ G P F E T AK +N
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSP-----FHEG---TSAKTYNNIMN 223
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 30/141 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ YLH + HRDIK+ N+LL ++ K+++FG + Q T V GT ++
Sbjct: 114 LDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 157 PD-----------DVCSFGVVLVELLTGAKP--------IRFTTFEEDKNITVAKHAK-- 195
P+ D+ S G+ +EL G P + F + +++K
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF 229
Query: 196 -----RCLNPSGKKRPAMKEV 211
CLN + RP KE+
Sbjct: 230 KEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 42/174 (24%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLET-------KYMH--DQNKEL------------- 79
+ F E + + + H ++VK G C+E +YM D NK L
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 80 ----PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
T L I+ + + M YL AS HRD+ + N L+ + K+ +FG SR
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
Query: 136 S-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
+ D + ++ P+ DV S GVVL E+ T G +P
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 36/151 (23%)
Query: 55 NHINVVKLIGCCLETKYMH------DQN--------KELPFTWEMQLRISIE---ASGTM 97
H N+VKL E ++ + N K PF+ E +R SI G +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFS-ESVIR-SIIYQILQG-L 112
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---SRAVDQTHITTQ------- 147
+++H +HRD+K N+L+ K+++FG +R SR +++T+
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 148 -VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ T Y +P D+ + G ++ EL T +P+
Sbjct: 170 LLRSTS-YSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 29/125 (23%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ +LH I +RD+K N+LLD K+++FG + + +T GT Y+
Sbjct: 109 LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDK------------NITVAKH 193
P+ D SFGV+L E+L G P F +ED+ ++K
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDELFDSILNDRPHFPRWISKE 222
Query: 194 AKRCL 198
AK CL
Sbjct: 223 AKDCL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 48/175 (27%)
Query: 39 AKVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-------------------KEL 79
++E F+ E+ I S+ H N+V L Y ++ E
Sbjct: 44 EELEDFMVEIDILSECKHPNIVGLYEA-----YFYENKLWILIEFCDGGALDSIMLELER 98
Query: 80 PFTWEMQLR-ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS-RSR 137
T E Q+R + + +++LH S + HRD+K+ NILL K+++FG S +++
Sbjct: 99 GLT-EPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154
Query: 138 AVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKP 176
+ Q T GT ++ P+ D+ S G+ L+EL P
Sbjct: 155 STLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 27/107 (25%)
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
L + + + M YL + HRD+ + NIL+ + Y AK+++FG SR + V
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------- 164
Query: 147 QVHGTFG----------------YLNPDDVCSFGVVLVELLT-GAKP 176
V T G Y DV S+GV+L E+++ G P
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + + YLH S+ I +RD+K NILLD + +++FG + V+ T+ GT
Sbjct: 104 EVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGT 159
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
YL P+ D G VL E+L G P
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 15/116 (12%)
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
+++ HL IY RD+K NILLD + K+++FG + ++ + +T GT Y+
Sbjct: 110 SLALEHLHQQGIIY-RDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYM 167
Query: 156 NPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNP 200
P+ D S G ++ ++LTGA P FT K I K L P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP--FTAENRKKTIDKILKGKLNLPP 221
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + + YLH S+ I +RD+K NILLD + +++FG + ++ T+ GT
Sbjct: 104 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTSTFCGT 159
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
YL P+ D G VL E+L G P
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 16/110 (14%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
T E + S + + M +L AS HRD+ + NILL + K+ +FG +R
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 140 DQTHITT-QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
D ++ ++ P+ DV SFGV+L E+ + GA P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 19/85 (22%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD---QTHITTQVHGTFGYLNPD------ 158
I +RD+K N+LLDD ++S+ G AV+ I + GT GY+ P+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGL----AVELKGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 159 -----DVCSFGVVLVELLTGAKPIR 178
D + G L E++ G P R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 31/182 (17%)
Query: 67 LETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126
+E Y Q E +++ + + + + M YL AS HRD+ + N+L+ +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 179
Query: 127 KVSNFGTSRS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-G 173
K+++FG +R +D TT ++ P+ DV SFGV+L E+ T G
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239
Query: 174 AKPIRFTTFEE-----------DKNITVAKH----AKRCLNPSGKKRPAMKEVASELAGI 218
P EE DK + C + +RP K++ +L I
Sbjct: 240 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
Query: 219 KA 220
A
Sbjct: 300 LA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 36/123 (29%), Positives = 55/123 (44%), Gaps = 35/123 (28%)
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT---HITTQVHGTFGYLNPD--- 158
S+ + HRD+K N+LLD K+++FGT +D+T T V GT Y++P+
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK--MDETGMVRCDTAV-GTPDYISPEVLK 216
Query: 159 ------------DVCSFGVVLVELLTGAKPI-------RFTTFEEDKN-------ITVAK 192
D S GV L E+L G P ++ + KN + ++K
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276
Query: 193 HAK 195
HAK
Sbjct: 277 HAK 279
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 45/239 (18%), Positives = 84/239 (35%), Gaps = 57/239 (23%)
Query: 21 NVNRILGQGGQDIVYKGMAKVEKFINEVVIQSQINHINVVKLIGCCLE------------ 68
V ++LG +D F + SQ++H ++VKL G C+
Sbjct: 33 VVLKVLGSDHRD--------SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKF 84
Query: 69 ---TKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----- 120
++H + + W++ + A S LH + H ++ NIL+
Sbjct: 85 GPLDVFLHREKNNVSLHWKLDV-----AKQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 121 DDKY--CAKVSNFGTSRS------RAVDQTHITTQ-VHGTFGYLNPD-DVCSFGVVLVEL 170
++ Y K+S+ G + R I + + L D SFG L+E+
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 171 -------LTGAKPIRFTTFEEDKNI-------TVAKHAKRCLNPSGKKRPAMKEVASEL 215
L+ F +D++ +A +C KRP+ + + +L
Sbjct: 200 CSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 18/93 (19%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH--------- 149
YLH SA+ + HRD+K +NIL++ K+ +FG +R D+
Sbjct: 118 YLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 150 -----GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ Y D+ S G + ELLT KP+
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 5e-04
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 30 GQDIVYKGM-----AKVEKFINEVVIQSQINHINVVKLIGCCL------------ETKYM 72
GQ++ K + K E INE+++ ++ + N+V + L +
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 73 HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132
D E + E + +LH + + HRDIKS N+LL K+++FG
Sbjct: 104 TDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFG 160
Query: 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+Q+ +T V GT ++ P+ D+ S G++ +E++ G P
Sbjct: 161 FCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 34/146 (23%), Positives = 49/146 (33%), Gaps = 50/146 (34%)
Query: 110 HRDIKSTNILLDDKYCAKVSNFGTS-------------------------RSRAVDQTHI 144
HRDIK NIL+D K+++FG R D
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 145 TTQVH---GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITV 190
+ + GT Y+ P+ D S GV+L E+L G P + + T
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF----YSDTLQETY 239
Query: 191 AK--HAKRCLNPSGKKRPAMKEVASE 214
K + K L + P V+ E
Sbjct: 240 NKIINWKESL-----RFPPDPPVSPE 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 33/182 (18%)
Query: 67 LETKYMHDQNK--ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124
+Y +D + + T++ + + + + M YL AS HRD+ + N+L+ +
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174
Query: 125 CAKVSNFGTSRS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT 172
K+++FG +R +D TT ++ P+ DV SFGV++ E+ T
Sbjct: 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 173 -GAKPIRFTTFEEDKNITVAKH---------------AKRCLNPSGKKRPAMKEVASELA 216
G P EE + H + C + RP K++ +L
Sbjct: 235 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
Query: 217 GI 218
I
Sbjct: 295 RI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 5e-04
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + +LH S + HRDIKS NILL K+++FG +Q+ +T V GT
Sbjct: 123 ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
++ P+ D+ S G++ +E++ G P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 20/98 (20%)
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS----RAVDQTHITTQVHGT 151
+ Y+H S + HRD+K +NILL+ K+++FG +RS + + T T
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 152 FGYLNPD------------DVCSFGVVLVELLTGAKPI 177
Y P+ D+ S G +L E+L G KP+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 16/91 (17%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-GTFGYLNPD-------- 158
I +RD+K N++LD + K+++FG + D +TT+ GT Y+ P+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
D +FGV+L E+L G P F +ED+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAP--FEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 34/156 (21%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETKYMHDQNK-ELPFTWEMQ-LRISIEASG------- 95
I E+ + ++NH N+VKL+ +H +NK L F + Q L+ ++AS
Sbjct: 47 IREISLLKELNHPNIVKLL------DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLP 100
Query: 96 -TMSYLH-------LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
SYL S + HRD+K N+L++ + K+++FG +R+ V T +
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160
Query: 148 V-----------HGTFGYLNPDDVCSFGVVLVELLT 172
V G Y D+ S G + E++T
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 13/82 (15%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I +RD+K NILLDD ++S+ G + QT I +V GT GY+ P+
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 159 --DVCSFGVVLVELLTGAKPIR 178
D + G +L E++ G P +
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 15/88 (17%)
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQVH------- 149
+Y H S I HRDIK NIL+ + K+ +FG +R+ RA + +T V
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 150 ----GTFGYLNPDDVCSFGVVLVELLTG 173
G Y P DV + G ++ ELL G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 39/147 (26%), Positives = 63/147 (42%), Gaps = 29/147 (19%)
Query: 110 HRDIKSTNILLDDKYCAKVSNFGTSR----SRAVDQTHITTQVHGTFGYLNPD------- 158
HRD+KS NI L K+ +FG S+ S ++D + + GT YL P+
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRY 248
Query: 159 ----DVCSFGVVLVELLTGAKPIRFTTFEEDKN-----------ITVAKHAKRCLNPSGK 203
D+ S GV+L ELLT +P + + E V+ K L+P
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308
Query: 204 KRPAMKEVASELAGIKAWNGASNVMEE 230
K PA++ +L + +N+ ++
Sbjct: 309 KNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 45/174 (25%)
Query: 43 KFINEVVIQSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTWEMQ 86
+F+ E + S NH N+VKL+G CL + Y+ D E +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104
Query: 87 LR----ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCA----KVSNFGTSRS- 136
L+ I ++ + YL + HRD+ + N L+ +K Y A K+ +FG +R
Sbjct: 105 LKELLDICLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161
Query: 137 ------RAVDQTHITTQ-------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
R + + + + G F DV SFGV++ E+LT G +P
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFT--TQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 33/113 (29%), Positives = 48/113 (42%), Gaps = 28/113 (24%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT------HITT---- 146
+ YLH + I HRD+K N+L+ K+++FG S+ + T HI
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 147 ----QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE 184
QV GT Y+ P+ D + G++L E L G P T EE
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 18/94 (19%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---SRAVDQTHITTQVHGTFG 153
+SYLH S I HRDIK NIL D K+ +FG S+ + + T + + V GT
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKP 176
+++P+ D+ S G +VE+LT P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 56/208 (26%)
Query: 26 LGQGGQDIVYKGMAKVEK-------------------FINEVVIQSQINHINVVKLIGCC 66
LG+G VYKG +K+ I EV + + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69
Query: 67 LETKYMHDQNKELPFTWEM---QLRISIEASGTMSYLH--------------LSASVPIY 109
+H + K L +E L+ ++ G +H +
Sbjct: 70 --HDIIHTE-KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 110 HRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------- 158
HRD+K N+L++++ K+++FG +R++++ + +V T Y PD
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 159 -DVCSFGVVLVELLTGAKPIRFTTFEED 185
D+ G + E+ TG +T EE
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 36/149 (24%), Positives = 62/149 (41%), Gaps = 29/149 (19%)
Query: 54 INHINVVKLIGCC------LETKYM-------HDQNKELPFTWEMQLRISIEASGTMSYL 100
++H +V+L+G C L T+ H + + L ++ + M YL
Sbjct: 66 LDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT--------- 151
V HR++ + NILL ++++FG + D H T
Sbjct: 126 EEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 152 --FG-YLNPDDVCSFGVVLVELLT-GAKP 176
FG Y + DV S+GV + E+++ GA+P
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 9e-04
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 68/210 (32%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKVE-KFINEVVIQSQ------------------INHIN 58
DS+ LG+G VYKG +KV K + VI+ Q + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 59 VVKLIGCCLETK----------------YM-------HDQNKELPFTWEMQLRISIEASG 95
+V L+ + TK YM H +N +L F +++ LR
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-FLFQL-LR------- 114
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
+SY+H I HRD+K N+L+ D K+++FG +R+++V +H + T Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYR 170
Query: 156 NPD------------DVCSFGVVLVELLTG 173
PD D+ G + VE++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 19/87 (21%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQ---------- 147
Y+H S I HRD+K +NI +++ K+ +FG +R + T ++ T+
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 189
Query: 148 -VHGTFGYLNPDDVCSFGVVLVELLTG 173
+H Y D+ S G ++ ELLTG
Sbjct: 190 WMH----YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 27/158 (17%)
Query: 42 EKFINEVVIQSQINHINVVKLIGC------------CLETKYMHDQNKELPFTWEMQLRI 89
E NEVVI H NVV++ LE + D E +
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 121
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
+ +S LH + HRDIKS +ILL K+S+FG ++ + +
Sbjct: 122 CLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKSLV 177
Query: 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
GT ++ P+ D+ S G++++E++ G P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 18/94 (19%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---SRAVDQTHITTQVHGTFG 153
+SYLH S I HRDIK NIL D K+ +FG S+ + + T I + V GT
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKP 176
+++P+ DV S +VE+LT P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 33/112 (29%), Positives = 49/112 (43%), Gaps = 15/112 (13%)
Query: 76 NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135
++E FT E E + YLH S + +RDIK N++LD K+++FG +
Sbjct: 87 SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
D + T GT YL P+ D GVV+ E++ G P
Sbjct: 144 EGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 37/165 (22%), Positives = 70/165 (42%), Gaps = 38/165 (23%)
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHIT 145
L I+I+ + M YL +S H+D+ + NIL+ ++ K+S+ G SR + D +
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKH 193
+ ++ P+ D+ SFGVVL E+ + G +P + F + I + +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP--YYGFSNQEVIEMVRK 241
Query: 194 AK-----------------RCLNPSGKKRPAMKEVASELAGIKAW 221
+ C +RP K++ + L ++W
Sbjct: 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL---RSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 16/91 (17%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-GTFGYLNPD-------- 158
I +RD+K N++LD + K+++FG + VD +TT+ GT Y+ P+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
D ++GV+L E+L G P F +ED+
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPP--FDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 22/119 (18%)
Query: 74 DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133
D P + LR S + + M +L AS HRD+ + N+LL D AK+ +FG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 134 SRSRAVDQTHITTQVHGT----FGYLNPD-----------DVCSFGVVLVELLT-GAKP 176
+R D ++ V G ++ P+ DV S+G++L E+ + G P
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 30/141 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ YLH + HRDIK+ N+LL ++ K+++FG + Q T V GT ++
Sbjct: 114 LDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 157 PD-----------DVCSFGVVLVELLTGAKP--------IRF-------TTFEEDKNITV 190
P+ D+ S G+ +EL G P + F T + +
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPF 229
Query: 191 AKHAKRCLNPSGKKRPAMKEV 211
+ CLN RP KE+
Sbjct: 230 KEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 20/93 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ Y+H SA V HRD+K +NIL+++ K+ +FG +R + +T V T Y
Sbjct: 121 LKYVH-SAGV--VHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYV-STRYYRA 173
Query: 157 PD------------DVCSFGVVLVELLTGAKPI 177
P+ D+ S G + E+L G KP+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 34/119 (28%), Positives = 50/119 (42%), Gaps = 16/119 (13%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
P T E + S + + M +L AS HRD+ + NILL + K+ +FG +R
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 140 DQTHIT----------TQVHGTFG--YLNPDDVCSFGVVLVELLT-GAKPIRFTTFEED 185
D ++ F Y DV SFGV+L E+ + GA P E+
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 19/100 (19%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-GTFGYLNP 157
+LH S I +RD+K N++LD + K+++FG + TT+ GT Y+ P
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAP 170
Query: 158 D-----------DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
+ D +FGV+L E+L G P F +ED+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPP--FDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAV---DQTH-ITTQVH-- 149
+++ H + HRD+K N+L+D K K+++ G R+ ++ TH I T +
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 150 -----GTFGYLNPDDVCSFGVVLVELLTGA 174
G+ Y P D+ S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 18/93 (19%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV--DQTHITTQVHGTFGYLN 156
Y+H SA+V HRD+K +N+LL+ K+ +FG +R D T T+ T Y
Sbjct: 121 YIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 157 PD------------DVCSFGVVLVELLTGAKPI 177
P+ D+ S G +L E+L+ +P+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 43/215 (20%), Positives = 89/215 (41%), Gaps = 48/215 (22%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLE----------------TKYMH---DQNKELPF 81
++ NE+ +I+ N++K+ G ++ Y+ D+ K+L F
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF 121
Query: 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141
+ +L ++I+ + L+ + P ++++ S + L+ + Y K+ G + +
Sbjct: 122 --KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177
Query: 142 -THITTQVHGTFGYLN--------PDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAK 192
++ V+ ++ LN DD+ S GVVL E+ TG P T +E ++ + K
Sbjct: 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237
Query: 193 HAK----------------RCLNPSGKKRPAMKEV 211
+ C + KRP +KE+
Sbjct: 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 41/156 (26%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETKYM-HD-----QNKELPF------TWEMQLRISIE 92
+ EVV+ S ++ I +V +E Y+ HD + + PF +QL
Sbjct: 69 VKEVVVGSNLDKIYMV------ME--YVEHDLKSLMETMKQPFLQSEVKCLMLQL----- 115
Query: 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV---- 148
SG +++LH I HRD+K++N+LL+++ K+ +FG +R T V
Sbjct: 116 LSG-VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW 171
Query: 149 -------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G Y D+ S G + ELLT KP+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTK-KPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 24/108 (22%)
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR-------- 135
M ++I A G MSYLH + H+DI + N ++D++ K+++ SR
Sbjct: 121 HMAIQI---ACG-MSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 136 ------SRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+R V + + V+ + + DV SFGV+L EL+T G P
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYS--SASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 16/102 (15%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-----------GTFGYLN 156
I HRDIK NIL+ K+ +FG +R+ A T V G Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 157 PDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCL 198
D+ + G ++ E+LTG +P+ F D +I H +CL
Sbjct: 181 AVDIWAVGCLVTEMLTG-EPL----FPGDSDIDQLYHIIKCL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 30/141 (21%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ YLH + HRDIK+ N+LL + K+++FG + Q T V GT ++
Sbjct: 114 LDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 157 PD-----------DVCSFGVVLVELLTGAKP--------IRF-------TTFEEDKNITV 190
P+ D+ S G+ +EL G P + F T E + + +
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 229
Query: 191 AKHAKRCLNPSGKKRPAMKEV 211
+ + CLN RP KE+
Sbjct: 230 KEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 17/108 (15%)
Query: 110 HRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------- 158
HRDIK N+LLD ++++FG+ D T ++ GT Y++P+
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 159 -----DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPS 201
D S GV + E+L G P + E + H +R PS
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 17/91 (18%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
Y+H S + HRD+K +N+LL+ K+ +FG +R+ + +T V T Y P+
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV-VTRWYRAPE 178
Query: 159 ------------DVCSFGVVLVELLTGAKPI 177
DV S G + ELL G KP+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 44/181 (24%), Positives = 69/181 (38%), Gaps = 45/181 (24%)
Query: 38 MAKVEKFINEVVIQSQINHINVVKLIGCCLET-------KYMH--DQNKEL--------- 79
+A + F E + + + H ++VK G C + +YM D NK L
Sbjct: 48 LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 107
Query: 80 -----------PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128
L I+ + + M YL AS HRD+ + N L+ K+
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKI 164
Query: 129 SNFGTSRS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAK 175
+FG SR + D + ++ P+ DV SFGV+L E+ T G +
Sbjct: 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
Query: 176 P 176
P
Sbjct: 225 P 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.6 bits (89), Expect = 0.002
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + +LH S + HRDIKS NILL K+++FG +Q+ +T V GT
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
++ P+ D+ S G++ +E++ G P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 15/96 (15%)
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
E + YLH S I +RD+K N++LD K+++FG + D + T GT
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGT 158
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
YL P+ D GVV+ E++ G P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 16/101 (15%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQVHGTFGYL 155
M YL AS HRD+ + N+L+ + K+++FG +R +D TT ++
Sbjct: 147 MEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM 203
Query: 156 NPD-----------DVCSFGVVLVELLT-GAKPIRFTTFEE 184
P+ DV SFGV+L E+ T G P EE
Sbjct: 204 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 41/156 (26%), Positives = 64/156 (41%), Gaps = 41/156 (26%)
Query: 47 EVVIQSQINHINVVKLIG--------CCLETKYMHDQNKELPFTW-------EMQLRISI 91
E+ I I+H ++ LI C + KY D FT+ ++ I+I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL-----FTYVDRSGPLPLEQAITI 190
Query: 92 EAS--GTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
+ ++YLH I HRD+K+ NI LD+ A + +FG + +D T Q +
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK--LDAHPDTPQCY 245
Query: 150 GTFG--------------YLNPDDVCSFGVVLVELL 171
G G Y D+ S G+VL E+
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 15/98 (15%)
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
S E S ++YLH I +RD+K N+LLD + K++++G + + T+
Sbjct: 102 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC 157
Query: 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
GT Y+ P+ D + GV++ E++ G P
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 14/83 (16%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRS--RAVDQTHITTQVH------------GTFG 153
I HRD+K TN+L++ K+ +FG S + ++ +T+I Q +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 154 YLNPDDVCSFGVVLVELLTGAKP 176
Y DV S G+ ++E+ G P
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 40/170 (23%)
Query: 37 GMAKVEKFINEVVIQSQINHINVVKLIGCCLE------TKYMH-----DQNKE------- 78
G E F+ E I ++ H +V L E T++M D KE
Sbjct: 41 GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLK 100
Query: 79 LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG------ 132
LP +M +I A G M+Y+ + HRD+++ NIL+ D K+++FG
Sbjct: 101 LPQLVDMAAQI---ADG-MAYIERMNYI---HRDLRAANILVGDNLVCKIADFGLARLIE 153
Query: 133 ----TSRSRA---VDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLTGAK 175
T+R A + T ++G F DV SFG++L EL+T +
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTI--KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 13/82 (15%)
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I +RD+K NILLDD+ ++S+ G + +T + +V GT GY+ P+
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 159 --DVCSFGVVLVELLTGAKPIR 178
D G ++ E++ G P R
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 56/208 (26%)
Query: 26 LGQGGQDIVYKGMAKV-------------------EKFINEVVIQSQINHINVVKLIGCC 66
LG+G VYKG + I E+ + ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 67 LETKYMHDQNK-ELPFTW-EMQLRISIEASGTMSYLHLSASVP----------------I 108
+H +NK L F + + L+ ++ G L + +
Sbjct: 64 --HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---------- 158
HRD+K N+L++ + K+++FG +R+ + + +V T Y PD
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEE 184
D+ S G ++ E++TG T E+
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 17/107 (15%)
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149
+ E + + +LH I +RD+K N+LLD + K+++FG + + T+
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFC 157
Query: 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED 185
GT Y+ P+ D + GV+L E+L G P F ED
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP--FEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.004
Identities = 49/212 (23%), Positives = 79/212 (37%), Gaps = 68/212 (32%)
Query: 18 DSFNVNRILGQGG-----------------------QDIVYKGMAKVEKFINEVVIQSQI 54
D F + LG G IV + +VE +NE I I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--LKQVEHVLNEKRILQSI 58
Query: 55 NHINVVKLIGCCLETK--YM-------------HDQNKELPFTWEM----QLRISIEASG 95
H +V L G + Y+ ++ P Q+ +++E
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE--- 115
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
YLH S+ I +RD+K N+LLD K+++FG ++ R +T+ GT YL
Sbjct: 116 ---YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYTLC---GTPEYL 165
Query: 156 NPD-----------DVCSFGVVLVELLTGAKP 176
P+ D + G+++ E+L G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 45/217 (20%), Positives = 92/217 (42%), Gaps = 57/217 (26%)
Query: 9 ISNELEKATD-SFNVNRILGQGGQDIVYKGM-------AKVEKFIN-------EVVIQSQ 53
I N++ ++ + S+ + I+G G +VY+ + ++K + E++I
Sbjct: 56 IDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN 115
Query: 54 INHINVVKL-----------------IGCCLE---------TKYMHDQNKELPFTWEMQL 87
+NHIN++ L + +E K+ N LP +
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF--LVK 173
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQ---TH 143
S + ++Y+H S I HRD+K N+L+D + K+ +FG++++ Q ++
Sbjct: 174 LYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 144 ITTQVH-------GTFGYLNPDDVCSFGVVLVELLTG 173
I ++ + G Y D+ S G ++ E++ G
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.7 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.69 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.56 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.45 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.34 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.34 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.8 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.65 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.5 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.56 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.03 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.88 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.5 | |
| PLN02236 | 344 | choline kinase | 92.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 92.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.05 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 91.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 91.37 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 91.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.16 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.28 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 90.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 89.69 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.55 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.21 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.94 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.73 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.71 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 87.22 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 85.71 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 85.54 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 83.86 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.01 Aligned_cols=195 Identities=26% Similarity=0.440 Sum_probs=172.3
Q ss_pred CCcccCceeeeeCCeeEEEeEc---------------------cHHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMA---------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~---------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
.+|...+.||+|||+.||++++ ..++..+||++.++|+|||||+++++|++.++++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999986 167899999999999999999999999998776532
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
....++++.++..++.||+.||.||| +++|+|||||..|++++++..+||+|||+|..+..+. .
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence 23457999999999999999999999 9999999999999999999999999999999776443 3
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
...+.+||+.|.||| ||||+||++|-||.|++||.... ++...+.+..+||.++|
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHh
Confidence 345579999999999 99999999999999999997553 34456889999999999
Q ss_pred CCCCCCCCCHHHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASELA 216 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~ 216 (288)
++||.+|||+++|+.+=-
T Consensus 254 ~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPF 271 (592)
T ss_pred cCCcccCCCHHHHhcCHh
Confidence 999999999999998743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.15 Aligned_cols=208 Identities=33% Similarity=0.568 Sum_probs=173.1
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
+....+++.+.+.||+|+||+||+|.++ .+.|.+|+.+|.+++|||||+++|+|.+..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 3444556667788999999999998763 348999999999999999999999987653
Q ss_pred -----cccc-------cC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEEeCCCCCCeeecCCC-ceEEecccCcc
Q 044995 71 -----YMHD-------QN-KELPFTWEMQLRISIEASGTMSYLHLSASVP-IYHRDIKSTNILLDDKY-CAKVSNFGTSR 135 (288)
Q Consensus 71 -----~l~~-------~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlkp~Nil~~~~~-~~kl~DfG~a~ 135 (288)
|+.. .. ....+++..+++++.||++||.||| +.+ |||||||++|||++.++ .+||+|||+++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 3321 11 3567999999999999999999999 777 99999999999999997 99999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchh
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDK 186 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~----------------~~~~~ 186 (288)
...... ...+...||+.||||| ||||||+++|||+||+.||.... .+..+
T Consensus 193 ~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 193 EKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 654322 2222357999999999 99999999999999999996433 34457
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
+..+..+|.+||+.||+.||++.+|+..|+.+......
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 88999999999999999999999999999988765443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=302.90 Aligned_cols=193 Identities=26% Similarity=0.382 Sum_probs=164.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------- 70 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 70 (288)
++++.+..||+|..|+||+++++ .+++.+|+++++.++||+||+++|+|....
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46677889999999999999875 567899999999999999999999987643
Q ss_pred cccccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 71 YMHDQN------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 71 ~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
||.... ..+.+++...-+++.++++||.|||. .++||||||||+|||++.+|.+||+|||.++.+... .
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 443321 12358889999999999999999992 278999999999999999999999999999876543 4
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC--------------------Cccch-hHHHHHH
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT--------------------TFEED-KNITVAK 192 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~--------------------~~~~~-~~~~~~~ 192 (288)
..+.+||..||||| ||||||++++|+++|+.||... ..+.. .+.+++.
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 45678999999999 9999999999999999998642 12333 6889999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++..||+.||.+||++.++++|=
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCH
Confidence 99999999999999999999873
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.43 Aligned_cols=216 Identities=44% Similarity=0.758 Sum_probs=177.4
Q ss_pred cccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceE
Q 044995 4 KTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCC 66 (288)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~ 66 (288)
..+.|+++++..+|++|.-.+.||+|+||.||+|... ..+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4678999999999999999999999999999998631 35699999999999999999999999
Q ss_pred ecccc--------ccc-------cCCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 67 LETKY--------MHD-------QNKEL-PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 67 ~~~~~--------l~~-------~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
.+.+. +.. ..... +++|..+++|+.++|+||+|||..+..+|||||||++|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 87652 111 11122 789999999999999999999987777899999999999999999999999
Q ss_pred ccCccccCC-CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------
Q 044995 131 FGTSRSRAV-DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------- 181 (288)
Q Consensus 131 fG~a~~~~~-~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------- 181 (288)
||+|+.... ........ .||.+|++|| ||||||++|.||+||+.+.+...
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976543 22211111 7999999999 99999999999999998764211
Q ss_pred ---------------ccc-hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 ---------------FEE-DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 ---------------~~~-~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
... .....+..+..+|++.+|.+||+|.+++++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 010 123457778899999999999999999999965543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=289.43 Aligned_cols=198 Identities=20% Similarity=0.338 Sum_probs=161.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecce-Eecc-cccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGC-CLET-KYMH- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~-~~~~-~~l~- 73 (288)
..+|+++++||+|+||+||++.+. .+....|+.+|++|+|||||+++++ +.+. +.++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 456999999999999999999752 5678899999999999999999983 3222 2111
Q ss_pred ----------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 74 ----------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 74 ----------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...+..-+++..+++++.|++.||..+|..- .+ |+||||||.||+++.+|.+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 1223346899999999999999999999421 44 9999999999999999999999999999
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------c-chhHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------E-EDKNI 188 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~-~~~~~ 188 (288)
.+...... ....+||+.||+|| ||||+||++|||+.-++||.+.++ + +..+.
T Consensus 177 ~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred HhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 87654443 33468999999999 999999999999999999976542 2 34578
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
++..+|..|+..||+.||+...++..+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 9999999999999999998555554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=306.91 Aligned_cols=208 Identities=27% Similarity=0.400 Sum_probs=173.4
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
+.++...+.+++.+.||+|-||+||.|.++ .+.|.+|+++|++|+|+|||+++++|...+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 344555566778899999999999999763 578999999999999999999999998754
Q ss_pred ---ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ---YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ---~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
|+... .+...+...+.+.++.|||+||+||. ++++|||||..+|||++++..+||+|||+|+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 33211 23446788899999999999999999 99999999999999999999999999999995544
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
+.........-...|.||| |||||||+||||+| |+.||...+ -+..++.++.+
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~ 435 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYE 435 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHH
Confidence 4443333333456799999 99999999999998 899986543 35567999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+|..||..+|++||||..+...|+.+...
T Consensus 436 lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999877653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=300.78 Aligned_cols=197 Identities=23% Similarity=0.315 Sum_probs=163.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
...+.|.+.+.||+|+||.|-+|..+ .....+|+++|++|+|||||++++++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35577889999999999999988642 22346999999999999999999998877
Q ss_pred ccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecccC
Q 044995 70 KYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGT 133 (288)
Q Consensus 70 ~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~DfG~ 133 (288)
++.+... ....+.+.....++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 6543221 2234666777889999999999999 9999999999999999655 6889999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTFE---------------- 183 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~~---------------- 183 (288)
|+... ......+.+||+.|.||| ||||+||+||-+++|.+||....-+
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 99764 334455689999999999 9999999999999999999643221
Q ss_pred ---chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 184 ---EDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 184 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
...+.+..++|.+||..||++||++.|++++=+
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 133778999999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=286.95 Aligned_cols=193 Identities=22% Similarity=0.286 Sum_probs=160.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
+.|+.+.++|+|+||+||+++++ .+-.++|+++|++|+|+|+|.++++|....-++...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888999999999999999875 344689999999999999999999876554333211
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
....++.....+++.|++.|+.|+| ++++|||||||+||||+.+|.+||||||+|+.+..+. ..
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-DN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-ch
Confidence 1224678889999999999999999 9999999999999999999999999999999876422 23
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------------------- 184 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------------------------- 184 (288)
-+..+.|.+|.||| ||||+||++.||++|++-|++.+..+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 34567899999999 99999999999999998886543211
Q ss_pred -----------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -----------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -----------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.-+.+++..||..||++|++-++++.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 114568899999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.60 Aligned_cols=209 Identities=26% Similarity=0.472 Sum_probs=174.8
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEc-----------------cHHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMA-----------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++..+.+.+...||+|.||+||+|.+ +.+.|.+|+.++++-+|.||+-++|+|....+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 478888889999999999999999999986 368899999999999999999999998766432
Q ss_pred -------------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 -------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 -------------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+.......|.....+.|+.|+++||.||| .++|||||||..||++.+++.|||+|||++.....
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 12223345778889999999999999999 99999999999999999999999999999864322
Q ss_pred C-CceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC-------------------ccch
Q 044995 140 D-QTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT-------------------FEED 185 (288)
Q Consensus 140 ~-~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~-------------------~~~~ 185 (288)
- .........|...||||| ||||||+++|||++|..||.... ...+
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 1 111122345888999999 99999999999999999996221 1123
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+..++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 467999999999999999999999999999888763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=284.73 Aligned_cols=195 Identities=28% Similarity=0.349 Sum_probs=162.9
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++++.||+|+||.||.++.+ .+....|..+|.+++||+||+++-.|.+.+.++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44689999999999999999998753 456778999999999999999998887765443
Q ss_pred c-------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 D-------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
. ..+...+++..+.-++..|+.||.||| +++||||||||+|||++.+|.++|+|||+++.....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 2 234457889999999999999999999 999999999999999999999999999999854322
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHA 194 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li 194 (288)
...+.+.+||+.||||| |.||||+++|||++|.+||...+ .+.-.+.+.++++
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 23344579999999999 99999999999999999996443 2223578899999
Q ss_pred HHhcCCCCCCCC----CHHHHHH
Q 044995 195 KRCLNPSGKKRP----AMKEVAS 213 (288)
Q Consensus 195 ~~cl~~~p~~Rp----~~~~i~~ 213 (288)
.++|..||++|. ++.+|-+
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhc
Confidence 999999999995 4555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.28 Aligned_cols=193 Identities=24% Similarity=0.412 Sum_probs=159.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..++|.+.++||+|+||+||+|+++ .+-...|+.+|+.++|||||++++++...++++..
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4588999999999999999999864 45578999999999999999999998877665543
Q ss_pred CC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC------CceEEecccCccc
Q 044995 76 NK-------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK------YCAKVSNFGTSRS 136 (288)
Q Consensus 76 ~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~------~~~kl~DfG~a~~ 136 (288)
.+ ...+++..+..++.|++.||++|| +++||||||||+|||++.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 32 235789999999999999999999 8999999999999999653 4689999999997
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNI 188 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~ 188 (288)
+.. .....+.+|++.||||| |+||+|+++|++++|+.||+..+. +...+.
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 653 33445678999999999 999999999999999999973322 223345
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
...+++...++.++.+|-++.+...
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhh
Confidence 5668888888999888877666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=288.58 Aligned_cols=198 Identities=27% Similarity=0.425 Sum_probs=163.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceE---------ecc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCC---------LET 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~---------~~~ 69 (288)
..++...+.||+|+||.||++... .+.+.+|+++|.+|+|||||+++|.. .-.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456788899999999999999763 34478999999999999999999952 223
Q ss_pred cccccc------CCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCC--
Q 044995 70 KYMHDQ------NKEL-PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAV-- 139 (288)
Q Consensus 70 ~~l~~~------~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~-- 139 (288)
+|.... .... .+++..+..+..|++.||.||| +++|+||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 333221 1112 6899999999999999999999 999999999999999998 79999999999986653
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCC-----------------CCccchhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRF-----------------TTFEEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~-----------------~~~~~~~~~~~ 190 (288)
..........||+.||||| |||||||++.||+||+.||.. ...+...+.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 2222233467999999999 999999999999999999864 23345567899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+++.+|+..||++||||.+++++..-
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 999999999999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.19 Aligned_cols=196 Identities=23% Similarity=0.312 Sum_probs=165.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------HHH--HHHHHHHHhcCC-CCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------VEK--FINEVVIQSQIN-HINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~--~~~E~~~l~~l~-HpnIv~l~~~~~~~~---- 70 (288)
...++|.+.++||.|.||.||+|+.+ .++ =+||++.|++|+ |||||++.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34588999999999999999999753 122 258999999999 999999999887765
Q ss_pred ----ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ----YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ----~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
||. ...+...|++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 221 1223567999999999999999999999 999999999999999998899999999999977654
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------ 184 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------ 184 (288)
..+ +..+.|.+|.||| ||||+||+++|+.+-++-|.+.+..+
T Consensus 164 pPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 PPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 443 4568999999999 99999999999999988886543211
Q ss_pred --------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 --------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 --------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.+..++|.+||+.||++||||.+.+++-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1266889999999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=286.61 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=169.2
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------------------HHHHHHHHHHHhcC
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------------------VEKFINEVVIQSQI 54 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------------~~~~~~E~~~l~~l 54 (288)
.|.-.+-.+..+.|++.+.||+|.||.|-+|++. .++..+||.+|++|
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 3444445677899999999999999999998641 46889999999999
Q ss_pred CCCceeeecceEecc---------ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCee
Q 044995 55 NHINVVKLIGCCLET---------KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNIL 119 (288)
Q Consensus 55 ~HpnIv~l~~~~~~~---------~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil 119 (288)
.|||||+|+++.-+. +|+.. ......++..++.+++.++..||+||| .++||||||||+|+|
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLL 242 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheE
Confidence 999999999875432 22221 112222889999999999999999999 889999999999999
Q ss_pred ecCCCceEEecccCccccCCC----CceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCC
Q 044995 120 LDDKYCAKVSNFGTSRSRAVD----QTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFT 180 (288)
Q Consensus 120 ~~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~ 180 (288)
++++|.+||+|||.+...... ........+||+.|+||| ||||+||+||-|+.|+.||...
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999998754211 111112357999999999 9999999999999999999532
Q ss_pred C--------------ccc--hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 181 T--------------FEE--DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 181 ~--------------~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
. ++. +....+.+||.++|..||++|.+..+|..+..-...
T Consensus 323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2 222 347889999999999999999999999888764433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.73 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=167.4
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKY 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 71 (288)
....+||.+++.||+|+|++||+|+++ .+...+|-.+|.+| .||.||+|+--|.+.+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345678999999999999999999863 33456788889999 89999999988777654
Q ss_pred cc-------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 MH-------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 l~-------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++ ...+.+.|++..+..++.+|+.||+||| +.|||||||||+|||++++|.+||.|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 43 2334456888889999999999999999 9999999999999999999999999999998764
Q ss_pred CCCce---------e---eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------
Q 044995 139 VDQTH---------I---TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-------------- 181 (288)
Q Consensus 139 ~~~~~---------~---~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-------------- 181 (288)
..... . ....+||..|.+|| |||+|||+||+|+.|.+||...+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 32111 1 13478999999999 99999999999999999996543
Q ss_pred ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 182 FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 182 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++..+..+.+|+.+.|..||++|++..+|.+|
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 566778999999999999999999999988876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=292.34 Aligned_cols=193 Identities=25% Similarity=0.407 Sum_probs=166.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH---- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~---- 73 (288)
++|.+.+.||+|+||.||||+.| .+.+.+|+++++.|+|||||.++++|.....+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 67999999999999999999864 345889999999999999999999876543322
Q ss_pred --------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 74 --------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 --------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....+..++++.+..++.++..||.||| +.+|+|||+||.|||++..|.+|++|||+|+.... .....
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 1234567999999999999999999999 99999999999999999999999999999997544 34455
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCC
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~ 200 (288)
+.+.||+.||||| |.||+||++||+++|++||...+ .+...+..+..++...|..
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 6678999999999 99999999999999999995322 2345578899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044995 201 SGKKRPAMKEVASE 214 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~ 214 (288)
||.+|.+..+++.|
T Consensus 238 dP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGH 251 (808)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999998865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=285.74 Aligned_cols=196 Identities=27% Similarity=0.325 Sum_probs=163.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------ 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 69 (288)
..+.|+.+++||+|.||.||++++. ..-..+||.||++|+|||||+|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4567888999999999999999863 12356999999999999999999876554
Q ss_pred ---ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 70 ---KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 ---~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+||.. ......|++.++..++.|++.||+|+| .++|+|||||.+|||||.+|.+||+|||+|+.....
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 34432 223446899999999999999999999 999999999999999999999999999999977665
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------ 184 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------ 184 (288)
.....+..+-|++|.+|| |+||.||||.||++|++.|.+.+..+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 555455567899999999 99999999999999998885433211
Q ss_pred -------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+....+|+..+|..||++|.||.+.++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 125677889999999999999999988864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=284.25 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=162.7
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
....++|++.+.||+|+||.||+|.+. .+.+.+|+.++.++ +|||||+++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345688999999999999999998520 24688999999999 89999999998754
Q ss_pred cc--------cccccC----------------------------------------------------------------
Q 044995 69 TK--------YMHDQN---------------------------------------------------------------- 76 (288)
Q Consensus 69 ~~--------~l~~~~---------------------------------------------------------------- 76 (288)
.+ |+....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 32 211000
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-eeeccccC
Q 044995 77 ----KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGT 151 (288)
Q Consensus 77 ----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt 151 (288)
...++++...+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 0124778888999999999999999 889999999999999999999999999999764322211 11223456
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHHHHHHHHhcCCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
..|+||| |||||||++|||++ |..||..... +...+..+.+++.+||+.||+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 7899999 99999999999997 9999865332 223467899999999999999
Q ss_pred CCCCHHHHHHHHHhchh
Q 044995 204 KRPAMKEVASELAGIKA 220 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~~~~ 220 (288)
+||++.++++.|+.+..
T Consensus 320 ~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 320 ERPTFSALVEILGDLLQ 336 (338)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=263.39 Aligned_cols=194 Identities=21% Similarity=0.262 Sum_probs=160.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
++|...++||+|.||.||+|++. .-..++|++.|+.++|+||+.++++|-..+.+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57888999999999999999863 2357899999999999999999999866543321
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
..+...++......++.++.+|++|+| .+.|+||||||.|+|++.+|.+||+|||+|+.........
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 233456888899999999999999999 8999999999999999999999999999999876554433
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------------------- 184 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------------------------- 184 (288)
... +-|.+|.||| ||||.||++.||+-|.+-|.+.+.-+
T Consensus 159 ~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred ccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 333 6789999999 99999999999999876664332111
Q ss_pred --------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 --------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 --------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.+..+++.++|..||.+|.++.|.+++=
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 1245679999999999999999999988763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=286.04 Aligned_cols=196 Identities=20% Similarity=0.246 Sum_probs=157.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---------- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---------- 74 (288)
.++|++.+.||+|+||.||++.+. .+.+.+|++++++++|||||++++++....+...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~ 170 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLY 170 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHH
Confidence 467999999999999999999763 3568899999999999999999998765443211
Q ss_pred --cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCC
Q 044995 75 --QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152 (288)
Q Consensus 75 --~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 152 (288)
......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..............||+
T Consensus 171 ~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 247 (391)
T PHA03212 171 CYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247 (391)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence 112235788889999999999999999 889999999999999999999999999998753322222223457999
Q ss_pred CCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-------------------------cc-------------
Q 044995 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-------------------------FE------------- 183 (288)
Q Consensus 153 ~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-------------------------~~------------- 183 (288)
.|+||| |||||||++|||++|..||.... ++
T Consensus 248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 999999 99999999999999997763210 00
Q ss_pred ------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++|||+.|++++-
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 01134678899999999999999999999754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=297.14 Aligned_cols=203 Identities=28% Similarity=0.439 Sum_probs=169.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 70 (288)
...+....+.||+|.||+||+|.. ..++|.+|++++..|+|||||+|+|+|.+++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345667789999999999999863 1578999999999999999999999998763
Q ss_pred ------cccc----------------cCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC
Q 044995 71 ------YMHD----------------QNK----ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124 (288)
Q Consensus 71 ------~l~~----------------~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~ 124 (288)
|+.. ... ..+++..+.+.|+.|||.||+||- ++.++||||-.+|+||+++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence 3210 101 334889999999999999999999 88899999999999999999
Q ss_pred ceEEecccCccccCCCCceeee-ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------
Q 044995 125 CAKVSNFGTSRSRAVDQTHITT-QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------- 181 (288)
Q Consensus 125 ~~kl~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------- 181 (288)
.+||+|||+++.+-...++... ...-...||+|| |||||||+|||+++ |+.||.+.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 9999999999865444433322 223456899999 99999999999998 889986543
Q ss_pred -----ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 -----FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
-++.++.++..||..||+.+|++||+++||..+|+.....
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3556799999999999999999999999999999877554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=285.29 Aligned_cols=195 Identities=26% Similarity=0.404 Sum_probs=166.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc------------------cHHHHHHHHHHHhcCCCCceeeecceEecc-------c
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA------------------KVEKFINEVVIQSQINHINVVKLIGCCLET-------K 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------~ 70 (288)
....|....+||+|+.|.||.++. +.+-+++|+.+|+..+|+|||.+++.|... |
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345688889999999999998864 256688999999999999999999876543 4
Q ss_pred ccccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 71 YMHDQ-----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 71 ~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
|+... .....+++.++..|+.+++.||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 55432 22335789999999999999999999 99999999999999999999999999999987765544 34
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC-----------------CccchhHHHHHHHHHHh
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT-----------------TFEEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~-----------------~~~~~~~~~~~~li~~c 197 (288)
.+.+||+.||||| ||||||++++||+.|++||-.. ..++..+..+++++.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 4568999999999 9999999999999999999532 13345588999999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|..|+++|+++.|+|+|
T Consensus 507 L~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcchhcCCCHHHHhcC
Confidence 99999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=272.69 Aligned_cols=194 Identities=21% Similarity=0.201 Sum_probs=158.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
++|++.+.||+|+||.||+++++ .+.+.+|+.++++++||||+++++++...+.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 57999999999999999998753 356789999999999999999999876554322111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 1235788889999999999999999 8899999999999999999999999999998654322222
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------------
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------------------ 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------------------ 183 (288)
.....|+..|+||| |||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23456899999999 9999999999999999999643210
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=284.67 Aligned_cols=202 Identities=28% Similarity=0.434 Sum_probs=165.8
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------HHH-HHHHHHHHhcCCCCceeeecceEecc-------cccc-
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------VEK-FINEVVIQSQINHINVVKLIGCCLET-------KYMH- 73 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~-~~~E~~~l~~l~HpnIv~l~~~~~~~-------~~l~- 73 (288)
+.|++.-+....++.||+|+.|.||+|+.+ +.+ -..+|+-|++|+||||+.+.|+|... +|..
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 445555666667899999999999999864 222 23477789999999999999987654 4332
Q ss_pred -----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 74 -----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 74 -----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
......++.......+..+|+.||.||| .+.|||||||.-||||..+..+||+|||.++..... .....+
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 1223346778888999999999999999 888999999999999999999999999999865432 334457
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC----------------CccchhHHHHHHHHHHhcCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~----------------~~~~~~~~~~~~li~~cl~~~ 201 (288)
+||..||||| |||||||+|||||||+.||... ..+..++..+.-|++.||+..
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 8999999999 9999999999999999999532 245677889999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 044995 202 GKKRPAMKEVASELAG 217 (288)
Q Consensus 202 p~~Rp~~~~i~~~l~~ 217 (288)
|.+||+|++|+.||.-
T Consensus 352 pRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLDI 367 (904)
T ss_pred CCCCccHHHHHHHHhh
Confidence 9999999999998863
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.34 Aligned_cols=207 Identities=26% Similarity=0.447 Sum_probs=170.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcCCCCceeeecceEecc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQINHINVVKLIGCCLET--- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 69 (288)
.++-++.+.||+|.||+||.|+. +.++|++|+.+|+.++|||||+++|+|.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 45567789999999999999964 157899999999999999999999999875
Q ss_pred ----cccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 70 ----KYMHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 70 ----~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+||... .....++..+.+.++.|||+|+.||+ ++++|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 344321 11335788999999999999999999 8889999999999999999999999999
Q ss_pred CccccCCCCceeee-ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccc
Q 044995 133 TSRSRAVDQTHITT-QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEE 184 (288)
Q Consensus 133 ~a~~~~~~~~~~~~-~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~ 184 (288)
+|+.+-........ ...-...||||| |||||||++||++| |..||.... .+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 99955433333322 212346899999 99999999999999 889985432 345
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCCCc
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGASN 226 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 226 (288)
.++..+.++|..||+.+|++||++.+|++.+..+........
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 668889999999999999999999999999888876655444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.01 Aligned_cols=194 Identities=25% Similarity=0.347 Sum_probs=163.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH---- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~---- 73 (288)
...|+..+.||+|+||.||+|.+. .+.+.+|+.+|.+++++||.++++.+..+..+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 356788899999999999999763 567889999999999999999999987664332
Q ss_pred ---c-----cCCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 74 ---D-----QNKEL-PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 74 ---~-----~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
+ ..+.. .+.+.....++.++..||.||| .++.+|||||+.|||+..+|.+||+|||++..+.......
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 1 12222 3377777888999999999999 8999999999999999999999999999998766544443
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhc
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl 198 (288)
.+.+||+.||||| ||||||++.+||++|.+|+.... +....+..+++++..||
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 6678999999999 99999999999999999985322 33456788999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||+.||+|.+++++
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=278.64 Aligned_cols=197 Identities=24% Similarity=0.327 Sum_probs=165.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCC-CCceeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 70 (288)
...+.|.+.+.||+|+||.|+.|.+. .+.+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45679999999999999999999652 223457999999999 999999999865432
Q ss_pred -------ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccc
Q 044995 71 -------YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRS 136 (288)
Q Consensus 71 -------~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~ 136 (288)
|.. .......+.+..+.+++.|++.|++|+| .++|+||||||+|||++.+ +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 221 1223467889999999999999999999 9999999999999999999 9999999999987
Q ss_pred cCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchh-HH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDK-NI 188 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~-~~ 188 (288)
.. .......+.+||+.|+||| ||||+||+||.|++|..||.... ++... +.
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSP 249 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCH
Confidence 64 2233445578999999999 99999999999999999997543 33445 88
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++..++.+||..||.+|+++.+|+++=
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 999999999999999999999999543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.46 Aligned_cols=194 Identities=23% Similarity=0.282 Sum_probs=156.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
.++|++.++||+|+||.||+|.++ ...+.+|++++++++||||+++++++.........
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999652 23678999999999999999999987654332111
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 11224678888999999999999999 88999999999999999999999999999875432221 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....+++.|+||| |||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 22345788999999 9999999999999999998543210
Q ss_pred ---------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.+..+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0124577899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.55 Aligned_cols=194 Identities=24% Similarity=0.292 Sum_probs=157.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
.++|++.+.||+|+||.||+|.++ ...+.+|+.++++++||||+++++++...+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999753 2357899999999999999999998766543221
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 159 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-T 159 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-c
Confidence 112235788889999999999999999 88999999999999999999999999999875432211 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------------------- 184 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------------------------- 184 (288)
.....+++.|+||| |||||||++|||++|..||.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 22345889999999 99999999999999999996421100
Q ss_pred -------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 012457799999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.15 Aligned_cols=197 Identities=21% Similarity=0.266 Sum_probs=160.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEccHH--------------------HHHHHHHHHhcCCCCceeeecceEec------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAKVE--------------------KFINEVVIQSQINHINVVKLIGCCLE------ 68 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------------~~~~E~~~l~~l~HpnIv~l~~~~~~------ 68 (288)
...+.|+.+++|++|+||+||+|+++.. .-++||.+|.+++|||||.+-++...
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3456799999999999999999987511 25799999999999999998776433
Q ss_pred ---cccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 69 ---TKYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 69 ---~~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++|+.. ..-..++...++..+..|++.|++||| .+.|+|||||++|+|+...|.+||+|||+|+....
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 334321 122357889999999999999999999 89999999999999999999999999999998765
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------- 184 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~----------------------- 184 (288)
.... .+..+-|.+|.||| |+||+|||+.||+++++-|.+....+
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 4332 33456789999999 99999999999999988775432111
Q ss_pred ----------------------h-hHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ----------------------D-KNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ----------------------~-~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
. .+..-.+|++.+|..||.+|-||.|.+++=
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 0 246778999999999999999999988763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.00 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=161.8
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceEe
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCCL 67 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 67 (288)
|....++|++.+.||+|+||.||++.+. .+.+.+|+++++.+ +|+|||+++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3444567999999999999999987620 34688999999999 8999999999876
Q ss_pred cccccccc------------------------------------------------------------------------
Q 044995 68 ETKYMHDQ------------------------------------------------------------------------ 75 (288)
Q Consensus 68 ~~~~l~~~------------------------------------------------------------------------ 75 (288)
....+...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 54221100
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++...++++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 01124678889999999999999999 8899999999999999999999999999997654322211
Q ss_pred -eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHHHHHHH
Q 044995 145 -TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITVAKHAK 195 (288)
Q Consensus 145 -~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~~~li~ 195 (288)
.....++..|+||| |||||||++|||++ |..||..... +...+.++.+++.
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK 349 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence 11223556799999 99999999999997 9999854321 1123678999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhch
Q 044995 196 RCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+||+.||++||++.++++.|+++.
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=258.15 Aligned_cols=183 Identities=28% Similarity=0.321 Sum_probs=158.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++++.||.|+||.|.+++.+ .+...+|.++|+.+.||+++++++.|.+..+++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4578999999999999999998763 4667889999999999999999999887766543
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+.-++.+|+.||+||| +.+|++|||||+|||+|.+|.+||.|||+|+....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 22 3346889999999999999999999 88899999999999999999999999999987543
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
.+.+.+||+.|+||| |.|||||++|||+.|.+||...+ ++.-.+.++.+|+.+
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 255679999999999 99999999999999999996443 344457788999999
Q ss_pred hcCCCCCCC
Q 044995 197 CLNPSGKKR 205 (288)
Q Consensus 197 cl~~~p~~R 205 (288)
+|+.|-.+|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 999998888
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.15 Aligned_cols=195 Identities=23% Similarity=0.321 Sum_probs=158.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
.++|+..+.||+|+||.||+++++ .+.|.+|+++++.++|+||+++++++...+.++...
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 456788899999999999999752 356889999999999999999999886654332111
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 77 --------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 77 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
......+.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 1123466777889999999999999 88999999999999999999999999999876532221 11234
Q ss_pred ccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHHH
Q 044995 149 HGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKHA 194 (288)
Q Consensus 149 ~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~li 194 (288)
.||..|+||| |||||||++|||++|+.||..... ....+.++.++|
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 6899999999 999999999999999999963221 223467899999
Q ss_pred HHhcCCCCCCCCCHHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+||+.||++||++.|++++-
T Consensus 309 ~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 309 SCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HHHccCChhhCcCHHHHhcCc
Confidence 999999999999999999863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=267.95 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=164.6
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
.++....++|++.+.||.|..++||+|+.. .+.+.+|+..|+.++||||++++..|.....
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 344566789999999999999999999752 5678899999999999999999998877654
Q ss_pred ccccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 72 MHDQN---------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 72 l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+.... -...+++..+..|+.+++.||.||| .+|-||||||+.||||+.+|.+||+|||.+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 32211 1123788889999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCcee--e-eccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC-------------------
Q 044995 137 RAVDQTHI--T-TQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT------------------- 181 (288)
Q Consensus 137 ~~~~~~~~--~-~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~------------------- 181 (288)
+....... . ...+||++||||| ||||||++..||++|..||....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 43322111 1 4568999999999 99999999999999999995321
Q ss_pred -cc----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 182 -FE----EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 182 -~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+ ...+..++.++..||+.||.+|||+++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 01 1235688999999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=278.55 Aligned_cols=201 Identities=27% Similarity=0.420 Sum_probs=159.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
....++|++.+.||+|+||.||+|++ ..+.+.+|++++..+ +|||||+++++|.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456899999999999999998852 034688999999999 89999999998765
Q ss_pred ccccccc-------------------------------------------------------------------------
Q 044995 69 TKYMHDQ------------------------------------------------------------------------- 75 (288)
Q Consensus 69 ~~~l~~~------------------------------------------------------------------------- 75 (288)
.+.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 4321100
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 76 ---------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 76 ---------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.....+++...+.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 01124678889999999999999999 889999999999999999999999999999765432
Q ss_pred Ccee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHHH
Q 044995 141 QTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITVA 191 (288)
Q Consensus 141 ~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~~ 191 (288)
.... .....++..|+||| |||||||++|||++ |..||..... +...+.++.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY 347 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence 2211 11223456799999 99999999999998 8888854321 123457899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
+++.+||+.||++||++.+|++.|++
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=274.45 Aligned_cols=193 Identities=21% Similarity=0.362 Sum_probs=155.1
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc---------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET--------- 69 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 69 (288)
+|++.+.||+|+||.||+|.++ ...+.+|++++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999752 23578999999999999999999876432
Q ss_pred ---ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 70 ---KYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 70 ---~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 22211 112235788999999999999999999 8899999999999999999999999999987543221
Q ss_pred c--eeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 142 T--HITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 142 ~--~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
. .......|+..|+||| |||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 1112346899999999 9999999999999999998543210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=269.00 Aligned_cols=202 Identities=23% Similarity=0.392 Sum_probs=161.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
..+|++.+.||+|+||.||+|++. .+.|.+|+.+++.++||||++++++|.....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~ 85 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 85 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCcee
Confidence 367999999999999999998631 3568899999999999999999999865421
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 111 011234678888999999999999999 889999999999999999999999999999865432
Q ss_pred Ccee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHH
Q 044995 141 QTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAK 192 (288)
Q Consensus 141 ~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~ 192 (288)
.... .....++..|++|| ||||||+++|||++ |..||..... +...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2211 11223456799999 99999999999998 9999864321 1234568899
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
++.+||+.||++||++.+++..+..+...
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 99999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=267.81 Aligned_cols=197 Identities=23% Similarity=0.389 Sum_probs=156.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEc-----------------------------------cHHHHHHHHHHHhcCCCCceee
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA-----------------------------------KVEKFINEVVIQSQINHINVVK 61 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------------------------~~~~~~~E~~~l~~l~HpnIv~ 61 (288)
.++|++.++||+|+||.||++.+ ....|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 47899999999999999998852 0346889999999999999999
Q ss_pred ecceEeccc-------ccccc-------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 044995 62 LIGCCLETK-------YMHDQ-------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109 (288)
Q Consensus 62 l~~~~~~~~-------~l~~~-------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 109 (288)
+++++.+.+ |+... .....+++...++++.|++.||.||| +.+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 999876542 22110 00123577788999999999999999 88999
Q ss_pred EeCCCCCCeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh--CCC
Q 044995 110 HRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT--GAK 175 (288)
Q Consensus 110 Hrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt--g~~ 175 (288)
||||||+|||++.++.+||+|||+++........ ......++..|+||| ||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999998754332221 122234577899999 99999999999987 556
Q ss_pred CCCCCCc----------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 176 PIRFTTF----------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 176 P~~~~~~----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
||..... +...+..+.+++.+||+.||++||++.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7643221 1234568899999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=263.69 Aligned_cols=199 Identities=21% Similarity=0.355 Sum_probs=160.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~- 73 (288)
.++|++.+.||+|+||.||+|.++ .+.|.+|+.++++++||||+++++++...+.+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999998531 346889999999999999999999876653221
Q ss_pred ------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 ------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
. ......+++..++.++.|++.||.||| +.+++||||||+|||++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 1 111236789999999999999999999 889999999999999999999999999987653222
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~l 193 (288)
.........++..|+||| |||||||++||+++ |..||.... .+...+..+.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 211112233567899999 99999999999875 999985322 223456789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+.+||+.+|++||++.+|.+.|+++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=251.67 Aligned_cols=205 Identities=23% Similarity=0.338 Sum_probs=163.8
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEc------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMA------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
+.+..++|++.+.||+|||+-||.++. ..+..++|++..++++||||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345567899999999999999999872 2677899999999999999999998764321
Q ss_pred ---cc--------------c-ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 71 ---YM--------------H-DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 71 ---~l--------------~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
|+ . ...+...+++.+.++|+.++++||++||.. ..+.+||||||.|||+.+.+.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 11 1 122333689999999999999999999933 2349999999999999999999999999
Q ss_pred CccccCCCCceee--------eccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC---------
Q 044995 133 TSRSRAVDQTHIT--------TQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT--------- 181 (288)
Q Consensus 133 ~a~~~~~~~~~~~--------~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~--------- 181 (288)
.++.......... ..-..|..|.||| |||||||+||+|+.|..||...-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 9875432211111 0123688999999 99999999999999999995211
Q ss_pred ---------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 ---------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.....+..+.+++..||+.||.+||++.+++..+..+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1123578999999999999999999999999998765
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=281.04 Aligned_cols=187 Identities=29% Similarity=0.475 Sum_probs=156.6
Q ss_pred ceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC---------
Q 044995 24 RILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN--------- 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~--------- 76 (288)
-+||+|.||+||.|++. .+-+..|+.+.++|+|.|||+++|.|.+..|+...+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999874 345778999999999999999999998877653222
Q ss_pred -----CCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCCCCceeeecc
Q 044995 77 -----KELPF--TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 77 -----~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
+-+++ .+...--+..||++||.||| ++.|+|||||-+|+|++. .|.+||+|||.++.+..-. ..+.+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 22344 56667778999999999999 888999999999999964 5899999999998764332 234457
Q ss_pred ccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCC-----------------CCCccchhHHHHHHHHHHhc
Q 044995 149 HGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIR-----------------FTTFEEDKNITVAKHAKRCL 198 (288)
Q Consensus 149 ~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~-----------------~~~~~~~~~~~~~~li~~cl 198 (288)
.||..||||| |||||||++.||.||++||- ....++..+.+...+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 8999999999 99999999999999999983 23456677889999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
.+||.+||++.++++.
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=263.06 Aligned_cols=189 Identities=22% Similarity=0.356 Sum_probs=156.1
Q ss_pred ceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEec--c---------cccc
Q 044995 24 RILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLE--T---------KYMH 73 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~---------~~l~ 73 (288)
..||+|++|.||+|... .+.|.+|+.+|++++|||||++++++.+ . +|+.
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 67999999999999742 3667899999999999999999998765 1 1221
Q ss_pred c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D------QNKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++...+.++.+++.||.||| . .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~ 178 (283)
T PHA02988 106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----F 178 (283)
T ss_pred CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----c
Confidence 1 112245788899999999999999999 5 378899999999999999999999999987543221 1
Q ss_pred ccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHHHHHh
Q 044995 147 QVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKHAKRC 197 (288)
Q Consensus 147 ~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~li~~c 197 (288)
...|+..|+||| |||||||++|||++|+.||..... +...+..+.+++.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 235788999999 999999999999999999964321 224577899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhch
Q 044995 198 LNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
|+.||++|||+.++++.|+.+.
T Consensus 259 l~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 259 TSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred hcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=268.40 Aligned_cols=191 Identities=23% Similarity=0.317 Sum_probs=157.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.+.++++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 57999999999999999999753 23577899999999999999999876655432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++.....++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 12235788889999999999999999 889999999999999999999999999998764322
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
.....|++.|+||| |||||||++|||++|..||.... ++...+..+.+++.+||
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence 12346899999999 99999999999999999996432 22334678999999999
Q ss_pred CCCCCCCCC-----HHHHHHHH
Q 044995 199 NPSGKKRPA-----MKEVASEL 215 (288)
Q Consensus 199 ~~~p~~Rp~-----~~~i~~~l 215 (288)
+.||.+||+ +.+++++-
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCc
Confidence 999999995 88877663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=276.00 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=157.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------- 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 70 (288)
+|++.+.||+|+||.||++.+. .+++.+|+++++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999998742 346889999999999999999999876543
Q ss_pred ----cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 ----YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 ----~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 1111 112345788999999999999999999 8899999999999999999999999999997644332
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc---------------------------
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------------------- 182 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------------------- 182 (288)
........++..|+||| |||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22223345788999999 999999999999999999854321
Q ss_pred -------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 -------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 -------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
....+.++.+++.+||+.||++|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 112245778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=270.28 Aligned_cols=195 Identities=25% Similarity=0.350 Sum_probs=159.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
..++|++.+.||+|+||.||++.++ .+.|.+|++++++++||||+++++++...+.++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3588999999999999999998753 35688999999999999999999987665432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 11234778888999999999999999 64 5999999999999999999999999998754322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------------------
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----------------------------- 182 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----------------------------- 182 (288)
......|+..|+||| |||||||++|||++|+.||.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 122346899999999 999999999999999999853210
Q ss_pred ---------------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 ---------------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 ---------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
....+.++.+++.+||+.||++|||+.+++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0013567899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=271.44 Aligned_cols=192 Identities=26% Similarity=0.317 Sum_probs=158.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+|+++ .+.+.+|+.++++++||||+++++++.+.+.++.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3578999999999999999999752 2457899999999999999999998876543321
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 11 2235778888899999999999999 8899999999999999999999999999997653221
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
....||+.|+||| |||||||++|||++|..||.... .+...+..+.+++.+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2346899999999 99999999999999999995432 122346788999999
Q ss_pred hcCCCCCCCCC-----HHHHHHH
Q 044995 197 CLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~-----~~~i~~~ 214 (288)
||+.||.+|++ +.+++.+
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999986 5777665
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=281.33 Aligned_cols=195 Identities=21% Similarity=0.326 Sum_probs=155.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEec-------------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLE------------- 68 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~------------- 68 (288)
..++|++.+.||+|+||.||+|.+. .....+|+.+|++++|||||++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 4567999999999999999999752 2345679999999999999999876532
Q ss_pred --cccccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccc
Q 044995 69 --TKYMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRS 136 (288)
Q Consensus 69 --~~~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~ 136 (288)
.+|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 144 lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 122211 112345788889999999999999999 8899999999999999865 4799999999986
Q ss_pred cCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
...... .....||+.|+||| |||||||++|||++|.+||......
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 543221 22346899999999 9999999999999999999643210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||.+|||+.|++++-
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 11245788999999999999999999999773
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=251.62 Aligned_cols=195 Identities=28% Similarity=0.391 Sum_probs=166.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++++.||+|-||.||.|+.+ ..++.+|+++...|+||||++++++|.+...++
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34688999999999999999999864 346779999999999999999999988764332
Q ss_pred c---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 74 D---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 74 ~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
. ......+++..+..+..|++.||.|+| .++||||||||+|+|++..+.+|++|||-+...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 1 112335788889999999999999999 8999999999999999999999999999886543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKH 193 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~l 193 (288)
.....+.+||..|.+|| |+|++|++.||++.|.+||.... ++...+.+.+++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 33345578999999999 99999999999999999996433 344557889999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l 215 (288)
|.+|+..+|.+|....|++++-
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHhccCccccccHHHHhhhH
Confidence 9999999999999999998874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=277.72 Aligned_cols=214 Identities=27% Similarity=0.414 Sum_probs=177.9
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecc---
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLET--- 69 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 69 (288)
.++|+....+..+..+||-|.||.||.|.|+ .++|++|+.+|+.++|||+|+|+|+|...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4788888899999999999999999999875 68899999999999999999999998653
Q ss_pred ----ccccccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 ----KYMHDQN--------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 ----~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+||...+ ....++.-..+.++.||..||+||. .+++|||||..+|+|++++..+||+|||+++..
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 4442211 1223555667889999999999999 889999999999999999999999999999987
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
..+.........-...|.||| |||+|||+|||+.| |..||.+.+ -++.++..+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHH
Confidence 654443333223356799999 99999999999998 889986443 456789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCCCc
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGASN 226 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 226 (288)
.+||+.||+.+|.+||++.|+.+.++.+-.....+.
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd 531 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD 531 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence 999999999999999999999999998865544433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=264.76 Aligned_cols=191 Identities=24% Similarity=0.301 Sum_probs=155.6
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
.|++.+.||+|+||.||++.+. ...+.+|++++++++|+||+++++++.+.+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788899999999999998642 13477899999999999999999887654322
Q ss_pred --ccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 73 --HDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 73 --~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
... .....+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 111 12235788899999999999999999 8899999999999999999999999999987643222
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
......|+..|+||| |||||||++|||++|+.||..... ....+..+.++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 122346899999999 999999999999999999964321 22346789999
Q ss_pred HHHhcCCCCCCCCC-----HHHHHHH
Q 044995 194 AKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+.+||+.||++||+ +++++++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999997 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=265.36 Aligned_cols=192 Identities=23% Similarity=0.313 Sum_probs=152.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC---CCCceeeecceEecc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI---NHINVVKLIGCCLET---- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~---- 69 (288)
++|++.+.||+|+||.||++.+. ...+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999998641 23567788877765 699999999987521
Q ss_pred --------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 70 --------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 70 --------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 11111 011234788899999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-------------------- 183 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-------------------- 183 (288)
+..... .......|+..|+||| |||||||++|||++|..||......
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 754332 2223356899999999 9999999999999999998643210
Q ss_pred ---------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=261.43 Aligned_cols=198 Identities=22% Similarity=0.314 Sum_probs=161.6
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc----
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET---- 69 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 69 (288)
......|...+.||+|+||.|+.+.++ .++.++|+++|+.++|+||+.+.+.+...
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345566777899999999999998763 46788999999999999999999886542
Q ss_pred --------ccc----cccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 70 --------KYM----HDQNKE-LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 70 --------~~l----~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
++| +...+. ..++...+.-++.|++.||.|+| +.+|+||||||.|+|++.+..+||+|||+|+.
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 222 112222 33888899999999999999999 88999999999999999999999999999997
Q ss_pred cCCC-CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------
Q 044995 137 RAVD-QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------- 184 (288)
Q Consensus 137 ~~~~-~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------- 184 (288)
.... .....+..+.|.+|.||| ||||.|||+.||++|++-|.+.+...
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 6432 122234567899999999 99999999999999999886543211
Q ss_pred --------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 --------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 --------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+....+|+.+||..||.+|+|++|.+++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 125678899999999999999999999887
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.54 Aligned_cols=192 Identities=23% Similarity=0.445 Sum_probs=157.6
Q ss_pred CCc-ccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--c
Q 044995 18 DSF-NVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--M 72 (288)
Q Consensus 18 ~~y-~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--l 72 (288)
++| +...+||+|+|-+||+|.+. .++|..|+.+|+.|+|||||++++++.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 344 55678999999999999863 4789999999999999999999999876532 1
Q ss_pred c-------c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccC
Q 044995 73 H-------D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRA 138 (288)
Q Consensus 73 ~-------~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~ 138 (288)
. . ..+...++......|+.||+.||.|||.. ..+|||||||.+||+|+.+ |.+||+|+|+|+...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 1 0 11233567888899999999999999965 7899999999999999754 999999999998654
Q ss_pred CCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCC-----------------CccchhHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT-----------------TFEEDKNITVA 191 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~-----------------~~~~~~~~~~~ 191 (288)
... ...+.||+.||||| ||||||+.++||+|+..||.-= .+.....++++
T Consensus 198 ~s~---aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred ccc---cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 322 22368999999999 9999999999999999998421 12223477999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++|.+|+.. .++|+++.|+|++
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhC
Confidence 999999999 9999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.97 Aligned_cols=201 Identities=21% Similarity=0.355 Sum_probs=162.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
...++|++.++||+|+||.||+|... .+.+.+|+.++++++|+||+++++++...+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 45678999999999999999998642 467889999999999999999998876554321
Q ss_pred --c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 74 --D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 74 --~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
. ......+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 1 011234677888899999999999999 888999999999999999999999999999865432222
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
......++..|+||| ||||||+++|+|++ |..||..... ....+.++.+++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 222234567899998 99999999999998 9999853221 12346789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhc
Q 044995 197 CLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
||+.+|++||+++++.+.|+++
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.41 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=160.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~- 71 (288)
.++|++.+.||+|+||.||+|... .+.|.+|++++.+++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 358899999999999999998531 3468899999999999999999998765432
Q ss_pred ------ccc---------cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC
Q 044995 72 ------MHD---------QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK 123 (288)
Q Consensus 72 ------l~~---------~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~ 123 (288)
+.. .. ....+++...+.++.|++.||.||| +.+++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 110 00 0134678888999999999999999 8899999999999999999
Q ss_pred CceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------
Q 044995 124 YCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--------- 181 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--------- 181 (288)
+.+||+|||+++....... .......+++.|+||| |||||||++|||++ |..||....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 1122334678899999 99999999999998 999985322
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+...+.++.+++.+||+.||++||++.+|+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2234578999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.42 Aligned_cols=193 Identities=26% Similarity=0.316 Sum_probs=155.6
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM 72 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l 72 (288)
+|++.+.||+|+||.||++.+. .+.+.+|+.++.++ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999987531 23577899999999 599999999877654332
Q ss_pred c-------c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 H-------D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~-------~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+ . ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 1 1 112345788899999999999999999 88999999999999999999999999999876433
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNIT 189 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~~ 189 (288)
..........||..|+||| |||||||++|||++|..||.... .+...+..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 3332333457999999999 99999999999999999995321 12234677
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp-----~~~~i~~~ 214 (288)
+.+++.+||+.||++|| ++.+++++
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 89999999999999999 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=283.53 Aligned_cols=198 Identities=19% Similarity=0.203 Sum_probs=153.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------------------------HHHHHHHHHHHhcCCCCc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------------------------VEKFINEVVIQSQINHIN 58 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------------------~~~~~~E~~~l~~l~Hpn 58 (288)
...++|++.+.||+|+||.||++..+ ...|.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 45688999999999999999987521 234778999999999999
Q ss_pred eeeecceEeccccccccCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec
Q 044995 59 VVKLIGCCLETKYMHDQNK-----------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD 121 (288)
Q Consensus 59 Iv~l~~~~~~~~~l~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~ 121 (288)
||++++++...++.+...+ ........+..++.|++.||.||| +++|+||||||+|||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 9999998876554322111 111234567789999999999999 88999999999999999
Q ss_pred CCCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCC-CCCCC--------
Q 044995 122 DKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP-IRFTT-------- 181 (288)
Q Consensus 122 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P-~~~~~-------- 181 (288)
.++.+||+|||+++..............||..|+||| |||||||++|||++|..+ +....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999866443333333457999999999 999999999999998754 32111
Q ss_pred ------------ccc----------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 182 ------------FEE----------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 182 ------------~~~----------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++. ..+..+.+++.+||+.||++||++.|++++-
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 000 0123456678999999999999999999763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=274.73 Aligned_cols=207 Identities=27% Similarity=0.436 Sum_probs=174.2
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
+...+...+.++||+|-||.||+|.. +.+.|+.|+.+|++++|||||+++|+|.+..
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P 464 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP 464 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence 33445556678999999999999963 2689999999999999999999999998763
Q ss_pred cc-------------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 YM-------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ~l-------------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.. +.......++......++.|++.+|.||| +.+.+||||..+|||+.+...+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 11 11223346778888999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC---------------CccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT---------------TFEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~---------------~~~~~~~~~~ 190 (288)
.....+..+...-...||||| |||-|||.+||++. |..||.+- ..++.+++.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 777666665544566899999 99999999999986 89999533 3456778999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
..++.+||.++|.+||++.+|...|..+.....
T Consensus 622 YslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999988876443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=258.00 Aligned_cols=196 Identities=26% Similarity=0.403 Sum_probs=155.8
Q ss_pred cccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecc--------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------- 69 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 69 (288)
|.+.+.||+|+||.||+|.+. .+.|.+|++++++++|+||++++++|...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 457789999999999998631 35688999999999999999999876432
Q ss_pred -----cccccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 70 -----KYMHDQ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 70 -----~~l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+|+... .....+++.....++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 111110 11234788999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCceee-eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccc
Q 044995 133 TSRSRAVDQTHIT-TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEE 184 (288)
Q Consensus 133 ~a~~~~~~~~~~~-~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~ 184 (288)
+++.......... ....++..|++|| ||||||+++|||++ |+.||.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9986543222111 1223566799998 99999999999999 888985422 123
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
..+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3467899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.90 Aligned_cols=194 Identities=24% Similarity=0.362 Sum_probs=157.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
..++|++.++||+|+||.||++.++ .+.+.+|++++++++||||++++++|.+.++++...
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3588999999999999999998753 256889999999999999999999987664332211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++.....++.+++.||.||| +. +|+|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 1234677888899999999999999 54 6999999999999999999999999998754321
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------------
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------------- 183 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------------- 183 (288)
......|+..|+||| |||||||++|||++|+.||......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 112346899999999 9999999999999999998532110
Q ss_pred --------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 --------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 --------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++||++.|++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 01245788999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=280.82 Aligned_cols=209 Identities=22% Similarity=0.353 Sum_probs=166.4
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCC-CCceeeecceE-e-----
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQIN-HINVVKLIGCC-L----- 67 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~-~----- 67 (288)
+.+...++++.+.|.+|||+.||.+.+. .+...+||++|++|+ |+|||.|+|.. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 3455667888999999999999998752 466789999999997 99999999931 1
Q ss_pred --------ccccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 68 --------ETKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 68 --------~~~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
.+||..+ ......|++.++++|+.++++|+.+||.+ ..+|||||||-+||||+.+|..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1122211 01122489999999999999999999965 678999999999999999999999999
Q ss_pred cCccccCCCCcee--------eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC--------
Q 044995 132 GTSRSRAVDQTHI--------TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT-------- 181 (288)
Q Consensus 132 G~a~~~~~~~~~~--------~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~-------- 181 (288)
|.+.......... .....-|+.|.+|| |||+|||+||.|+....||....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 9987433222111 01124688999999 99999999999999999996541
Q ss_pred --cc--chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 --FE--EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 --~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
++ ...+..+.+||..||+.||++||++-+++..+-.+....
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22 356889999999999999999999999999988876554
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=271.20 Aligned_cols=196 Identities=22% Similarity=0.313 Sum_probs=157.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
...++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999652 346789999999999999999999865332
Q ss_pred ---------cccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 ---------YMHDQN---KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 ---------~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.... ....++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 221110 0124677888899999999999999 8899999999999999999999999999997543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------- 184 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------------- 184 (288)
.. .......||..|+||| |||||||++|+|++|+.||.......
T Consensus 175 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 22 1223346899999999 99999999999999999996432100
Q ss_pred ---------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0134678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.60 Aligned_cols=198 Identities=24% Similarity=0.363 Sum_probs=158.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
..+|++.+.||+|+||.||+|.+. .+.|.+|+.++.+++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 356888999999999999998631 35688999999999999999999987654221
Q ss_pred c----------------cc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC
Q 044995 73 H----------------DQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK 123 (288)
Q Consensus 73 ~----------------~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~ 123 (288)
. .. .....+++..+..++.|++.||.||| +++|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCC
Confidence 1 00 01124778888999999999999999 8899999999999999999
Q ss_pred CceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------
Q 044995 124 YCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--------- 181 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--------- 181 (288)
+.+||+|||+++....... .......+++.|+||| |||||||++|||++ |..||....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876533221 1122234577899999 99999999999998 888875322
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+...+..+.+++.+||+.+|++||++.+|+.+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.11 Aligned_cols=187 Identities=24% Similarity=0.303 Sum_probs=153.0
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ------- 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~------- 75 (288)
+.||+|+||.||++.++ ...+.+|++++++++||||+++++++...++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999998652 24577899999999999999999887665433211
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 76 ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 76 ------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
.....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 12235788889999999999999999 8899999999999999999999999999987532221 1223356
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCCC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGKK 204 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~~ 204 (288)
||+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+||+.||++
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999 99999999999999999995432 23345778999999999999999
Q ss_pred CC-----CHHHHHHH
Q 044995 205 RP-----AMKEVASE 214 (288)
Q Consensus 205 Rp-----~~~~i~~~ 214 (288)
|| ++.+++++
T Consensus 237 R~~~~~~~~~~ll~h 251 (323)
T cd05571 237 RLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCCCCCCHHHHHcC
Confidence 99 78888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=258.59 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=161.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM------ 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l------ 72 (288)
...+|.+.+.||+|+||.||+|.++ .+.+.+|++++++++|+||++++++|...+.+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 3467889999999999999998752 45789999999999999999999987654322
Q ss_pred -cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 73 -HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 73 -~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.. ......+++...+.++.|++.||.||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 11 112235788889999999999999999 889999999999999999999999999998765432221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~ 196 (288)
......++..|++|| |||||||++|||++ |..||.... .+...+.++.+++.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 111222456799999 99999999999998 999985422 223346789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhc
Q 044995 197 CLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
||+.||++||++.++++.|+.+
T Consensus 241 cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=260.63 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=164.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
.++|.+.+.||+|+||.||++.. ..+.|.+|+.++++++||||++++++|...++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 47899999999999999999862 0346889999999999999999999887653321
Q ss_pred cc--------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceE
Q 044995 74 DQ--------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAK 127 (288)
Q Consensus 74 ~~--------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~k 127 (288)
.. .....+++.....++.|++.+|.||| +.+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 10 11124789999999999999999999 88999999999999999999999
Q ss_pred EecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-------------
Q 044995 128 VSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------- 181 (288)
Q Consensus 128 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------- 181 (288)
|+|||+++....... .......++..|+||| ||||||+++|+|++ |..||....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999875432221 1112234567899999 99999999999998 899985332
Q ss_pred --ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 --FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.....+.++.+++.+||+.||.+||++.++++.|+++...
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1223467899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=261.13 Aligned_cols=199 Identities=25% Similarity=0.391 Sum_probs=159.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
+|++.+.||+|+||.||+|.+. .+.+.+|+.+++.++||||+++++.|...+....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5888999999999999998631 3468899999999999999999998765422110
Q ss_pred -------------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 75 -------------------------------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 75 -------------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
......+++...+.++.|++.||.||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 001124778889999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--- 181 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--- 181 (288)
||+++++.+||+|||+++........ ......++..|++|| ||||||+++|||++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999998754322221 112234567899999 99999999999998 999985432
Q ss_pred ------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 ------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122346789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=256.84 Aligned_cols=195 Identities=25% Similarity=0.418 Sum_probs=158.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-------cc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-------HD 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-------~~ 74 (288)
++|++.+.||+|+||.||++..+ .+.|.+|++++++++||||++++++|...+.. ..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 56889999999999999998652 45789999999999999999999987654322 11
Q ss_pred -------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 75 -------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 75 -------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
......+++.....++.+++.||.||| +++|+|+||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 111235788999999999999999999 8899999999999999999999999999987643322222222
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhcCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl~~ 200 (288)
..++..|+||| ||||||+++|||++ |+.||..... +...+..+.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccC
Confidence 23556799998 99999999999999 8999854321 223466789999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 044995 201 SGKKRPAMKEVASEL 215 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l 215 (288)
||++||++.++++.|
T Consensus 241 ~p~~Rps~~~l~~~l 255 (256)
T cd05114 241 KPEGRPTFAELLRAI 255 (256)
T ss_pred CcccCcCHHHHHHhh
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=269.94 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=157.6
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46689999999999999999998642 356778999999999999999999865332
Q ss_pred ---------cccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 ---------YMHDQN---KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 ---------~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 211100 0123677888899999999999999 8899999999999999999999999999997543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------- 184 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------------- 184 (288)
.. .......||..|+||| |||||||++|+|++|+.||.......
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred Cc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 22 1223346899999999 99999999999999999986432100
Q ss_pred ---------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0124578999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=258.84 Aligned_cols=200 Identities=21% Similarity=0.348 Sum_probs=160.1
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
++|++.+.||+|+||.||+|.+. ..++..|+.++++++||||+++++++.....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 57888999999999999998641 2456778888999999999999998754321
Q ss_pred ---ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 72 ---MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 72 ---l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
+.. ......+++.....++.|++.||.||| +++++||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 111 112335788999999999999999999 8889999999999999999999999999997543222
Q ss_pred -ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHH
Q 044995 142 -THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKH 193 (288)
Q Consensus 142 -~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~l 193 (288)
........++..|++|| ||||||+++|||++ |..||..... +......+.++
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence 11222344677899999 99999999999998 9999854321 12245678899
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+||..||++||++.|+++.|..+..
T Consensus 244 i~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 244 MVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.53 Aligned_cols=193 Identities=26% Similarity=0.356 Sum_probs=159.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
...++|++.+.||+|+||.||+|.++ .+.+.+|+.+++.++||||+++++++.+.+++
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34578999999999999999998631 34577899999999999999999988765433
Q ss_pred ccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+.. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 211 12235788889999999999999999 88999999999999999999999999999976432
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHA 194 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li 194 (288)
. .....||+.|+||| |||||||++|||++|..||.... .+...+..+.+++
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 2 12356999999999 99999999999999999996433 2233467889999
Q ss_pred HHhcCCCCCCCC-----CHHHHHHH
Q 044995 195 KRCLNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp-----~~~~i~~~ 214 (288)
.+||+.||.+|+ ++.+++++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999999995 78887765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=260.74 Aligned_cols=194 Identities=21% Similarity=0.286 Sum_probs=156.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCc-eeeecceEeccc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHIN-VVKLIGCCLETK----- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~----- 70 (288)
...|..+++||+|+||+||+|+.+ .....+|+.+|++|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456778889999999999999864 123579999999999999 999999987654
Q ss_pred -ccc---------------ccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 71 -YMH---------------DQNKE-LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 71 -~l~---------------~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
.+. ..... ..++...+..++.|++.||+||| +++|+||||||.|||++++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 221 11110 24666788999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE----------------- 184 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~----------------- 184 (288)
|+....+.... +..++|.+|.||| ||||+|||+.||++++.-|.+....+
T Consensus 167 Ara~~ip~~~y-t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRTY-TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcccc-cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99665443332 2345888999999 99999999999999988775332110
Q ss_pred ---------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ---------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ---------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.......+++.+||+.+|.+|.++...+++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 012478899999999999999999999887
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=265.44 Aligned_cols=195 Identities=22% Similarity=0.299 Sum_probs=157.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
.++|.+.+.||+|+||.||+|+++ ...+.+|++++++++||||+++++++...+.....
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999998652 24678999999999999999999987655332211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 11224678888899999999999999 889999999999999999999999999998754322211
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|+||| |||||||++|||++|+.||......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 12235788999999 9999999999999999998543211
Q ss_pred ---------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||.+|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 01245778999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=277.66 Aligned_cols=195 Identities=24% Similarity=0.331 Sum_probs=168.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~- 74 (288)
.+-|++++.||.|+-|.|-.|++. ...+.+|+.+|+-+.||||+++++++....+++.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356899999999999999988752 3568899999999999999999999887755432
Q ss_pred ------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 75 ------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++++.++.+++.||+.|+.|+| ..+|+||||||+|+|++.++.+||+|||+|..... .
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--g 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--G 165 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC--C
Confidence 234567999999999999999999999 88899999999999999998999999999975332 2
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
....+.||++.|.+|| ||||.|||||.||||+.||+..+ ++...+.+..+|+.+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 2334568999999999 99999999999999999997543 345668899999999
Q ss_pred hcCCCCCCCCCHHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~ 216 (288)
|+..||+.|-|++||++|-.
T Consensus 246 ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HhccCccccccHHHHhhCch
Confidence 99999999999999999853
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=255.77 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=159.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~------- 73 (288)
.++|++.+.||+|+||.||++.++ .+.|.+|+.++++++||||++++++|.+.+.+.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357889999999999999998642 457899999999999999999999876554321
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 1 111225789999999999999999999 889999999999999999999999999998755332222112
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhcC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCLN 199 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl~ 199 (288)
...++..|++|| ||||||+++|||++ |..||..... +...+..+.+++.+||+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223556799998 99999999999998 9999853321 22346789999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 044995 200 PSGKKRPAMKEVASELA 216 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~ 216 (288)
.||.+||++.+|++.|+
T Consensus 240 ~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 240 EKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCcccCCCHHHHHHhhC
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.62 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=160.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..+.|++-+.||+|.|+.||++.+. .+++.+|++|.+.|+|||||++.+.+.+..|.+..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 5688999999999999999987542 56788999999999999999999876665444321
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccCC
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~~ 139 (288)
. ....+++..+-.+..||+.+|.|+| .++|+|||+||.|+|+.+ ...+||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 1 1134677778889999999999999 999999999999999943 3478999999998765
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~~~ 190 (288)
.........||+.||+|| |||+.|++||-|+.|.+||.+.+ .....+++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 333444567999999999 99999999999999999996522 112347889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++|+++||..||.+|-|+.|.+++
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCC
Confidence 999999999999999999998864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=268.33 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=162.4
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEc--------------c----------HHHHHHHHHHHhcC-CCCceeeecceEe
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMA--------------K----------VEKFINEVVIQSQI-NHINVVKLIGCCL 67 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------~----------~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 67 (288)
|....++|++.+.||+|+||.||+|.+ + .+.+.+|+.++.++ +|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 344567899999999999999998842 1 24577899999999 8999999999875
Q ss_pred ccc--------cccc---------cC------------------------------------------------------
Q 044995 68 ETK--------YMHD---------QN------------------------------------------------------ 76 (288)
Q Consensus 68 ~~~--------~l~~---------~~------------------------------------------------------ 76 (288)
..+ |+.. ..
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 432 1110 00
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-eeeccccC
Q 044995 77 ----KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGT 151 (288)
Q Consensus 77 ----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt 151 (288)
....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...... ......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 0125788899999999999999999 889999999999999999999999999999865332221 12223456
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHHHHHHHHhcCCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
..|+||| |||||||++|||++ |..||..... +.....++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 7899999 99999999999998 9999854321 122356889999999999999
Q ss_pred CCCCHHHHHHHHHhchh
Q 044995 204 KRPAMKEVASELAGIKA 220 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~~~~ 220 (288)
+||++.+++++|+.+..
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.11 Aligned_cols=196 Identities=25% Similarity=0.294 Sum_probs=161.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|+++..||+|+||.||+++.+ ++..+.|-.+|...++|+||+|+-.|.+.++++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 46789999999999999999999753 567788999999999999999999998888776
Q ss_pred ccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC-
Q 044995 74 DQNK-------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV- 139 (288)
Q Consensus 74 ~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~- 139 (288)
..++ ...|++..+.-++.+++.|+..+| ..|+|||||||+|+|||..|.+||+|||+++.+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 5443 335889999999999999999999 99999999999999999999999999999853211
Q ss_pred --------------------CCcee-------------------------eeccccCCCCCChh-----------hHHHH
Q 044995 140 --------------------DQTHI-------------------------TTQVHGTFGYLNPD-----------DVCSF 163 (288)
Q Consensus 140 --------------------~~~~~-------------------------~~~~~gt~~y~aPE-----------DiwSl 163 (288)
..... ....+||+.||||| |.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00000 01146999999999 99999
Q ss_pred HHHHHHHHhCCCCCCCCCcc------------------chhHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 044995 164 GVVLVELLTGAKPIRFTTFE------------------EDKNITVAKHAKRCLNPSGKKRPA---MKEVASE 214 (288)
Q Consensus 164 G~il~elltg~~P~~~~~~~------------------~~~~~~~~~li~~cl~~~p~~Rp~---~~~i~~~ 214 (288)
|||+||||.|-+||...+.. ...+.+..+||.+||. ||++|.. +.||-+|
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999755422 2346889999999999 9999965 5555443
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=261.58 Aligned_cols=200 Identities=23% Similarity=0.415 Sum_probs=159.3
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~ 75 (288)
++|++.+.||+|+||.||+|..+ .+.|.+|++++.++ +||||+++++++.....++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 68999999999999999998542 24688999999999 799999999987654321100
Q ss_pred C-----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 76 N-----------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 76 ~-----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
. ....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 0 1124778889999999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-------------
Q 044995 127 KVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------- 181 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------- 181 (288)
||+|||++...... ........+..|++|| |||||||++|||++ |..||....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998643211 1111112345699998 99999999999997 999985432
Q ss_pred --ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 --FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12235678999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=259.07 Aligned_cols=201 Identities=25% Similarity=0.401 Sum_probs=158.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
....++|++.+.||+|+||.||+|.++ ..+|.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346788999999999999999987521 23588999999999999999999987654
Q ss_pred ccccccC-----------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 70 KYMHDQN-----------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 70 ~~l~~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
....... ....+++...+.++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 3211100 0123567788899999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC------------
Q 044995 127 KVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------ 181 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------ 181 (288)
+|+|||+++......... .....++..|+||| |||||||++|||++ |..||....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987543222111 11223567899999 99999999999999 788885332
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 223346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.19 Aligned_cols=191 Identities=23% Similarity=0.324 Sum_probs=158.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||+|++. .+.+.+|+.++.+++||||+++++++...++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999752 24577899999999999999999987765433211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 12235788889999999999999999 88999999999999999999999999999875432
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc----------------------hhHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------DKNITV 190 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------------~~~~~~ 190 (288)
......||+.|+||| |||||||++|||++|..||......+ ..+.++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 223456999999999 99999999999999999996432110 226788
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+++.+||..+|++||++.+++++-
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCc
Confidence 9999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=269.13 Aligned_cols=195 Identities=20% Similarity=0.291 Sum_probs=157.9
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-- 70 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 70 (288)
+....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3456789999999999999999999642 245778999999999999999998764321
Q ss_pred -----------cc----cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 71 -----------YM----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 71 -----------~l----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
++ ........+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 10 01112235888999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------- 184 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------- 184 (288)
..... .....||..|+||| |||||||++|+|++|..||.......
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 64332 12346899999999 99999999999999999986432100
Q ss_pred --------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 --------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 --------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112346799999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.16 Aligned_cols=197 Identities=21% Similarity=0.263 Sum_probs=158.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD------ 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~------ 74 (288)
...+|++.+.||+|+||.||++... ...+.+|++++++++|||||++++++.....+..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 3457999999999999999998531 2346789999999999999999987655432211
Q ss_pred ------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-eeeec
Q 044995 75 ------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQ 147 (288)
Q Consensus 75 ------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 147 (288)
......+++..++.++.|++.||.||| .++|+||||||+|||++.++.++|+|||++........ .....
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~ 246 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence 122346889999999999999999999 88999999999999999999999999999875543222 11224
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------------------
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------------------------- 183 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------------------------- 183 (288)
..||+.|+||| |||||||++|||++|..||......
T Consensus 247 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 326 (392)
T PHA03207 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK 326 (392)
T ss_pred cccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHH
Confidence 56999999999 9999999999999999998543210
Q ss_pred ------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.++|.+||..||++||++.|++.+-
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 01134677899999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=255.44 Aligned_cols=199 Identities=24% Similarity=0.403 Sum_probs=161.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-- 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-- 72 (288)
.++|++.+.||+|+||.||+|.++ ...|.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 468999999999999999998641 35688999999999999999999987654322
Q ss_pred -----ccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 73 -----HDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 73 -----~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
... .....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 111 11235789999999999999999999 889999999999999999999999999999866422
Q ss_pred Cc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 141 QT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
.. .......++..|++|| ||||||+++|+|++ |..||.... .+...+..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 1122223456799999 99999999999998 999984221 22345678999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
++.+||+.+|++||++.+++++|+++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=259.02 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=162.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
..+|.+.+.||+|+||.||++.+. .+.|.+|++++++++|+||+++++++...+...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356888999999999999998521 356889999999999999999999876543221
Q ss_pred cc-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC
Q 044995 74 DQ-----------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124 (288)
Q Consensus 74 ~~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~ 124 (288)
.. .....+++...+.++.|++.||.||| +++|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 10 01123788899999999999999999 88999999999999999999
Q ss_pred ceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------
Q 044995 125 CAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------- 181 (288)
Q Consensus 125 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------- 181 (288)
.++|+|||++........ .......++..|+||| ||||||+++|||++ |..||....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999875433221 1122334678899999 99999999999999 999984322
Q ss_pred -----ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 -----FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.....+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 122346789999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=272.22 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=162.6
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC-CCceeeecceEe
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN-HINVVKLIGCCL 67 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 67 (288)
++...++|.+.+.||+|+||.||+|++. .+.|.+|+++++++. |||||+++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3455788999999999999999988631 357889999999996 999999999876
Q ss_pred ccc-------cccccC----------------------------------------------------------------
Q 044995 68 ETK-------YMHDQN---------------------------------------------------------------- 76 (288)
Q Consensus 68 ~~~-------~l~~~~---------------------------------------------------------------- 76 (288)
+.. |+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 542 221000
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCe
Q 044995 77 --------------------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNI 118 (288)
Q Consensus 77 --------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Ni 118 (288)
....+++..++.++.|++.||.||| ..+|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhE
Confidence 0123677788899999999999999 88999999999999
Q ss_pred eecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---
Q 044995 119 LLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF--- 182 (288)
Q Consensus 119 l~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~--- 182 (288)
|++.++.+||+|||+++........ ......++..|+||| |||||||++|||++ |..||.....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999999998765332221 112234677899999 99999999999997 8899854221
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+...+..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 2234678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=263.15 Aligned_cols=189 Identities=22% Similarity=0.309 Sum_probs=148.0
Q ss_pred CceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc---------ccccc-
Q 044995 23 NRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET---------KYMHD- 74 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------~~l~~- 74 (288)
.++||+|+||.||+|.++ ...+.+|++++++++||||+++++++... ++...
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999999999999742 24678999999999999999999876432 12110
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----cCCCceEEecccCcccc
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~DfG~a~~~ 137 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||+ +..+.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 011235788889999999999999999 8899999999999999 45578999999999765
Q ss_pred CCCCc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------
Q 044995 138 AVDQT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------- 184 (288)
Q Consensus 138 ~~~~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------- 184 (288)
..... .......||+.|+||| |||||||++|||++|+.||.......
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 43221 1123456899999999 99999999999999999985322100
Q ss_pred ------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=258.33 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=158.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
.++|++.+.||+|+||.||+|... ...|.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 367899999999999999998630 2568899999999999999999998665432
Q ss_pred -----cccc---------C--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC
Q 044995 72 -----MHDQ---------N--------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK 123 (288)
Q Consensus 72 -----l~~~---------~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~ 123 (288)
+... . ....+++...+.++.+++.||.||| +++|+|+||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 1110 0 0124678888999999999999999 8899999999999999999
Q ss_pred CceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------
Q 044995 124 YCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--------- 181 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--------- 181 (288)
+.+||+|||+++....... .......++..|+||| ||||||+++|||++ |..||....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976432221 1122234567799999 99999999999998 988985422
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=251.53 Aligned_cols=199 Identities=27% Similarity=0.359 Sum_probs=166.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecceE
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIGCC 66 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~ 66 (288)
....+.|.-.+.||.|..++|-++.++ .+.-.+|+.+|+++ .||||+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 345667888899999998888776442 46677899999998 599999999998
Q ss_pred eccccccc-------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 67 LETKYMHD-------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 67 ~~~~~l~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
....|+.. ......+++....+|+.|+..|++||| .++|+||||||+|||++++..+||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 87765532 233446889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCC-----------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRF----------------- 179 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~----------------- 179 (288)
++.+... ......+||++|+||| |+||+|+++|.|+.|.+||..
T Consensus 170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 9976543 3345679999999999 999999999999999999831
Q ss_pred -CCccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 180 -TTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 180 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
...-.+.+....+||.+||+.||.+|-|+.|.+++--.
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 11223567889999999999999999999999987544
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=254.96 Aligned_cols=201 Identities=21% Similarity=0.350 Sum_probs=162.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
...++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++++...+....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45678999999999999999998642 4678999999999999999999998765532211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+++.....++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 111235788999999999999999999 889999999999999999999999999998865422211
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
.......+..|+||| ||||||+++|||++ |+.||..... +...+..+.+++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 111122345799999 99999999999999 9999854321 22346789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhc
Q 044995 197 CLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
||+.+|++||++.++++.|+.+
T Consensus 240 ~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 240 CWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.33 Aligned_cols=191 Identities=24% Similarity=0.290 Sum_probs=152.3
Q ss_pred cccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHH---hcCCCCceeeecceEecccccccc
Q 044995 20 FNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQ---SQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
|++.+.||+|+||.||++.++ .+.+.+|++++ +.++||||+++++++...+.++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999998642 23456666654 567899999999987665432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 12346889999999999999999999 8899999999999999999999999999987532221 1
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
......|++.|+||| |||||||++|||++|+.||.... .+...+..+.+++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 223456999999999 99999999999999999996543 22345778899999999
Q ss_pred CCCCCCCC-----CHHHHHHH
Q 044995 199 NPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp-----~~~~i~~~ 214 (288)
+.||++|| ++.+++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhC
Confidence 99999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=276.33 Aligned_cols=193 Identities=21% Similarity=0.287 Sum_probs=158.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------ 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~------ 73 (288)
.|.+.+.||+|+||.||++... ...+.+|+.+++.++|||||+++++|...+.++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3899999999999999998642 245778999999999999999999876654322
Q ss_pred -cc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 74 -DQ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 -~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.. ....++++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 11 12345788889999999999999999 88999999999999999999999999999986543221
Q ss_pred -eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 143 -HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 143 -~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
......+||+.|+||| |||||||++|||++|..||.... .+...+.++.+++.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence 1233456999999999 99999999999999999986432 12234678999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.||++||++.+++.+
T Consensus 305 ~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHhccChhhCcCHHHHHhC
Confidence 9999999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=259.90 Aligned_cols=192 Identities=23% Similarity=0.301 Sum_probs=152.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------HHH-HHHHHHHHhcCCCCceeeecceEeccc-----cccccC--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------VEK-FINEVVIQSQINHINVVKLIGCCLETK-----YMHDQN-- 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~-~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~l~~~~-- 76 (288)
=.|...+.+|.|+||.||+|... ..+ -.+|+++|++++|||||++.-+|.... ++....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 35777899999999999999753 122 247999999999999999988875421 111111
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCCCC
Q 044995 77 --------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 77 --------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~~~ 141 (288)
....++...+.-+..|+.+||.||| ..+|+||||||.|+|+|.+ |.+||||||.|+.+....
T Consensus 104 mP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 104 MPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred chHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 1234555566778999999999999 8999999999999999865 999999999999775544
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------------
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------- 184 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------- 184 (288)
.. .....|..|.||| ||||.||++.||+-|++-|.+.+..+
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 33 3345788999999 99999999999999999886543211
Q ss_pred ------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.+..+++.++|.++|.+|.++.|++.+
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 126789999999999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=272.53 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=162.1
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
+....++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++.+..+
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999998652 2346789999999999999999988776543
Q ss_pred ccccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 MHDQN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 32211 1224677888889999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cc--hh
Q 044995 140 DQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF----------------EE--DK 186 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~----------------~~--~~ 186 (288)
..........||+.|+||| |||||||++|||++|..||..... +. ..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 3222223456999999998 999999999999999999964321 11 24
Q ss_pred HHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKK--RPAMKEVASEL 215 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~--Rp~~~~i~~~l 215 (288)
+.++.+++.+||+.+|++ |+++.+++++-
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 678999999999999988 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.08 Aligned_cols=198 Identities=21% Similarity=0.367 Sum_probs=161.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
++|++.+.||+|+||.||+|+++ ...|.+|++++++++||||+++++++...+..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999742 2468899999999999999999998765432211
Q ss_pred ---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 75 ---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 75 ---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
......++......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 011234678888999999999999999 88999999999999999999999999999876432
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~ 190 (288)
... ......|+..|+||| ||||||+++|||++|..||..... ....+..+
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 221 112345788999999 999999999999999999853321 11345679
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+++.+||+.+|++||++.++++.++.+.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.05 Aligned_cols=200 Identities=25% Similarity=0.415 Sum_probs=161.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc------cc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK------YM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~l 72 (288)
...++|++.++||+|+||.||++.++ .+.|.+|+.++++++|+||+++++++.... ++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM 82 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence 34578999999999999999998642 467999999999999999999998864432 21
Q ss_pred cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 73 HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 73 ~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.. ......+++.....++.+++.||.||| +.+|+|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 11 112234788899999999999999999 8889999999999999999999999999987543322211
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHh
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~c 197 (288)
.....++..|+||| ||||||+++|||++ |..||.... .+...+..+.+++.+|
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 12223556799999 99999999999999 888985432 1234567899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHh
Q 044995 198 LNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l~~ 217 (288)
|..||++|||+.++.+.|+.
T Consensus 240 l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 240 WKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cccCcccCcCHHHHHHHHhc
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=272.43 Aligned_cols=209 Identities=28% Similarity=0.462 Sum_probs=169.0
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecce
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGC 65 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~ 65 (288)
+.|+..-++-.+.++||+|+||+||+|+.+ ..+|++|+++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 456666777788899999999999998642 4679999999999999999999999
Q ss_pred Eeccccc-------cc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 66 CLETKYM-------HD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 66 ~~~~~~l-------~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+...+-+ .+ ......++..+.+.++.+++.||+||| ++++|||||-.+|+|++.++.+||+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcc
Confidence 7665321 11 111125889999999999999999999 999999999999999999999999999
Q ss_pred cCccccCCCCceeee-ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------------c
Q 044995 132 GTSRSRAVDQTHITT-QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------------F 182 (288)
Q Consensus 132 G~a~~~~~~~~~~~~-~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------------~ 182 (288)
|+++.-.. ..... ...-...|+||| |||||||++||+++ |..||.+.. .
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99875431 11111 112346799999 99999999999998 788986443 3
Q ss_pred cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 183 EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 183 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
+...+.++..++.+||..||++||+|.++.+.|+.+......
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 345578899999999999999999999999999988776554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=257.17 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=160.6
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
...++|++.+.||+|+||.||+|.++ ...|.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 45678999999999999999987641 246889999999999999999999876553
Q ss_pred cccccC-----------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceE
Q 044995 71 YMHDQN-----------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAK 127 (288)
Q Consensus 71 ~l~~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~k 127 (288)
...... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 221111 1123577888999999999999999 88999999999999999999999
Q ss_pred EecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC--------------
Q 044995 128 VSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT-------------- 180 (288)
Q Consensus 128 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~-------------- 180 (288)
|+|||+++....... .......++..|+||| |||||||++||+++ |..||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 999999875432221 1122234677899999 99999999999998 99998532
Q ss_pred -CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 181 -TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 181 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 233445788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=274.69 Aligned_cols=195 Identities=19% Similarity=0.295 Sum_probs=155.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---------- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---------- 74 (288)
...|.+.+.||+|+||.||++.+. ...+.+|+++|++|+|+|||++++++...+....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~ 247 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY 247 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHH
Confidence 457999999999999999999863 2457799999999999999999998765532211
Q ss_pred ---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-eeecccc
Q 044995 75 ---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHG 150 (288)
Q Consensus 75 ---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g 150 (288)
......+++..++.++.|++.||.||| .++|+||||||+|||++.++.+||+|||+++........ ......|
T Consensus 248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 324 (461)
T PHA03211 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAG 324 (461)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCC
Confidence 111235889999999999999999999 889999999999999999999999999999765332211 1223569
Q ss_pred CCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-------------------------ccc----------
Q 044995 151 TFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-------------------------FEE---------- 184 (288)
Q Consensus 151 t~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-------------------------~~~---------- 184 (288)
|..|+||| |||||||++|||++|..|+.... ++.
T Consensus 325 T~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~ 404 (461)
T PHA03211 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQY 404 (461)
T ss_pred CcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHH
Confidence 99999999 99999999999999875542110 000
Q ss_pred ---------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ---------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ---------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.++|.+||+.||.+|||+.|++++
T Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 405 RHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 012367789999999999999999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.47 Aligned_cols=191 Identities=27% Similarity=0.386 Sum_probs=154.6
Q ss_pred eeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc------ccc--
Q 044995 25 ILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------MHD-- 74 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------l~~-- 74 (288)
.||+|+||.||+|.++ .+.|.+|+.+++.++||||+++++++....+ ...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 6899999999998531 3578899999999999999999998754322 111
Q ss_pred ----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee--ecc
Q 044995 75 ----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT--TQV 148 (288)
Q Consensus 75 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--~~~ 148 (288)
......+++.....++.|++.||.||| +++|+||||||.||+++.++.+||+|||+++.......... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 112235788899999999999999999 88999999999999999999999999999976543332211 122
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC---------------CccchhHHHHHHHHHHhcCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT---------------TFEEDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~---------------~~~~~~~~~~~~li~~cl~~~ 201 (288)
.++..|+||| ||||||+++|||++ |..||... ..+...+.++.++|.+||+.|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 3457899999 99999999999998 99998532 233446789999999999999
Q ss_pred CCCCCCHHHHHHHHHhc
Q 044995 202 GKKRPAMKEVASELAGI 218 (288)
Q Consensus 202 p~~Rp~~~~i~~~l~~~ 218 (288)
|++||++.+|.+.|++.
T Consensus 239 p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 239 VDERPGFAVVELRLRNY 255 (257)
T ss_pred chhCcCHHHHHHHHhcc
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=266.86 Aligned_cols=194 Identities=23% Similarity=0.361 Sum_probs=159.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEeccccccccC
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~~ 76 (288)
...|+++++||+||.+.||++... ...|.+|+.+|.+|+ |.+||++++|-....|++...
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456899999999999999998742 467999999999995 999999999988888887766
Q ss_pred CCCCCCHH-------------HHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 77 KELPFTWE-------------MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 77 ~~~~l~~~-------------~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
+.+..+.. ...-+..|++.++.++| .++|||.||||.|+|+- .|.+||+|||+|..+......
T Consensus 440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 55543222 34557889999999999 99999999999999986 578999999999876544332
Q ss_pred -eeeccccCCCCCChh----------------------hHHHHHHHHHHHHhCCCCCCCC-----------------Ccc
Q 044995 144 -ITTQVHGTFGYLNPD----------------------DVCSFGVVLVELLTGAKPIRFT-----------------TFE 183 (288)
Q Consensus 144 -~~~~~~gt~~y~aPE----------------------DiwSlG~il~elltg~~P~~~~-----------------~~~ 183 (288)
.....+||+.||+|| ||||||||||+|+.|+.||... +++
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 223457999999999 9999999999999999998411 222
Q ss_pred chh-HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 EDK-NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ~~~-~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
... ..++.++++.||..||++||++.++|++
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222 3349999999999999999999999976
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=261.49 Aligned_cols=202 Identities=23% Similarity=0.395 Sum_probs=160.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~ 73 (288)
..++|++.+.||+|+||.||+|.++ .+.|.+|+.++.++ +|+||+++++++...++.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3478999999999999999999642 24678899999999 8999999999876654221
Q ss_pred ccC-----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC
Q 044995 74 DQN-----------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124 (288)
Q Consensus 74 ~~~-----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~ 124 (288)
... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 100 1124788899999999999999999 88999999999999999999
Q ss_pred ceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-----------
Q 044995 125 CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------- 181 (288)
Q Consensus 125 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------- 181 (288)
.+||+|||++....... ......++..|+||| |||||||++|||+| |..||....
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999986422111 111112356799998 99999999999998 999985322
Q ss_pred ----ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 ----FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+...+..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12234678899999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.61 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=160.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|.+.+.||+|+||.||+|.+. .+.|.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467999999999999999998531 35789999999999999999999987765322
Q ss_pred ccc---------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 73 HDQ---------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 73 ~~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
... .....+++.....++.|++.||.||| .++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 111 11234678889999999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-----------
Q 044995 126 AKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------- 181 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------- 181 (288)
+||+|||+++........ ......++..|+||| ||||||+++|||++ |..||....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999998754322211 112234567899999 99999999999998 999985322
Q ss_pred ----ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 182 ----FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 182 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 12345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=269.98 Aligned_cols=200 Identities=24% Similarity=0.305 Sum_probs=160.4
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
++....++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455688999999999999999998752 234778999999999999999999877664
Q ss_pred cccccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 YMHDQN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 ~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+++... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 433211 1224678888999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cc--h
Q 044995 139 VDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF----------------EE--D 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~----------------~~--~ 185 (288)
...........||+.|+||| |||||||++|||++|..||..... +. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 33322333457999999999 999999999999999999964321 11 2
Q ss_pred hHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKK--RPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~--Rp~~~~i~~~ 214 (288)
.+..+.+++.+|+..++.+ |+++.+++++
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 3667889999999855543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.94 Aligned_cols=201 Identities=22% Similarity=0.418 Sum_probs=162.6
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc------c
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK------Y 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 71 (288)
++..++|++.++||+|+||.||+|..+ .++|.+|+.++++++|+||+++++++.... +
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY 81 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence 345688999999999999999998752 468999999999999999999998864331 2
Q ss_pred ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 72 MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 72 l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
+.. ......+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 111 112235788889999999999999999 889999999999999999999999999998765422221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
......++..|++|| ||||||+++||+++ |..||..... +...+.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 222234567899999 99999999999999 9999864321 12345689999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHh
Q 044995 197 CLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
||+.+|++||+++++++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=263.90 Aligned_cols=187 Identities=24% Similarity=0.300 Sum_probs=152.6
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ------- 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~------- 75 (288)
+.||+|+||.||++.++ ...+.+|+++++.++||||+++++++...+.+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999998642 34678899999999999999999887655432211
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 76 ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 76 ------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 12235788899999999999999999 8899999999999999999999999999987532221 1223356
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCCC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGKK 204 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~~ 204 (288)
||+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+||+.||++
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 999999999 99999999999999999995432 22344678999999999999999
Q ss_pred CC-----CHHHHHHH
Q 044995 205 RP-----AMKEVASE 214 (288)
Q Consensus 205 Rp-----~~~~i~~~ 214 (288)
|+ ++.+++++
T Consensus 237 R~~~~~~~~~~il~h 251 (328)
T cd05593 237 RLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCCCCCHHHHhcC
Confidence 97 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=252.62 Aligned_cols=196 Identities=25% Similarity=0.402 Sum_probs=157.0
Q ss_pred cccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
|++.+.||+|+||.||+|... .+.+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999988631 3468899999999999999999998754322
Q ss_pred --------ccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 72 --------MHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 72 --------l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+.. ......+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 110 011235788889999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCceee-eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------cc
Q 044995 132 GTSRSRAVDQTHIT-TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FE 183 (288)
Q Consensus 132 G~a~~~~~~~~~~~-~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~ 183 (288)
|+++.......... ....++..|++|| |||||||++|||++ |..||.... .+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99876533222111 1123456799998 99999999999999 888885332 22
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.74 Aligned_cols=203 Identities=22% Similarity=0.362 Sum_probs=163.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 70 (288)
...++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35688999999999999999999742 355889999999999999999999876531
Q ss_pred -------cc---------cccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEe
Q 044995 71 -------YM---------HDQNK-----ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS 129 (288)
Q Consensus 71 -------~l---------~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~ 129 (288)
+. ..... ...+++...+.++.+++.||.||| +.+++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 11 11111 135788999999999999999999 8899999999999999999999999
Q ss_pred cccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------
Q 044995 130 NFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--------------- 181 (288)
Q Consensus 130 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--------------- 181 (288)
|||+++......... .....++..|+||| ||||||+++||+++ |+.||....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999997543322211 12234567799999 99999999999999 999985321
Q ss_pred ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.....+.++.+++.+||..||++||++.++++.|+.+..
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112346789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=263.57 Aligned_cols=187 Identities=26% Similarity=0.316 Sum_probs=152.1
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-------cc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH-------DQ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~-------~~ 75 (288)
+.||+|+||.||++.++ ...+.+|++++++++||||+++++++...+.++ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999998642 235678999999999999999998876554322 11
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 76 ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 76 ------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 12235788999999999999999999 8899999999999999999999999999987532211 1222356
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCCC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGKK 204 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~~ 204 (288)
||+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+||+.||++
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 899999999 99999999999999999985432 23345778999999999999999
Q ss_pred CC-----CHHHHHHH
Q 044995 205 RP-----AMKEVASE 214 (288)
Q Consensus 205 Rp-----~~~~i~~~ 214 (288)
|+ ++.+++++
T Consensus 237 R~~~~~~~~~~~l~h 251 (323)
T cd05595 237 RLGGGPSDAKEVMEH 251 (323)
T ss_pred hCCCCCCCHHHHHcC
Confidence 98 88888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=262.18 Aligned_cols=185 Identities=24% Similarity=0.294 Sum_probs=150.0
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---------
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--------- 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--------- 75 (288)
||+|+||.||++.++ .+.+.+|+.++++++||||+++++++...+.++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999998752 24577899999999999999999887665432211
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccC
Q 044995 76 ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 76 ----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 12335788899999999999999999 8899999999999999999999999999987532222 122345699
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGKKRP 206 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~~Rp 206 (288)
+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+||+.||++||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999 99999999999999999996432 2334567899999999999999997
Q ss_pred C---HHHHHHH
Q 044995 207 A---MKEVASE 214 (288)
Q Consensus 207 ~---~~~i~~~ 214 (288)
+ +.+++.+
T Consensus 237 ~~~~~~e~l~h 247 (312)
T cd05585 237 GYNGAQEIKNH 247 (312)
T ss_pred CCCCHHHHHcC
Confidence 5 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=251.38 Aligned_cols=199 Identities=24% Similarity=0.386 Sum_probs=160.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc------ccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK------YMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~l~ 73 (288)
..++|.+.+.||+|+||.||++.++ .+.|.+|++++++++|+||+++++++.... ++.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 3467999999999999999998642 357899999999999999999998764332 221
Q ss_pred c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 74 D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 ~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
. ......+++..+..++.+++.||.||| +.+|+|+||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 1 112234688889999999999999999 88899999999999999999999999999975533221111
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhc
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl 198 (288)
....++..|++|| ||||||+++|||++ |..||..... +...+..+.+++.+||
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCW 240 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 2233567899999 99999999999999 8999854321 2234678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh
Q 044995 199 NPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~~ 217 (288)
+.||++||++.++++.|++
T Consensus 241 ~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 241 KKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCcccCcCHHHHHHHHhc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.67 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=156.9
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35689999999999999999998642 346789999999999999999998764332
Q ss_pred ---------cccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 ---------YMHDQN---KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 ---------~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
|+.... -...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 221100 0123677888899999999999999 8899999999999999999999999999997543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------- 184 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------------- 184 (288)
.. .......||..|+||| |||||||++|||++|+.||.......
T Consensus 178 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 178 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 22 1223346899999999 99999999999999999985432100
Q ss_pred ---------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.....+.+++.+||+.||++|||+.+++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0124578999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=254.32 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=161.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
.++|++.+.||+|+||.||+|++. .+.+.+|+.+++.++|+||++++++|....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 478899999999999999998631 346788999999999999999999875432
Q ss_pred ---cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ---YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ---~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
++.. ......+++...+.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 1111 111235788999999999999999999 889999999999999999999999999999865432
Q ss_pred Ccee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 141 QTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
.... .....++..|++|| |||||||++|||++ |..||.... .+...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 2211 11123456799999 99999999999998 899985322 12234678899
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
++.+||+.||++||++.++++.|+.+...
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 99999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=253.26 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=161.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecc------cccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLET------KYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~l~ 73 (288)
..++|++.++||+|+||.||+|+++ .+.|.+|++++++++||||+++++++.+. +++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 4578999999999999999998642 45789999999999999999999876432 2221
Q ss_pred cc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 74 DQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 ~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.. .....+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.++|+|||.++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 10 11234688899999999999999999 88999999999999999999999999999875543222222
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhc
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl 198 (288)
....++..|++|| ||||||+++|||++ |..||..... ....+..+.+++.+||
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 240 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 240 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence 2234567899999 99999999999999 8888854321 2234678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhc
Q 044995 199 NPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+.||++||++.++++.|+..
T Consensus 241 ~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 241 RKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=267.42 Aligned_cols=194 Identities=25% Similarity=0.295 Sum_probs=159.0
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.+. .+.+.+|++++..++||||+++++++.+.+++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999998753 245788999999999999999998876654332111
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC--
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-- 141 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-- 141 (288)
....+++..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 1245788899999999999999999 8899999999999999999999999999987554322
Q ss_pred --------------------------ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---
Q 044995 142 --------------------------THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--- 181 (288)
Q Consensus 142 --------------------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--- 181 (288)
........||+.|+||| |||||||++|||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 01122346899999999 99999999999999999995432
Q ss_pred -------------ccc--hhHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Q 044995 182 -------------FEE--DKNITVAKHAKRCLNPSGKKRPA-MKEVASEL 215 (288)
Q Consensus 182 -------------~~~--~~~~~~~~li~~cl~~~p~~Rp~-~~~i~~~l 215 (288)
.+. ..+.++.++|.+||. ||.+||+ +.+++++-
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 111 137889999999997 9999999 99999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.95 Aligned_cols=205 Identities=24% Similarity=0.386 Sum_probs=164.2
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceE
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCC 66 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~ 66 (288)
++....++|++.+.||+|+||.||++..+ ...+.+|+.+++++ +|+||++++++|
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45566788999999999999999998631 23578899999999 899999999987
Q ss_pred ecccccccc-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 67 LETKYMHDQ-----------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 67 ~~~~~l~~~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
...+.+... .....+++...+.++.|++.||.||| +.+|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence 655322110 12335788899999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--- 181 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--- 181 (288)
|+++.++.+||+|||+++......... .....++..|+||| |||||||++|||++ |..||....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999998654322211 11223456799999 99999999999997 888885432
Q ss_pred ------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 182 ------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 182 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 12234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.05 Aligned_cols=193 Identities=22% Similarity=0.244 Sum_probs=152.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
.|++++.||+|+||.||+|+++ .+.+.+|++++++++||||+++++++.+.++++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999652 245788999999999999999999987665432211
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC---
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ--- 141 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~--- 141 (288)
....+++..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 2235778888889999999999999 8899999999999999999999999999975321000
Q ss_pred -------------------------------------------ceeeeccccCCCCCChh-----------hHHHHHHHH
Q 044995 142 -------------------------------------------THITTQVHGTFGYLNPD-----------DVCSFGVVL 167 (288)
Q Consensus 142 -------------------------------------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il 167 (288)
........||+.|+||| |||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 00012346999999999 999999999
Q ss_pred HHHHhCCCCCCCCCcc------------------chhHHHHHHHHHH--hcCCCCCCCCCHHHHHHH
Q 044995 168 VELLTGAKPIRFTTFE------------------EDKNITVAKHAKR--CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 168 ~elltg~~P~~~~~~~------------------~~~~~~~~~li~~--cl~~~p~~Rp~~~~i~~~ 214 (288)
|||++|..||...... ...+.++.+++.+ |+..++..|+++.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999643211 1236788899988 445666669999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.06 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=156.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
.+|++.+.||+|+||.||++.++ .+.|.+|++++++++||||+++++++...++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46889999999999999998642 35788999999999999999999887654432111
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 76 --------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 76 --------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
.....+++...+.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 11235788899999999999999999 8889999999999999999999999999987543222111111
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
..++..|+||| ||||||+++|||++ |..||.... .+...+.++.+++.+||+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 22345799998 99999999999999 899985332 1223477899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 044995 201 SGKKRPAMKEVASEL 215 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l 215 (288)
+|++||++.++++.|
T Consensus 241 ~p~~Rpt~~~~l~~l 255 (256)
T cd05059 241 KPEDRPAFKKLLSQL 255 (256)
T ss_pred ChhhCcCHHHHHHHh
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=267.41 Aligned_cols=193 Identities=26% Similarity=0.312 Sum_probs=155.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||+++++ ...+.+|+.+++.++||||+++++++.+.++++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999998752 23467899999999999999999988766443221
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 12335788999999999999999999 889999999999999999999999999998653211100
Q ss_pred -------------------------------------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCC
Q 044995 144 -------------------------------------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAK 175 (288)
Q Consensus 144 -------------------------------------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~ 175 (288)
.....+||+.|+||| |||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 011246899999999 99999999999999999
Q ss_pred CCCCCCc----------------cc--hhHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 044995 176 PIRFTTF----------------EE--DKNITVAKHAKRCLNPSGKKRPA---MKEVASE 214 (288)
Q Consensus 176 P~~~~~~----------------~~--~~~~~~~~li~~cl~~~p~~Rp~---~~~i~~~ 214 (288)
||..... +. ..+.++.+++.+|+. +|.+|++ +.+++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9964321 11 236788999999996 9999987 8888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=267.73 Aligned_cols=203 Identities=23% Similarity=0.296 Sum_probs=162.6
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
..++....++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456667799999999999999999998753 2346789999999999999999998776
Q ss_pred cccccccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 69 TKYMHDQN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 69 ~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
..+++... ....++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 54432211 1224677888889999999999999 88999999999999999999999999999986
Q ss_pred cCCCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c--
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF----------------E-- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~----------------~-- 183 (288)
.............||+.|+||| |||||||++|||++|..||..... +
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 5433322333457999999998 999999999999999999964321 1
Q ss_pred chhHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKK--RPAMKEVASEL 215 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~--Rp~~~~i~~~l 215 (288)
...+..+.++|.+||..++.+ |+++.+++++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 134678899999999844433 78999998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=266.77 Aligned_cols=194 Identities=22% Similarity=0.318 Sum_probs=153.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--------- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--------- 74 (288)
...+|++.+.||+|+||.||+|++. ......|+.++++++||||+++++++....+...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l 143 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDL 143 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcH
Confidence 3467999999999999999999763 2345689999999999999999998776543211
Q ss_pred ----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecccc
Q 044995 75 ----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG 150 (288)
Q Consensus 75 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 150 (288)
......+++..+..++.|++.||.||| .++|+||||||+|||++.++.+||+|||+++...... ......|
T Consensus 144 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~g 218 (357)
T PHA03209 144 YTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAG 218 (357)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccccc
Confidence 122346889999999999999999999 8899999999999999999999999999987432211 1223468
Q ss_pred CCCCCChh-----------hHHHHHHHHHHHHhCCCCC-CCCC---------------------------cc--------
Q 044995 151 TFGYLNPD-----------DVCSFGVVLVELLTGAKPI-RFTT---------------------------FE-------- 183 (288)
Q Consensus 151 t~~y~aPE-----------DiwSlG~il~elltg~~P~-~~~~---------------------------~~-------- 183 (288)
|..|+||| |||||||++|||+++..|+ .... ++
T Consensus 219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 298 (357)
T PHA03209 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298 (357)
T ss_pred cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence 99999999 9999999999999865443 2110 00
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+....++|.+||+.||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0112344568999999999999999999876
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=254.20 Aligned_cols=196 Identities=23% Similarity=0.359 Sum_probs=157.1
Q ss_pred CCcccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
.+|.+.++||+|+||.||++.. ..+.|.+|++++++++|+||+++++++........
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 5788899999999999998842 13578999999999999999999998765432111
Q ss_pred cC----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 75 QN----------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 75 ~~----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
.. ....+++...+.++.|++.||.||| +.+|+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 00 0124788899999999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC------------
Q 044995 127 KVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------ 181 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------ 181 (288)
||+|||++......... ......+++.|+||| |||||||++|||++ |..||....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 99999998754322211 112223567899999 99999999999998 899984321
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 12334678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=262.00 Aligned_cols=188 Identities=26% Similarity=0.308 Sum_probs=151.9
Q ss_pred CceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 23 NRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
++.||+|+||.||++... ...+.+|+.++++++||||+++++++...+.++...
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999987531 134678999999999999999999877654332111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
....+.+..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 2234677788889999999999999 88999999999999999999999999999875332221 2
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcC
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~ 199 (288)
.....|++.|+||| |||||||++|||++|..||.... .+...+..+.+++.+||+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 23356999999999 99999999999999999996432 233456789999999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 044995 200 PSGKKRP-----AMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp-----~~~~i~~~ 214 (288)
.||++|| ++.+++++
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcC
Confidence 9999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=267.16 Aligned_cols=194 Identities=24% Similarity=0.332 Sum_probs=166.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
.++|..++++|+|+||.++..+++ .+...+|+.++++++|||||.+.+.|.+.+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999987653 3467899999999999999999998766543
Q ss_pred ---ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ---MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ---l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
..+ ..+...++++...+++.|++.|+.||| ++.|+|||||+.||+++.++.+||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 221 112356899999999999999999999 888999999999999999999999999999987654
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHA 194 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li 194 (288)
.. ...+..||+.||.|| |||||||++|||++-+.+|...+ .+...+.++..+|
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 42 344578999999999 99999999999999999997544 3445578999999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..|++.+|+.||++.+++.+
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999976
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=254.90 Aligned_cols=199 Identities=25% Similarity=0.364 Sum_probs=156.5
Q ss_pred CCc-ccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 18 DSF-NVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 18 ~~y-~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
++| ++.+.||+|+||+||++.. ..+.|.+|++++++++||||++++++|...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8899999999999977531 1356889999999999999999999875431
Q ss_pred ------cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ------YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ------~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++.. ......+++..+..++.|++.||.||| +++|+|+||||+|||++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 1111 011235789999999999999999999 88999999999999999999999999999876543
Q ss_pred CCcee--eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-------------------------
Q 044995 140 DQTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------------- 181 (288)
Q Consensus 140 ~~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------------- 181 (288)
..... .....++..|++|| ||||||+++|||++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 22111 11123456689999 99999999999999998874221
Q ss_pred -----ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 182 -----FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 182 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+...+.++.+++.+||+.||++||+++++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01223578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=273.90 Aligned_cols=201 Identities=23% Similarity=0.299 Sum_probs=162.4
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEec--
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLE-- 68 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 68 (288)
.+.....++|++.+.||+|+||.||++.+. ...+.+|+.++..++|+||+++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344566789999999999999999998642 3467889999999999999998765422
Q ss_pred -------------cccccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 69 -------------TKYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 69 -------------~~~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
.+|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCC
Confidence 122211 111235788889999999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCC-ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------
Q 044995 126 AKVSNFGTSRSRAVDQ-THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------ 181 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------ 181 (288)
+||+|||+++...... ........||+.|+||| |||||||++|||++|+.||....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999987643321 11223456999999999 99999999999999999996433
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+...+.++.+++.+||+.||++||++.+++++
T Consensus 262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 233457789999999999999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.59 Aligned_cols=200 Identities=24% Similarity=0.413 Sum_probs=163.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
....+|++.++||+|+||.||+|.++ .+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45678999999999999999998752 46788999999999999999999987655322
Q ss_pred --cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 73 --HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 73 --~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.. ......+++.....++.+++.||.||| +++|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 11 112235788999999999999999999 88899999999999999999999999999876533221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
. .....++..|++|| ||||||+++|+|++ |..||.... .+...+..+.+++.
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 1 11233566799998 99999999999998 899985432 12344678999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhc
Q 044995 196 RCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+||+.||++||++.++++.|+.+
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=258.19 Aligned_cols=189 Identities=23% Similarity=0.317 Sum_probs=147.7
Q ss_pred CceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc---------ccccc-
Q 044995 23 NRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET---------KYMHD- 74 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------~~l~~- 74 (288)
..+||+|+||.||+|..+ ...+.+|++++++++||||+++++++... ++...
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 468999999999999742 24688999999999999999999987432 12110
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----cCCCceEEecccCcccc
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~DfG~a~~~ 137 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 011235788889999999999999999 8899999999999999 45679999999999865
Q ss_pred CCCCc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------
Q 044995 138 AVDQT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------- 183 (288)
Q Consensus 138 ~~~~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------------- 183 (288)
..... .......||..|+||| |||||||++|||+||+.||......
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 1122346889999999 9999999999999999998532110
Q ss_pred -----------------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
......+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=258.66 Aligned_cols=208 Identities=24% Similarity=0.372 Sum_probs=164.4
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIG 64 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~ 64 (288)
.++...++|.+.+.||+|+||.||++.+. ...+.+|+++++++ +||||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 44556688999999999999999987520 23577899999999 7999999999
Q ss_pred eEeccccccccC-----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCC
Q 044995 65 CCLETKYMHDQN-----------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKS 115 (288)
Q Consensus 65 ~~~~~~~l~~~~-----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp 115 (288)
+|......+... ....+++...+.++.|++.||+||| +.+++||||||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp 168 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 168 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence 876553221100 1124788899999999999999999 88999999999
Q ss_pred CCeeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-
Q 044995 116 TNILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT- 181 (288)
Q Consensus 116 ~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~- 181 (288)
+||+++.++.+||+|||+++......... .....++..|+||| |||||||++|||++ |..||....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999987543221111 11122456799998 99999999999998 888875322
Q ss_pred --------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 --------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+...+.++.+++.+||..+|++||++.++++.|+.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 22234678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=250.68 Aligned_cols=195 Identities=26% Similarity=0.363 Sum_probs=158.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++.+.+.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 67999999999999999998641 2467889999999999999999999876543321
Q ss_pred c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. .....+++.....++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 1 11234677888999999999999999 8899999999999999999999999999987543221
Q ss_pred ceee--eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHHHH
Q 044995 142 THIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITVAK 192 (288)
Q Consensus 142 ~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~~~ 192 (288)
.... ....++..|+||| ||||||+++|||++|+.||.... .+...+..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1111 2245778899999 99999999999999999985322 22345678999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++.+||..+|++||++.+++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCC
Confidence 99999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=254.23 Aligned_cols=192 Identities=22% Similarity=0.289 Sum_probs=155.1
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+|++.+.||+|+||.||+|+++ .+.+.+|+.++++++||||+++++++...+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999752 2467899999999999999999999776532211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 111245788899999999999999999 88999999999999999999999999999875432211
Q ss_pred eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------------------
Q 044995 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF----------------------------- 182 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~----------------------------- 182 (288)
......++..|+||| ||||||+++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 112234678899999 999999999999999999864321
Q ss_pred --------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01135677899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.09 Aligned_cols=199 Identities=19% Similarity=0.286 Sum_probs=152.3
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCC------ceeeecceE
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHI------NVVKLIGCC 66 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~Hp------nIv~l~~~~ 66 (288)
.+++....++|++.+.||+|+||.||++.+. ...+..|++++..++|. +|+++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3455566789999999999999999999752 23456688888777654 578887776
Q ss_pred eccc-ccc------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCC--------
Q 044995 67 LETK-YMH------------DQNKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKY-------- 124 (288)
Q Consensus 67 ~~~~-~l~------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~-------- 124 (288)
.... ++. .......+++..+..++.|++.||.||| . .+|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 5432 110 0112346888899999999999999999 6 4899999999999997654
Q ss_pred --------ceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-
Q 044995 125 --------CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE- 184 (288)
Q Consensus 125 --------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~- 184 (288)
.+||+|||.+..... ......||+.|+||| |||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998764221 223457999999999 99999999999999999996432100
Q ss_pred -------------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHH
Q 044995 185 -------------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMK 209 (288)
Q Consensus 185 -------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~ 209 (288)
.....+.+||.+||+.||++|||+.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 0123466899999999999999999
Q ss_pred HHHHHH
Q 044995 210 EVASEL 215 (288)
Q Consensus 210 ~i~~~l 215 (288)
|+++|=
T Consensus 434 e~L~Hp 439 (467)
T PTZ00284 434 QMTTHP 439 (467)
T ss_pred HHhcCc
Confidence 999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=262.20 Aligned_cols=193 Identities=23% Similarity=0.251 Sum_probs=158.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++|+||+++++++.+.+++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 57999999999999999998652 245778999999999999999998876654322111
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 77 --------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 77 --------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 1135788889999999999999999 88999999999999999999999999999986544333
Q ss_pred eeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cc--hhH
Q 044995 143 HITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTTF----------------EE--DKN 187 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~~----------------~~--~~~ 187 (288)
.......||+.|+||| |||||||++|||++|..||..... +. ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 3333346899999998 999999999999999999954321 11 246
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.+++.+||. ||++||++.+++++
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 788999999998 99999999998865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=254.80 Aligned_cols=197 Identities=25% Similarity=0.385 Sum_probs=157.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------------------HHHHHHHHHHHhcCCCCceee
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------------------VEKFINEVVIQSQINHINVVK 61 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------------------~~~~~~E~~~l~~l~HpnIv~ 61 (288)
.++|++.+.||+|+||.||++.+. .+.|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999986421 356889999999999999999
Q ss_pred ecceEeccccccccC-------------C-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 62 LIGCCLETKYMHDQN-------------K-----------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 62 l~~~~~~~~~l~~~~-------------~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
++++|.......... . ...+++...+.++.|++.||.||| +.+|+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 999876643221100 0 115788999999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh--CCCCCCCCCc-
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT--GAKPIRFTTF- 182 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt--g~~P~~~~~~- 182 (288)
|+++.++.++|+|||+++....... .......++..|+||| |||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875432221 1122334677899999 99999999999998 6677743221
Q ss_pred ---------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 ---------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 ---------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+...+.++.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1122468999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.57 Aligned_cols=192 Identities=32% Similarity=0.555 Sum_probs=150.5
Q ss_pred ccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-------
Q 044995 21 NVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------- 70 (288)
Q Consensus 21 ~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 70 (288)
++.+.||.|.||.||+|.++ .+.|.+|++.+++++||||++++|+|...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999998653 468999999999999999999999998532
Q ss_pred cccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 71 YMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 71 ~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+... ......+++.....++.|++.||.||| +.+++|+||+++||++++++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 2211 112356889999999999999999999 88899999999999999999999999999886522221
Q ss_pred -eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHH
Q 044995 143 -HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHA 194 (288)
Q Consensus 143 -~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li 194 (288)
.......+...|+||| ||||||+++|||++ |+.||.... .+...+..+.+++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 1222234667899999 99999999999999 788885332 2334577899999
Q ss_pred HHhcCCCCCCCCCHHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+||+.||++||++.++++.|
T Consensus 239 ~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHT-SSGGGS--HHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=251.49 Aligned_cols=198 Identities=22% Similarity=0.378 Sum_probs=162.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
++|++.+.||+|+||.||++.++ .+.|.+|+++++.++|+||+++++++.+.++.+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999998742 3468899999999999999999998766532211
Q ss_pred ---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 75 ---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 75 ---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
......+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 112345788899999999999999999 88999999999999999999999999999875533
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~ 190 (288)
.... .....|+..|+||| ||||||+++|+|++|..||..... ....+..+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 2221 12345888999999 999999999999999999853321 11345789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+++.+||+.||++|||+.+|++.++++.
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=256.37 Aligned_cols=202 Identities=26% Similarity=0.420 Sum_probs=161.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
....++|.+.+.||+|+||.||++.+. .+.+.+|+++++++ +|+||++++++|..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344568999999999999999988530 24688999999999 79999999998765
Q ss_pred cccccc---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 69 TKYMHD---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 69 ~~~l~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
.+.+.. ......+++.....++.+++.||.||| +++|+|+||||+|||++.++.++++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 532211 111123789999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cc
Q 044995 134 SRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EE 184 (288)
Q Consensus 134 a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~ 184 (288)
++........ ......++..|+||| |||||||++|||++ |..||..... +.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 9865433221 112234567899999 99999999999998 9999854321 11
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
..+.++.+++.+||+.+|++||++.++++.|+++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2367899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=254.60 Aligned_cols=202 Identities=25% Similarity=0.420 Sum_probs=160.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
.++|+..+.||+|+||.||+|.+. ...+.+|+.++++++||||++++++|.....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 85 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL 85 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence 467888999999999999998641 2367899999999999999999998865321
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++..++.++.|++.||.||| +++|+|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 111 111224778889999999999999999 889999999999999999999999999999865432
Q ss_pred Cce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 141 QTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
... ......++..|++|| ||||||+++|||++ |..||.... .+...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 221 111233567899999 99999999999997 889985432 11234678899
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
++.+||..+|++||++.++++.|+.+...
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=255.16 Aligned_cols=191 Identities=21% Similarity=0.271 Sum_probs=151.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcC---CCCceeeecceEecc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQI---NHINVVKLIGCCLET------ 69 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~------ 69 (288)
+|++.+.||+|+||.||++.++ ...+.+|+.+++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999753 13466788877765 799999999876532
Q ss_pred ------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 70 ------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 70 ------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 12111 111234788999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
..... ......|+..|+||| |||||||++|||++|..||......
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 53222 122346889999999 9999999999999999988432110
Q ss_pred -------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=255.76 Aligned_cols=198 Identities=18% Similarity=0.254 Sum_probs=150.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEccH----------------------H----------HHHHHHHHHhcCCCCceeee
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAKV----------------------E----------KFINEVVIQSQINHINVVKL 62 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~----------------------~----------~~~~E~~~l~~l~HpnIv~l 62 (288)
...++|++.+.||+|+||.||+|.+.. + ....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 344789999999999999999986421 0 11223344567789999999
Q ss_pred cceEeccc------cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 63 IGCCLETK------YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 63 ~~~~~~~~------~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
++++.... ++.. .......++.....++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 98654321 1100 011123567778899999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCc------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------
Q 044995 127 KVSNFGTSRSRAVDQT------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------ 183 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------ 183 (288)
+|+|||+++....... .......||+.|+||| |||||||++|||++|..||......
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999976532211 1112246999999999 9999999999999999999654211
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++..||..+|++||++.+|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 12356788999999999999999999999876
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=257.00 Aligned_cols=206 Identities=22% Similarity=0.366 Sum_probs=162.9
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEc--------------------------cHHHHHHHHHHHhcC-CCCceeeecce
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMA--------------------------KVEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
+....++|.+.+.||+|+||.||++++ ....+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344567899999999999999998752 034678999999999 69999999998
Q ss_pred Eecccccccc-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 66 CLETKYMHDQ-----------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 66 ~~~~~~l~~~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
|....+++.. .....+++...+.++.|++.||.||| +++|+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 7654322110 01134788889999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC--
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT-- 181 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~-- 181 (288)
|||++.++.+||+|||+++......... .....++..|++|| ||||||+++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997653221111 11122446799999 99999999999999 888885432
Q ss_pred -------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 -------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+.++.+++.+||+.||++||++.++++.|.++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1233456899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=266.21 Aligned_cols=205 Identities=22% Similarity=0.398 Sum_probs=162.5
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC-CCceeeecceE
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN-HINVVKLIGCC 66 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~ 66 (288)
+++...++|.+.+.||+|+||.||+|++. .+.+.+|+++|.++. |||||+++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35566678999999999999999998631 246889999999998 99999999987
Q ss_pred ecccc-------ccc---------c-------------------------------------------------------
Q 044995 67 LETKY-------MHD---------Q------------------------------------------------------- 75 (288)
Q Consensus 67 ~~~~~-------l~~---------~------------------------------------------------------- 75 (288)
..... +.. .
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 65421 110 0
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCC
Q 044995 76 ----------------------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKS 115 (288)
Q Consensus 76 ----------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp 115 (288)
.....+++...+.++.|++.||.||| +.+|+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence 00113567778899999999999999 88999999999
Q ss_pred CCeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc
Q 044995 116 TNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF 182 (288)
Q Consensus 116 ~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~ 182 (288)
+|||+++++.+||+|||+++........ ......++..|++|| ||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999754322111 112234678899999 99999999999998 8889854221
Q ss_pred ----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 183 ----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 183 ----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+...+.++.+++.+||+.+|.+||++++|++.|+.+.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=269.18 Aligned_cols=195 Identities=24% Similarity=0.359 Sum_probs=158.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
..+.|.|+..||.|+||.||++..+ .++|+-||.||..++||+||+|++.|+-.+.+..
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4466788899999999999999764 6789999999999999999999986543322211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
..-..++.+.++..++.|++.||.||| +++|||||||..|||++-+|.++|+|||++...... ..
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 111236888999999999999999999 999999999999999999999999999997543221 12
Q ss_pred eeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHH
Q 044995 144 ITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITV 190 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~ 190 (288)
....+.||+.||||| ||||||++|.||..+.+|-...+ -+..-+..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 233467999999999 99999999999999999963211 112236689
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||..||..||++.+++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.27 Aligned_cols=187 Identities=24% Similarity=0.312 Sum_probs=151.9
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-------ccc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-------HDQ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-------~~~ 75 (288)
+.||+|+||.||++.++ ...+.+|+++++.++||||+++++++...+.+ ...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999998642 24567899999999999999999887655432 211
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 ------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 ------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 12335788999999999999999999 6 6899999999999999999999999999875322211 12234
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 6999999999 99999999999999999995432 2334577899999999999999
Q ss_pred CCC-----CHHHHHHH
Q 044995 204 KRP-----AMKEVASE 214 (288)
Q Consensus 204 ~Rp-----~~~~i~~~ 214 (288)
+|+ ++.+++++
T Consensus 237 ~R~~~~~~~~~~il~h 252 (325)
T cd05594 237 QRLGGGPDDAKEIMQH 252 (325)
T ss_pred HhCCCCCCCHHHHhcC
Confidence 996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=263.78 Aligned_cols=194 Identities=22% Similarity=0.290 Sum_probs=153.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.++ .+.+.+|++++++++|||||++++++.+.++++...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 57999999999999999998642 245778999999999999999999887664432211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 2235678888889999999999999 88999999999999999999999999999863211000
Q ss_pred ---------------------------------------------eeeeccccCCCCCChh-----------hHHHHHHH
Q 044995 143 ---------------------------------------------HITTQVHGTFGYLNPD-----------DVCSFGVV 166 (288)
Q Consensus 143 ---------------------------------------------~~~~~~~gt~~y~aPE-----------DiwSlG~i 166 (288)
......+||+.|+||| |||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0001246899999999 99999999
Q ss_pred HHHHHhCCCCCCCCCc----------------cc--hhHHHHHHHHHHhcCCCCCCC---CCHHHHHHHH
Q 044995 167 LVELLTGAKPIRFTTF----------------EE--DKNITVAKHAKRCLNPSGKKR---PAMKEVASEL 215 (288)
Q Consensus 167 l~elltg~~P~~~~~~----------------~~--~~~~~~~~li~~cl~~~p~~R---p~~~~i~~~l 215 (288)
+|||++|..||..... +. ..+.++.+++.+||. +|.+| +++.+++.+-
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999954321 11 235688999999997 66665 5999988763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=258.01 Aligned_cols=196 Identities=21% Similarity=0.305 Sum_probs=165.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-- 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-- 72 (288)
...+|++.+.||+|.||.|-++... .-.+.+|++||..|+||||+.++++|...+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3468999999999999999988651 23578999999999999999999998765322
Q ss_pred -----------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 73 -----------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 73 -----------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
....+...+++.++..++.||.+|+.|+| .++++|||||.+|||+|.++.+||+|||++......
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 22345567999999999999999999999 999999999999999999999999999998754322
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------cchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF-------------EEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~-------------~~~~~~~~~~li~~ 196 (288)
....+++|++.|.+|| |-||||++||-|+.|..||++... ....+.....||+.
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRW 285 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHH
Confidence 2334578999999888 999999999999999999976542 23446678899999
Q ss_pred hcCCCCCCCCCHHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~ 216 (288)
||..||++|.|+.+|..+.+
T Consensus 286 mLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHhcCcccchhHHHHhhhhe
Confidence 99999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=256.15 Aligned_cols=195 Identities=23% Similarity=0.311 Sum_probs=157.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
.++|++.+.||+|+||.||+|.++ ...+.+|+.++++++||||+++++++...+.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467999999999999999998652 23578899999999999999999997655432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 11234678888999999999999999 889999999999999999999999999998754322211
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|++|| ||||||+++|||++|+.||...+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 12234688899998 9999999999999999998543210
Q ss_pred ---------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.++|.+||+.||.+|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 12355778999999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=254.39 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=155.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEc---------------------------------cHHHHHHHHHHHhcCCCCceeeec
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA---------------------------------KVEKFINEVVIQSQINHINVVKLI 63 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~---------------------------------~~~~~~~E~~~l~~l~HpnIv~l~ 63 (288)
.++|++.+.||+|+||.||++.+ ..+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999997642 034688999999999999999999
Q ss_pred ceEeccccccccC-------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCe
Q 044995 64 GCCLETKYMHDQN-------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNI 118 (288)
Q Consensus 64 ~~~~~~~~l~~~~-------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Ni 118 (288)
+++...+...... ....+++...+.++.+++.||.||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 9876543221110 0113577888999999999999999 88999999999999
Q ss_pred eecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh--CCCCCCCCCc--
Q 044995 119 LLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT--GAKPIRFTTF-- 182 (288)
Q Consensus 119 l~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt--g~~P~~~~~~-- 182 (288)
+++.++.+||+|||++......... ......++..|+||| ||||||+++|+|++ +..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999998754322211 112233567899999 99999999999998 5667753211
Q ss_pred --------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 --------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 --------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
....+..+.+++.+||+.||++||++++|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1123577999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=250.61 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=162.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
..++|.+.+.||+|+||.||+|.+. .+.|.+|+.++++++||||++++++|.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~l 83 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI 83 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEE
Confidence 3467899999999999999998631 3468899999999999999999998765422
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
... ......+++..++.++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 110 011224788999999999999999999 889999999999999999999999999998765433
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~l 193 (288)
.........++..|+||| ||||||+++||+++ |..||.... .+...+..+.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 222222223456799999 99999999999986 999985432 223456789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+||..+|++||++.++++.|+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.58 Aligned_cols=191 Identities=25% Similarity=0.385 Sum_probs=152.7
Q ss_pred eeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------cccc---
Q 044995 25 ILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------YMHD--- 74 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~l~~--- 74 (288)
.||+|+||.||+|.++ .+.|.+|+.++++++||||++++++|.... |+..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999987531 356889999999999999999999875432 2211
Q ss_pred ----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee--cc
Q 044995 75 ----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT--QV 148 (288)
Q Consensus 75 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~--~~ 148 (288)
......+++..+++++.|++.||.||| +++++|+||||+|||++.++.+||+|||++............ ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 112335788999999999999999999 889999999999999999999999999998754333221111 11
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~~ 201 (288)
.++..|+||| ||||||+++||+++ |..||.... .+...+.++.+++.+||+.|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 2356899998 99999999999996 999985332 22334678999999999999
Q ss_pred CCCCCCHHHHHHHHHhc
Q 044995 202 GKKRPAMKEVASELAGI 218 (288)
Q Consensus 202 p~~Rp~~~~i~~~l~~~ 218 (288)
|++||++.+|.+.|+.+
T Consensus 239 ~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 239 WEDRPNFAKVEERMRTY 255 (257)
T ss_pred hhhCcCHHHHHHHHhhh
Confidence 99999999999999765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=282.01 Aligned_cols=203 Identities=23% Similarity=0.347 Sum_probs=160.4
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
+.+.+...++|++++.||+|+||.||++.++ ...|..|+.++++|+|||||+++++|...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445567789999999999999999998752 35688999999999999999999977432
Q ss_pred ---------cccccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEEeCCCCCCeeecC----
Q 044995 70 ---------KYMHDQ----------NKELPFTWEMQLRISIEASGTMSYLHLSA----SVPIYHRDIKSTNILLDD---- 122 (288)
Q Consensus 70 ---------~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----~~~iiHrdlkp~Nil~~~---- 122 (288)
+|+... .....+++..++.|+.||+.||.|||... ..+|+||||||+|||++.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 222110 11235889999999999999999999432 156999999999999953
Q ss_pred -------------CCceEEecccCccccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCC
Q 044995 123 -------------KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKP 176 (288)
Q Consensus 123 -------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P 176 (288)
.+.+||+|||++....... ......||+.|+||| |||||||++|||++|..|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2458999999997653221 123356999999999 999999999999999999
Q ss_pred CCCCCcc---------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 177 IRFTTFE---------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 177 ~~~~~~~---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|...... ...+.++.+||..||+.+|.+||++.+++.+
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9533211 1236789999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=276.92 Aligned_cols=202 Identities=26% Similarity=0.439 Sum_probs=169.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEec------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLE------ 68 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 68 (288)
....++.++||.|.||+||+|+.+ +.+|+.|+.||.+++||||++|.|+...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 355678899999999999999753 5679999999999999999999998644
Q ss_pred -cccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 69 -TKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 69 -~~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+|||+. ...++.|.+.+...+++.|+.||.||- +.+.+||||..+|||++.+-.+||+|||+++.+..+
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 466643 234456889999999999999999999 999999999999999999999999999999977554
Q ss_pred Cceeeecccc--CCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC---------------CccchhHHHHH
Q 044995 141 QTHITTQVHG--TFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT---------------TFEEDKNITVA 191 (288)
Q Consensus 141 ~~~~~~~~~g--t~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~---------------~~~~~~~~~~~ 191 (288)
.....++.-| ...|.||| |||||||++||.++ |+.||-.. ..+.+++..+.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 4222222223 35799999 99999999999886 99998433 23557899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+||..||+.|..+||.|.+|+..|.++.+.
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=262.48 Aligned_cols=194 Identities=24% Similarity=0.272 Sum_probs=151.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+.++.+++|+||+++++.+.+...++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999998652 2457789999999999999999998766543221
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 112346788999999999999999999 88999999999999999999999999999875421100
Q ss_pred ---------------------------------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCC
Q 044995 143 ---------------------------------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR 178 (288)
Q Consensus 143 ---------------------------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~ 178 (288)
......+||+.|+||| |||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0012346999999999 99999999999999999996
Q ss_pred CCCc----------------cc--hhHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 044995 179 FTTF----------------EE--DKNITVAKHAKRCLN--PSGKKRPAMKEVASE 214 (288)
Q Consensus 179 ~~~~----------------~~--~~~~~~~~li~~cl~--~~p~~Rp~~~~i~~~ 214 (288)
.... +. ..+.+..+++.+++. .++..||++.||+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 4321 11 235678888888554 223346899999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=254.35 Aligned_cols=191 Identities=26% Similarity=0.319 Sum_probs=155.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------ 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------ 71 (288)
+|++.+.||+|+||.||++.+. ...+.+|+.++++++||||+++++.+...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999998752 1346789999999999999999988765432
Q ss_pred -ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 72 -MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 72 -l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+.. ......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 211 112235788999999999999999999 88999999999999999999999999999876432221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
.....|+..|+||| ||||||+++|||++|..||..... +...+..+.++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 12346899999999 999999999999999999964322 12346778999
Q ss_pred HHHhcCCCCCCCC-----CHHHHHHH
Q 044995 194 AKRCLNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp-----~~~~i~~~ 214 (288)
+.+||+.||++|| ++.+++++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999 78888766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.53 Aligned_cols=199 Identities=22% Similarity=0.405 Sum_probs=163.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH-- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~-- 73 (288)
+++|++.+.||+|+||.||+|.+. .+.+.+|++++++++|+||+++++++...++..
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 368999999999999999998652 456889999999999999999999876653221
Q ss_pred -----c----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 74 -----D----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 74 -----~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
. ......+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 1 112234788899999999999999999 8899999999999999999999999999987543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cc-hhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EE-DKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~-~~~~~ 189 (288)
..... .....++..|+||| ||||||+++|+|++|..||..... +. ..+..
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 32211 12245788899999 999999999999999999854321 11 34568
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=251.83 Aligned_cols=193 Identities=23% Similarity=0.359 Sum_probs=157.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||++++++|...+......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47888999999999999999742 356889999999999999999999887654332111
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 77 -------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 77 -------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
....+++.....++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV 154 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCC
Confidence 1124678888899999999999999 889999999999999999999999999998754322 122346
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------------cchhHHHHHHHHH
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------------EEDKNITVAKHAK 195 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------------~~~~~~~~~~li~ 195 (288)
|+..|+||| ||||||+++|+|++|..||..... ....+.++.+++.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 889999999 999999999999999999853110 1123567899999
Q ss_pred HhcCCCCCCCCCHHHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+||+.||++||++.|++++-.
T Consensus 235 ~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 235 QCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHhhCChhhCCCHHHHhcCcc
Confidence 999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=250.80 Aligned_cols=196 Identities=23% Similarity=0.316 Sum_probs=157.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
..++|++.+.||+|+||.||+|+++ .+.+.+|+.++++++||||+++++++...+.+...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3468999999999999999999742 34577899999999999999999987655432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........ .
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 12235788889999999999999999 88999999999999999999999999999875432211 1
Q ss_pred eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhHHHHH
Q 044995 145 TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKNITVA 191 (288)
Q Consensus 145 ~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~~~~~ 191 (288)
.....|+..|+||| ||||||+++|||++|..||..... ....+..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 12245788899998 999999999999999999842210 012356899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+++.+||+.||++||++++++++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=266.66 Aligned_cols=190 Identities=26% Similarity=0.312 Sum_probs=161.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCC-CCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l 72 (288)
...++|.++++||+|.||.|+++..+ ++..+.|.+|+.... ||.++.++.+|...+.+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 45689999999999999999988642 677888988887775 99999999886554332
Q ss_pred ------------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 73 ------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 73 ------------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
........+++..+.-++..++.||.||| +++||+||||.+|||+|.+|.+||+|||+++.....
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 22334457899999999999999999999 999999999999999999999999999999965433
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------chhHHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------EDKNITVAKHAK 195 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------~~~~~~~~~li~ 195 (288)
. ..+.+.+||+.||||| |.|||||+||||+.|+.||.+.+.+ ...+.+...+++
T Consensus 522 g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 G-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred C-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 3 3566789999999999 9999999999999999999865532 334789999999
Q ss_pred HhcCCCCCCCCCH
Q 044995 196 RCLNPSGKKRPAM 208 (288)
Q Consensus 196 ~cl~~~p~~Rp~~ 208 (288)
++|..||++|..+
T Consensus 601 ~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 601 RLLRKNPEKRLGS 613 (694)
T ss_pred HHhccCcccccCC
Confidence 9999999999654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=252.58 Aligned_cols=202 Identities=24% Similarity=0.366 Sum_probs=159.3
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
+...++|++.+.||+|+||.||+|..+ ...+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999987421 23578899999999999999999987554
Q ss_pred ccccccC-----------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 70 KYMHDQN-----------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 70 ~~l~~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
+...... ......+.....++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 3221100 0123456678889999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC------------
Q 044995 127 KVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------ 181 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------ 181 (288)
+|+|||+++......... .....++..|++|| |||||||++|||++ |..||....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987543222111 11223567799999 99999999999998 788885322
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+...+..+.+++.+||+.||++||++.++++.|++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1223467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=254.91 Aligned_cols=206 Identities=23% Similarity=0.390 Sum_probs=163.3
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEc--------------------------cHHHHHHHHHHHhcC-CCCceeeecce
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMA--------------------------KVEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
+....++|++.+.||+|+||.||++++ ..+.+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 446678899999999999999998852 024578999999999 89999999998
Q ss_pred Eecccccc-------c---------c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 66 CLETKYMH-------D---------Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 66 ~~~~~~l~-------~---------~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
+......+ . . .....+++...+.++.|++.||.||| +++|+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccc
Confidence 76543211 0 0 01124678888999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc-
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF- 182 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~- 182 (288)
||+++.++.+||+|||+++......... .....++..|+||| ||||||+++|||++ |..||.....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999998654322211 12223567799999 99999999999998 7788753321
Q ss_pred --------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 183 --------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 183 --------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+...+..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 223467899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=266.89 Aligned_cols=193 Identities=22% Similarity=0.230 Sum_probs=153.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.++ .+.+.+|++++++++|+||+++++.+.+.+.++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999998752 245778999999999999999999877654432211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC--
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-- 141 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-- 141 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 2234678888889999999999999 8899999999999999999999999999975321000
Q ss_pred ----------------------------------------ceeeeccccCCCCCChh-----------hHHHHHHHHHHH
Q 044995 142 ----------------------------------------THITTQVHGTFGYLNPD-----------DVCSFGVVLVEL 170 (288)
Q Consensus 142 ----------------------------------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il~el 170 (288)
........||+.|+||| |||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00011246999999999 999999999999
Q ss_pred HhCCCCCCCCCcc------------------chhHHHHHHHHHHhcCCCCCCCC---CHHHHHHH
Q 044995 171 LTGAKPIRFTTFE------------------EDKNITVAKHAKRCLNPSGKKRP---AMKEVASE 214 (288)
Q Consensus 171 ltg~~P~~~~~~~------------------~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~~~ 214 (288)
++|+.||...... ...+.++.+++.+|+ .+|.+|+ ++.+++++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999643311 124668888999976 5999999 88999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=256.25 Aligned_cols=207 Identities=23% Similarity=0.378 Sum_probs=163.5
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEc--------------------------cHHHHHHHHHHHhcC-CCCceeeecc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMA--------------------------KVEKFINEVVIQSQI-NHINVVKLIG 64 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~ 64 (288)
+++....+|++.+.||+|+||.||++.+ ..+.+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 4555567899999999999999998852 034688999999999 7999999999
Q ss_pred eEecccccc-------c---------c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCC
Q 044995 65 CCLETKYMH-------D---------Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKS 115 (288)
Q Consensus 65 ~~~~~~~l~-------~---------~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp 115 (288)
+|...+.+. . . .....+++...+.++.|++.||.||| .++|+||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence 876553221 0 0 01124678888999999999999999 88999999999
Q ss_pred CCeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-
Q 044995 116 TNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT- 181 (288)
Q Consensus 116 ~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~- 181 (288)
+|||++.++.+||+|||+++........ ......++..|+||| ||||||+++|||++ |..||....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998754332111 111123456799999 99999999999998 888885332
Q ss_pred --------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 --------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+.++.+++.+||+.+|++||++.++++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1223466899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=250.74 Aligned_cols=198 Identities=28% Similarity=0.402 Sum_probs=156.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||+|.+. ...|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3578999999999999999988652 2468899999999999999999998665422
Q ss_pred -------ccc---------c----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEE
Q 044995 72 -------MHD---------Q----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKV 128 (288)
Q Consensus 72 -------l~~---------~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl 128 (288)
+.. . .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 111 0 01124788999999999999999999 88899999999999997654 6899
Q ss_pred ecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc-------------
Q 044995 129 SNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF------------- 182 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~------------- 182 (288)
+|||+++......... ......+..|+||| |||||||++|||++ |..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999998653221111 11122346799999 99999999999997 9999864321
Q ss_pred --cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 --EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+...+..+.+++.+||+.||++||++.+++++|.
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2234678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=252.16 Aligned_cols=197 Identities=22% Similarity=0.368 Sum_probs=155.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEc-----------------------------------cHHHHHHHHHHHhcCCCCceee
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA-----------------------------------KVEKFINEVVIQSQINHINVVK 61 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------------------------~~~~~~~E~~~l~~l~HpnIv~ 61 (288)
.++|++.+.||+|+||.||++.+ ..+.|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 36799999999999999998631 1356889999999999999999
Q ss_pred ecceEeccccccccC------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 62 LIGCCLETKYMHDQN------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 62 l~~~~~~~~~l~~~~------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
+++++...+...... ....+++.....++.|++.||.||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 999876543221100 0123667789999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh--CCCCCCCCCc-
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT--GAKPIRFTTF- 182 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt--g~~P~~~~~~- 182 (288)
||++.++.++|+|||+++......... .....++..|++|| |||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987543222111 11223456799998 99999999999998 7788743221
Q ss_pred ---------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 ---------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 ---------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1224578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.27 Aligned_cols=185 Identities=22% Similarity=0.409 Sum_probs=147.9
Q ss_pred ceeeeeCCeeEEEeEcc------------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 24 RILGQGGQDIVYKGMAK------------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~------------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
+.||+|+||.||+|+.. ...|.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999621 236788999999999999999999876542
Q ss_pred ----cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc-------eEEeccc
Q 044995 71 ----YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC-------AKVSNFG 132 (288)
Q Consensus 71 ----~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~-------~kl~DfG 132 (288)
|+.. ......+++...+.++.|++.||.||| +++|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 2211 112345888999999999999999999 889999999999999976553 8999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHH-hCCCCCCCCCcc-------------chh
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELL-TGAKPIRFTTFE-------------EDK 186 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~ell-tg~~P~~~~~~~-------------~~~ 186 (288)
++...... ....++..|+||| |||||||++|||+ +|..||...... ...
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS 232 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCC
Confidence 98654321 2235788899999 9999999999997 588887543321 123
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
..++.+++.+||+.||++||++.+|++.|+
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.60 Aligned_cols=196 Identities=25% Similarity=0.443 Sum_probs=158.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc--------cccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET--------KYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~l~ 73 (288)
..++|++.+.||+|+||.||++..+ .+.|.+|+.++++++|+||+++++++... +++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 3468999999999999999998542 45789999999999999999999875432 1221
Q ss_pred c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 74 D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 ~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
. ......+++...+.++.+++.||.||| .++|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 1 111224778889999999999999999 8899999999999999999999999999987543221
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhc
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl 198 (288)
....++..|+||| |||||||++|||++ |+.||..... ....+..+.+++.+||
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 1223456799999 99999999999998 9999864322 1234678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhc
Q 044995 199 NPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+.+|++||++.++++.|+.+
T Consensus 237 ~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 237 HLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCChhhCcCHHHHHHHHhcC
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=265.85 Aligned_cols=192 Identities=22% Similarity=0.240 Sum_probs=151.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
+|++++.||+|+||.||+|.++ .+.+.+|++++++++|+|||++++++.+.++++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999752 245788999999999999999999887654332111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC---
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ--- 141 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~--- 141 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 2235678888899999999999999 8899999999999999999999999999975321000
Q ss_pred -------------------------------------------ceeeeccccCCCCCChh-----------hHHHHHHHH
Q 044995 142 -------------------------------------------THITTQVHGTFGYLNPD-----------DVCSFGVVL 167 (288)
Q Consensus 142 -------------------------------------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il 167 (288)
........||+.|+||| |||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 00012246899999999 999999999
Q ss_pred HHHHhCCCCCCCCCc----------------c--chhHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 044995 168 VELLTGAKPIRFTTF----------------E--EDKNITVAKHAKRCLNPSGKKRPA---MKEVASE 214 (288)
Q Consensus 168 ~elltg~~P~~~~~~----------------~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~i~~~ 214 (288)
|||++|+.||..... + ...+.+..+++.+++ .+|.+|++ +.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999964321 1 123678888888876 49999987 8887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.00 Aligned_cols=191 Identities=25% Similarity=0.422 Sum_probs=151.2
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccccC-----
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQN----- 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~~----- 76 (288)
+.||+|+||.||+|.++ .+.|.+|+++++++ +||||++++++|....+.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999998642 24678899999999 8999999999876654321100
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 77 ------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 77 ------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
....+++.....++.|++.||+||| +.+++|+||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 1124678899999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccch
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEED 185 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~ 185 (288)
++....... .......+..|+||| ||||||+++|||++ |..||.... .+..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 986322111 111112355799999 99999999999997 999985332 1223
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+.++.+++.+||+.||.+||++.++++.|+.+.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 4578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.99 Aligned_cols=201 Identities=24% Similarity=0.392 Sum_probs=162.1
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
+...++|++.+.||+|+||.||++..+ .+.+.+|+.++++++|+||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 356789999999999999999998642 46799999999999999999999987653221
Q ss_pred --cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 73 --HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 73 --~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.. ......+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 11 111235788899999999999999999 88899999999999999999999999999876543211
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
.......++..|++|| ||||||+++|||++ |+.||.... .+...+.++.+++.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1111223456799999 99999999999998 999985432 12234678999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHh
Q 044995 196 RCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
+||+.+|++||++.++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=256.49 Aligned_cols=187 Identities=22% Similarity=0.288 Sum_probs=147.1
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhc-CCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQ-INHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||+|.++ .+.+..|..++.. ++||||+++++++...++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999652 2334566666664 5899999999887655432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 12235788889999999999999999 8899999999999999999999999999987543222 222345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||..|+||| |||||||++|||++|..||.... .+...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 6999999999 99999999999999999996433 2233567889999999999999
Q ss_pred CCCCHH-HHHHH
Q 044995 204 KRPAMK-EVASE 214 (288)
Q Consensus 204 ~Rp~~~-~i~~~ 214 (288)
+||++. +++++
T Consensus 237 ~R~~~~~~l~~h 248 (316)
T cd05592 237 KRLGVDGDIRQH 248 (316)
T ss_pred HcCCChHHHHcC
Confidence 999864 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.70 Aligned_cols=200 Identities=24% Similarity=0.401 Sum_probs=160.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
..++|+..+.||+|+||.||+|..+ .+.|.+|++++++++|+||+++++++...+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3467888999999999999988641 346889999999999999999999876554321
Q ss_pred -------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 74 -------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 74 -------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
. ......+++.....++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 1 112245788899999999999999999 88999999999999999999999999999875532
Q ss_pred CCceee--eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 140 DQTHIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
...... .....+..|++|| |||||||++|||++ |..||.... ...+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 221111 1112345699999 99999999999997 999984322 122346788
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+++.+||+.+|++||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=254.58 Aligned_cols=182 Identities=24% Similarity=0.327 Sum_probs=144.0
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHH-HHhcCCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVV-IQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||+++++ ...+.+|.. +++.++||||+++++++.+.+.++..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999752 123445554 67889999999999887655332211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccccc
Confidence 12235778888889999999999999 889999999999999999999999999998753221 1222345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||+.|+||| |||||||++|||++|..||...+ .+...+..+.+++.+||+.||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHh
Confidence 6899999999 99999999999999999996443 2234567889999999999999
Q ss_pred CCCCHH
Q 044995 204 KRPAMK 209 (288)
Q Consensus 204 ~Rp~~~ 209 (288)
+|+++.
T Consensus 237 ~R~~~~ 242 (321)
T cd05603 237 RRLGAK 242 (321)
T ss_pred hcCCCC
Confidence 999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.66 Aligned_cols=186 Identities=24% Similarity=0.302 Sum_probs=149.4
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCC-ceeeecceEecccccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHI-NVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~l~~~- 75 (288)
+|++.+.||+|+||.||+|.++ .+.+..|++++..++|+ +|+++++++...+.++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999998652 34577899999999765 577888776554332211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 12235788899999999999999999 88999999999999999999999999999874322111
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
......||..|+||| |||||||++|||++|+.||.... .+...+.++.+++.+||
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 223356999999999 99999999999999999996433 23345778899999999
Q ss_pred CCCCCCCCCH
Q 044995 199 NPSGKKRPAM 208 (288)
Q Consensus 199 ~~~p~~Rp~~ 208 (288)
..||.+|++.
T Consensus 237 ~~~P~~R~~~ 246 (324)
T cd05587 237 TKHPAKRLGC 246 (324)
T ss_pred hcCHHHcCCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.56 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=158.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++.+.||+|+||.||+|+.+ .+.|.+|++++++++|+||+++++++.+.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 368999999999999999998731 25689999999999999999999987654321
Q ss_pred -------c---------ccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 73 -------H---------DQNK------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 73 -------~---------~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
. .... ...+++..+..++.|++.+|.||| +.+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 1 1110 125789999999999999999999 88899999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------------c
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------------F 182 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------------~ 182 (288)
||++...............++..|++|| ||||||+++|+|++ |..||.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9998754322222222234567799999 99999999999998 788884321 1
Q ss_pred cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
....+..+.+++.+||+.||++||++.++++.|.
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.03 Aligned_cols=201 Identities=22% Similarity=0.375 Sum_probs=161.2
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc------c
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK------Y 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 71 (288)
+...++|++.+.||+|+||.||++.+. .+.|.+|++++++++|+||+++++++.... +
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 81 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence 345689999999999999999998641 357889999999999999999998865432 2
Q ss_pred ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 72 MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 72 l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
+.. ......+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 111 112234677888999999999999999 888999999999999999999999999998755332222
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
......++..|++|| ||||||+++|++++ |..||..... ....+.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 238 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence 222233567799999 99999999999999 9999864322 12345789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHh
Q 044995 197 CLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
||+.+|++||++.++.+.|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 239 CWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=257.74 Aligned_cols=184 Identities=27% Similarity=0.292 Sum_probs=149.3
Q ss_pred CceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc----
Q 044995 23 NRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
++.||+|+||.||++.+. ...+.+|++++++++||||+++++++...+.++..
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 368999999999987531 23467899999999999999999987665432211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 12335788999999999999999999 8899999999999999999999999999987543321 1223
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~ 201 (288)
...|+..|+||| |||||||++|||++|+.||.... .+...+..+.+++.+||+.|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 456899999999 99999999999999999996432 23345778999999999999
Q ss_pred CCCCCCHHH
Q 044995 202 GKKRPAMKE 210 (288)
Q Consensus 202 p~~Rp~~~~ 210 (288)
|++||++.+
T Consensus 237 P~~R~~a~~ 245 (318)
T cd05582 237 PANRLGAGP 245 (318)
T ss_pred HhHcCCCCC
Confidence 999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=245.58 Aligned_cols=190 Identities=28% Similarity=0.430 Sum_probs=150.5
Q ss_pred ceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------ccc---
Q 044995 24 RILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHD--- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~--- 74 (288)
+.||+|+||.||+|+++ ...|.+|++++++++||||++++++|...+. +..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999998652 3568999999999999999999998765432 211
Q ss_pred ----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee-eccc
Q 044995 75 ----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT-TQVH 149 (288)
Q Consensus 75 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~ 149 (288)
......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 112235788899999999999999999 88999999999999999999999999999875432111100 0111
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCCCC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNPSG 202 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~~p 202 (288)
.+..|+||| ||||||+++|||++ |..||.... .+...+..+.+++.+||+.||
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 245699999 99999999999998 888874322 223346789999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 044995 203 KKRPAMKEVASELA 216 (288)
Q Consensus 203 ~~Rp~~~~i~~~l~ 216 (288)
++||++.++++.|+
T Consensus 238 ~~Rps~~~~~~~l~ 251 (252)
T cd05084 238 GQRPSFSTVHQELQ 251 (252)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.11 Aligned_cols=199 Identities=25% Similarity=0.412 Sum_probs=158.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||++.++ .+.|.+|+.++++++||||++++++|.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999998631 3468899999999999999999998765432
Q ss_pred ccccC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 72 MHDQN-----------------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 72 l~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
..... ....+++..++.++.|++.||.||| ..+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 21100 1123677888999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC--
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT-- 181 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~-- 181 (288)
||+++.++.++|+|||++......... .......+..|+||| |||||||++|||++ |..||....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998754322111 111223456799999 99999999999997 888874322
Q ss_pred -------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 182 -------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 182 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+...+.++.+++.+||+.||++||++.|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 123456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=259.16 Aligned_cols=195 Identities=26% Similarity=0.335 Sum_probs=164.8
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCC-CCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l 72 (288)
...+.|++.+.||+|.||.||+++.+ .+.+.+|+++|+++. |||||.+.++|.....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45578999999999999999998753 357889999999999 99999999998876543
Q ss_pred cccCCCC------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC----CCceEEecccCccc
Q 044995 73 HDQNKEL------------PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD----KYCAKVSNFGTSRS 136 (288)
Q Consensus 73 ~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~----~~~~kl~DfG~a~~ 136 (288)
+...+.. .+++..+..++.|++.++.||| ..+|+||||||+|+|+.. ++.+|++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 3211110 2899999999999999999999 899999999999999943 35799999999987
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKN 187 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~ 187 (288)
... .......+||+.|+||| ||||+|+++|.|++|..||...+. -...+
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 654 44455678999999999 999999999999999999965441 12347
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.+++.+++..||..|+++.++++|
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 889999999999999999999999996
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=254.88 Aligned_cols=183 Identities=24% Similarity=0.347 Sum_probs=144.8
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHH-HHhcCCCCceeeecceEeccccc-------cc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVV-IQSQINHINVVKLIGCCLETKYM-------HD 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~l-------~~ 74 (288)
+.||+|+||.||++.++ ...+.+|.. +++.++||||+++++++...+.+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999752 123445544 56789999999999887654322 11
Q ss_pred c------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 75 Q------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 75 ~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
. .....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 1 12335788889999999999999999 889999999999999999999999999998753221 1222345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||+.|+||| |||||||++|||++|..||..... ....+..+.+++.+||+.||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 6899999999 999999999999999999964321 223477899999999999999
Q ss_pred CCCCHHH
Q 044995 204 KRPAMKE 210 (288)
Q Consensus 204 ~Rp~~~~ 210 (288)
+||++.+
T Consensus 237 ~R~~~~~ 243 (323)
T cd05575 237 KRLGAKD 243 (323)
T ss_pred hCCCCCC
Confidence 9999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=244.97 Aligned_cols=193 Identities=27% Similarity=0.385 Sum_probs=154.1
Q ss_pred ceeeeeCCeeEEEeEc----------------------cHHHHHHHHHHHhcCCCCceeeecceEecccc------ccc-
Q 044995 24 RILGQGGQDIVYKGMA----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKY------MHD- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------l~~- 74 (288)
++||+|+||.||+|.. ..+.+.+|++++++++|+|||++++++....+ ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 4799999999998853 13468899999999999999999998754321 111
Q ss_pred -----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee--ec
Q 044995 75 -----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT--TQ 147 (288)
Q Consensus 75 -----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--~~ 147 (288)
......+++..+..++.|++.+|.||| ..+++|+||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 011225788999999999999999999 88899999999999999999999999999876543322211 11
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
..++..|+||| ||||||+++|||++ |..||.... .+...+..+.+++.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 22346799999 99999999999998 999985422 2234467899999999999
Q ss_pred CCCCCCCHHHHHHHHHhch
Q 044995 201 SGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l~~~~ 219 (288)
||++||++.++++.|+++.
T Consensus 238 ~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 238 RPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ChhhCcCHHHHHHHHHhcc
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.16 Aligned_cols=191 Identities=23% Similarity=0.264 Sum_probs=152.3
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----------
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---------- 74 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---------- 74 (288)
||+|+||.||++..+ ...+..|++++++++||||+++++++....++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999998642 1235679999999999999999988765533211
Q ss_pred -----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 75 -----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 75 -----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 112234778888899999999999999 8899999999999999999999999999987654322 122346
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhHHHHHHHHHHhcC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKNITVAKHAKRCLN 199 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~~~~~~li~~cl~ 199 (288)
|+..|+||| |||||||++|||++|..||..... ....+.++.+++.+||+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 899999999 999999999999999999854211 01236778999999999
Q ss_pred CCCCCCCCHHHHHHHHHhchhh
Q 044995 200 PSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.||++||++.|+++.+......
T Consensus 236 ~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 236 KKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred cCHhhCCCCccchhhhhcChhh
Confidence 9999999998888777665544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.50 Aligned_cols=186 Identities=24% Similarity=0.301 Sum_probs=149.6
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~- 75 (288)
+|++.+.||+|+||.||++.++ .+.+..|..++..+ +|++|+++++++...+.++..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999998652 23456778887777 589999998887655432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 12235788899999999999999999 8899999999999999999999999999987533221 1
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
......||+.|+||| |||||||++|||++|+.||.... .+...+.++.+++.+||
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 236 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHc
Confidence 223456899999999 99999999999999999996543 22345678999999999
Q ss_pred CCCCCCCCCH
Q 044995 199 NPSGKKRPAM 208 (288)
Q Consensus 199 ~~~p~~Rp~~ 208 (288)
+.||++|++.
T Consensus 237 ~~~p~~R~~~ 246 (323)
T cd05616 237 TKHPGKRLGC 246 (323)
T ss_pred ccCHHhcCCC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.55 Aligned_cols=192 Identities=23% Similarity=0.319 Sum_probs=157.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD----- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~----- 74 (288)
+|++.+.||+|+||.||++.++ .+.+.+|+.++++++|+||+++++.+.+..+++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999998642 3568889999999999999999998766543221
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......++......++.|++.||.||| +.+|+|+||||+||+++.++.++++|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 112234678889999999999999999 88999999999999999999999999999875533222 1
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhc
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl 198 (288)
.....|+..|+||| |+||||+++|+|++|..||.... .+...+..+.+++.+||
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHH
Confidence 22346888999999 99999999999999999996433 12234677899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++||++.+++..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.10 Aligned_cols=203 Identities=25% Similarity=0.406 Sum_probs=158.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceEecc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLET 69 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 69 (288)
-..++|++.+.||+|+||.||+|.+. ...+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 34578999999999999999998520 24578999999999 689999999877542
Q ss_pred c--------ccccc---------C--------------------------------------------------------
Q 044995 70 K--------YMHDQ---------N-------------------------------------------------------- 76 (288)
Q Consensus 70 ~--------~l~~~---------~-------------------------------------------------------- 76 (288)
+ |+... .
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 1 11100 0
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-eeec
Q 044995 77 --------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQ 147 (288)
Q Consensus 77 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 147 (288)
....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 0113677888899999999999999 889999999999999999999999999998754322111 1112
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHHHHHHHHhcC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITVAKHAKRCLN 199 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~~~li~~cl~ 199 (288)
..++..|+||| ||||||+++|+|++ |..||..... +...+.++.+++.+||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 23566799999 99999999999997 9999854321 11235678999999999
Q ss_pred CCCCCCCCHHHHHHHHHhchh
Q 044995 200 PSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.||++||++.+|+++|+.+..
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.15 Aligned_cols=187 Identities=24% Similarity=0.359 Sum_probs=149.5
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc-------cc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM-------HD 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l-------~~ 74 (288)
+.||+|+||.||++.++ .+.+.+|..++.++ +||||+++++++...+.+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999998752 23477899999888 799999999987665432 21
Q ss_pred ------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 75 ------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 75 ------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 112346889999999999999999999 8899999999999999999999999999987432211 122345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------------ccchhHHHHHHHH
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------------FEEDKNITVAKHA 194 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------------~~~~~~~~~~~li 194 (288)
.||+.|+||| |||||||++|||++|+.||.... .+...+.++.+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 7999999999 99999999999999999995311 1223456789999
Q ss_pred HHhcCCCCCCCCC------HHHHHHH
Q 044995 195 KRCLNPSGKKRPA------MKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~------~~~i~~~ 214 (288)
.+||+.||.+|++ +.+++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999997 5676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.82 Aligned_cols=199 Identities=25% Similarity=0.404 Sum_probs=159.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~- 73 (288)
.++|++.+.||+|+||.||+|.++ .+.|.+|+.++++++||||+++++++...++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467899999999999999988641 356889999999999999999999876554322
Q ss_pred ------cc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 ------DQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.. .....+++.....++.|++.||.||| +.+++||||||+|||++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 11 11235788889999999999999999 889999999999999999999999999998865433
Q ss_pred Cceeee--ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHH
Q 044995 141 QTHITT--QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 141 ~~~~~~--~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~ 191 (288)
...... ...++..|++|| |+||||+++||+++ |..||.... .....+..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 221111 122345799999 99999999999886 999985322 1123467889
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+++.+||+.+|++||++.++++.|.++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=252.93 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=156.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
++|++.+.||+|+||.||++.+. .+++.+|++++++++||||++++++|...+++....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 57999999999999999998642 246889999999999999999999887654332211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
....+++.....++.|++.||.||| + .+++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 1235678888999999999999999 6 489999999999999999999999999987543221
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------------
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------------------ 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------------------ 183 (288)
.....|+..|++|| ||||||+++|+|++|..||......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 22346888999999 9999999999999999998421100
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
...+.++.+++.+||+.||++||++.+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 013457889999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=251.91 Aligned_cols=194 Identities=25% Similarity=0.379 Sum_probs=158.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
..+|++.+.||+|+||.||+|.+. .+.+.+|+.+++.+.|+||+++++.+...+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999742 457889999999999999999999876653322111
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 77 ----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 77 ----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
....+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++......... ..
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~ 174 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cC
Confidence 1224678889999999999999999 889999999999999999999999999998754322211 12
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl 198 (288)
...|+..|+||| |||||||++|+|++|+.||..... +...+..+.+++.+||
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 245888999999 999999999999999999854321 2234567899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
..||++||++.+++++
T Consensus 255 ~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 255 DMDVEKRGSAKELLQH 270 (296)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.81 Aligned_cols=181 Identities=25% Similarity=0.319 Sum_probs=146.3
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ .+.+.+|..++..+ +||||+++++++...+.++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999998752 24567788888776 699999999987665432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 12335788889999999999999999 8899999999999999999999999999987532221 122335
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||+.|+||| |||||||++|||++|..||..... +...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence 6999999999 999999999999999999964432 223467899999999999999
Q ss_pred CCCCH
Q 044995 204 KRPAM 208 (288)
Q Consensus 204 ~Rp~~ 208 (288)
+|+++
T Consensus 237 ~R~~~ 241 (320)
T cd05590 237 MRLGS 241 (320)
T ss_pred HCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=245.15 Aligned_cols=196 Identities=27% Similarity=0.440 Sum_probs=160.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~ 73 (288)
..++|++.+.||+|+||.||++... .+++.+|+.++++++|+||+++++++..... +.
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4578999999999999999998652 4578999999999999999999998764322 11
Q ss_pred c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 74 D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 ~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
. ......+++.....++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 1 011125789999999999999999999 88999999999999999999999999999876532211
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhc
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl 198 (288)
....+..|++|| ||||||+++||+++ |..||..... +...+..+.+++.+||
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 123456789998 99999999999997 9999854321 2234678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhc
Q 044995 199 NPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~~~ 218 (288)
..+|++||++.++++.|+.+
T Consensus 237 ~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 237 ELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=257.30 Aligned_cols=187 Identities=25% Similarity=0.355 Sum_probs=148.0
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ .+.+.+|+.++.++ +||||+++++++...+.++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999998752 23467888888776 899999999987665432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccc
Confidence 12235788899999999999999999 88999999999999999999999999999875322111 22345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------------ccchhHHHHHHHH
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------------FEEDKNITVAKHA 194 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------------~~~~~~~~~~~li 194 (288)
.||..|+||| |||||||++|||++|..||.... .+...+..+.+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 6899999999 99999999999999999994211 1223467788999
Q ss_pred HHhcCCCCCCCCC------HHHHHHH
Q 044995 195 KRCLNPSGKKRPA------MKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~------~~~i~~~ 214 (288)
.+||+.||++||+ +.+++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999998 4566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=246.98 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=161.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
.++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++||||++++++|....
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQL 85 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEE
Confidence 367889999999999999998631 356889999999999999999999876532
Q ss_pred ---cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ---YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ---~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
++.. ......+++...+.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 1111 111235789999999999999999999 889999999999999999999999999999865432
Q ss_pred Cceee-eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHH
Q 044995 141 QTHIT-TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAK 192 (288)
Q Consensus 141 ~~~~~-~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~ 192 (288)
..... ....++..|++|| ||||||+++||+++ |..||..... +...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 22111 1122356799999 99999999999998 9999864331 2234578899
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++.+||..||++||++.++++.|+.+..
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.79 Aligned_cols=185 Identities=22% Similarity=0.270 Sum_probs=148.2
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-------ccccc--
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------YMHDQ-- 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------~l~~~-- 75 (288)
||+|+||+||++.++ .+.+..|++++++++|+||+++.+++.... |+...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999998652 245678999999999999999988765442 32211
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 76 --------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 76 --------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
.....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 12235788999999999999999999 88999999999999999999999999999875433222 1223
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHHHHHhc
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~li~~cl 198 (288)
..|++.|+||| |||||||++|||++|+.||..... +...+..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 46899999999 999999999999999999964321 1234678999999999
Q ss_pred CCCCCCCC-----CHHHHHHH
Q 044995 199 NPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp-----~~~~i~~~ 214 (288)
+.||++|| ++++++++
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 55666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=242.67 Aligned_cols=190 Identities=30% Similarity=0.457 Sum_probs=152.2
Q ss_pred ceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-----------
Q 044995 24 RILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD----------- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~----------- 74 (288)
+.||+|+||.||+|... ...|.+|++++++++||||++++++|........
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999998642 2468899999999999999999998876533211
Q ss_pred ---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccC
Q 044995 75 ---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 75 ---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
......+.+.....++.+++.+|.|+| .++++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 111234788999999999999999999 88999999999999999999999999999875432221111122345
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCCCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNPSGKK 204 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~ 204 (288)
..|+||| ||||||+++|++++ |..||.... .+...+..+.+++.+||+.+|++
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 6799999 99999999999998 999985332 22335688999999999999999
Q ss_pred CCCHHHHHHHHH
Q 044995 205 RPAMKEVASELA 216 (288)
Q Consensus 205 Rp~~~~i~~~l~ 216 (288)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=244.74 Aligned_cols=192 Identities=25% Similarity=0.406 Sum_probs=157.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++.+.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888899999999999998652 4578899999999999999999998766532211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 111235788888999999999999999 88999999999999999999999999999876543222
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHh
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~c 197 (288)
......|+..|+||| ||||||+++|+|++|+.||.... .....+..+.+++.+|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 122345888999999 99999999999999999986433 1223467899999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.+|++||++.+++++
T Consensus 237 l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 237 LTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCCcccCcCHHHHhhC
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=244.30 Aligned_cols=193 Identities=30% Similarity=0.465 Sum_probs=149.8
Q ss_pred ceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------ccc
Q 044995 24 RILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--------YMH 73 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------~l~ 73 (288)
+.||+|+||.||+|.+. .+.|.+|+.+++.++||||++++++|...+ ++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999988631 357888999999999999999999875432 111
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce---
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--- 143 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--- 143 (288)
. ........+...+.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 0 011223567778889999999999999 889999999999999999999999999998754322111
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhC-CCCCCCCC---------------ccchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG-AKPIRFTT---------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg-~~P~~~~~---------------~~~~~~~~~~~li~~ 196 (288)
......++..|+||| ||||||+++|||++| ..||.... .+...+..+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 111234567899999 999999999999995 55654211 122346789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhch
Q 044995 197 CLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
||+.+|++||++.++++.|+++.
T Consensus 238 cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 238 CWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HcCCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=248.14 Aligned_cols=193 Identities=22% Similarity=0.294 Sum_probs=156.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
++|++.+.||+|+||.||++.++ .+.+.+|++++++++|+||+++++++...+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999998652 24578999999999999999999987665432
Q ss_pred --cc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 73 --HD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 73 --~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.. ......+++..+..++.|++.+|.||| +.+|+|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 11 112235789999999999999999999 88999999999999999999999999999876543221 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|++|| ||||||+++|||++|..||......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 12234778899998 9999999999999999998643210
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 1124568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.20 Aligned_cols=187 Identities=22% Similarity=0.293 Sum_probs=150.1
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||+|+++ .+.+..|.+++..+ +||||+++++++...+.+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999998652 23467888888865 799999999987665432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccccc
Confidence 12235788889999999999999999 88999999999999999999999999999875332221 22335
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||..|+||| |||||||++|||++|+.||..... +...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 6899999999 999999999999999999965431 223467899999999999999
Q ss_pred CCC-------CHHHHHHH
Q 044995 204 KRP-------AMKEVASE 214 (288)
Q Consensus 204 ~Rp-------~~~~i~~~ 214 (288)
+|+ ++.+++++
T Consensus 237 ~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 237 KRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCCCCCCCCHHHHhcC
Confidence 999 77777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=254.34 Aligned_cols=187 Identities=23% Similarity=0.317 Sum_probs=150.8
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ .+.+.+|.+++..+ +||||+++++++...+.+...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999998652 24567888888887 699999999987655432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccce
Confidence 12235889999999999999999999 88999999999999999999999999999875322221 22334
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.|+..|+||| |||||||++|+|++|+.||.... .+...+..+.+++.+||+.||+
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHH
Confidence 6899999999 99999999999999999996432 2233567899999999999999
Q ss_pred CCCCH-----HHHHHH
Q 044995 204 KRPAM-----KEVASE 214 (288)
Q Consensus 204 ~Rp~~-----~~i~~~ 214 (288)
+||++ .+++++
T Consensus 237 ~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 237 KRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCCCCCCCHHHHhcC
Confidence 99998 777665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=246.97 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=155.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLET----- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 69 (288)
.++|++.+.||+|+||.||++..+ .+.|.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 468999999999999999997521 35788999999999999999999876432
Q ss_pred ----ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 ----KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ----~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+|+.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 22211 111235788999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceee--eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------------
Q 044995 139 VDQTHIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------------ 181 (288)
Q Consensus 139 ~~~~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------------ 181 (288)
....... ....++..|+||| ||||||+++|||++|..++....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3322111 1122344589999 99999999999999866542111
Q ss_pred -------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 -------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.....+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1122356899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=249.01 Aligned_cols=206 Identities=25% Similarity=0.342 Sum_probs=165.2
Q ss_pred cceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEe
Q 044995 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCL 67 (288)
Q Consensus 6 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 67 (288)
+.+.++.+....++|++.+.||+|+||.||++.++ .+.+.+|+.+++++ +||||++++++|.
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred ceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 34566888889999999999999999999998652 24678899999999 6999999999764
Q ss_pred cc------------cccccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 68 ET------------KYMHDQ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 68 ~~------------~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
.. +|+... .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence 21 222110 12235778888899999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc-------
Q 044995 126 AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF------- 182 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~------- 182 (288)
+||+|||+++....... ......|+..|+||| |||||||++|||++|+.||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 99999999876533221 222345889999997 999999999999999999853321
Q ss_pred ----------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 ----------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 ----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+...+.++.+++.+||+.||++||++.|+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 112356799999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.62 Aligned_cols=192 Identities=20% Similarity=0.265 Sum_probs=153.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+|++.+.||+|+||.||+++++ ...+.+|++++++++||||+++++++.+...+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999998752 2457789999999999999999998765432211
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 75 ---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 75 ---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
......+++..+..++.|++.||.||| ..+|+|+||||+||+++.++.+||+|||+++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 156 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-Y 156 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-c
Confidence 112345789999999999999999999 889999999999999999999999999998754332211 1
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------- 182 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------- 182 (288)
....++..|+||| |||||||++|||++|..|+.....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 2235788899999 999999999999999888532110
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01134677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=249.08 Aligned_cols=192 Identities=24% Similarity=0.341 Sum_probs=156.7
Q ss_pred cccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-------c
Q 044995 20 FNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH-------D 74 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~-------~ 74 (288)
|++.+.||+|+||.||++.+. .+.|.+|+++++.++||||++++++|...++.. .
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 678899999999999998752 456889999999999999999999876654321 1
Q ss_pred -------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 75 -------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 75 -------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
.....++++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 112346888999999999999999999 8899999999999999999999999999986543221 12223
Q ss_pred cccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHH
Q 044995 148 VHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHA 194 (288)
Q Consensus 148 ~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li 194 (288)
..++..|++|| |||||||++|||++|..||.... .+...+.++.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 45888999998 99999999999999999985322 1123456899999
Q ss_pred HHhcCCCCCCCCCHHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+||+.||++||++.+++++-
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHccCChhhCcCHHHHhcCC
Confidence 999999999999999988664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=239.45 Aligned_cols=195 Identities=24% Similarity=0.369 Sum_probs=157.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~----- 70 (288)
..++.+.+..||.|+.|.|++++.+ .+++++.+.++.+.. .|.||+.+|+|....
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3455666788999999999998653 467788888766654 899999999987542
Q ss_pred --ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 71 --YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 71 --~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.|. ...-..++++..+-++...+..||.||.. .++|+|||+||+|||+|+.|.+|+||||++..+....
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 110 11223468888888999999999999984 4589999999999999999999999999997654333
Q ss_pred eeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC--c----------------cchhHHHH
Q 044995 143 HITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT--F----------------EEDKNITV 190 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~--~----------------~~~~~~~~ 190 (288)
..+...|.+.||||| ||||||++++||+||+.||.+-. + ....+..+
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 334457999999999 99999999999999999996521 1 11257899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++..||..|+.+||...+++++
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999886
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=276.25 Aligned_cols=200 Identities=23% Similarity=0.355 Sum_probs=159.0
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.++||+|+||.||+|.+. .++|.+|++++++++||||+++++++.+.+......
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999652 356899999999999999999999876653221100
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 77 ------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 77 ------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
....+++...+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 0123456677889999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCc-----------------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-
Q 044995 133 TSRSRAVDQT-----------------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE- 183 (288)
Q Consensus 133 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~- 183 (288)
+++....... .......||+.|+||| |||||||++|||+||..||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521100 0112246999999999 9999999999999999999543211
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhchh
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRP-AMKEVASELAGIKA 220 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp-~~~~i~~~l~~~~~ 220 (288)
...+..+.+++.+||+.||++|+ ++.++++.|+....
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 12356789999999999999995 67888888877654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=253.46 Aligned_cols=190 Identities=24% Similarity=0.302 Sum_probs=147.4
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHH-HHhcCCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVV-IQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ ...+.+|.. +++.++||||+++++++...+.++..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999752 123344443 56789999999999887665432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+.+..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 12234677888889999999999999 8899999999999999999999999999987532221 122345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||+.|+||| |||||||++|||++|..||.... .....+..+.+++.+||+.||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHH
Confidence 6999999999 99999999999999999996432 1224567899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 044995 204 KRPAMKEVASELAG 217 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~ 217 (288)
+|+++.+.+..+.+
T Consensus 237 ~R~~~~~~~~~i~~ 250 (325)
T cd05602 237 KRLGAKDDFMEIKN 250 (325)
T ss_pred HCCCCCCCHHHHhc
Confidence 99998755444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=255.33 Aligned_cols=194 Identities=21% Similarity=0.271 Sum_probs=154.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.++ .+.|.+|+.+++.++|+||+++++++.+.++++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999998752 234778999999999999999999877654332111
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 77 --------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 77 --------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 1235778888999999999999999 88999999999999999999999999999875543332
Q ss_pred eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------chhH
Q 044995 143 HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------EDKN 187 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~~-------------------~~~~ 187 (288)
.......||+.|+||| |||||||++|||++|+.||...... ...+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 2223346899999998 9999999999999999999643211 1246
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKK--RPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~--Rp~~~~i~~~ 214 (288)
..+.+++.+|+..++++ |+++.+++++
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 78899999988654433 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=243.59 Aligned_cols=196 Identities=26% Similarity=0.431 Sum_probs=157.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-------c
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-------H 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-------~ 73 (288)
..+|++.+.||+|+||.||++.+. .+.|.+|++++++++||||+++++++...... .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357889999999999999998642 36799999999999999999999987654322 1
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++..+..++.+++.+|.||| +.+++|+||||+||+++.++.+||+|||++............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 1 112235788889999999999999999 888999999999999999999999999998754322211111
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~ 199 (288)
...++..|+||| ||||||+++|||++ |..||.... .+...+..+.+++.+||+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 239 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 223456899998 99999999999998 999985332 122346789999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 044995 200 PSGKKRPAMKEVASEL 215 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l 215 (288)
.+|++||++.++++.|
T Consensus 240 ~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 240 ERPEDRPSFSLLLHQL 255 (256)
T ss_pred cChhhCCCHHHHHHhh
Confidence 9999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=249.30 Aligned_cols=192 Identities=21% Similarity=0.281 Sum_probs=154.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|+||.||+|+++ .+.+.+|++++++++||||+++++++.+.+.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999652 24688999999999999999999987654332111
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 12245788899999999999999999 889999999999999999999999999998754322211
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|+||| ||||||+++|||+||+.||......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 12234677899998 9999999999999999998543211
Q ss_pred --------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0124567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=248.26 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=157.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
..+.|++.++||+|+||.||+|.++ .+.+.+|+.++++++|+||+++++++.....+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3477999999999999999999752 45688999999999999999999987654322
Q ss_pred --ccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 73 --HDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 73 --~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
... .....+++..+..++.|++.+|.||| +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 111 11235788999999999999999999 8899999999999999999999999999886532211 1
Q ss_pred eeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHH
Q 044995 144 ITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITV 190 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~ 190 (288)
......++..|++|| |||||||++|||++|..||..... +...+.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 122345788899987 999999999999999999853221 12335688
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+.||++||++.+++++
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcC
Confidence 999999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=256.60 Aligned_cols=196 Identities=20% Similarity=0.323 Sum_probs=157.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
..++|++.+.||+|+||.||+|.+. ..++.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999998642 345788999999999999999998765432
Q ss_pred ------cccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ------YMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ------~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 1111 112235788899999999999999999 889999999999999999999999999998754322
Q ss_pred Cce--eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 141 QTH--ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 141 ~~~--~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
... ......|+..|+||| ||||||+++|+|++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 211 112346788999999 9999999999999999998542210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0124567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=248.41 Aligned_cols=191 Identities=25% Similarity=0.303 Sum_probs=153.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM----- 72 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l----- 72 (288)
.|+..+.||+|+||+||++.+. .+.+.+|++++++++|+||+.+.+.+...+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999998652 13467899999999999999998876554322
Q ss_pred --cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 73 --HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 73 --~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.. ......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 11 112235889999999999999999999 88999999999999999999999999999865432211
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
.....|+..|+||| |+||||+++|||++|..||..... ....+..+.++
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence 12346899999999 999999999999999999964321 22345678999
Q ss_pred HHHhcCCCCCCCCC-----HHHHHHH
Q 044995 194 AKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+.+||+.||++||+ +.+++++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcC
Confidence 99999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=252.04 Aligned_cols=194 Identities=20% Similarity=0.262 Sum_probs=154.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.++||+|+||.||++.++ .+.|.+|+.++..++|+||+++++++.+.+.++..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 57999999999999999998752 23477899999999999999999887654322111
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 11235788888999999999999999 88999999999999999999999999999875543333
Q ss_pred eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c---chhH
Q 044995 143 HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF----------------E---EDKN 187 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~----------------~---~~~~ 187 (288)
.......||+.|+||| |||||||++|||++|+.||..... + ...+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 2333456999999998 999999999999999999954321 1 1346
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKK--RPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~--Rp~~~~i~~~ 214 (288)
.++.+++.+|+..++++ |+++.+++++
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 78899999988665544 6889999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=244.95 Aligned_cols=189 Identities=22% Similarity=0.283 Sum_probs=145.1
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN------ 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~------ 76 (288)
+.||+|+||.||+|... ...|.+|+.+++.++|+||+++++.|.....+....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999998531 246889999999999999999999876543221100
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 1112356777899999999999999 8899999999999999999999999999986533221111
Q ss_pred -eeccccCCCCCChh------------------hHHHHHHHHHHHHh-CCCCCCCCCc--------------------cc
Q 044995 145 -TTQVHGTFGYLNPD------------------DVCSFGVVLVELLT-GAKPIRFTTF--------------------EE 184 (288)
Q Consensus 145 -~~~~~gt~~y~aPE------------------DiwSlG~il~ellt-g~~P~~~~~~--------------------~~ 184 (288)
.....++..|+||| |||||||++|||++ |..||..... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 12223566799998 89999999999999 7888753321 11
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
..+..+.+++..|| .||++||++.+|++.|.
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 34567788999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=252.72 Aligned_cols=187 Identities=21% Similarity=0.279 Sum_probs=147.8
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhc-CCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQ-INHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ .+.+..|..++.. ++||||+++++++...++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999998752 2345677777765 5899999999987665433211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 12235788889999999999999999 8899999999999999999999999999987432111 122345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||..|+||| |||||||++|||++|..||.... .+...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 6999999999 99999999999999999996433 1223467889999999999999
Q ss_pred CCCCHH-HHHHH
Q 044995 204 KRPAMK-EVASE 214 (288)
Q Consensus 204 ~Rp~~~-~i~~~ 214 (288)
+|+++. +++++
T Consensus 237 ~R~~~~~~~~~h 248 (316)
T cd05620 237 RRLGVVGNIRGH 248 (316)
T ss_pred HcCCChHHHHcC
Confidence 999974 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=252.38 Aligned_cols=186 Identities=24% Similarity=0.302 Sum_probs=147.8
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhc-CCCCceeeecceEeccccccccC-----
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQ-INHINVVKLIGCCLETKYMHDQN----- 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~l~~~~----- 76 (288)
+.||+|+||.||+|.++ .+.+..|..+++. ++||||+++++++.+.+.+....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999752 2345677888775 59999999999876654332111
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 77 --------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 77 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence 1235788889999999999999999 88999999999999999999999999999875322211 22335
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.||..|+||| |||||||++|||++|..||.... .+...+.++.+++.+||+.||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHh
Confidence 6899999999 99999999999999999996433 1223466789999999999999
Q ss_pred CCCCHH-HHHH
Q 044995 204 KRPAMK-EVAS 213 (288)
Q Consensus 204 ~Rp~~~-~i~~ 213 (288)
+||++. ++++
T Consensus 237 ~R~~~~~~l~~ 247 (316)
T cd05619 237 RRLGVKGDIRQ 247 (316)
T ss_pred hcCCChHHHHc
Confidence 999986 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=246.91 Aligned_cols=198 Identities=23% Similarity=0.361 Sum_probs=157.3
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLET----- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 69 (288)
..|++.+.||+|+||.||++... .+.|.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45789999999999999987520 35788999999999999999999987653
Q ss_pred ----cccccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 ----KYMHDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ----~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+|.... .....+++..++.++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 122111 11225788999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCC--------------------------
Q 044995 139 VDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRF-------------------------- 179 (288)
Q Consensus 139 ~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~-------------------------- 179 (288)
..... ......++..|+||| ||||||+++|||+++..|...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 33221 112234667799999 999999999999997655311
Q ss_pred ----CCccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 180 ----TTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 180 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
...+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011223467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=244.06 Aligned_cols=196 Identities=27% Similarity=0.450 Sum_probs=155.0
Q ss_pred cccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677899999999999998631 346889999999999999999999765321
Q ss_pred -------cccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 71 -------YMHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 71 -------~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+... ......+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 1110 011124678889999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------c
Q 044995 132 GTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------E 183 (288)
Q Consensus 132 G~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~ 183 (288)
|+++........ ......++..|++|| ||||||+++|||++ |..||..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 998754322211 112223456788998 99999999999999 8888753321 1
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=252.76 Aligned_cols=191 Identities=25% Similarity=0.327 Sum_probs=149.1
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHH-HHhcCCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVV-IQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||++.++ ...+.+|.. +++.++||||+++++++...+.++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999998652 134455554 56789999999999887655332211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 12345788899999999999999999 8899999999999999999999999999987532211 122345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHHHHhcCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li~~cl~~~p~ 203 (288)
.|+..|+||| |||||||++|||++|..||..... ....+..+.+++.+||+.||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHH
Confidence 6999999999 999999999999999999964432 123466788999999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 044995 204 KRPAMKEVASELAGI 218 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~~ 218 (288)
+||++.+.++.+...
T Consensus 237 ~R~~~~~~~~~i~~h 251 (325)
T cd05604 237 RRLGAKEDFLEIQEH 251 (325)
T ss_pred hcCCCCCCHHHHhcC
Confidence 999987555555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=245.73 Aligned_cols=191 Identities=31% Similarity=0.524 Sum_probs=155.3
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------ 73 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~------ 73 (288)
|++.+.||+|+||.||++.+. .....+|+.++++++||||+++++++...+++.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 778899999999999999763 223456999999999999999999876653321
Q ss_pred -c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 -D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 -~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++..+..++.|++.||.+|| +.+|+|+||||+||+++.++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccccccc
Confidence 1 012346788999999999999999999 8899999999999999999999999999987531 1222333
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc---------------------hhHHHHHHH
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------------DKNITVAKH 193 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------------------~~~~~~~~l 193 (288)
...++..|+||| ||||||+++|+|++|..||....... .....+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 456888999999 99999999999999999997552111 013789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+||+.||++||++.+++++
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=248.23 Aligned_cols=195 Identities=21% Similarity=0.254 Sum_probs=154.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
.+++|++.+.||+|+||.||+|.+. ...+.+|+.+++.++|+||+++++++...+....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999998642 1357899999999999999999998766533211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+.+..+..++.|++.||.||| ..+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 111234677788889999999999999 88999999999999999999999999999875432211
Q ss_pred eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------------
Q 044995 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------------------- 183 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------------------- 183 (288)
......++..|+||| ||||||+++|||++|..||......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 112234688899998 9999999999999999998532210
Q ss_pred -------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+|+..||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0113577899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=249.45 Aligned_cols=193 Identities=24% Similarity=0.304 Sum_probs=156.3
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
++|++.+.||+|+||.||+|.++ .+.+.+|+++++.++||||+++++++...+.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999998752 24578999999999999999999987665432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++.....++.|++.+|.||| +.+|+|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 11234789999999999999999999 88999999999999999999999999999876533221 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|+||| ||||||+++|||++|..||......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 22245788899998 9999999999999999888532210
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 1224568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=246.66 Aligned_cols=184 Identities=23% Similarity=0.420 Sum_probs=146.0
Q ss_pred eeeeeCCeeEEEeEcc------------------------------------------HHHHHHHHHHHhcCCCCceeee
Q 044995 25 ILGQGGQDIVYKGMAK------------------------------------------VEKFINEVVIQSQINHINVVKL 62 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~------------------------------------------~~~~~~E~~~l~~l~HpnIv~l 62 (288)
.||+|+||.||+|... ...|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998621 2468889999999999999999
Q ss_pred cceEeccc-------ccccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----
Q 044995 63 IGCCLETK-------YMHDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---- 124 (288)
Q Consensus 63 ~~~~~~~~-------~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---- 124 (288)
+++|.... |+... .....+++..++.++.|++.||.||| +++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99986643 22211 12345788899999999999999999 88999999999999997543
Q ss_pred ---ceEEecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHH-hCCCCCCCCC-------
Q 044995 125 ---CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELL-TGAKPIRFTT------- 181 (288)
Q Consensus 125 ---~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~ell-tg~~P~~~~~------- 181 (288)
.+|++|||++...... ....++..|+||| ||||||+++|||+ +|..||....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543211 1224677899998 9999999999995 6899985432
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+......+.+++.+||+.+|++||++.++++.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 12223467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=244.66 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=157.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
.++|++.+.||+|+||.||+|.++ .+.|..|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 356889999999999999988641 3578899999999999999999998765432
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++...+.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 211 111235788899999999999999999 889999999999999999999999999998754322
Q ss_pred Ccee--eeccc--cCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHH
Q 044995 141 QTHI--TTQVH--GTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNIT 189 (288)
Q Consensus 141 ~~~~--~~~~~--gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~ 189 (288)
.... ..... .+..|++|| ||||||+++||+++ |..||.... .+.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 1111 11111 234699998 99999999999886 999985322 12344678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+.+++.+||+.+|++||++.+++..|+++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=245.03 Aligned_cols=185 Identities=22% Similarity=0.386 Sum_probs=146.8
Q ss_pred ceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-------c
Q 044995 24 RILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------Y 71 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------~ 71 (288)
+.||+|+||.||+|.++ .+.|.+|+.++++++||||+++++++...+ |
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999998641 246788999999999999999999876542 2
Q ss_pred cccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc--------eEEecccCccc
Q 044995 72 MHDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC--------AKVSNFGTSRS 136 (288)
Q Consensus 72 l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~--------~kl~DfG~a~~ 136 (288)
+... .....+++...+.++.|++.||.||| +++|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 2111 11225788889999999999999999 889999999999999976654 69999998864
Q ss_pred cCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCC-CCCCCCC-------------ccchhHHHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGA-KPIRFTT-------------FEEDKNITV 190 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~-~P~~~~~-------------~~~~~~~~~ 190 (288)
... .....++..|+||| ||||||+++|||++|. .||.... .+.....++
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTEL 232 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHH
Confidence 322 12245788899998 9999999999999984 5653221 222334679
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+++.+||+.||++||+++++++.|+
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHhcC
Confidence 99999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=244.08 Aligned_cols=189 Identities=22% Similarity=0.308 Sum_probs=146.6
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cccc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHDQ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~~ 75 (288)
+.||+|+||.||+|... ...|.+|+.++++++||||+++++++.+... +...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999998531 2468899999999999999999998765432 2110
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 01123456677789999999999999 8899999999999999999999999999987543222211
Q ss_pred -eeccccCCCCCChh------------------hHHHHHHHHHHHHh-CCCCCCCCCcc--------------------c
Q 044995 145 -TTQVHGTFGYLNPD------------------DVCSFGVVLVELLT-GAKPIRFTTFE--------------------E 184 (288)
Q Consensus 145 -~~~~~gt~~y~aPE------------------DiwSlG~il~ellt-g~~P~~~~~~~--------------------~ 184 (288)
.....++..|+||| ||||||+++|||++ |..||...... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234677899998 99999999999996 99998532211 1
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
..+..+.+++.+|| .+|++||++.+|+..|+
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 23567888999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=242.89 Aligned_cols=191 Identities=27% Similarity=0.415 Sum_probs=151.2
Q ss_pred ceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 24 RILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
+.||+|+||.||+|+.+ ...|.+|+.++++++||||++++++|...+......
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46899999999988641 346789999999999999999999876553221100
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-----ceEEecccC
Q 044995 77 ------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-----CAKVSNFGT 133 (288)
Q Consensus 77 ------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-----~~kl~DfG~ 133 (288)
....+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 1233678889999999999999999 88899999999999998777 899999999
Q ss_pred ccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccch
Q 044995 134 SRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEED 185 (288)
Q Consensus 134 a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~ 185 (288)
++........ ......++..|++|| ||||||+++|||++ |..||.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 8754322111 111224567899999 99999999999998 999985322 2234
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+..+.+++.+||..+|++||++.++++.|++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 46789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=243.85 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=157.4
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
|++..++++.....||+|+||.||+|.+. .+.+.+|+.++++++|+||+++++++...++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566777777789999999999999742 356889999999999999999999877654322
Q ss_pred ccC--------------CCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccc
Q 044995 74 DQN--------------KELPF--TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRS 136 (288)
Q Consensus 74 ~~~--------------~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~ 136 (288)
... ....+ ++..+..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 111 11233 66777888999999999999 889999999999999976 67999999999875
Q ss_pred cCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchh
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDK 186 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~ 186 (288)
...... ......|+..|+||| ||||||+++|+|++|..||.... .+...
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence 432221 112235788899999 99999999999999999985321 12234
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.++.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 5688999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=243.48 Aligned_cols=193 Identities=25% Similarity=0.446 Sum_probs=156.4
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
+|.+...||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999642 1457889999999999999999998776543
Q ss_pred cccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 MHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
.... .....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 3211 11235778888899999999999999 8899999999999999999999999999987654
Q ss_pred CCCce-----eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhH
Q 044995 139 VDQTH-----ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKN 187 (288)
Q Consensus 139 ~~~~~-----~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~ 187 (288)
..... ......|+..|++|| ||||||+++|+|++|..||.... .+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence 22111 111235788899998 99999999999999999985321 223456
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=246.68 Aligned_cols=196 Identities=23% Similarity=0.356 Sum_probs=157.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEecc-------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCLET------- 69 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------- 69 (288)
...+.|++.+.||+|+||.||+|.++ ...+.+|+.+++++ +|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45678999999999999999998652 45688999999998 699999999987542
Q ss_pred ------ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 70 ------KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 70 ------~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
+++.. ......+++..+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 11111 112235788889999999999999999 8899999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCC----------------cc
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTT----------------FE 183 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~----------------~~ 183 (288)
....... ......|+..|+||| |||||||++|||++|..||.... ..
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 5432211 222346888899998 99999999999999999984321 11
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1235789999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=241.73 Aligned_cols=194 Identities=27% Similarity=0.388 Sum_probs=159.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ----- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~----- 75 (288)
.++|++.+.||+|+||.||++.++ .+.|.+|++++++++|+||+++++++.....+...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 478999999999999999999753 45789999999999999999999987765433211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
.....+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 12345789999999999999999999 88899999999999999999999999999886543221 122
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl 198 (288)
...++..|++|| ||||||+++|+|++|+.||..... +...+..+.+++.+||
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 345788999999 999999999999999999853221 1123467899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++||++.+++++
T Consensus 238 ~~~P~~Rps~~~il~~ 253 (256)
T cd06612 238 VKDPEERPSAIQLLQH 253 (256)
T ss_pred hcChhhCcCHHHHhcC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=275.20 Aligned_cols=127 Identities=29% Similarity=0.439 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC-----------------CCCceee
Q 044995 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA-----------------VDQTHIT 145 (288)
Q Consensus 83 ~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~-----------------~~~~~~~ 145 (288)
....++++.+|+.||.|+| +.+||||||||.||+++++..+||+|||+|+... .......
T Consensus 696 ~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~ 772 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL 772 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence 4567789999999999999 8999999999999999999999999999998621 0111123
Q ss_pred eccccCCCCCChh--------------hHHHHHHHHHHHHh-----------------CCCCCCCCCccchhHHHHHHHH
Q 044995 146 TQVHGTFGYLNPD--------------DVCSFGVVLVELLT-----------------GAKPIRFTTFEEDKNITVAKHA 194 (288)
Q Consensus 146 ~~~~gt~~y~aPE--------------DiwSlG~il~ellt-----------------g~~P~~~~~~~~~~~~~~~~li 194 (288)
+..+||..|+||| |+|||||+++||+. |..|++ ..+.......-+.+|
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCC-cccccccchHHHHHH
Confidence 4457999999999 99999999999985 445554 444555677888999
Q ss_pred HHhcCCCCCCCCCHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~ 213 (288)
.++++.||++||||.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=248.01 Aligned_cols=192 Identities=27% Similarity=0.320 Sum_probs=155.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH---- 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~---- 73 (288)
.|++.+.||+|+||.||++.+. .+.+.+|+.++++++|+||+.+++.+...+++.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4778899999999999998652 134678999999999999999998765543321
Q ss_pred ---c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 74 ---D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 ---~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 1 112234788889999999999999999 88999999999999999999999999999875432221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
.....|+..|+||| ||||||+++|+|++|..||..... ....+.++.++
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 12246899999999 999999999999999999964321 12345678999
Q ss_pred HHHhcCCCCCCCCC-----HHHHHHHH
Q 044995 194 AKRCLNPSGKKRPA-----MKEVASEL 215 (288)
Q Consensus 194 i~~cl~~~p~~Rp~-----~~~i~~~l 215 (288)
+.+||+.||++||+ +.|++++-
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 99999999999999 88888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=247.29 Aligned_cols=194 Identities=24% Similarity=0.299 Sum_probs=158.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
++|++.+.||+|+||.||+|.++ .+.+.+|++++++++|+||+++++++...+....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999998752 3568899999999999999999999876543211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.+++.||.||| ..+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 112234788899999999999999999 8899999999999999999999999999988655433222
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc------------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------ 182 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------ 182 (288)
.....++..|+||| ||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 23346788899998 999999999999999998853211
Q ss_pred ----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+...+.++.+++.+||..+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 11126778999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=248.07 Aligned_cols=195 Identities=24% Similarity=0.363 Sum_probs=159.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
...+|++.+.||+|+||.||++.+. .+.+.+|+.+++.++|+||++++++|...++.....
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3478999999999999999999742 456889999999999999999999887654332211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....+++.....++.+++.+|.||| +.+|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 1234678889999999999999999 88999999999999999999999999999875433221 12
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHh
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~c 197 (288)
....++..|++|| ||||||+++|+|++|..||..... +...+..+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 2345888999999 999999999999999999854221 123356788999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.||++||++.+++++
T Consensus 253 l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 253 LEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=262.05 Aligned_cols=188 Identities=27% Similarity=0.388 Sum_probs=157.3
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------c
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------K 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------~ 70 (288)
-|..++.||.|+||.||-+++. .+++++||+.|.+++|||+|.+.|+|... +
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4677899999999999988762 56899999999999999999999997643 3
Q ss_pred ccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 71 YMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 71 ~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
|..+. ....++.+..+..|+.+.+.||.||| +++.||||||..|||+++.|.+||+|||.|.....
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 32211 12346788889999999999999999 89999999999999999999999999999875432
Q ss_pred eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKHA 194 (288)
Q Consensus 145 ~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~li 194 (288)
...++||+.||||| |||||||+..||...++|+...+. ..+-+..+..++
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 34468999999999 999999999999999999743221 123367899999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..||+.-|.+|||..+++.+
T Consensus 259 d~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHhhCcccCCcHHHHhhc
Confidence 99999999999999988764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=247.00 Aligned_cols=195 Identities=26% Similarity=0.338 Sum_probs=160.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
..++|++.+.||+|+||.||++.+. .+.|.+|++++++++|+||+++++++....+++..
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3578999999999999999999752 45788999999999999999999987765433211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.+|.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 11235788999999999999999999 88999999999999999999999999998865432221
Q ss_pred eeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHH
Q 044995 144 ITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITV 190 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~ 190 (288)
......++..|++|| ||||||+++|||++|..||..... +...+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 122345788899998 999999999999999999854321 12345789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+.+|++||++.+++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcC
Confidence 999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=248.16 Aligned_cols=194 Identities=23% Similarity=0.374 Sum_probs=159.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
..+|++.+.||.|+||.||+|.+. .+.+.+|+.+++.++||||+++++++...+.++..
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 346999999999999999998642 46788999999999999999999987665432211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
.....+++..+..++.+++.+|.||| +.+++|+||||+||+++.++.+||+|||++........ ...
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCC
Confidence 11235789999999999999999999 88999999999999999999999999999875433222 122
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl 198 (288)
...++..|++|| |||||||++|+|++|..||..... +...+..+.++|.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 345888999999 999999999999999999864321 2234567899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
..||++||++.+++++
T Consensus 254 ~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 254 EMDVEKRGSAKELLQH 269 (296)
T ss_pred hcChhhCCCHHHHhhC
Confidence 9999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=251.75 Aligned_cols=187 Identities=23% Similarity=0.335 Sum_probs=148.4
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc-------cc
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM-------HD 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l-------~~ 74 (288)
+.||+|+||.||++.++ .+.+.+|+.++.++ +||||+++++++...+.+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999998642 23477899998888 699999999987655432 11
Q ss_pred c------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 75 Q------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 75 ~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
. .....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 1 12235889999999999999999999 8899999999999999999999999999987432211 122345
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------------ccchhHHHHHHHHHH
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------------~~~~~~~~~~~li~~ 196 (288)
.||+.|+||| |||||||++|||++|..||.... .+...+..+.+++.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6999999999 99999999999999999995321 122345678999999
Q ss_pred hcCCCCCCCCCH------HHHHHH
Q 044995 197 CLNPSGKKRPAM------KEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~------~~i~~~ 214 (288)
||+.||++|+++ .++.++
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999984 465544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=253.11 Aligned_cols=194 Identities=21% Similarity=0.279 Sum_probs=155.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||+++++ .+.+.+|+.++..++|+||+++++++.+.++++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999998752 234778999999999999999999876654332111
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 77 --------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 77 --------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 1235788888999999999999999 88999999999999999999999999999876544333
Q ss_pred eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c---chhH
Q 044995 143 HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF----------------E---EDKN 187 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~----------------~---~~~~ 187 (288)
.......||+.|+||| |||||||++|||++|+.||..... + ...+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 3333356999999999 999999999999999999954321 1 1236
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKK--RPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~--Rp~~~~i~~~ 214 (288)
.++.+++.+|+..++++ |+++++++++
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 78999999999876544 4678888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=245.48 Aligned_cols=194 Identities=24% Similarity=0.317 Sum_probs=156.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
.++|++.+.||+|+||.||++.+. ...+.+|+.+++.++||||+++++.+...++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 458899999999999999998752 245788999999999999999999876654332111
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....+++.....++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++....... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 2235788999999999999999999 8899999999999999999999999999987543221 112
Q ss_pred eccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhHHHHHH
Q 044995 146 TQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKNITVAK 192 (288)
Q Consensus 146 ~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~~~~~~ 192 (288)
....|+..|+||| |||||||++|+|++|..||..... ....+..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 2346889999998 999999999999999999742211 0123467889
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++||++.+++++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.59 Aligned_cols=196 Identities=21% Similarity=0.390 Sum_probs=161.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM- 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l- 72 (288)
..++..+.++||+|.||+|++|.|+ ..+|++|+.+|.+|+|+|+|+|||+..+...+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mM 187 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMM 187 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhH
Confidence 3345667789999999999999874 57899999999999999999999998764221
Q ss_pred -----------ccc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 -----------HDQ--NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 -----------~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
... .....|.......++.||+.||.||. .+++|||||-.+|+|+.....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 111 23345677788899999999999999 88999999999999999889999999999998766
Q ss_pred CCceeee--ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC---------------CccchhHHHH
Q 044995 140 DQTHITT--QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT---------------TFEEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~--~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~---------------~~~~~~~~~~ 190 (288)
+...... ...-.+.|.||| |||+|||++|||+| |+.||.+. ..+..++..+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 5544321 122345789999 99999999999998 78898432 2355679999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||..+|.+||+|..|.+.
T Consensus 345 Y~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHh
Confidence 999999999999999999999754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=249.00 Aligned_cols=193 Identities=24% Similarity=0.297 Sum_probs=154.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecc--cccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLET--KYMH 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~l~ 73 (288)
.|++.++||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++... +.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999998752 14567899999999999999999998765 2221
Q ss_pred c-----------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC----CCceEEeccc
Q 044995 74 D-----------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD----KYCAKVSNFG 132 (288)
Q Consensus 74 ~-----------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~----~~~~kl~DfG 132 (288)
. ......++...+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 1 111135788889999999999999999 889999999999999998 8999999999
Q ss_pred CccccCCCCc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc--------------
Q 044995 133 TSRSRAVDQT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE-------------- 184 (288)
Q Consensus 133 ~a~~~~~~~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~-------------- 184 (288)
+++....... .......++..|+||| ||||||+++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543222 1122345788899999 99999999999999999985332211
Q ss_pred ----------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ----------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ----------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 223467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=257.73 Aligned_cols=193 Identities=24% Similarity=0.290 Sum_probs=152.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+.++.+++||||+++++.+.+.++++..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999998652 34577899999999999999999887665432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 12345788899999999999999999 88999999999999999999999999999864321100
Q ss_pred ---------------------------------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCC
Q 044995 143 ---------------------------------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR 178 (288)
Q Consensus 143 ---------------------------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~ 178 (288)
......+||+.|+||| |||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0011346999999999 99999999999999999995
Q ss_pred CCCcc----------------c--hhHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 044995 179 FTTFE----------------E--DKNITVAKHAKRCLNPSGKKRPA---MKEVASE 214 (288)
Q Consensus 179 ~~~~~----------------~--~~~~~~~~li~~cl~~~p~~Rp~---~~~i~~~ 214 (288)
..... . ..+.++.+++.+++. ||.+|++ +.+++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 43211 1 135678889998774 9999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=244.39 Aligned_cols=193 Identities=27% Similarity=0.356 Sum_probs=159.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++.+.||.|+||.||+|.+. ...+.+|+++++.++|+||+++++++.+..++...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999998752 34688999999999999999999987765433211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
.....+++.....++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||+++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 11226889999999999999999999 88999999999999999999999999999976543321 122
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cch-hHHHHHHHHHHhcC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EED-KNITVAKHAKRCLN 199 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~-~~~~~~~li~~cl~ 199 (288)
...++..|++|| ||||||+++|+|++|..||..... ... .+..+.+++.+||.
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 345788899999 999999999999999999853221 111 46789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.||++||++++++++
T Consensus 237 ~~p~~Rpt~~~il~~ 251 (274)
T cd06609 237 KDPKERPSAKELLKH 251 (274)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=241.54 Aligned_cols=194 Identities=26% Similarity=0.457 Sum_probs=156.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecccc------ccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------MHD-- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------l~~-- 74 (288)
.++|++.+.||+|+||.||++... .+.|.+|+.++++++||||+++++++..... +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 467999999999999999997532 4578999999999999999999998755432 111
Q ss_pred ------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 75 ------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 75 ------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
......+++...+.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 111234688889999999999999999 8899999999999999999999999999987532211 112
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHHhcCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~cl~~~ 201 (288)
..+..|++|| ||||||+++|||++ |..||..... ....+..+.+++.+||+.+
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETE 237 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 2456799998 99999999999998 9999854322 2234678899999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 044995 202 GKKRPAMKEVASELAG 217 (288)
Q Consensus 202 p~~Rp~~~~i~~~l~~ 217 (288)
|++||++.++++.|++
T Consensus 238 p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 238 PKKRPSFHKLREKLEK 253 (254)
T ss_pred hhhCcCHHHHHHHHcc
Confidence 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.20 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=157.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
.++|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++.....+..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 478999999999999999999752 4678899999999999999999998765543211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 011246788899999999999999999 88999999999999999999999999999875432211 1
Q ss_pred eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhHHHHH
Q 044995 145 TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKNITVA 191 (288)
Q Consensus 145 ~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~~~~~ 191 (288)
.....++..|++|| ||||||+++|||++|..||..... ....+.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 12345777888888 999999999999999999854320 112256789
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++.+||..||.+||++.+++.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=240.08 Aligned_cols=193 Identities=27% Similarity=0.357 Sum_probs=158.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|+..+.||+|+||.||.++.. ..++.+|++++++++|+||+++++++.+.+.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999998877642 35688999999999999999999998765433211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++.....++.|++.+|.||| +.+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 11235788899999999999999999 88899999999999999999999999999876543332
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cchhHHHHHHHHHHh
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EEDKNITVAKHAKRC 197 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~~~~~~~~li~~c 197 (288)
......++..|+||| ||||||+++|||++|..||..... ....+.++.+++.+|
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 223346889999999 999999999999999999864322 122467899999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l 215 (288)
|+.+|++||++.++++++
T Consensus 237 l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 237 LQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCcccCCCHHHHhhCc
Confidence 999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=251.18 Aligned_cols=203 Identities=20% Similarity=0.277 Sum_probs=164.3
Q ss_pred cceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecce
Q 044995 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGC 65 (288)
Q Consensus 6 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~ 65 (288)
++....++....++|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 45667888889999999999999999999998642 3467789999999999999999988
Q ss_pred Eecccc--------cc---------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEE
Q 044995 66 CLETKY--------MH---------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKV 128 (288)
Q Consensus 66 ~~~~~~--------l~---------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl 128 (288)
+..... +. .......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 753311 10 0111235788899999999999999999 889999999999999999999999
Q ss_pred ecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc------------
Q 044995 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------ 184 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------ 184 (288)
+|||++...... .....++..|+||| |||||||++|||++|+.||.......
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998754321 12345788899999 99999999999999999985322100
Q ss_pred ---------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+++.+||+.||.+||++.+++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 1245678999999999999999999998774
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=252.41 Aligned_cols=192 Identities=21% Similarity=0.334 Sum_probs=155.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|.+.+.||+|+||.||+|.+. ...+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3589999999999999999998742 235789999999999999999999875432
Q ss_pred --------ccccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 --------YMHDQ---NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 --------~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++... .....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 11110 01125788889999999999999999 88999999999999999999999999999875432
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------ 183 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------ 183 (288)
.. ....++..|+||| |||||||++|||++|+.||......
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 170 EM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 21 2235678899999 9999999999999999999653310
Q ss_pred ---------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=246.37 Aligned_cols=204 Identities=26% Similarity=0.311 Sum_probs=164.3
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
.|.+.++....++|++.+.||+|+||.||++..+ .+.+.+|+.+++++ +||||++++++|..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4566788888999999999999999999998652 35677899999998 89999999998754
Q ss_pred cc------------cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 69 TK------------YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 69 ~~------------~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
.+ |+.. ......+++.....++.|++.||.||| ..+|+|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 32 2211 012345788899999999999999999 8899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc--------
Q 044995 127 KVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF-------- 182 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~-------- 182 (288)
||+|||++........ ......|+..|++|| |||||||++|||++|+.||.....
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999999875432221 112235788899998 999999999999999999853321
Q ss_pred ---------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ---------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+......+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 12234578899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=244.15 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=157.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEec--c---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLE--T--- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~--- 69 (288)
++|++.+.||+|+||.||++... .+.|.+|++++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56888899999999999998631 3578999999999999999999998765 2
Q ss_pred ----ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 ----KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ----~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+++.. ......+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 12111 011124788889999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcee--eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------------
Q 044995 139 VDQTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----------------------- 182 (288)
Q Consensus 139 ~~~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----------------------- 182 (288)
...... .....++..|++|| ||||||+++|||++|..|+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 222211 11123455689998 999999999999999988753211
Q ss_pred -------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 183 -------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 183 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+...+.++.+++.+||+.+|++||++.|++++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.33 Aligned_cols=193 Identities=26% Similarity=0.351 Sum_probs=157.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
....|++.+.||+|+||.||+|.+. .+.+.+|+++++.++||||++++++|...+....
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4466999999999999999998642 2468899999999999999999999876532211
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
......+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 112235788999999999999999999 889999999999999999999999999998654322
Q ss_pred ceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHH
Q 044995 142 THITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVA 191 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~ 191 (288)
....++..|+||| ||||||+++|||++|..||..... ....+..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 1235778899987 999999999999999999854321 112356789
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+++.+||+.||++||++.+++.+..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChh
Confidence 9999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=244.95 Aligned_cols=194 Identities=23% Similarity=0.281 Sum_probs=154.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
.++|++.+.||+|+||.||+|.++ ...+.+|++++++++|+||+++++++.+.++....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 478999999999999999999753 23467899999999999999999987765432111
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 11235788889999999999999999 88999999999999999999999999999875432211 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|+||| ||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 11224677899998 9999999999999999998543200
Q ss_pred ----------------chhH--HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKN--ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~--~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.... ..+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0011 667799999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=245.57 Aligned_cols=192 Identities=23% Similarity=0.349 Sum_probs=156.1
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+.++++++|+||+++++.+...++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 57899999999999999998752 356889999999999999999999776543221
Q ss_pred --c---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 74 --D---------QNKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 74 --~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. ......+++.....++.+++.||.||| . .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 1 111226788999999999999999999 5 489999999999999999999999999987543221
Q ss_pred ceeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchh
Q 044995 142 THITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDK 186 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~ 186 (288)
.....++..|++|| |||||||++|+|++|..||.... .+...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 12235777899997 99999999999999999985322 12234
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.++.+++.+||+.+|++||++.+++++-
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 67889999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=244.08 Aligned_cols=193 Identities=21% Similarity=0.276 Sum_probs=157.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++....+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999998742 35788999999999999999999987665432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.....+++..+..++.|++.+|.||| +.+|+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 12245788999999999999999999 88999999999999999999999999999876543322122
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------- 182 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------- 182 (288)
....++..|+||| ||||||+++|||++|..||.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 2345888999998 999999999999999877743210
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01235778899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.03 Aligned_cols=194 Identities=22% Similarity=0.262 Sum_probs=155.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc--ccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET--KYMHD 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~l~~ 74 (288)
.++|++.+.||+|+||.||+|.++ ...+.+|+.++++++||||+++++++... .+...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 367999999999999999999753 12467899999999999999999987654 22211
Q ss_pred c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. .....+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 0 11225789999999999999999999 8889999999999999999999999999988654332
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc---------------------------
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------------------- 182 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------------------- 182 (288)
.. .....++..|+||| ||||||+++|+|++|..||.....
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 11 12235778899999 999999999999999998853211
Q ss_pred ------------------cch-hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ------------------EED-KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ------------------~~~-~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.. .+..+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001 25668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=240.84 Aligned_cols=194 Identities=29% Similarity=0.402 Sum_probs=158.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++.+.||.|+||.||+|... .+.+.+|+++++.++|+||+++++.+...+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999998741 35688999999999999999999987665432211
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +.+|+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 11134788889999999999999999 88999999999999999999999999999876543322
Q ss_pred e---eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------chhH
Q 044995 143 H---ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------EDKN 187 (288)
Q Consensus 143 ~---~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------~~~~ 187 (288)
. ......|+..|++|| |+||||+++|+|++|+.||...... ...+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 2 123345888999998 9999999999999999998543211 1335
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 778999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=245.82 Aligned_cols=198 Identities=26% Similarity=0.324 Sum_probs=158.2
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
+...++|++.+.||+|+||.||+|.++ ...+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346689999999999999999999753 245678999999999999999998875433
Q ss_pred --------------cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 71 --------------YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 71 --------------~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
++.. ......+++..+..++.|++.||.||| +.+|+|+||||+||++++++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 1111 111235789999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc----------------
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF---------------- 182 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~---------------- 182 (288)
||++...............++..|++|| |||||||++|||++|+.||.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9998765433221112224567799998 999999999999999999853211
Q ss_pred ----------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01235788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=240.11 Aligned_cols=193 Identities=25% Similarity=0.462 Sum_probs=155.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
+|++.+.||+|+||.||+|... .+.+.+|++++++++|+||++++++|.+.++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5888999999999999998641 24588899999999999999999998765432211
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC--
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD-- 140 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~-- 140 (288)
.....+++..+..++.|++.+|.||| +.+|+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 12235788888899999999999999 888999999999999999999999999998754211
Q ss_pred ---CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHH
Q 044995 141 ---QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNIT 189 (288)
Q Consensus 141 ---~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~ 189 (288)
.........|+..|++|| ||||||+++|+|++|..||.... .+...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 111112345888999999 99999999999999999985322 22234678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=243.93 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=157.3
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+.|+..+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++........
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777889999999999999652 3468899999999999999999998765532211
Q ss_pred --------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 75 --------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 75 --------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
......+++..+..++.+++.|+.||| +++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 112235788889999999999999999 88999999999999999999999999999876543221 112
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
...++..|++|| ||||||+++|||++|..||.... .....+..+.+++.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 235788899999 99999999999999999985321 1123467899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 044995 201 SGKKRPAMKEVASEL 215 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l 215 (288)
+|++||++.+++++-
T Consensus 240 ~p~~Rp~~~~il~~~ 254 (277)
T cd06642 240 DPRFRPTAKELLKHK 254 (277)
T ss_pred CcccCcCHHHHHHhH
Confidence 999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=237.93 Aligned_cols=192 Identities=21% Similarity=0.313 Sum_probs=155.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------- 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 70 (288)
+|++.+.||+|+||.||++.++ .+.+.+|++++++++|+|++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999988652 346788999999999999999988764322
Q ss_pred ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 71 YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 71 ~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
++... .....+++..+..++.+++.++.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 11110 11234788999999999999999999 88999999999999999999999999999876533221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
......+++.|+||| ||||||+++|+|++|+.||..... +...+..+.+++.+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 222345888999999 999999999999999999864321 22345789999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
||+.||++||++.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhccCcccCCCHHHHhcC
Confidence 999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=240.04 Aligned_cols=193 Identities=26% Similarity=0.363 Sum_probs=151.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecc--ccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLET--KYM 72 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~l 72 (288)
.+|+..+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++... .++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999998642 24578899999999999999999987542 111
Q ss_pred -------cc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 -------HD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 -------~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
.. ......+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 11 011234778888899999999999999 88999999999999999999999999999875432
Q ss_pred CCc--eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHH
Q 044995 140 DQT--HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~--~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~ 190 (288)
... .......++..|+||| |||||||++|||++|+.||.... .+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 111 1112245788999999 99999999999999999985322 122235567
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++ +||..+|++||+++|++++
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 7777 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.76 Aligned_cols=202 Identities=22% Similarity=0.327 Sum_probs=161.0
Q ss_pred eHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEecc-
Q 044995 9 ISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCLET- 69 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 69 (288)
+..++....+.|++.+.||+|+||.||+|.+. ...+..|+.+++++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 55667778899999999999999999998752 34678899999998 699999999887421
Q ss_pred ------------ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEe
Q 044995 70 ------------KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS 129 (288)
Q Consensus 70 ------------~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~ 129 (288)
+|+.. ......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence 22211 112234677788899999999999999 8899999999999999999999999
Q ss_pred cccCccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc-----------
Q 044995 130 NFGTSRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF----------- 182 (288)
Q Consensus 130 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~----------- 182 (288)
|||++........ ......|+..|+||| |||||||++|||++|..||.....
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 9999875432211 122345888999997 999999999999999999853211
Q ss_pred -----cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -----EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.++|.+||+.||.+||++.||+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 11246789999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=244.45 Aligned_cols=193 Identities=19% Similarity=0.246 Sum_probs=153.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCC-CCceeeecceEecccc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKY----- 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 71 (288)
++|++.+.||+|+||.||+|.+. ...+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 57999999999999999999752 246788999999995 6999999987654322
Q ss_pred -------ccc--------cC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccC
Q 044995 72 -------MHD--------QN--KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGT 133 (288)
Q Consensus 72 -------l~~--------~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~ 133 (288)
+.. .. ....+++..+..++.|++.||.||| ..+|+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 111 00 1235789999999999999999999 889999999999999998 88999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------ 183 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------ 183 (288)
+......... .....+++.|+||| ||||||+++|+|++|..||...+..
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 158 GRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 8754322111 11224677899999 9999999999999999998543210
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.++|.+||+.||++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1245678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=248.25 Aligned_cols=186 Identities=24% Similarity=0.315 Sum_probs=148.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCC-CCceeeecceEecccccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~- 75 (288)
+|+..+.||+|+||.||++.++ .+.+..|..++..+. |++|+++++++...+.++..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999998652 235678888888886 56777888876654432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 12245789999999999999999999 88999999999999999999999999999875332211
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
......||+.|+||| |||||||++|||++|..||.... .+...+.++.+++.+||
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 223346899999999 99999999999999999996543 22345678899999999
Q ss_pred CCCCCCCCCH
Q 044995 199 NPSGKKRPAM 208 (288)
Q Consensus 199 ~~~p~~Rp~~ 208 (288)
+.||.+|++.
T Consensus 237 ~~~p~~R~~~ 246 (323)
T cd05615 237 TKHPSKRLGC 246 (323)
T ss_pred ccCHhhCCCC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=241.64 Aligned_cols=194 Identities=26% Similarity=0.364 Sum_probs=158.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
..|+..+.||+|+||.||+|.++ .+.+.+|+.++++++|+||+++++++.+..+...
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999752 3468899999999999999999998776543221
Q ss_pred --------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 75 --------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 75 --------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
......+++.....++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 112235788888899999999999999 88999999999999999999999999999876543221 122
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
...++..|+||| |+||||+++|||++|..||.... .....+..+.+++.+||+.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 235788899999 99999999999999999985322 1223467899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 044995 201 SGKKRPAMKEVASEL 215 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l 215 (288)
+|++||++.+++.+-
T Consensus 240 ~p~~Rp~~~~il~~~ 254 (277)
T cd06640 240 DPSFRPTAKELLKHK 254 (277)
T ss_pred CcccCcCHHHHHhCh
Confidence 999999999998874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=240.06 Aligned_cols=189 Identities=21% Similarity=0.261 Sum_probs=143.9
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN------ 76 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~------ 76 (288)
+.||+|+||.||++... .+.|.+|+.+++.++||||+++++.|......+...
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999998521 357899999999999999999999876543221110
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC-cee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-THI 144 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~ 144 (288)
.....++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 1123455667789999999999999 8889999999999999999999999999976422111 111
Q ss_pred eeccccCCCCCChh------------------hHHHHHHHHHHHHh-CCCCCCCCCc--------------------cch
Q 044995 145 TTQVHGTFGYLNPD------------------DVCSFGVVLVELLT-GAKPIRFTTF--------------------EED 185 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------------DiwSlG~il~ellt-g~~P~~~~~~--------------------~~~ 185 (288)
.....++..|+||| ||||||+++|||++ |..||..... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 12345777888887 99999999999997 5667743221 112
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+..+.+++..|| .+|++||++.++++.|.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=237.90 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=158.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc---------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET--------- 69 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 69 (288)
+|++.+.||.|+||.||++.+. .+.+.+|++++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999998642 35688899999999999999999876532
Q ss_pred ccccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 KYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSA--SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 ~~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+++.. ......+++..++.++.+++.||.|||..+ +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 11111 111346788899999999999999999554 678999999999999999999999999998865
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~ 191 (288)
...... .....++..|++|| |+||||+++|+|++|..||.... .+...+..+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 433321 22346888999999 99999999999999999986442 2334467899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++.+||+.+|++||++.+|+++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=238.15 Aligned_cols=190 Identities=25% Similarity=0.416 Sum_probs=152.5
Q ss_pred ceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecc------ccccc-
Q 044995 24 RILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLET------KYMHD- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~l~~- 74 (288)
+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++.+... ++...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 46899999999998642 34688999999999999999999887651 11110
Q ss_pred -------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce--ee
Q 044995 75 -------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--IT 145 (288)
Q Consensus 75 -------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~ 145 (288)
......+++.....++.|++.||.||| .++++|+||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 011135788999999999999999999 889999999999999999999999999998865432211 11
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------------ccchhHHHHHHHHHHh
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------------~~~~~~~~~~~li~~c 197 (288)
....++..|++|| ||||||+++|||++ |..||.... .+...+..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 1234677899999 99999999999999 999984321 1223467899999999
Q ss_pred cCCCCCCCCCHHHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l~ 216 (288)
|+.+|++||++.++++.|.
T Consensus 238 l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 238 WAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCcccCCCHHHHHHHhc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=250.61 Aligned_cols=196 Identities=21% Similarity=0.295 Sum_probs=156.3
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999998742 246778999999999999999998765332
Q ss_pred ---------cccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 ---------YMHDQN---KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 ---------~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.... ....++......++.|++.||.||| ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 211100 0112678888899999999999999 8899999999999999999999999999997643
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------------ 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------------ 183 (288)
... ......++..|+||| |||||||++|+|++|+.||......
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 170 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 322 122345788999999 9999999999999999998533210
Q ss_pred ---------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++||++.|++++=
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 01244578999999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=244.94 Aligned_cols=196 Identities=25% Similarity=0.383 Sum_probs=159.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
.++|++.+.||+|+||.||++.+. .+.|.+|+++++.++||||+++++++.....+...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468899999999999999998642 35788999999999999999999987765432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++.....++.+++.+|.||| + .+++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 12235788889999999999999999 5 47999999999999999999999999998643221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------------ch
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------------ED 185 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------------~~ 185 (288)
......|+..|++|| |||||||++|+|++|..||...... ..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 112346889999999 9999999999999999999643211 11
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+.++.+++.+||+.||++||++.|++++...+
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 346789999999999999999999999875444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=236.94 Aligned_cols=190 Identities=30% Similarity=0.452 Sum_probs=155.8
Q ss_pred ceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-------
Q 044995 24 RILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD------- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~------- 74 (288)
+.||+|+||.||++.+. .+.+.+|+++++.++|+||+++++++.....+..
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999998653 4578899999999999999999998766432210
Q ss_pred ------cCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 75 ------QNK---------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 75 ------~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
... ...+++.....++.|++.||.||| +++++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 011 256899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHH
Q 044995 140 DQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 140 ~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~ 191 (288)
... .......++..|+||| ||||||+++|||++ |..||.... .+...+.++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 321 1122345788899999 99999999999999 699986432 2234468899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+++.+||..||++||++.+++++|+
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=239.57 Aligned_cols=193 Identities=28% Similarity=0.444 Sum_probs=156.3
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------------HHHHHHHHHHHhc-CCCCceeeecceEec
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------------VEKFINEVVIQSQ-INHINVVKLIGCCLE 68 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~ 68 (288)
+|++.+.||+|+||.||++.++ ..++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 5888999999999999998752 1346778887764 799999999998766
Q ss_pred ccccccc-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEec
Q 044995 69 TKYMHDQ-----------------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 69 ~~~l~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
.++.... .....+++...+.++.|++.+|.||| . .+++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 5432211 12235788889999999999999999 5 5799999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc----------------c
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----------------E 183 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----------------~ 183 (288)
||++....... ......|+..|++|| ||||||+++|||++|+.||..... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc
Confidence 99987644322 223346888999998 999999999999999999854321 1
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
...+..+.+++.+||+.||++||++.|+.++++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 134678999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=245.07 Aligned_cols=196 Identities=23% Similarity=0.315 Sum_probs=154.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||++.++ ...+.+|++++++++||||++++++|...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4578999999999999999999752 224578999999999999999999865432
Q ss_pred ----------cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 71 ----------YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 71 ----------~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
+... ......+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 1110 111225789999999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCce---eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------
Q 044995 135 RSRAVDQTH---ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------- 183 (288)
Q Consensus 135 ~~~~~~~~~---~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------- 183 (288)
......... ......++..|+||| ||||||+++|||++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 754332211 112235678899999 9999999999999999988543210
Q ss_pred -----------------c-------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------E-------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------~-------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
. ..+..+.++|.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 013456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=243.01 Aligned_cols=190 Identities=26% Similarity=0.343 Sum_probs=156.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++.+.+++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999998652 34578899999999999999999987665432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....++......++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 12245788889999999999999999 889999999999999999999999999998765433
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhc
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl 198 (288)
.....+++.|++|| ||||||+++|+|++|..||.... .+...+..+.+++.+||
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence 22346889999999 99999999999999999985433 12234678899999999
Q ss_pred CCCCCCCC-----CHHHHHHH
Q 044995 199 NPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp-----~~~~i~~~ 214 (288)
..||.+|+ +++|++++
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCHHHccCcccCCHHHHHcC
Confidence 99999998 66666544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=241.19 Aligned_cols=192 Identities=25% Similarity=0.383 Sum_probs=152.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHH-HhcCCCCceeeecceEecccc------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVI-QSQINHINVVKLIGCCLETKY------ 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~------ 71 (288)
++|++.+.||+|+||.||++.++ ..++..|+.+ ++.++||||+++++++.....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 57999999999999999998752 2345666665 667799999999998765432
Q ss_pred -ccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 -MHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 -l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++..+..++.|++.||.||| ++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 211 112245789999999999999999999 76 8999999999999999999999999998754322
Q ss_pred CceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHH
Q 044995 141 QTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNI 188 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~ 188 (288)
. ......++..|++|| |+||||+++|+|++|+.||..... ....+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence 1 112235788899998 999999999999999999853211 112357
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+++.+||..+|++||++.+++++
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=246.37 Aligned_cols=195 Identities=25% Similarity=0.307 Sum_probs=155.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
.++|++.+.||+|+||.||++.++ ...+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 689999999999999999999753 235778999999999999999998764321
Q ss_pred ---------cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 71 ---------YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 71 ---------~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+|+||||+||++++++.++|+|||+++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 1110 112346889999999999999999999 8899999999999999999999999999987
Q ss_pred ccCCCCce----------eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------
Q 044995 136 SRAVDQTH----------ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------- 183 (288)
Q Consensus 136 ~~~~~~~~----------~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------- 183 (288)
........ ......++..|+||| ||||||+++|||++|..||......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 112235678899999 9999999999999999998532210
Q ss_pred ----------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
......+.+++.+||+.||++|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0112467899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=247.60 Aligned_cols=191 Identities=17% Similarity=0.221 Sum_probs=147.5
Q ss_pred cCceeeee--CCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc----
Q 044995 22 VNRILGQG--GQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 22 ~~~~lG~G--~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
++++||+| +|++||++.++ .+.+.+|+++++.++||||++++++|...+.+...
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 78899998652 23466799999999999999999988765432210
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH- 143 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~- 143 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 11234788899999999999999999 889999999999999999999999999865432111100
Q ss_pred -----eeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 144 -----ITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 144 -----~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
......++..|+||| |||||||++|||++|..||......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 011124667799998 9999999999999999998532100
Q ss_pred --------------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 --------------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 --------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++|||+.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 01245788999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=241.04 Aligned_cols=196 Identities=27% Similarity=0.377 Sum_probs=158.6
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEeccc------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCLETK------ 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------ 70 (288)
..+++|++.+.||+|+||.||+|.++ .+.|.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999763 35788999999999 7999999999875432
Q ss_pred -------cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 71 -------YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 71 -------~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
++.. ......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 2111 001246788889999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc---------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF--------------- 182 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~--------------- 182 (288)
+........ ......|+..|+||| ||||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 875432221 122345788899998 999999999999999999853221
Q ss_pred --cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11234678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=237.92 Aligned_cols=192 Identities=21% Similarity=0.299 Sum_probs=156.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++...++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999987642 34688999999999999999999987655432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++...+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 11224678888999999999999999 88999999999999999999999999999875433221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHh
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~c 197 (288)
......|+..|+||| |+||||+++|+|++|..||.... .+...+.++.+++.+|
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 112235788899999 99999999999999999985332 2234467899999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.+|++||++.+++++
T Consensus 237 l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 237 FKRNPRDRPSVNSILEK 253 (256)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=241.54 Aligned_cols=192 Identities=21% Similarity=0.296 Sum_probs=155.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD----- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~----- 74 (288)
+|++.+.||+|++|.||+|+++ .+.+.+|+.++++++|+||+++++++.+.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999752 3567889999999999999999999876543211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 111235789999999999999999999 88999999999999999999999999999875432211 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|++|| ||||||+++|+|++|..||......
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 12234678899998 9999999999999999998643311
Q ss_pred --------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0124567799999999999999999998854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.95 Aligned_cols=193 Identities=24% Similarity=0.381 Sum_probs=162.1
Q ss_pred CCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecc-------cccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLET-------KYMH- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------~~l~- 73 (288)
+-|.++++||+|+||.||++.++ .+++.+|+.+|++++.|++|+++|.|... +|.-
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 45889999999999999998764 67899999999999999999999976432 2221
Q ss_pred ------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 74 ------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 74 ------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
......++++.++..++...+.||+||| ...-||||||..|||++.+|..||+|||+|..+..... ...+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCc
Confidence 1224457899999999999999999999 77789999999999999999999999999987654333 2345
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhcC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl~ 199 (288)
+.||+.||||| ||||||++..||..|++||.... -++.-+.++.+++++||-
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 77999999999 99999999999999999985332 122336789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.+|++|-|+.+++++
T Consensus 269 K~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 269 KKPEERKTALRLCEH 283 (502)
T ss_pred CCHHHHHHHHHHhhh
Confidence 999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=241.22 Aligned_cols=189 Identities=21% Similarity=0.271 Sum_probs=152.2
Q ss_pred cccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEecc--cccccc--
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLET--KYMHDQ-- 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~l~~~-- 75 (288)
|++.+.||+|+||.||++.++ .....+|+.++.++. |+||+++++++.+. +.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999752 123457888898885 99999999998765 332211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +.+|+|+||||+||+++. +.+||+|||+++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 11235789999999999999999999 889999999999999999 99999999999765432221
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
....++..|+||| |||||||++|||++|..||...+..
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2235788899999 9999999999999999999643210
Q ss_pred --------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 1235788999999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.06 Aligned_cols=185 Identities=26% Similarity=0.269 Sum_probs=144.1
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC---CCCceeeecceEecccccccc------
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI---NHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
||+|+||.||++.++ ...+..|..++..+ +||||+++++++...+.++..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999998753 12344566666655 699999999887655332211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 12345788899999999999999999 8899999999999999999999999999987532222 122345
Q ss_pred ccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------chhHHHHHHHHHHhcCCC
Q 044995 149 HGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------EDKNITVAKHAKRCLNPS 201 (288)
Q Consensus 149 ~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------~~~~~~~~~li~~cl~~~ 201 (288)
.||..|+||| |||||||++|||++|..||...... ...+.++.+++.+||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~ 236 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence 6999999999 9999999999999999998644321 124678899999999999
Q ss_pred CCCCCC----HHHHHHH
Q 044995 202 GKKRPA----MKEVASE 214 (288)
Q Consensus 202 p~~Rp~----~~~i~~~ 214 (288)
|++||+ +.+++++
T Consensus 237 P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 237 PQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHCCCCCCCHHHHhcC
Confidence 999984 5555553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=234.20 Aligned_cols=190 Identities=29% Similarity=0.459 Sum_probs=151.5
Q ss_pred ceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-----------
Q 044995 24 RILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD----------- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~----------- 74 (288)
++||+|+||.||++.+. .+.|.+|++++++++|+||+++++++...+....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999998642 3578899999999999999999998766533211
Q ss_pred ---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee-ecccc
Q 044995 75 ---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT-TQVHG 150 (288)
Q Consensus 75 ---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~g 150 (288)
......+++...+.++.+++.+|.||| +++++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 012235678888999999999999999 88999999999999999999999999999875432111111 11223
Q ss_pred CCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 151 TFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 151 t~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
+..|++|| ||||||+++|||++ |..||.... .+...+.++.+++.+||..+|+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence 55699999 99999999999999 888885322 2234467899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 044995 204 KRPAMKEVASELA 216 (288)
Q Consensus 204 ~Rp~~~~i~~~l~ 216 (288)
+||++.|+++.|.
T Consensus 238 ~Rp~~~ell~~l~ 250 (251)
T cd05041 238 NRPSFSEIYNELQ 250 (251)
T ss_pred hCcCHHHHHHHhh
Confidence 9999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=243.35 Aligned_cols=192 Identities=25% Similarity=0.352 Sum_probs=153.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEecccc------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKY------ 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~------ 71 (288)
++|+..+.||+|+||.||++.+. ...+.+|+.++.++. |+||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 56777889999999999998752 346788999999996 9999999998755421
Q ss_pred -ccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 -MHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 -l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+.. ......+++.....++.+++.||+||| + .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 111 012346788899999999999999999 5 4899999999999999999999999999875432
Q ss_pred CCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------cch
Q 044995 140 DQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF--------------------EED 185 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~--------------------~~~ 185 (288)
... .....|+..|+||| ||||||+++|||++|+.||..... ...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 221 12235788899997 999999999999999999853210 012
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+.++.+++.+||+.||++||++.+|+++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45678999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=243.90 Aligned_cols=197 Identities=22% Similarity=0.277 Sum_probs=154.9
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
++|++.+.||+|+||.||++.++ .+.+.+|+++++.++||||+++++.+...+++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 57999999999999999988652 34577899999999999999999987665432111
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC--
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-- 141 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-- 141 (288)
.....+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 12235788888999999999999999 8899999999999999999999999999886321100
Q ss_pred ------------ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------
Q 044995 142 ------------THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------- 183 (288)
Q Consensus 142 ------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------- 183 (288)
........++..|+||| ||||||+++|||++|..||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 00111235788899998 9999999999999999998643211
Q ss_pred --chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 184 --EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 184 --~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
...+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1246779999999999999999996555555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=241.09 Aligned_cols=191 Identities=24% Similarity=0.374 Sum_probs=155.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++.+.||+|+||.||++.++ .+++.+|++++++++||||+++++.+.........
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47888999999999999998653 35688999999999999999999887654322110
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++.....++.|++.+|.||| + .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 11146788888999999999999999 7 89999999999999999999999999998754322111
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------------ccch-hHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------------FEED-KNITVA 191 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------------~~~~-~~~~~~ 191 (288)
...++..|++|| ||||||+++|+|++|..||.... .+.. .+.++.
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 146888999999 99999999999999999985431 0111 456799
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++|.+||..||++||++.+++.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=241.32 Aligned_cols=191 Identities=21% Similarity=0.272 Sum_probs=153.4
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc----
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
|++.+.||+|++|.||+|.++ .+.+.+|++++++++||||+++++++.+.++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999998642 24688999999999999999999998765432111
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.....+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 11125789999999999999999999 889999999999999999999999999998754322211 1
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------- 182 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------- 182 (288)
....++..|+||| ||||||+++|+|++|..||...+.
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 1224678899998 999999999999999999853321
Q ss_pred ------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=241.87 Aligned_cols=192 Identities=22% Similarity=0.272 Sum_probs=152.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~- 74 (288)
+|++.+.||+|+||.||+|.++ ...+..|++++++++|+||+++++++.+.+++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888899999999999999752 1246689999999999999999998766432211
Q ss_pred -----------cCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 75 -----------QNKE-LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 -----------~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.... ..+++..+..++.|++.||.||| ..+|+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 0111 25889999999999999999999 88999999999999999999999999999876543221
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------------
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------------- 183 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------------- 183 (288)
. .....++..|+||| |||||||++|||++|..||......
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 158 K-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred c-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 1 12224677899998 9999999999999997776432210
Q ss_pred ---------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1124577889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=236.19 Aligned_cols=185 Identities=23% Similarity=0.415 Sum_probs=146.8
Q ss_pred ceeeeeCCeeEEEeEcc---------------------------HHHHHHHHHHHhcCCCCceeeecceEecc------c
Q 044995 24 RILGQGGQDIVYKGMAK---------------------------VEKFINEVVIQSQINHINVVKLIGCCLET------K 70 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 70 (288)
+.||+|+||.||+|.++ ...|.+|+.++++++||||++++++|... +
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 46999999999988652 34688999999999999999999987542 1
Q ss_pred cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-------ceEEecccCccc
Q 044995 71 YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-------CAKVSNFGTSRS 136 (288)
Q Consensus 71 ~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-------~~kl~DfG~a~~ 136 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++..
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 1111 011125788889999999999999999 88999999999999998777 799999999875
Q ss_pred cCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHh-CCCCCCCCCc-------------cchhHHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLT-GAKPIRFTTF-------------EEDKNIT 189 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~ellt-g~~P~~~~~~-------------~~~~~~~ 189 (288)
... .....++..|+||| ||||||+++|||++ |..||..... +......
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T cd05037 158 VLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE 232 (259)
T ss_pred ccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchH
Confidence 432 11234667788887 99999999999999 5777744321 1122368
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+.+++.+||..+|++||++.++++.|+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 233 LANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.38 Aligned_cols=196 Identities=24% Similarity=0.329 Sum_probs=156.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||+|.++ ...+.+|+.++++++|+||+++++++.+..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4578999999999999999999752 124668999999999999999998875432
Q ss_pred ----cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ----YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ----~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+... ......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 1110 011245788999999999999999999 888999999999999999999999999998765432
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------- 183 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------- 183 (288)
... .....++..|+||| ||||||+++|||++|..||...+..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 12224577899999 9999999999999999998532210
Q ss_pred -------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 -------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 -------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.++|.+||+.||++||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 01256778999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=238.48 Aligned_cols=193 Identities=26% Similarity=0.381 Sum_probs=157.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+-|++.+.||+|+||.||+|.++ .+.|.+|+.++.+++||||+++++++....+...
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 44778899999999999998642 3468899999999999999999998776543221
Q ss_pred --------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 75 --------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 75 --------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
......+++..+..++.+++.++.||| ..+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 112235788999999999999999999 88999999999999999999999999999875533221 112
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
...++..|++|| |+|||||++|+|++|..||.... .....+.++.+++.+||+.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 235788899998 99999999999999999985321 2223467899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044995 201 SGKKRPAMKEVASE 214 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~ 214 (288)
+|++||++.+++++
T Consensus 240 ~p~~Rp~~~~~l~~ 253 (277)
T cd06641 240 EPSFRPTAKELLKH 253 (277)
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=249.01 Aligned_cols=196 Identities=18% Similarity=0.296 Sum_probs=157.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 69 (288)
.++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999998742 34677899999999999999998875421
Q ss_pred ----ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 70 ----KYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 ----~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+|+.. ......+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 22211 112345889999999999999999999 889999999999999999999999999998754322
Q ss_pred Cc---eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 141 QT---HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 141 ~~---~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
.. .......|+..|++|| ||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 1112346888999999 9999999999999999998543210
Q ss_pred -----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 -----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 -----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.+|++||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 12356788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=240.67 Aligned_cols=193 Identities=20% Similarity=0.279 Sum_probs=153.1
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999752 24578899999999999999999998765432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCCCCc
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +++|+|+||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 11223567778889999999999999 889999999999999985 56799999999875432211
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc----------------------------
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF---------------------------- 182 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~---------------------------- 182 (288)
. .....++..|++|| ||||||+++|+|+||..||.....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1 12234678899998 999999999999999999853211
Q ss_pred ---------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ---------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01235667899999999999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=236.44 Aligned_cols=191 Identities=24% Similarity=0.382 Sum_probs=155.6
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
+|+..+.||+|+||.||+|..+ .+.+.+|+.++++++|+||+++++++.....+...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999998642 24688999999999999999999987665332110
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++.....++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 11234788888999999999999999 8899999999999999999999999999987543322
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITVAKHA 194 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~~~li 194 (288)
......|+..|++|| |+||||+++|+|++|..||.... .+...+..+.+++
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 122345788899998 99999999999999999985322 1223467889999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+||+.+|++||++.+++.+
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=237.45 Aligned_cols=193 Identities=26% Similarity=0.346 Sum_probs=153.0
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--cc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--YM 72 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~l 72 (288)
++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++.+.. ++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999998642 246788999999999999999999876531 11
Q ss_pred -------cc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 -------HD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 -------~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
.. ......+++...+.++.+++.+|.||| +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 11 011234677888999999999999999 88899999999999999999999999999875432
Q ss_pred CCc--eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHH
Q 044995 140 DQT--HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~--~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~ 190 (288)
... .......|+..|+||| ||||||+++|||++|..||.... .+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 111 1112245888999999 99999999999999999985321 122345678
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||. +|++||++++++++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcC
Confidence 899999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=244.59 Aligned_cols=193 Identities=24% Similarity=0.328 Sum_probs=155.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
+.|.....||+|+||.||++.+. .+.+.+|+.++++++|+||+++++.+...++....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555678999999999998642 35688999999999999999999987665432211
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 76 --------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 76 --------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
.....+++.....++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......... ...
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 177 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKS 177 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cce
Confidence 11235788899999999999999999 889999999999999999999999999998754322211 122
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------chhHHHHHHHHHHhcC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-----------------EDKNITVAKHAKRCLN 199 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~~~~~~li~~cl~ 199 (288)
..|+..|+||| ||||||+++|||++|..||...... ...+..+.+++.+||.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 45888999999 9999999999999999998543211 1235678899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.||++||++.+++++
T Consensus 258 ~~P~~Rpt~~~il~~ 272 (292)
T cd06658 258 REPSQRATAQELLQH 272 (292)
T ss_pred CChhHCcCHHHHhhC
Confidence 999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=249.84 Aligned_cols=196 Identities=24% Similarity=0.344 Sum_probs=157.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcC-CCCceeeecceEeccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETK---- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~---- 70 (288)
..++|++.+.||+|+||.||+|.+. ...+.+|+.+++++ +||||++++++|...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 5688999999999999999998652 23467899999999 9999999999875432
Q ss_pred -----cccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 -----YMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 -----~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
++.. ......+.+.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 1110 011125778888899999999999999 8899999999999999999999999999987654322
Q ss_pred c----eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 142 T----HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 142 ~----~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
. .......|+..|++|| ||||||+++|+|++|+.||......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 1222346888999999 9999999999999999998532210
Q ss_pred -----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0125678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=241.95 Aligned_cols=196 Identities=25% Similarity=0.368 Sum_probs=159.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
..++|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++.|...+..+...
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3478999999999999999999642 356889999999999999999999887654322111
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 1224678888999999999999999 88999999999999999999999999998865433222 12
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHh
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~c 197 (288)
....+++.|++|| ||||||+++|++++|+.||..... ....+..+.+++.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 2345888899999 999999999999999999854321 112346789999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l 215 (288)
|..+|++||++.+++.+-
T Consensus 253 l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 253 LEMDVEKRGSAKELLQHP 270 (293)
T ss_pred ccCChhhCcCHHHHhcCH
Confidence 999999999999999773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=236.74 Aligned_cols=193 Identities=25% Similarity=0.398 Sum_probs=155.2
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|+||.||++.+. .+.+.+|+.++++++|+||+++++++...+.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999641 45788999999999999999999987654322111
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.....+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 11234778888999999999999999 88899999999999999999999999999876543322111
Q ss_pred ---eccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC----------------ccch--hHHHH
Q 044995 146 ---TQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT----------------FEED--KNITV 190 (288)
Q Consensus 146 ---~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~----------------~~~~--~~~~~ 190 (288)
....++..|++|| ||||||+++|++++|..||.... .+.. .+..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1245778899998 99999999999999999985331 1111 26778
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=238.96 Aligned_cols=192 Identities=24% Similarity=0.373 Sum_probs=157.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC---CCceeeecceEecccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN---HINVVKLIGCCLETKY----- 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~----- 71 (288)
.|++.+.||+|+||.||+|.+. .+.+.+|+.++++++ ||||++++++|.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888899999999999998752 356889999999997 9999999998766532
Q ss_pred --ccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 72 --MHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 72 --l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
+.. ......+++..++.++.+++.+|.||| +.+|+|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K 157 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence 211 112236788999999999999999999 88999999999999999999999999999876543322 1
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------c-hhHHHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------E-DKNITVAKHAKR 196 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------~-~~~~~~~~li~~ 196 (288)
.....|+..|+||| |+||||+++|+|++|..||...... . ..+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 22345888899999 9999999999999999998543211 1 246789999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
||+.||++||++.+++.+
T Consensus 238 ~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 238 CLDEEPKERLSAEELLKS 255 (277)
T ss_pred HcCCCcccCcCHHHHhhC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=249.90 Aligned_cols=199 Identities=23% Similarity=0.368 Sum_probs=160.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc-------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK------- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 70 (288)
..+...+.++||+|-||+|.++.. .+.+|.+|+++|.+|+|||||+++|+|..++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 446678889999999999998753 2578999999999999999999999997653
Q ss_pred ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 71 YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 71 ~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
|++.. .+...+.-...++|+.||+.||+||. +.+++||||.+.|+|++.++++||+|||+++.+-....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 44321 11111344567789999999999999 88899999999999999999999999999986544333
Q ss_pred ee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh--CCCCCCCCC----------------------ccchh
Q 044995 143 HI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT--GAKPIRFTT----------------------FEEDK 186 (288)
Q Consensus 143 ~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt--g~~P~~~~~----------------------~~~~~ 186 (288)
+. ....+-...|||+| |||+||+++||+++ .+.||...+ .+..+
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 33 23344567899999 99999999999976 677875322 23345
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
+.++.++|.+||..|.++||+++++...|..
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 7889999999999999999999999988864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=248.08 Aligned_cols=194 Identities=20% Similarity=0.288 Sum_probs=157.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 69 (288)
.++|++.+.||+|+||.||++.+. ...+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999998742 24577899999999999999999876433
Q ss_pred -----ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 70 -----KYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 70 -----~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+++.. ......+++.....++.|++.||.||| +++++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 22211 112346789999999999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------- 182 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------- 182 (288)
.. .......++..|+||| |||||||++|+|++|..||...+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 22 1122345788899999 999999999999999999854321
Q ss_pred --------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 01235667899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=235.67 Aligned_cols=191 Identities=24% Similarity=0.345 Sum_probs=155.1
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
+|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++.+...+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999987642 356889999999999999999998876543221
Q ss_pred --cc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCCCCc
Q 044995 74 --DQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 --~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~~~~ 142 (288)
.. .....+++..+..++.+++.+|.||| +++|+|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 10 11234788899999999999999999 8899999999999999754 5689999999876543221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~ 196 (288)
.....++..|+||| ||||||+++|+|++|..||.... .+...+..+.+++.+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 22345788999999 99999999999999999986432 222346789999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
||+.||++||++.+++++
T Consensus 236 ~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HccCChhhCCCHHHHhhC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=247.01 Aligned_cols=197 Identities=19% Similarity=0.283 Sum_probs=159.3
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
..+....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++....
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 445667899999999999999999998642 245789999999999999999998775432
Q ss_pred c-------------c----cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 71 Y-------------M----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 71 ~-------------l----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
. + ........+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 88 SLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 1 1 00111236789999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------ 183 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------ 183 (288)
+....... ....++..|++|| |+||||+++|+|++|..||......
T Consensus 165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 87543221 2235788899998 9999999999999999998643210
Q ss_pred ---------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=243.80 Aligned_cols=194 Identities=25% Similarity=0.326 Sum_probs=156.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
..|+....||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++...+.....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44566678999999999998652 45688999999999999999999987655332211
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 76 --------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 76 --------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
.....+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 12235788899999999999999999 88999999999999999999999999999875432221 1223
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhcC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCLN 199 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl~ 199 (288)
..|+..|+||| ||||||+++|||++|+.||..... ....+..+.+++.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 46889999999 999999999999999999853321 11235678999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 044995 200 PSGKKRPAMKEVASEL 215 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l 215 (288)
.+|++||++.+++++-
T Consensus 257 ~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 257 REPQERATAQELLDHP 272 (297)
T ss_pred CCcccCcCHHHHhhCh
Confidence 9999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=236.64 Aligned_cols=193 Identities=22% Similarity=0.394 Sum_probs=155.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc----------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK----------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~----------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
+|.+.+.||+|+||.||+|... .+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4788899999999999998531 135778999999999999999999876653
Q ss_pred ccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 YMHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
..... .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 32211 12245788888999999999999999 889999999999999999999999999998754
Q ss_pred CCCCc-eeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c----
Q 044995 138 AVDQT-HITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTF----------------E---- 183 (288)
Q Consensus 138 ~~~~~-~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~----------------~---- 183 (288)
..... .......|+..|++|| |+||||+++|++++|..||..... +
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 32211 1122345788899998 999999999999999999853221 1
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1235789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=233.37 Aligned_cols=193 Identities=30% Similarity=0.489 Sum_probs=154.9
Q ss_pred cccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
|++.+.||.|+||.||++.+. .+.+.+|+.+++.++|+||+++++++.+.+.....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999998642 34788999999999999999999987764322110
Q ss_pred ------------CCCCC--CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 76 ------------NKELP--FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 76 ------------~~~~~--l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
..... +++.....++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 01111 788999999999999999999 8899999999999999999999999999987654432
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHA 194 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li 194 (288)
........++..|++|| ||||||+++|+|++ |..||.... .+...+.++.+++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 22221223678899998 99999999999998 788875322 1223467899999
Q ss_pred HHhcCCCCCCCCCHHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+||..||++|||+.++++.|
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.11 Aligned_cols=193 Identities=25% Similarity=0.375 Sum_probs=159.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++.+.||+|++|.||++.++ .+.+.+|++.+.+++|+||+++++++...+.+...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999653 45788999999999999999999987665332211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++...+.++.|++.+|.||| + .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 11246788999999999999999999 8 89999999999999999999999999998765432222
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccch-hHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEED-KNITVAKHA 194 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~-~~~~~~~li 194 (288)
.....++..|++|| |+||||+++|+|++|..||.... .... .+..+.+++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 12345788999999 99999999999999999986542 1122 467899999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+||+.+|++||++.+++++
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHccCChhhCCCHHHHHhC
Confidence 99999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=238.95 Aligned_cols=192 Identities=25% Similarity=0.291 Sum_probs=154.8
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc--ccccc---
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET--KYMHD--- 74 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~l~~--- 74 (288)
|++.+.||+|+||.||+|.+. .+.+.+|++++++++|+|++++++++... ++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999752 24588899999999999999999998765 32211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..++.++.|++.||.||| ..+++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 111236888999999999999999999 8899999999999999999999999999987654432212
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
.....++..|++|| ||||||+++|||++|..||......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 22334677899998 9999999999999999998532210
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0015678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.64 Aligned_cols=193 Identities=25% Similarity=0.426 Sum_probs=155.2
Q ss_pred CcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
+|+..+.||+|+||.||++.+. .+.+.+|++++++++|+||+++++++.+.+.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5888999999999999998641 3468899999999999999999999876543211
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVD 140 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~ 140 (288)
.....++++.....++.|++.||.||| +.+++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 112235788889999999999999999 88999999999999998765 6999999998765432
Q ss_pred Cce---eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhH
Q 044995 141 QTH---ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKN 187 (288)
Q Consensus 141 ~~~---~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~ 187 (288)
... ......++..|++|| ||||||+++|+|++|..||..... +...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 111 112345788999999 999999999999999999853321 12345
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.++.+++.+||..+|++||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 788899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=248.63 Aligned_cols=194 Identities=21% Similarity=0.310 Sum_probs=158.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH-- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~-- 73 (288)
+.+=|.+.+.||+|-|.+|-++++- ...+.+|++-|+-++|||||+||++.-..-.++
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4566899999999999999776541 346889999999999999999999853321111
Q ss_pred ------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceEEecccCccccCCC
Q 044995 74 ------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~~~~ 140 (288)
.......+.+..+.+++.||..|+.|+| +..++||||||+|+.+. +-|-+||.|||++..+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 1122345888999999999999999999 55699999999999875 5689999999999765432
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHA 194 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li 194 (288)
....+.+|++.|.||| ||||||||||.|+.|+.||...+. +...+.+.++||
T Consensus 173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 3345578999999999 999999999999999999965432 334578999999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..||..||++|.+.++|+..
T Consensus 251 ~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHhcCchhhccHHHHhcc
Confidence 99999999999999998764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=274.17 Aligned_cols=198 Identities=23% Similarity=0.310 Sum_probs=157.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
..+-+++-...||.|.||.||.+..- .....+|..++..++|||+|+++|+-...+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34445666788999999999998752 345678999999999999999999855443
Q ss_pred ---cccc-----cCCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 ---YMHD-----QNKEL-PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 ---~l~~-----~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
|... ..+.. -.++.....+..|++.|+.||| +++||||||||+||+++.+|.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 2211 11111 2345555667889999999999 8899999999999999999999999999998765432
Q ss_pred c---eeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCC----------------CCCccchhHH
Q 044995 142 T---HITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIR----------------FTTFEEDKNI 188 (288)
Q Consensus 142 ~---~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~----------------~~~~~~~~~~ 188 (288)
. .......||+.||||| ||||+||++.||+||+.||. ....++..+.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence 1 1123457999999999 99999999999999999984 2234556788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+-.+++.+||..||++|-++.||+++-
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 999999999999999999999888774
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=242.27 Aligned_cols=194 Identities=23% Similarity=0.324 Sum_probs=154.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
++|++.+.||+|+||.||++.+. .+.+.+|+++++.++|+||+++++.+.+.++...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999998642 2457889999999999999999998765543211
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
......+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 111245788889999999999999999 8899999999999999999999999999886432211
Q ss_pred c----------------------------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc
Q 044995 142 T----------------------------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF 182 (288)
Q Consensus 142 ~----------------------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~ 182 (288)
. .......|+..|++|| ||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 0111235788999999 999999999999999999853321
Q ss_pred --------------cc--hhHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 044995 183 --------------EE--DKNITVAKHAKRCLNPSGKKRPA----MKEVASE 214 (288)
Q Consensus 183 --------------~~--~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 214 (288)
+. ..+..+.+++.+||..||++||+ +.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 13678999999999999999999 5555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=237.84 Aligned_cols=190 Identities=28% Similarity=0.377 Sum_probs=155.6
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
+|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++.+.+.+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999753 35788999999999999999999876654322111
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 11246888999999999999999999 8899999999999999999999999999987643322 1
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKR 196 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~ 196 (288)
.....|+..|++|| |+||||+++|+|++|..||..... +...+..+.+++.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 22345788899999 999999999999999999875431 22346789999999
Q ss_pred hcCCCCCCCCCH--HHHHH
Q 044995 197 CLNPSGKKRPAM--KEVAS 213 (288)
Q Consensus 197 cl~~~p~~Rp~~--~~i~~ 213 (288)
||+.||.+||++ .|+++
T Consensus 236 ~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HccCChhHcCCccHHHHhc
Confidence 999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=239.94 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=158.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
..|+..+.||+|+||.||++.+. .+.+.+|++++++++|||+++++++|.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44788899999999999998642 2468899999999999999999998766532
Q ss_pred --ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 72 --MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 72 --l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
+.. ......+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 211 012345788999999999999999999 889999999999999999999999999988643321
Q ss_pred eeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKH 193 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~l 193 (288)
....|+..|++|| |||||||++|||++|..||..... ....+..+.++
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2235788899998 999999999999999999743221 12345678999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+.+||+.+|.+||++.++++++..+.
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.08 Aligned_cols=192 Identities=25% Similarity=0.383 Sum_probs=155.4
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
+|++.+.||+|+||.||++.++ .+.+.+|+.++++++|+||+++++.+......+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999998752 3467899999999999999999998766543211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCCCc
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~~~ 142 (288)
......+++.....++.+++.||.||| +.+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 111224688899999999999999999 88899999999999998775 569999999876543221
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
......|++.|+||| |+||||+++|||++|..||..... ....+.++.+++.+
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 122245888999999 999999999999999999864321 12335689999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
||..+|++||++.+++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 237 LFKVSPRDRPSITSILKR 254 (257)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=249.46 Aligned_cols=194 Identities=22% Similarity=0.282 Sum_probs=157.0
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
....++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++|+||+++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 346789999999999999999998652 2456789999999999999999876543321
Q ss_pred -----------cc----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 72 -----------MH----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 72 -----------l~----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+. .......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 11 1112236788999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
.... .....++..|++|| ||||||+++|||++|+.||......
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5332 12235788899998 9999999999999999998533211
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0125678899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=236.85 Aligned_cols=192 Identities=26% Similarity=0.340 Sum_probs=155.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecc---------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLET--------- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 69 (288)
++|+..+.||.|++|.||++.++ ..++.+|++++++++||||++++++|.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 57889999999999999999752 35688999999999999999999987542
Q ss_pred ccccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 70 KYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 70 ~~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+|+.. ......++......++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 12211 112234678888999999999999999 88999999999999999999999999999875432
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------------c-----
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------------E----- 183 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------------~----- 183 (288)
... ....++..|++|| ||||||+++|+|++|..||..... .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 211 1235778899998 999999999999999999864411 0
Q ss_pred -chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 -EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 -~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||..||++||++.|++++-
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 01145788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=239.83 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=156.3
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEeccccc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYM 72 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l 72 (288)
+....++|++.+.||+|+||.||++.++ ...+.+|+.++.++. |+||++++++|.+..++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3456688999999999999999998753 234667887666665 99999999998765432
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+... ....+++.....++.+++.||.||| + .+|+||||+|+||++++++.+||+|||++....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 2111 1235788888999999999999999 6 489999999999999999999999999987543
Q ss_pred CCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c--ch
Q 044995 139 VDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF----------------E--ED 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~----------------~--~~ 185 (288)
..... ....++..|+||| ||||||+++|+|++|+.||..... + ..
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 22211 2234677899987 999999999999999999854111 1 12
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+.++.+++.+||+.||++||++.+++.+-
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 467899999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=251.41 Aligned_cols=191 Identities=24% Similarity=0.307 Sum_probs=152.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC-C-----CceeeecceEecccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN-H-----INVVKLIGCCLETKYMH- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~l~- 73 (288)
-+|.+.+.||+|.||.|.+|.+. ..+-..|+++|..|+ | -|+|+++++|...+++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 37899999999999999999763 234567999999987 3 68999999976554331
Q ss_pred -------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC--CceEEecccCccccC
Q 044995 74 -------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK--YCAKVSNFGTSRSRA 138 (288)
Q Consensus 74 -------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~--~~~kl~DfG~a~~~~ 138 (288)
..+....++...+..++.||+.+|.+|| +.+|||+||||+|||+.+. ..+||+|||.|....
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 2344556899999999999999999999 8899999999999999533 489999999998643
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------- 184 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------------- 184 (288)
.... +..-+..|.||| ||||||||+.||++|.+-|.+.+..+
T Consensus 343 q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 343 QRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred Ccce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 3222 456788999999 99999999999999976663221000
Q ss_pred ------------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHH
Q 044995 185 ------------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMKE 210 (288)
Q Consensus 185 ------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~ 210 (288)
.....+.+++.+||..||.+|+|..+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 01346789999999999999999999
Q ss_pred HHHHH
Q 044995 211 VASEL 215 (288)
Q Consensus 211 i~~~l 215 (288)
.++|=
T Consensus 499 al~Hp 503 (586)
T KOG0667|consen 499 ALNHP 503 (586)
T ss_pred HhcCc
Confidence 98873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=239.94 Aligned_cols=206 Identities=23% Similarity=0.333 Sum_probs=162.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhc--CCCCceeeecceE-----------ec
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQ--INHINVVKLIGCC-----------LE 68 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~--l~HpnIv~l~~~~-----------~~ 68 (288)
....+..+.+.||+|.||+||+|.++ ...+.+|.++.+. |+|+||+.+++.- +.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 34466788899999999999999874 5678899998875 6999999998762 22
Q ss_pred ccc-----ccccCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 69 TKY-----MHDQNKELPFTWEMQLRISIEASGTMSYLH-----LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 69 ~~~-----l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++| ++.......++....++++..++.||++|| .++...|.|||||+.|||+.+++.+.|+|||+|....
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 222 333334457889999999999999999999 3457789999999999999999999999999997543
Q ss_pred CCCc---eeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhC----------CCCCCCC--------
Q 044995 139 VDQT---HITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTG----------AKPIRFT-------- 180 (288)
Q Consensus 139 ~~~~---~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg----------~~P~~~~-------- 180 (288)
.... ...+..+||..||||| ||||||.++||++-. +.||...
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 3221 2233457999999999 999999999999862 4666321
Q ss_pred ------------------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 181 ------------------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 181 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+........+.++|+.||..||..|-|+-.|.+.|.++..
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1112335678899999999999999999999999988764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=229.39 Aligned_cols=191 Identities=29% Similarity=0.429 Sum_probs=156.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MH 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~ 73 (288)
+|++.+.||+|++|.||++.+. .+.+.+|++++++++|+||+++++++...+. +.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5888999999999999999752 3568899999999999999999998765432 11
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++.....++.+++.+|.||| ..+++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 0 011136788999999999999999999 88999999999999999999999999999876543321 23
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cchh--HHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EEDK--NITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~~--~~~~~~li~~cl 198 (288)
...++..|++|| ||||||+++|+|++|..||...+. .... +..+.+++.+||
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence 346888999999 999999999999999999864411 1111 578999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++||++.+++++
T Consensus 236 ~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 236 QKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=235.67 Aligned_cols=191 Identities=20% Similarity=0.285 Sum_probs=154.3
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM------- 72 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l------- 72 (288)
|++.+.||+|++|.||++.+. ...+.+|++++++++|+||+++++++......
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677899999999999999652 34678899999999999999999987654322
Q ss_pred cc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 73 HD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 73 ~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
.. ......+++..+..++.+++.||.||| ..+|+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 11 111246788999999999999999999 8899999999999999999999999999987654332 1112
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------------------
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF-------------------------------- 182 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~-------------------------------- 182 (288)
...++..|++|| ||||||+++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 235778899999 999999999999999999853321
Q ss_pred ------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.++|.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 01235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=242.29 Aligned_cols=197 Identities=19% Similarity=0.275 Sum_probs=158.1
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc-
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET- 69 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 69 (288)
.++...+++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||++++++|...
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 345567899999999999999999998642 35678999999999999999999987542
Q ss_pred ccccc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 KYMHD-----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ~~l~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.... ......++......++.|++.||.||| ..+|+|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred CcEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 22111 112235677788889999999999999 8899999999999999999999999999987543
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
... ....++..|++|| ||||||+++|+|++|..||......
T Consensus 160 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 PQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 211 2234677889998 9999999999999999998543210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.++|.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1234678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=235.61 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=154.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ----- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~----- 75 (288)
.|...+.||+|++|.||++.++ .+.+.+|+.+++.++||||+++++++...++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4666689999999999998642 34688999999999999999999987654322111
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.+|.||| +.+|+||||+|+||+++.++.++|+|||++......... ....
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 175 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSL 175 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccc
Confidence 11135788888999999999999999 889999999999999999999999999988754332211 1224
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhcCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl~~ 200 (288)
.|+..|++|| ||||||+++|||++|..||..... ....+..+.+++.+||+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 5888999999 999999999999999999853221 111457899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044995 201 SGKKRPAMKEVASE 214 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~ 214 (288)
+|++||++.+++++
T Consensus 256 ~p~~Rpt~~~il~~ 269 (285)
T cd06648 256 DPAQRATAAELLNH 269 (285)
T ss_pred ChhhCcCHHHHccC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=243.38 Aligned_cols=195 Identities=22% Similarity=0.307 Sum_probs=153.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEec----------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLE---------- 68 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 68 (288)
.++|++.+.||.|+||.||+|.++ .+.+.+|++++++++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999752 3568899999999999999999875432
Q ss_pred -----------cccccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceEEeccc
Q 044995 69 -----------TKYMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFG 132 (288)
Q Consensus 69 -----------~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~DfG 132 (288)
.+++.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 222211 111235788999999999999999999 88999999999999997 45678999999
Q ss_pred CccccCCCCce--eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc----------------
Q 044995 133 TSRSRAVDQTH--ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF---------------- 182 (288)
Q Consensus 133 ~a~~~~~~~~~--~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~---------------- 182 (288)
+++........ ......++..|+||| |||||||++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98754321111 112235788899999 999999999999999999853210
Q ss_pred ----------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 01134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=241.65 Aligned_cols=193 Identities=22% Similarity=0.310 Sum_probs=153.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcC-CCCceeeecceEecc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQI-NHINVVKLIGCCLET------ 69 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------ 69 (288)
+|++.+.||+|+||.||++.+. .+.+.+|+.+++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4888899999999999998742 24578899999999 599999999864322
Q ss_pred -----ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 70 -----KYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 70 -----~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 11110 112345788999999999999999999 88999999999999999999999999999975432
Q ss_pred CCce---eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 140 DQTH---ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 140 ~~~~---~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
.... ......|+..|+||| ||||||+++|+|++|..||......
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2111 112346889999999 9999999999999999998643210
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0124578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=241.76 Aligned_cols=193 Identities=22% Similarity=0.336 Sum_probs=156.4
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------- 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 70 (288)
+|++.+.||+|+||.||++.+. .+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999742 346889999999999999999998876543
Q ss_pred ----cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 ----YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 ----~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
++.. ......+++..+..++.+++.||.||| +.+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 1110 112236788999999999999999999 8899999999999999999999999999988654332
Q ss_pred c--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------
Q 044995 142 T--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------ 183 (288)
Q Consensus 142 ~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------ 183 (288)
. .......++..|+||| ||||||+++|+|++|..||......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 1122345788899998 9999999999999999998543210
Q ss_pred ---------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1124567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=231.50 Aligned_cols=211 Identities=24% Similarity=0.282 Sum_probs=164.2
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
.....++|++++.||.|.-|.||++..+ ..+...|.+||+.++||.++.|+..+...+|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 3445678999999999999999998642 4567789999999999999999998777655
Q ss_pred ccc---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 72 MHD---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 72 l~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
... .+....+++..+.-++.+++.||+||| -.|||.|||||+||||.++|.+.|+||.++..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 432 223345888999999999999999999 88999999999999999999999999987642
Q ss_pred cCC---------------------------------CCc----------------------eeeeccccCCCCCChh---
Q 044995 137 RAV---------------------------------DQT----------------------HITTQVHGTFGYLNPD--- 158 (288)
Q Consensus 137 ~~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE--- 158 (288)
... ... ......+||-.|+|||
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 110 000 0112256999999999
Q ss_pred --------hHHHHHHHHHHHHhCCCCCCCCCccc----------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 159 --------DVCSFGVVLVELLTGAKPIRFTTFEE----------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 159 --------DiwSlG~il~elltg~~P~~~~~~~~----------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|.|+|||++|||+.|..||.+.+..+ ..+...++||+++|..||.+|.....=...
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 99999999999999999997655322 235789999999999999999884444444
Q ss_pred HHhchhhcCCCc
Q 044995 215 LAGIKAWNGASN 226 (288)
Q Consensus 215 l~~~~~~~~~~~ 226 (288)
++...-..+...
T Consensus 389 IK~HpFF~gVnW 400 (459)
T KOG0610|consen 389 IKRHPFFEGVNW 400 (459)
T ss_pred hhcCccccCCCh
Confidence 444444444433
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=232.00 Aligned_cols=193 Identities=26% Similarity=0.354 Sum_probs=154.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
.+|++.+.||+|+||.||++.++ .+.|.+|++++++++|+||+++++++.+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999998642 246788999999999999999999875431
Q ss_pred -----cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 -----YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 -----~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... ......+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 1111 011235778888999999999999999 88899999999999999999999999999875432
Q ss_pred CC--ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC----------------CccchhHHHH
Q 044995 140 DQ--THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNITV 190 (288)
Q Consensus 140 ~~--~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~----------------~~~~~~~~~~ 190 (288)
.. ........++..|+||| |+|||||++|+|++|..||... ..+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 11112345888999999 9999999999999999998532 1234456789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+ ++..||++.+++.+
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcC
Confidence 999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=228.81 Aligned_cols=193 Identities=27% Similarity=0.409 Sum_probs=158.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc--cccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET--KYMHDQ- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~l~~~- 75 (288)
+|++.+.||+|++|.||+|.+. .+.+.+|+.++++++|+||+++++.+... ......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5788899999999999999752 45688999999999999999999987765 322110
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.+++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 11126788999999999999999999 889999999999999999999999999998765443321
Q ss_pred -eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHH
Q 044995 144 -ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHA 194 (288)
Q Consensus 144 -~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li 194 (288)
......++..|++|| ||||||+++|+|++|..||.... .+...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 122345888999999 99999999999999999986432 2233467899999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+||+.||++||++.+++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=270.57 Aligned_cols=199 Identities=23% Similarity=0.383 Sum_probs=155.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccCCC----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNKE---- 78 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~~~---- 78 (288)
...|...+.||+|+||.||+|.++ .....+|++.+++++|||||+++++|.+.+......+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 356778889999999999999752 11234679999999999999999998765433221111
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCC
Q 044995 79 ------LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152 (288)
Q Consensus 79 ------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 152 (288)
..++|..+.+++.|++.||+|||..+..+|+||||||+||+++.++..++. ||.+...... ....++.
T Consensus 769 ~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~ 842 (968)
T PLN00113 769 NLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISS 842 (968)
T ss_pred cHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccc
Confidence 137889999999999999999997667799999999999999988887775 6655432111 1235789
Q ss_pred CCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------------------------cchhHHH
Q 044995 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------------------------EEDKNIT 189 (288)
Q Consensus 153 ~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------------------------~~~~~~~ 189 (288)
.|+||| |||||||++|||+||+.||..... ......+
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 999999 999999999999999999742110 0112345
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+.+++.+||+.||++||+|.|+++.|+++...
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 77899999999999999999999999987653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=237.51 Aligned_cols=195 Identities=24% Similarity=0.335 Sum_probs=158.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..+.|+..+.||+|+||.||+|+++ .+++.+|+++++.++|+|++++++++........
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3455888899999999999998742 2467889999999999999999998766533211
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
......+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 112235788889999999999999999 889999999999999999999999999998754321
Q ss_pred ceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHH
Q 044995 142 THITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVA 191 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~ 191 (288)
....++..|+||| |||||||++|+|++|..||..... ....+..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 2235788899998 999999999999999999743211 123466789
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
++|.+||+.+|++||++.+++++....
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=236.84 Aligned_cols=187 Identities=26% Similarity=0.374 Sum_probs=153.3
Q ss_pred cccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 20 FNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
|...+.||+|+||.||+|++. .+.+.+|++++++++|||++++++++.+.++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999642 24678999999999999999999988765432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....++++..+..++.|++.+|.||| +.+|+|+||+|+||+++.++.+||+|||++..... .
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 12345788899999999999999999 88999999999999999999999999998864321 1
Q ss_pred eccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHHHH
Q 044995 146 TQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKHAK 195 (288)
Q Consensus 146 ~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~li~ 195 (288)
....|+..|++|| ||||||+++|+|++|..||..... ....+..+.+++.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 2345788899998 999999999999999999854221 1123457899999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.+|.+||++.+++.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=234.07 Aligned_cols=197 Identities=25% Similarity=0.380 Sum_probs=160.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
...+.|+..+.||+|+||.||++.++ .+.+.+|++++++++|+||+++++++......+...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 46677999999999999999998763 457889999999999999999999876543322110
Q ss_pred ------------CC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 77 ------------KE-LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 77 ------------~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
.. ..+++..+..++.+++.||.||| ..+|+|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 11 26888899999999999999999 89999999999999999999999999998765432221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAK 195 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~ 195 (288)
......++..|++|| ||||||+++|+|++|..||..... ....+..+.+++.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 112235788899999 999999999999999999854321 1114567999999
Q ss_pred HhcCCCCCCCCCHHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l 215 (288)
+||+.+|.+||++.+++++-
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHhccChhhCcCHHHHhhCh
Confidence 99999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=234.91 Aligned_cols=193 Identities=26% Similarity=0.324 Sum_probs=152.3
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcC-CCCceeeecceEecccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKY- 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~- 71 (288)
+|++.+.||+|+||.||++.+. .+.+.+|++++.++ +|+||+++++++.....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5888999999999999987641 24577899999999 59999999887655432
Q ss_pred ------cccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 ------MHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 ------l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... .....+++..+..++.|++.||.||| +.+++||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 2211 12235778888889999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNI 188 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~ 188 (288)
..........|+..|++|| ||||||+++|+|++|..||.... .+...+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 3222223346888999998 99999999999999999985321 1223456
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp-----~~~~i~~~ 214 (288)
.+.+++.+||+.||++|| ++.+++++
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 788999999999999997 66666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=235.83 Aligned_cols=190 Identities=24% Similarity=0.332 Sum_probs=155.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
.-.+.|+.-++||+||||+||-++.+ ....++|-.+|.+++.+.||.+--.|...+-
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44577899999999999999987642 2346789999999999999998665544321
Q ss_pred -----ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 -----MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 -----l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
|.+ ......+++..++-++.+|+.||++|| ..+|+.|||||+|||+|+.|.++|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 111 112246899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCC------------------CCccchhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRF------------------TTFEEDKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~------------------~~~~~~~~~~ 189 (288)
..... ...+||.+||||| |.|||||+||||+.|+.||.. ..+++..+.+
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 44433 2347999999999 999999999999999999942 2234556889
Q ss_pred HHHHHHHhcCCCCCCCCCHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMK 209 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~ 209 (288)
..++....|..||++|...+
T Consensus 417 akslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHccCHHHhccCC
Confidence 99999999999999996543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=233.79 Aligned_cols=194 Identities=25% Similarity=0.368 Sum_probs=157.0
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCC-CCceeeecceEecccccccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~ 75 (288)
++|.+.+.||+|+||.||++..+ .+.+.+|++++++++ |+||+++++++...+.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999998752 245788999999999 99999999887654332211
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 12226889999999999999999999 88999999999999999999999999999875433221
Q ss_pred -------------------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------
Q 044995 143 -------------------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------- 181 (288)
Q Consensus 143 -------------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------- 181 (288)
.......++..|++|| ||||||+++|++++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 1122345788899998 99999999999999999986432
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAM----KEVASE 214 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~----~~i~~~ 214 (288)
.+...+..+.+++.+||+.||++||++ .+++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 223346789999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=234.29 Aligned_cols=196 Identities=24% Similarity=0.287 Sum_probs=155.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcC-CCCceeeecceEecccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKY- 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~- 71 (288)
+|++.+.||+|+||.||++.+. .+.+.+|++++.++ +||||+++++.+...+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999987531 23577899999999 59999999887654432
Q ss_pred ------cccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 ------MHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 ------l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... .....+++.....++.|++.+|.||| ..+++|+||||.||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 2111 11235778888999999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNI 188 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~ 188 (288)
..........|+..|++|| ||||||+++|||++|..||.... .+...+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 3322223345788999999 99999999999999999985321 1122357
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 217 (288)
.+.+++.+||+.||++|||+.++.+.|+.
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 88999999999999999998877766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=232.12 Aligned_cols=190 Identities=24% Similarity=0.303 Sum_probs=150.7
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcC---CCCceeeecceEecccc-----
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQI---NHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 71 (288)
|++.+.||+|+||.||+|.++ ...+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999853 23466788877665 69999999999876543
Q ss_pred ccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 72 MHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 72 l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+.. ......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 111 011224789999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
..... .....++..|++|| ||||||+++|||++|..||......
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 33221 12234788899998 9999999999999999888543210
Q ss_pred ------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0123567889999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=230.78 Aligned_cols=191 Identities=25% Similarity=0.350 Sum_probs=152.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
+|.+.+.||+|+||.||++.+. ...+..|+.++++++||||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999987542 224667999999999999999998765443
Q ss_pred --cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 --YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 --~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
|+.. ......+++..+..++.|++.||.||| +.+++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 2211 012245788999999999999999999 889999999999999975 569999999987653
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
.... ......|+..|++|| |+||||+++|+|++|..||.... .+...+.++.+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHH
Confidence 3221 122345788899998 99999999999999999985322 22344678999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++||++.+++++
T Consensus 236 li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 236 IMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=248.65 Aligned_cols=154 Identities=31% Similarity=0.475 Sum_probs=128.7
Q ss_pred cccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---------- 70 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---------- 70 (288)
+...+.||+||||.||+|+++ ++...+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455689999999999999853 577889999999999999999998743322
Q ss_pred ---c---------ccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee--cCCC--ceEEecccCc
Q 044995 71 ---Y---------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL--DDKY--CAKVSNFGTS 134 (288)
Q Consensus 71 ---~---------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~--~~~~--~~kl~DfG~a 134 (288)
| +..-.....+++...+.++.+++.||.||| +++|+||||||.||++ +.+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 1 112223446899999999999999999999 8999999999999998 3334 5699999999
Q ss_pred cccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCC
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIR 178 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~ 178 (288)
+.++.+. ....++||..|++|| |.|||||++|+++||..||.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9776544 445678999999998 99999999999999999994
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=228.21 Aligned_cols=190 Identities=27% Similarity=0.359 Sum_probs=155.5
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|+||.||++.++ ...+.+|++++++++|+||+++++++......+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999998642 34678899999999999999999886654322110
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 76 --------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 76 --------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.....+++..+..++.+++.||.||| +.+++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 11235788888999999999999999 889999999999999999999999999998765433
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------cchhHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------EEDKNITVAKHAK 195 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------~~~~~~~~~~li~ 195 (288)
......++..|++|| |+||||+++|+|++|..||..... ....+.++.+++.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 112235788999999 999999999999999999864332 2234577999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=226.98 Aligned_cols=192 Identities=25% Similarity=0.433 Sum_probs=157.3
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
+|++.+.||+|++|.||++++. .+.+.+|++++++++|+|++++++++...++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999998642 35688999999999999999999987665432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.....+++.....++.|++.+|.||| +.+|+|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 11245789999999999999999999 889999999999999999999999999998865433221 1
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhcC
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl~ 199 (288)
....++..|++|| ||||||+++|+|++|..||.... .+...+..+.+++.+||.
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 2345788899998 99999999999999999985322 122346789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999998753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=246.03 Aligned_cols=195 Identities=24% Similarity=0.297 Sum_probs=163.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
.-...|.+...||+|.|+.|.++++. ..++.+|+++|+.|+|||||+++.+......++.
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 45677999999999999999999752 4668999999999999999999998765433221
Q ss_pred c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. .....+....+..++.|+.++++|+| .+.|+|||||.+|||++.+..+||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc--
Confidence 1 12223455788899999999999999 99999999999999999999999999999987653
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc--------------hhHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE--------------DKNITVAKHAK 195 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~--------------~~~~~~~~li~ 195 (288)
.....+++|++.|.||| |+||+|+++|-|+.|..||++....+ -.+.+..++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 33445678999999999 99999999999999999998665433 22668899999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
++|-.+|.+|++.++|.++
T Consensus 288 k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HhhccCccccCCHHHhhhh
Confidence 9999999999999988654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=229.08 Aligned_cols=184 Identities=28% Similarity=0.330 Sum_probs=149.7
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---------
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--------- 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--------- 75 (288)
||.|+||.||++++. .+.+.+|+.++++++||||+++++.+.+...+...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999998753 24688999999999999999999987665432211
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccC
Q 044995 76 ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 76 ----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
.....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 12235788889999999999999999 8899999999999999999999999999988654322 12234578
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHHHHHHHHHHhcCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNITVAKHAKRCLNPSG 202 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~~~~~li~~cl~~~p 202 (288)
..|++|| |+||||+++|+|++|..||.... .+...+.++.+++.+||+.||
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 8999999 99999999999999999996444 111235788999999999999
Q ss_pred CCCCC-----HHHHHHH
Q 044995 203 KKRPA-----MKEVASE 214 (288)
Q Consensus 203 ~~Rp~-----~~~i~~~ 214 (288)
++||+ +.|++++
T Consensus 236 ~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 236 EERLGNLKGGIKDIKKH 252 (262)
T ss_pred hhCcCCcccCHHHHhcC
Confidence 99999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=226.92 Aligned_cols=192 Identities=28% Similarity=0.411 Sum_probs=157.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
+|++.+.||+|+||.||++.+. .+.+.+|++++++++|+|++++++.+...+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999998753 346889999999999999999998765543221
Q ss_pred --c----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 74 --D----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 74 --~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. ......+++.....++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 1 001256888999999999999999999 8899999999999999999999999999987654332
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
.......|+..|++|| |+||||+++|+|++|..||.... .+...+..+.+++.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1222346888899999 99999999999999999986442 22245678999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||..+|++||++.+++++
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 237 SLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=227.22 Aligned_cols=199 Identities=24% Similarity=0.271 Sum_probs=156.6
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
.....|++...||+|.||.||++..+ .....+|+.+++.++||||+.+..++...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45678999999999999999999532 124568999999999999999988876521
Q ss_pred --------cc----------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC----CceEE
Q 044995 71 --------YM----------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK----YCAKV 128 (288)
Q Consensus 71 --------~l----------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~----~~~kl 128 (288)
|- +...+...++...+..|+.||+.|+.||| ++=|+||||||.|||+..+ |.+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 11 12233346888899999999999999999 8889999999999999665 89999
Q ss_pred ecccCccccCCCCce--eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc------------
Q 044995 129 SNFGTSRSRAVDQTH--ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------ 182 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------ 182 (288)
+|||+++.....-.. ....++-|.+|.||| ||||.|||+.||+|-++-|.+.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999976543222 234467789999999 999999999999997766632210
Q ss_pred ----------------------cc--------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------------EE--------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------------~~--------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++ ..+....+|+.++|..||-+|-|+.+.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 00 013346788999999999999999999887
Q ss_pred HH
Q 044995 215 LA 216 (288)
Q Consensus 215 l~ 216 (288)
.=
T Consensus 338 ~y 339 (438)
T KOG0666|consen 338 PY 339 (438)
T ss_pred cc
Confidence 53
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=230.48 Aligned_cols=183 Identities=24% Similarity=0.296 Sum_probs=145.3
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-------cccc---
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------YMHD--- 74 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------~l~~--- 74 (288)
||+|+||.||++.++ .+.+.+|++++++++||||+++++.+...+ |+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999998642 235678999999999999999998765543 2211
Q ss_pred -----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccc
Q 044995 75 -----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH 149 (288)
Q Consensus 75 -----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 149 (288)
......+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 111235788899999999999999999 8899999999999999999999999999987543211 112235
Q ss_pred cCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHHHHHhcCC
Q 044995 150 GTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 150 gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~li~~cl~~ 200 (288)
++..|++|| ||||||+++|+|++|+.||..... +...+..+.+++.+||+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 778899999 999999999999999999854321 223467899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 044995 201 SGKKRP-----AMKEVAS 213 (288)
Q Consensus 201 ~p~~Rp-----~~~~i~~ 213 (288)
||++|| ++.+++.
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=226.38 Aligned_cols=196 Identities=23% Similarity=0.320 Sum_probs=158.0
Q ss_pred HhcCCcccC-ceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhcC-CCCceeeecceEecc----------
Q 044995 15 KATDSFNVN-RILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQI-NHINVVKLIGCCLET---------- 69 (288)
Q Consensus 15 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~---------- 69 (288)
..+++|++. ++||-|-.|.|-.+.++ ..+..+|+++..+. .|||||.++++|...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 367888775 57999999999998875 34667899987766 599999999986442
Q ss_pred -cccc------c--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceEEecccCcccc
Q 044995 70 -KYMH------D--QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 -~~l~------~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~DfG~a~~~ 137 (288)
+.|. . ......+++.++..|..||+.|+.||| ..+|.||||||+|+|.. .+..+||+|||+|+..
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 2222 1 223456999999999999999999999 99999999999999995 4568999999999864
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------cc----c
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FE----E 184 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~----~ 184 (288)
.... ...+.+-|+.|.||| |+||+||++|-|+.|-+||.... ++ .
T Consensus 215 ~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 215 QEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred CCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 4322 223456799999999 99999999999999999995322 22 2
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+....++|+.+|..+|.+|.|+.++.++-
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 3478899999999999999999999998763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=236.67 Aligned_cols=189 Identities=21% Similarity=0.271 Sum_probs=144.8
Q ss_pred ceeeee--CCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc------
Q 044995 24 RILGQG--GQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G--~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
..||+| +||+||++.+. .+.+.+|+.+++.++||||++++++|...+++...
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999752 35688999999999999999999998765432111
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee--
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI-- 144 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-- 144 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 11224778888899999999999999 8899999999999999999999999998543221110000
Q ss_pred ----eeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------
Q 044995 145 ----TTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTF------------------------- 182 (288)
Q Consensus 145 ----~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~------------------------- 182 (288)
.....++..|++|| |||||||++|||++|..||.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00112456799998 999999999999999999853210
Q ss_pred ------------------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 ------------------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 ------------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
....+..+.+++.+||+.||++|||+.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 011345788999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=237.06 Aligned_cols=197 Identities=21% Similarity=0.274 Sum_probs=154.3
Q ss_pred hcCCccc-CceeeeeCCeeEEEeEcc----------------H----------------HHHHHHHHHHhcCCCCceeee
Q 044995 16 ATDSFNV-NRILGQGGQDIVYKGMAK----------------V----------------EKFINEVVIQSQINHINVVKL 62 (288)
Q Consensus 16 ~~~~y~~-~~~lG~G~~g~Vy~~~~~----------------~----------------~~~~~E~~~l~~l~HpnIv~l 62 (288)
..++|.. .+.||+|+||.||++.++ . ..+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3467754 577999999999999742 0 136789999999999999999
Q ss_pred cceEecccccccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 63 IGCCLETKYMHDQ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 63 ~~~~~~~~~l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
++++...++.... .....+++.....++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred eEEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9987765443221 12235788889999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCC-------------ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--
Q 044995 131 FGTSRSRAVDQ-------------THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-- 183 (288)
Q Consensus 131 fG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-- 183 (288)
||++....... ........++..|++|| |||||||++|||++|..||......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99987543110 01111224677899998 9999999999999999998533210
Q ss_pred ----------------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ----------------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ----------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.+|++||++.|++.+-
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 11256788999999999999999999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=230.26 Aligned_cols=190 Identities=25% Similarity=0.309 Sum_probs=151.7
Q ss_pred cccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC-CCceeeecceEecccc-------c
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKY-------M 72 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~-------l 72 (288)
|++.+.||+|+||.||+|... .....+|+..+++++ |+||+++++++...+. +
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999752 123467999999999 9999999988765432 2
Q ss_pred cc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 73 HD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 73 ~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.. ......+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||+++....... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 11 011135788999999999999999999 88999999999999999999999999999875543222 1
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------------ 183 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------------ 183 (288)
....++..|+||| |+||||+++|||++|..||......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345788899998 9999999999999999988533210
Q ss_pred --------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0113678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-34 Score=233.69 Aligned_cols=193 Identities=24% Similarity=0.350 Sum_probs=148.3
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHH-hcCCCCceeeecceEecc-------c
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQ-SQINHINVVKLIGCCLET-------K 70 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~-------~ 70 (288)
++.+.+..||.|+||+|+|-.++ .++++.|.+.. +.-+.||||+++|.+... +
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34455788999999999987653 56788898764 445799999999985432 1
Q ss_pred cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.|.. ..+...+++...-+|......||.||-. ...|||||+||+|||++..|.+||||||++..+...
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 1110 1122346677677777788899999974 457999999999999999999999999998765332
Q ss_pred CceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCc------------------cc---hh
Q 044995 141 QTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTF------------------EE---DK 186 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~------------------~~---~~ 186 (288)
...+.-.|...||||| ||||||++|||++||..||..... +. ..
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 2223346899999999 999999999999999999853221 11 24
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+..+..+|..|+..|-++||...++.++
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 6789999999999999999999998765
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=232.10 Aligned_cols=188 Identities=24% Similarity=0.317 Sum_probs=152.1
Q ss_pred CceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---------
Q 044995 23 NRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--------- 75 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--------- 75 (288)
...||+|+||.||++..+ .+.+.+|+.+++.++|+||+++++.+...++....
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999998652 34688999999999999999999987665433211
Q ss_pred ---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCC
Q 044995 76 ---NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152 (288)
Q Consensus 76 ---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 152 (288)
.....+++.....++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++........ ......|+.
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~ 180 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTP 180 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCc
Confidence 11235788889999999999999999 88999999999999999999999999998865432221 112245788
Q ss_pred CCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhcCCCCCC
Q 044995 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCLNPSGKK 204 (288)
Q Consensus 153 ~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl~~~p~~ 204 (288)
.|++|| |+||||+++|+|++|..||..... ....+..+.+++.+||+.||.+
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCccc
Confidence 999999 999999999999999999854321 1123567899999999999999
Q ss_pred CCCHHHHHHH
Q 044995 205 RPAMKEVASE 214 (288)
Q Consensus 205 Rp~~~~i~~~ 214 (288)
||++.+++++
T Consensus 261 R~~~~~ll~~ 270 (292)
T cd06657 261 RATAAELLKH 270 (292)
T ss_pred CcCHHHHhcC
Confidence 9999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-33 Score=240.99 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=161.1
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecc
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIG 64 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~ 64 (288)
+++-...-++|-++..||+|||++||++.+- .+...+|.+|.+.|+||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3444555678999999999999999998641 345678999999999999999999
Q ss_pred eEec--------ccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceE
Q 044995 65 CCLE--------TKYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAK 127 (288)
Q Consensus 65 ~~~~--------~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~k 127 (288)
++.. -+|..+. .....+++.++..|+.||+.||.||... ..+|||-||||.|||+. ..|.+|
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 8533 2333221 1223478899999999999999999966 68999999999999993 348999
Q ss_pred EecccCccccCCCCc------eeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----
Q 044995 128 VSNFGTSRSRAVDQT------HITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF---- 182 (288)
Q Consensus 128 l~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~---- 182 (288)
|.|||+++..+.+.. ..+....||++|++|| ||||+|||+|.++.|+.||.....
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999997654332 2234567999999999 999999999999999999953221
Q ss_pred ----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 044995 183 ----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 183 ----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
....+.+..++|++||++.-++|.+..++..
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1134678899999999999999998777654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=229.00 Aligned_cols=191 Identities=24% Similarity=0.321 Sum_probs=153.1
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC---
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN--- 76 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~--- 76 (288)
|++.+.||+|+||.||+|+.. .+.+.+|+.++++++|+||+++++++.+.++.....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 667789999999999998753 246778999999999999999999876654322111
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 77 ----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 77 ----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
....+++..+..++.+++.+|.||| +.+|+|+||+|+||++++++.++|+|||+++....... ...
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 1135788999999999999999999 88999999999999999999999999999876543221 112
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------------
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------------ 184 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------------ 184 (288)
...++..|+||| ||||||+++|||++|..||.......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 234567899998 99999999999999999985432100
Q ss_pred -------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||..||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=209.87 Aligned_cols=193 Identities=19% Similarity=0.284 Sum_probs=149.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH---- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~---- 73 (288)
++|.-.++||+|.||+||+++.+ ....++|+-+++.++|.|||+++++....+.+.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35667789999999999999753 356899999999999999999999865543221
Q ss_pred ---------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 74 ---------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 74 ---------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
...-.+.++...+..++.|+++||.++| ++++.||||||.|+||+.+|.+|++|||+++.+.......
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 1122345788889999999999999999 9999999999999999999999999999999776544333
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHh-CCCCCCCCCccc---------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLT-GAKPIRFTTFEE--------------------------- 184 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~ellt-g~~P~~~~~~~~--------------------------- 184 (288)
.. -+-|.+|.+|. |+||-||++.|+.. |++-|.+....+
T Consensus 159 sa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred ec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 22 24577888887 99999999999986 554454322111
Q ss_pred ----------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ----------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ----------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..-++++++.+.-+|.+|-++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 012345677888888888888888876654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=232.56 Aligned_cols=207 Identities=24% Similarity=0.372 Sum_probs=158.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhc--CCCCceeeecceEecc-----ccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQ--INHINVVKLIGCCLET-----KYM---- 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~-----~~l---- 72 (288)
.+..++.+.||+|.||.||||... .+.|..|-+|... ++|+||++++++-... +|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 456778899999999999999753 5678888888664 6899999998763221 221
Q ss_pred --c-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 --H-----DQNKELPFTWEMQLRISIEASGTMSYLHLS------ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 --~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
. .......++|....+|+..+++||+|||.. ++.+|+|||||++|||+.+++++.|+|||+|..+..
T Consensus 289 fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred eccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 1 122334689999999999999999999943 456899999999999999999999999999987653
Q ss_pred CCce-eeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCC-------CCcc-----------
Q 044995 140 DQTH-ITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRF-------TTFE----------- 183 (288)
Q Consensus 140 ~~~~-~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~-------~~~~----------- 183 (288)
.... ....-+||..||||| ||||+|.+||||++.-.-+.. ..+.
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 3222 122357999999999 999999999999985322210 0000
Q ss_pred --------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 184 --------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 184 --------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
.....-+.+.+..||..|++.|.|+.=+.+++..+.....
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0114467888999999999999999999999888766543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=251.06 Aligned_cols=205 Identities=25% Similarity=0.437 Sum_probs=165.6
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEc--------------------------cHHHHHHHHHHHhcCC-CCceeeecc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMA--------------------------KVEKFINEVVIQSQIN-HINVVKLIG 64 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------------------~~~~~~~E~~~l~~l~-HpnIv~l~~ 64 (288)
.++...++..+.+.||+|.||.|++|.. ..+.+..|+++|+.+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 4556666677788999999999999862 1467999999999985 999999999
Q ss_pred eEeccccc----------------cccC-----------CC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCC
Q 044995 65 CCLETKYM----------------HDQN-----------KE--LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKS 115 (288)
Q Consensus 65 ~~~~~~~l----------------~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp 115 (288)
+|.....+ .... .. ..+.....+.++.||+.||+||+ +.+++||||-.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 98774221 1000 01 13888899999999999999999 88899999999
Q ss_pred CCeeecCCCceEEecccCccccCCCCceeeeccccC--CCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC
Q 044995 116 TNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT--FGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT 181 (288)
Q Consensus 116 ~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt--~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~ 181 (288)
+|||+..+..+||+|||+++..............|+ ..||||| |||||||+|||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999996655444443323333 3499999 99999999999998 888987522
Q ss_pred ----------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 182 ----------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 182 ----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
.+..+..++.++|+.||+.+|++||++.++.+.++.+.
T Consensus 527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 23445788999999999999999999999999998853
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=228.47 Aligned_cols=185 Identities=23% Similarity=0.298 Sum_probs=143.4
Q ss_pred eeeeeCCeeEEEeEcc---------------------HHHHHHHHHH---HhcCCCCceeeecceEeccc-------ccc
Q 044995 25 ILGQGGQDIVYKGMAK---------------------VEKFINEVVI---QSQINHINVVKLIGCCLETK-------YMH 73 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~---l~~l~HpnIv~l~~~~~~~~-------~l~ 73 (288)
.||+|+||.||++.+. ...+.+|..+ +...+||||+.+++++...+ |+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999988652 1223445443 33457999999988776543 221
Q ss_pred c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 74 D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 74 ~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
. ......+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cC
Confidence 1 112345889999999999999999999 88899999999999999999999999999865432211 22
Q ss_pred cccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhc
Q 044995 148 VHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 148 ~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl 198 (288)
..|+..|+||| |||||||++|+|++|..||.... .+...+.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence 35899999999 99999999999999999995322 12234678899999999
Q ss_pred CCCCCCCC-----CHHHHHHHH
Q 044995 199 NPSGKKRP-----AMKEVASEL 215 (288)
Q Consensus 199 ~~~p~~Rp-----~~~~i~~~l 215 (288)
+.||++|| ++.+++++.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999 588888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=231.51 Aligned_cols=193 Identities=16% Similarity=0.203 Sum_probs=147.4
Q ss_pred cccCceeeeeCCeeEEEeEc------------------cHHHHHHHHHHHhcCCCCceeeecceEecccccccc------
Q 044995 20 FNVNRILGQGGQDIVYKGMA------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
|.+.+.+|.|+++.||++.. ..+.+.+|++++++++|+||+++++++...+.+...
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34555666667777776543 135789999999999999999999987765432211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc----
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT---- 142 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~---- 142 (288)
.....+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 11234678888999999999999999 88999999999999999999999999998764422111
Q ss_pred --eeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------
Q 044995 143 --HITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------ 183 (288)
Q Consensus 143 --~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~~------------------------ 183 (288)
.......++..|+||| |||||||++|||++|..||......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1112234677899998 9999999999999999998532110
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++||++.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 01135678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=226.02 Aligned_cols=187 Identities=28% Similarity=0.342 Sum_probs=147.6
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cccc--
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHDQ-- 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~~-- 75 (288)
||+|+||.||++.+. .+.+.+|++++++++||||+++++.+..... +...
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999998752 3467889999999999999999987655432 2110
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-------ee
Q 044995 76 ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-------HI 144 (288)
Q Consensus 76 ----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-------~~ 144 (288)
.....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 11235788899999999999999999 88999999999999999999999999999875432211 12
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchh--HHHHHHHHHHh
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDK--NITVAKHAKRC 197 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~--~~~~~~li~~c 197 (288)
.....++..|++|| ||||||+++|+|++|..||..... +... +..+.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 22345788899998 999999999999999999853321 1122 67899999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l 215 (288)
|+.+|++||++.++.+.|
T Consensus 238 l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred hcCCHhhcCCCccHHHHh
Confidence 999999999995544444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=245.98 Aligned_cols=197 Identities=25% Similarity=0.426 Sum_probs=160.5
Q ss_pred ccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc------c
Q 044995 21 NVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK------Y 71 (288)
Q Consensus 21 ~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 71 (288)
+..++||+|+||+||+|.+ +.++|+.|+-+|.+|+|||+++++++|.... +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 3457899999999999975 1568999999999999999999999997653 2
Q ss_pred cc-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 72 MH-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 72 l~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
+. .......+.....+.|..||++||.||| .++++||||-.+|+|+.+...+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 21 1223446778889999999999999999 9999999999999999999999999999999876554433
Q ss_pred eec-cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 145 TTQ-VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 145 ~~~-~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
... ..-.+.|||-| |||||||++||++| |..||.+... +..++.++..++.+
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVK 935 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHH
Confidence 322 11234566665 99999999999998 8999865432 34567889999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhchh
Q 044995 197 CLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
||..|++.||+|+++.+.+.++.+
T Consensus 936 Cwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HhccCcccCccHHHHHHHHHHHhc
Confidence 999999999999999998877644
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=224.50 Aligned_cols=198 Identities=22% Similarity=0.246 Sum_probs=151.8
Q ss_pred eHHHHHHhcCCcccCcee--eeeCCeeEEEeEcc------------HHHH-HHHHHHHhcC-CCCceeeecceEecccc-
Q 044995 9 ISNELEKATDSFNVNRIL--GQGGQDIVYKGMAK------------VEKF-INEVVIQSQI-NHINVVKLIGCCLETKY- 71 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~------------~~~~-~~E~~~l~~l-~HpnIv~l~~~~~~~~~- 71 (288)
...++....++|++.+.+ |+|+||.||++..+ .+.+ ..|+.....+ +||||+++++.+...+.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 345556667888888877 99999999998753 1111 1233333322 79999999998765432
Q ss_pred ------ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccC
Q 044995 72 ------MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRA 138 (288)
Q Consensus 72 ------l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~ 138 (288)
+.. ......+++..+..++.|++.||.||| +.+++||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 211 112237899999999999999999999 88899999999999999888 99999999987543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~ 189 (288)
... ...++..|+||| ||||||+++|||++|..||..... ....+..
T Consensus 162 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 162 TPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred CCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 221 235788999999 999999999999999999963321 1124678
Q ss_pred HHHHHHHhcCCCCCCCCC-HHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPA-MKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~-~~~i~~~ 214 (288)
+.+++.+||+.||.+||+ +++++++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcC
Confidence 899999999999999996 6888754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=220.60 Aligned_cols=181 Identities=32% Similarity=0.344 Sum_probs=146.8
Q ss_pred eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---------
Q 044995 26 LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--------- 75 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--------- 75 (288)
||+|+||.||++.++ .+.+..|+.++++++|+||+++++.+....+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999998642 24688999999999999999999887655432211
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccC
Q 044995 76 ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 76 ----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
.....+++.....++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 11225788999999999999999999 8899999999999999999999999999987653321 112334578
Q ss_pred CCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHhcCCCCCCCC
Q 044995 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRCLNPSGKKRP 206 (288)
Q Consensus 152 ~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~cl~~~p~~Rp 206 (288)
..|++|| |+||||+++|++++|..||.... .+...+..+.+++.+||..||++||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 8899998 99999999999999999996443 2333467899999999999999999
Q ss_pred CHHH
Q 044995 207 AMKE 210 (288)
Q Consensus 207 ~~~~ 210 (288)
++.+
T Consensus 237 ~~~~ 240 (250)
T cd05123 237 GSGG 240 (250)
T ss_pred Cccc
Confidence 9943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=223.62 Aligned_cols=184 Identities=22% Similarity=0.286 Sum_probs=143.7
Q ss_pred eeeeeCCeeEEEeEcc---------------------HHHHHHHHH---HHhcCCCCceeeecceEeccccc-------c
Q 044995 25 ILGQGGQDIVYKGMAK---------------------VEKFINEVV---IQSQINHINVVKLIGCCLETKYM-------H 73 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~l-------~ 73 (288)
.||+|+||.||++.+. ...+..|.. +++...||||+++++++...+.+ .
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999988642 112344443 44556899999998876654322 1
Q ss_pred c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 74 D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 74 ~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cC
Confidence 1 112335889999999999999999999 88999999999999999999999999999875432211 23
Q ss_pred cccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhc
Q 044995 148 VHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 148 ~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl 198 (288)
..|+..|+||| ||||||+++|||++|..||.... .+...+.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 46899999999 99999999999999999996431 12234678999999999
Q ss_pred CCCCCCCC-----CHHHHHHH
Q 044995 199 NPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp-----~~~~i~~~ 214 (288)
..+|++|| ++.+++++
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhC
Confidence 99999999 88898864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=238.94 Aligned_cols=195 Identities=24% Similarity=0.242 Sum_probs=153.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEccH--------------HHHHHHHHHH-hcCCCCceeeecceEeccccccccCCCC-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAKV--------------EKFINEVVIQ-SQINHINVVKLIGCCLETKYMHDQNKEL- 79 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--------------~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~l~~~~~~~- 79 (288)
.+++|.+...+|.|+|+.|-.+.+.. ..-.+|+.++ ..-+||||+++.+.|.+....+...+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 47889999999999999999887641 1234566444 4447999999999988775544322111
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee-cCCCceEEecccCccccCCCCceeeec
Q 044995 80 -----------PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL-DDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 80 -----------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~-~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
+.....+..|+.+++.++.||| .++|+||||||+|||+ ++.+.++|+|||.++..... ..+
T Consensus 400 g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred ccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 1222566679999999999999 8999999999999999 68899999999999866543 112
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-------------ccchhHHHHHHHHHHhcCCCCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-------------FEEDKNITVAKHAKRCLNPSGK 203 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-------------~~~~~~~~~~~li~~cl~~~p~ 203 (288)
.+-|..|.||| ||||||++||+|++|+.||.... +....+...++|+.+||+.||.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChh
Confidence 24577899999 99999999999999999985332 2255688999999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 044995 204 KRPAMKEVASELAG 217 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~ 217 (288)
+|+++.++..+=..
T Consensus 553 ~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLGADEIGAHPWF 566 (612)
T ss_pred hCcChhhhccCcch
Confidence 99999999877543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=221.02 Aligned_cols=182 Identities=26% Similarity=0.261 Sum_probs=141.6
Q ss_pred ceeeeeCCeeEEEeEcc---------------------HHHHHHHHHH-HhcCCCCceeeecceEecccccccc------
Q 044995 24 RILGQGGQDIVYKGMAK---------------------VEKFINEVVI-QSQINHINVVKLIGCCLETKYMHDQ------ 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~l~~~------ 75 (288)
+.||+|+||.||+|.+. ...+..|..+ ...++|+||+++++++...+.++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999998652 1123444443 4556899999999988765432211
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 76 -------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 76 -------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
.....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++.... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 12235788899999999999999999 88999999999999999999999999999875332 1223
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHHHHHhcC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKHAKRCLN 199 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~li~~cl~ 199 (288)
.++..|++|| ||||||+++|+|++|..||..... ....+..+.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 5788899998 999999999999999999853321 11246789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 044995 200 PSGKKRPAMKEVAS 213 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~ 213 (288)
.||++||++.++.+
T Consensus 234 ~~p~~R~~~~~~~~ 247 (260)
T cd05611 234 MDPAKRLGANGYQE 247 (260)
T ss_pred CCHHHccCCCcHHH
Confidence 99999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=231.78 Aligned_cols=195 Identities=23% Similarity=0.271 Sum_probs=162.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
...+++.+..||-||||.|=+...+ .+....|-++|.+++.|.||++|--|.+.+|++.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4456777888999999999876532 4567789999999999999999887777776653
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
..+.+.+....+.-++..+.+|++||| .++||.|||||+|++++.+|.+||.|||+|+.+..
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 334456777778888999999999999 99999999999999999999999999999997654
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITVAKHA 194 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~~~li 194 (288)
...+.+.+||+.|.||| |.||||+++|||++|.+||++.+ ++........++|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 44567789999999999 99999999999999999997544 3334466788999
Q ss_pred HHhcCCCCCCCCC-----HHHHHHHH
Q 044995 195 KRCLNPSGKKRPA-----MKEVASEL 215 (288)
Q Consensus 195 ~~cl~~~p~~Rp~-----~~~i~~~l 215 (288)
++++..+|.+|.. +.||.+|.
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhh
Confidence 9999999999965 56666554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=211.60 Aligned_cols=194 Identities=19% Similarity=0.280 Sum_probs=155.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc---------------cHHHHHHHHHHHhcCC-CCceeeecceEeccc---------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA---------------KVEKFINEVVIQSQIN-HINVVKLIGCCLETK--------- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~---------------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--------- 70 (288)
..++|++.+++|+|.|++||.|.. +.+++.+|+.+|..|. ||||+++++...+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 468899999999999999999973 3678999999999997 999999999876642
Q ss_pred cccc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCCCCceeee
Q 044995 71 YMHD---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 71 ~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
++.. ..-...++...+..++.+++.||.|+| +.||+|||+||.|++|+.. -.++|+|+|+|...........
T Consensus 116 ~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV- 191 (338)
T KOG0668|consen 116 YVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV- 191 (338)
T ss_pred hhccccHHHHhhhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee-
Confidence 1111 111224666777889999999999999 9999999999999999854 6899999999987654443322
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------------
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------------ 184 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------------ 184 (288)
.+.+..|--|| |+|||||++..|+..+.||.......
T Consensus 192 -RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 192 -RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred -eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 24677788899 99999999999999999984222111
Q ss_pred ----------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ----------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ----------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
-.+++..+++.+.|..|..+|+|+.|...+
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 015788999999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=217.10 Aligned_cols=202 Identities=22% Similarity=0.303 Sum_probs=157.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..+.|.-..+||+|.||+||+++.+ ....++|+++|..|+|+|++.+++.|....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3456777889999999999998764 123568999999999999999999875431
Q ss_pred -----ccc-----------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 71 -----YMH-----------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 71 -----~l~-----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
|+. ..+....++...+.+++.++..||.|+| ...|+|||+|++|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 110 1223346888999999999999999999 888999999999999999999999999999
Q ss_pred cccCCCCcee---eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc---------------
Q 044995 135 RSRAVDQTHI---TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE--------------- 184 (288)
Q Consensus 135 ~~~~~~~~~~---~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~--------------- 184 (288)
+.+....... -+..+-|.+|.+|| |||.-||++.||.|+.+-+.+.+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7554322211 12234588999999 99999999999999987764322100
Q ss_pred ----------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 185 ----------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 185 ----------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
....+..+++.++|..||.+|+++++++.+.-....
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 013477899999999999999999999988755443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=243.66 Aligned_cols=128 Identities=20% Similarity=0.232 Sum_probs=101.4
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCCCCceeeeccccCCCCCChh----
Q 044995 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158 (288)
Q Consensus 84 ~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE---- 158 (288)
..+..++.|++.||.||| +++|+||||||+|||++. ++.+||+|||+++..............+++.|+|||
T Consensus 255 ~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 255 KIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhc
Confidence 345578999999999999 889999999999999985 589999999999865444333444567899999999
Q ss_pred -----------------------------hHHHHHHHHHHHHhCCCCCCCCC-----------c---------cc-----
Q 044995 159 -----------------------------DVCSFGVVLVELLTGAKPIRFTT-----------F---------EE----- 184 (288)
Q Consensus 159 -----------------------------DiwSlG~il~elltg~~P~~~~~-----------~---------~~----- 184 (288)
|||||||++|||+++..++.... . ..
T Consensus 332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred cCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 99999999999999876643110 0 00
Q ss_pred ---------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ---------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ---------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.......+|+.+||+.||++|||+.+++++
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 001123479999999999999999999987
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.56 Aligned_cols=195 Identities=26% Similarity=0.367 Sum_probs=158.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecce-------Ee
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGC-------CL 67 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~-------~~ 67 (288)
-.++|+.+++||+|.||.|-+++.+ ...-+.|-++|+..+||.+..+.-. |.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3578899999999999999988754 3345678899999999999877543 33
Q ss_pred cccc------ccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 68 ETKY------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 68 ~~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.++| ....+....+++....-+...|..||.||| +++|+.||||.+|+|+|.+|.+||.|||+++.- ...
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKY 321 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc-ccc
Confidence 3333 333444557888888999999999999999 899999999999999999999999999999853 223
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC--------------CccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT--------------TFEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~--------------~~~~~~~~~~~~li~~ 196 (288)
.....+.+||+.|+||| |.|.+|+++|||+.|+.||... .++...+.+...|+..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence 34456689999999999 9999999999999999999643 3555668899999999
Q ss_pred hcCCCCCCCCC-----HHHHHHH
Q 044995 197 CLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+|..||.+|.. +.||.++
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhh
Confidence 99999999943 5565543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=216.07 Aligned_cols=208 Identities=21% Similarity=0.308 Sum_probs=167.6
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecce
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGC 65 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~ 65 (288)
.+++.....++++...+-+|.||.||.|.+. ...|+.|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4567778888999999999999999999652 4567888888999999999999998
Q ss_pred Eeccc-----------------ccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC
Q 044995 66 CLETK-----------------YMH-----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK 123 (288)
Q Consensus 66 ~~~~~-----------------~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~ 123 (288)
+.+.. |+. .......+.-.+...++.|++.|++||| .++|||.||..+|++|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence 76531 111 1112234566677889999999999999 9999999999999999999
Q ss_pred CceEEecccCccccCCCCceeeec-cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC----------
Q 044995 124 YCAKVSNFGTSRSRAVDQTHITTQ-VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT---------- 180 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~~~~~~-~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~---------- 180 (288)
-.+||+|=.+++.+.......... -.....||++| ||||||+++|||+| |+.||-..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 999999999999776544433211 12345799999 99999999999998 88897422
Q ss_pred -----CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 181 -----TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 181 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.-+-.++.++..+|..||..+|++||+++++..-|.++..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2344678999999999999999999999999999987754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=244.23 Aligned_cols=202 Identities=24% Similarity=0.288 Sum_probs=167.8
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
..++....+||.++++||+|+||.|..++++ ..-|..|-.+|..-+.+-||.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567778899999999999999999998863 2347788889999899999999877777
Q ss_pred cccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 69 TKYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 69 ~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.+|++..+ ....+++..+.-++..|..||..|| +.|+|||||||+|||+|..|.+||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 66655322 2335889999999999999999999 8899999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCC----------------Ccc
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFT----------------TFE 183 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~----------------~~~ 183 (288)
.+..+..-.....+|||.|++|| |.||+||++|||+.|..||... .+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 66655555556678999999999 9999999999999999999532 233
Q ss_pred --chhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH
Q 044995 184 --EDKNITVAKHAKRCLNPSGKKRPA---MKEVASEL 215 (288)
Q Consensus 184 --~~~~~~~~~li~~cl~~~p~~Rp~---~~~i~~~l 215 (288)
.+.+.+..+||.+.+. +|+.|.. +.++..|.
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 3468899999998775 5788877 88887763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=240.36 Aligned_cols=116 Identities=24% Similarity=0.283 Sum_probs=97.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.++||+|+||.||+|.+. .+.+.+|+.+++.++||||+++++++....+++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999753 25688899999999999999999876554332211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
. ....+++..++.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 1 1234678889999999999999999 8899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=213.50 Aligned_cols=188 Identities=22% Similarity=0.316 Sum_probs=150.2
Q ss_pred ceeeeeCCeeEEEeEc------------------cHHHHHHHHHHHhcCC-CCceeeecceEecccccccc---------
Q 044995 24 RILGQGGQDIVYKGMA------------------KVEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQ--------- 75 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~------------------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~--------- 75 (288)
+.||+|+|+.|-.+.. .+.+..+|++++.+.+ |+||++|+++|.+...++..
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6799999999977642 2678899999999985 99999999999877544321
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecccCccccCCCCce-----
Q 044995 76 ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTH----- 143 (288)
Q Consensus 76 ----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~----- 143 (288)
.+...+++.++.++..+|+.||.||| .++|.||||||+|||..+. .-+||+||.+...+......
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 22335889999999999999999999 9999999999999999543 36899999887643322211
Q ss_pred -eeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCC-------------------------
Q 044995 144 -ITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTT------------------------- 181 (288)
Q Consensus 144 -~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~------------------------- 181 (288)
...+.+|+..||||| |.||||+|+|-|++|.+||.+.-
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 112356888999999 99999999999999999994321
Q ss_pred ----ccc----hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 182 ----FEE----DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 182 ----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++ ..+.+..+++..++..|+.+|.++.+++.+
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111 126788999999999999999999998874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=230.47 Aligned_cols=187 Identities=24% Similarity=0.309 Sum_probs=153.4
Q ss_pred CceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc---------
Q 044995 23 NRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH--------- 73 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~--------- 73 (288)
.+.||+|-||+||-|+++ .+.+.+|+.||+++.||.||.+.-.|...+.++
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999988753 456789999999999999999987766554322
Q ss_pred -----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecccCccccCCCCceee
Q 044995 74 -----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 74 -----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
...+.+.+++....-++.||+.||.||| .++|+|+||||+|||+.+. -.+||||||+|+.+.... -.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 1334556788877888899999999999 8999999999999999543 479999999999875432 23
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc----------------hhHHHHHHHHHHhc
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE----------------DKNITVAKHAKRCL 198 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~----------------~~~~~~~~li~~cl 198 (288)
..++||+.|+||| |+||.|+|+|--++|..||...+... +.+.+..++|..+|
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 4578999999999 99999999999999999996443222 33678899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+..-.+|-+....+.+
T Consensus 804 qVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHhcchHhhccc
Confidence 9999999998887765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=225.47 Aligned_cols=132 Identities=17% Similarity=0.184 Sum_probs=102.9
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh--
Q 044995 81 FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-- 158 (288)
Q Consensus 81 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-- 158 (288)
+++..+..++.|++.+|.||| ..+|+||||||+|||++.++.+||+|||++...............+++.|++||
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 456778889999999999999 888999999999999999999999999998754322221111223477888888
Q ss_pred -------------------------------hHHHHHHHHHHHHhCCC-CCCCCC-------------------------
Q 044995 159 -------------------------------DVCSFGVVLVELLTGAK-PIRFTT------------------------- 181 (288)
Q Consensus 159 -------------------------------DiwSlG~il~elltg~~-P~~~~~------------------------- 181 (288)
||||+||++|+|++|.. ||....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 99999999999999875 553110
Q ss_pred --ccchhHHHHHHHHHHhcCCCC---CCCCCHHHHHHHH
Q 044995 182 --FEEDKNITVAKHAKRCLNPSG---KKRPAMKEVASEL 215 (288)
Q Consensus 182 --~~~~~~~~~~~li~~cl~~~p---~~Rp~~~~i~~~l 215 (288)
..+..+....+++.++|..+| .+|+|+.|+++|-
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 011235678899999999766 6899999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=207.27 Aligned_cols=173 Identities=23% Similarity=0.177 Sum_probs=135.7
Q ss_pred eCCeeEEEeEcc-------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cccc------CCCCCCC
Q 044995 29 GGQDIVYKGMAK-------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHDQ------NKELPFT 82 (288)
Q Consensus 29 G~~g~Vy~~~~~-------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~~------~~~~~l~ 82 (288)
|.||.||++.++ ...+.+|...+....||||+++++++.+.+. +... .....++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 789999998763 2345667777777789999999998765433 2211 1223578
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh----
Q 044995 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158 (288)
Q Consensus 83 ~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE---- 158 (288)
+.....++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+....... ....++..|++||
T Consensus 84 ~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 84 EECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGI 156 (237)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCC
Confidence 8899999999999999999 8899999999999999999999999999876543211 1223566799998
Q ss_pred -------hHHHHHHHHHHHHhCCCCCCCCC----------ccchhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 159 -------DVCSFGVVLVELLTGAKPIRFTT----------FEEDKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 159 -------DiwSlG~il~elltg~~P~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
||||+|+++|||++|..|+.... .+...+..+.+++.+||+.||++|+++
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999999999999998764221 233456789999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=214.23 Aligned_cols=199 Identities=22% Similarity=0.361 Sum_probs=152.9
Q ss_pred eHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCC--C----ceeeecce
Q 044995 9 ISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINH--I----NVVKLIGC 65 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~H--p----nIv~l~~~ 65 (288)
.++.....+++|.++..+|+|.||.|.++.+. .+..+-|+++|+++.+ | -+|++.++
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 34444455899999999999999999998763 3556678999999842 2 25666444
Q ss_pred -------Eecccccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---------
Q 044995 66 -------CLETKYMH-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD--------- 122 (288)
Q Consensus 66 -------~~~~~~l~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~--------- 122 (288)
|...+.+. ..+...+++...+..|+.|++.++.||| +..++|-||||+|||+.+
T Consensus 160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEecc
Confidence 33333221 2345568999999999999999999999 999999999999999821
Q ss_pred -----------CCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC
Q 044995 123 -----------KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT 180 (288)
Q Consensus 123 -----------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~ 180 (288)
+-.+||+|||.|+...... ..++.|..|.||| ||||+||||+||.||..-|..-
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2257999999998543322 4567899999999 9999999999999998877421
Q ss_pred Ccc------------------------------------------------------------chhHHHHHHHHHHhcCC
Q 044995 181 TFE------------------------------------------------------------EDKNITVAKHAKRCLNP 200 (288)
Q Consensus 181 ~~~------------------------------------------------------------~~~~~~~~~li~~cl~~ 200 (288)
+.. +....++.+|+.++|..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 100 01145789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044995 201 SGKKRPAMKEVASE 214 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~ 214 (288)
||.+|+|+.|++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=203.97 Aligned_cols=195 Identities=23% Similarity=0.301 Sum_probs=151.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc--------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 69 (288)
.+.+-.+-||-|+||+||..++. .+++.+|+++|..++|.|++..++.....
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34455688999999999987752 46788999999999999999988764321
Q ss_pred ----cccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 70 ----KYMH-----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 ----~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.+. .......++.+.+.-++.||++||+||| +.+|+||||||.|+|++++..+||+|||+++.....
T Consensus 133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 2221 1223456788888889999999999999 889999999999999999999999999999876554
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF-------------------------- 182 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~-------------------------- 182 (288)
.....+.-+-|..|.||| ||||.||++.||+..+.-|.....
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 444444445678899999 999999999999987766632110
Q ss_pred ----------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 ----------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 ----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.....+...+...++..||+.|.+..+.+.++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 112234566778889999999999988887765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=226.07 Aligned_cols=202 Identities=24% Similarity=0.337 Sum_probs=163.8
Q ss_pred eHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEecc-
Q 044995 9 ISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCLET- 69 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 69 (288)
.++.+...++.|++.+.||.|.+|.||+++.+ .++...|.++++.+ .|||++.++|++.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34555677888999999999999999999753 46677888888877 699999999986432
Q ss_pred -----------cccc--------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 70 -----------KYMH--------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 70 -----------~~l~--------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
||.. .......+.|..+..|++.++.|+.+|| .+.++|||+|-.|||++.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence 2211 1122456788999999999999999999 88899999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc------------
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF------------ 182 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~------------ 182 (288)
||++..++.... ...+..||+.||||| |+||||++..||..|.+|+-....
T Consensus 167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 999987654332 334567999999999 999999999999999999742221
Q ss_pred -----cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -----EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+..-+.++.++|..||..|-.+||+..+++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 12236789999999999999999999888764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=195.25 Aligned_cols=166 Identities=22% Similarity=0.315 Sum_probs=129.4
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhc-CCCCceeeecceEecc-
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQ-INHINVVKLIGCCLET- 69 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~- 69 (288)
+.++...++..-...||+|+||.|-+-++. .++.++|+.+..+ ..+|.+|.++|.+...
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 346667778888899999999998665431 4567888887555 4799999999974332
Q ss_pred ------ccc---------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 70 ------KYM---------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 70 ------~~l---------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
+.| ........+++...-+|+..+..||.|||+ ...|||||+||+||||+.+|.+|+||||++
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 111 112344567888888999999999999994 347999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCC
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFT 180 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~ 180 (288)
..+..... .+--.|...||||| ||||||+++.||++++.||...
T Consensus 197 G~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 197 GYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 76543222 12235888999999 9999999999999999998643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=207.64 Aligned_cols=190 Identities=24% Similarity=0.285 Sum_probs=147.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEccHHH---------------------HHHHHHHHhcC-CCCceeeecceEec---
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAKVEK---------------------FINEVVIQSQI-NHINVVKLIGCCLE--- 68 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---------------------~~~E~~~l~~l-~HpnIv~l~~~~~~--- 68 (288)
.+-..+|..+.+||+|+||.|.++..+-.+ -+.|-++|.-. +-|.++++..+|..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345568999999999999999998754221 22344444433 35666766555433
Q ss_pred ----------cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 69 ----------TKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 69 ----------~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.|+...+.+.+.+..+.-++..|+-||-+|| +++||.||||.+||+++.+|.+||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 344444455566788889999999999999999 9999999999999999999999999999998533
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKH 193 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~l 193 (288)
. ....+.+.+||+.|+||| |.||||++||||+.|++||++... +...+.+..++
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 2 233445689999999999 999999999999999999986543 33447788889
Q ss_pred HHHhcCCCCCCCCC
Q 044995 194 AKRCLNPSGKKRPA 207 (288)
Q Consensus 194 i~~cl~~~p~~Rp~ 207 (288)
....|...|.+|..
T Consensus 581 ckg~ltK~P~kRLG 594 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHhhcCCccccC
Confidence 99999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=197.17 Aligned_cols=168 Identities=28% Similarity=0.379 Sum_probs=136.2
Q ss_pred HHHHHHHHHHHhcCCCCceeeecceEecccc-------ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 044995 41 VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107 (288)
Q Consensus 41 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 107 (288)
.+.+.+|++.+++++|+||+++++++..... ... ......+++.....++.+++.++.||| ..+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~ 107 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLH---SNG 107 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HcC
Confidence 4788999999999999999999998765422 111 001112688889999999999999999 889
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCC
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P 176 (288)
++|+||+|.||+++.++.++|+|||.+....... ......++..|++|| ||||||+++|++++|..|
T Consensus 108 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 185 (244)
T smart00220 108 IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPP 185 (244)
T ss_pred eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 222345788899998 999999999999999999
Q ss_pred CCCCCcc---------------ch---hHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 044995 177 IRFTTFE---------------ED---KNITVAKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 177 ~~~~~~~---------------~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
|...... .. .+.++.+++.+||..+|++||++.++++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 186 FPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 8651110 01 5678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=218.60 Aligned_cols=156 Identities=23% Similarity=0.353 Sum_probs=133.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEccH------------HH--------------HHHHHHHHhcCC---CCceeeecceEe
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAKV------------EK--------------FINEVVIQSQIN---HINVVKLIGCCL 67 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~~------------~~--------------~~~E~~~l~~l~---HpnIv~l~~~~~ 67 (288)
..+|..++.+|+|+||.|+.+.++. ++ .-.|++||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4568999999999999999998751 22 236999999998 999999999999
Q ss_pred ccccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 68 ETKYMHDQNK--------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 68 ~~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
+.+|++...+ ...+++.++..|+.|++.|+++|| +.+|+|||||-+|+.++.+|.+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 9988764322 124788899999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCC
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIR 178 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~ 178 (288)
+..... ..-...+||..|.||| |||++|++||.++..+.||.
T Consensus 717 aa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 865432 2223467999999999 99999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=224.03 Aligned_cols=190 Identities=25% Similarity=0.410 Sum_probs=141.8
Q ss_pred cCceeeeeCCe-eEEEeEcc-------------HHHHHHHHHHHhcC-CCCceeeecceEecccccc-------------
Q 044995 22 VNRILGQGGQD-IVYKGMAK-------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMH------------- 73 (288)
Q Consensus 22 ~~~~lG~G~~g-~Vy~~~~~-------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~------------- 73 (288)
-.+.+|.|+-| .||+|... .+-..+||.+|+.- +|||||++++.-.+..|++
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dl 592 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDL 592 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHH
Confidence 34668888877 46888753 22346899999888 5999999988644444332
Q ss_pred --ccCCCCCC-CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---C--CceEEecccCccccCCCCcee-
Q 044995 74 --DQNKELPF-TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---K--YCAKVSNFGTSRSRAVDQTHI- 144 (288)
Q Consensus 74 --~~~~~~~l-~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~--~~~kl~DfG~a~~~~~~~~~~- 144 (288)
........ .-...+.++.|++.||++|| +.+|+||||||.||||.. + ..++|+|||+++.+.......
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 21011111 11335678899999999999 788999999999999964 3 478999999999876554332
Q ss_pred -eeccccCCCCCChh-----------hHHHHHHHHHHHHhC-CCCCCCCCc---------------cchhHHHHHHHHHH
Q 044995 145 -TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG-AKPIRFTTF---------------EEDKNITVAKHAKR 196 (288)
Q Consensus 145 -~~~~~gt~~y~aPE-----------DiwSlG~il~elltg-~~P~~~~~~---------------~~~~~~~~~~li~~ 196 (288)
.....||-+|+||| ||+|+||++|+.++| ..||...-. ......+..+||.+
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ 749 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKDLISR 749 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHHHHHH
Confidence 34567999999999 999999999999996 899853211 11112388999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
|++++|..||+|.+++.|
T Consensus 750 ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 750 MLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hcCCCcccCCCHHHHhCC
Confidence 999999999999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=208.34 Aligned_cols=188 Identities=22% Similarity=0.223 Sum_probs=142.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
....-|..++.||-|+||+|.++... ......|-.||..-+.+-||+|+-.|.+.+.++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34455777889999999999998631 234556888999999999999999888876555
Q ss_pred ccCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 DQNKE-------------LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
..++. +-|.+..+.-++.++..|+++.| ..|+|||||||+|||||.+|.+||.|||+++-+...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence 43332 34677788888899999999999 999999999999999999999999999998522100
Q ss_pred C--------c---------------------------------eeeeccccCCCCCChh-----------hHHHHHHHHH
Q 044995 141 Q--------T---------------------------------HITTQVHGTFGYLNPD-----------DVCSFGVVLV 168 (288)
Q Consensus 141 ~--------~---------------------------------~~~~~~~gt~~y~aPE-----------DiwSlG~il~ 168 (288)
. . ......+||+.|+||| |.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0 0011246999999999 9999999999
Q ss_pred HHHhCCCCCCCCCcc------------------chhHHHHHHHHHHhcCCCCCCCC
Q 044995 169 ELLTGAKPIRFTTFE------------------EDKNITVAKHAKRCLNPSGKKRP 206 (288)
Q Consensus 169 elltg~~P~~~~~~~------------------~~~~~~~~~li~~cl~~~p~~Rp 206 (288)
||+.|+.||-..+.. ...+.+..++|.+++. +++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999543321 2346677777766443 345553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=193.01 Aligned_cols=192 Identities=21% Similarity=0.289 Sum_probs=149.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM---- 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l---- 72 (288)
..+|.-+.-+|.|.- .|..+.+. .++..+|..++..++|+||++++.++.-.+.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777778888887 55555431 35678999999999999999999987654332
Q ss_pred ---------ccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 73 ---------HDQ---NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 73 ---------~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
... .....++-.....|+.|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.....
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 110 01123555667789999999999999 889999999999999999999999999999854332
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-------------------------- 183 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-------------------------- 183 (288)
...+..+.|..|.||| ||||+||++.||++|..-|.+...-
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 4556677899999999 9999999999999998776422100
Q ss_pred ------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.......++++.+||-.||++|-++++++.|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0113467889999999999999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=188.83 Aligned_cols=190 Identities=19% Similarity=0.297 Sum_probs=141.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceE-eccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCC-LETKYMHD-- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~-~~~~~l~~-- 74 (288)
..+.|.+.+.||+|-||.+-++.++ ..+|.+|..---.| .|.||+.-+++. ...+++..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578999999999999999999874 57888888754445 599999887652 22222211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec--CCCceEEecccCccccCCCCc
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD--DKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~DfG~a~~~~~~~~ 142 (288)
..+...+.+....+++.|+++|+.||| +++++|||||.+||||- +...+||||||..+.......
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 112234667778899999999999999 99999999999999993 346899999999875432211
Q ss_pred eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCccc----------------------
Q 044995 143 HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------------- 184 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~~~---------------------- 184 (288)
...-+..|.+|| |||.||+++|.++||..||......+
T Consensus 179 ----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 179 ----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred ----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 122345677887 99999999999999999996443222
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVA 212 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 212 (288)
..+..+..+.++-+.+++++|--..+..
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1256677888899999999994444443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=190.50 Aligned_cols=190 Identities=23% Similarity=0.337 Sum_probs=146.6
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEccH---------------------HHHHHHHHHHhc-CCCCceeeecceEecc--
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAKV---------------------EKFINEVVIQSQ-INHINVVKLIGCCLET-- 69 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---------------------~~~~~E~~~l~~-l~HpnIv~l~~~~~~~-- 69 (288)
....++|.++++||+|+|..|..++.+. +-...|-.+..+ -+||.+|.+..+|...
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 3567899999999999999999887531 112234444433 4799999998775432
Q ss_pred -----------ccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 -----------KYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 -----------~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.|........++++.+.-+...|+.||.||| +++||.||||.+|+|++..|.+||.|+|+.+.--
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 33333344456899999999999999999999 9999999999999999999999999999998532
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--c--------------------ch
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--E--------------------ED 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--~--------------------~~ 185 (288)
.....+.+.+||+.|.||| |.|+||++++||+.|+.||+-... + ..
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 2333456789999999999 999999999999999999963221 1 11
Q ss_pred hHHHHHHHHHHhcCCCCCCCCC
Q 044995 186 KNITVAKHAKRCLNPSGKKRPA 207 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~ 207 (288)
.+.....+++.-|+.||.+|..
T Consensus 482 lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcC
Confidence 2345566788889999999843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=210.20 Aligned_cols=195 Identities=25% Similarity=0.327 Sum_probs=156.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
...++|+++.++|.|.||.|||++++ ..-..+|+-+++..+|||||.|+|.+.-.+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 56789999999999999999999875 234567888899999999999998764332
Q ss_pred -ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 71 -YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 71 -~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
|.. ......++++.+....+.....||.||| +.+-+|||||-.|||+++.|.+|+.|||.+..+......
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 211 1122347888889999999999999999 889999999999999999999999999998765432222
Q ss_pred eeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCC-----------------C--ccchhHHHH
Q 044995 144 ITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFT-----------------T--FEEDKNITV 190 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~-----------------~--~~~~~~~~~ 190 (288)
.....||+.||||| |||++|++..|+..-+.|.... . ....-...+
T Consensus 169 -rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred -hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 12356999999999 9999999999998877774211 1 111236788
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
.++++.|+..+|++||++..++.
T Consensus 248 h~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee
Confidence 99999999999999999987765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=176.84 Aligned_cols=168 Identities=35% Similarity=0.560 Sum_probs=136.8
Q ss_pred eeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-------cccc-----
Q 044995 26 LGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-------YMHD----- 74 (288)
Q Consensus 26 lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------~l~~----- 74 (288)
||+|++|.||++... .+.+.+|++.++.++|++|+++++++.... +...
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999998752 256999999999999999999999876532 1110
Q ss_pred cCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCCCCceeeeccccC
Q 044995 75 QNKE--LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 75 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
.... ..+++.....++.+++.++.+|| ..+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 0011 25788889999999999999999 889999999999999998 89999999999875443221 11223466
Q ss_pred CCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 152 FGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 152 ~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..|++|| |+|++|+++++| ..+.+++..|++.||++||++.+++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 7788886 999999999999 689999999999999999999998865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=201.26 Aligned_cols=195 Identities=18% Similarity=0.215 Sum_probs=147.5
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC------CCceeeecceEeccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN------HINVVKLIGCCLETK 70 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~------HpnIv~l~~~~~~~~ 70 (288)
+..-++|.+....|+|=|+.|.+|.+. .+.=++|+++|++|+ --|+++|+-.|...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 344578888899999999999999764 234568999999985 356777766544443
Q ss_pred cccc---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCc
Q 044995 71 YMHD---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTS 134 (288)
Q Consensus 71 ~l~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a 134 (288)
.+.. ......|....+..++.|+..||..|- ..+|+|.||||+|||+++. ..+||||||.|
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 3322 223334666677789999999999999 7789999999999999755 67899999998
Q ss_pred cccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------------- 184 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------------- 184 (288)
.....+. .+...-+..|.||| |+||.||+||||.||+.-|++.+...
T Consensus 585 ~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 7544322 12334566799999 99999999999999998875432110
Q ss_pred -------------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHH
Q 044995 185 -------------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMK 209 (288)
Q Consensus 185 -------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~ 209 (288)
.....+.+|+.+|+..||++|-+..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0134688999999999999999999
Q ss_pred HHHHH
Q 044995 210 EVASE 214 (288)
Q Consensus 210 ~i~~~ 214 (288)
+.|+|
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 88875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=216.90 Aligned_cols=133 Identities=17% Similarity=0.185 Sum_probs=100.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-------------------CCceEEecccCccccCC
Q 044995 79 LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-------------------KYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 79 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-------------------~~~~kl~DfG~a~~~~~ 139 (288)
..+++..++.++.||+.||.||| +++|+||||||+|||++. ++.+|++|||+++....
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~ 151 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI 151 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence 45889999999999999999999 889999999999999954 34566667776653211
Q ss_pred CC---------------ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------cc
Q 044995 140 DQ---------------THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------FE 183 (288)
Q Consensus 140 ~~---------------~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------~~ 183 (288)
.. ........||+.||||| |||||||+||||++|..|+.... .+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~ 231 (793)
T PLN00181 152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLP 231 (793)
T ss_pred ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcC
Confidence 00 00011235788999999 99999999999999988864211 00
Q ss_pred c---hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 E---DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
. ........++.+||+.||.+||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 232 PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 0 123456788999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=171.79 Aligned_cols=124 Identities=21% Similarity=0.230 Sum_probs=103.2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh
Q 044995 79 LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158 (288)
Q Consensus 79 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE 158 (288)
..+++..+..++.|++.||.||| +.+ ||+|||++.++.+|+ ||+++...... ..|++.|||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE 74 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPE 74 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------CCCcccccChH
Confidence 46899999999999999999999 555 999999999999999 99987543221 25889999999
Q ss_pred -----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------chhHH--HHHHHHHHhcCCCCC
Q 044995 159 -----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------EDKNI--TVAKHAKRCLNPSGK 203 (288)
Q Consensus 159 -----------DiwSlG~il~elltg~~P~~~~~~~----------------------~~~~~--~~~~li~~cl~~~p~ 203 (288)
|||||||++|||++|+.||...... ..... ++.+++.+||+.||+
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~ 154 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ 154 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence 9999999999999999998532110 01122 589999999999999
Q ss_pred CCCCHHHHHHHHHhch
Q 044995 204 KRPAMKEVASELAGIK 219 (288)
Q Consensus 204 ~Rp~~~~i~~~l~~~~ 219 (288)
+||++.++++++..+.
T Consensus 155 ~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 155 RREAANHYLAHCRALF 170 (176)
T ss_pred cccCHHHHHHHHHHHH
Confidence 9999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=186.05 Aligned_cols=201 Identities=20% Similarity=0.300 Sum_probs=152.8
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcC-CCCceeeecceEecccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKY 71 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 71 (288)
.+....+.|.+.++||+|.|++||++++. ..+...|++.|..+ .+.||+++.+++...+.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34556678999999999999999998653 45788999999988 49999999988655432
Q ss_pred ccccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCC-
Q 044995 72 MHDQNK----------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAV- 139 (288)
Q Consensus 72 l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~- 139 (288)
...... ...++...+..++..+..||.++| .+|||||||||.|+|.+.. +.-.|.|||+|.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 211111 124678889999999999999999 9999999999999999754 6778999999851100
Q ss_pred ---------------C-----------------Cc----------eeeeccccCCCCCChh------------hHHHHHH
Q 044995 140 ---------------D-----------------QT----------HITTQVHGTFGYLNPD------------DVCSFGV 165 (288)
Q Consensus 140 ---------------~-----------------~~----------~~~~~~~gt~~y~aPE------------DiwSlG~ 165 (288)
. .. .......||++|.||| ||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 0001235999999999 9999999
Q ss_pred HHHHHHhCCCCCCCCC------------------------------------------------cc--------------
Q 044995 166 VLVELLTGAKPIRFTT------------------------------------------------FE-------------- 183 (288)
Q Consensus 166 il~elltg~~P~~~~~------------------------------------------------~~-------------- 183 (288)
|+.-++++..||.... ..
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 9999999999982110 00
Q ss_pred ----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ----EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+..+..+.+++.+|+..||.+|-++++.|++-
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00134678899999999999999999998763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=168.05 Aligned_cols=157 Identities=33% Similarity=0.470 Sum_probs=125.2
Q ss_pred cccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------- 73 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~------- 73 (288)
|++.+.||+|++|.||++... .+.+.+|++.+++++|+|++++++++.......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999998642 457888999999999999999999876543211
Q ss_pred c------cCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D------QNKELP-FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~------~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ...... +++.....++.+++.++.+|| ..+++|+||++.||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 1 001112 788889999999999999999 889999999999999999999999999998765433211112
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCC
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRF 179 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~ 179 (288)
...++..|++|| ||||||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234667788887 999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=179.89 Aligned_cols=101 Identities=23% Similarity=0.335 Sum_probs=82.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC--------CCceeeecceEecc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN--------HINVVKLIGCCLET--- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~--------HpnIv~l~~~~~~~--- 69 (288)
++|.+.++||-|-|++||++.+. .+..+.||++|++++ -.+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 78999999999999999998652 466788999999884 35699999987543
Q ss_pred --------cccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee
Q 044995 70 --------KYMH-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL 120 (288)
Q Consensus 70 --------~~l~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~ 120 (288)
+++- .......++...+..|+.|++.||.|||..+ +|||-||||+|||+
T Consensus 158 G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 2221 1234456888999999999999999999644 89999999999999
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=174.24 Aligned_cols=143 Identities=17% Similarity=0.118 Sum_probs=103.1
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceee-ecce-
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVK-LIGC- 65 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~-l~~~- 65 (288)
.+....++|++.+.||+|+||+||+|.++ .+.|.+|+++|++++|+||+. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~ 91 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATG 91 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcC
Confidence 34456788999999999999999998541 234889999999999999984 4432
Q ss_pred --EeccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCC-CCCCeeecCCCceEEecccCccccCCCCc
Q 044995 66 --CLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDI-KSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 66 --~~~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-kp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+...+|+....-.. ........++.+++.+|.||| +.+|+|||| ||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred CcEEEEEccCCCCHHH-hCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 22233332211000 000112567889999999999 889999999 99999999889999999999986543221
Q ss_pred ee-------eeccccCCCCCChh
Q 044995 143 HI-------TTQVHGTFGYLNPD 158 (288)
Q Consensus 143 ~~-------~~~~~gt~~y~aPE 158 (288)
.. .....+++.|++||
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcc
Confidence 11 12456788889988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=163.03 Aligned_cols=201 Identities=22% Similarity=0.293 Sum_probs=152.6
Q ss_pred CcccCceeeeeCCeeEEEeEccH-------------------HHHHHHHHHHhcCCC----CceeeecceEe-cccccc-
Q 044995 19 SFNVNRILGQGGQDIVYKGMAKV-------------------EKFINEVVIQSQINH----INVVKLIGCCL-ETKYMH- 73 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~~-------------------~~~~~E~~~l~~l~H----pnIv~l~~~~~-~~~~l~- 73 (288)
+|++.+.||+|+||.||.+.+.. ..+..|+.++..+.. .++..+++... ...|-.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999997521 157789999998873 57777777663 332211
Q ss_pred -------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-----CceEEecccCcc
Q 044995 74 -------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-----YCAKVSNFGTSR 135 (288)
Q Consensus 74 -------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-----~~~kl~DfG~a~ 135 (288)
.......++...+++++.|++.+|++|| +.+++||||||+|++++.. ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 1122356889999999999999999999 9999999999999999754 468999999998
Q ss_pred --ccCCCCc-----e-e-eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------
Q 044995 136 --SRAVDQT-----H-I-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------ 183 (288)
Q Consensus 136 --~~~~~~~-----~-~-~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------ 183 (288)
....... . . .....||..|.++. |+||++.++.|++.|..||......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 3211111 0 1 12345999999987 9999999999999999999543321
Q ss_pred -------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 184 -------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 184 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
...+.++.++...+-..+...+|....+...++......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 113456777777777789999999999998887766554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=159.98 Aligned_cols=192 Identities=19% Similarity=0.293 Sum_probs=147.2
Q ss_pred CcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD------ 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~------ 74 (288)
+..+.-+|.+...|+.|+|+++ ..+|..|.-.|+-+.||||+.+++.|.....+..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 3445567888899999999875 3468888888999999999999999976532211
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEe--cccCccccCCCCce
Q 044995 75 ---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS--NFGTSRSRAVDQTH 143 (288)
Q Consensus 75 ---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~--DfG~a~~~~~~~~~ 143 (288)
.......+-.++.+++.++++|+.|||+. +.-|..-.|.+..++||++.+.+|+ |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 11223456778999999999999999965 4455666789999999998877764 322221
Q ss_pred eeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITVAKH 193 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~~~l 193 (288)
......-.+.||+|| |+|||.+++|||.|.+.||.... .+...+..+.++
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 111122467899999 99999999999999999995322 344557789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+.-|++.||.+||.++.|+-.|+++.
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-21 Score=178.79 Aligned_cols=191 Identities=21% Similarity=0.290 Sum_probs=145.2
Q ss_pred ccCceeeeeCCeeEEEeEcc-------HHH-----------------HHHHHHHHhcCCCCceeeecceEec-------c
Q 044995 21 NVNRILGQGGQDIVYKGMAK-------VEK-----------------FINEVVIQSQINHINVVKLIGCCLE-------T 69 (288)
Q Consensus 21 ~~~~~lG~G~~g~Vy~~~~~-------~~~-----------------~~~E~~~l~~l~HpnIv~l~~~~~~-------~ 69 (288)
...+.+|.|++|.|+..... .+. +..|.-+-..|.|+|++..+..+.+ +
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999977765431 111 2334455567899999876654322 2
Q ss_pred cccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc--
Q 044995 70 KYMH-----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-- 142 (288)
Q Consensus 70 ~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-- 142 (288)
+|.. .......+....+..++.|+..|+.|+| ..+|.|||+|++|+++..+|.+||+|||.+........
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 3321 1222235778889999999999999999 89999999999999999999999999999875543332
Q ss_pred -eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------hh
Q 044995 143 -HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE-----------------------DK 186 (288)
Q Consensus 143 -~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~-----------------------~~ 186 (288)
......+|+-.|+||| ||||.|+++..|++|+.||......+ ..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 3345578999999999 99999999999999999995433221 22
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+..-+.+|.++|+.||.+|-|+.+|++.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhC
Confidence 5677888999999999999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-20 Score=158.72 Aligned_cols=131 Identities=21% Similarity=0.237 Sum_probs=99.6
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee--cCCC--ceEEecccCccccCC---CCcee--eeccccC
Q 044995 81 FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL--DDKY--CAKVSNFGTSRSRAV---DQTHI--TTQVHGT 151 (288)
Q Consensus 81 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~--~~~~--~~kl~DfG~a~~~~~---~~~~~--~~~~~gt 151 (288)
.+.....-|+.|+++|+.||| .++|.|||+|++|||+ ++++ .+.|+|||++-.-+. .-.+. .-..-|.
T Consensus 338 ~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN 414 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN 414 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence 455667778899999999999 9999999999999999 4444 568999998642111 00111 1112366
Q ss_pred CCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCC----------------CccchhHHHHHHHHHHhc
Q 044995 152 FGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNITVAKHAKRCL 198 (288)
Q Consensus 152 ~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~----------------~~~~~~~~~~~~li~~cl 198 (288)
-.-|||| |.|+.|.+.||+++...||... ..++.++..+.+++...|
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLL 494 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHh
Confidence 7789999 9999999999999999999541 234456788999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++|++.+-....
T Consensus 495 ~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANV 510 (598)
T ss_pred cCCccccCCccHHHhH
Confidence 9999999886544443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=142.98 Aligned_cols=155 Identities=15% Similarity=0.039 Sum_probs=112.4
Q ss_pred ccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCC-CCceeeecce---EeccccccccC
Q 044995 21 NVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQIN-HINVVKLIGC---CLETKYMHDQN 76 (288)
Q Consensus 21 ~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~-HpnIv~l~~~---~~~~~~l~~~~ 76 (288)
.+...|++|+||+||.+... ...|.+|+++|++|. |++|++++++ +...+|+.+..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~ 84 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAA 84 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCcc
Confidence 45688999999999976531 125789999999995 4667666654 66666665432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCC-CCCCeeecCCCceEEecccCccccCCCCce----e-------
Q 044995 77 KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDI-KSTNILLDDKYCAKVSNFGTSRSRAVDQTH----I------- 144 (288)
Q Consensus 77 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~------- 144 (288)
-...... ....++.++..+|.++| ..+|+|||| ||.|||++.++.++|+|||++......... .
T Consensus 85 L~~~~~~-~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 85 MYQRPPR-GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred HHhhhhh-hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 2111111 23457789999999999 889999999 799999999999999999999854322210 0
Q ss_pred -eeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCC
Q 044995 145 -TTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRF 179 (288)
Q Consensus 145 -~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~ 179 (288)
......++.|+.|+ +.++.|.-+|.++|+..+.-.
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00122577888887 667899999999999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-18 Score=148.69 Aligned_cols=192 Identities=31% Similarity=0.428 Sum_probs=150.2
Q ss_pred cccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCC-ceeeecceEecccc--c-----c
Q 044995 20 FNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHI-NVVKLIGCCLETKY--M-----H 73 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~--l-----~ 73 (288)
|.+.+.||.|+||.||++.+. ...|.+|+.++..+.|+ +|+++.+++..... + .
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 778899999999999998652 45689999999999988 79999988754431 1 0
Q ss_pred ------ccCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCCCce
Q 044995 74 ------DQNKE---LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 74 ------~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~ 143 (288)
..... ..+.......+..+++.++.|+| ..+++|||+||+||+++..+ .+++.|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 00111 25778889999999999999999 88899999999999999888 7999999998754433221
Q ss_pred -----eeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc---cc---------h-------
Q 044995 144 -----ITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF---EE---------D------- 185 (288)
Q Consensus 144 -----~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~---~~---------~------- 185 (288)
......|+..|++|| |+||+|++++++++|..||..... .. .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 234457888899887 999999999999999999765432 00 0
Q ss_pred h--------HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 K--------NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~--------~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
. ...+.+++.+|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 1467899999999999999887776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-18 Score=144.82 Aligned_cols=203 Identities=16% Similarity=0.203 Sum_probs=151.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEc----------------cHHHHHHHHHHHhcCC-CCceeeecceEecccccccc--
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMA----------------KVEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~----------------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~-- 75 (288)
+..-+|++.++||+|+||++|.|+. +..++..|.+..+.|. .++|..++-+-.++.+--..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4456799999999999999999974 2346777888888875 57787776554433221000
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-----CceEEecccCccccCC
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-----YCAKVSNFGTSRSRAV 139 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-----~~~kl~DfG~a~~~~~ 139 (288)
.-...|+...++.++.|++.-++|+| ++.+|.|||||+|.||+.. ..+-++|||+|+....
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 01125788999999999999999999 8899999999999999643 4688999999987654
Q ss_pred CCceee------eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc------------------
Q 044995 140 DQTHIT------TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------------ 184 (288)
Q Consensus 140 ~~~~~~------~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------------ 184 (288)
..+... ....||..||+-. |.=|||-++.+.|-|..||.+...+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 333222 2356999999864 99999999999999999996543221
Q ss_pred ----hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 185 ----DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 185 ----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
..+.++...+.-.-..+-.+-|+.+-+...+..+..
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 236677777777778888888997776666555543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=141.21 Aligned_cols=201 Identities=18% Similarity=0.215 Sum_probs=147.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEc----------------cHHHHHHHHHHHhcCCC-CceeeecceEeccccccccC-
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMA----------------KVEKFINEVVIQSQINH-INVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~----------------~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~l~~~~- 76 (288)
...+.|+++++||+|+||.+|.|.. +...+..|.++...|+| ..|..+..+..+..|-....
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4568899999999999999999864 23457789999988875 34444444444443321111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccCCCC
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~~~~ 141 (288)
-...++...++-++-|++.-++|+| .++.|||||||+|.|.+- ...+-++|||+|+..-...
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 1124677888999999999999999 888999999999999853 3467899999998653322
Q ss_pred cee------eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc--------------------
Q 044995 142 THI------TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE-------------------- 184 (288)
Q Consensus 142 ~~~------~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~-------------------- 184 (288)
+.. .....||..|.+-. |+=|+|.+|..+.-|..||.+.....
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 211 23356888887643 99999999999999999997543221
Q ss_pred --hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 185 --DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 185 --~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
..+.++.-.+.-|-..--++-|+..-+.+...-+
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 2266788888999988888999977666655443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-19 Score=168.92 Aligned_cols=194 Identities=16% Similarity=0.236 Sum_probs=138.7
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------HHHHH---HHHHHHhcCCCCceeeecceEecc-------cc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------VEKFI---NEVVIQSQINHINVVKLIGCCLET-------KY 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~---~E~~~l~~l~HpnIv~l~~~~~~~-------~~ 71 (288)
+|...+.||++.|=.|.+|++. .+.|. +|++ ....+|||++.+.-+-... .|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777899999999888887653 23343 4445 5566899999876542221 12
Q ss_pred ----cc-ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc--CCCCc--
Q 044995 72 ----MH-DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR--AVDQT-- 142 (288)
Q Consensus 72 ----l~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~--~~~~~-- 142 (288)
++ ......-+...+...|+.|++.||.-+| ..+|.|+|||.+||||+.-..+.|+||...+.. +.+..
T Consensus 103 vkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 103 VKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 12 2222333566778889999999999999 889999999999999999889999999876532 11111
Q ss_pred --eeeeccccCCCCCChh----------------------hHHHHHHHHHHHHh-CCCCCCCC---------C------c
Q 044995 143 --HITTQVHGTFGYLNPD----------------------DVCSFGVVLVELLT-GAKPIRFT---------T------F 182 (288)
Q Consensus 143 --~~~~~~~gt~~y~aPE----------------------DiwSlG~il~ellt-g~~P~~~~---------~------~ 182 (288)
+.-.+...-.+|+||| ||||+||++.||++ |++||... . .
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 1011112234688888 99999999999987 67787311 1 1
Q ss_pred cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
....+..++.++..|++.||++|-++++.++.-.
T Consensus 260 e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 260 EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1123557889999999999999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=141.26 Aligned_cols=115 Identities=22% Similarity=0.318 Sum_probs=82.0
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-----
Q 044995 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158 (288)
Q Consensus 84 ~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----- 158 (288)
...+.+..|+.+.+++|| ..+|+|+||+|+|++++.+|.+.|+||+....... .... ...+..|.+||
T Consensus 145 ~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~ 217 (288)
T PF14531_consen 145 AARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCA 217 (288)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhh
Confidence 344566789999999999 88999999999999999999999999987653321 1111 23446688887
Q ss_pred --------------hHHHHHHHHHHHHhCCCCCCCCCccc----------hhHHHHHHHHHHhcCCCCCCC
Q 044995 159 --------------DVCSFGVVLVELLTGAKPIRFTTFEE----------DKNITVAKHAKRCLNPSGKKR 205 (288)
Q Consensus 159 --------------DiwSlG~il~elltg~~P~~~~~~~~----------~~~~~~~~li~~cl~~~p~~R 205 (288)
|.|+||+++|.|.++..||....... +.+..+..||.++|+.||.+|
T Consensus 218 ~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 218 GQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999999999996433211 347889999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=165.92 Aligned_cols=178 Identities=24% Similarity=0.354 Sum_probs=125.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--HHHHHHHHHHHhcCCCCceeeecce-EeccccccccCCCCCCCHHHHHHHHHH
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--VEKFINEVVIQSQINHINVVKLIGC-CLETKYMHDQNKELPFTWEMQLRISIE 92 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~-~~~~~~l~~~~~~~~l~~~~~~~i~~~ 92 (288)
..++|..++.|..|+||.||..+++ +++|..-++ -+.|-=.||..+.+. +..++-........+++...
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdm------- 152 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDM------- 152 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccchhhhccccccCCcceechhhhhcccCCCCcchh-------
Confidence 4578999999999999999999887 666654111 001111223333221 11111111111222333222
Q ss_pred HHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC--------------CceeeeccccCCCCCChh
Q 044995 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD--------------QTHITTQVHGTFGYLNPD 158 (288)
Q Consensus 93 i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~--------------~~~~~~~~~gt~~y~aPE 158 (288)
+.+++||| +.+|+|||+||+|.+|..-|.+|+.|||+++..... .......++||+.|.|||
T Consensus 153 -vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 153 -VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred -hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 67899999 999999999999999999999999999998642110 111123468999999999
Q ss_pred -----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhcCCCCCCC
Q 044995 159 -----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCLNPSGKKR 205 (288)
Q Consensus 159 -----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl~~~p~~R 205 (288)
|.|++|+++||.+-|..||.+.+. .+..+.+.++++.++|+.+|..|
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 999999999999999999976532 22347799999999999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=157.58 Aligned_cols=176 Identities=24% Similarity=0.266 Sum_probs=136.4
Q ss_pred eeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCC-CCceeeecceEeccccc--------
Q 044995 25 ILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQIN-HINVVKLIGCCLETKYM-------- 72 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l-------- 72 (288)
.+|+|.||.|+.+.. .......|..++..++ ||.+|++...+....-+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368999999986531 0124556778888887 99999998776543221
Q ss_pred -----cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeec
Q 044995 73 -----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 73 -----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
....+...+.+.....+...++-+++++| +.+|+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 12223344666777778888999999999 889999999999999999999999999999864322221
Q ss_pred cccCCCCCChh---------hHHHHHHHHHHHHhCCCCCCC----------CCccchhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 148 VHGTFGYLNPD---------DVCSFGVVLVELLTGAKPIRF----------TTFEEDKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 148 ~~gt~~y~aPE---------DiwSlG~il~elltg~~P~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
+||..||||| |.||||++.+||+||..||.. ..++........+++..++..+|.+|.-.
T Consensus 154 -cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 154 -CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -ccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 7999999999 999999999999999999965 12344556677888889999999999554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=151.50 Aligned_cols=169 Identities=25% Similarity=0.464 Sum_probs=129.0
Q ss_pred HhcCCCCceeeecceEecccccc--------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EEeCCCC
Q 044995 51 QSQINHINVVKLIGCCLETKYMH--------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPI-YHRDIKS 115 (288)
Q Consensus 51 l~~l~HpnIv~l~~~~~~~~~l~--------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i-iHrdlkp 115 (288)
|+.+.|.|+.+++|.+.+...+. .......+++.-...+..+++.||.|+| ..+| .|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 46789999999999987763221 1223456788888899999999999999 5455 9999999
Q ss_pred CCeeecCCCceEEecccCccccCCC-CceeeeccccCCCCCChh------------------hHHHHHHHHHHHHhCCCC
Q 044995 116 TNILLDDKYCAKVSNFGTSRSRAVD-QTHITTQVHGTFGYLNPD------------------DVCSFGVVLVELLTGAKP 176 (288)
Q Consensus 116 ~Nil~~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE------------------DiwSlG~il~elltg~~P 176 (288)
.|++++..+.+||+|||+....... .........-...|.||| ||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765321 111111122345678887 999999999999999999
Q ss_pred CCCCCccc-------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 177 IRFTTFEE-------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 177 ~~~~~~~~-------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
|....... ....++..++..||..+|.+||++.++...++.+....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 85422111 22346888999999999999999999999888776643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-18 Score=152.83 Aligned_cols=123 Identities=28% Similarity=0.423 Sum_probs=90.3
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC-----ceeeeccccCCCCCCh
Q 044995 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-----THITTQVHGTFGYLNP 157 (288)
Q Consensus 83 ~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~gt~~y~aP 157 (288)
+...+.++.|++.+++| ++.+|+|+||.||+...+..+||.|||+........ ....+..+||..||+|
T Consensus 358 ~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred hhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCH
Confidence 34455677777777777 568999999999999888899999999987654333 2234557899999999
Q ss_pred h-----------hHHHHHHHHHHHHh-CCCCCCC---------CCcc---chhHHHHHHHHHHhcCCCCCCCCCHHHH
Q 044995 158 D-----------DVCSFGVVLVELLT-GAKPIRF---------TTFE---EDKNITVAKHAKRCLNPSGKKRPAMKEV 211 (288)
Q Consensus 158 E-----------DiwSlG~il~ellt-g~~P~~~---------~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i 211 (288)
| ||||||++|+||+. -...+.. ..++ ....++-..++.+++.+.|.+||++.+.
T Consensus 432 EQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 432 EQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 9 99999999999997 2222211 1111 0113455689999999999999955443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.2e-17 Score=132.29 Aligned_cols=113 Identities=16% Similarity=0.147 Sum_probs=86.0
Q ss_pred cCceeeeeCCeeEEEeEcc-------------------------------------------HHHHHHHHHHHhcCCCCc
Q 044995 22 VNRILGQGGQDIVYKGMAK-------------------------------------------VEKFINEVVIQSQINHIN 58 (288)
Q Consensus 22 ~~~~lG~G~~g~Vy~~~~~-------------------------------------------~~~~~~E~~~l~~l~Hpn 58 (288)
+.+.||+|+||.||+|.+. ...+.+|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999752 011357889999998888
Q ss_pred eeeecce-----Eecccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCce
Q 044995 59 VVKLIGC-----CLETKYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 59 Iv~l~~~-----~~~~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~ 126 (288)
|.....+ +..++++... .....++......++.+++.++.++| . .+|+||||||+|||++ ++.+
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCE
Confidence 7432221 3344444322 12235677888999999999999999 7 8999999999999998 7899
Q ss_pred EEecccCccccC
Q 044995 127 KVSNFGTSRSRA 138 (288)
Q Consensus 127 kl~DfG~a~~~~ 138 (288)
+|+|||+++...
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-17 Score=133.69 Aligned_cols=111 Identities=16% Similarity=0.232 Sum_probs=83.3
Q ss_pred CceeeeeCCeeEEEeEcc------------------H--------HHH-----------------HHHHHHHhcCCCCce
Q 044995 23 NRILGQGGQDIVYKGMAK------------------V--------EKF-----------------INEVVIQSQINHINV 59 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------~--------~~~-----------------~~E~~~l~~l~HpnI 59 (288)
...||+|+||.||+|.+. . .+| .+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 478999999999999742 0 122 239999999876554
Q ss_pred -----eeecceEecccccccc------CCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEEeCCCCCCeeecCCCceE
Q 044995 60 -----VKLIGCCLETKYMHDQ------NKELPFTWEMQLRISIEASGTMSYL-HLSASVPIYHRDIKSTNILLDDKYCAK 127 (288)
Q Consensus 60 -----v~l~~~~~~~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdlkp~Nil~~~~~~~k 127 (288)
+.....+..++|+... .....++...+..++.|++.+|.|+ | ..+|+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEE
Confidence 3222334445555421 2234678889999999999999999 7 77899999999999998 47899
Q ss_pred EecccCcccc
Q 044995 128 VSNFGTSRSR 137 (288)
Q Consensus 128 l~DfG~a~~~ 137 (288)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-17 Score=135.76 Aligned_cols=147 Identities=10% Similarity=0.128 Sum_probs=101.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------------HHH------HHHHHHHHhcCCCCceeeecceEecc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------------VEK------FINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~------~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
...++|++.+.||.|+||.||..... .+. |.+|++.+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45688999999999999999986541 112 67999999999999999988875533
Q ss_pred c---------------cccccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 70 K---------------YMHDQNK--ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 70 ~---------------~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+ |+.+..- ...++ .....+++.+|..+| ..+++|+|+||.||+++.+| ++|+|||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~----~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEIS----EDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhcc----HHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 2 2221100 00111 234568999999999 99999999999999999888 9999999
Q ss_pred CccccCCCCceeeeccccCCCCCChhhHHHHHHHHHHHH
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELL 171 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPEDiwSlG~il~ell 171 (288)
..+........ ....--..|--..||||||+++..+.
T Consensus 180 ~~~~~~e~~a~--d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK--DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH--HHHHHHhHhcccccccceeEeehHHH
Confidence 87654221111 00111112222239999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.4e-16 Score=127.26 Aligned_cols=110 Identities=14% Similarity=0.143 Sum_probs=79.7
Q ss_pred cccCceeeeeCCeeEEEeEc---------------cHHHHHHHHHHHhcC-----CCCceeeecceEeccc---ccc-cc
Q 044995 20 FNVNRILGQGGQDIVYKGMA---------------KVEKFINEVVIQSQI-----NHINVVKLIGCCLETK---YMH-DQ 75 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~---------------~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~l~-~~ 75 (288)
+.-.+.||+|+||.||.-.. ..+.+.+|+++++++ .||||++++|++.... ++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 34467899999999996321 145789999999999 6799999999987652 311 11
Q ss_pred CC-----C---------CCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEEeCCCCCCeeecC----CCceEEecccCc
Q 044995 76 NK-----E---------LPFTWEMQLRISIEASGTM-SYLHLSASVPIYHRDIKSTNILLDD----KYCAKVSNFGTS 134 (288)
Q Consensus 76 ~~-----~---------~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~iiHrdlkp~Nil~~~----~~~~kl~DfG~a 134 (288)
.+ . ..+++. ..++.+++.++ +||| +++|+||||||+|||++. ++.++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 11 1 122333 34567777777 9999 889999999999999963 347999995433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.6e-15 Score=138.23 Aligned_cols=117 Identities=15% Similarity=0.142 Sum_probs=87.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
....|...+.||+|+||.||+|.+. .+++.+|++++++++|+||+....++...+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445567899999999999996431 2457899999999999999876655544221
Q ss_pred ccccC---CCCCCCH--HHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 72 MHDQN---KELPFTW--EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 72 l~~~~---~~~~l~~--~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
..... ....+.. .....++.+++.+|.+|| +.+|+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 11111 1112221 235678899999999999 8899999999999999 577899999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-14 Score=117.99 Aligned_cols=109 Identities=20% Similarity=0.252 Sum_probs=80.6
Q ss_pred CceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------cc
Q 044995 23 NRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------KY 71 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------~~ 71 (288)
++.||+|++|.||+|... ..++.+|++++..+.|+||.....++... ++
T Consensus 1 ~~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred CcccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 367999999999999521 23577899999999999887655554322 22
Q ss_pred ccccCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 72 MHDQNKE---LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 72 l~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+....-. ..... ....++.+++.+|.++| ..+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 2111000 00111 45688999999999999 88999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.9e-14 Score=117.27 Aligned_cols=123 Identities=18% Similarity=0.104 Sum_probs=87.6
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------------------------HHHHHHHHHHHh
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------------------------VEKFINEVVIQS 52 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------------------------~~~~~~E~~~l~ 52 (288)
++......|.+.+.||+|+||.||++..+ ...+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445889999999999999998652 012567888888
Q ss_pred cCCCCc--eeeecce---EeccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceE
Q 044995 53 QINHIN--VVKLIGC---CLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAK 127 (288)
Q Consensus 53 ~l~Hpn--Iv~l~~~---~~~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~k 127 (288)
.+.|++ +...++. +...+++....-...........++.+++.++.++| ..+|+|+||||+||+++.++.++
T Consensus 89 ~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 89 ALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred HHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEE
Confidence 888774 3333332 333344433211111111445678899999999999 88999999999999999999999
Q ss_pred EecccCcccc
Q 044995 128 VSNFGTSRSR 137 (288)
Q Consensus 128 l~DfG~a~~~ 137 (288)
|+|||++...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.8e-14 Score=118.51 Aligned_cols=117 Identities=15% Similarity=0.105 Sum_probs=85.5
Q ss_pred cCCcccCceeeeeCCeeEEEeE-cc--------------H----------------------------HHHHHHHHHHhc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGM-AK--------------V----------------------------EKFINEVVIQSQ 53 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~-~~--------------~----------------------------~~~~~E~~~l~~ 53 (288)
.-.|++.+.||+|+||.||+|. +. . ..+.+|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999997 21 0 124579999999
Q ss_pred CCCCc--eeeecc---eEecccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEEeCCCCCCeeec
Q 044995 54 INHIN--VVKLIG---CCLETKYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVP-IYHRDIKSTNILLD 121 (288)
Q Consensus 54 l~Hpn--Iv~l~~---~~~~~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlkp~Nil~~ 121 (288)
+.+.+ +.++++ .+...+++... .....+.......++.|++.++.+|| ..+ |+||||||+||+++
T Consensus 107 L~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 107 LYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH 183 (237)
T ss_pred HHhcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE
Confidence 97532 233332 23333433321 12233455567789999999999999 888 99999999999999
Q ss_pred CCCceEEecccCcccc
Q 044995 122 DKYCAKVSNFGTSRSR 137 (288)
Q Consensus 122 ~~~~~kl~DfG~a~~~ 137 (288)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 789999999998743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.4e-15 Score=139.63 Aligned_cols=196 Identities=23% Similarity=0.322 Sum_probs=149.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCC-CCceeeecceEecccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~- 73 (288)
...|.+.+.||+|+|+.|-..... .+....|..+-+.+. |.|++++++.....++..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 457888999999999998765321 234445888888887 999999998765543321
Q ss_pred ------------cc-CCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccC
Q 044995 74 ------------DQ-NKEL-PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRA 138 (288)
Q Consensus 74 ------------~~-~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~ 138 (288)
.. .... ..+...+-.++.|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 11 1122 44556678899999999999993 45699999999999999998 99999999998765
Q ss_pred C--CCceeeecccc-CCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------c
Q 044995 139 V--DQTHITTQVHG-TFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------E 184 (288)
Q Consensus 139 ~--~~~~~~~~~~g-t~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------------~ 184 (288)
. .........+| ++.|+||| |+||.|+++.-+++|..|+...... .
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 23333444678 99999999 9999999999999999998532211 1
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.......+++.+++..+|+.|.+.+++...
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cCChhhhhcccccccCCchhcccccccccc
Confidence 235677888999999999999998776544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.3e-13 Score=111.81 Aligned_cols=108 Identities=19% Similarity=0.251 Sum_probs=76.0
Q ss_pred eeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--ccccc-CC
Q 044995 25 ILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--YMHDQ-NK 77 (288)
Q Consensus 25 ~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~l~~~-~~ 77 (288)
.||+|+||.||+|... .+++.+|++++..+.|+++.....++...+ ++... ..
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999731 245678999999999876544333322221 21110 01
Q ss_pred CCCCCHHHHH---HHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 78 ELPFTWEMQL---RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 78 ~~~l~~~~~~---~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
...+...... .++.+++.+|.+|| ..+++|+|++|.||+++ ++.+++.|||++..
T Consensus 81 g~~l~~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGNDELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 1111111111 78999999999999 88999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.3e-13 Score=129.05 Aligned_cols=206 Identities=20% Similarity=0.226 Sum_probs=131.3
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEccHH--------------HHHHHHHHHhcCC---CCceeeecce-------E
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAKVE--------------KFINEVVIQSQIN---HINVVKLIGC-------C 66 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~~E~~~l~~l~---HpnIv~l~~~-------~ 66 (288)
.+++...+.|.|.+.||+|+||.||+|..... +|.--.+++.+|+ -+-|+.+..+ .
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34556678899999999999999999976311 1222233444444 1112222111 1
Q ss_pred ecccc------ccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-------CCCceEEecccC
Q 044995 67 LETKY------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-------DKYCAKVSNFGT 133 (288)
Q Consensus 67 ~~~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-------~~~~~kl~DfG~ 133 (288)
+..+| +...+....+++....-+..|++.-++.|| ..+|||+||||+|.||. +...++|+|||.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 11222 222334556888889999999999999999 88899999999999993 235789999999
Q ss_pred ccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCC-C-C-CC-----ccch-hHHHHHH
Q 044995 134 SRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI-R-F-TT-----FEED-KNITVAK 192 (288)
Q Consensus 134 a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~-~-~-~~-----~~~~-~~~~~~~ 192 (288)
+-.+..-.. ..-...++|-.+-.+| |-|.|..+++-||.|+.-- . + .+ ++.- .-.-..+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~~~W~~ 927 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKRDMWNK 927 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhHHHHHH
Confidence 865432222 2223345666677777 9999999999999986421 0 0 00 0110 1123446
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
+...+|+.|=..=|...+|...++.+.
T Consensus 928 ~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 928 FFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 677778733333377777777776653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.6e-12 Score=104.46 Aligned_cols=50 Identities=18% Similarity=0.105 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 84 EMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 84 ~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.....++.+++.++.++| . .+|+|+||||+||+++ ++.++|+|||.+...
T Consensus 114 ~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 114 EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 567889999999999999 7 8899999999999999 889999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.9e-12 Score=97.44 Aligned_cols=114 Identities=18% Similarity=0.189 Sum_probs=87.1
Q ss_pred cCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCC--CceeeecceEecc-------ccccccCCC
Q 044995 22 VNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINH--INVVKLIGCCLET-------KYMHDQNKE 78 (288)
Q Consensus 22 ~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~-------~~l~~~~~~ 78 (288)
+.+.||+|.++.||++... ...+.+|+.++..++| .+++++++++... +++.....
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~- 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL- 80 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec-
Confidence 4678999999999998751 2478999999999987 4788877665432 22222111
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 79 LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 79 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
..++......++.+++.++.++|..+..+++|+|++|.||+++..+.+++.|||.+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 1124566778899999999999955446899999999999999889999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.5e-12 Score=106.65 Aligned_cols=88 Identities=17% Similarity=0.237 Sum_probs=63.1
Q ss_pred HHHHHHHHHHhcCCCCce--eeecceEecc-----------cccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 044995 42 EKFINEVVIQSQINHINV--VKLIGCCLET-----------KYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHL 102 (288)
Q Consensus 42 ~~~~~E~~~l~~l~HpnI--v~l~~~~~~~-----------~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~ 102 (288)
.++.+|++++.+|.|++| ++.+++.... +++... .....++. ..+.+++.+|.+||
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH- 159 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFH- 159 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHH-
Confidence 457789999999998885 5555543221 111110 01112222 24678999999999
Q ss_pred CCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 103 ~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
..+|+||||||.|||++.++.++|+|||.+..
T Consensus 160 --~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 160 --DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred --HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 89999999999999999888999999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.4e-10 Score=102.61 Aligned_cols=164 Identities=15% Similarity=0.128 Sum_probs=110.3
Q ss_pred ceeHHHHHHhcCCcccC---ceeeeeCCeeEEEeEcc----HHHHHHHHHHHhcCCCCceeeecceEeccccccccCCCC
Q 044995 7 LFISNELEKATDSFNVN---RILGQGGQDIVYKGMAK----VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNKEL 79 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~---~~lG~G~~g~Vy~~~~~----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~~~~ 79 (288)
.|.++=-....+.+.+. .....|++-.||..... .+...+.++-|+.++||||++|++.+.....++...+..
T Consensus 12 ~fpY~le~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 12 QFPYDLEETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred cCCcccccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 33333333344444443 24455777777776543 345678889999999999999999988777555444332
Q ss_pred -CC-------CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccC
Q 044995 80 -PF-------TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151 (288)
Q Consensus 80 -~l-------~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 151 (288)
|+ ........+.||+.||.|||. ..+++|++|.-+.|+++..|..||++|-++.......... ....--
T Consensus 92 ~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~-~~~~~~ 168 (690)
T KOG1243|consen 92 RPLETVLKELGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA-KSLYLI 168 (690)
T ss_pred ccHHHHHHHhHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc-ccchhh
Confidence 22 233445567899999999973 5679999999999999999999999998765432211100 000011
Q ss_pred CCCCCh-----h----hHHHHHHHHHHHHhC
Q 044995 152 FGYLNP-----D----DVCSFGVVLVELLTG 173 (288)
Q Consensus 152 ~~y~aP-----E----DiwSlG~il~elltg 173 (288)
..|..| + |.|-|||+++|++.|
T Consensus 169 ~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDPSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCccccchhhhhHHHHHHHHhCc
Confidence 123333 3 999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-11 Score=104.07 Aligned_cols=164 Identities=18% Similarity=0.255 Sum_probs=110.5
Q ss_pred HHhcCCCCceeeecceEecccc------------ccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 044995 50 IQSQINHINVVKLIGCCLETKY------------MHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107 (288)
Q Consensus 50 ~l~~l~HpnIv~l~~~~~~~~~------------l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 107 (288)
-+-++.|-|||+++.++.+.++ +.. ......+......+++.||..||.|||.+ ..+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3566789999999998776544 110 00112355666778999999999999966 789
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCcccc---CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhC
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSR---AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG 173 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~---~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg 173 (288)
|+|+++..+.|++..+|-+|+.--...... ............+-++|.+|+ |||+||+...||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998887632111100 000000111123566777777 999999999999987
Q ss_pred CCCCCCCC--ccc----------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 174 AKPIRFTT--FEE----------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 174 ~~P~~~~~--~~~----------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.--...+ ... -.....++++.+|++..|..||+|++++-|
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 65311110 000 012344677999999999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.8e-11 Score=108.02 Aligned_cols=194 Identities=19% Similarity=0.258 Sum_probs=139.9
Q ss_pred cCCcccCceeee--eCCeeEEEeEc--c--------------------HHHHHHHHHHHhcCC-CCceeeecceEecccc
Q 044995 17 TDSFNVNRILGQ--GGQDIVYKGMA--K--------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKY 71 (288)
Q Consensus 17 ~~~y~~~~~lG~--G~~g~Vy~~~~--~--------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 71 (288)
...|.+...+|. |.+|.||.+.. . ..+=++|+...++++ |+|.|+....+.+.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 355677789999 99999999876 1 122345666666664 9999998887777665
Q ss_pred ccccCCCC-------------CCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccC
Q 044995 72 MHDQNKEL-------------PFTWEMQLRISIEASG----TMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGT 133 (288)
Q Consensus 72 l~~~~~~~-------------~l~~~~~~~i~~~i~~----~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~ 133 (288)
++...+.. .++.........+... ||.++| ..+++|-|+||+||++..+ ..++++|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 54332211 2455556666777777 999999 8899999999999999888 8899999999
Q ss_pred ccccCCCC----ceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCC---------------Cccc
Q 044995 134 SRSRAVDQ----THITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT---------------TFEE 184 (288)
Q Consensus 134 a~~~~~~~----~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~---------------~~~~ 184 (288)
...+.... ........|...|++|| ||||+|.+..+..++..+.... ++-+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 87654332 11112225777899999 9999999999998876554221 0111
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
..+.++...+..+++.++..|+++..+..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 22456667899999999999999887765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-10 Score=100.92 Aligned_cols=208 Identities=19% Similarity=0.269 Sum_probs=138.4
Q ss_pred ccceeHHH-HHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceee
Q 044995 5 TKLFISNE-LEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVK 61 (288)
Q Consensus 5 ~~~~~~~~-~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~ 61 (288)
.+.|+-++ ....+.+|.++..||.|.|+.|++...+ ...-+.|+-+...+ .|.++++
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34555555 4556778999999999999999985421 11123566555555 4888888
Q ss_pred ecceEecccc-------ccccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceE
Q 044995 62 LIGCCLETKY-------MHDQNK------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAK 127 (288)
Q Consensus 62 l~~~~~~~~~-------l~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~k 127 (288)
++..+..... ...... ...+.....+++..+++.++.++| +..++|+|+||+||++..+ +..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhh
Confidence 7776544322 211111 123566677888999999999999 8999999999999999875 7889
Q ss_pred EecccCccccCCCCceeeeccccCCCC------------CChhhHHHHHHHHHHHHhCCCCCCC-----------CCccc
Q 044995 128 VSNFGTSRSRAVDQTHITTQVHGTFGY------------LNPDDVCSFGVVLVELLTGAKPIRF-----------TTFEE 184 (288)
Q Consensus 128 l~DfG~a~~~~~~~~~~~~~~~gt~~y------------~aPEDiwSlG~il~elltg~~P~~~-----------~~~~~ 184 (288)
++|||+.+.+....... ...+..| .++-|++|||..+.+.+++..--.. .....
T Consensus 408 ~~~~~~~t~~~~~~~~~---~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~ 484 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSSGVF---HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLP 484 (524)
T ss_pred ccccccccccceecccc---cccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCC
Confidence 99999986422111100 0112222 2222999999999999998542110 00111
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
....++..+...+..+++..||.+.++..+.+..
T Consensus 485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 2236777888889999999999998887665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-08 Score=81.67 Aligned_cols=109 Identities=17% Similarity=0.049 Sum_probs=70.6
Q ss_pred ceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCCCCcee-eecceEec-----cccccccCCCCCCC
Q 044995 24 RILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQINHINVV-KLIGCCLE-----TKYMHDQNKELPFT 82 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~HpnIv-~l~~~~~~-----~~~l~~~~~~~~l~ 82 (288)
+.|+.|.++.||+++.. ...+.+|+.+++.+.+.+++ +++.+... .+++....-...
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~-- 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE-- 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc--
Confidence 56788888899976531 13467899999988665543 34443322 233332211100
Q ss_pred HHHHHHHHHHHHHHHHHhhcCC--CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 83 WEMQLRISIEASGTMSYLHLSA--SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 83 ~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
......+..+++.+|..||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 82 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0112345678999999999332 12359999999999998 6679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-08 Score=92.11 Aligned_cols=48 Identities=13% Similarity=0.140 Sum_probs=39.4
Q ss_pred HHHHHHHHH-HHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 87 LRISIEASG-TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 87 ~~i~~~i~~-~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
..++..++. .+..+| ..+++|+|+||.||+++.++.+++.|||++..+
T Consensus 259 ~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 259 KALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 345555554 467778 889999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-07 Score=83.02 Aligned_cols=136 Identities=16% Similarity=0.251 Sum_probs=103.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-
Q 044995 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD- 158 (288)
Q Consensus 80 ~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE- 158 (288)
...|...++.+..++.+...|| ..|-.-+|+.++|+|+++++.+.|.|=.....- .........+|...|.+||
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--~ng~~~~cpVg~~eftPPEl 187 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--ANGTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec--cCCceEecccCccccCCHHH
Confidence 4679999999999999999999 888889999999999999999999874322111 1111222246888999999
Q ss_pred ---------------hHHHHHHHHHHHHhC-CCCCCCCCcc-----------------------------------chhH
Q 044995 159 ---------------DVCSFGVVLVELLTG-AKPIRFTTFE-----------------------------------EDKN 187 (288)
Q Consensus 159 ---------------DiwSlG~il~elltg-~~P~~~~~~~-----------------------------------~~~~ 187 (288)
|.|.||+++++++.| +.||.+.... ...+
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence 999999999999886 8998543211 1125
Q ss_pred HHHHHHHHHhcCCC--CCCCCCHHHHHHHHHhchh
Q 044995 188 ITVAKHAKRCLNPS--GKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 188 ~~~~~li~~cl~~~--p~~Rp~~~~i~~~l~~~~~ 220 (288)
..+..+..+|+... +.-||++..-+..|..+..
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 67888999998743 5679999887777666544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-07 Score=77.59 Aligned_cols=89 Identities=17% Similarity=0.116 Sum_probs=64.0
Q ss_pred HHHHHHHhcCC-----CCceeeecceEecccccccc------CCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEEeC
Q 044995 45 INEVVIQSQIN-----HINVVKLIGCCLETKYMHDQ------NKELPFTWEMQLRISIEASGTMSYL-HLSASVPIYHRD 112 (288)
Q Consensus 45 ~~E~~~l~~l~-----HpnIv~l~~~~~~~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrd 112 (288)
.+|++.|+++. -|.++.+...+..++++... .....++......+..+++.+|..| | ..+|+|+|
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 38999988874 45555554445555655431 1122344455667788999999988 8 78899999
Q ss_pred CCCCCeeecCCCceEEecccCcccc
Q 044995 113 IKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 113 lkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
|++.|||+. ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 467999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-08 Score=94.67 Aligned_cols=121 Identities=18% Similarity=0.293 Sum_probs=87.6
Q ss_pred HHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee--------eccccCCCCCChh---
Q 044995 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT--------TQVHGTFGYLNPD--- 158 (288)
Q Consensus 90 ~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--------~~~~gt~~y~aPE--- 158 (288)
+.+++.|+.|+|. +..+||++|.|++|.++.++..||+.|+++........... .-..-...|.|||
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445589999994 45799999999999999999999999998754332111110 0012345689998
Q ss_pred --------hHHHHHHHHHHHHh-CCCCCCCC------------------CccchhHHHHHHHHHHhcCCCCCCCCCHHHH
Q 044995 159 --------DVCSFGVVLVELLT-GAKPIRFT------------------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEV 211 (288)
Q Consensus 159 --------DiwSlG~il~ellt-g~~P~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 211 (288)
|++|+|+++|.+.. |+.-+... ......+.++.+-+.+++..+..-||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 99999999999884 44333211 1223457899999999999999999976665
Q ss_pred H
Q 044995 212 A 212 (288)
Q Consensus 212 ~ 212 (288)
.
T Consensus 263 ~ 263 (700)
T KOG2137|consen 263 L 263 (700)
T ss_pred h
Confidence 4
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-06 Score=80.96 Aligned_cols=33 Identities=21% Similarity=0.257 Sum_probs=29.8
Q ss_pred CCCeEEeCCCCCCeeecCCC----ceEEecccCcccc
Q 044995 105 SVPIYHRDIKSTNILLDDKY----CAKVSNFGTSRSR 137 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a~~~ 137 (288)
..+++|+|+||.||+++.++ .+++.|||+...+
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 67899999999999998887 9999999998654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=69.96 Aligned_cols=111 Identities=17% Similarity=0.210 Sum_probs=74.6
Q ss_pred cCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC-----CCceee--ecceEeccc
Q 044995 22 VNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN-----HINVVK--LIGCCLETK 70 (288)
Q Consensus 22 ~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~-----HpnIv~--l~~~~~~~~ 70 (288)
.+..|-+|+=+.|+++... ..+..+|+++|.++. -|-++- .++-+.-++
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678889999999987642 456788999998874 333322 122222233
Q ss_pred cccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecccCccc
Q 044995 71 YMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRS 136 (288)
Q Consensus 71 ~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG~a~~ 136 (288)
|+.. .... .........++..+-+.+.-|| ..+|+|+||..+||++..++ .+-++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 3322 1111 1122223678888889999999 88999999999999995443 458999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-07 Score=91.57 Aligned_cols=126 Identities=28% Similarity=0.330 Sum_probs=95.0
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC--------------------
Q 044995 81 FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD-------------------- 140 (288)
Q Consensus 81 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~-------------------- 140 (288)
.+...+......+..+++||| ...+.|+|++|.|+|+..++..++.|||+.......
T Consensus 901 ~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~ 977 (1205)
T KOG0606|consen 901 LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSR 977 (1205)
T ss_pred cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccc
Confidence 444455566677888999999 777999999999999999999999999843321100
Q ss_pred ----------CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------c
Q 044995 141 ----------QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------F 182 (288)
Q Consensus 141 ----------~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~ 182 (288)
.........||+.|.+|| |.|++|++++|.++|..||.... -
T Consensus 978 ~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g 1057 (1205)
T KOG0606|consen 978 SERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEG 1057 (1205)
T ss_pred cccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCC
Confidence 001112356899999999 99999999999999999985332 1
Q ss_pred cchhHHHHHHHHHHhcCCCCCCCCCHH
Q 044995 183 EEDKNITVAKHAKRCLNPSGKKRPAMK 209 (288)
Q Consensus 183 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ 209 (288)
+...+....+++...+..++.+|-.+.
T Consensus 1058 ~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1058 PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ccccChhhhhhhhhhhccCchhccCcc
Confidence 223467788889999999999986544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.8e-07 Score=70.56 Aligned_cols=91 Identities=19% Similarity=0.200 Sum_probs=59.1
Q ss_pred HHHHHHHHHHHhcCCC--CceeeecceEecc-----ccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCC
Q 044995 41 VEKFINEVVIQSQINH--INVVKLIGCCLET-----KYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDI 113 (288)
Q Consensus 41 ~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~-----~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl 113 (288)
.++-.+|++++.++.- -++..++++.... +|+....-.. +-+.....++..+-.-+.-|| ..+|+|+||
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd-~l~~~~~~~~r~vG~~vg~lH---~~givHGDL 118 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKD-ALEEARPDLLREVGRLVGKLH---KAGIVHGDL 118 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHH-HHHhcchHHHHHHHHHHHHHH---hcCeecCCC
Confidence 4677889999988753 2333344443222 3332211000 001112456777778888999 899999999
Q ss_pred CCCCeeecCCCceEEecccCccc
Q 044995 114 KSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 114 kp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
.++||++.+.. +.++|||++..
T Consensus 119 TtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 119 TTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ccceEEEeCCc-EEEEECCcccc
Confidence 99999998654 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=72.71 Aligned_cols=159 Identities=16% Similarity=0.195 Sum_probs=111.8
Q ss_pred HHHHHHhcCCCCceeeecceEecc-----------cccc----------------------ccCCCCCCCHHHHHHHHHH
Q 044995 46 NEVVIQSQINHINVVKLIGCCLET-----------KYMH----------------------DQNKELPFTWEMQLRISIE 92 (288)
Q Consensus 46 ~E~~~l~~l~HpnIv~l~~~~~~~-----------~~l~----------------------~~~~~~~l~~~~~~~i~~~ 92 (288)
.-++.++++.|+|||++.+++... +|+. ........++...+.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 457889999999999998876522 1110 0112234677889999999
Q ss_pred HHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChhhHHHHHHHHHHHHh
Q 044995 93 ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLT 172 (288)
Q Consensus 93 i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPEDiwSlG~il~ellt 172 (288)
+..||.++| +.|+.-+-|.+.+||++.+.+++|+..|+...+..+.... ..-.--+|.=.||.++..|.|
T Consensus 402 LtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~-------le~~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 402 LTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEP-------LESQQQNDLRDLGLLLLALAT 471 (655)
T ss_pred HHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCCcc-------hhHHhhhhHHHHHHHHHHHhh
Confidence 999999999 7889999999999999988889998877765443322100 000011288899999999999
Q ss_pred CCCC-CCC--------CCccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 173 GAKP-IRF--------TTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 173 g~~P-~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
|..- +.. .......+.++++++.-....++++ -++.+++.++
T Consensus 472 ~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 472 GTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred cccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 9532 111 1122344678888888888888887 7777877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.6e-06 Score=69.47 Aligned_cols=112 Identities=17% Similarity=0.123 Sum_probs=77.9
Q ss_pred cccCceeeeeCCeeEEEeEcc---------------------------------------HHHHHHHHHHHhcCCCC--c
Q 044995 20 FNVNRILGQGGQDIVYKGMAK---------------------------------------VEKFINEVVIQSQINHI--N 58 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~---------------------------------------~~~~~~E~~~l~~l~Hp--n 58 (288)
+.+...||.|-=+.||.|.+. +....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999998641 34567899999998654 5
Q ss_pred eeeecce---EeccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 59 VVKLIGC---CLETKYMHDQNK-ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 59 Iv~l~~~---~~~~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
|.+.+++ +..++++..... ...+..+..-.++..|+.-+.-+- ..||+|+|+..-||+++++|.+.++||--+
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeCccc
Confidence 5555554 444555543211 112234445555556666555555 667999999999999999999999999544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-05 Score=64.93 Aligned_cols=112 Identities=16% Similarity=0.210 Sum_probs=76.3
Q ss_pred ceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCC--ceeeecceEec----------ccccc
Q 044995 24 RILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHI--NVVKLIGCCLE----------TKYMH 73 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~----------~~~l~ 73 (288)
+.||.|.++.||++... ...+.+|+++++.+.+. ++.+++.++.. .+++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56788888888886421 24678999999998753 34555554433 12222
Q ss_pred ccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------
Q 044995 74 DQNKE-----LPFTWEMQLRISIEASGTMSYLHLSA-------------------------------------------- 104 (288)
Q Consensus 74 ~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------------- 104 (288)
...-. ..++......++.+++..|.+||...
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 21110 23566677788888888888888421
Q ss_pred ---------CCCeEEeCCCCCCeeecC--CCceEEecccCcc
Q 044995 105 ---------SVPIYHRDIKSTNILLDD--KYCAKVSNFGTSR 135 (288)
Q Consensus 105 ---------~~~iiHrdlkp~Nil~~~--~~~~kl~DfG~a~ 135 (288)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999987 5678999998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.7e-06 Score=66.74 Aligned_cols=93 Identities=22% Similarity=0.214 Sum_probs=56.9
Q ss_pred HHHHHHHHHHHhcCCCC--ceeeecc---eEecccccc--ccC----CCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCe
Q 044995 41 VEKFINEVVIQSQINHI--NVVKLIG---CCLETKYMH--DQN----KELPFTWEMQLRISIEASGTMSY-LHLSASVPI 108 (288)
Q Consensus 41 ~~~~~~E~~~l~~l~Hp--nIv~l~~---~~~~~~~l~--~~~----~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~i 108 (288)
.....+|.+.|.++..- ++.+.++ .+..++|+. ... ....++......++.++...+.. +| ..+|
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~---~~gi 128 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYNRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH---KAGI 128 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH---CTTE
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEeCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH---hcCc
Confidence 45677899999999754 3344443 345556665 110 00111123355667777774444 67 8899
Q ss_pred EEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 109 iHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+|+||.+.|||++++ .+.|+|||.+...
T Consensus 129 vHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 129 VHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred eecCCChhhEEeecc-eEEEEecCcceec
Confidence 999999999999877 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.9e-05 Score=67.86 Aligned_cols=52 Identities=15% Similarity=0.132 Sum_probs=44.6
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-------CCceEEecccCcc
Q 044995 81 FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-------KYCAKVSNFGTSR 135 (288)
Q Consensus 81 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-------~~~~kl~DfG~a~ 135 (288)
.+......++.+++..+.-|| ..+|+|+|+++.|||++. ++.+.++||+.+.
T Consensus 135 ~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 135 PDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 344566688899999999999 999999999999999974 4688999999875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.8e-05 Score=61.36 Aligned_cols=91 Identities=19% Similarity=0.257 Sum_probs=72.1
Q ss_pred HHHHHHHhcCCC-CceeeecceEec---ccccccc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEe
Q 044995 45 INEVVIQSQINH-INVVKLIGCCLE---TKYMHDQ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHR 111 (288)
Q Consensus 45 ~~E~~~l~~l~H-pnIv~l~~~~~~---~~~l~~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr 111 (288)
..|.-+++.+++ +++.+++|+|-. .++.... .....-+|..+.+|+.++++.+.+++......+.-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 458888888887 699999999733 2333311 122346899999999999999999996555668889
Q ss_pred CCCCCCeeecCCCceEEecccCcc
Q 044995 112 DIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 112 dlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
|++++|+-+++++.+|+.|.....
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcc
Confidence 999999999999999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=5.6e-05 Score=62.08 Aligned_cols=123 Identities=17% Similarity=0.109 Sum_probs=79.0
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEc----------------------cHHHHHHHHHHHhcCCCCc--eeeecce
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMA----------------------KVEKFINEVVIQSQINHIN--VVKLIGC 65 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~----------------------~~~~~~~E~~~l~~l~Hpn--Iv~l~~~ 65 (288)
++.+.....++-..=--|+||.+-|++-.. ....|.+|...+.+|..-+ +.+.+.+
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~ 89 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFG 89 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCcccee
Confidence 334444444443334456788888876541 1457999999998886433 3333311
Q ss_pred -----------Eeccccccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 66 -----------CLETKYMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 66 -----------~~~~~~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
+..++-+.. .....+.+......+..+++..+.-|| ..++.|+|+.+.||+++.++.
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~ 166 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGK 166 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCC
Confidence 111111110 001113455666789999999999999 999999999999999976666
Q ss_pred --eEEecccCcc
Q 044995 126 --AKVSNFGTSR 135 (288)
Q Consensus 126 --~kl~DfG~a~ 135 (288)
++++||--++
T Consensus 167 ~~v~lIDlEk~r 178 (216)
T PRK09902 167 AEAGFLDLEKSR 178 (216)
T ss_pred eeEEEEEhhccc
Confidence 9999997655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.65 E-value=6.5e-05 Score=62.07 Aligned_cols=52 Identities=21% Similarity=0.262 Sum_probs=45.2
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecccCccc
Q 044995 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRS 136 (288)
Q Consensus 82 ~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG~a~~ 136 (288)
+......++.+++..+.-|| ..+|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred chhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 44566788999999999999 99999999999999998776 889999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=66.19 Aligned_cols=166 Identities=16% Similarity=0.162 Sum_probs=106.7
Q ss_pred HHHHHHHhcCCCCceeeecceEeccccc-----------------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 044995 45 INEVVIQSQINHINVVKLIGCCLETKYM-----------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107 (288)
Q Consensus 45 ~~E~~~l~~l~HpnIv~l~~~~~~~~~l-----------------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 107 (288)
.-|...+.++.|+|++.++.+-.+.... .....-...+....+.+..++..|+.|+| ...
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h---~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH---SLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH---Hhc
Confidence 3466678889999999999886554221 11223345677888889999999999999 444
Q ss_pred eEEeCCCCC---CeeecCCCceEEe--cccCccccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHH
Q 044995 108 IYHRDIKST---NILLDDKYCAKVS--NFGTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVE 169 (288)
Q Consensus 108 iiHrdlkp~---Nil~~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~e 169 (288)
+.|.-|... +-..+..+...++ ||+..+........... .-...+.+++ |+|.+|..+..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 555544443 3333455566666 88877655433221111 1122233333 99999999999
Q ss_pred HHhCCCCCCCCCcc-----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 170 LLTGAKPIRFTTFE-----EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 170 lltg~~P~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+..|..+-...... ........+...+|+..++++|+++.+++.+.
T Consensus 385 ~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 98876542211111 11112677888999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=1.4e-05 Score=74.62 Aligned_cols=151 Identities=20% Similarity=0.159 Sum_probs=102.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEccHH------------HHHHHHHHHhcCCCCc-eeeecceEecccccccc------C-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAKVE------------KFINEVVIQSQINHIN-VVKLIGCCLETKYMHDQ------N- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~~~------------~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~l~~~------~- 76 (288)
+.-+.....+++|+++.++|.+...+ ...-++++|.+++||| .+..++-+....+.... .
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 33345556788999999999875432 3446889999999999 77777666555443211 0
Q ss_pred -C-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeecc
Q 044995 77 -K-------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 77 -~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
. ...+...+...+...-..+++++| +..=+|+| ||+..+ +..|..||+....+.... .....
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 0 011222333445556667889999 44457888 777654 678999999987665433 33445
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI 177 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~ 177 (288)
.+++.+++|| |.||+|.--.++.-|.+|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 7899999999 9999998777777776663
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0028 Score=53.21 Aligned_cols=56 Identities=16% Similarity=0.148 Sum_probs=43.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 80 ~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++....+..+..++...+.-|-. ..+++|+||..-|||+. ++.+.|+|||-|....
T Consensus 162 ~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 162 PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 34444677777788888877761 36899999999999999 7889999999876443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0015 Score=54.68 Aligned_cols=29 Identities=17% Similarity=0.189 Sum_probs=25.4
Q ss_pred CCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3468999999999999877 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0025 Score=50.81 Aligned_cols=110 Identities=15% Similarity=0.231 Sum_probs=69.3
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceee-ecce---EeccccccccCCCCCC
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVK-LIGC---CLETKYMHDQNKELPF 81 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~-l~~~---~~~~~~l~~~~~~~~l 81 (288)
.+..+.||+|.+|.||+|.+. +..+..|+++|..++--++.. ++.+ +..++|+... +|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~----~L 99 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGR----PL 99 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCc----ch
Confidence 345678999999999998653 677999999999987655532 3333 2223444331 11
Q ss_pred C-HHH--HHHHHHHHHHHHHHhhcCCCCCeEEeCCC-CCCeeecCCCceEEecccCccc
Q 044995 82 T-WEM--QLRISIEASGTMSYLHLSASVPIYHRDIK-STNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 82 ~-~~~--~~~i~~~i~~~l~~lH~~~~~~iiHrdlk-p~Nil~~~~~~~kl~DfG~a~~ 136 (288)
. +.. -.+-...++...--|. ..+|-|..|. |...++..++.+-|+||--|+.
T Consensus 100 ~~~~~~~~rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGGDRKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcccHHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 1 111 1233344455544455 6679999987 4444444455899999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.012 Score=49.47 Aligned_cols=31 Identities=26% Similarity=0.427 Sum_probs=26.0
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.||++++++...|.||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3458999999999999876666799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0054 Score=53.65 Aligned_cols=111 Identities=14% Similarity=0.119 Sum_probs=69.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------------------------HHHHHHHHHHHhcCCC---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------------------------VEKFINEVVIQSQINH--- 56 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------------------------~~~~~~E~~~l~~l~H--- 56 (288)
-+.++++||-|-=+.||.+-+. +-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4677899999999999987542 1234578887777742
Q ss_pred --CceeeecceEeccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 57 --INVVKLIGCCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 57 --pnIv~l~~~~~~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
|-.+..--+|..++++....-...-.....-.+...+..-+.-|. .+|+||+|..-=||++.+++.++++||-
T Consensus 173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 173 PVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred CCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHH---HcCceecccchheeEEecCCCEEEeech
Confidence 333333333555554432211111111122233344444455565 8899999999999999999999999995
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.006 Score=49.90 Aligned_cols=109 Identities=24% Similarity=0.288 Sum_probs=74.2
Q ss_pred CCcccCceeeeeCC-eeEEEeEcc-------------------------------------HHHHHHHHHHHhcCC---C
Q 044995 18 DSFNVNRILGQGGQ-DIVYKGMAK-------------------------------------VEKFINEVVIQSQIN---H 56 (288)
Q Consensus 18 ~~y~~~~~lG~G~~-g~Vy~~~~~-------------------------------------~~~~~~E~~~l~~l~---H 56 (288)
++++.++.||.|.- |.||++... .+.|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 999997531 234778888776664 5
Q ss_pred Cce--eeecceEeccc--ccc-c---cC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 57 INV--VKLIGCCLETK--YMH-D---QN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 57 pnI--v~l~~~~~~~~--~l~-~---~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
.++ |+.+|+..-.+ -+. . .. +..+-.......-+.++.+-|..+| ..+|+-+|+++.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ 193 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH---KLGIVPRDVKPR 193 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH---HCCeeeccCccc
Confidence 555 89999875431 110 0 00 0001111223445567777788899 888999999999
Q ss_pred CeeecCCCceEEecccCc
Q 044995 117 NILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a 134 (288)
|.. .-||+|||.+
T Consensus 194 ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 194 NYR-----GGKLVDFSSS 206 (207)
T ss_pred ccc-----CCEEEecccC
Confidence 987 3589999864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0044 Score=51.35 Aligned_cols=43 Identities=19% Similarity=0.308 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 89 i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
+...+...+.-+| ..|++|+|..|.|+++++++ +++.||+..+
T Consensus 140 ~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 4455677889999 89999999999999998554 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.05 Score=44.57 Aligned_cols=109 Identities=17% Similarity=0.267 Sum_probs=64.9
Q ss_pred CceeeeeCCeeEEEeEc-------------------------------cHHHHHHHHHHHhcCC------CCceeeecce
Q 044995 23 NRILGQGGQDIVYKGMA-------------------------------KVEKFINEVVIQSQIN------HINVVKLIGC 65 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~-------------------------------~~~~~~~E~~~l~~l~------HpnIv~l~~~ 65 (288)
...||+|+.-.||.-.+ ....+.+|+.-..++. +.+|.+++|+
T Consensus 6 ~~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred CcccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 46789999999996321 1356778887776666 8888999998
Q ss_pred Eecc-------ccccccCCCCCCCHHHHH-------HHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC--C--ceE
Q 044995 66 CLET-------KYMHDQNKELPFTWEMQL-------RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK--Y--CAK 127 (288)
Q Consensus 66 ~~~~-------~~l~~~~~~~~l~~~~~~-------~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~--~--~~k 127 (288)
...+ +.+.........+....+ .+...+-.-..||- ...|+.+|++|.||++... + .+.
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHH---HcCCeecCCCcccEEEEecCCCceEEE
Confidence 6543 111111111111111111 12222333345666 6679999999999999422 2 466
Q ss_pred Eec-ccCc
Q 044995 128 VSN-FGTS 134 (288)
Q Consensus 128 l~D-fG~a 134 (288)
|+| ||-.
T Consensus 163 lIDG~G~~ 170 (199)
T PF10707_consen 163 LIDGLGEK 170 (199)
T ss_pred EEeCCCCc
Confidence 776 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.036 Score=52.01 Aligned_cols=34 Identities=21% Similarity=0.243 Sum_probs=30.3
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
..+++|.|..|.||++..+|.+.+.|||+...+.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 5689999999999999999999999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.11 Score=52.04 Aligned_cols=30 Identities=17% Similarity=0.293 Sum_probs=23.9
Q ss_pred CCeEEeCCCCCCeeecC-CC-ceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDD-KY-CAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~-~~-~~kl~DfG~a~ 135 (288)
..++|+|+++.|||++. +. ..-|.||.++.
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~ 256 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELST 256 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeeccc
Confidence 35999999999999974 23 35799998765
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.21 Score=44.26 Aligned_cols=28 Identities=29% Similarity=0.541 Sum_probs=24.9
Q ss_pred eEEeCCCCCCeeecCCC-ceEEecccCcc
Q 044995 108 IYHRDIKSTNILLDDKY-CAKVSNFGTSR 135 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~-~~kl~DfG~a~ 135 (288)
+||+|+.+.||+++.+. .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999998776 48899999765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.047 Score=48.07 Aligned_cols=31 Identities=16% Similarity=0.235 Sum_probs=26.6
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.||+++.+....|.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999866666899999775
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.35 Score=45.57 Aligned_cols=34 Identities=18% Similarity=0.198 Sum_probs=28.7
Q ss_pred CCCeEEeCCCCCCeeec----CCCceEEecccCccccC
Q 044995 105 SVPIYHRDIKSTNILLD----DKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~----~~~~~kl~DfG~a~~~~ 138 (288)
..|++|+|-.|.||++. .++.+.+-|||+...+.
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 55799999999999997 35789999999987543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.12 Score=45.25 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=27.3
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.||+++.++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999888777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.21 Score=43.54 Aligned_cols=31 Identities=26% Similarity=0.323 Sum_probs=27.1
Q ss_pred CCCeEEeCCCCCCeeecCC----CceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDK----YCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~----~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5578999999999999874 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.17 Score=42.24 Aligned_cols=31 Identities=23% Similarity=0.417 Sum_probs=26.8
Q ss_pred CCCeEEeCCCCCCeeecC-CCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDD-KYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||+++ ++.+.|+||-.+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 456899999999999987 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.058 Score=44.56 Aligned_cols=31 Identities=23% Similarity=0.349 Sum_probs=21.9
Q ss_pred CCCeEEeCCCCCCeeec-CCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLD-DKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~-~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 56799999999999998 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.087 Score=42.63 Aligned_cols=28 Identities=11% Similarity=0.215 Sum_probs=24.8
Q ss_pred CeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 107 ~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+|+|+.|.||++++++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 469999999999998777 8899999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.13 Score=42.92 Aligned_cols=39 Identities=18% Similarity=0.111 Sum_probs=33.1
Q ss_pred HHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 94 SGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 94 ~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
...|.-.|+. ..+.+|+|..|+||+.|+.|.+||.|-+.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 4566777855 56799999999999999999999999874
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.42 E-value=1.7 Score=38.81 Aligned_cols=31 Identities=16% Similarity=0.433 Sum_probs=26.4
Q ss_pred CCCeEEeCCCCCCeeecC-CCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDD-KYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~ 135 (288)
...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 456899999999999975 4689999998774
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.11 Score=43.75 Aligned_cols=30 Identities=20% Similarity=0.263 Sum_probs=26.3
Q ss_pred CCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..++|+|+.|.|||+++++...|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999987778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.097 Score=45.46 Aligned_cols=31 Identities=23% Similarity=0.282 Sum_probs=26.9
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3579999999999999987777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.05 E-value=0.35 Score=42.22 Aligned_cols=30 Identities=30% Similarity=0.307 Sum_probs=25.6
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 467999999999999987 568899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.23 Score=43.94 Aligned_cols=99 Identities=21% Similarity=0.315 Sum_probs=50.5
Q ss_pred HHHHHHHHHHHHHhh---cCCCCCeEEeCCCCCCeeecCC------------------CceEEecccCccccCCCCceee
Q 044995 87 LRISIEASGTMSYLH---LSASVPIYHRDIKSTNILLDDK------------------YCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 87 ~~i~~~i~~~l~~lH---~~~~~~iiHrdlkp~Nil~~~~------------------~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.-+..|++ |-|+- ..+..+.+|-||||+|||+-+. -.++|.||.+++..........
T Consensus 278 kfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i~NkkIk 355 (434)
T PF05445_consen 278 KFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANIINKKIK 355 (434)
T ss_pred HHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcccchhhhh
Confidence 33555654 44422 2235678999999999999321 1356778887764332211111
Q ss_pred e--ccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHHHh
Q 044995 146 T--QVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~--~~~gt~~y~aPEDiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~li~~c 197 (288)
. .......| |++=|--+++. ..| ....+.+....+.+++..|
T Consensus 356 ~s~~~~~Nwyy----Dfhff~Htl~k----~yp--eI~~D~~f~~~L~Ef~~~c 399 (434)
T PF05445_consen 356 NSIKVEHNWYY----DFHFFKHTLFK----TYP--EIEKDPEFNKALEEFIMCC 399 (434)
T ss_pred cccccccceee----ehHHHHHHHHH----hCc--ccccChhHHHHHHHHhhhh
Confidence 0 00011112 77665544442 222 2223445566677777744
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=91.64 E-value=0.14 Score=43.53 Aligned_cols=29 Identities=14% Similarity=0.282 Sum_probs=25.3
Q ss_pred CCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..++|+|+.+.||++++++ +.|.||..+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3589999999999998876 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=91.37 E-value=0.12 Score=54.17 Aligned_cols=72 Identities=13% Similarity=0.012 Sum_probs=53.1
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhC
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG 173 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg 173 (288)
+.-.+|++||+.|.+|..+..+|++++|+.+....... ......+++.|+.++ |+|+.|+-+|++..|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 34468999999999999999999999999983222111 112234555566655 999999999999888
Q ss_pred CCCC
Q 044995 174 AKPI 177 (288)
Q Consensus 174 ~~P~ 177 (288)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7765
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=91.25 E-value=1.1 Score=39.87 Aligned_cols=81 Identities=16% Similarity=0.158 Sum_probs=59.1
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChhhH
Q 044995 81 FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPDDV 160 (288)
Q Consensus 81 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPEDi 160 (288)
+.....++++.+....|.-+. +.-.|-=|.|+||+++.++.+-+..+|+-..++ |.=|.||+.
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp-------------Pye~tee~f 144 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLP-------------PYEMTEERF 144 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecchhccCC-------------CCCCCHHHH
Confidence 344556666666666665543 335677789999999999999999999864322 222678888
Q ss_pred H-HHHHHHHHHHhCCCCCC
Q 044995 161 C-SFGVVLVELLTGAKPIR 178 (288)
Q Consensus 161 w-SlG~il~elltg~~P~~ 178 (288)
| ++-+++..++.|+.+|.
T Consensus 145 ~~~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 145 LKEYKALAIYAFNGKFSFE 163 (434)
T ss_pred HHHHHHHHHHHHcCCccHH
Confidence 8 68888889999999883
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.38 Score=43.12 Aligned_cols=52 Identities=25% Similarity=0.321 Sum_probs=42.8
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 82 ~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
.+++.+.++.+.+.-+.-+.. ....-|||+.-.||||+ +|.+.|+||-+++.
T Consensus 319 ~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 578888888887766665542 34678999999999999 99999999999984
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.73 E-value=1.4 Score=40.22 Aligned_cols=30 Identities=17% Similarity=0.269 Sum_probs=25.6
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.||++..+ .++|+||-++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 6679999999999999765 58999997664
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.28 E-value=0.24 Score=42.86 Aligned_cols=30 Identities=17% Similarity=0.398 Sum_probs=24.9
Q ss_pred CCeEEeCCCCCCeeecCCCc-eEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDDKYC-AKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~~~~-~kl~DfG~a~ 135 (288)
..++|+|+++.|||+++++. .-|.||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 35899999999999987454 5699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.06 E-value=0.76 Score=40.67 Aligned_cols=36 Identities=22% Similarity=0.183 Sum_probs=24.4
Q ss_pred HHHHHHHHHHHHHHh-hcCCCCCeEEeCCCCCCeeec
Q 044995 86 QLRISIEASGTMSYL-HLSASVPIYHRDIKSTNILLD 121 (288)
Q Consensus 86 ~~~i~~~i~~~l~~l-H~~~~~~iiHrdlkp~Nil~~ 121 (288)
..-+..|++.-.-.+ ...+..+.+|-||||+|||+-
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 444667776544333 233356789999999999993
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=90.05 E-value=2.2 Score=38.40 Aligned_cols=31 Identities=19% Similarity=0.280 Sum_probs=25.6
Q ss_pred CCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 104 ~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
....++|+|+.+.||++++++ ++++|+.++.
T Consensus 190 ~~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred CcceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 366899999999999997654 7899997664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.88 E-value=0.33 Score=42.75 Aligned_cols=32 Identities=16% Similarity=0.241 Sum_probs=28.4
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
...++|+|+.+.||+++..+.+-|.||+++..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 45799999999999999888899999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.69 E-value=1.9 Score=39.33 Aligned_cols=38 Identities=11% Similarity=0.309 Sum_probs=28.5
Q ss_pred HHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 97 l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
|.+.-......++|+||.|.||+++++ ..|+.|.-++-
T Consensus 218 Lk~~F~~~~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 218 LKFSFMTNAQALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred HHHHHHhcchhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 333333346679999999999999976 58999977663
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.55 E-value=0.32 Score=39.69 Aligned_cols=31 Identities=19% Similarity=0.198 Sum_probs=25.5
Q ss_pred CCCeEEeCCCCCCeeecCC--C---ceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDK--Y---CAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~--~---~~kl~DfG~a~ 135 (288)
...++|+|+.+.||++..+ | .+.+.||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4578999999999999644 3 68999998775
|
subfamily of choline kinases |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.21 E-value=0.23 Score=40.86 Aligned_cols=30 Identities=23% Similarity=0.391 Sum_probs=20.9
Q ss_pred CCeEEeCCCCCCeee-cCCCceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILL-DDKYCAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~-~~~~~~kl~DfG~a~ 135 (288)
..+.|.|+.+.|||+ +.++.++++||-.+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 457899999999999 788999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.94 E-value=0.66 Score=47.62 Aligned_cols=31 Identities=26% Similarity=0.418 Sum_probs=25.7
Q ss_pred CCCeEEeCCCCCCeeecCCC--ce-EEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKY--CA-KVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~--~~-kl~DfG~a~ 135 (288)
..++||.|+.+.|||++.++ .+ -|+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 56799999999999998764 44 499999764
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.73 E-value=0.95 Score=38.96 Aligned_cols=29 Identities=24% Similarity=0.280 Sum_probs=26.5
Q ss_pred CeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 107 ~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
-++|.|+.|.|+|.++.+.+.|+||--|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 58999999999999998999999997665
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.71 E-value=0.89 Score=39.84 Aligned_cols=31 Identities=16% Similarity=0.272 Sum_probs=27.6
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.|+|+++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999988889999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=87.22 E-value=3.6 Score=37.68 Aligned_cols=37 Identities=8% Similarity=0.214 Sum_probs=27.7
Q ss_pred HHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 97 l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
|.+.-......++|+||.+.||+++.++ .++.|.-++
T Consensus 221 Lk~~f~~~~~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 221 LKSMFCERAQALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred HHHHHHhcccceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 3333334467899999999999998765 888887655
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.71 E-value=0.75 Score=41.91 Aligned_cols=31 Identities=26% Similarity=0.423 Sum_probs=21.0
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEccHHH
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAKVEK 43 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~ 43 (288)
.++.+-..|. -.-||.|.-+.||+|+.+...
T Consensus 184 ~~~eiF~efn-~~PIGsG~IAQVY~atl~~a~ 214 (565)
T KOG1236|consen 184 KIEEIFSEFN-REPIGSGCIAQVYRATLKTAY 214 (565)
T ss_pred cHHHHHHhcC-CcccccchhhhhhhhhhhHHH
Confidence 4444444443 356999999999999866443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.54 E-value=1.7 Score=38.46 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=24.3
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.|||++ + .+.|.||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 45789999999999995 3 57899999764
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.86 E-value=1.6 Score=44.67 Aligned_cols=31 Identities=23% Similarity=0.259 Sum_probs=25.1
Q ss_pred CCCeEEeCCCCCCeeecCC--Cc---eEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDK--YC---AKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~--~~---~kl~DfG~a~ 135 (288)
..++||.|+.+.|||++.+ +. ..|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5789999999999999754 22 3799999764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 288 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 2e-64
Identities = 84/285 (29%), Positives = 122/285 (42%), Gaps = 80/285 (28%)
Query: 11 NELEKATDSFNVNRILGQGGQDIVYKGM----AKV-------------EKFINEVVIQSQ 53
+LE+AT++F+ ++G G VYKG+ AKV E+F E+ S
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 54 INHINVVKLIGCCLETK-------YMH----------DQNKELPFTWEMQLRISIEASGT 96
H ++V LIG C E YM + +WE +L I I A+
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV-DQTHITTQVHGTFGYL 155
+ YLH + I HRD+KS NILLD+ + K+++FG S+ DQTH++T V GT GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 156 NPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNIT--------------- 189
+P+ DV SFGVVL E+L I + E N+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 190 ----------------VAKHAKRCLNPSGKKRPAMKEVASELAGI 218
A +CL S + RP+M +V +L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-61
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 81/293 (27%)
Query: 5 TKLFISNELEKATDSFNVNRILGQGGQDIVYKG-------------------MAKVEKFI 45
K F EL+ A+D+F+ ILG+GG VYKG +++ F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQ 75
Query: 46 NEVVIQSQINHINVVKLIGCCLETK-------YM---------HDQNK-ELPFTWEMQLR 88
EV + S H N+++L G C+ YM ++ + + P W + R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
I++ ++ ++YLH I HRD+K+ NILLD+++ A V +FG ++ TH+TT V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAK-- 195
GT G++ P+ DV +GV+L+EL+TG + D ++ + K
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 196 -------------------------------RCLNPSGKKRPAMKEVASELAG 217
C S +RP M EV L G
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-57
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 85/299 (28%)
Query: 4 KTKLFISNELEKATDSFN------VNRILGQGGQDIVYKGMAK-----VEK--------- 43
+ F EL+ T++F+ +G+GG +VYKG V+K
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 44 ------FINEVVIQSQINHINVVKLIGCCLETK-------YM---------HDQNKELPF 81
F E+ + ++ H N+V+L+G + YM + P
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV-D 140
+W M+ +I+ A+ +++LH HRDIKS NILLD+ + AK+S+FG +R+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 141 QTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT---------- 180
QT +T+++ GT Y+ P+ D+ SFGVVL+E++TG +
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 181 --TFEEDKNIT-----------------VAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220
+E+K I + A +CL+ KRP +K+V L + A
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 71/264 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGM--------------AKVEKFINEVVIQSQINHINVVKLI 63
V ++G+G +V K ++ + FI E+ S++NH N+VKL
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 64 GCCLE-----TKYM---------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109
G CL +Y H +T + ++ S ++YLH +
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 110 HRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---------- 158
HRD+K N+LL K+ +FGT+ QTH+T G+ ++ P+
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 159 -DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA----------------------K 195
DV S+G++L E++T KP F+E
Sbjct: 184 CDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 196 RCLNPSGKKRPAMKEVASELAGIK 219
RC + +RP+M+E+ + +
Sbjct: 239 RCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-39
Identities = 59/267 (22%), Positives = 98/267 (36%), Gaps = 73/267 (27%)
Query: 18 DSFNVNRILGQGGQDIVYKGM------------------AKVEKFINEVVIQSQINHINV 59
N+ +G G V++ +V +F+ EV I ++ H N+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 60 VKLIGCCLE-------TKYM---------HDQNKELPFTWEMQLRISIEASGTMSYLHLS 103
V +G + T+Y+ H +L ++ + + M+YLH +
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
+ PI HR++KS N+L+D KY KV +FG SR +A + GT ++ P+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDE 214
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA------------------ 194
DV SFGV+L EL T +P + V
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 195 ---KRCLNPSGKKRPAMKEVASELAGI 218
+ C KRP+ + L +
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-38
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 92/281 (32%)
Query: 18 DSFNVNRILGQGGQDIVYKG-------------------------MAKVEKFINEVVIQS 52
+ + +G+GG +V+KG + K ++F EV I S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 53 QINHINVVKLIGCCLE-----TKYM---------HDQNKELPFTWEMQLRISIEASGTMS 98
+NH N+VKL G +++ D+ + W ++LR+ ++ + +
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALGIE 136
Query: 99 YLHLSASVPIYHRDIKSTNILLDDK-----YCAKVSNFGTSRSRAVDQTHITTQVHGTFG 153
Y+ + + PI HRD++S NI L CAKV++FG S+ H + + G F
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQ 191
Query: 154 YLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA------ 194
++ P+ D SF ++L +LTG P F+E +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKFINMIREEG 246
Query: 195 -----------------KRCLNPSGKKRPAMKEVASELAGI 218
+ C + KKRP + EL+ +
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-36
Identities = 62/269 (23%), Positives = 102/269 (37%), Gaps = 84/269 (31%)
Query: 24 RILGQGGQDIVYKGM--------------------AKVEKFINEVVIQSQINHINVVKLI 63
I+G GG VY+ +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 64 GCCLE-------TKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109
G CL+ ++ K +P ++ + +++ + M+YLH A VPI
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 110 HRDIKSTNILLDDKY--------CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--- 158
HRD+KS+NIL+ K K+++FG +R +T + G + ++ P+
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGL--AREWHRTTKMSAA-GAYAWMAPEVIR 187
Query: 159 --------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA---------------- 194
DV S+GV+L ELLTG P F + VA
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 195 -----KRCLNPSGKKRPAMKEVASELAGI 218
+ C NP RP+ + +L I
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-36
Identities = 43/272 (15%), Positives = 83/272 (30%), Gaps = 82/272 (30%)
Query: 18 DSFNVNRILGQGGQDIVYKGM-------AKV-----------EKFINEVVIQSQINHINV 59
N L + ++KG KV F E +H NV
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 60 VKLIGCCLE---------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHL 102
+ ++G C T +M + ++ +++ + M++LH
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH- 128
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158
+ I + S ++++D+ A++S S + ++ P+
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQK 182
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA-------------- 194
D+ SF V+L EL+T P F + N+ +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 195 -------KRCLNPSGKKRPAMKEVASELAGIK 219
K C+N KRP + L ++
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 49/299 (16%), Positives = 90/299 (30%), Gaps = 92/299 (30%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGMA-------KV--------EKFINEVVIQSQINH 56
L + + + +G V+K K+ + EV + H
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH 77
Query: 57 INVVKLIGCCLE-----------TKYM-----HDQNKELPFTWEMQLRISIEASGTMSYL 100
N+++ IG T + D K +W I+ + ++YL
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYL 137
Query: 101 HLSASV-------PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTF 152
H I HRDIKS N+LL + A +++FG + ++ T GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 153 GYLNPD----------------DVCSFGVVLVELLTGAKPIRFT---------------- 180
Y+ P+ D+ + G+VL EL +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 181 TFEEDKNITVAKH---------------------AKRCLNPSGKKRPAMKEVASELAGI 218
+ E+ + + V K + C + + R + V + +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 56/268 (20%), Positives = 95/268 (35%), Gaps = 78/268 (29%)
Query: 18 DSFNVNRILGQGGQDIVYKGM-----------------AKVEKFINEVVIQSQINHINVV 60
V + +G G VYKG +++ F NEV + + H+N++
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 61 KLIGCCLE------TKYM-------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
+G T++ H E F + + I+ + + M YLH +
Sbjct: 84 LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSR-SRAVDQTHITTQVHGTFGYLNPD-------- 158
I HRD+KS NI L + K+ +FG + +H Q+ G+ ++ P+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA------------------ 194
DV +FG+VL EL+TG P + N
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 195 -------KRCLNPSGKKRPAMKEVASEL 215
CL +RP+ + +E+
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 45/269 (16%), Positives = 85/269 (31%), Gaps = 75/269 (27%)
Query: 22 VNRILGQGGQDIVYKGM-----------------AKVEKFINEVVIQSQINHINVVKLIG 64
+ ++G+G VY G +++ F EV+ Q H NVV +G
Sbjct: 37 IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 65 CCLE-------TKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYH 110
C+ T ++ ++ +I+ E M YLH + I H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 111 RDIKSTNILLDDKYCAKVSNFGTSRSRAV----DQTHITTQVHGTFGYLNPD-------- 158
+D+KS N+ D+ +++FG V + +G +L P+
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 159 ------------DVCSFGVVLVELLTGAKP----------------IRFTTFEEDKNITV 190
DV + G + EL P ++ + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEI 272
Query: 191 AKHAKRCLNPSGKKRPAMKEVASELAGIK 219
+ C ++RP ++ L +
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 56/272 (20%), Positives = 97/272 (35%), Gaps = 78/272 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKG--------MAK----------VEKFINEVVIQSQINHINV 59
+LG+G K M F+ EV + + H NV
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 60 VKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSYLHLSA 104
+K IG + T+Y+ ++ + + W ++ + + ASG M+YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG-MAYLH--- 125
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT-------------TQVHGT 151
S+ I HRD+ S N L+ + V++FG +R ++T V G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP---IRFTTFEEDKNI--------- 188
++ P+ DV SFG+VL E++ T + N+
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 189 -----TVAKHAKRCLNPSGKKRPAMKEVASEL 215
+ RC + +KRP+ ++ L
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 49/314 (15%), Positives = 94/314 (29%), Gaps = 103/314 (32%)
Query: 8 FISNELEKATDSFNVNRILGQGGQDIVYKGM-------AKV------EKFINEVVIQ--S 52
++E D+ + ++G+G VYKG KV + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62
Query: 53 QINHINVVKLIGCCLE------------TKYMH-----DQNKELPFTWEMQLRISIEASG 95
+ H N+ + I +Y W R++ +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 96 TMSYLHLSASV------PIYHRDIKSTNILLDDKYCAKVSNFGTSR-------SRAVDQT 142
++YLH I HRD+ S N+L+ + +S+FG S R ++
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 143 HITTQVHGTFGYLNP------------------DDVCSFGVVLVELLTGAKPIRFT---- 180
+ GT Y+ P D+ + G++ E+ +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 181 --------------TFEEDKNI----------------------TVAKHAKRCLNPSGKK 204
TFE+ + + ++ + + C + +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 205 RPAMKEVASELAGI 218
R + +A +
Sbjct: 303 RLTAQXAEERMAEL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-25
Identities = 46/288 (15%), Positives = 85/288 (29%), Gaps = 94/288 (32%)
Query: 24 RILGQGGQDIVYKGM-------AKV------EKFINEVVIQ--SQINHINVVKLIGCCLE 68
+G+G V++G K+ + + E + + H N++ I +
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 69 -----------TKYM-----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASV-----P 107
T Y +D + LRI + + +++LH+
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSR----SRAVDQTHITTQVHGTFGYLNPD----- 158
I HRD+KS NIL+ +++ G + S +V GT Y+ P+
Sbjct: 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDET 192
Query: 159 ------------DVCSFGVVLVELLTGAKPIRFT---------------TFEEDKNITVA 191
D+ +FG+VL E+ +FE+ + +
Sbjct: 193 IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 252
Query: 192 KHA---------------------KRCLNPSGKKRPAMKEVASELAGI 218
K C + R + L I
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-23
Identities = 48/288 (16%), Positives = 84/288 (29%), Gaps = 92/288 (31%)
Query: 24 RILGQGGQDIVYKGM-------AKV------EKFINEVVIQ--SQINHINVVKLIG---- 64
+ +G+G V+ G KV + E I + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 65 -------CCLETKYM-----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASV-----P 107
L T Y +D K + L+++ + + +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH---GTFGYLNPD------ 158
I HRD+KS NIL+ +++ G + D + + GT Y+ P+
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFT---------------TFEEDKNITVAK 192
D+ SFG++L E+ ++E+ + I K
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK 282
Query: 193 HA---------------------KRCLNPSGKKRPAMKEVASELAGIK 219
C + R V LA +
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-23
Identities = 47/304 (15%), Positives = 91/304 (29%), Gaps = 96/304 (31%)
Query: 11 NELEKATDSFNVN--RILGQGGQDIVYKGM-------AKV------EKFINEVVIQ--SQ 53
L + T + + +G+G V++G K+ + E I
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM 92
Query: 54 INHINVVKLIG-----------CCLETKYM-----HDQNKELPFTWEMQLRISIE-ASGT 96
+ H N++ I L + Y D T E +++++ ASG
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG- 151
Query: 97 MSYLHLSASV-----PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH-- 149
+++LH+ I HRD+KS NIL+ +++ G + I +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 150 -GTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFT----------- 180
GT Y+ P+ D+ + G+V E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 181 ----TFEEDKNITVAKHA---------------------KRCLNPSGKKRPAMKEVASEL 215
+ EE + + + + C +G R + L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
Query: 216 AGIK 219
+ +
Sbjct: 332 SQLS 335
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 44/223 (19%), Positives = 80/223 (35%), Gaps = 59/223 (26%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQG--GQDIVYKGMAK--------------VEKF 44
T+ F + + + +G+G G V G + + F
Sbjct: 176 TVAAQDEFYRSGWALNMKELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIKNDATAQAF 233
Query: 45 INEVVIQSQINHINVVKLIGCCLE--------TKYMHD--------QNKELPFTWEMQLR 88
+ E + +Q+ H N+V+L+G +E T+YM + L+
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
S++ M YL HRD+ + N+L+ + AKVS+FG ++ ++
Sbjct: 294 FSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQ 343
Query: 149 HGT-------------FG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFG++L E+ + G P
Sbjct: 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-20
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 76/235 (32%)
Query: 9 ISNELEKATDSF---------NVNRILGQG--GQDIVYKGMAK----------------- 40
++ EL +A + N ++G+G G VY G
Sbjct: 7 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGC--VYHGTLLDNDGKKIHCAVKSLNRI 64
Query: 41 -----VEKFINEVVIQSQINHINVVKLIGCCLETK--------YMHD-------QNKELP 80
V +F+ E +I +H NV+ L+G CL ++ YM +N+
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124
Query: 81 FTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
T + + ++ A G M YL AS HRD+ + N +LD+K+ KV++FG +R +
Sbjct: 125 PTVKDLIGFGLQVAKG-MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--M 178
Query: 140 DQTHITTQVHGTFGYLNP-----------------DDVCSFGVVLVELLT-GAKP 176
+ + T L P DV SFGV+L EL+T GA P
Sbjct: 179 YDKEYYSVHNKTGAKL-PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 57/222 (25%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQG--GQDIVYKGMAK--------------VEKF 44
++ F + + + +G+G G V G + + F
Sbjct: 4 SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIKNDATAQAF 61
Query: 45 INEVVIQSQINHINVVKLIGCCLE--------TKYMHD--------QNKELPFTWEMQLR 88
+ E + +Q+ H N+V+L+G +E T+YM + L+
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ- 147
S++ M YL HRD+ + N+L+ + AKVS+FG ++ + +
Sbjct: 122 FSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTG 174
Query: 148 ------------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
F DV SFG++L E+ + G P
Sbjct: 175 KLPVKWTAPEALREKKFS--TKSDVWSFGILLWEIYSFGRVP 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 68/216 (31%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQS 52
F ++LG G G VYKG+ ++ ++E + +
Sbjct: 15 TEFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 53 QINHINVVKLIGCCLE------TKYM-----------HDQNKELPFTWEMQLRISIEASG 95
+++ +V +L+G CL T+ M H N + ++I A G
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---AKG 129
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ-------- 147
M+YL + HRD+ + N+L+ K+++FG ++ ++ +
Sbjct: 130 -MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 148 ------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+H + + DV S+GV + EL+T G+KP
Sbjct: 186 MALESILHRIYT--HQSDVWSYGVTVWELMTFGSKP 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 53/205 (25%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
++ + LG G G+ V+ G + F+ E + Q+ H +
Sbjct: 13 ETLKLVERLGAGQFGE--VWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 60 VKLIGCCLE------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
V+L + T+YM + + T L ++ + + M+++
Sbjct: 71 VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG------------TFG 153
HRD+++ NIL+ D K+++FG +R ++ T + +G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 154 -YLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFG++L E++T G P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 55/223 (24%), Positives = 84/223 (37%), Gaps = 67/223 (30%)
Query: 12 ELEKATDSFNVNRILGQG--GQDIVYKGMAK----------------------VEKFINE 47
+ + +R++G+G G VY G VE F+ E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGV--VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 48 VVIQSQINHINVVKLIGCCLE--------TKYM-----HD--QNKELPFTWEMQLRISIE 92
++ +NH NV+ LIG L YM ++ + T + + ++
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 93 -ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
A G M YL A HRD+ + N +LD+ + KV++FG +R + +
Sbjct: 133 VARG-MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHR 186
Query: 152 FGYLNP-----------------DDVCSFGVVLVELLT-GAKP 176
L P DV SFGV+L ELLT GA P
Sbjct: 187 HARL-PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 67/211 (31%)
Query: 24 RILGQG--GQDIVYKGMAK----------------------VEKFINEVVIQSQINHINV 59
++G+G G VY G V +F+ E +I +H NV
Sbjct: 95 EVIGRGHFGC--VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 60 VKLIGCCLETK--------YMHD-------QNKELPFTWEMQLRISIE-ASGTMSYLHLS 103
+ L+G CL ++ YM +N+ T + + ++ A G M +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-MKFL--- 208
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP------ 157
AS HRD+ + N +LD+K+ KV++FG +R + + + T L P
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKL-PVKWMAL 265
Query: 158 -----------DDVCSFGVVLVELLT-GAKP 176
DV SFGV+L EL+T GA P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 51/205 (24%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------VEKFINEVVIQSQINHIN 58
+ LG G G+ VY+G+ K VE+F+ E + +I H N
Sbjct: 220 TDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 59 VVKLIGCCLE-------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLS 103
+V+L+G C T++M + + + L ++ + S M YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
+ HR++ + N L+ + + KV++FG SR D + P+
Sbjct: 338 NFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 159 ------DVCSFGVVLVELLT-GAKP 176
DV +FGV+L E+ T G P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-19
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE------TKYM-----HD--QNKELPFTWEMQLR 88
E+ + E I Q+++ +V+LIG C + H K
Sbjct: 55 EEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 114
Query: 89 ISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ + + G M YL HRD+ + N+LL +++ AK+S+FG S++ D ++ T +
Sbjct: 115 LLHQVSMG-MKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 148 VHG------------TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
G F + + DV S+GV + E L+ G KP
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-19
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 55/206 (26%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+S + LGQG G+ V+ G E F+ E + ++ H +
Sbjct: 184 ESLRLEVKLGQGCFGE--VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 241
Query: 60 VKLIGCCLE------TKYMHD--------QNKELPFTWEMQLRISIE-ASGTMSYLHLSA 104
V+L E T+YM + ++ + ASG M+Y+
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG-MAYVERMN 300
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
V HRD+++ NIL+ + KV++FG +R ++ T + F
Sbjct: 301 YV---HRDLRAANILVGENLVCKVADFG--LARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 153 -GYLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFG++L EL T G P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 53/269 (19%), Positives = 93/269 (34%), Gaps = 76/269 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHIN 58
+ + +G+G V+ G + KF+ E I Q +H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 59 VVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSA 104
+V+LIG C + + + + + + L++ +A+ M YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--- 230
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
S HRD+ + N L+ +K K+S+FG SR D + +
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 153 -GYLNPDDVCSFGVVLVELLT-GAKPIRFTTFEEDKNITVAKHA---------------- 194
Y + DV SFG++L E + GA P + N +
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP-----YPNLSNQQTREFVEKGGRLPCPELCPDAV 344
Query: 195 ----KRCLNPSGKKRPAMKEVASELAGIK 219
++C +RP+ + EL I+
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 51/262 (19%), Positives = 90/262 (34%), Gaps = 79/262 (30%)
Query: 20 FNVNRILGQGGQDIVYKGMAKV--------------EKFINEVVIQSQINHINVVKLIGC 65
F ++G GG V+K ++ EK EV ++++H+N+V GC
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 66 CLETKY-------------------------------MHDQNKELPFTWEMQLRISIEAS 94
Y ++ + + L + + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 95 GTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGY 154
+ Y+H S + +RD+K +NI L D K+ +FG S D T GT Y
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSK-GTLRY 187
Query: 155 LNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA--------- 194
++P+ D+ + G++L ELL FE K T +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFTDLRDGIISDIFDKK 243
Query: 195 -----KRCLNPSGKKRPAMKEV 211
++ L+ + RP E+
Sbjct: 244 EKTLLQKLLSKKPEDRPNTSEI 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 58/210 (27%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAKV----------------------EKFINEVVIQSQ 53
+ + R +G+G G V++G+ EKF+ E + Q
Sbjct: 390 ERIELGRCIGEGQFGD--VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 54 INHINVVKLIGCCLE------TKYM-----HD--QNKELPFTWEMQLRISIEASGTMSYL 100
+H ++VKLIG E + Q ++ + + + S ++YL
Sbjct: 448 FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG---------- 150
S HRDI + N+L+ C K+ +FG SR ++ + G
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFG--LSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 151 --TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
F + + DV FGV + E+L G KP
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 55/207 (26%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------VEKFINEVVIQSQINHIN 58
+ LG G G+ VY+G+ K VE+F+ E + +I H N
Sbjct: 13 TDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 59 VVKLIGCCLE-------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLS 103
+V+L+G C T++M + + + L ++ + S M YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF----------- 152
HRD+ + N L+ + + KV++FG SR D T F
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLA 185
Query: 153 --GYLNPDDVCSFGVVLVELLT-GAKP 176
+ DV +FGV+L E+ T G P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 52/261 (19%), Positives = 87/261 (33%), Gaps = 68/261 (26%)
Query: 18 DSFNVNRILGQGGQDIVYK------GMAKVEKFI--------------NEVVIQSQINHI 57
+ + V +G G K G V K + +EV + ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 58 NVVKLIGC---------CLETKY----------MHDQNKELPFTWEMQLRISIEASGTMS 98
N+V+ + +Y + E LR+ + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 99 YLH--LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
H + HRD+K N+ LD K K+ +FG +R D + T V GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTTFEE-DKNITVAKHA---------- 194
P+ D+ S G +L EL P + +E I K
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 195 ----KRCLNPSGKKRPAMKEV 211
R LN RP+++E+
Sbjct: 245 NEIITRMLNLKDYHRPSVEEI 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 55/206 (26%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+S + LGQG G+ V+ G E F+ E + ++ H +
Sbjct: 267 ESLRLEVKLGQGCFGE--VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 324
Query: 60 VKLIGCCLE------TKYMHD--------QNKELPFTWEMQLRISIE-ASGTMSYLHLSA 104
V+L E T+YM + ++ + ASG M+Y+
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG-MAYVERMN 383
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
V HRD+++ NIL+ + KV++FG +R ++ T + F
Sbjct: 384 YV---HRDLRAANILVGENLVCKVADFG--LARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 153 -GYLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFG++L EL T G P
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 40/205 (19%), Positives = 77/205 (37%), Gaps = 53/205 (25%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+S + + LG G G+ V+ VE F+ E + + H +
Sbjct: 188 ESLKLEKKLGAGQFGE--VWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 60 VKLIGCCLE------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
VKL + T++M ++ + S + + M+++
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------- 152
HRD+++ NIL+ K+++FG +R ++ T + F
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 153 GYLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFG++L+E++T G P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 30/162 (18%)
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLE------TKYMHD-------QNKELPFTWEMQLR 88
E+ + E I Q+++ +V+LIG C + K
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 89 ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
+ + S M YL HR++ + N+LL +++ AK+S+FG S++ D ++ T +
Sbjct: 441 LLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 149 HG------------TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
G F + + DV S+GV + E L+ G KP
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 43/213 (20%), Positives = 85/213 (39%), Gaps = 62/213 (29%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQS 52
F ++LG G G VYKG+ ++ ++E + +
Sbjct: 15 TEFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 53 QINHINVVKLIGCCLE------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMS 98
+++ +V +L+G CL T+ M + + + L ++ A G M+
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG-MN 131
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ----------- 147
YL + HRD+ + N+L+ K+++FG ++ ++ +
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 148 ---VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+H + + DV S+GV + EL+T G+KP
Sbjct: 189 ESILHRIYT--HQSDVWSYGVTVWELMTFGSKP 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-18
Identities = 46/224 (20%), Positives = 79/224 (35%), Gaps = 73/224 (32%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQS 52
+ + +ILG+G G V +G K +E+F++E
Sbjct: 34 NLLILGKILGEGEFGS--VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 53 QINHINVVKLIGCCLE------------TKYM------------HDQNKELPFTWEMQLR 88
+H NV++L+G C+E +M + + L+
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 89 ISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
++ A G M YL ++ HRD+ + N +L D V++FG S+ + Q
Sbjct: 152 FMVDIALG-MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYRQ 205
Query: 148 VHGT-------------FG-YLNPDDVCSFGVVLVELLT-GAKP 176
Y + DV +FGV + E+ T G P
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-18
Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 56/209 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV----------------------EKFINEVVIQSQIN 55
+ + R +G+G V++G+ EKF+ E + Q +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 56 HINVVKLIGCCLE------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSYLH 101
H ++VKLIG E + Q ++ + + + ++ ++YL
Sbjct: 75 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA-LAYLE 133
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG----------- 150
V HRDI + N+L+ C K+ +FG SR ++ + G
Sbjct: 134 SKRFV---HRDIAARNVLVSSNDCVKLGDFG--LSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 151 -TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
F + + DV FGV + E+L G KP
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-18
Identities = 42/216 (19%), Positives = 76/216 (35%), Gaps = 68/216 (31%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQS 52
++LG G G V+KG+ + + ++
Sbjct: 13 TELRKLKVLGSGVFGT--VHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 53 QINHINVVKLIGCCLE------TKYM-----------HDQNKELPFTWEMQLRISIEASG 95
++H ++V+L+G C T+Y+ H ++I A G
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI---AKG 127
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ-------- 147
M YL + HR++ + N+LL +V++FG + D +
Sbjct: 128 -MYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 148 ------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
G + + DV S+GV + EL+T GA+P
Sbjct: 184 MALESIHFGKYT--HQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-18
Identities = 41/207 (19%), Positives = 80/207 (38%), Gaps = 57/207 (27%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+ + + LG G G V G K ++F E +++H +
Sbjct: 8 EEITLLKELGSGQFGV--VKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL 65
Query: 60 VKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSYLHLSA 104
VK G C + T+Y+ + ++ L + + G M++L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG-MAFLESHQ 124
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ--------------VHG 150
+ HRD+ + N L+D C KVS+FG +R +D ++++ +
Sbjct: 125 FI---HRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 151 TFGYLNPDDVCSFGVVLVELLT-GAKP 176
+ + DV +FG+++ E+ + G P
Sbjct: 181 KYS--SKSDVWAFGILMWEVFSLGKMP 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 59/207 (28%)
Query: 22 VNRILGQG--GQDIVYKGM----------------------AKVEKFINEVVIQSQINHI 57
++ LG G G V KG A ++ + E + Q+++
Sbjct: 21 EDKELGSGNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 58 NVVKLIGCCLE------TKYM-----HD---QNKELPFTWEMQLRISIEASGTMSYLHLS 103
+V++IG C + + QN+ + ++L + + G M YL
Sbjct: 79 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV-SMG-MKYL--- 133
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG------------T 151
HRD+ + N+LL ++ AK+S+FG S++ D+ + Q HG
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 152 FG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ + + DV SFGV++ E + G KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 48/249 (19%), Positives = 81/249 (32%), Gaps = 97/249 (38%)
Query: 9 ISNELEKATDSFNVNR-------ILGQG--GQDIVYKGMAK------------------- 40
IS+EL++ + + +LG+G G V + K
Sbjct: 7 ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGS--VREAQLKQEDGSFVKVAVKMLKADII 64
Query: 41 ----VEKFINEVVIQSQINHINVVKLIGCCLE-------------TKYM----------- 72
+E+F+ E + +H +V KL+G L +M
Sbjct: 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 73 -HDQNKELPFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130
+ +R ++ A G M YL +S HRD+ + N +L + V++
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACG-MEYL---SSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 131 FGTSRS-------RAVDQTHI---------------TTQVHGTFGYLNPDDVCSFGVVLV 168
FG SR R + + T DV +FGV +
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH----------SDVWAFGVTMW 230
Query: 169 ELLT-GAKP 176
E++T G P
Sbjct: 231 EIMTRGQTP 239
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 55/206 (26%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+ LG G G V G + ++FI E + ++H +
Sbjct: 24 KDLTFLKELGTGQFGV--VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 60 VKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSYLHLSA 104
V+L G C + T+YM + + F + L + + M YL
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA-MEYL---E 137
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
S HRD+ + N L++D+ KVS+FG SR V T+ V F
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 153 -GYLNPDDVCSFGVVLVELLT-GAKP 176
+ + D+ +FGV++ E+ + G P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 63/264 (23%), Positives = 94/264 (35%), Gaps = 87/264 (32%)
Query: 18 DSFNVNRILGQG-------------GQDIVYKGMAK--------VEKFINEVVIQSQINH 56
+ F + R LG+G + K + K + EV IQS + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 57 INVVKLIGCCLETKYMHDQNK-----------EL--------PFTWEMQLRISIEASGTM 97
N+++L G Y HD + + F + E + +
Sbjct: 69 PNILRLYG------YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP 157
SY H S + HRDIK N+LL K+++FG S A GT YL P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC--GTLDYLPP 176
Query: 158 D-----------DVCSFGVVLVELLTGAKPIRFTTFEED------KNIT---------VA 191
+ D+ S GV+ E L G P FE + K I+ V
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVT 231
Query: 192 KHAK----RCLNPSGKKRPAMKEV 211
+ A+ R L + +RP ++EV
Sbjct: 232 EGARDLISRLLKHNPSQRPMLREV 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 50/215 (23%), Positives = 78/215 (36%), Gaps = 68/215 (31%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------------VEKFINEVVIQSQ 53
+ +NRILG+G G+ VY+G+ EKF++E VI
Sbjct: 12 EDVVLNRILGEGFFGE--VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 54 INHINVVKLIGCCLE------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSY 99
++H ++VKLIG E + + + + S++ M+Y
Sbjct: 70 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA-MAY 128
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP-- 157
L V HRDI NIL+ C K+ +FG SR ++ P
Sbjct: 129 LESINCV---HRDIAVRNILVASPECVKLGDFG--LSRYIEDEDYYKASVTRL----PIK 179
Query: 158 ---------------DDVCSFGVVLVELLT-GAKP 176
DV F V + E+L+ G +P
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 59/212 (27%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAKV----------------------EKFINEVVIQSQ 53
++ +I+G G G+ V G +V F++E I Q
Sbjct: 49 SRIHIEKIIGSGDSGE--VCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 54 INHINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMS 98
+H N+++L G T+YM + + + FT + + +G M
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG-MR 165
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG-------- 150
YL V HRD+ + N+L+D KVS+FG SR D T G
Sbjct: 166 YLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 151 ----TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
F + + DV SFGVV+ E+L G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 55/210 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV----------------------EKFINEVVIQSQIN 55
+ ++++++G G V G K+ F+ E I Q +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 56 HINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSYL 100
H N+++L G + T+YM + + + FT + + ASG M YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG-MKYL 163
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG---------- 150
V HRD+ + NIL++ KVS+FG R D T G
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 151 --TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ + + DV S+G+VL E+++ G +P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 66/224 (29%)
Query: 22 VNRILGQGGQDIVYKG-----------------MAK----VEKFINEVVIQSQINHINVV 60
+ LG GG VY + +++F EV SQ++H N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 61 KLI-----------------GCCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLS 103
+I G L +Y+ P + + + + + + + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLS-EYIESHG---PLSVDTAINFTNQILDGIKHAH-- 128
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT--QVHGTFGYLNPD--- 158
+ I HRDIK NIL+D K+ +FG ++A+ +T +T V GT Y +P+
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGI--AKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 159 --------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA-KH 193
D+ S G+VL E+L G P F + +++A KH
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPP-----FNGETAVSIAIKH 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 43/206 (20%), Positives = 69/206 (33%), Gaps = 66/206 (32%)
Query: 24 RILGQG--GQDIVYKG----------------------MAKVEKFINEVVIQSQINHINV 59
+ LG+G G V + F E+ I + H N+
Sbjct: 16 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 60 VKLIGCCLE---------TKYM-----------HDQNKELPFTWEMQLRISIEASGTMSY 99
VK G C +Y+ H + + + +I G M Y
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI---CKG-MEY 129
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------- 152
L + HRD+ + NIL++++ K+ +FG ++ D+ + G
Sbjct: 130 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 153 ------GYLNPDDVCSFGVVLVELLT 172
+ DV SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 44/270 (16%), Positives = 85/270 (31%), Gaps = 65/270 (24%)
Query: 3 KKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAKVE------KFI----------- 45
L N ++ + + + +G+G + + K I
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 46 ---NEVVIQSQINHINVVKLIGCCLETKYMH---------------DQNKELPFTWEMQL 87
EV + + + H N+V+ E ++ + K + F + L
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 88 RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
++ + ++H I HRDIKS NI L ++ +FG +R
Sbjct: 129 DWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE-DKNITVAKHA- 194
+ GT YL+P+ D+ + G VL EL T + + I
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244
Query: 195 -------------KRCLNPSGKKRPAMKEV 211
+ + + RP++ +
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 89/232 (38%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
+ ++R LGQG G VY+G+AK +F+NE +
Sbjct: 25 EKITMSRELGQGSFGM--VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 52 SQINHINVVKLIGCCLETK-------YM----------------HDQNKELPFTWEMQLR 88
+ N +VV+L+G + + M + P + ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 89 ISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-------RAVD 140
++ E A G M+YL + HRD+ + N ++ + + K+ +FG +R R
Sbjct: 143 MAGEIADG-MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 141 QTHI---------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+ + TT DV SFGVVL E+ T +P
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTY----------SDVWSFGVVLWEIATLAEQP 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 42/211 (19%), Positives = 66/211 (31%), Gaps = 67/211 (31%)
Query: 24 RILGQG--GQDIVYKGMAK----------------------VEKFINEVVIQSQINHINV 59
LG+G G V F E+ I ++ +
Sbjct: 29 SQLGKGNFGS--VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 60 VKLIGCCLETK---------YM-----------HDQNKELPFTWEMQLRISIEASGTMSY 99
VK G Y+ H + +I G M Y
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI---CKG-MEY 142
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG--------- 150
L S HRD+ + NIL++ + K+++FG ++ +D+ + + G
Sbjct: 143 LG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 151 ---TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ + DV SFGVVL EL T K
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-17
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 53/205 (25%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK----------------VEKFINEVVIQSQINHINV 59
+ +G G G V+ G E FI E + +++H +
Sbjct: 8 SELTFVQEIGSGQFGL--VHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 60 VKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
V+L G CLE T++M + + F E L + ++ M+YL
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------- 152
+ HRD+ + N L+ + KVS+FG +R V T+ F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 153 GYLNPDDVCSFGVVLVELLT-GAKP 176
Y + DV SFGV++ E+ + G P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-17
Identities = 44/203 (21%), Positives = 71/203 (34%), Gaps = 60/203 (29%)
Query: 24 RILGQG--GQDIVYKG----------------------MAKVEKFINEVVIQSQINHINV 59
+ LG+G G V + F E+ I + H N+
Sbjct: 47 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 60 VKLIGCCLE---------TKYM-----HD--QNKELPFTWEMQLRISIE-ASGTMSYLHL 102
VK G C +Y+ D Q + L+ + + G M YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG-MEYL-- 161
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF---------- 152
+ HRD+ + NIL++++ K+ +FG ++ D+ + + G
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 153 ---GYLNPDDVCSFGVVLVELLT 172
+ DV SFGVVL EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 56/211 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV-----------------------EKFINEVVIQSQI 54
+++G G VYKGM K F+ E I Q
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 55 NHINVVKLIGCCLE-------TKYMHD-------QNKELPFTWEMQLRISIE-ASGTMSY 99
+H N+++L G + T+YM + + K+ F+ + + A+G M Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG-MKY 162
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG--------- 150
L V HRD+ + NIL++ KVS+FG SR D T G
Sbjct: 163 LANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 151 ---TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
++ + + DV SFG+V+ E++T G +P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 71/221 (32%)
Query: 11 NELEKATDSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFI 45
EK R LG+G G+ V +
Sbjct: 16 THFEK--RFLKRIRDLGEGHFGK--VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK 71
Query: 46 NEVVIQSQINHINVVKLIGCCLE---------TKYMHD-------QNKELPFTWEMQLRI 89
E+ I + H N+VK G C E +++ + + QL+
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 90 SIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
+++ G M YL S HRD+ + N+L++ ++ K+ +FG +++ D+ + T +
Sbjct: 132 AVQICKG-MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 149 HGTFGYLNP-----------------DDVCSFGVVLVELLT 172
P DV SFGV L ELLT
Sbjct: 188 DRDS----PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 45/211 (21%), Positives = 74/211 (35%), Gaps = 56/211 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGM------------------------AKVEKFINEVVIQSQ 53
+ LG G +V +G ++ FI EV
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 54 INHINVVKLIGCCLE------TKYM-----HD--QNKELPFTWEMQLRISIE-ASGTMSY 99
++H N+++L G L T+ D + + F R +++ A G M Y
Sbjct: 78 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG-MGY 136
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG--------- 150
L + HRD+ + N+LL + K+ +FG R+ + H Q H
Sbjct: 137 LESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 151 ---TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ + D FGV L E+ T G +P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 69/272 (25%)
Query: 4 KTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEK 43
+FI+++ ++ + + LG G V K K
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 44 FINEVVIQSQINHINVVKLIGCCLETKYMHD-----QNKEL--------PFTWEMQLRIS 90
+ EV + ++H N++KL + + + + EL F I
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 91 IEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQ 147
+ ++YLH I HRD+K N+LL+ K K+ +FG S + +
Sbjct: 143 KQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKE 197
Query: 148 VHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTT--------------FE 183
GT Y+ P+ DV S GV+L LL G P T F+
Sbjct: 198 RLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 184 EDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
+ V++ AK + L ++R + ++
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 59/273 (21%), Positives = 98/273 (35%), Gaps = 74/273 (27%)
Query: 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKF 44
+F+ + +D + R+LG+G V K E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 45 INEVVIQSQINHINVVKLIGCCLETKYMHD-----QNKEL--------PFTWEMQLRISI 91
+ EV + Q++H N++KL + Y + EL F+ RI
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQV 148
+ ++Y+H I HRD+K N+LL+ K ++ +FG S + +
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDK 188
Query: 149 HGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT----------------TF 182
GT Y+ P+ DV S GV+L LL+G P F TF
Sbjct: 189 IGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP--FNGANEYDILKKVEKGKYTF 246
Query: 183 EEDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
E + V++ AK + L R + ++
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 43/213 (20%), Positives = 70/213 (32%), Gaps = 60/213 (28%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQS 52
R LG+G G+ V + E+ I
Sbjct: 31 RYLKKIRDLGEGHFGK--VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR 88
Query: 53 QINHINVVKLIGCCLE---------TKYM-----HDQNKELPFTWEMQLRISIE-ASGTM 97
+ H +++K GCC + +Y+ D L + + G M
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEG-M 147
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG------- 150
+YLH + HRD+ + N+LLD+ K+ +FG +++ + + G
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 151 -----TFG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ DV SFGV L ELLT
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 72/261 (27%)
Query: 19 SFNVNRILGQG--GQDIVYKGM-------------AKVEKFINEVVIQSQIN-HINVVKL 62
SF +LG G G IVY+GM EV + + + H NV++
Sbjct: 25 SFCPKDVLGHGAEGT-IVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY 83
Query: 63 IGCCLETKYMH-----------D--QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109
+ ++ + + + K+ + + + + +++LH S+ I
Sbjct: 84 FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 110 HRDIKSTNILLDDK-----YCAKVSNFGTSRSRAVDQ--THITTQVHGTFGYLNPD---- 158
HRD+K NIL+ A +S+FG + AV + + V GT G++ P+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI--------------TVAKHA 194
D+ S G V +++ + + NI A
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
Query: 195 K----RCLNPSGKKRPAMKEV 211
+ + + +KRP+ K V
Sbjct: 261 RELIEKMIAMDPQKRPSAKHV 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 45/284 (15%), Positives = 84/284 (29%), Gaps = 93/284 (32%)
Query: 20 FNVNRILGQGGQDIVYK------------------GMAKVEKFINEVVIQSQINHINVVK 61
+ + LG+GG V E+ E + NH N+++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 62 LIGCCLETK------YM---------------HDQNKELPFTWEMQLRISIEASGTMSYL 100
L+ CL + ++ ++K T + L + + + +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFG---------TSRSRAVDQTHITTQVHGT 151
H + HRD+K TNILL D+ + + G +A+ Q T
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ-RCT 206
Query: 152 FGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAK-- 195
Y P+ DV S G VL ++ G P ++ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-----YDMVFQKGDSVALAVQ 261
Query: 196 --------------------RCLNPSGKKRPAMKEVASELAGIK 219
+ +RP + + S+L ++
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 47/281 (16%), Positives = 88/281 (31%), Gaps = 90/281 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKGM-----------------AKVEKFINEVVIQSQINHINV 59
F +LGQG V K K+ ++EV++ + +NH V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 60 VKLIGCCLETKYMHDQNKELP-----------------FTW--EMQLRISIEASGT---- 96
V+ LE + + + L +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 97 ----MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS--------------RA 138
+SY+H S I HRD+K NI +D+ K+ +FG +++
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKP---------- 176
++T+ + GT Y+ + D+ S G++ E++
Sbjct: 182 GSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 177 IRFTTFEEDKNI--TVAKHAK----RCLNPSGKKRPAMKEV 211
+R + E + K K ++ KRP + +
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-15
Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 94/278 (33%)
Query: 9 ISNELEKATDSFNVNRILGQGGQDIVY-------------KGMAK--------VEKFINE 47
++ + + + F V +LG+G VY K + K V++ NE
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 48 VVIQSQINHINVVKLIGCCLETK-----------------YMHDQNKELP------FTWE 84
V I Q+ H ++++L E Y+ ++ K F +
Sbjct: 62 VKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS-RSRAVDQTH 143
+ I M YLH S I HRD+ +N+LL K+++FG + + + + H
Sbjct: 121 I-----ITG---MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED------K 186
T GT Y++P+ DV S G + LL G P F+ D
Sbjct: 170 YTLC--GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP-----FDTDTVKNTLN 222
Query: 187 NIT---------VAKHAK----RCLNPSGKKRPAMKEV 211
+ ++ AK + L + R ++ V
Sbjct: 223 KVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 77/222 (34%)
Query: 24 RILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQSQINHIN 58
LG+G G+ V+ + F E + + + H +
Sbjct: 47 WELGEGAFGK--VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 59 VVKLIGCCLE-------TKYM---------------------HDQNKELPFTWEMQLRIS 90
+V+ G C E +YM + P L ++
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 91 IE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQ- 147
+ A+G M YL A + HRD+ + N L+ K+ +FG SR + D + +
Sbjct: 165 SQVAAG-MVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 148 ------------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
++ F DV SFGVVL E+ T G +P
Sbjct: 221 MLPIRWMPPESILYRKFT--TESDVWSFGVVLWEIFTYGKQP 260
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 46/261 (17%), Positives = 86/261 (32%), Gaps = 71/261 (27%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK------VEKFI---------------NEVVIQSQINH 56
+F + + +G+G VY+ K + E+ + Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 57 INVVKLIGCCLETKYMH-----------------DQNKELPFTWEMQLRISIEASGTMSY 99
NV+K +E ++ + ++ + ++ + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD- 158
+H S + HRDIK N+ + K+ + G R + T + V GT Y++P+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTTFEED---KNITVAKHA----------- 194
D+ S G +L E+ P K I +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 195 ----KRCLNPSGKKRPAMKEV 211
C+NP +KRP + V
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 39/205 (19%), Positives = 71/205 (34%), Gaps = 58/205 (28%)
Query: 23 NRILGQGGQDIVYKGM--------------------AKVEKFINEVVIQSQINHINVVKL 62
+ +G+G VYKG+ ++ ++F E + + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 63 IGCCLETKYMHDQNKELPFTWEM----QLRISIEASGTM----------------SYLHL 102
T K + E+ L+ ++ M +LH
Sbjct: 91 YDSWEST---VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH- 146
Query: 103 SASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTHITTQVHGTF--------- 152
+ + PI HRD+K NI + K+ + G + + + V GT
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE 203
Query: 153 -GYLNPDDVCSFGVVLVELLTGAKP 176
Y DV +FG+ ++E+ T P
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 49/227 (21%), Positives = 75/227 (33%), Gaps = 79/227 (34%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
+ + R LG G G+ VY+G F+ E +I
Sbjct: 71 KNITLIRGLGHGAFGE--VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128
Query: 52 SQINHINVVKLIGCCLE-------TKYM-------------HDQNKELPFTWEMQLRISI 91
S+ NH N+V+ IG L+ + M ++ L ++
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 92 E-ASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ A G YL HRDI + N LL AK+ +FG +R + + +
Sbjct: 189 DIACG-CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRK 242
Query: 148 VHGTFGYLNP-----------------DDVCSFGVVLVELLT-GAKP 176
G L P D SFGV+L E+ + G P
Sbjct: 243 --GGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-15
Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 71/232 (30%)
Query: 18 DSFNVNRILGQGGQDIVYKG-------------------MAKVEKFINEVVIQSQINHIN 58
+ ++ ILGQG V++G + V+ + E + ++NH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 59 VVKLIGC-----------CLE-------TKYMHDQNKELPFTWEMQLRISIE--ASGTMS 98
+VKL +E + + + E + I + G M+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGG-MN 126
Query: 99 YLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGY 154
+L I HR+IK NI+ D + K+++FG +R ++ ++GT Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEY 181
Query: 155 LNPD-------------------DVCSFGVVLVELLTGAKPIRFTTFEEDKN 187
L+PD D+ S GV TG+ P F FE +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRR 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 49/227 (21%), Positives = 75/227 (33%), Gaps = 79/227 (34%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
+ + R LG G G+ VY+G F+ E +I
Sbjct: 30 KNITLIRGLGHGAFGE--VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87
Query: 52 SQINHINVVKLIGCCLE-------TKYM-------------HDQNKELPFTWEMQLRISI 91
S+ NH N+V+ IG L+ + M ++ L ++
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 92 E-ASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ A G YL HRDI + N LL AK+ +FG +R + + +
Sbjct: 148 DIACG-CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYYRK 201
Query: 148 VHGTFGYLNP-----------------DDVCSFGVVLVELLT-GAKP 176
G L P D SFGV+L E+ + G P
Sbjct: 202 --GGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 47/276 (17%), Positives = 91/276 (32%), Gaps = 99/276 (35%)
Query: 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINH--IN 58
+++ + +G GG V++ + + ++ + NE+ +++
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 59 VVKLIGCCLETKYMH--------------DQNKELP------FTWEMQLRISIEASGTMS 98
+++L + +Y++ + K + + M +EA +
Sbjct: 90 IIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM-----LEA---VH 141
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI--TTQVHGTFGYLN 156
+H I H D+K N L+ D K+ +FG + D T + +QV GT Y+
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 196
Query: 157 PD----------------------DVCSFGVVLVELLTGAKPIRFTTFEED----KNITV 190
P+ DV S G +L + G P F I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIID 254
Query: 191 AKHA---------------KRCLNPSGKKRPAMKEV 211
H K CL K+R ++ E+
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 56/229 (24%), Positives = 84/229 (36%), Gaps = 70/229 (30%)
Query: 22 VNRILGQGGQDIVYKGM---------AKV------------EKFINEVVIQSQINHINVV 60
+ ILG GG V+ KV +F E + +NH +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 61 KL------IGCCLETKY--MHDQNKEL--------------PFTWEMQLRISIEASGTMS 98
+ Y M E P T + + + +A ++
Sbjct: 76 AVYDTGEAETPAGPLPYIVM-----EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT--QVHGTFGYLN 156
+ H + I HRD+K NI++ KV +FG +R+ A +T V GT YL+
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA-KH 193
P+ DV S G VL E+LTG P F D ++VA +H
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQH 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 54/264 (20%), Positives = 90/264 (34%), Gaps = 87/264 (32%)
Query: 18 DSFNVNRILGQG-------------GQDIVYKGMAK--------VEKFINEVVIQSQINH 56
D F++ R LG+G + K + K + E+ IQS + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 57 INVVKLIGCCLETKYMHDQNK-----------EL--------PFTWEMQLRISIEASGTM 97
N++++ Y HD+ + EL F + E + +
Sbjct: 74 PNILRMYN------YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP 157
Y H + HRDIK N+L+ K K+++FG S + + GT YL P
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGTLDYLPP 181
Query: 158 D-----------DVCSFGVVLVELLTGAKPIRFTTFEED------KNIT---------VA 191
+ D+ GV+ E L G P F+ + I ++
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-----FDSPSHTETHRRIVNVDLKFPPFLS 236
Query: 192 KHAK----RCLNPSGKKRPAMKEV 211
+K + L +R +K V
Sbjct: 237 DGSKDLISKLLRYHPPQRLPLKGV 260
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 46/203 (22%), Positives = 71/203 (34%), Gaps = 56/203 (27%)
Query: 24 RILGQGGQDIVYKGM------------------AKVEKFINEVVIQSQINHINVVKLIGC 65
+LG+G IVY G + E+ + + H N+V+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 66 CLETKY----------------MHDQNKELPFTWEMQLRISIEA--SGTMSYLHLSASVP 107
E + + + L E + + G + YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEG-LKYLH---DNQ 142
Query: 108 IYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTHITTQVHGT-------------FG 153
I HRDIK N+L++ K+S+FGTS+ R T GT G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 154 YLNPDDVCSFGVVLVELLTGAKP 176
Y D+ S G ++E+ TG P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 45/224 (20%), Positives = 81/224 (36%), Gaps = 79/224 (35%)
Query: 24 RILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQSQINHI 57
LG+ G+ VYKG E+F +E ++++++ H
Sbjct: 15 EELGEDRFGK--VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 58 NVVKLIGCCLE-------TKYM----------------------HDQNKELPFTWEMQLR 88
NVV L+G + Y D+ + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 89 ISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
+ + A+G M YL +S + H+D+ + N+L+ DK K+S+ G R V
Sbjct: 133 LVAQIAAG-MEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKL 186
Query: 148 VHGT-------------FG-YLNPDDVCSFGVVLVELLT-GAKP 176
+ + +G + D+ S+GVVL E+ + G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 59/282 (20%), Positives = 92/282 (32%), Gaps = 84/282 (29%)
Query: 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------------- 40
+++ + K +S+ R LG G V K
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 41 -----VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------------DQ-NKELPFT 82
E+ NE+ + ++H N++KL + KY + +Q F
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAV 139
I + + YLH I HRDIK NILL++K K+ +FG S
Sbjct: 145 ECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--F 199
Query: 140 DQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT--------- 180
+ + GT Y+ P+ DV S GV++ LL G P F
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDIIK 257
Query: 181 -------TFEEDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
F+ + ++ AK L KR +E
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 49/223 (21%), Positives = 74/223 (33%), Gaps = 78/223 (34%)
Query: 24 RILGQG--GQDIVYKGMAK-----------------------VEKFINEVVIQSQINHIN 58
R LG+G G+ V+ + F E + + + H +
Sbjct: 21 RELGEGAFGK--VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 59 VVKLIGCCLE-------TKYM----------------------HDQNKELPFTWEMQLRI 89
+VK G C + +YM + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 90 SIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV 148
+ + ASG M YL AS HRD+ + N L+ K+ +FG SR V T
Sbjct: 139 ASQIASG-MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG--MSRDVYSTDYYRVG 192
Query: 149 HGT-------------FG-YLNPDDVCSFGVVLVELLT-GAKP 176
T + + DV SFGV+L E+ T G +P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 47/276 (17%), Positives = 91/276 (32%), Gaps = 99/276 (35%)
Query: 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINH--IN 58
+++ + +G GG V++ + + ++ + NE+ +++
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 59 VVKLIGCCLETKYMH--------------DQNKELP------FTWEMQLRISIEASGTMS 98
+++L + +Y++ + K + + M +EA +
Sbjct: 71 IIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM-----LEA---VH 122
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI--TTQVHGTFGYLN 156
+H I H D+K N L+ D K+ +FG + D T + +QV GT Y+
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 177
Query: 157 PD----------------------DVCSFGVVLVELLTGAKPIRFTTFEED----KNITV 190
P+ DV S G +L + G P F I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIID 235
Query: 191 AKHA---------------KRCLNPSGKKRPAMKEV 211
H K CL K+R ++ E+
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-14
Identities = 52/260 (20%), Positives = 84/260 (32%), Gaps = 81/260 (31%)
Query: 20 FNVNRILGQGGQDIVYKG-------------MAK--------VEKFINEVVIQSQINHIN 58
+ R LG+GG ++ + K EK E+ I + H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 59 VVKLIGCCLETK---YM---HDQNKEL--------PFTWEMQLRISIE--ASGTMSYLHL 102
VV G E ++ + + L T E + R + G YLH
Sbjct: 77 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYYLRQIVLG-CQYLH- 132
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTS-RSRAVDQTHITTQVHGTFGYLNPD--- 158
+ HRD+K N+ L++ K+ +FG + + + GT Y+ P+
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLS 188
Query: 159 --------DVCSFGVVLVELLTGAKPIRFTTFEED------KNIT---------VAKHAK 195
DV S G ++ LL G P FE I + A
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP-----FETSCLKETYLRIKKNEYSIPKHINPVAA 243
Query: 196 ----RCLNPSGKKRPAMKEV 211
+ L RP + E+
Sbjct: 244 SLIQKMLQTDPTARPTINEL 263
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 45/227 (19%), Positives = 75/227 (33%), Gaps = 90/227 (39%)
Query: 24 RILGQG--GQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINV 59
++G+G GQ V K K F E+ + ++ +H N+
Sbjct: 31 DVIGEGNFGQ--VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 60 VKLIGCCLETK-------YM----------------------HDQNKELPFTWEMQLRIS 90
+ L+G C Y + + + L +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 91 IE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS----RAVDQTHI- 144
+ A G M YL + HRD+ + NIL+ + Y AK+++FG SR +
Sbjct: 149 ADVARG-MDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 145 --------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
TT DV S+GV+L E+++ G P
Sbjct: 205 VRWMAIESLNYSVYTTN----------SDVWSYGVLLWEIVSLGGTP 241
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-14
Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 71/232 (30%)
Query: 18 DSFNVNRILGQGGQDIVYKG-------------------MAKVEKFINEVVIQSQINHIN 58
+ ++ ILGQG V++G + V+ + E + ++NH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 59 VVKLIGC-----------CLE-------TKYMHDQNKELPFTWEMQLRISIE--ASGTMS 98
+VKL +E + + + E + I + G M+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGG-MN 126
Query: 99 YLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGY 154
+L I HR+IK NI+ D + K+++FG +R ++ ++GT Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEY 181
Query: 155 LNPD-------------------DVCSFGVVLVELLTGAKPIRFTTFEEDKN 187
L+PD D+ S GV TG+ P F FE +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRR 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 52/260 (20%), Positives = 84/260 (32%), Gaps = 81/260 (31%)
Query: 20 FNVNRILGQGGQDIVYKGM---------AKV------------EKFINEVVIQSQINHIN 58
+ R LG+GG ++ K+ EK E+ I + H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 59 VVKLIGCCLETK---YM---HDQNKEL--------PFTWEMQLRISIE--ASGTMSYLHL 102
VV G E ++ + + L T E + R + G YLH
Sbjct: 103 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYYLRQIVLG-CQYLH- 158
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTS-RSRAVDQTHITTQVHGTFGYLNPD--- 158
+ HRD+K N+ L++ K+ +FG + + + GT Y+ P+
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLS 214
Query: 159 --------DVCSFGVVLVELLTGAKPIRFTTFEED------KNIT---------VAKHAK 195
DV S G ++ LL G P FE I + A
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP-----FETSCLKETYLRIKKNEYSIPKHINPVAA 269
Query: 196 ----RCLNPSGKKRPAMKEV 211
+ L RP + E+
Sbjct: 270 SLIQKMLQTDPTARPTINEL 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 54/265 (20%), Positives = 90/265 (33%), Gaps = 81/265 (30%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINH 56
+ +N+ +LG+G V K + + EV + +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 57 INVVKLIGCCLETKYMHD-----QNKEL--------PFTWEMQ----LRISIEASGTMSY 99
N++KL ++ + EL F+ E ++ ++Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDAARIIKQVFSG---ITY 136
Query: 100 LHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+H I HRD+K NILL+ K K+ +FG S Q GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 157 PD----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNITV 190
P+ DV S GV+L LL+G P F F+ + T+
Sbjct: 192 PEVLRGTYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 191 AKHAK----RCLNPSGKKRPAMKEV 211
+ AK + L R +
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-14
Identities = 54/277 (19%), Positives = 92/277 (33%), Gaps = 87/277 (31%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV-------------------EKFINEVVIQSQINHIN 58
F + LG+GG +V++ KV EK + EV +++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 59 VVKLIGCCLET----------------------------KYMHDQNKELPFTWEMQLRIS 90
+V+ LE +M+ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 91 IEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR------------SRA 138
++ + + +LH S + HRD+K +NI KV +FG +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 139 VDQTHITTQVHGTFGYLNP-----------DDVCSFGVVLVELLT--GAKPIRFTTFEED 185
T QV GT Y++P D+ S G++L ELL + R T +
Sbjct: 182 PAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240
Query: 186 KNITVAKHA-----------KRCLNPSGKKRPAMKEV 211
+N+ + L+PS +RP +
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 41/227 (18%), Positives = 78/227 (34%), Gaps = 73/227 (32%)
Query: 22 VNRILGQGGQDIVYKG-----------------MAK----VEKFINEVVIQSQINHINVV 60
+ R++G+GG VY+ ++ + E ++ +VV
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 61 KLIGCCLETKYMHDQNKELPFTW-EMQ------LRISIEASGTMSY---LHLSASVP--- 107
+HD + + +M+ L + G ++ + + +
Sbjct: 98 P----------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 108 -------IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT--QVHGTFGYLNPD 158
HRD+K NIL+ A + +FG + A +T GT Y+ P+
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGI--ASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA-KH 193
D+ + VL E LTG+ P ++ D ++V H
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP-----YQGD-QLSVMGAH 246
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 52/248 (20%), Positives = 82/248 (33%), Gaps = 107/248 (43%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
+ + + LG+G G+ V K A + ++E +
Sbjct: 23 KNLVLGKTLGEGEFGK--VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80
Query: 52 SQINHINVVKLIGCCLE-------TKYM------------------------------HD 74
Q+NH +V+KL G C + +Y D
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 75 QNKELPFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133
E T + + + + G M YL A + + HRD+ + NIL+ + K+S+FG
Sbjct: 141 HPDERALTMGDLISFAWQISQG-MQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 134 SRSRAVDQTHI------------------------TTQVHGTFGYLNPDDVCSFGVVLVE 169
SR V + TTQ DV SFGV+L E
Sbjct: 197 SRD--VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ----------SDVWSFGVLLWE 244
Query: 170 LLT-GAKP 176
++T G P
Sbjct: 245 IVTLGGNP 252
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 47/223 (21%), Positives = 77/223 (34%), Gaps = 66/223 (29%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKG-------------------MAKVEKFINEVVIQSQI 54
+ + + LG GG V + E++ E+ I ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 55 NHINVVKLIGCCLET-----------------------KYMHDQNKELPFTWEMQLRISI 91
NH NVV + KY++ E +R +
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRTLL 127
Query: 92 E--ASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAVDQTHITT 146
+S + YLH I HRD+K NI+L + K+ + G ++ +DQ + T
Sbjct: 128 SDISSA-LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCT 181
Query: 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR 178
+ GT YL P+ D SFG + E +TG +P
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 47/294 (15%), Positives = 96/294 (32%), Gaps = 95/294 (32%)
Query: 8 FISNELEKATDSFNVNRILGQG--GQDIVYKGM-------------AKVEKFINEVVIQS 52
I N + + +ILG G G +V++G + + E+ + +
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGT-VVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLT 63
Query: 53 QI-NHINVVKLIGCCLETKYMH-----------D--QNKELPFTWEMQLRISIEASGTM- 97
+ +H NV++ ++++ D ++K ++L+ +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLR 122
Query: 98 ------SYLHLSASVPIYHRDIKSTNILLDDKYC-------------AKVSNFGTSRSRA 138
++LH S+ I HRD+K NIL+ +S+FG +
Sbjct: 123 QIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 139 VDQTHITTQVH---GTFGYLNPD------------------DVCSFGVVLVELLTGAKP- 176
Q+ T ++ GT G+ P+ D+ S G V +L+ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 177 ---------------IRFTTFEEDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
+ + ++ A + ++ KRP +V
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 46/276 (16%), Positives = 90/276 (32%), Gaps = 99/276 (35%)
Query: 20 FNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINH--IN 58
+++ + +G GG V++ + + ++ + NE+ +++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 59 VVKLIGCCLETKYMH--------------DQNKELP------FTWEMQLRISIEASGTMS 98
+++L + +Y++ + K + + M +EA +
Sbjct: 118 IIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM-----LEA---VH 169
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI--TTQVHGTFGYLN 156
+H I H D+K N L+ D K+ +FG + D T + +QV G Y+
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMP 224
Query: 157 PD----------------------DVCSFGVVLVELLTGAKPIRFTTFEED----KNITV 190
P+ DV S G +L + G P F I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIID 282
Query: 191 AKHA---------------KRCLNPSGKKRPAMKEV 211
H K CL K+R ++ E+
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 49/240 (20%), Positives = 82/240 (34%), Gaps = 103/240 (42%)
Query: 24 RILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQSQINHI 57
R +G+G G+ V++ A F E + ++ ++
Sbjct: 53 RDIGEGAFGR--VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 58 NVVKLIGCCLETK-------YM------------------------------HDQNKELP 80
N+VKL+G C K YM P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 81 FTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS--- 136
+ QL I+ + A+G M+YL + HRD+ + N L+ + K+++FG SR+
Sbjct: 171 LSCAEQLCIARQVAAG-MAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 137 ----RAVDQTHI---------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+A I TT+ DV ++GVVL E+ + G +P
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTE----------SDVWAYGVVLWEIFSYGLQP 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 33/204 (16%), Positives = 63/204 (30%), Gaps = 61/204 (29%)
Query: 22 VNRILGQGGQDIVY--------------KGMAK------VEKFINEVVIQSQINHINVVK 61
V + GG +Y KG+ + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 62 L--IGCCLETKYMHDQN--------------KEL---PFTWEMQLRISIEASGTMSYLHL 102
+ E H K + +E +SYLH
Sbjct: 144 IFNFV---EHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH- 199
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP----- 157
S+ + + D+K NI+L ++ K+ + G ++ ++GT G+ P
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS--RINSF---GYLYGTPGFQAPEIVRT 251
Query: 158 -----DDVCSFGVVLVELLTGAKP 176
D+ + G L L
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 58/194 (29%)
Query: 36 KGMAKVEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNK-----------EL----- 79
+K + F NE+ I + I + + G + + ++ +
Sbjct: 82 SIKSKYDDFKNELQIITDIKNEYCLTCEG------IITNYDEVYIIYEYMENDSILKFDE 135
Query: 80 ---PFTWEMQLRISIE---------ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAK 127
I I+ + SY+H I HRD+K +NIL+D K
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNS-FSYIH--NEKNICHRDVKPSNILMDKNGRVK 192
Query: 128 VSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGA 174
+S+FG S + I GT+ ++ P+ D+ S G+ L +
Sbjct: 193 LSDFGESEY--MVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 175 KPIRFTTFEEDKNI 188
P F ++
Sbjct: 250 VP-----FSLKISL 258
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 52/242 (21%), Positives = 81/242 (33%), Gaps = 101/242 (41%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
D + + LG+G GQ V + A ++E+ I
Sbjct: 27 DRLKLGKPLGRGAFGQ--VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 52 SQI-NHINVVKLIGCCLE--------TKYM----------------------HDQNKELP 80
I +H+NVV L+G C + ++ + +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 81 FTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
T E + S + A G M +L AS HRD+ + NILL +K K+ +FG +R +
Sbjct: 145 LTLEHLICYSFQVAKG-MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--I 198
Query: 140 DQTHI------------------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GA 174
+ T Q DV SFGV+L E+ + GA
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----------SDVWSFGVLLWEIFSLGA 248
Query: 175 KP 176
P
Sbjct: 249 SP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 46/241 (19%), Positives = 80/241 (33%), Gaps = 98/241 (40%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK--------------------------VEKFINEVV 49
D + + LG+G GQ V A + ++E+
Sbjct: 81 DKLTLGKPLGEGCFGQ--VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 50 IQSQI-NHINVVKLIGCCLE-------TKYM----------------------HDQNKEL 79
+ I H N++ L+G C + +Y ++ E
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 80 PFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-- 136
T++ + + + A G M YL AS HRD+ + N+L+ + K+++FG +R
Sbjct: 199 QMTFKDLVSCTYQLARG-MEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 137 -----RAVDQTHI---------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAK 175
+ + T Q DV SFGV++ E+ T G
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ----------SDVWSFGVLMWEIFTLGGS 304
Query: 176 P 176
P
Sbjct: 305 P 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-13
Identities = 38/204 (18%), Positives = 65/204 (31%), Gaps = 51/204 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVI-QSQINH 56
SF LG G V+K +K + + EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 57 INVVKLIGC-------CLETKY------MHDQNKELPFTWEMQLR-ISIEASGTMSYLHL 102
V+L L+T+ H + E Q+ + +++LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLP-EAQVWGYLRDTLLALAHLH- 174
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158
S + H D+K NI L + K+ +FG + G Y+ P+
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPELLQG 230
Query: 159 ------DVCSFGVVLVELLTGAKP 176
DV S G+ ++E+ +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 34/194 (17%), Positives = 66/194 (34%), Gaps = 47/194 (24%)
Query: 26 LGQGGQDIVYKG--------MA----KVEKF-INEVVIQSQINHINVVKLIGCCLETKYM 72
+G+G V++ A ++E F + E+V + ++ +V L G E ++
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 73 ------------HDQNKEL-PFTWEMQLR-ISIEASGTMSYLHLSASVPIYHRDIKSTNI 118
K++ E + +A + YLH + I H D+K+ N+
Sbjct: 126 NIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 181
Query: 119 LLDDK-YCAKVSNFGTSRSRAVDQTHITTQVHGTF---------------GYLNPDDVCS 162
LL A + +FG + D + D+ S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 163 FGVVLVELLTGAKP 176
+++ +L G P
Sbjct: 242 SCCMMLHMLNGCHP 255
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 48/241 (19%), Positives = 78/241 (32%), Gaps = 98/241 (40%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK--------------------------VEKFINEVV 49
D + + LG+G GQ V A + I+E+
Sbjct: 69 DRLVLGKPLGEGAFGQ--VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 50 IQSQI-NHINVVKLIGCCLE-------TKYM----------------------HDQNKEL 79
+ I H N++ L+G C + +Y N E
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 80 PFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-- 136
+ + + + + A G M YL AS HRD+ + N+L+ + K+++FG +R
Sbjct: 187 QLSSKDLVSCAYQVARG-MEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 137 -----RAVDQTHI---------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAK 175
+ + T Q DV SFGV+L E+ T G
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ----------SDVWSFGVLLWEIFTLGGS 292
Query: 176 P 176
P
Sbjct: 293 P 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 26/208 (12%), Positives = 53/208 (25%), Gaps = 36/208 (17%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
+L+++++ ++ LH + H ++ +I+LD + ++ F
Sbjct: 207 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 140 DQTHITTQVHGTFGYLNP----------------DDVCSFGVVLVELLTGAKPIRFTT-- 181
+ D + G+ + + P T
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDDA 321
Query: 182 --------FEEDKNITVAKHA--KRCLNPSGKKRPAMKEVASELAGIKAWNGASNVMEEG 231
F KNI A + L + R + + S +
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381
Query: 232 ILGRAPTVGGTFKPVPQPRLEVPARTGR 259
PT G P + P G
Sbjct: 382 QTDGEPTREGGAPPSGTSQ---PDEAGA 406
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 48/285 (16%), Positives = 91/285 (31%), Gaps = 90/285 (31%)
Query: 20 FNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQSQI-NHINVV 60
V R+L +GG VY+ K I EV ++ H N+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 61 KLIGCCLETK-----------------------YMHDQNKELPFTWEMQLRISIEASGTM 97
+ K ++ P + + L+I + +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT----------- 146
++H PI HRD+K N+LL ++ K+ +FG++ + + + +
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 147 QVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAK 192
+ T Y P+ D+ + G +L L P FE+ + +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----FEDGAKLRIVN 263
Query: 193 HA-----------------KRCLNPSGKKRPAMKEVASELAGIKA 220
+ L + ++R ++ EV +L I A
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 38/229 (16%), Positives = 70/229 (30%), Gaps = 88/229 (38%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAKV-------------------------EKFINEVVI 50
+ N LGQG + ++KG+ + E F +
Sbjct: 8 EDLIFNESLGQGTFTK--IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 51 QSQINHINVVKLIGCCLETK----------------YMHDQNKELPFTWEMQLRISIEAS 94
S+++H ++V G C+ Y+ + W++++ + A+
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL-AA 124
Query: 95 GTMSYLHLSASVPIYHRDIKSTNILLD--------DKYCAKVSNFGTSRSRAVDQTHITT 146
M +L + H ++ + NILL + K+S+ G S +
Sbjct: 125 A-MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT---------- 170
Query: 147 QVHGTFGYLNP------------------DDVCSFGVVLVELLT-GAKP 176
V D SFG L E+ + G KP
Sbjct: 171 -VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 46/241 (19%), Positives = 80/241 (33%), Gaps = 98/241 (40%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK--------------------------VEKFINEVV 49
D + + LG+G GQ V A + ++E+
Sbjct: 35 DKLTLGKPLGEGAFGQ--VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 50 IQSQI-NHINVVKLIGCCLE-------TKYM----------------------HDQNKEL 79
+ I H N++ L+G C + +Y ++ E
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 80 PFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-- 136
T++ + + + A G M YL AS HRD+ + N+L+ + K+++FG +R
Sbjct: 153 QMTFKDLVSCTYQLARG-MEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 137 -----RAVDQTHI---------------TTQVHGTFGYLNPDDVCSFGVVLVELLT-GAK 175
+ + T Q DV SFGV++ E+ T G
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ----------SDVWSFGVLMWEIFTLGGS 258
Query: 176 P 176
P
Sbjct: 259 P 259
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 33/235 (14%), Positives = 63/235 (26%), Gaps = 67/235 (28%)
Query: 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMA--------------KVEK--FINEVV 49
+ E + + V+ +LG+G VY+ KV+K E
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 50 IQSQI-------NHINVVKLIGC-------CLETKYM-----------HDQNKELPFTWE 84
I +Q+ +K L + + E
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 85 MQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA-----------KVSNFGT 133
+ + ++ + +H I H DIK N +L + + + + G
Sbjct: 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 134 SRS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
S + + I T T G+ + D + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 50/242 (20%), Positives = 80/242 (33%), Gaps = 100/242 (41%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
+ + + LG G G+ V + A E ++E+ +
Sbjct: 23 NRLSFGKTLGAGAFGK--VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 52 SQI-NHINVVKLIGCCLE-------TKYM------------------------HDQNKEL 79
S + NH+N+V L+G C T+Y ++ EL
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 80 PFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138
E L S + A G M++L AS HRD+ + NILL K+ +FG +R
Sbjct: 141 ALDLEDLLSFSYQVAKG-MAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--- 193
Query: 139 VDQTHITTQVHGTFGYLNPD-----------------------DVCSFGVVLVELLT-GA 174
+ Y+ DV S+G+ L EL + G+
Sbjct: 194 --------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 175 KP 176
P
Sbjct: 246 SP 247
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 48/268 (17%), Positives = 86/268 (32%), Gaps = 83/268 (30%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQIN 55
+ + +G+G V + K V++F E+ I ++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 56 HINVVKLIGCCLETKYMH------------DQNKELPFTWEMQLRISIEASGTM------ 97
H N+++L + ++ ++ E +A+ M
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES------DAARIMKDVLSA 118
Query: 98 -SYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQVHGTFG 153
+Y H + + HRD+K N L K+ +FG + + GT
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPY 173
Query: 154 YLNPD----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKN 187
Y++P D S GV++ LL G P F+ TF E
Sbjct: 174 YVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP--FSAPTDSEVMLKIREGTFTFPEKDW 231
Query: 188 ITVAKHAK----RCLNPSGKKRPAMKEV 211
+ V+ A+ R L S K+R +
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 47/229 (20%), Positives = 78/229 (34%), Gaps = 78/229 (34%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
++ + LG G G+ V + A E ++E+ I
Sbjct: 46 NNLQFGKTLGAGAFGK--VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 52 SQI-NHINVVKLIGCCLE-------TKYM--------------------HDQNKELPFTW 83
S + H N+V L+G C T+Y +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 84 EMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
L S + A G M++L AS HRD+ + N+LL + + AK+ +FG +R D
Sbjct: 164 RDLLHFSSQVAQG-MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 143 HITTQ--------------VHGTFGYLNPDDVCSFGVVLVELLT-GAKP 176
+I + DV S+G++L E+ + G P
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEIFSLGLNP 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-12
Identities = 46/202 (22%), Positives = 74/202 (36%), Gaps = 47/202 (23%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHIN 58
+ +G+G IV K E NEVVI H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 59 VVKLIGCCLETK-------YMH-----DQNKELPFTWEMQL-RISIEASGTMSYLHLSAS 105
VV++ L + ++ D ++ E Q+ + ++YLH +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-EEQIATVCEAVLQALAYLH---A 159
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT-----------FGY 154
+ HRDIKS +ILL K+S+FG + D + V GT Y
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLY 218
Query: 155 LNPDDVCSFGVVLVELLTGAKP 176
D+ S G++++E++ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-12
Identities = 53/270 (19%), Positives = 90/270 (33%), Gaps = 89/270 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHI 57
D F R LG G V+ + +E+ E+ + ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 58 NVVKLIGCCLETKYMH-----------------DQNKELPFTWEMQLRISIEASGTM--- 97
N++K+ + M+ Q + + E + M
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS-EG------YVAELMKQM 133
Query: 98 ----SYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQVHG 150
+Y H S + H+D+K NIL D K+ +FG + +T G
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAG 188
Query: 151 TFGYLNPD----------DVCSFGVVLVELLTGAKPIRFT----------------TFEE 184
T Y+ P+ D+ S GVV+ LLTG P FT +
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP--FTGTSLEEVQQKATYKEPNYAV 246
Query: 185 D-KNITV-AKH-AKRCLNPSGKKRPAMKEV 211
+ + +T A K+ L ++RP+ +V
Sbjct: 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 19/161 (11%), Positives = 45/161 (27%), Gaps = 34/161 (21%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
+L+++++ ++ LH + H ++ +I+LD + ++ F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 140 DQTHITTQVHGT-----------------FGYLNPDDVCSFGVVLVELLTGAKPIRFT-- 180
++ D + G+V+ + P T
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITKD 316
Query: 181 --------TFEEDKNITV-AKHA-KRCLNPSGKKRPAMKEV 211
F KNI + + L + R +
Sbjct: 317 AALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 53/267 (19%), Positives = 90/267 (33%), Gaps = 85/267 (31%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINH 56
+ +N+ +LG+G V K + + EV + +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 57 INVVKLIGCCLETKYMH------------DQNKELPFTWEMQLRISIEASGTM------- 97
N++KL ++ + D+ + E +A+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGI 134
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQVHGTFGY 154
+Y+H I HRD+K NILL+ K K+ +FG S Q GT Y
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYY 189
Query: 155 LNPD----------DVCSFGVVLVELLTGAKPIRFT----------------TFEED--K 186
+ P+ DV S GV+L LL+G P F F+ +
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQWR 247
Query: 187 NITV-AKH-AKRCLNPSGKKRPAMKEV 211
I+ AK ++ L R +
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 47/202 (23%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHIN 58
+ +GQG VY M E INE+++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 59 VVKLIGCCLETK-------YMH-----DQNKELPFTWEMQL-RISIEASGTMSYLHLSAS 105
+V + L Y+ D E E Q+ + E + +LH S
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLH---S 134
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT-----------FGY 154
+ HRDIKS NILL K+++FG +Q+ +T V GT Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 155 LNPDDVCSFGVVLVELLTGAKP 176
D+ S G++ +E++ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 52/255 (20%), Positives = 92/255 (36%), Gaps = 60/255 (23%)
Query: 18 DSFNVNRILGQGGQDIVYKG--------MAKVEKFIN-------------EVVIQSQINH 56
D F LG G +V+K MA+ K I+ E+ + + N
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMAR--KLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 57 INVVKLIGC---------CLETKYM-----HDQNKELPFTWEMQL-RISIEASGTMSYLH 101
+V G C+E +M K+ E L ++SI ++YL
Sbjct: 91 PYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR--SRAVDQTHITTQVHGTFGYLNPD- 158
I HRD+K +NIL++ + K+ +FG S ++ + + GT Y++P+
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPER 201
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAM 208
D+ S G+ LVE+ G PI +E + + + + R
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 209 KEVASELAGIKAWNG 223
+ + +
Sbjct: 262 RPLNKFGMDSRPPMA 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 14/164 (8%), Positives = 33/164 (20%), Gaps = 35/164 (21%)
Query: 80 PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139
++ + + L S + H N+ + + +
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 140 DQTHITTQV---------HGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITV 190
+ V T + + + G+ + + P T +
Sbjct: 247 RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306
Query: 191 AKHA-----------------------KRCLNPSGKKRPAMKEV 211
R LN ++R E
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 44/218 (20%), Positives = 73/218 (33%), Gaps = 65/218 (29%)
Query: 18 DSFNVNRILGQGGQDIVYKGM-------------------AKVEKFINEVVIQSQINHIN 58
D + + ++G G +V +++ + E+ SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 59 VVKLIGC---------------------CLETKYMHDQNKELPFTWEMQLRISI---EAS 94
+V ++ ++K E I+ E
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-EST--IATILREVL 131
Query: 95 GTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF-- 152
+ YLH HRD+K+ NILL + ++++FG S A +V TF
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 153 --------------GYLNPDDVCSFGVVLVELLTGAKP 176
GY D+ SFG+ +EL TGA P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 41/248 (16%), Positives = 76/248 (30%), Gaps = 107/248 (43%)
Query: 18 DSFNVNRILGQG--GQDIVYKGMAK------------------------VEKFINEVVIQ 51
++ ++LG G G+ V A E ++E+ +
Sbjct: 45 ENLEFGKVLGSGAFGK--VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 52 SQI-NHINVVKLIGCCLE-------TKYM-----------------------------HD 74
+Q+ +H N+V L+G C +Y +
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 75 QNKELPFTWEMQLRISIE-ASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133
+ T+E L + + A G M +L HRD+ + N+L+ K+ +FG
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKG-MEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 134 SRSRAVDQTHI------------------------TTQVHGTFGYLNPDDVCSFGVVLVE 169
+R + T + DV S+G++L E
Sbjct: 219 ARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----------SDVWSYGILLWE 266
Query: 170 LLT-GAKP 176
+ + G P
Sbjct: 267 IFSLGVNP 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 47/202 (23%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVV 60
+ F+V LG+G VYK + K +++ I E+ I Q + +VV
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87
Query: 61 KLIGCCL-ETK------YM-----HD--QNKELPFTWEMQLR-ISIEASGTMSYLHLSAS 105
K G T Y D + + T E ++ I + YLH
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQSTLKGLEYLH---F 143
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT-----------FGY 154
+ HRDIK+ NILL+ + AK+++FG + T + GT GY
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 202
Query: 155 LNPDDVCSFGVVLVELLTGAKP 176
D+ S G+ +E+ G P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-11
Identities = 39/274 (14%), Positives = 81/274 (29%), Gaps = 85/274 (31%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAKV--------------------EKFINEV-VIQSQIN 55
T F+ +G G V+K + ++ + + EV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 56 HINVVKLIGCCLETKYMHDQN-----------------KELPFTWEMQLR-ISIEASGTM 97
H +VV+ E +M QN F E +L+ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK-EAELKDLLLQVGRGL 128
Query: 98 SYLHLSASVPIYHRDIKSTNILLD-------------------DKYCAKVSNFGTSRSRA 138
Y+H S+ + H DIK +NI + +K K+ + G +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 139 VDQTHITT-------QVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA 191
Q + + +L D+ + + +V ++ I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRNGDQWHEIRQG 243
Query: 192 KHA--------------KRCLNPSGKKRPAMKEV 211
+ K ++P ++RP+ +
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 49/270 (18%), Positives = 89/270 (32%), Gaps = 86/270 (31%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQIN 55
D +++ LG G +V++ + K NE+ I +Q++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 56 HINVVKLIGCCLETKYMH------------DQ--NKELPFTWEMQLRISIEASGTM---- 97
H ++ L + M D+ ++ + E E M
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-EA------EVINYMRQAC 159
Query: 98 ---SYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTSRSRAVDQTHITTQVHGTF 152
++H I H DIK NI+ + K + K+ +FG + ++ I T
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATA 214
Query: 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRFT----------------TFEED 185
+ P+ D+ + GV+ LL+G P F F+ED
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDED 272
Query: 186 KNITVAKHAK----RCLNPSGKKRPAMKEV 211
+V+ AK L +KR + +
Sbjct: 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-11
Identities = 48/207 (23%), Positives = 73/207 (35%), Gaps = 56/207 (27%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHI 57
+ F +G+G V+KG+ +E E+ + SQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 58 NVVKLIGCCLETK-------YM-----HDQNKELPFTWEMQLR-ISIEASGTMSYLHLSA 104
V K G L+ Y+ D + P E Q+ I E + YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-ETQIATILREILKGLDYLH--- 136
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------------ 152
S HRDIK+ N+LL + K+++FG + Q T TF
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG-----QLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 153 ---GYLNPDDVCSFGVVLVELLTGAKP 176
Y + D+ S G+ +EL G P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 44/229 (19%), Positives = 88/229 (38%), Gaps = 61/229 (26%)
Query: 1 TIKKTKLFISNELEKATD---SFNVNRILGQGGQDIVYKGMAK----------------- 40
+++K++ + + + D + + LG G VYK K
Sbjct: 1 SMRKSREY--EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE 58
Query: 41 -VEKFINEVVIQSQINHINVVKLIGCCLE----------------TKYMHDQNKELPFTW 83
+E +I E+ I + +H +VKL+G M + ++ L
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT--- 115
Query: 84 EMQLR-ISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS----RSRA 138
E Q++ + + +++LH S I HRD+K+ N+L+ + ++++FG S ++
Sbjct: 116 EPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172
Query: 139 VDQTHITT-----------QVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
+ I T + Y D+ S G+ L+E+ P
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 51/269 (18%), Positives = 85/269 (31%), Gaps = 87/269 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINH 56
T+ + + LG+G +V + + +K E I + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 57 INVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM---- 97
N+V+L E + + L I +AS +
Sbjct: 70 PNIVRLHDSISEEGHHY---------LIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120
Query: 98 ---SYLHLSASVPIYHRDIKSTNILLDDKYCA---KVSNFGTSRSRAVDQTHITTQVHGT 151
+ H + + HR++K N+LL K K+++FG + +Q GT
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEED- 185
GYL+P+ D+ + GV+L LL G P F
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236
Query: 186 -KNITV-AKH-AKRCLNPSGKKRPAMKEV 211
+T AK + L + KR E
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 39/265 (14%), Positives = 82/265 (30%), Gaps = 76/265 (28%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQIN 55
+ D ++++ LG G +V++ + E E+ S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 56 HINVVKLIGCCLETKYMH------------DQ--NKELPFTWEMQ----LRISIEASGTM 97
H +V L + M ++ ++ + E + +R + +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS-EDEAVEYMRQVCKG---L 268
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
++H H D+K NI+ K K+ +FG + +D GT +
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFA 323
Query: 156 NPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITV 190
P+ D+ S GV+ LL+G P ++ +
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 383
Query: 191 AKHAK----RCLNPSGKKRPAMKEV 211
++ K + L R + +
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 89/284 (31%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKF 44
++ + + +D F V LG+G IVY+ K +
Sbjct: 36 SLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV 95
Query: 45 INEVVIQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS------ 90
E+ + +++H N++KL + ++L RI
Sbjct: 96 RTEIGVLLRLSHPNIIKLKEIFETPTEIS---------LVLELVTGGELFDRIVEKGYYS 146
Query: 91 -IEASGTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCA---KVSNFGTSRSRAV 139
+A+ + +YLH I HRD+K N+L K+++FG S+ V
Sbjct: 147 ERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--V 201
Query: 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+ + V GT GY P+ D+ S G++ LL G +P F D+ +
Sbjct: 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP--FYDERGDQFM 259
Query: 189 -----------------TVAKHAK----RCLNPSGKKRPAMKEV 211
V+ +AK + + KKR +
Sbjct: 260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 70/231 (30%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------V 41
+ + F+ N K +D+++V LG+G +V + + K
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 42 EKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS--- 90
+K E I ++ H N+V+L E + + L I
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHY---------LVFDLVTGGELFEDIVARE 123
Query: 91 ----IEASGTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCA---KVSNFGTSRS 136
+AS + +Y H S I HR++K N+LL K K+++FG +
Sbjct: 124 FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
V+ + GT GYL+P+ D+ + GV+L LL G P
Sbjct: 181 --VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 49/283 (17%), Positives = 89/283 (31%), Gaps = 89/283 (31%)
Query: 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEK 43
L ++++ D + + ++G+G +V + + + E
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 44 FINEVVIQSQINHINVVKLIGCCLETKYMH-----------------DQNKELPFTWEMQ 86
E I + H ++V+L+ ++ + ++ E
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-EA- 130
Query: 87 LRISIEASGTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCA---KVSNFGTSRS 136
AS M Y H I HRD+K +LL K + K+ FG +
Sbjct: 131 -----VASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182
Query: 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED 185
+V GT ++ P+ DV GV+L LL+G P T
Sbjct: 183 LGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241
Query: 186 KNI-------------TVAKHAK----RCLNPSGKKRPAMKEV 211
+ I +++ AK R L +R + E
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 43/204 (21%), Positives = 71/204 (34%), Gaps = 48/204 (23%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN 55
F+ R +G G VY + I EV ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 56 HINVVKLIGCCLETK-------YMH------DQNKELPFTWEMQLR-ISIEASGTMSYLH 101
H N ++ GC L Y + + P E+++ ++ A ++YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-EVEIAAVTHGALQGLAYLH 171
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT---------QVHGTF 152
S + HRD+K+ NILL + K+ +FG++ A + + T
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG 228
Query: 153 GYLNPDDVCSFGVVLVELLTGAKP 176
Y DV S G+ +EL P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 46/269 (17%), Positives = 83/269 (30%), Gaps = 85/269 (31%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAKVE------KFI-----------NEVVIQSQINH 56
++ + + + LG+G IV++ + KF+ E+ I + H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 57 INVVKLIGCCLETKYMH------------DQ--NKELPFTWEMQLRISIEASGTM----- 97
N++ L + + ++ E E +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN-ER------EIVSYVHQVCE 113
Query: 98 --SYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTSRSRAVDQTHITTQVHGTFG 153
+LH S I H DI+ NI+ + + K+ FG +R + +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ--ARQLKPGDNFRLLFTAPE 168
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDK 186
Y P+ D+ S G ++ LL+G P F TF+E+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEA 226
Query: 187 NITVAKHAK----RCLNPSGKKRPAMKEV 211
++ A R L K R E
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-10
Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 70/216 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINH 56
+D+++V LG+G +V + + K +K E I ++ H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 57 INVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM---- 97
N+V+L E + + L I +AS +
Sbjct: 65 PNIVRLHDSIQEESFHY---------LVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 115
Query: 98 ---SYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAVDQTHITTQVHGT 151
+Y H S I HR++K N+LL K K+++FG + V+ + GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAGT 170
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
GYL+P+ D+ + GV+L LL G P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 47/217 (21%), Positives = 78/217 (35%), Gaps = 47/217 (21%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAKVEKFINEVVIQSQINHINVVK 61
+ K KL + +A + + +E+ E+ I +++H NVVK
Sbjct: 46 LSKKKL-----IRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK 100
Query: 62 L---IGCCLETK-YM---HDQNKELPFTWEMQLRISIEA---------SGTMSYLHLSAS 105
L + E YM + +S + G + YLH
Sbjct: 101 LVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQARFYFQDLIKG-IEYLH---Y 155
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------- 158
I HRDIK +N+L+ + K+++FG S ++ V GT ++ P+
Sbjct: 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRK 214
Query: 159 -------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
DV + GV L + G P F D+ I
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCP--F----MDERI 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 48/214 (22%), Positives = 74/214 (34%), Gaps = 69/214 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQSQINHIN 58
+F +LG G V+ + NE+ + +I H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 59 VVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM------ 97
+V L T + + MQL RI +AS +
Sbjct: 68 IVTLEDIYESTTHYY---------LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 98 -SYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFG 153
YLH I HRD+K N+L ++ +++FG S+ ++Q I + GT G
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPG 172
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKP 176
Y+ P+ D S GV+ LL G P
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 41/215 (19%), Positives = 75/215 (34%), Gaps = 67/215 (31%)
Query: 47 EVVIQSQINHINVVKLIGCCLETK---YM----HDQNKELPFTWEMQLRISIEASGTMS- 98
E+ I S++ H N++K++ E + + H +L F + I+ +
Sbjct: 79 EIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDL-FAF-------IDRHPRLDE 129
Query: 99 ---------------YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
YL I HRDIK NI++ + + K+ +FG++ +
Sbjct: 130 PLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKL 185
Query: 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA 191
T GT Y P+ ++ S GV L L+ P F E + A
Sbjct: 186 FYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-----FCELEETVEA 239
Query: 192 KHA-------------KRCLNPSGKKRPAMKEVAS 213
L P ++R ++++ +
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 45/174 (25%), Positives = 67/174 (38%), Gaps = 43/174 (24%)
Query: 47 EVVIQSQINHINVVKLIG-CCLETK--------YMHDQNKELPFTWEMQLRISI-EA--- 93
E+ + ++ H NV++L+ E K Y +E+ + R + +A
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFPVCQAHGY 114
Query: 94 -----SGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS---RSRAVDQTHIT 145
G + YLH S I H+DIK N+LL K+S G + A D T T
Sbjct: 115 FCQLIDG-LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 146 TQ----------VHGTFGYLNPD-DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
+Q +G + D+ S GV L + TG P F E NI
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP--F----EGDNI 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 50/280 (17%), Positives = 89/280 (31%), Gaps = 101/280 (36%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVI 50
D + +++ LG G V + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 51 QSQINHINVVKLIGCCLETKYMH-----DQNKELPFTWEMQLRISIEASGTMS------- 98
++NH ++K+ + + + + EL F + + +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL-FDK-------VVGNKRLKEATCKLY 244
Query: 99 ---------YLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQTHITT 146
YLH I HRD+K N+LL ++ K+++FG S+ + +T +
Sbjct: 245 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH--SKILGETSLMR 299
Query: 147 QVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFT------------ 180
+ GT YL P+ D S GV+L L+G P F+
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKDQI 357
Query: 181 -----TFEEDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
F + V++ A + L K R +E
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 60/220 (27%)
Query: 8 FISNELEKATDSFNVNR--ILGQGGQDIVYKGMAK------------------VEKFINE 47
++ + + V++ ILG G V+K E+ NE
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE 136
Query: 48 VVIQSQINHINVVKLIGCCLETKYMH------------DQ--NKELPFTWEMQ----LRI 89
+ + +Q++H N+++L + D+ ++ T E+ ++
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDTILFMKQ 195
Query: 90 SIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTSRSRAVDQTHITTQ 147
E + ++H + I H D+K NIL ++ K+ +FG +R
Sbjct: 196 ICEG---IRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKV 247
Query: 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
GT +L P+ D+ S GV+ LL+G P
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 61/205 (29%)
Query: 26 LGQGGQDIVYKG--------MA-----------KVEKFINEV-VIQSQINHINVVKLIGC 65
LG+G +V K MA + ++ + ++ + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 66 ---------CLE---------TKYMHDQNKELPFTWEMQL-RISIEASGTMSYLHLSASV 106
C+E K + D+ + +P E L +I++ + +LH S
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIP---EDILGKIAVSIVKALEHLHSKLS- 130
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------- 158
+ HRD+K +N+L++ K+ +FG S VD G Y+ P+
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPERINPELNQ 187
Query: 159 -------DVCSFGVVLVELLTGAKP 176
D+ S G+ ++EL P
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFP 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 59/279 (21%), Positives = 93/279 (33%), Gaps = 97/279 (34%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVV 49
E D ++ LG G +V K K E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 50 IQSQINHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEAS 94
I +I H NV+ L + L ++L ++ EA+
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVI-----LI----LELVAGGELFDFLAEKESLTEEEAT 117
Query: 95 GTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCA----KVSNFGTSRSRAVDQTH 143
+ YLH S+ I H D+K NI+L D+ K+ +FG + +D +
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT------------ 180
+ GT ++ P+ D+ S GV+ LL+GA P F
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVS 230
Query: 181 ----TFEEDKNITVAKHAK----RCLNPSGKKRPAMKEV 211
FE++ + AK R L KKR +++
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 37/139 (26%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCA-KVSNFGTSRSRAVDQTHITTQVHGTFGYLNP 157
+ H S + HRDIK NIL+D + K+ +FG+ + T GT Y P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS--GALLHDEPYTDFD-GTRVYSPP 207
Query: 158 D------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA----------- 194
+ V S G++L +++ G P FE D+ I A+
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP-----FERDQEILEAELHFPAHVSPDCCA 262
Query: 195 --KRCLNPSGKKRPAMKEV 211
+RCL P RP+++E+
Sbjct: 263 LIRRCLAPKPSSRPSLEEI 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 44/216 (20%), Positives = 78/216 (36%), Gaps = 71/216 (32%)
Query: 47 EVVIQSQINHI--NVVKLIGCCLETK---YM----HDQNKELPFTWEMQLRISIEASGTM 97
EVV+ +++ V++L+ E + + ++L F + I G +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDL-FDF-------ITERGAL 146
Query: 98 S----------------YLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVD 140
+ H + + HRDIK NIL+D ++ K+ +FG+ +
Sbjct: 147 QEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS--GALLK 201
Query: 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
T T GT Y P+ V S G++L +++ G P FE D+ I
Sbjct: 202 DTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEI 255
Query: 189 TVAKHA-------------KRCLNPSGKKRPAMKEV 211
+ + CL RP +E+
Sbjct: 256 IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 49/221 (22%), Positives = 76/221 (34%), Gaps = 69/221 (31%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVV 49
+K D +++ LG G IV K K E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 50 IQSQINHINVVKLIGCCLETKYMH------------DQNKELPFTWEMQLRISIEASGTM 97
I Q+ H NV+ L + D + E EA+ +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE------EATSFI 121
Query: 98 -------SYLHLSASVPIYHRDIKSTNILLDDKYCA----KVSNFGTSRSRAVDQTHITT 146
+YLH + I H D+K NI+L DK K+ +FG + ++
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK 176
Query: 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+ GT ++ P+ D+ S GV+ LL+GA P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 48/221 (21%), Positives = 76/221 (34%), Gaps = 75/221 (33%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQS 52
D + + LG G IV K K E+ EV I
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 53 QINHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM 97
+I H N++ L + L ++L ++ EA+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVV-----LI----LELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 98 -------SYLHLSASVPIYHRDIKSTNILLDDKYCA----KVSNFGTSRSRAVDQTHITT 146
YLH S I H D+K NI+L DK K+ +FG + ++ +
Sbjct: 115 KQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFK 169
Query: 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+ GT ++ P+ D+ S GV+ LL+GA P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 48/172 (27%)
Query: 39 AKVEKFINEVVIQSQINHINVVKLIGCCLETK---YM---HDQNKELPFTWEMQLRISIE 92
++K EV I +NH N+VKL +ET+ Y+ + E+ F + +
Sbjct: 56 TSLQKLFREVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEV-FDY-------LV 106
Query: 93 ASGTMS----------------YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
A G M Y H I HRD+K+ N+LLD K+++FG S +
Sbjct: 107 AHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-N 162
Query: 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKP 176
+ G Y P+ DV S GV+L L++G+ P
Sbjct: 163 EFTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 49/221 (22%), Positives = 78/221 (35%), Gaps = 69/221 (31%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVV 49
+K D +++ LG G IV K K E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 50 IQSQINHINVVKLIGCCLETKYMH-----DQNKELPFTWEMQLRIS-------IEASGTM 97
I Q+ H N++ L + EL F ++ EA+ +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-FD-----FLAQKESLSEEEATSFI 121
Query: 98 -------SYLHLSASVPIYHRDIKSTNILLDDKYCA----KVSNFGTSRSRAVDQTHITT 146
+YLH + I H D+K NI+L DK K+ +FG + ++
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK 176
Query: 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
+ GT ++ P+ D+ S GV+ LL+GA P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 44/186 (23%), Positives = 66/186 (35%), Gaps = 58/186 (31%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETK---YM---HDQNKELPFTWEMQLRISIEAS 94
E E+ I +NH NVVK G Y+ + EL F IE
Sbjct: 49 PENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGEL-FDR-------IEPD 99
Query: 95 GTMS----------------YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138
M YLH + I HRDIK N+LLD++ K+S+FG +
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA---T 153
Query: 139 VDQTHITTQVHGTF---------------GYLNPD-DVCSFGVVLVELLTGAKPIRFTTF 182
V + + ++ + DV S G+VL +L G P +
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-----W 208
Query: 183 EEDKNI 188
++ +
Sbjct: 209 DQPSDS 214
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 47/227 (20%), Positives = 81/227 (35%), Gaps = 60/227 (26%)
Query: 3 KKTKLFISNELEKAT-DSFNVNRILGQGGQDIVYKGM-------------------AKVE 42
+ L I + +A + +G G V+K + +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 43 KFINEV-VIQSQINHINVVKLIGC---------CLETKYM------HDQNKELPFTWEMQ 86
+ + ++ V+ + +V+ G +E M + + P E
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME--LMGTCAEKLKKRMQGPIP-ERI 125
Query: 87 L-RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
L ++++ + YL + HRD+K +NILLD++ K+ +FG S R VD
Sbjct: 126 LGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS-GRLVDDKAKD 182
Query: 146 TQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKP 176
G Y+ P+ DV S G+ LVEL TG P
Sbjct: 183 RSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 55/231 (23%), Positives = 82/231 (35%), Gaps = 64/231 (27%)
Query: 3 KKTKLFISNE--LEKATDSFNVNRILGQGGQDIVYKG--------MA-KV------EKFI 45
KL IS E + + +G+G V K MA K EK
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 46 NEV-----VIQSQINHINVVKLIGC---------CLE----------TKYMHDQNKELPF 81
++ V+ + +V+ G C+E + +P
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP- 123
Query: 82 TWEMQL-RISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140
E L +I++ +++L + I HRDIK +NILLD K+ +FG S + VD
Sbjct: 124 --EEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVD 178
Query: 141 QTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKP 176
T G Y+ P+ DV S G+ L EL TG P
Sbjct: 179 SIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-09
Identities = 38/178 (21%), Positives = 64/178 (35%), Gaps = 40/178 (22%)
Query: 70 KYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS 129
+M+ + + L I I+ + + +LH S + HRD+K +NI KV
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 130 NFGTSR------------SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVV 166
+FG + T QV GT Y++P+ D+ S G++
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 167 LVELLTGAKP----------IRFTTFEEDKNITVAKHA---KRCLNPSGKKRPAMKEV 211
L ELL +R F + + L+PS +RP ++
Sbjct: 266 LFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 44/186 (23%), Positives = 66/186 (35%), Gaps = 58/186 (31%)
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETK---YM---HDQNKELPFTWEMQLRISIEAS 94
E E+ I +NH NVVK G Y+ + EL F IE
Sbjct: 49 PENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGEL-FDR-------IEPD 99
Query: 95 GTMS----------------YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138
M YLH + I HRDIK N+LLD++ K+S+FG +
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA---T 153
Query: 139 VDQTHITTQVHGTF---------------GYLNPD-DVCSFGVVLVELLTGAKPIRFTTF 182
V + + ++ + DV S G+VL +L G P +
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-----W 208
Query: 183 EEDKNI 188
++ +
Sbjct: 209 DQPSDS 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 86/268 (32%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAKVE------KFIN--------EV-VIQSQINHINVVK 61
TD + V +G G + + + K K I+ E+ ++ H N++
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 62 LIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM-------SY 99
L + KY++ +L +I EAS + Y
Sbjct: 81 LKDVYDDGKYVY---------VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 100 LHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
LH + + HRD+K +NIL + ++ +FG ++ + + T T ++
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFV 187
Query: 156 NPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNI---------------- 188
P+ D+ S GV+L +LTG P + + I
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247
Query: 189 -TVAKHAK----RCLNPSGKKRPAMKEV 211
+V+ AK + L+ +R V
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 37/218 (16%), Positives = 65/218 (29%), Gaps = 63/218 (28%)
Query: 17 TDSFNVNRILGQGGQDI--VYKGMAK--------------------VEKFINEVVIQSQI 54
+ + ++G+G +D+ V K V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 55 NHINVVKLIGCCLE-------TKYM-----HD---QNKELPFTWEMQLR-ISIEASGTMS 98
NH N+V + T +M D + E+ + I +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQGVLKALD 142
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-------RAVDQTHITTQVHGT 151
Y+H V HR +K+++IL+ +S ++ S + V V
Sbjct: 143 YIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KV 198
Query: 152 -------------FGYLNPDDVCSFGVVLVELLTGAKP 176
GY D+ S G+ EL G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 20/127 (15%)
Query: 65 CCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124
+E + + + T E + S + + M +L AS HRD+ + NILL +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 230
Query: 125 CAKVSNFGTSRSRAVDQTHITTQ--------------VHGTFGYLNPDDVCSFGVVLVEL 170
K+ +FG +R D ++ + + DV SFGV+L E+
Sbjct: 231 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEI 288
Query: 171 LT-GAKP 176
+ GA P
Sbjct: 289 FSLGASP 295
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 41/217 (18%), Positives = 80/217 (36%), Gaps = 59/217 (27%)
Query: 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAKVEKF-------------------INEVVI 50
+ + + + +G+G +VYK + I E+ +
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 51 QSQINHINVVKLIGCC------------LET---KYMHDQNKELPF----TWEMQLRISI 91
+++H N+V LI +E K + + L + QL +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL---L 129
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV--- 148
+++ H I HRD+K N+L++ K+++FG +R+ + T +V
Sbjct: 130 RG---VAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 149 --------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G+ Y D+ S G + E++TG KP+
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 4e-08
Identities = 33/163 (20%), Positives = 64/163 (39%), Gaps = 39/163 (23%)
Query: 45 INEVVIQSQINHINVVKLIGCC------------LET---KYMHDQNKELPF----TWEM 85
+ E+ + ++ H N+V+L + KY N +L ++
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
QL ++ + + H S + HRD+K N+L++ K++NFG +R+ + +
Sbjct: 109 QL---LKG---LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
Query: 146 TQV-----------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+V G Y D+ S G + EL +P+
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 48/227 (21%), Positives = 77/227 (33%), Gaps = 81/227 (35%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAKV---------------------------EKFINEVV 49
+++ ILG+G +V + + K E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 50 IQSQIN-HINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEA 93
I +++ H N+++L + L ++ E
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFF---------LVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 94 SGTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
M LH + I HRD+K NILLDD K+++FG S +D
Sbjct: 127 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 147 QVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKP 176
+V GT YL P+ D+ S GV++ LL G+ P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 42/229 (18%), Positives = 75/229 (32%), Gaps = 78/229 (34%)
Query: 9 ISNELEKATDSFNVNRILGQGGQDIVYKG--------------------------MAKVE 42
+S + D + +++ LG G V
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 43 KFINEVVIQSQINHINVVKLIGCCLETKYMH-----DQNKELPFTWEMQLRISIEASGTM 97
E+ I ++NH ++K+ + + + + EL F + + +
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL-FDK-------VVGNKRL 111
Query: 98 S----------------YLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRA 138
YLH I HRD+K N+LL + K+++FG S+
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH--SKI 166
Query: 139 VDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTG 173
+ +T + + GT YL P+ D S GV+L L+G
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 40/175 (22%), Positives = 63/175 (36%), Gaps = 52/175 (29%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETK---------------YM-HD-----QNKELPFT- 82
+ E+ I + H NVV LI C + HD N + FT
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123
Query: 83 -----WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS- 136
L +G + Y+H I HRD+K+ N+L+ K+++FG +R+
Sbjct: 124 SEIKRVMQML-----LNG-LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 137 ---RAVDQTHITTQV-----------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ T +V G Y P D+ G ++ E+ T PI
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 65/226 (28%)
Query: 18 DSFNVNRILGQGG-----------------------QDIVYKG---MAKVEKFINEVVIQ 51
+ F+V+RI+G+GG + I K +A E+ + +V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 52 SQINHINVVKLIGC-------CLETKYM-------HDQNKELPFTWEMQLRI-SIEASGT 96
S + +V + M H + F+ E +R + E
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FS-EADMRFYAAEIILG 304
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ ++H + + +RD+K NILLD+ ++S+ G + + + H V GT GY+
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMA 358
Query: 157 PD------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITV 190
P+ D S G +L +LL G P F + +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEI 402
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 46/206 (22%), Positives = 71/206 (34%), Gaps = 65/206 (31%)
Query: 23 NRILGQGGQDIVYKGM---------------AKVEKFINEVVIQSQI-NHINVVKLIGCC 66
++ LG+G I K + E+ H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 67 LETKYMHDQNKELPFTWEMQL--------RIS-------IEASGTM-------SYLHLSA 104
+ + M+L RI EAS M S++H
Sbjct: 76 HDQLHTF---------LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH--- 123
Query: 105 SVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--- 158
V + HRD+K N+L D+ K+ +FG +R + D + T T Y P+
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLN 182
Query: 159 --------DVCSFGVVLVELLTGAKP 176
D+ S GV+L +L+G P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 59/209 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV---------------EKF----INEVVIQSQINHIN 58
+++ LG+G VYKG +K+ E I EV + + H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 59 VVKLIGCC------------LET---KYMHDQNKELPF----TWEMQLRISIEASGTMSY 99
+V L L+ +Y+ D + + QL G ++Y
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL-----LRG-LAY 115
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV----------- 148
H + HRD+K N+L++++ K+++FG +R++++ +V
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172
Query: 149 HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G+ Y D+ G + E+ TG +P+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATG-RPL 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 44/226 (19%), Positives = 81/226 (35%), Gaps = 75/226 (33%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAKVEKFINEVV--------------------IQSQ 53
K D F V R+ GQG V G EK V +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLG---KEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAV 75
Query: 54 INHINVVKLIGC-------------------CLET------KYMHDQNKELP------FT 82
++H N+V+L + + + + P F
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA-KVSNFGTSRSRAVDQ 141
+++ +R ++ LH SV + HRDIK N+L+++ K+ +FG+++ + +
Sbjct: 136 FQL-IR-------SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 142 TH---ITTQ-------VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ I ++ + G Y D+ S G + E++ G +PI
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 67/223 (30%)
Query: 10 SNELEKATDSFNVNRILGQGGQDIVYKGMA----------KV---EKFIN-EVVIQSQIN 55
S+ +++G G +VY+ KV ++F N E+ I +++
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD 105
Query: 56 HINVVKLIGC------------------CLET------KYMHDQNKELP------FTWEM 85
H N+V+L + ++ + LP + +++
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQ--T 142
R +++Y+H S I HRDIK N+LLD D K+ +FG+++ +
Sbjct: 166 -FR-------SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 143 H-ITTQ-------VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
I ++ + G Y + DV S G VL ELL G +PI
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 19/102 (18%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT---------Q 147
+ Y H + HRD+K N+LLD AK+++FG S + + T+ +
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180
Query: 148 VHGTFGYLNPD-DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
V Y P+ D+ S GV+L LL G P F +D+++
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP--F----DDEHV 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-07
Identities = 39/209 (18%), Positives = 78/209 (37%), Gaps = 59/209 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKVEKF-------------------INEVVIQSQINHIN 58
+ ++ +G+G +VYK + I E+ I ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 59 VVKLIGCC------------LET---KYMHDQNKELPF----TWEMQLRISIEASGTMSY 99
+VKL L+ K + L ++ +QL + ++Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL---LNG---IAY 115
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQV----------- 148
H + HRD+K N+L++ + K+++FG +R+ + T ++
Sbjct: 116 CH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 149 HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G+ Y D+ S G + E++ G P+
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 52/183 (28%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 33 IVYKGMAKVEKFINEVVIQSQINHINVVKLIGCCLETK---YM---HDQNKELPFTWEMQ 86
+ +G A E E++ + H N+V+ + T + + EL +
Sbjct: 52 YIERGAAIDENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGEL-YERICN 109
Query: 87 L-RIS-IEA--------SGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA--KVSNFGTS 134
R S EA SG +SY H S+ I HRD+K N LLD K+ +FG S
Sbjct: 110 AGRFSEDEARFFFQQLLSG-VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
Query: 135 RSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF 182
+S +V + + V GT Y+ P+ DV S GV L +L GA P F
Sbjct: 166 KS-SVLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-----F 218
Query: 183 EED 185
E+
Sbjct: 219 EDP 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 42/233 (18%), Positives = 75/233 (32%), Gaps = 74/233 (31%)
Query: 4 KTKLFISNELEKATDSFNVN-RILGQGGQDIVYKGMAK--------------------VE 42
T+ +E + + + + LG+G +V + ++K
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73
Query: 43 KFINEVVIQSQINHI-NVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RISIEA 93
+ ++E+ + V+ L T + L ++ E
Sbjct: 74 EILHEIAVLELAKSCPRVINLHEVYENTSEII-----LI----LEYAAGGEIFSLCLPEL 124
Query: 94 SGTMS----------------YLHLSASVPIYHRDIKSTNILLDDKYCA---KVSNFGTS 134
+ +S YLH I H D+K NILL Y K+ +FG S
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 135 RSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP 176
R + ++ GT YL P+ D+ + G++ LLT P
Sbjct: 182 RK--IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 42/217 (19%), Positives = 70/217 (32%), Gaps = 63/217 (29%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHIN 58
F + ++G G VYKG E+ E+ + + +H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 59 VVKLIGCCLETKYMHDQNK-----EL----------------PFTWEMQLR-ISIEASGT 96
+ G ++ ++ E E + I E
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEWIAYICREILRG 141
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH------------- 143
+S+LH + HRDIK N+LL + K+ +FG S +D+T
Sbjct: 142 LSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWM 196
Query: 144 ----ITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
I + Y D+ S G+ +E+ GA P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 50/210 (23%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMA---------KV---EKFIN-EVVIQSQINHINVV 60
E+ ++ +++G G +V++ KV ++F N E+ I + H NVV
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVV 95
Query: 61 KLIGCCLETKYMHDQNK-----E-LPFTWEMQLRISIEASGTMS---------------- 98
L D+ E +P T R + TM
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 99 YLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQ--TH-ITTQ------- 147
Y+H S+ I HRDIK N+LLD K+ +FG+++ + I ++
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ G Y D+ S G V+ EL+ G +P+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 19/102 (18%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT---------Q 147
+ Y H I HRD+K N+LLDD K+++FG S T+ +
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 148 VHGTFGYLNPD-DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
V Y P+ DV S G+VL +L G P F +D+ I
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP--F----DDEFI 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 19/92 (20%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YL + I HRD+K NILLD+ +++F + + + T + GT Y+ P+
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM--LPRETQITTMAGTKPYMAPE 184
Query: 159 DVC--------------SFGVVLVELLTGAKP 176
S GV ELL G +P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 46/226 (20%), Positives = 78/226 (34%), Gaps = 80/226 (35%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVI 50
++ ++G+G +V + + + E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 51 QSQI-NHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IEAS 94
Q+ H +++ LI + +M L ++ E
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMF---------LVFDLMRKGELFDYLTEKVALSEKETR 203
Query: 95 GTM-------SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ 147
M S+LH + I HRD+K NILLDD ++S+FG S ++ +
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRE 258
Query: 148 VHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKP 176
+ GT GYL P+ D+ + GV+L LL G+ P
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 19/101 (18%)
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT---------QV 148
Y H + HRD+K N+LLD AK+++FG S + + T+ +V
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 149 HGTFGYLNPD-DVCSFGVVLVELLTGAKPIRFTTFEEDKNI 188
Y P+ D+ S GV+L LL G P F +D ++
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLP--F----DDDHV 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 15/92 (16%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCA-KVSNFGTSRSRAVDQTH---ITTQ----- 147
+ ++H S+ I HRDIK N+L++ K K+ +FG+++ + I ++
Sbjct: 154 VGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210
Query: 148 --VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ G Y D+ S G V EL+ G KP+
Sbjct: 211 ELMLGATEYTPSIDLWSIGCVFGELILG-KPL 241
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 52/214 (24%), Positives = 79/214 (36%), Gaps = 55/214 (25%)
Query: 12 ELEKAT-DSFNVNRILGQGG-----------QDIVY--KGMAK--------VEKFINEVV 49
E + T ++F R+LG+GG +Y K + K +NE
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 50 IQSQINHINVVKLIGC-------CLETKYM-------HDQN-KELPFTWEMQLRI-SIEA 93
I ++N VV L CL M H + + F E + + E
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEI 295
Query: 94 SGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFG 153
+ LH I +RD+K NILLDD ++S+ G + QT GT G
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKP 176
Y+ P+ D + G +L E++ G P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 55/325 (16%), Positives = 88/325 (27%), Gaps = 119/325 (36%)
Query: 1 TIKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------- 40
+ ++ F L + +++ +GQG +V +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 41 ---VEKFINEVVIQSQINHINVVKLI----------------------------GCCLET 69
VE+ EV + +++H N+ +L
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 70 KYMHDQNKELPFTWEMQLRISI------------------EASGTM-------SYLHLSA 104
K D K +I S M YLH
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--- 185
Query: 105 SVPIYHRDIKSTNILLDDKYCA--KVSNFGTSR---SRAVDQTHITTQVHGTFGYLNPD- 158
+ I HRDIK N L K+ +FG S+ + + T GT ++ P+
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 159 ------------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNITV 190
D S GV+L LL GA P F FE +
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVP--FPGVNDADTISQVLNKKLCFENPNYNVL 303
Query: 191 AKHAK----RCLNPSGKKRPAMKEV 211
+ A+ LN + +R
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 45/216 (20%), Positives = 76/216 (35%), Gaps = 56/216 (25%)
Query: 12 ELEKAT-DSFNVNRILGQGG-----------QDIVY--KGMAK--------VEKFINEVV 49
E + D F R+LG+GG +Y K + K + + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 50 IQSQINHINVVKLIGC-------CLETKYM----------HDQNKELPFTWEMQLRI-SI 91
I ++++ +V L CL M + F E + +
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTA 296
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
+ + +LH I +RD+K N+LLDD ++S+ G + QT GT
Sbjct: 297 QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKP 176
G++ P+ D + GV L E++ P
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 22/87 (25%), Positives = 44/87 (50%), Gaps = 12/87 (13%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQ-------VHG 150
Y+H +A + HRD+K N+ +++ K+ +FG +R + T ++ T+ +
Sbjct: 143 YIH-AAGI--IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN 199
Query: 151 TFGYLNPDDVCSFGVVLVELLTGAKPI 177
Y D+ S G ++ E++TG K +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 17/90 (18%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ----------- 147
+LH SA + HRD+K +NI++ K+ +FG +R+ + + T
Sbjct: 142 HLH-SAGI--IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 196
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
V GY D+ S G ++ E++ G +
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 12/87 (13%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQ-------VHG 150
Y+H SA V HRD+K N+ +++ K+ +FG +R + T + T+ +
Sbjct: 141 YIH-SAGV--VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILS 197
Query: 151 TFGYLNPDDVCSFGVVLVELLTGAKPI 177
Y D+ S G ++ E+LTG K +
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQ-------VHG 150
Y+H SA + HRD+K +N+ +++ K+ +FG +R A + T ++ T+ +
Sbjct: 147 YIH-SADI--IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLN 203
Query: 151 TFGYLNPDDVCSFGVVLVELLTGAKPI 177
Y D+ S G ++ ELLTG + +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 35/168 (20%), Positives = 70/168 (41%), Gaps = 45/168 (26%)
Query: 45 INEVVIQSQINHINVVKLIGCC------------LET---KYMHDQNKEL---PFT---- 82
I E+ + ++ H N+V+L ++ KYM +
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 83 --WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140
++ QL ++ +++ H I HRD+K N+L++ + K+ +FG +R+ +
Sbjct: 111 KYFQWQL---LQG---LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161
Query: 141 QTHITTQV-----------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+++V G+ Y D+ S G +L E++TG KP+
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 40/163 (24%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETK-------YM-HD-----QNKELPFT------WEM 85
+ E+ + +++H N++ L+ +M D ++ L T + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 86 QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145
G + YLH I HRD+K N+LLD+ K+++FG ++S T
Sbjct: 120 MT-----LQG-LEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 146 TQV-----------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
QV G Y D+ + G +L ELL P
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 17/90 (18%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQ----------- 147
+LH SA + HRD+K +NI++ K+ +FG +R+ + + T
Sbjct: 179 HLH-SAGI--IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
V GY D+ S G ++ E++ K +
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 68/230 (29%)
Query: 10 SNELEKATDSFNVNRI-LGQGGQDIVYKG------------MAKVEKF------INEVVI 50
S+E E+ D F +G+G VYK + ++E E+ +
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL 71
Query: 51 QSQINHINVVKLIGCCLE-----------------TKYMHDQNKELPFTWEMQLRISIEA 93
++ H NV+ L L + +QL +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 94 S-------GTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTSRSRAV--- 139
S G + YLH + + HRD+K NIL+ ++ K+++ G +R
Sbjct: 132 SLLYQILDG-IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPI 177
+ V TF Y P+ D+ + G + ELLT +PI
Sbjct: 188 PLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 46/213 (21%), Positives = 75/213 (35%), Gaps = 64/213 (30%)
Query: 17 TDSFNVNR-ILGQGGQDIVY-------------KGMAKVEKFINEVVIQSQI-NHINVVK 61
TD + +++ +LG G V K + K EV Q ++V
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 86
Query: 62 LIGCCLETKYMHDQNKELPFTWEMQL--------RIS---------IEASGTM------- 97
++ E + + + M+ RI EA+ M
Sbjct: 87 ILDVY-ENMHHGKRCLLII----MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 98 SYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAVDQTHITTQVHGTFGY 154
+LH S I HRD+K N+L K K+++FG ++ Q + T T Y
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPYY 195
Query: 155 LNPD-----------DVCSFGVVLVELLTGAKP 176
+ P+ D+ S GV++ LL G P
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 45/202 (22%), Positives = 73/202 (36%), Gaps = 62/202 (30%)
Query: 24 RILGQGGQDIVY-------------KGMAKVEKFINEVVIQSQI-NHINVVKLIGCCLET 69
++LG G V K + K EV + + ++V+++ E
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVY-EN 126
Query: 70 KYMHDQNKELPFTWEMQL--------RISI---------EASGTM-------SYLHLSAS 105
Y + + M+ RI EAS M YLH S
Sbjct: 127 LYAGRKCLLIV----MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 179
Query: 106 VPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158
+ I HRD+K N+L K K+++FG ++ + +TT T Y+ P+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGP 237
Query: 159 -------DVCSFGVVLVELLTG 173
D+ S GV++ LL G
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCG 259
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 36/102 (35%), Positives = 48/102 (47%), Gaps = 18/102 (17%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+LH + I +RDIK NILLD +++FG S+ D+T GT Y+ PD
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 159 DVC-------------SFGVVLVELLTGAKPIRFTTFEEDKN 187
V S GV++ ELLTGA P FT E +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNS 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 19/94 (20%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+H + HRDIK NIL+D ++++FG+ D T ++ GT Y++P+
Sbjct: 190 SVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 159 ----------------DVCSFGVVLVELLTGAKP 176
D S GV + E+L G P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-06
Identities = 43/219 (19%), Positives = 71/219 (32%), Gaps = 70/219 (31%)
Query: 18 DSFNVNRILGQG-----------GQDIVY--KGMAK--------VEKFINEVVIQSQINH 56
D F + +++G+G VY K M K V F E + +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 57 INVVKLIGCCLETK---YM------------HDQNKELPFTWEM------QLRISIEASG 95
+ +L + + Y+ EM ++ ++I+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID--- 176
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYL 155
+H + HRDIK NILLD ++++FG+ D T + GT YL
Sbjct: 177 ---SVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 156 NP---------------DDVC---SFGVVLVELLTGAKP 176
+P C + GV E+ G P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 7e-06
Identities = 23/94 (24%), Positives = 42/94 (44%), Gaps = 19/94 (20%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCA-KVSNFGTSRSRAVDQTH---ITTQVH----- 149
Y+H SA+V HRD+K N+ ++ + K+ +FG +R +H ++ +
Sbjct: 135 YIH-SANV--LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 150 ------GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
Y D+ + G + E+LTG K +
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 8e-06
Identities = 36/165 (21%), Positives = 61/165 (36%), Gaps = 44/165 (26%)
Query: 45 INEVVIQSQINHINVVKLIGCC------------LET---KYMHDQNKELP------FTW 83
+ E+ + Q+ H N+V L+ + + + +P TW
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
Q ++A +++ H HRD+K NIL+ K+ +FG +R +
Sbjct: 110 --QT---LQA---VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158
Query: 144 ITTQVH-----------GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+V G Y P DV + G V ELL+G P+
Sbjct: 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 10/137 (7%), Positives = 27/137 (19%), Gaps = 34/137 (24%)
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
+R + H + + + + +
Sbjct: 132 IRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL------------------ 170
Query: 147 QVHGTFGYLNP----DDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVA-KHAKRCLNPS 201
+ DD+ G L LL P + A +
Sbjct: 171 ---AYPATMPDANPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEP 225
Query: 202 GKKRPAMKEVASELAGI 218
++ +++ +
Sbjct: 226 ADIDR---DIPFQISAV 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 24/89 (26%), Positives = 36/89 (40%), Gaps = 14/89 (15%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT---HITTQ-------V 148
LH A V HRD+ NILL D + +F +R D ++T + V
Sbjct: 149 VLH-EAGV--VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 149 HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
G+ D+ S G V+ E+ K +
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 35/165 (21%), Positives = 61/165 (36%), Gaps = 44/165 (26%)
Query: 45 INEVVIQSQINHINVVKLIGCC------------LET---KYMHDQNKELP------FTW 83
+ E+ + Q+ H N+V L+ C ++ + L + +
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143
Q+ I + + H S I HRDIK NIL+ K+ +FG +R+ A
Sbjct: 132 --QI---ING---IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180
Query: 144 ITTQVH-----------GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+V G Y DV + G ++ E+ G +P+
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 33/167 (19%), Positives = 63/167 (37%), Gaps = 44/167 (26%)
Query: 45 INEVVIQSQINHINVVKLIGCCLETK-------YMH-------DQNKELPF----TWEMQ 86
I EV + ++ H N+++L Y D+N ++ ++ Q
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA-----KVSNFGTSRSRAVDQ 141
L +G +++ H S HRD+K N+LL + K+ +FG +R+ +
Sbjct: 141 L-----ING-VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 142 THITTQV-----------HGTFGYLNPDDVCSFGVVLVELLTGAKPI 177
T ++ G+ Y D+ S + E+L P+
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 15/90 (16%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS-RSRAVDQTHITTQVHGTFGYLNP 157
YLH I HRD+K NILL++ ++++FGT+ + GT Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 158 D-----------DVCSFGVVLVELLTGAKP 176
+ D+ + G ++ +L+ G P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 47/237 (19%), Positives = 74/237 (31%), Gaps = 89/237 (37%)
Query: 16 ATDSFNVN---------RILGQGGQDIVYKGMAK------------------VEKFINEV 48
+TDSF+ +LG+G V + + EV
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 49 VIQSQI-NHINVVKLIGCCLETKYMHDQNKELPFTWEMQL--------RIS-------IE 92
+ Q H NV++LI E + L + I +E
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFY-----LV----FEKMRGGSILSHIHKRRHFNELE 112
Query: 93 ASGTM-------SYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSR------- 135
AS + +LH + I HRD+K NIL + K+ +F
Sbjct: 113 ASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 136 SRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKP 176
+ + T G+ Y+ P+ D+ S GV+L LL+G P
Sbjct: 170 CSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 27/93 (29%), Positives = 39/93 (41%), Gaps = 18/93 (19%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+H S+ HRD+K N+LLD K+++FGT + GT Y++P+
Sbjct: 183 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 159 ---------------DVCSFGVVLVELLTGAKP 176
D S GV L E+L G P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 18/93 (19%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH---ITTQVH------ 149
Y+H SA+V HRD+K +N+LL+ K+ +FG +R D H +T V
Sbjct: 143 YIH-SANV--LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 150 -----GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
+ GY D+ S G +L E+L+ +PI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 14/89 (15%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YLH +V +Y RD+K N++LD K+++FG + + GT YL P+
Sbjct: 263 YLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE 319
Query: 159 -----------DVCSFGVVLVELLTGAKP 176
D GVV+ E++ G P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 19/75 (25%), Positives = 29/75 (38%), Gaps = 3/75 (4%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
Y+H SA + HRD+K N L++ KV +FG +R+ + +
Sbjct: 171 YVH-SAGI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 159 DVCSFGVVLVELLTG 173
L LTG
Sbjct: 228 VTFPHTKNLKRQLTG 242
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 24/100 (24%), Positives = 36/100 (36%), Gaps = 25/100 (25%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF------ 152
LH ++V HRD+K +N+L++ KV +FG +R +
Sbjct: 127 VLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 153 ---------------GYLNPDDVCSFGVVLVELLTGAKPI 177
Y DV S G +L EL +PI
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 35/156 (22%), Positives = 60/156 (38%), Gaps = 36/156 (23%)
Query: 52 SQINHINVVKLIGCCLETKYMHDQNKELPFTW-EMQLRISIEASGT-------------- 96
H NVV+L+ C ++ + L F + LR ++ +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 97 ----MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152
+ +LH + I HRD+K NIL+ K+++FG +R + +T V T
Sbjct: 129 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV-TL 183
Query: 153 GYLNPD-----------DVCSFGVVLVELLTGAKPI 177
Y P+ D+ S G + E+ KP+
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 18/92 (19%), Positives = 39/92 (42%), Gaps = 14/92 (15%)
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCA-KVSNFGTSRSRAVDQT---HITTQVH--- 149
+ Y H S+ I HRD+K N+++D ++ ++ ++G + Q + ++
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 150 ----GTFGYLNPDDVCSFGVVLVELLTGAKPI 177
Y D+ S G +L ++ +P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 36/156 (23%)
Query: 52 SQINHINVVKLIGCCLETKYMHDQNKELPFTW-EMQLRISIEASGT-------------- 96
H NVV+L C ++ + L F + L ++
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 97 ----MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTF 152
+ +LH S + HRD+K NIL+ K+++FG +R + +T+ V T
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TL 183
Query: 153 GYLNPD-----------DVCSFGVVLVELLTGAKPI 177
Y P+ D+ S G + E+ KP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 15/89 (16%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+LH S+ I +RD+K NILLD++ K+++FG S+ ++D GT Y+ P+
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 159 DVC-----------SFGVVLVELLTGAKP 176
V SFGV++ E+LTG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
++H + + HRD+K N LL+ KV +FG +R+ ++ P
Sbjct: 144 FIH-ESGI--IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 159 D 159
+
Sbjct: 201 N 201
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 43/194 (22%), Positives = 66/194 (34%), Gaps = 61/194 (31%)
Query: 24 RILGQGGQDIVY-------------KGMAKVEKFINEVVIQSQI-NHINVVKLIGCCLET 69
++LG G V K + K EV + + ++V+++ E
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVY-EN 82
Query: 70 KYMHDQNKELPFTWEMQL--------RISI---------EASGTM-------SYLHLSAS 105
Y + + M+ RI EAS M YLH S
Sbjct: 83 LYAGRKCLLIV----MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 135
Query: 106 VPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPDDVCS 162
+ I HRD+K N+L K K+++FG + G Y D+ S
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFG-----------FAKETTGE-KYDKSCDMWS 183
Query: 163 FGVVLVELLTGAKP 176
GV++ LL G P
Sbjct: 184 LGVIMYILLCGYPP 197
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 33/211 (15%), Positives = 69/211 (32%), Gaps = 59/211 (27%)
Query: 20 FNVNRILGQGGQDIVYKG---------MAKVEKFINEV--------VIQSQINHINVVKL 62
+ V R +G+G ++++G K E ++ + + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 63 IGCCLETKY---------------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
E + + ++ F+ + + + + +H
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH---EKS 126
Query: 108 IYHRDIKSTNILL---DDKYCAKVS--NFGTSRS--RAVDQTHI----TTQVHGTFGY-- 154
+ +RDIK N L+ + K + +FG + V + HI + GT Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 155 LNP---------DDVCSFGVVLVELLTGAKP 176
+N DD+ + G V + L G+ P
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 5e-04
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+LH I +RD+K NI+L+ + K+++FG + ++ +T GT Y+ P+
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPE 191
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
D S G ++ ++LTGA P FT K
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKK 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 3/61 (4%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
YLH S + HRD+K +NILL+ + KV++FG SRS +
Sbjct: 124 YLH-SGGL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 159 D 159
D
Sbjct: 181 D 181
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 18/122 (14%)
Query: 75 QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL-DDKYCA-KVSNFG 132
+ + + + + + +L + + I H D+K NILL + K A K+ +FG
Sbjct: 148 NTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
Query: 133 TSRSRAVDQTHITTQVHGTF----------GYLNPDDVCSFGVVLVELLTGAKPIRFTTF 182
+S I + F Y D+ S G +LVE+ TG +P+ F+
Sbjct: 207 SS---CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL-FSGA 261
Query: 183 EE 184
E
Sbjct: 262 NE 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD 158
+LH S I +RD+K NILLD K+++FG + + T GT Y+ P+
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFTTFEEDK 186
D SFGV+L E+L G P F +E++
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 21/137 (15%), Positives = 51/137 (37%), Gaps = 24/137 (17%)
Query: 59 VVKLIGCCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNI 118
V+ +G L+ D + + + L+++ + +LH H ++ + NI
Sbjct: 136 VLPSLGRSLQ--SALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI 190
Query: 119 LLDDKYCAKV--SNFGTSRSRAVDQTHI------TTQVHGTFGY--LNP---------DD 159
+D + ++V + +G + H+ + G + ++ D
Sbjct: 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSD 250
Query: 160 VCSFGVVLVELLTGAKP 176
+ S G +++ L G P
Sbjct: 251 LQSLGYCMLKWLYGFLP 267
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.47 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.89 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.62 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.44 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 91.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 86.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 85.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 84.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 82.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.62 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=360.07 Aligned_cols=206 Identities=25% Similarity=0.447 Sum_probs=169.6
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
.|++..++|++.++||+|+||+||+|+++ .+.|.+|+++|++++|||||+++|+|.+..
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iV 109 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV 109 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEE
Confidence 35566788999999999999999999753 467999999999999999999999976542
Q ss_pred --cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 --YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 --~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
|+.. ......+++..++.|+.|++.||.||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 3321 123356899999999999999999999 8899999999999999999999999999998654322
Q ss_pred -ceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC--------------------ccchh
Q 044995 142 -THITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT--------------------FEEDK 186 (288)
Q Consensus 142 -~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~--------------------~~~~~ 186 (288)
.......+||+.||||| |||||||++|||+||+.||.... ....+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 22334567999999999 99999999999999999996422 12345
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.++.+++.+||+.||++||||.||+++|+.+..
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 7889999999999999999999999999987754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=357.12 Aligned_cols=203 Identities=23% Similarity=0.391 Sum_probs=163.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 70 (288)
..++|.+.++||+|+||.||+|+++ .+.|.+|+++|++|+|||||+++|+|.+.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467888899999999999999631 467999999999999999999999987653
Q ss_pred -----ccccc---------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC
Q 044995 71 -----YMHDQ---------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY 124 (288)
Q Consensus 71 -----~l~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~ 124 (288)
|+... ....++++..++.|+.|++.||.||| +++|+||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence 22211 01246899999999999999999999 88899999999999999999
Q ss_pred ceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC-----------
Q 044995 125 CAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT----------- 180 (288)
Q Consensus 125 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~----------- 180 (288)
.+||+|||+++....... .......||+.||||| |||||||++|||+| |+.||...
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986543322 2233467999999999 99999999999999 89999643
Q ss_pred ----CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 181 ----TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 181 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
..+..++.++.+++.+||+.||++||||.||+++|+.+...
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 23445688999999999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=355.01 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=168.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
.++|.+.+.||+|+||.||+|++. .+.|.+|+++|++|+|||||+++|+|.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 478999999999999999999631 467999999999999999999999987653
Q ss_pred ----ccccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceE
Q 044995 71 ----YMHDQ-------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAK 127 (288)
Q Consensus 71 ----~l~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~k 127 (288)
|+... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 22211 12246899999999999999999999 88899999999999999999999
Q ss_pred EecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-------------
Q 044995 128 VSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------- 181 (288)
Q Consensus 128 l~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------- 181 (288)
|+|||+|+......... .....||+.||||| |||||||++|||+| |+.||...+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998654333222 23356999999999 99999999999999 899996432
Q ss_pred --ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 --FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+.++.+++.+||+.||++|||+.+|++.|+++...
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3455688999999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=360.37 Aligned_cols=194 Identities=21% Similarity=0.292 Sum_probs=159.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH--- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~--- 73 (288)
.++|++++.||+|+||+||+|+++ .+.|.+|+++|++|+|||||++++++.+.+.++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999753 467999999999999999999999987654332
Q ss_pred ----c--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 74 ----D--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 74 ----~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. ......+++..++.++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 1 122345788899999999999999999 8899999999999999999999999999998654221
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
......+||+.||||| |||||||++|||++|+.||...+ .+...+.++.+||.
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 1223467999999999 99999999999999999996543 23345788999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.||++|||+.|++++
T Consensus 259 ~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999886
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=353.00 Aligned_cols=207 Identities=24% Similarity=0.359 Sum_probs=170.0
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeee
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKL 62 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l 62 (288)
++...|+ ..+++++.++||+|+||+||+|.+. .+.|.+|+.+|++++|||||++
T Consensus 17 ~~~~~ei--~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 17 QAKLKEI--SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp --CCCBC--CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCcccC--CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 3344443 3467788899999999999998631 4689999999999999999999
Q ss_pred cceEeccc-------ccccc----------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCC
Q 044995 63 IGCCLETK-------YMHDQ----------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDI 113 (288)
Q Consensus 63 ~~~~~~~~-------~l~~~----------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl 113 (288)
+|+|.+.+ |+... .....+++..++.++.|++.||.||| +++||||||
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDL 171 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDL 171 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCc
Confidence 99987643 22110 01235889999999999999999999 888999999
Q ss_pred CCCCeeecCCCceEEecccCccccCCCC-ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCC
Q 044995 114 KSTNILLDDKYCAKVSNFGTSRSRAVDQ-THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFT 180 (288)
Q Consensus 114 kp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~ 180 (288)
||+|||+++++.+||+|||+++...... ........||+.||||| |||||||++|||+| |..||...
T Consensus 172 K~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 172 ATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp SGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred cccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 22234457999999999 99999999999998 89999643
Q ss_pred C---------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 181 T---------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 181 ~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+ .+..++.++.+++.+||+.||++||||.||+++|+.+
T Consensus 252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2 3456788999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=340.49 Aligned_cols=194 Identities=21% Similarity=0.276 Sum_probs=154.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~- 74 (288)
.++|++.+.||+|+||+||+|+++ .+.+.+|+++|++++|||||++++++.+.+.++.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999752 4578999999999999999999999876543321
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 112346899999999999999999999 889999999999999999999999999999864332 2
Q ss_pred eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
.....+||+.||||| |||||||++|||++|+.||...+ ++...+.++.+++.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 233467999999999 99999999999999999996543 2344578899999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l 215 (288)
|+.||++|||+.|++++=
T Consensus 247 L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp SCSSGGGSCCHHHHHHCH
T ss_pred ccCChhHCcCHHHHHcCc
Confidence 999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=354.55 Aligned_cols=211 Identities=25% Similarity=0.393 Sum_probs=176.7
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCC-Cceeee
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINH-INVVKL 62 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~H-pnIv~l 62 (288)
|..++|+...++|++.+.||+|+||.||+|.+. .+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 556778888999999999999999999998631 4579999999999976 899999
Q ss_pred cceEecc--------ccccc---------c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeC
Q 044995 63 IGCCLET--------KYMHD---------Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRD 112 (288)
Q Consensus 63 ~~~~~~~--------~~l~~---------~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd 112 (288)
+|+|.+. ||+.. . .....+++..++.++.|++.||.||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9998653 22211 0 01234889999999999999999999 88999999
Q ss_pred CCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCC
Q 044995 113 IKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRF 179 (288)
Q Consensus 113 lkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~ 179 (288)
|||+|||+++++.+||+|||+|+....... .......||+.||||| |||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433 2334567999999999 99999999999998 8999965
Q ss_pred CC----------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 180 TT----------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 180 ~~----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.. .+...+.++.++|.+||+.||++||||.||+++|+.+...
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 33 2334578999999999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=349.43 Aligned_cols=194 Identities=23% Similarity=0.308 Sum_probs=165.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
.+.|++.++||+|+||.||+|+++ .+.+.+|+++|++++|||||+++++|.+.+.++...
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999763 456899999999999999999999987765433221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 77 ----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 77 ----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+....... ...
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 228 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 228 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccc
Confidence 1235899999999999999999999 88999999999999999999999999999987644332 234
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl 198 (288)
..+||+.||||| |||||||++|||++|+.||...+ .....+.++.+||.+||
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 568999999999 99999999999999999996432 12245788999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++|||+.|++++
T Consensus 309 ~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 309 VRDPAQRATAAELLKH 324 (346)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=345.55 Aligned_cols=201 Identities=24% Similarity=0.333 Sum_probs=169.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||+||+|+++ .+.+.+|+++|++|+|||||++++++.+.+.++..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999753 45789999999999999999999998776544322
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC-
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ- 141 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~- 141 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 2 2236899999999999999999999 8899999999999999999999999999998764332
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
.....+.+||+.||||| |||||||++|||++|..||...+ ++...+.++.++|.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 23344578999999999 99999999999999999996543 344567899999999
Q ss_pred hcCCCCCCCCCHHHHHHH--HHhchh
Q 044995 197 CLNPSGKKRPAMKEVASE--LAGIKA 220 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~--l~~~~~ 220 (288)
||+.||++|||+.|++.+ |.+...
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCC
Confidence 999999999999987543 444433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=339.81 Aligned_cols=188 Identities=21% Similarity=0.394 Sum_probs=156.5
Q ss_pred ccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEec-----------c
Q 044995 21 NVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLE-----------T 69 (288)
Q Consensus 21 ~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----------~ 69 (288)
++.++||+|+||.||+|.++ .+.|.+|+++|++|+|||||+++++|.. .
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 67788999999999999753 4679999999999999999999998753 1
Q ss_pred cccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeec-CCCceEEecccCccccCCC
Q 044995 70 KYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 ~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~~~~ 140 (288)
+|+... .....+++..+..++.|++.||.||| +++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 333221 12246899999999999999999999 776 99999999999997 4789999999999854322
Q ss_pred CceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~l 193 (288)
.....+||+.||||| |||||||++|||+||+.||.... .+...+.++.++
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred ---ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 233468999999999 99999999999999999996432 122345789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|.+||+.||++|||+.|+++|
T Consensus 263 i~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=347.43 Aligned_cols=203 Identities=19% Similarity=0.188 Sum_probs=166.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN------ 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~------ 76 (288)
..+.|++.++||+|+||.||+|+++ ...+.+|+.+|++|+|||||++++++.+.++++...
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3467888899999999999999864 122358999999999999999999987765433211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCCCce----e
Q 044995 77 -------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTH----I 144 (288)
Q Consensus 77 -------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~----~ 144 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.+| .+||+|||+|+........ .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 2236899999999999999999999 89999999999999999887 5999999999865432211 1
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~ 196 (288)
....+||+.||||| |||||||++|||++|+.||.... .+...+.++.++|.+
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~ 292 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQE 292 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHH
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHH
Confidence 23357999999999 99999999999999999996432 233457889999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 197 CLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
||+.||++|||+.|++++|......
T Consensus 293 ~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 293 GLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=351.34 Aligned_cols=194 Identities=23% Similarity=0.307 Sum_probs=165.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
.+.|++.++||+|+||.||+|+++ .+.+.+|+.+|++++|||||+++++|.+.+.++...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999763 467899999999999999999999987765433221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 77 ----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 77 ----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+.+..... ...
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 305 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 305 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence 1235899999999999999999999 88999999999999999999999999999987643322 234
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~li~~cl 198 (288)
..+||+.||||| |||||||++|||++|+.||..... ....+.++.+||.+||
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 385 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 385 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence 568999999999 999999999999999999964321 2235789999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
..||++|||+.|++++
T Consensus 386 ~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 386 VRDPAQRATAAELLKH 401 (423)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=337.77 Aligned_cols=188 Identities=27% Similarity=0.295 Sum_probs=152.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
.++|++++.||+|+||+||+|++. ..++.+|+++|++++|||||++++++.+.+.++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 367999999999999999998641 346889999999999999999999987765433
Q ss_pred ccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 DQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
... ....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 211 2236899999999999999999999 889999999999999999999999999999864332
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAK 195 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~ 195 (288)
. ......+||+.||||| |||||||++|||+||+.||...+ ++...+.++.++|.
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2 2234467999999999 99999999999999999996543 34456889999999
Q ss_pred HhcCCCCCCCCCH
Q 044995 196 RCLNPSGKKRPAM 208 (288)
Q Consensus 196 ~cl~~~p~~Rp~~ 208 (288)
+||+.||++|||+
T Consensus 259 ~~L~~dP~~R~ta 271 (304)
T 3ubd_A 259 MLFKRNPANRLGA 271 (304)
T ss_dssp HHTCSSGGGSTTC
T ss_pred HHcccCHHHCCCC
Confidence 9999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=331.38 Aligned_cols=205 Identities=19% Similarity=0.321 Sum_probs=157.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------HHHHH--HHHHHHhcCCCCceeeecceEecc-----------cc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------VEKFI--NEVVIQSQINHINVVKLIGCCLET-----------KY 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~--~E~~~l~~l~HpnIv~l~~~~~~~-----------~~ 71 (288)
.+|.+.++||+|+||+||+|+++ .+.+. .|+..+.+++|||||+++++|.+. ||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 56889999999999999999763 33444 455556789999999999998653 22
Q ss_pred cccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 72 MHDQ-----NKELPFTWEMQLRISIEASGTMSYLHLS-----ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 72 l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
+... .....+++..+++++.|++.||.|||+. +..+|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 2211 1223688999999999999999999932 23389999999999999999999999999998654433
Q ss_pred cee---eeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCC--------------------
Q 044995 142 THI---TTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTT-------------------- 181 (288)
Q Consensus 142 ~~~---~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~-------------------- 181 (288)
... ....+||+.||||| |||||||++|||+||..||....
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 221 23357999999999 99999999999999976652110
Q ss_pred -----------cc-----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 -----------FE-----EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 -----------~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+ .+....+.+++.+||+.||++||||.||++.|+.+....
T Consensus 243 ~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00 012357889999999999999999999999999887643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=329.11 Aligned_cols=192 Identities=27% Similarity=0.416 Sum_probs=144.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecc--------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 69 (288)
.++|++++.||+|+||+||+|+++ .+.|.+|+++|++|+|||||++++++.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999753 46789999999999999999999987542
Q ss_pred -----------cccccc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEe
Q 044995 70 -----------KYMHDQ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS 129 (288)
Q Consensus 70 -----------~~l~~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~ 129 (288)
+|+... .......+..++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 222111 11113456678899999999999999 8899999999999999999999999
Q ss_pred cccCccccCCCCce-----------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------
Q 044995 130 NFGTSRSRAVDQTH-----------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------ 181 (288)
Q Consensus 130 DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------ 181 (288)
|||+|+........ .....+||+.||||| |||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99999865432211 123357999999999 99999999999996 764221
Q ss_pred -------cc---chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 182 -------FE---EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 182 -------~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++ ...+....+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1223456789999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=337.40 Aligned_cols=195 Identities=19% Similarity=0.304 Sum_probs=161.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEec--------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLE-------- 68 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------- 68 (288)
.++|++++.||+|+||+||+|+++ .+.+++|+++|++|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999763 4578899999999999999999987542
Q ss_pred -----cccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 69 -----TKYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 69 -----~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
.+|+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 233321 223457999999999999999999999 8899999999999999999999999999998653
Q ss_pred CCC---ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------
Q 044995 139 VDQ---THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------- 183 (288)
Q Consensus 139 ~~~---~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------------- 183 (288)
... .......+||+.||||| ||||+||++|||++|+.||.+.+..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 321 22234568999999999 9999999999999999999654311
Q ss_pred -------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+||.+||..||++|||+.|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0125678899999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.19 Aligned_cols=203 Identities=17% Similarity=0.258 Sum_probs=163.0
Q ss_pred eHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 9 ISNELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
.++.+....++|++.++||+|+||+||+|+++ ..++.+|+++|+.+ +|||||++++++.+
T Consensus 12 l~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 12 LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HHHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34556667889999999999999999999642 45788999999998 69999999999877
Q ss_pred cccccccCCC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCcccc
Q 044995 69 TKYMHDQNKE----------LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSR 137 (288)
Q Consensus 69 ~~~l~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~ 137 (288)
.++++...+. ..+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 6544322111 24789999999999999999999 8899999999999999876 89999999999754
Q ss_pred CCCCc---------------------------eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCC
Q 044995 138 AVDQT---------------------------HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIR 178 (288)
Q Consensus 138 ~~~~~---------------------------~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~ 178 (288)
..... ......+||+.|+||| ||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 32110 1122357999999999 99999999999999999994
Q ss_pred CCCcc---------------------------------------------------------------------chhHHH
Q 044995 179 FTTFE---------------------------------------------------------------------EDKNIT 189 (288)
Q Consensus 179 ~~~~~---------------------------------------------------------------------~~~~~~ 189 (288)
..... ...+.+
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 32210 112457
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+|+.+||+.||++|+|+.|+++|
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 7899999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=330.39 Aligned_cols=193 Identities=19% Similarity=0.245 Sum_probs=163.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
.++|++.+.||+|+||.||+|.++ .+.+.+|+++|++|+|||||++++++.+...++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 478999999999999999999763 467889999999999999999999987654322
Q ss_pred --c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC--CceEEecccCccccCCCCc
Q 044995 74 --D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK--YCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 --~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~--~~~kl~DfG~a~~~~~~~~ 142 (288)
. ......+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 1 123346889999999999999999999 8899999999999999754 899999999998765433
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
.....+||+.||||| |||||||++|||++|..||..... ....+.++.+|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 233457999999999 999999999999999999964331 12347789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|.+||+.||++||++.|+++|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=328.90 Aligned_cols=193 Identities=22% Similarity=0.277 Sum_probs=159.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHH---HHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFIN---EVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~---E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||+|+++ ...+.+ ++.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3578999999999999999999763 122333 4667788899999999999877654
Q ss_pred ccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 MHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++... ....+++..+..++.||+.||.||| +++||||||||+|||++.+|.+||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 43221 2236899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~ 189 (288)
... ..+.+||+.||||| |||||||++|||++|..||.... ++...+.+
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 332 23468999999999 99999999999999999996432 23345788
Q ss_pred HHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+.+||.+||+.||++|++ +.||++|
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 999999999999999998 6777765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=301.14 Aligned_cols=217 Identities=35% Similarity=0.599 Sum_probs=179.9
Q ss_pred CccccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeec
Q 044995 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLI 63 (288)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~ 63 (288)
+...+.|+.+++....++|++.+.||+|+||.||+|.++ ...|.+|++++++++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345678999999999999999999999999999998742 22689999999999999999999
Q ss_pred ceEecccc-------ccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 64 GCCLETKY-------MHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 64 ~~~~~~~~-------l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
++|...+. +.. ......+++..+..++.|++.||.|||..+..+|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99866432 211 1122348999999999999999999993323399999999999999999999
Q ss_pred EEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC---------------
Q 044995 127 KVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT--------------- 180 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~--------------- 180 (288)
||+|||+++..............||+.|+||| ||||||+++|||++|..||...
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999876544444445566999999999 9999999999999999998410
Q ss_pred ------------------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 181 ------------------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 181 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
......+..+.+++.+||+.||++|||+.+++++|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11223457899999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.30 Aligned_cols=210 Identities=28% Similarity=0.417 Sum_probs=162.3
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
+...++....++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++++...
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 445556677789999999999999999999642 45789999999999999999999998765
Q ss_pred ccccccC-------------CC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeecCCCceEEecc
Q 044995 70 KYMHDQN-------------KE---LPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 70 ~~l~~~~-------------~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+.+.... .. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 4221110 11 13888999999999999999999 888 999999999999999999999999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccc
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEE 184 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~ 184 (288)
|+++...... .......||+.|+||| ||||||+++|||++|..||.... .+.
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 9997543221 1223356999999999 99999999999999999996432 233
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
..+.++.+++.+||+.||++||++.++++.|+.+...
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 4578899999999999999999999999999988653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.03 Aligned_cols=212 Identities=36% Similarity=0.592 Sum_probs=173.2
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
.|...++...+++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||++++++|...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4555666778899999999999999999999752 46799999999999999999999987654
Q ss_pred cc-------ccc-----c-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 70 KY-------MHD-----Q-----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 70 ~~-------l~~-----~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+. +.. . .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 32 211 0 11124889999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCC-ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-------------------
Q 044995 133 TSRSRAVDQ-THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------- 181 (288)
Q Consensus 133 ~a~~~~~~~-~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------- 181 (288)
+++...... ........||+.|+||| ||||||+++|||++|+.||....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997543222 22223346899999999 99999999999999999985321
Q ss_pred ------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 ------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.....+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 1123466889999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.08 Aligned_cols=214 Identities=32% Similarity=0.555 Sum_probs=177.3
Q ss_pred cccceeHHHHHHhcCCcccC------ceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCC
Q 044995 4 KTKLFISNELEKATDSFNVN------RILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHI 57 (288)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~Hp 57 (288)
..+.|+++++...+++|... +.||+|+||.||+|.+. .+.|.+|++++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34689999999999999877 89999999999998642 46789999999999999
Q ss_pred ceeeecceEecccccc----------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec
Q 044995 58 NVVKLIGCCLETKYMH----------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD 121 (288)
Q Consensus 58 nIv~l~~~~~~~~~l~----------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~ 121 (288)
||+++++++...+... .......+++..++.++.|++.||.||| +.+|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999986543211 1112345889999999999999999999 88999999999999999
Q ss_pred CCCceEEecccCccccCCCCc-eeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc-------
Q 044995 122 DKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE------- 183 (288)
Q Consensus 122 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~------- 183 (288)
.++.+||+|||+++....... .......||+.|+||| ||||||+++|+|++|..||......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 2233456899999999 9999999999999999998643221
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
...+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1234678899999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=288.40 Aligned_cols=195 Identities=25% Similarity=0.372 Sum_probs=163.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++...+.+....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4578999999999999999999752 567899999999999999999999887654322111
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 77 -----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 77 -----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 173 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-cc
Confidence 1224788999999999999999999 88999999999999999999999999999876543322 23
Q ss_pred eccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHh
Q 044995 146 TQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 146 ~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~c 197 (288)
....||+.|+||| |||||||++|||++|..||.... .+...+..+.+++.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 3457999999999 99999999999999999996432 2334577899999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.||++||++.|++++
T Consensus 254 l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.07 Aligned_cols=202 Identities=24% Similarity=0.396 Sum_probs=166.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM------ 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l------ 72 (288)
.++|++.+.||+|+||.||++.+. .+.|.+|++++++++||||+++++++.+.+.+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 478999999999999999999752 46789999999999999999999998765422
Q ss_pred -cc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 73 -HD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 73 -~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 11 011346889999999999999999999 8889999999999999999999999999997653322111
Q ss_pred -------------eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------c
Q 044995 145 -------------TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-----------------E 183 (288)
Q Consensus 145 -------------~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-----------------~ 183 (288)
.....||+.|+||| ||||||+++|||++|..||..... +
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 11356999999999 999999999999999998753221 2
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 23456799999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=294.24 Aligned_cols=199 Identities=24% Similarity=0.300 Sum_probs=165.5
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
.+.....++|++.+.||+|+||.||+|.+. .+++.+|+++++.++||||+++++++...+
T Consensus 8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334455789999999999999999999752 456889999999999999999999987654
Q ss_pred cccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 YMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 322111 1235788999999999999999999 889999999999999999999999999999765
Q ss_pred CCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVA 191 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~ 191 (288)
.... .....+||+.|+||| |||||||++|||++|..||..... +...+.++.
T Consensus 165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242 (328)
T ss_dssp SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4322 233457999999999 999999999999999999975432 333578899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++.+||+.||++|||+.|++++
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=286.82 Aligned_cols=203 Identities=26% Similarity=0.399 Sum_probs=164.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||++.+. .+.|.+|+.++++++||||+++++++...+.++.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999742 4678999999999999999999999876543221
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 11 1235889999999999999999999 8889999999999999999999999999998654433
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------------------cchhHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-------------------EEDKNITVA 191 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-------------------~~~~~~~~~ 191 (288)
........||+.|+||| ||||||+++|||++|+.||..... ....+..+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 33334457999999999 999999999999999999975432 123467899
Q ss_pred HHHHHhcCCCCCCCC-CHHHHHHHHHhchhh
Q 044995 192 KHAKRCLNPSGKKRP-AMKEVASELAGIKAW 221 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp-~~~~i~~~l~~~~~~ 221 (288)
+++.+||+.||++|| ++.++.+.|+.+...
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 999999999999998 899999999887554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.38 Aligned_cols=205 Identities=23% Similarity=0.366 Sum_probs=169.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
+...++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++.....+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 345688999999999999999998752 567999999999999999999999987654321111
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 1124889999999999999999999 889999999999999999999999999999865544333
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~ 196 (288)
......+++.|+||| ||||||+++|+|++ |..||.... .+...+..+.+++.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence 333345677899999 99999999999999 999986432 223347789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 197 CLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
||+.||++|||+.+++++|+.+...
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999988654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=294.15 Aligned_cols=201 Identities=22% Similarity=0.387 Sum_probs=165.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
.++|++.+.||+|+||.||+|++. .+.|.+|+.++++++||||++++++|.......
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 467999999999999999998741 357899999999999999999999987654211
Q ss_pred ------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 ------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 0 112346889999999999999999999 889999999999999999999999999999865433
Q ss_pred Cce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 141 QTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
... ......+|..|+||| |||||||++|||++ |..||.... .+...+..+.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 221 222345678899999 99999999999999 999996433 22345778999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++.+||+.||++||++.+++++|+.+..
T Consensus 251 li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 251 IMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999999999988764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.51 Aligned_cols=197 Identities=20% Similarity=0.264 Sum_probs=162.1
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
....++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...+.+..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 345688999999999999999999752 3568899999999999999999999876543211
Q ss_pred -------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 -------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 -------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 112335889999999999999999999 8899999999999999999999999999998654322
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------------
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------- 184 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------------------- 184 (288)
. ......||+.|+||| |||||||++|+|++|+.||.......
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 223346899999999 99999999999999999996433211
Q ss_pred -------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.++.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 124578899999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.11 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=166.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
..++|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||++++++|...+.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567999999999999999998752 457899999999999999999999987653321
Q ss_pred -------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 74 -------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 74 -------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 1 112346889999999999999999999 88999999999999999999999999999986543
Q ss_pred CCc--eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 140 DQT--HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~--~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
... .......+|+.|+||| ||||||+++|||++ |..||.... .+...+..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 283 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL 283 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHH
Confidence 322 1222234677899999 99999999999999 999985432 233457889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+++.+||+.||++||++.++++.|+.+...
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999988764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=288.20 Aligned_cols=208 Identities=25% Similarity=0.407 Sum_probs=160.1
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
.+++...++|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc
Confidence 344566789999999999999999998641 4578999999999999999999998754
Q ss_pred cc------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 69 TK------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 69 ~~------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.. ++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccc
Confidence 32 2211 112235889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNI 188 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~ 188 (288)
..............+++.|+||| ||||||+++|||++ |..||.... .+...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 65443332333345678899999 99999999999997 999986432 2234577
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+.+++.+||+.||++||++.+++++|+.+...
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 899999999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.22 Aligned_cols=214 Identities=25% Similarity=0.400 Sum_probs=175.7
Q ss_pred ccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcC-CCCce
Q 044995 5 TKLFISNELEKATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQI-NHINV 59 (288)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l-~HpnI 59 (288)
...|...+++...++|++.+.||+|+||.||+|.+ ..+.|.+|+++++++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34677888999999999999999999999999962 135699999999999 78999
Q ss_pred eeecceEeccc--------cccc---------cCC---------------------------------------------
Q 044995 60 VKLIGCCLETK--------YMHD---------QNK--------------------------------------------- 77 (288)
Q Consensus 60 v~l~~~~~~~~--------~l~~---------~~~--------------------------------------------- 77 (288)
|+++++|.+.+ |+.. ...
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999876532 1110 000
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 78 ------------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 78 ------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
...+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 112889999999999999999999 88999999999999999999999999999986543
Q ss_pred CCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc----------------cchhHHHH
Q 044995 140 DQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF----------------EEDKNITV 190 (288)
Q Consensus 140 ~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~----------------~~~~~~~~ 190 (288)
... .......||+.|+||| ||||||+++|||++ |..||..... +...+.++
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 325 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence 322 2333456889999999 99999999999998 9999965432 23346789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+++.+||+.||++||++.+++++|+.+...
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.63 Aligned_cols=203 Identities=23% Similarity=0.396 Sum_probs=166.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc--------------------------cHHHHHHHHHHHhcC-CCCceeeecceEec
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA--------------------------KVEKFINEVVIQSQI-NHINVVKLIGCCLE 68 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~--------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 68 (288)
..++|++.+.||+|+||.||+|.+ ..+.+.+|+++++++ +||||++++++|..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357899999999999999999863 145789999999999 89999999999866
Q ss_pred ccccc-------c---------c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCee
Q 044995 69 TKYMH-------D---------Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNIL 119 (288)
Q Consensus 69 ~~~l~-------~---------~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil 119 (288)
.+.++ . . .....+++..++.++.|++.||.||| +++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 53221 1 0 01124788999999999999999999 889999999999999
Q ss_pred ecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-----
Q 044995 120 LDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----- 181 (288)
Q Consensus 120 ~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----- 181 (288)
++.++.+||+|||+++....... .......+|+.|+||| |||||||++|||++ |..||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986543222 1122345678899999 99999999999999 999986433
Q ss_pred ----------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 ----------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+.++.+++.+||+.||++||++.|++++|+.+...
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2234567899999999999999999999999999988654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=290.36 Aligned_cols=197 Identities=24% Similarity=0.375 Sum_probs=163.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH--- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~--- 73 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4589999999999999999999652 356889999999999999999999987653221
Q ss_pred ----------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 74 ----------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 74 ----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
.......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 1122346899999999999999999999 88999999999999999999999999999975432221
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------chhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-----------------EDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~~~~~~l 193 (288)
.......||+.|+||| |||||||++|+|++|..||...... ...+..+.++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 1223457999999999 9999999999999999999643321 2346788999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.+||+.||++|||+.|++++-
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHccCChhhCcCHHHHhhCh
Confidence 9999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.72 Aligned_cols=204 Identities=21% Similarity=0.293 Sum_probs=165.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCCCCceeeecceEeccc---------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQINHINVVKLIGCCLETK--------- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------- 70 (288)
...++|++.+.||+|+||.||+|++. ...+.+|+.++++++|||||++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 45678999999999999999999753 345667899999999999999999976542
Q ss_pred --cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeEEeCCCCCCeeecCCCceEEecccC
Q 044995 71 --YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASV----------PIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 71 --~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~----------~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
|+.. ......+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 1111 011235889999999999999999999 77 999999999999999999999999999
Q ss_pred ccccCCCCce-eeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------
Q 044995 134 SRSRAVDQTH-ITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTFE------------- 183 (288)
Q Consensus 134 a~~~~~~~~~-~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~~------------- 183 (288)
++........ ......||+.|+||| |||||||++|||++|+.||......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9765433221 222356899999999 9999999999999999998543210
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
...+.++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01234589999999999999999999999999988764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.68 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=168.0
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
++....++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++|||||+++++|...+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 44455678999999999999999999753 24688999999999999999999998765432
Q ss_pred ccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 73 HDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 73 ~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 111 11224788999999999999999999 8889999999999999999999999999997543
Q ss_pred CCCceee-eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 139 VDQTHIT-TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 139 ~~~~~~~-~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
....... ....++..|+||| |||||||++|||++ |..||.... .+...+.++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2211111 1123567799999 99999999999998 999986432 233457789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+++.+||+.||++|||+.++++.|+.+...
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.02 Aligned_cols=205 Identities=26% Similarity=0.401 Sum_probs=169.6
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
+....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3445678999999999999999999752 5779999999999999999999999876532
Q ss_pred --ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 72 --MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 72 --l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 211 122345889999999999999999999 88899999999999999999999999999976543222
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
.......++..|+||| ||||||+++|+|++ |..||.... .+...+..+.+++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 2222345677899999 99999999999999 999986432 12334778999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 196 RCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+||+.||++||++.+++++|+.+..
T Consensus 242 ~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999998865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=290.59 Aligned_cols=196 Identities=21% Similarity=0.272 Sum_probs=164.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+++++.++||||+++++++.....+..
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3578999999999999999999852 2468899999999999999999999876543221
Q ss_pred c------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 75 Q------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 1 11235889999999999999999999 8889999999999999999999999999998654322
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
.....+||+.|+||| |||||||++|+|++|..||.... .+...+..+.+++.+
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 223357999999999 99999999999999999996432 233457899999999
Q ss_pred hcCCCCCCCCCHHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~ 216 (288)
||+.||.+|||+.|++++-.
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHH
T ss_pred HcCCChhHCcCHHHHHhChh
Confidence 99999999999999988743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.03 Aligned_cols=203 Identities=26% Similarity=0.451 Sum_probs=160.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc-----ccccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET-----KYMHD--- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~l~~--- 74 (288)
.++|++.+.||+|+||.||++.+. .+.|.+|++++++++||||+++++++.+. +|+..
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSL 86 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBH
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCH
Confidence 468999999999999999999752 56799999999999999999999986543 22211
Q ss_pred ------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc-eEEecccCccccCCCCceeeec
Q 044995 75 ------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC-AKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 75 ------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~-~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
......+++..++.++.|++.||.|||..+.++|+||||||+|||++.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~ 162 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTN 162 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----ccc
Confidence 111124678899999999999999999433389999999999999988775 799999998754322 123
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhcC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl~ 199 (288)
..||..|+||| ||||||+++|||++|+.||.... .....+..+.+++.+||+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTC
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhc
Confidence 45899999999 99999999999999999996432 122446789999999999
Q ss_pred CCCCCCCCHHHHHHHHHhchhhcC
Q 044995 200 PSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
.||++||++.++++.|+.+.....
T Consensus 243 ~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 243 KDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp SSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999998876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=285.75 Aligned_cols=193 Identities=21% Similarity=0.289 Sum_probs=157.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++...+.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999752 3678899999999999999999999876543221
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 75 ---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 75 ---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence 112246889999999999999999999 88999999999999999999999999999875432221 12
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------------ 183 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------------ 183 (288)
....||+.|+||| |||||||++|||++|..||......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 2346899999999 9999999999999999998643210
Q ss_pred -------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1246778899999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=282.95 Aligned_cols=205 Identities=26% Similarity=0.489 Sum_probs=160.3
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
.+...++|++.+.||+|+||.||+|++. .+.|.+|++++++++||||+++++++....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~ 98 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 98 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence 3456788999999999999999998752 467999999999999999999999765432
Q ss_pred -cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC-
Q 044995 71 -YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ- 141 (288)
Q Consensus 71 -~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~- 141 (288)
++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 2211 123346889999999999999999999 8889999999999999999999999999987543211
Q ss_pred ceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------cchhH
Q 044995 142 THITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF--------------------EEDKN 187 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~--------------------~~~~~ 187 (288)
........||+.|+||| ||||||+++|+|++|+.||..... ....+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence 12223356899999999 999999999999999999964321 12456
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 789999999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.33 Aligned_cols=211 Identities=21% Similarity=0.352 Sum_probs=172.7
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc-
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK- 70 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 70 (288)
+..++++...++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++|||||++++++....
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 257 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI 257 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCcc
Confidence 445667778889999999999999999999752 578999999999999999999999876432
Q ss_pred -----ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 -----YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 -----~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
++... .....+++...+.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 22110 01125778889999999999999999 888999999999999999999999999999865
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
............++..|+||| |||||||++|||++ |+.||.... .+...+.++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 414 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 414 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 432211122234677899999 99999999999999 999996432 233457889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=286.97 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=169.7
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceE
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCC 66 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~ 66 (288)
.++....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 444556788999999999999999999641 36788999999999999999999987
Q ss_pred eccccccccC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 044995 67 LETKYMHDQN-------------------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109 (288)
Q Consensus 67 ~~~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 109 (288)
...+.+.... ....+++..++.++.|++.||.||| +++|+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence 6553221100 1123788999999999999999999 88899
Q ss_pred EeCCCCCCeeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCC
Q 044995 110 HRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKP 176 (288)
Q Consensus 110 Hrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P 176 (288)
||||||+|||++.++.+||+|||+++......... .....+++.|+||| ||||||+++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654332221 22335678899999 99999999999999 9999
Q ss_pred CCCCC---------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 177 IRFTT---------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 177 ~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
|.... .+...+..+.+++.+||+.||++||++.+++++|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 86433 2234578899999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=287.64 Aligned_cols=195 Identities=20% Similarity=0.268 Sum_probs=163.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.+++.++||||+++++++.+.+.+.
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4589999999999999999999753 456889999999999999999999987653321
Q ss_pred --c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC--CCceEEecccCccccCCCCc
Q 044995 74 --D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD--KYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 --~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 1 112236899999999999999999999 889999999999999986 7899999999998654332
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~~~l 193 (288)
......||+.|+||| |||||||++|+|++|..||...... ...+.++.++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 223456999999999 9999999999999999999654321 1346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.+||..||++|||+.|++++-
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHcCCChhHCcCHHHHhcCh
Confidence 9999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.65 Aligned_cols=195 Identities=23% Similarity=0.323 Sum_probs=146.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...+.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999652 36789999999999999999999998765422111
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 76 -----------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 76 -----------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 11134788899999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
.... ......||+.|+||| |||||||++|||++|+.||......
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3222 122346899999999 9999999999999999999643210
Q ss_pred -------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 1235688999999999999999999999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=283.78 Aligned_cols=193 Identities=20% Similarity=0.266 Sum_probs=159.7
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++.+.+.+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999752 36788999999999999999999998765432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence 12346899999999999999999999 88999999999999999999999999999986543222 2
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc------------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------ 182 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------ 182 (288)
.....||+.|+||| |||||||++|||++|..||.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 23346899999999 999999999999998888521111
Q ss_pred --------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 01245678899999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=287.72 Aligned_cols=210 Identities=24% Similarity=0.374 Sum_probs=160.5
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceE
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCC 66 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~ 66 (288)
.+++....++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4455567788999999999999999998642 35788999999999999999999987
Q ss_pred ecccc-------------ccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec
Q 044995 67 LETKY-------------MHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD 121 (288)
Q Consensus 67 ~~~~~-------------l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~ 121 (288)
...+. +.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEc
Confidence 65421 111 011125889999999999999999999 88999999999999999
Q ss_pred CCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-------
Q 044995 122 DKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------- 181 (288)
Q Consensus 122 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------- 181 (288)
.++.+||+|||+++........ ......+++.|+||| |||||||++|||++ |..||....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 9999999999999765332221 122234677899999 99999999999999 999996432
Q ss_pred --------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 --------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+...+.++.+++.+||+.||++||++.++++.|+++....
T Consensus 252 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 23345688999999999999999999999999999887643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.22 Aligned_cols=211 Identities=22% Similarity=0.378 Sum_probs=173.9
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc-
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK- 70 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 70 (288)
|-.++++...++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (279)
T 1qpc_A 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 82 (279)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred cchhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCc
Confidence 344567777899999999999999999998642 578999999999999999999999876542
Q ss_pred -----cccc-----cCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 -----YMHD-----QNK---ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 -----~l~~-----~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
++.. ... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 2211 011 125889999999999999999999 889999999999999999999999999999866
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
............++..|+||| ||||||+++|||++ |..||.... .+...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHH
Confidence 543322233345678899999 99999999999999 999986432 223456789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+++.+||+.||++||++.++++.|+.+...
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=288.45 Aligned_cols=201 Identities=22% Similarity=0.390 Sum_probs=161.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||++++++|.......
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 478999999999999999999741 467999999999999999999999987654211
Q ss_pred ------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 ------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 0 112345889999999999999999999 889999999999999999999999999999865332
Q ss_pred Cc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 141 QT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
.. .......+|+.|+||| |||||||++|||++ |..||.... .+...+.++.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 21 1122234677899999 99999999999999 999996433 22345778999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++.+||+.||++||++.++++.|+.+..
T Consensus 251 li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 251 IMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=284.26 Aligned_cols=206 Identities=23% Similarity=0.328 Sum_probs=169.6
Q ss_pred cceeHHHHHHhcCC----------cccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCC
Q 044995 6 KLFISNELEKATDS----------FNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHI 57 (288)
Q Consensus 6 ~~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~Hp 57 (288)
..|+.+++...++. |+..+.||+|+||.||+|+++ .+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46788888877764 777889999999999999752 46799999999999999
Q ss_pred ceeeecceEeccccccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 58 NVVKLIGCCLETKYMHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 58 nIv~l~~~~~~~~~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
||++++++|...+.+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCc
Confidence 99999998876532211 112236889999999999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------
Q 044995 126 AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------ 182 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------ 182 (288)
+||+|||+++....... ......||+.|+||| ||||||+++|||++|+.||.....
T Consensus 180 ~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 258 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP 258 (321)
T ss_dssp EEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred EEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999876543322 223457999999999 999999999999999999854321
Q ss_pred -----cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 -----EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
....+..+.+++.+||+.||++||++.+++++-
T Consensus 259 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 123467899999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.32 Aligned_cols=196 Identities=22% Similarity=0.358 Sum_probs=160.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------------------------------HHHHHHHHHH
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------------------------------VEKFINEVVI 50 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------------------------~~~~~~E~~~ 50 (288)
...++|++.+.||+|+||.||+|.+. .+.+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999642 1458899999
Q ss_pred HhcCCCCceeeecceEecc---------cccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 51 QSQINHINVVKLIGCCLET---------KYMH-----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 51 l~~l~HpnIv~l~~~~~~~---------~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
+++++||||+++++++.+. +++. .......+++..+..++.|++.||.||| +.+|+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999998652 2221 1122346899999999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF 182 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~ 182 (288)
|||++.++.+||+|||+++....... ......||+.|+||| |||||||++|||++|..||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986543322 223456999999999 999999999999999999964321
Q ss_pred ----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 12356889999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.34 Aligned_cols=207 Identities=26% Similarity=0.405 Sum_probs=171.9
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
++++...++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++|||||+++++|...+.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 445566788999999999999999999753 5789999999999999999999999876532
Q ss_pred -----ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 -----MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 -----l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 211 112345889999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVA 191 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~ 191 (288)
...........++..|+||| |||||||++|||++ |..||..... +...+..+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 33322222334677899999 99999999999999 9999864332 334578899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++|.+||+.||++||++.+|++.|+.+..
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.84 Aligned_cols=206 Identities=17% Similarity=0.195 Sum_probs=168.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+++++++ +||||+++++++...++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4578999999999999999999752 34688999999999 999999999987665432110
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc-----eEEecccCccccCCC
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC-----AKVSNFGTSRSRAVD 140 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~-----~kl~DfG~a~~~~~~ 140 (288)
.....+++..++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++.....
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 01346899999999999999999999 889999999999999988876 999999999865432
Q ss_pred Cce------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-------------------
Q 044995 141 QTH------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------------- 184 (288)
Q Consensus 141 ~~~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------------- 184 (288)
... ......||+.|+||| |||||||++|||++|..||.......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 221 123457999999999 99999999999999999997643221
Q ss_pred ---hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCCC
Q 044995 185 ---DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225 (288)
Q Consensus 185 ---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 225 (288)
..+ ++.+++..||+.||.+||++.+|++.|+.+....+..
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 123 8999999999999999999999999999887665443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.22 Aligned_cols=201 Identities=22% Similarity=0.378 Sum_probs=163.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 71 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||++++++|.....
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 468999999999999999999742 2457789999999999999999999865432
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 111 111246788899999999999999999 888999999999999999999999999999875433
Q ss_pred Cce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHHH
Q 044995 141 QTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVAK 192 (288)
Q Consensus 141 ~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~~ 192 (288)
... ......|+..|+||| ||||||+++|||++ |..||..... +...+.++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence 222 223456788999999 99999999999999 9999965432 2234567889
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++.+||+.||++||++.+++++|+.+..
T Consensus 249 li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999988754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=300.21 Aligned_cols=195 Identities=23% Similarity=0.315 Sum_probs=147.6
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
.++|++.+.||+|+||.||+|.++ .+++.+|+++|++++|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999652 467899999999999999999999874331
Q ss_pred ------ccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ------YMH-----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ------~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++. .......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 111 0112345899999999999999999999 88999999999999999999999999999986542
Q ss_pred CCc--------------------------eeeeccccCCCCCChh------------hHHHHHHHHHHHHh---------
Q 044995 140 DQT--------------------------HITTQVHGTFGYLNPD------------DVCSFGVVLVELLT--------- 172 (288)
Q Consensus 140 ~~~--------------------------~~~~~~~gt~~y~aPE------------DiwSlG~il~ellt--------- 172 (288)
... ......+||+.|+||| |||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 211 1123457899999999 99999999999999
Q ss_pred --CCCCCCCCCc-----------------------------------------------------------------cch
Q 044995 173 --GAKPIRFTTF-----------------------------------------------------------------EED 185 (288)
Q Consensus 173 --g~~P~~~~~~-----------------------------------------------------------------~~~ 185 (288)
|.++|.+... ...
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 5566643220 011
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+.++.+|+.+||..||++|||+.|++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 25678899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=278.86 Aligned_cols=196 Identities=31% Similarity=0.523 Sum_probs=165.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
..++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4578999999999999999999752 167999999999999999999999986654
Q ss_pred cccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeecCCCc-----eEEecc
Q 044995 71 YMHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLDDKYC-----AKVSNF 131 (288)
Q Consensus 71 ~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~~~~~-----~kl~Df 131 (288)
++.. ......+++..++.++.|++.||.||| +++ |+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 3311 123346899999999999999999999 888 999999999999987765 999999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC-----------------
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT----------------- 181 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~----------------- 181 (288)
|+++.... ......||+.|+||| ||||||+++|||++|+.||....
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 99974332 223456999999999 99999999999999999996432
Q ss_pred -ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 -FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2234577899999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.46 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=155.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~- 73 (288)
.++|++.+.||+|+||.||+|+++ .+.|.+|+.++++++||||++++++|...+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999998642 357999999999999999999999987653221
Q ss_pred ------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 ------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 1 112236889999999999999999999 889999999999999999999999999999865433
Q ss_pred Ccee--eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHH
Q 044995 141 QTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 141 ~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~ 191 (288)
.... .....++..|+||| ||||||+++|||++ |+.||.... .+...+..+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 2211 11223567899999 99999999999998 999985432 1234567899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+++.+||+.||++||++.++++.|+.+...
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999988654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.21 Aligned_cols=208 Identities=19% Similarity=0.274 Sum_probs=163.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------------------HHHHHHHHHHHhcCCCCceee
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------------------VEKFINEVVIQSQINHINVVK 61 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------------------~~~~~~E~~~l~~l~HpnIv~ 61 (288)
..++|++.+.||+|+||.||+|.++ ...+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999999541 122445566677888999999
Q ss_pred ecceEecc-----------ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec--C
Q 044995 62 LIGCCLET-----------KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD--D 122 (288)
Q Consensus 62 l~~~~~~~-----------~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~--~ 122 (288)
+++++... +++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence 99987653 12100 112246899999999999999999999 88999999999999998 8
Q ss_pred CCceEEecccCccccCCCCce------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--
Q 044995 123 KYCAKVSNFGTSRSRAVDQTH------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-- 183 (288)
Q Consensus 123 ~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-- 183 (288)
++.+||+|||+++........ ......||+.|+||| |||||||++|||++|+.||......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999765432211 112345999999999 9999999999999999999742211
Q ss_pred -----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCCCc
Q 044995 184 -----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGASN 226 (288)
Q Consensus 184 -----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 226 (288)
...+.++.+++..||+.||++||++.+|++.|+.+....+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 1236688999999999999999999999999999877655443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.19 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=170.8
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecceE
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIGCC 66 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~ 66 (288)
+...++|.+.+.||+|+||.||+|.+. .+.+.+|+++++++ +|||||+++++|
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445678999999999999999998630 36789999999999 999999999998
Q ss_pred ecccccc-------c---------c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 67 LETKYMH-------D---------Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 67 ~~~~~l~-------~---------~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
...+.+. . . .....+++..++.++.|++.||.||| +.+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 6653211 1 0 01235899999999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--- 181 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--- 181 (288)
||++.++.+||+|||+++....... .......+|+.|+||| |||||||++|||++ |..||....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543221 2222345778899999 99999999999999 999986432
Q ss_pred ------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 182 ------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 182 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
.+...+.++.+++.+||+.||++||++.+++++|+.+......
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2334578899999999999999999999999999999765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=282.44 Aligned_cols=207 Identities=24% Similarity=0.369 Sum_probs=167.4
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..+....++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++...+.+..
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 344566788999999999999999998642 5779999999999999999999999876542211
Q ss_pred --------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 75 --------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 75 --------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 011245889999999999999999999 889999999999999999999999999999765432
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~l 193 (288)
.........+|+.|+||| ||||||+++|+|++ |..||.... .+...+..+.++
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 222222334677899999 99999999999998 999986432 223347789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+||+.||++||++.+++++|+.+..
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.08 Aligned_cols=196 Identities=21% Similarity=0.251 Sum_probs=161.3
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
...++|++.+.||+|+||.||++.++ .+.+.+|++++++++|||||++++++.+.+.++.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45688999999999999999999652 3568899999999999999999999876543321
Q ss_pred c-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceEEecccCccccC
Q 044995 75 Q-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 75 ~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~DfG~a~~~~ 138 (288)
. .....+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 1 12245889999999999999999999 88999999999999997 45789999999997654
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------c----chhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------E----EDKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~----~~~~~~ 189 (288)
.... ......||+.|+||| |||||||++|+|++|..||..... + ...+.+
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 3322 223457999999999 999999999999999999954321 1 234788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+++.+||+.||++||++.|++++
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.23 Aligned_cols=195 Identities=25% Similarity=0.297 Sum_probs=163.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||.||+++++ .+.+.+|++++++++||||+++++++...+.++..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 578999999999999999998752 35688999999999999999999988765433211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 1 1235789999999999999999999 8899999999999999999999999999998533222
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
......+||+.|+||| |||||||++|||++|..||.... ++...+.++.++|.+|
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 2233457999999999 99999999999999999996433 2334578899999999
Q ss_pred cCCCCCCCC-----CHHHHHHHH
Q 044995 198 LNPSGKKRP-----AMKEVASEL 215 (288)
Q Consensus 198 l~~~p~~Rp-----~~~~i~~~l 215 (288)
|+.||++|| ++.|++++-
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSG
T ss_pred hhcCHHHhcCCCCCCHHHHHcCC
Confidence 999999999 899988763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=292.23 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=163.2
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
|.+.......++|++.+.||+|+||.||++.++ .+.+.+|++++++++|||||++++++.
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 444444456688999999999999999999752 357889999999999999999999987
Q ss_pred ccccccc-------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecc
Q 044995 68 ETKYMHD-------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNF 131 (288)
Q Consensus 68 ~~~~l~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~Df 131 (288)
+.+..+. ......+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+||
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 6543221 112345789999999999999999999 8899999999999999754 46999999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc--------------c---
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF--------------E--- 183 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~--------------~--- 183 (288)
|++....... ......||+.|+||| |||||||++|+|++|..||..... +
T Consensus 176 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 253 (362)
T 2bdw_A 176 GLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 253 (362)
T ss_dssp TTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred CcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 9998654322 223457999999999 999999999999999999954321 1
Q ss_pred -chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++||++.+++++
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2347789999999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.32 Aligned_cols=194 Identities=25% Similarity=0.311 Sum_probs=162.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999752 3678999999999999999999999876543
Q ss_pred ccc-------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----ceEEecccCc
Q 044995 72 MHD-------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY----CAKVSNFGTS 134 (288)
Q Consensus 72 l~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a 134 (288)
++. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 211 122346899999999999999999999 88999999999999998776 7999999999
Q ss_pred cccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------ch
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------ED 185 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~ 185 (288)
+...... ......||+.|+||| |||||||++|+|++|..||...... ..
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 8654322 223457999999999 9999999999999999999654311 13
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+..+.++|.+||..||++|||+.|++++
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 46679999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=299.07 Aligned_cols=195 Identities=21% Similarity=0.288 Sum_probs=156.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||+|.+. .+++.+|+.+|+.++|||||++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999652 467889999999999999999999875432
Q ss_pred --------ccccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 --------YMHDQ---NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 --------~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
|+... .-...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 22110 01124788999999999999999999 88899999999999999999999999999986543
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------ 184 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------------------ 184 (288)
. .......||+.|+||| |||||||++|||++|+.||.+....+
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 2233457999999999 99999999999999999997543100
Q ss_pred --------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 --------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 --------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.++.+|+.+||..||++|||+.|++++-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0145789999999999999999999999873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=296.23 Aligned_cols=203 Identities=23% Similarity=0.298 Sum_probs=169.6
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
..++....++|++.+.||+|+||.||+++++ .+.+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455667789999999999999999999763 1237799999999999999999999877
Q ss_pred cccccccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 69 TKYMHDQNK------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 69 ~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
.+.++...+ ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 654332211 235788999999999999999999 88999999999999999999999999999986
Q ss_pred cCCCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc----------------c--
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF----------------E-- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~----------------~-- 183 (288)
............+||+.|+||| |||||||++|||++|..||..... +
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 6544433444568999999999 999999999999999999965431 1
Q ss_pred chhHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKK--RPAMKEVASEL 215 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~--Rp~~~~i~~~l 215 (288)
...+.++.++|.+||..+|.+ ||++.||++|-
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 135788999999999999988 99999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=283.60 Aligned_cols=209 Identities=25% Similarity=0.391 Sum_probs=175.6
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
++++...++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||+++++++...+.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 456667889999999999999999999753 478999999999999999999999986653221
Q ss_pred c---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 74 D---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 74 ~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
. ......+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 1 112345889999999999999999999 8889999999999999999999999999998765
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVA 191 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~ 191 (288)
...........+++.|+||| ||||||+++|+|++ |..||..... +...+..+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence 44444444456788999999 99999999999999 9999864332 234567899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
+++.+||+.||++||++.++++.|+.+....
T Consensus 243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 243 ELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999886543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=277.67 Aligned_cols=197 Identities=28% Similarity=0.487 Sum_probs=157.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~- 74 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++...+.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 4578999999999999999999642 3678899999999999999999999866542211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEEeCCCCCCeeecC--------CCceEEeccc
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP---IYHRDIKSTNILLDD--------KYCAKVSNFG 132 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~---iiHrdlkp~Nil~~~--------~~~~kl~DfG 132 (288)
......+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 112346889999999999999999999 666 999999999999975 6789999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccch
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEED 185 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~ 185 (288)
+++...... .....||+.|+||| ||||||+++|+|++|+.||.... .+..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 997543322 12346899999999 99999999999999999996432 2334
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+..+.+++.+||+.||++||++.|++++|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 578899999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.87 Aligned_cols=214 Identities=24% Similarity=0.385 Sum_probs=174.8
Q ss_pred cccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCce
Q 044995 4 KTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINV 59 (288)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnI 59 (288)
....|..++++...++|++.+.||+|+||.||+|.++ ...|.+|++++++++||||
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 3456777888888999999999999999999997531 3468899999999999999
Q ss_pred eeecceEeccccccccC-----------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 60 VKLIGCCLETKYMHDQN-----------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 60 v~l~~~~~~~~~l~~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
+++++++...+...... ....+++..++.++.|++.||.||| +++|+||||||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAAR 167 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGG
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccc
Confidence 99999986653221100 1134588899999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC--
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT-- 181 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~-- 181 (288)
|||++.++.+||+|||+++........ ......+|+.|+||| ||||||+++|||++ |..||....
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 999999999999999999755332221 122335688899999 99999999999999 899986432
Q ss_pred -------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 -------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+...+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 233457789999999999999999999999999987744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.11 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=165.4
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
....++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++++.+...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 87 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence 345688999999999999999998631 4678999999999999999999998765432
Q ss_pred ------ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 ------MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 ------l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 111 011234788999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~ 191 (288)
...........+++.|+||| ||||||+++|||++ |+.||.... .+...+..+.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY 244 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 43332333345778899999 99999999999998 999985322 2234567899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+++.+||+.||++||++.+++++|+.+...
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.09 Aligned_cols=207 Identities=24% Similarity=0.384 Sum_probs=168.5
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
.+....++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34556789999999999999999998642 357899999999999999999999986
Q ss_pred cccccc-------c---------cC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEE
Q 044995 68 ETKYMH-------D---------QN---------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYH 110 (288)
Q Consensus 68 ~~~~l~-------~---------~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 110 (288)
..+.+. . .. ....+++..++.++.|++.||.||| +++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 543221 1 00 0146889999999999999999999 889999
Q ss_pred eCCCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCC
Q 044995 111 RDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPI 177 (288)
Q Consensus 111 rdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~ 177 (288)
|||||+|||++.++.+||+|||+++....... .......+|+.|+||| ||||||+++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999875432221 1222345788999999 99999999999999 99998
Q ss_pred CCCC---------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 178 RFTT---------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 178 ~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.... .+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 6432 2334577899999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.10 Aligned_cols=204 Identities=24% Similarity=0.415 Sum_probs=167.6
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
++++...++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++|||||+++++|...+
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 344556788999999999999999998753 578999999999999999999999876542
Q ss_pred --cccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 --YMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 --~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 1111 011123688899999999999999999 889999999999999999999999999999854321
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~l 193 (288)
.....++..|+||| ||||||+++|||++ |..||.... .+...+..+.++
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 12235788999999 99999999999998 999996433 233457899999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
|.+||+.||++|||+.++++.|+.+...
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.70 Aligned_cols=195 Identities=21% Similarity=0.292 Sum_probs=160.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999652 35689999999999999999999998765432
Q ss_pred cccC-----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEeccc
Q 044995 73 HDQN-----------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFG 132 (288)
Q Consensus 73 ~~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG 132 (288)
+... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 2111 1224788999999999999999999 88999999999999997654 49999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------------c----c
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF-------------E----E 184 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~-------------~----~ 184 (288)
+++....... ......||+.|+||| |||||||++|+|++|..||..... . .
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccc
Confidence 9986543222 223456999999999 999999999999999999964321 0 1
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.++.+++.+||+.||++||++.+++++
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 346789999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=279.67 Aligned_cols=203 Identities=21% Similarity=0.330 Sum_probs=161.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhc--CCCCceeeecceEecc-----------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQ--INHINVVKLIGCCLET----------- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----------- 69 (288)
..++|++.+.||+|+||.||+|++. .+.+.+|.+++.. ++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 4678999999999999999999752 4567778777766 8999999999886432
Q ss_pred ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 70 KYMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLS-----ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 70 ~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+++.. ......+++..++.++.|++.||.|||.. ++++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence 22211 11234689999999999999999999932 256799999999999999999999999999975443
Q ss_pred CCcee---eeccccCCCCCChh-----------------hHHHHHHHHHHHHhC----------CCCCCCCCc-------
Q 044995 140 DQTHI---TTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTG----------AKPIRFTTF------- 182 (288)
Q Consensus 140 ~~~~~---~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg----------~~P~~~~~~------- 182 (288)
..... .....||+.|+||| |||||||++|||++| ..||.....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~ 245 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh
Confidence 32221 12346999999998 999999999999999 788743211
Q ss_pred -------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 183 -------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 183 -------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
....+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 112457899999999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.90 Aligned_cols=195 Identities=25% Similarity=0.352 Sum_probs=162.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++.+.||+|+||.||++.++ .+.+.+|+++|++++|||||+++++|.+.+.++
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999752 357889999999999999999999987654332
Q ss_pred cc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 DQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 11 12346899999999999999999999 889999999999999999999999999999865432
Q ss_pred CceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHH
Q 044995 141 QTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNIT 189 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~ 189 (288)
.......||+.|+||| |||||||++|||++|..||.... .+...+..
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 2234457999999999 99999999999999999996332 23345678
Q ss_pred HHHHHHHhcCCCCCCCCC-HHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPA-MKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~-~~~i~~~ 214 (288)
+.++|.+||+.||++||+ +.+++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 999999999999999998 6666553
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.37 Aligned_cols=209 Identities=22% Similarity=0.352 Sum_probs=166.7
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
.+.++...++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++||||+++++++.+..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~i 255 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI 255 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEE
Confidence 3455667788999999999999999999753 478999999999999999999999876532
Q ss_pred ---ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ---YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ---~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 22110 01124788999999999999999999 88999999999999999999999999999986543
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
..........++..|+||| ||||||+++|||++ |+.||.... .+...+..+.+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 3222222344678899999 99999999999999 999996432 23455788999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+|.+||+.||++|||+.++++.|+.+...
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.52 Aligned_cols=197 Identities=25% Similarity=0.363 Sum_probs=152.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCC-CCceeeecceEeccc---
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQIN-HINVVKLIGCCLETK--- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--- 70 (288)
...++|++.+.||+|+||.||+|.++ .+++.+|+.+++++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35689999999999999999999752 456889999999997 999999999986432
Q ss_pred ------cccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ------YMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ------~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 1111 011235788889999999999999999 889999999999999999999999999999754321
Q ss_pred --------------------CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----
Q 044995 141 --------------------QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---- 184 (288)
Q Consensus 141 --------------------~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---- 184 (288)
........+||+.|+||| |||||||++|||++|+.||.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011123357999999999 99999999999999999996543110
Q ss_pred ---------------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCC
Q 044995 185 ---------------------------------------------------------DKNITVAKHAKRCLNPSGKKRPA 207 (288)
Q Consensus 185 ---------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~ 207 (288)
..+.++.+++.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 23567899999999999999999
Q ss_pred HHHHHHH
Q 044995 208 MKEVASE 214 (288)
Q Consensus 208 ~~~i~~~ 214 (288)
+.|++++
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=279.83 Aligned_cols=203 Identities=23% Similarity=0.359 Sum_probs=161.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEc----c------------------HHHHHHHHHHHhcCCCCceeeecceEecc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMA----K------------------VEKFINEVVIQSQINHINVVKLIGCCLET---- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~----~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 69 (288)
..++|++.+.||+|+||.||+++. . .+.|.+|++++++++||||++++++|...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999972 1 46789999999999999999999987542
Q ss_pred -----ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 -----KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 -----~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 22211 011224889999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC------------------------
Q 044995 138 AVDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT------------------------ 180 (288)
Q Consensus 138 ~~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~------------------------ 180 (288)
...... ......++..|+||| ||||||+++|||++|..|+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 432221 122234677799999 9999999999999999887432
Q ss_pred -------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 181 -------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 181 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
..+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11234567899999999999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.80 Aligned_cols=203 Identities=24% Similarity=0.322 Sum_probs=164.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||+|.+. ...+.+|+.++++++|||||++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3578999999999999999998721 3468899999999999999999999866532
Q ss_pred -------ccc-------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEE
Q 044995 72 -------MHD-------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKV 128 (288)
Q Consensus 72 -------l~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl 128 (288)
+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 211 011235889999999999999999999 88999999999999998544 5999
Q ss_pred ecccCccccCCCC-ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC--------------
Q 044995 129 SNFGTSRSRAVDQ-THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT-------------- 181 (288)
Q Consensus 129 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~-------------- 181 (288)
+|||+++...... ........||+.|+||| |||||||++|||++ |..||....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999997542211 11222345788999999 99999999999998 999986432
Q ss_pred -ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 -FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 2334577899999999999999999999999999988654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.55 Aligned_cols=199 Identities=21% Similarity=0.351 Sum_probs=160.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
..++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||+++++++...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999998531 467999999999999999999999987653
Q ss_pred ccccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc--------eEE
Q 044995 71 YMHDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC--------AKV 128 (288)
Q Consensus 71 ~l~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~--------~kl 128 (288)
..... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence 22111 11223888999999999999999999 888999999999999987776 999
Q ss_pred ecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCC-CCCCCCC-------------c
Q 044995 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGA-KPIRFTT-------------F 182 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~-~P~~~~~-------------~ 182 (288)
+|||++..... .....||..|+||| ||||||+++|||++|. .||.... .
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence 99999875422 12345889999999 9999999999999954 4443221 2
Q ss_pred cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 183 EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 183 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
+...+.++.+++.+||+.||++||++.+++++|+.+....
T Consensus 238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2334567899999999999999999999999999886643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=286.75 Aligned_cols=207 Identities=22% Similarity=0.364 Sum_probs=168.4
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcC-CCCceeeecceE
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQI-NHINVVKLIGCC 66 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 66 (288)
+++...++|++.+.||+|+||.||+|.+ ..+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556678999999999999999999874 135789999999999 899999999988
Q ss_pred eccccccc----------------cCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEE
Q 044995 67 LETKYMHD----------------QNK--------------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYH 110 (288)
Q Consensus 67 ~~~~~l~~----------------~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 110 (288)
...+.+.. ... ...+++..++.++.|++.||.||| +++|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 65432211 000 123788999999999999999999 889999
Q ss_pred eCCCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCC
Q 044995 111 RDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPI 177 (288)
Q Consensus 111 rdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~ 177 (288)
|||||+|||++.++.+||+|||++........ .......||+.|+||| ||||||+++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986543322 2233345788999999 99999999999998 99999
Q ss_pred CCCCc----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 178 RFTTF----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 178 ~~~~~----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
..... +...+.++.+++.+||+.||++||++.+++++|+.+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 65432 223467899999999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.80 Aligned_cols=191 Identities=26% Similarity=0.349 Sum_probs=161.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||.||+++++ .+.+.+|+.+++.++||||+++++++.+.+.++..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 578999999999999999998752 35678899999999999999999998765433211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 1 2235788999999999999999999 889999999999999999999999999999864322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
....+||+.|+||| |||||||++|||++|..||.... ++...+.++.+++.+|
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 23457999999999 99999999999999999996433 2334577899999999
Q ss_pred cCCCCCCCC-----CHHHHHHH
Q 044995 198 LNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp-----~~~~i~~~ 214 (288)
|+.||++|| ++.+++++
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hccCHHHcCCCcCCCHHHHhcC
Confidence 999999999 78888765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=287.67 Aligned_cols=215 Identities=21% Similarity=0.319 Sum_probs=160.2
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCC-CCceeeecceEe
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQIN-HINVVKLIGCCL 67 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 67 (288)
.|..+.++....+|++.+.||+|+||.||++.+. .+.+.+|+.+++++. ||||+++++++.
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 3444555566678999999999999999999752 467889999999996 999999998874
Q ss_pred cc---------------cccc--------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeecC
Q 044995 68 ET---------------KYMH--------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLDD 122 (288)
Q Consensus 68 ~~---------------~~l~--------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~~ 122 (288)
.. +++. .......+++..++.++.|++.||.||| ..+ |+||||||+|||++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECC
Confidence 21 1211 1112346899999999999999999999 778 999999999999999
Q ss_pred CCceEEecccCccccCCCCcee-----------eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCC
Q 044995 123 KYCAKVSNFGTSRSRAVDQTHI-----------TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPI 177 (288)
Q Consensus 123 ~~~~kl~DfG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~ 177 (288)
++.+||+|||+++......... .....||+.|+||| ||||||+++|||++|..||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 9999999999998654322111 11345899999998 9999999999999999998
Q ss_pred CCCCc------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 178 RFTTF------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 178 ~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
..... ....+..+.+++.+||+.||++||++.|++++|+.+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred cchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 53221 123345688999999999999999999999999998765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.62 Aligned_cols=203 Identities=27% Similarity=0.263 Sum_probs=165.9
Q ss_pred ccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC-----CCceeee
Q 044995 5 TKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN-----HINVVKL 62 (288)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~-----HpnIv~l 62 (288)
...|+.++.....++|++.++||+|+||.||+|.+. .+.+..|+.+++++. |||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 456777777788899999999999999999999762 356788999999987 9999999
Q ss_pred cceEeccccccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC------
Q 044995 63 IGCCLETKYMHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD------ 122 (288)
Q Consensus 63 ~~~~~~~~~l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~------ 122 (288)
++++...+.+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence 998776543221 112234889999999999999999999 889999999999999975
Q ss_pred -------------------CCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh
Q 044995 123 -------------------KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT 172 (288)
Q Consensus 123 -------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt 172 (288)
++.+||+|||+++..... .....||+.|+||| |||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999754322 22356899999999 99999999999999
Q ss_pred CCCCCCCCCccc------------------------------------------------------------hhHHHHHH
Q 044995 173 GAKPIRFTTFEE------------------------------------------------------------DKNITVAK 192 (288)
Q Consensus 173 g~~P~~~~~~~~------------------------------------------------------------~~~~~~~~ 192 (288)
|+.||....... ..+..+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999996433110 00156779
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++|||+.|++++
T Consensus 335 li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcCChhhCCCHHHHhcC
Confidence 9999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=280.77 Aligned_cols=208 Identities=25% Similarity=0.408 Sum_probs=171.0
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcC-CCCceeeecce
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
.++....++|++.+.||+|+||.||+|.+ ..+.+.+|+++++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 44556678999999999999999999963 146789999999999 99999999999
Q ss_pred Eecccccc-------c---------cC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCC
Q 044995 66 CLETKYMH-------D---------QN---------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIK 114 (288)
Q Consensus 66 ~~~~~~l~-------~---------~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk 114 (288)
|...+... . .. ....+++..++.++.|++.||.||| +++|+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence 86543221 0 00 1124889999999999999999999 8899999999
Q ss_pred CCCeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC
Q 044995 115 STNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT 181 (288)
Q Consensus 115 p~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~ 181 (288)
|+|||++.++.+||+|||+++........ ......+++.|+||| ||||||+++|||++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999865443322 223345788899999 99999999999999 999996543
Q ss_pred c----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 F----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ~----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
. +...+..+.+++.+||+.||.+||++.+++++|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2 223467899999999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=273.99 Aligned_cols=196 Identities=20% Similarity=0.325 Sum_probs=164.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc--c----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET--K---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~---- 70 (288)
...++|++.+.||+|+||.||+|+++ .+.|.+|+.++++++||||+++++++... .
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 34578999999999999999999753 45799999999999999999999998764 2
Q ss_pred ---cccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 ---YMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ---~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
++.. ......+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 1111 112225899999999999999999999 777 999999999999999999999999887643
Q ss_pred CCCCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKN 187 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~ 187 (288)
.. ....||+.|+||| ||||||+++|||++|+.||.... .+...+
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence 22 2235899999999 99999999999999999996432 233457
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 88999999999999999999999999998875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=286.70 Aligned_cols=196 Identities=24% Similarity=0.315 Sum_probs=157.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l 72 (288)
...++|++.+.||+|+||.||+++++ .+.+.+|.++++.+ +||||+++++++...+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45689999999999999999999753 34578899999988 799999999998765433
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 2111 1235889999999999999999999 88999999999999999999999999999985332
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHA 194 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li 194 (288)
. .......+||+.|+||| |||||||++|||++|..||.... ++...+..+.+++
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2 22234467999999999 99999999999999999996543 2334577899999
Q ss_pred HHhcCCCCCCCCCH------HHHHHH
Q 044995 195 KRCLNPSGKKRPAM------KEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~------~~i~~~ 214 (288)
.+||+.||.+||++ .+++++
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhC
Confidence 99999999999998 677665
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=283.19 Aligned_cols=194 Identities=26% Similarity=0.338 Sum_probs=161.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999998642 46799999999999999999999988765322
Q ss_pred c-------c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----ceEEecccCcc
Q 044995 73 H-------D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY----CAKVSNFGTSR 135 (288)
Q Consensus 73 ~-------~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a~ 135 (288)
. . ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 1 1 123346889999999999999999999 88999999999999998777 79999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chh
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDK 186 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~ 186 (288)
....... .....||+.|+||| |||||||++|+|++|..||...... ...
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence 6543222 23356999999999 9999999999999999999644321 133
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+..+.+++.+||+.||++|||+.+++++-
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 66789999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.49 Aligned_cols=195 Identities=30% Similarity=0.413 Sum_probs=160.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.+......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999752 3468899999999999999999999876643221
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 11 1135788999999999999999999 889999999999999999999999999998644322
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
......|+..|+||| ||||||+++|+|++|..||.... .+...+..+.+++.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 123346899999999 99999999999999999997543 233356789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~ 216 (288)
||+.||++||++.|++++-.
T Consensus 241 ~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HCCSSGGGSCCHHHHHHCHH
T ss_pred HhccChhhCCCHHHHhhCcc
Confidence 99999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=287.78 Aligned_cols=196 Identities=23% Similarity=0.297 Sum_probs=153.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
..++|++.+.||+|+||.||+++++ .+.+.+|+.++++++||||+++++++...+.+...
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4578999999999999999999763 36789999999999999999999998765432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc--eEEecccCccccCCCCce
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC--AKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~ 143 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++. +||+|||+++..... .
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 172 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--C
Confidence 11235889999999999999999999 889999999999999987664 999999998743222 1
Q ss_pred eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------chhHHHHH
Q 044995 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------EDKNITVA 191 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------~~~~~~~~ 191 (288)
......||+.|+||| |||||||++|+|++|+.||...... ...+..+.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 223346999999999 9999999999999999999643221 12467899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
++|.+||+.||++|||+.|++++-.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred HHHHHHccCChhHCcCHHHHHhCcc
Confidence 9999999999999999999998743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=279.93 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=162.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3478999999999999999999753 467889999999999999999999876532
Q ss_pred ---cccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----cCCCceEEecccCc
Q 044995 71 ---YMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTS 134 (288)
Q Consensus 71 ---~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~DfG~a 134 (288)
++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 2211 111223899999999999999999999 8899999999999999 77788999999999
Q ss_pred cccCCCCceeeeccccCCCCCChh-------------------hHHHHHHHHHHHHhCCCCCCCCC--------------
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-------------------DVCSFGVVLVELLTGAKPIRFTT-------------- 181 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-------------------DiwSlG~il~elltg~~P~~~~~-------------- 181 (288)
+....... .....||..|+||| |||||||++|||++|..||....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 86543322 22346899999998 99999999999999999985211
Q ss_pred -----------------------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 182 -----------------------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 182 -----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.....+..+.+++.+||+.||++||++.|++++..+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1123456888999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.86 Aligned_cols=207 Identities=20% Similarity=0.291 Sum_probs=162.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhcC--CCCceeeecceEecc----ccccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQI--NHINVVKLIGCCLET----KYMHD 74 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~----~~l~~ 74 (288)
....++|++.+.||+|+||.||+|+++ ...+.+|.+++..+ +||||+++++++... ..+..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 345678999999999999999999753 34566777777665 899999999987654 21111
Q ss_pred c------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 75 Q------------NKELPFTWEMQLRISIEASGTMSYLHLSASV--------PIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 75 ~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--------~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
. .....+++..++.++.|++.||.||| .. +|+||||||+|||++.++.+||+|||++
T Consensus 113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 1 11235788999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCcee---eeccccCCCCCChh-----------------hHHHHHHHHHHHHhC----------CCCCCCCCc--
Q 044995 135 RSRAVDQTHI---TTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTG----------AKPIRFTTF-- 182 (288)
Q Consensus 135 ~~~~~~~~~~---~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg----------~~P~~~~~~-- 182 (288)
+......... .....||+.|+||| |||||||++|||++| +.||.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7554322211 12346999999999 999999999999999 666643210
Q ss_pred ------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 183 ------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 183 ------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
....+.++.+++.+||+.||++||++.+++++|+.+.....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 11446779999999999999999999999999999877543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=295.70 Aligned_cols=203 Identities=20% Similarity=0.249 Sum_probs=169.7
Q ss_pred eHHHHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 9 ISNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 9 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
.++++....++|++.++||+|+||.||+++++ .+.+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35566677899999999999999999999753 123889999999999999999999987
Q ss_pred cccccccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccC
Q 044995 68 ETKYMHDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGT 133 (288)
Q Consensus 68 ~~~~l~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~ 133 (288)
+.+.++.. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 65432211 11346899999999999999999999 88899999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc---------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF--------------- 182 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~--------------- 182 (288)
++.............+||+.|+||| |||||||++|||++|+.||.....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence 9876554444444567999999998 999999999999999999964431
Q ss_pred -c---chhHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 044995 183 -E---EDKNITVAKHAKRCLNPSGKK--RPAMKEVASE 214 (288)
Q Consensus 183 -~---~~~~~~~~~li~~cl~~~p~~--Rp~~~~i~~~ 214 (288)
+ ...+.++.++|.+||..+|++ ||++.|++++
T Consensus 302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 125788999999999988888 9999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=281.63 Aligned_cols=213 Identities=25% Similarity=0.411 Sum_probs=174.3
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEc------------------------cHHHHHHHHHHHhcC-CCCceee
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMA------------------------KVEKFINEVVIQSQI-NHINVVK 61 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------------------------~~~~~~~E~~~l~~l-~HpnIv~ 61 (288)
.+...++....++|++.+.||+|+||.||+|.+ ..+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 466777888889999999999999999999962 135788999999999 7999999
Q ss_pred ecceEeccc--------cccc---------cCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEe
Q 044995 62 LIGCCLETK--------YMHD---------QNK-------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHR 111 (288)
Q Consensus 62 l~~~~~~~~--------~l~~---------~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr 111 (288)
++++|...+ ++.. ... ...+++..+..++.|++.||.||| +.+|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999876532 1110 000 112788999999999999999999 8899999
Q ss_pred CCCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCC
Q 044995 112 DIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIR 178 (288)
Q Consensus 112 dlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~ 178 (288)
||||+||+++.++.+||+|||+++....... .......||+.|+||| ||||||+++|||++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986543322 2233456788999999 99999999999998 999996
Q ss_pred CCCc----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 179 FTTF----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 179 ~~~~----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.... +...+..+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 5432 2234678999999999999999999999999999886543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=280.48 Aligned_cols=200 Identities=27% Similarity=0.390 Sum_probs=154.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLET----- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 69 (288)
..++|++.+.||+|+||.||++.+. .+.|.+|++++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4588999999999999999999752 35788999999999999999999986543
Q ss_pred ------ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 ------KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 ------~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+|+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 22211 011235889999999999999999999 888999999999999999999999999999765
Q ss_pred CCCCc--eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chh
Q 044995 138 AVDQT--HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDK 186 (288)
Q Consensus 138 ~~~~~--~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~ 186 (288)
..... .......||+.|+||| ||||||+++|||++|+.||...... ...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 43221 1223356899999999 9999999999999999999654321 124
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHhc
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKE-VASELAGI 218 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l~~~ 218 (288)
+.++.+++.+||+.||++||++.+ +.+.+...
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 678999999999999999997555 44555544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=284.51 Aligned_cols=207 Identities=23% Similarity=0.356 Sum_probs=169.5
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecce
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
++++...++|++.+.||+|+||.||+|.+. .+.+.+|+++++++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356667789999999999999999998741 45789999999999 89999999999
Q ss_pred EeccccccccC---------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCe
Q 044995 66 CLETKYMHDQN---------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNI 118 (288)
Q Consensus 66 ~~~~~~l~~~~---------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Ni 118 (288)
|...+.+.... ....+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceE
Confidence 87653221110 1234688999999999999999999 88999999999999
Q ss_pred eecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---
Q 044995 119 LLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF--- 182 (288)
Q Consensus 119 l~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~--- 182 (288)
|++.++.+||+|||+++....... .......+++.|+||| ||||||+++|||++ |..||.....
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986543322 2223345788899999 99999999999998 9999865432
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+...+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 22346789999999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=275.37 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=167.3
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++...+.+..
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 44578999999999999999998752 4689999999999999999999999876532211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 111235789999999999999999999 8889999999999999999999999999987643222112
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHh
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~c 197 (288)
.....++..|+||| ||||||+++|+|++ |..||.... .+...+..+.+++.+|
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence 22234677899999 99999999999999 899986432 1233467899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhchh
Q 044995 198 LNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
|+.||++||++.+++++|+.+..
T Consensus 242 l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=274.71 Aligned_cols=207 Identities=15% Similarity=0.146 Sum_probs=168.9
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccc---
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~--- 74 (288)
...++|++.+.||+|+||.||+|.+. .+.+.+|+++++++ +|+||+++++++........
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 34578999999999999999999842 34688999999999 79999999988765432211
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc-----eEEecccCccccCC
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC-----AKVSNFGTSRSRAV 139 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~-----~kl~DfG~a~~~~~ 139 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++. +||+|||+++....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 011235899999999999999999999 889999999999999977665 99999999986543
Q ss_pred CCce------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------
Q 044995 140 DQTH------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------- 183 (288)
Q Consensus 140 ~~~~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------- 183 (288)
.... ......||+.|+||| ||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3221 123456999999999 9999999999999999999763321
Q ss_pred ---chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 184 ---EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 184 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
...+.++.+++.+||+.||++||++.+|++.|+.+......
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 12366899999999999999999999999999998765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.10 Aligned_cols=195 Identities=19% Similarity=0.270 Sum_probs=161.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------ 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------ 71 (288)
..++|++.+.||+|+||.||+|.++ ...+.+|+++|++++||||+++++++.+...
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3578999999999999999999753 3568899999999999999999999866532
Q ss_pred -ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC--CCceEEecccCccccCCCC
Q 044995 72 -MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD--KYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 72 -l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~DfG~a~~~~~~~ 141 (288)
+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. .+.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 211 112236899999999999999999999 889999999999999974 4789999999998654332
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAK 192 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~ 192 (288)
. .....||+.|+||| |||||||++|||++|..||..... ....+.++.+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2 22346999999999 999999999999999999964331 1234778999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+|.+||+.||++||++.+++++-
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHHcCCChhHCcCHHHHhhCc
Confidence 99999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=280.70 Aligned_cols=195 Identities=22% Similarity=0.278 Sum_probs=156.9
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCC---CCceeeecceEec
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQIN---HINVVKLIGCCLE 68 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 68 (288)
...++|++.+.||+|+||.||+|++. ...+.+|++++++++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45689999999999999999999752 246788888887775 9999999998765
Q ss_pred cc------------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEe
Q 044995 69 TK------------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVS 129 (288)
Q Consensus 69 ~~------------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~ 129 (288)
.. ++.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 32 1110 111223899999999999999999999 8889999999999999999999999
Q ss_pred cccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------
Q 044995 130 NFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------- 183 (288)
Q Consensus 130 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------- 183 (288)
|||+++...... ......||+.|+||| |||||||++|||++|..||......
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998654322 223457999999999 9999999999999999999543211
Q ss_pred --------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1235678899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=278.84 Aligned_cols=194 Identities=20% Similarity=0.288 Sum_probs=155.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++...+.+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 478999999999999999999752 4568899999999999999999999876543211
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 112345889999999999999999999 889999999999999999999999999999765432221
Q ss_pred eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------------
Q 044995 144 ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------------------- 183 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------------------- 183 (288)
.....||..|+||| ||||||+++|+|++|..||......
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 22346899999999 9999999999999999999654311
Q ss_pred -----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1234568899999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=291.37 Aligned_cols=196 Identities=20% Similarity=0.280 Sum_probs=156.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||+|.++ .+++.+|+++|++++||||+++++++....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4589999999999999999999752 367899999999999999999999876542
Q ss_pred -------cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 -------YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 -------~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 1110 112345899999999999999999999 8889999999999999999999999999998654
Q ss_pred CCCc---------------------eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCC--------
Q 044995 139 VDQT---------------------HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPI-------- 177 (288)
Q Consensus 139 ~~~~---------------------~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~-------- 177 (288)
.... ......+||+.|+||| |||||||++|||++|..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 3221 1124467999999999 9999999999999854443
Q ss_pred ---CCCCc--------------------------------------------------------------cchhHHHHHH
Q 044995 178 ---RFTTF--------------------------------------------------------------EEDKNITVAK 192 (288)
Q Consensus 178 ---~~~~~--------------------------------------------------------------~~~~~~~~~~ 192 (288)
.+... ....+.++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 22110 0123678889
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|+.+||+.||++|||+.|++++
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=289.18 Aligned_cols=197 Identities=22% Similarity=0.307 Sum_probs=158.0
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc---------
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET--------- 69 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 69 (288)
++...++|++.+.||+|+||.||+|.+. ...+.+|+++++.++|||||+++++|...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 4567889999999999999999999763 23456899999999999999999987431
Q ss_pred ------------------------------------ccccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 044995 70 ------------------------------------KYMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSA 104 (288)
Q Consensus 70 ------------------------------------~~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 104 (288)
+|+.. ......+++..+..++.|++.||.|||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--- 158 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--- 158 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 12211 012346889999999999999999999
Q ss_pred CCCeEEeCCCCCCeeec-CCCceEEecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHH
Q 044995 105 SVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELL 171 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~ell 171 (288)
+.+|+||||||+|||++ .++.+||+|||+++....... .....||..|+||| |||||||++|||+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 88999999999999997 678999999999986543222 23346899999999 9999999999999
Q ss_pred hCCCCCCCCCc-------------------------------------------cchhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 172 TGAKPIRFTTF-------------------------------------------EEDKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 172 tg~~P~~~~~~-------------------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
+|+.||..... +...+.++.+++.+||+.||++|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999975431 11245678999999999999999999
Q ss_pred HHHHHH
Q 044995 209 KEVASE 214 (288)
Q Consensus 209 ~~i~~~ 214 (288)
.|++++
T Consensus 317 ~e~l~h 322 (383)
T 3eb0_A 317 YEAMAH 322 (383)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.03 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=153.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
..++|++.+.||+|+||.||+|+++ .+.+.+|++++++++|||||+++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999753 467999999999999999999999875431
Q ss_pred ----------------------------------------------------------cccc---------cCCCCCCCH
Q 044995 71 ----------------------------------------------------------YMHD---------QNKELPFTW 83 (288)
Q Consensus 71 ----------------------------------------------------------~l~~---------~~~~~~l~~ 83 (288)
++.. ........+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 1110 011123456
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-----------eeeeccccCC
Q 044995 84 EMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-----------HITTQVHGTF 152 (288)
Q Consensus 84 ~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~gt~ 152 (288)
..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 678899999999999999 88999999999999999999999999999986543321 1123346999
Q ss_pred CCCChh-----------hHHHHHHHHHHHHhCCCCCCC----------CC---ccchhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 153 GYLNPD-----------DVCSFGVVLVELLTGAKPIRF----------TT---FEEDKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 153 ~y~aPE-----------DiwSlG~il~elltg~~P~~~----------~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
.|+||| ||||||+++|||++|..|+.. .. .....+..+.+++.+||+.||++||++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 999999 999999999999999877521 01 112335678899999999999999999
Q ss_pred HHHHHH
Q 044995 209 KEVASE 214 (288)
Q Consensus 209 ~~i~~~ 214 (288)
.|++++
T Consensus 321 ~~~l~~ 326 (332)
T 3qd2_B 321 TDIIEN 326 (332)
T ss_dssp HHHHHS
T ss_pred HHHhhc
Confidence 999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=283.93 Aligned_cols=199 Identities=20% Similarity=0.243 Sum_probs=157.8
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
+....++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4456789999999999999999999752 13578999999999999999999998655
Q ss_pred cccc-------c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 70 KYMH-------D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 70 ~~l~-------~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+.+. . ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 3221 1 122345788889999999999999999 88899999999999999999999999999986
Q ss_pred cCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
...... ......||+.|+||| |||||||++|||++|..||......
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 543222 223356899999999 9999999999999999998543210
Q ss_pred ---------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 12247899999999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=283.86 Aligned_cols=202 Identities=23% Similarity=0.268 Sum_probs=160.2
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
.++....++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||++++++|.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345667789999999999999999999652 357889999999999999999999987
Q ss_pred ccccccccCC-----------------------------------------------------CCCCCHHHHHHHHHHHH
Q 044995 68 ETKYMHDQNK-----------------------------------------------------ELPFTWEMQLRISIEAS 94 (288)
Q Consensus 68 ~~~~l~~~~~-----------------------------------------------------~~~l~~~~~~~i~~~i~ 94 (288)
+.+......+ ...+++..+..++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 6543221111 11235667888999999
Q ss_pred HHHHHhhcCCCCCeEEeCCCCCCeeecCCC--ceEEecccCccccCCCC---ceeeeccccCCCCCChh-----------
Q 044995 95 GTMSYLHLSASVPIYHRDIKSTNILLDDKY--CAKVSNFGTSRSRAVDQ---THITTQVHGTFGYLNPD----------- 158 (288)
Q Consensus 95 ~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~--~~kl~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE----------- 158 (288)
.||.||| +.+|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||
T Consensus 179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999 88899999999999997665 89999999997543211 11223456899999999
Q ss_pred --hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 159 --DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 159 --DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
||||||+++|||++|+.||...... ...+..+.+++.+||+.||++||++.+++++-
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 9999999999999999999643321 12467899999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=303.68 Aligned_cols=209 Identities=22% Similarity=0.352 Sum_probs=171.0
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
.+.++...++|++.+.||+|+||.||+|.++ .+.|.+|+++|++++|||||+++++|.+..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~l 338 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI 338 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceE
Confidence 4556667788999999999999999999753 478999999999999999999999876532
Q ss_pred ---ccccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ---YMHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ---~l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
|+... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 22110 01124788999999999999999999 88999999999999999999999999999986542
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
..........++..|+||| |||||||++|||++ |+.||.... .+...+..+.+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2111112234677899999 99999999999999 999996432 23345778999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+|.+||+.||++||++.+|++.|+.+...
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=276.38 Aligned_cols=208 Identities=24% Similarity=0.336 Sum_probs=170.0
Q ss_pred HhcCCcccCc-eeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--
Q 044995 15 KATDSFNVNR-ILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK-- 70 (288)
Q Consensus 15 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 70 (288)
...++|.+.+ .||+|+||.||+|.+. .+.+.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 85 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcE
Confidence 3457787777 9999999999998631 467889999999999999999999985432
Q ss_pred ----cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 ----YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 ----~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 2111 123346899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCceee--eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 140 DQTHIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 140 ~~~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
...... ....+|+.|+||| ||||||+++|||++ |..||.... .+...+..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 332221 2234678899999 99999999999998 999996432 234557899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCCC
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGAS 225 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 225 (288)
.+++.+||+.||++||++.+++++|+.+.......
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999997765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=288.34 Aligned_cols=196 Identities=24% Similarity=0.340 Sum_probs=159.8
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l 72 (288)
...++|++.+.||+|+||.||+++++ .+.+.+|..++.++ +|||||++++++...+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34578999999999999999999753 23478899999887 899999999998765433
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 2111 1235889999999999999999999 88999999999999999999999999999985322
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------------ccch
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------------FEED 185 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------------~~~~ 185 (288)
. .......+||+.|+||| |||||||++|||++|+.||.... ++..
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 2 22334567999999999 99999999999999999995321 2233
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAM------KEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~------~~i~~~ 214 (288)
.+.++.++|.+||+.||++||++ .|++++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 46789999999999999999985 566554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.19 Aligned_cols=192 Identities=21% Similarity=0.221 Sum_probs=152.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.++||+|+||.||+|.++ ...+.+|+..+.++ +||||++++++|.+.+.+....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 77999999999999999999753 23455666655554 9999999999987664332111
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 1235899999999999999999999 8889999999999999999999999999987654322
Q ss_pred eeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCC-------------ccchhHHHHHHHHHHhcCC
Q 044995 144 ITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTT-------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~-------------~~~~~~~~~~~li~~cl~~ 200 (288)
......||+.|+||| |||||||++|||++|..|+.... .....+.++.+++.+||+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 291 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEP 291 (311)
T ss_dssp ---CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence 223346899999999 99999999999999976653211 1223467899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044995 201 SGKKRPAMKEVASE 214 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~ 214 (288)
||++||++.|++++
T Consensus 292 dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 292 DPKLRATAEALLAL 305 (311)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.07 Aligned_cols=192 Identities=23% Similarity=0.273 Sum_probs=161.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+++++ .+.+.+|+++++.++||||+++++++.+.+.++.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3478999999999999999999752 3568899999999999999999998876543321
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 11 1235789999999999999999999 889999999999999999999999999999865432
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
....+||+.|+||| |||||||++|||++|..||.... ++...+.++.++|.+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23457999999999 99999999999999999996433 234457889999999
Q ss_pred hcCCCCCCCCC-----HHHHHHH
Q 044995 197 CLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~-----~~~i~~~ 214 (288)
||+.||++||+ +.+++++
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhcCHHhccCCccCCHHHHHhC
Confidence 99999999998 7777765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=275.88 Aligned_cols=194 Identities=25% Similarity=0.350 Sum_probs=156.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
..++|.+.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++...+.+...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3477999999999999999998752 47899999999999999999999998765422211
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccc
Q 044995 76 ----------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRS 136 (288)
Q Consensus 76 ----------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~ 136 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 11245889999999999999999999 8899999999999999 4567899999999976
Q ss_pred cCCCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------chhHHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE-----------------EDKNIT 189 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~~~ 189 (288)
..... ......||..|+||| ||||||+++|||++|..||...... ...+.+
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred cCCcc--cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 44322 223356899999999 9999999999999999999654321 123678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+++.+||+.||++||++.|++++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.60 Aligned_cols=208 Identities=23% Similarity=0.369 Sum_probs=163.0
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
+++....++|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445566788999999999999999988531 356899999999999999999999876
Q ss_pred ccc------------cccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC
Q 044995 68 ETK------------YMHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK 123 (288)
Q Consensus 68 ~~~------------~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~ 123 (288)
... ++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 532 1111 122346899999999999999999999 8899999999999999999
Q ss_pred CceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------
Q 044995 124 YCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--------- 181 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--------- 181 (288)
+.+||+|||+++....... .......+++.|+||| ||||||+++|+|++ |..||....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 9999999999976543221 1122335678899999 99999999999999 888986432
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2234567899999999999999999999999999988764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=273.89 Aligned_cols=203 Identities=26% Similarity=0.384 Sum_probs=162.5
Q ss_pred CcccCceeeeeCCeeEEEeEc----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccccc----
Q 044995 19 SFNVNRILGQGGQDIVYKGMA----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETKYM---- 72 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l---- 72 (288)
.|++.+.||+|+||.||+|.+ ..+.|.+|+.++++++||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 355668999999999999863 146789999999999999999999998654321
Q ss_pred ----c-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 73 ----H-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 73 ----~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
. .......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 1 0112345788999999999999999999 8889999999999999999999999999997543321
Q ss_pred ---ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCC-CCCC---------------ccchhHHHHH
Q 044995 142 ---THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI-RFTT---------------FEEDKNITVA 191 (288)
Q Consensus 142 ---~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~-~~~~---------------~~~~~~~~~~ 191 (288)
........++..|+||| ||||||+++|+|++|..|+ .... .+...+..+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 11122345788899999 9999999999999965554 3221 2233467899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
+++.+||+.||++|||+.++++.|+.+......
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999998776544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=292.07 Aligned_cols=193 Identities=23% Similarity=0.293 Sum_probs=156.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc-------------c
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET-------------K 70 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------------~ 70 (288)
.+|++.+.||+|+||.||+|+++ ...+.+|+++|++++|||||+++++|... +
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 46999999999999999999863 22345799999999999999999887431 2
Q ss_pred cccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCCC
Q 044995 71 YMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~~ 140 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 134 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 134 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred cccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 2111 012346888999999999999999999 8899999999999999855 67899999999865432
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF-------------------------- 182 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~-------------------------- 182 (288)
.. .....||+.|+||| |||||||++|||++|+.||.....
T Consensus 211 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 211 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp CC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred CC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 22 23356899999999 999999999999999999965431
Q ss_pred -----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 -----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 -----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
....+.++.+|+.+||..||++||++.|++++-
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 112357899999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=284.68 Aligned_cols=199 Identities=20% Similarity=0.327 Sum_probs=160.1
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCC--CceeeecceEeccccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINH--INVVKLIGCCLETKYM 72 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~l 72 (288)
....++|++.+.||+|+||.||++.+. .+.|.+|+.++++++| |||+++++++...+++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 345678999999999999999998652 3678999999999987 9999999998776543
Q ss_pred cccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 73 HDQN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 73 ~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.... ....+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 85 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 3211 1235788999999999999999999 88899999999999997 578999999999865433
Q ss_pred Cce-eeeccccCCCCCChh----------------------hHHHHHHHHHHHHhCCCCCCCCC----------------
Q 044995 141 QTH-ITTQVHGTFGYLNPD----------------------DVCSFGVVLVELLTGAKPIRFTT---------------- 181 (288)
Q Consensus 141 ~~~-~~~~~~gt~~y~aPE----------------------DiwSlG~il~elltg~~P~~~~~---------------- 181 (288)
... ......||+.|+||| |||||||++|||++|..||....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 221 223457999999998 99999999999999999996421
Q ss_pred -ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 182 -FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 182 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+...+.++.+++.+||+.||++|||+.+++++..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 22334578999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.49 Aligned_cols=207 Identities=23% Similarity=0.388 Sum_probs=168.8
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecceE
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIGCC 66 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~ 66 (288)
....++|++.+.||+|+||.||+|.+. .+.+.+|+++++++ +||||++++++|
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445688999999999999999998631 35688999999999 899999999998
Q ss_pred ecccccc-------c---------cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCC
Q 044995 67 LETKYMH-------D---------QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTN 117 (288)
Q Consensus 67 ~~~~~l~-------~---------~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~N 117 (288)
...+.+. . .. ....+++..++.++.|++.||.||| +.+|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccce
Confidence 6653221 1 00 0123788999999999999999999 8899999999999
Q ss_pred eeecCCCceEEecccCccccCCCCcee-eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---
Q 044995 118 ILLDDKYCAKVSNFGTSRSRAVDQTHI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT--- 181 (288)
Q Consensus 118 il~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~--- 181 (288)
||++.++.+||+|||+++......... .....+++.|+||| ||||||+++|||++ |..||....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999998654332221 22335678899999 99999999999999 999986432
Q ss_pred ------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 182 ------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 182 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
.+...+..+.+++.+||+.||++||++.+++++|+++.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 223456789999999999999999999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.71 Aligned_cols=201 Identities=18% Similarity=0.297 Sum_probs=156.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------------------HHHHHHHHHHHhcCCCCceeeecc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------------------VEKFINEVVIQSQINHINVVKLIG 64 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------------~~~~~~E~~~l~~l~HpnIv~l~~ 64 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999752 124667888899999999999999
Q ss_pred eEec----cccccc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC--ce
Q 044995 65 CCLE----TKYMHD------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY--CA 126 (288)
Q Consensus 65 ~~~~----~~~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~--~~ 126 (288)
++.. ..+++. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence 8766 222111 112236899999999999999999999 88999999999999998776 99
Q ss_pred EEecccCccccCCCCce------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------
Q 044995 127 KVSNFGTSRSRAVDQTH------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------- 182 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------- 182 (288)
||+|||+++........ ......||..|+||| |||||||++|||++|+.||.....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999765322111 113346999999999 999999999999999999953211
Q ss_pred ---------cc---------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 183 ---------EE---------DKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 183 ---------~~---------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+. ..+.++.+++.+||+.||++||++.+|++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 345589999999999999999999999999987644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=290.66 Aligned_cols=194 Identities=24% Similarity=0.308 Sum_probs=164.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~- 73 (288)
..++|.+.+.||+|+||.||+|+++ .+.+.+|+.+++.++||||+++++++...+.++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999752 346889999999999999999999876653221
Q ss_pred ------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 74 ------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 74 ------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 1123446899999999999999999999 8899999999999999999999999999998654322
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc--------------cchhHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------EEDKNITVAKHAK 195 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~li~ 195 (288)
.....+||+.|+||| |||||||++|+|++|..||..... +...+.++.+++.
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 223457999999999 999999999999999999975432 2235678999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.||++|||+.+++++
T Consensus 249 ~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTC
T ss_pred HHcCCCchhCcCHHHHHhC
Confidence 9999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=274.38 Aligned_cols=208 Identities=23% Similarity=0.332 Sum_probs=167.4
Q ss_pred HHHHHhcCCcccCc-eeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEe
Q 044995 11 NELEKATDSFNVNR-ILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCL 67 (288)
Q Consensus 11 ~~~~~~~~~y~~~~-~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~ 67 (288)
+++....++|++.+ .||+|+||.||+|.+. .+.|.+|++++++++||||+++++++.
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 88 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 88 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence 34455567899888 9999999999999421 467899999999999999999999985
Q ss_pred cccc------ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 68 ETKY------MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 68 ~~~~------l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...+ +.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 4321 110 011235889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceee--eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchh
Q 044995 136 SRAVDQTHIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDK 186 (288)
Q Consensus 136 ~~~~~~~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~ 186 (288)
.......... ....++..|+||| ||||||+++|+|++ |..||.... .+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6544333222 2234568899999 99999999999999 999996432 23345
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 78899999999999999999999999999988654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.35 Aligned_cols=195 Identities=20% Similarity=0.331 Sum_probs=163.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999742 12567899999999999999999998766
Q ss_pred cccccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 70 KYMHDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 70 ~~l~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
+.+... .....+++..+..++.|++.||.||| .++|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 432211 12235889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC--------ccchhHHHHHHHHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT--------FEEDKNITVAKHAK 195 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~--------~~~~~~~~~~~li~ 195 (288)
....... .....||+.|+||| |||||||++|||++|..||.... .+...+.++.+++.
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVS 256 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHH
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHH
Confidence 6543322 23356999999999 99999999999999999995322 22345789999999
Q ss_pred HhcCCCCCCCCCHHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l 215 (288)
+||+.||++||++.+++++-
T Consensus 257 ~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 257 GLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHTCSSGGGSCCHHHHHHCT
T ss_pred HHccCChhhCcCHHHHhcCc
Confidence 99999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.35 Aligned_cols=201 Identities=23% Similarity=0.403 Sum_probs=164.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~ 74 (288)
.++|++.+.||+|+||.||+|+++ .+.+.+|+++++++ +||||+++++++...+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 478999999999999999998642 34688999999999 99999999999876543211
Q ss_pred c-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 75 Q-----------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 75 ~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
. .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 0 11236889999999999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC------------
Q 044995 126 AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------ 181 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------ 181 (288)
+||+|||+++...... ......++..|+||| ||||||+++|||++ |..||....
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 9999999987432211 112235688999999 99999999999998 999996432
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
.+...+..+.+++.+||+.||++||++.+++++|+.+....
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 22345788999999999999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=281.45 Aligned_cols=188 Identities=25% Similarity=0.347 Sum_probs=155.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~ 74 (288)
.++|++.+.||+|+||.||+++++ .+.+.+|+.+++++ +||||+++++++...+.++.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999752 34578999999988 89999999999876543321
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 11 1235889999999999999999999 8899999999999999999999999999998533222
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------------ccchhH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------------FEEDKN 187 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------------~~~~~~ 187 (288)
......+||+.|+||| |||||||++|||++|..||.... ++...+
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 2234457999999999 99999999999999999995421 123346
Q ss_pred HHHHHHHHHhcCCCCCCCCCH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~ 208 (288)
.++.+++.+||+.||++||++
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCC
Confidence 788999999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=291.26 Aligned_cols=199 Identities=22% Similarity=0.310 Sum_probs=145.9
Q ss_pred HhcCCccc-CceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEec--cc---
Q 044995 15 KATDSFNV-NRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLE--TK--- 70 (288)
Q Consensus 15 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~--- 70 (288)
...+.|++ .++||+|+||.||+|.++ .+.+.+|+.+|++++|||||++++++.. ..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34455776 558999999999999842 3578999999999999999999999854 22
Q ss_pred ----cccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----cCCCceEE
Q 044995 71 ----YMHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKV 128 (288)
Q Consensus 71 ----~l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~----~~~~~~kl 128 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 1110 011224889999999999999999999 8889999999999999 67789999
Q ss_pred ecccCccccCCCCc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----------
Q 044995 129 SNFGTSRSRAVDQT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------- 184 (288)
Q Consensus 129 ~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------- 184 (288)
+|||+++....... .......||+.|+||| |||||||++|||++|..||.......
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999986543211 2223457899999999 99999999999999999995432100
Q ss_pred ---------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 044995 185 ---------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVAS 213 (288)
Q Consensus 185 ---------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 213 (288)
..+..+.+||.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00456789999999999999999999998
Q ss_pred HHH
Q 044995 214 ELA 216 (288)
Q Consensus 214 ~l~ 216 (288)
+-.
T Consensus 334 hp~ 336 (405)
T 3rgf_A 334 DPY 336 (405)
T ss_dssp SGG
T ss_pred Chh
Confidence 743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.68 Aligned_cols=199 Identities=19% Similarity=0.290 Sum_probs=162.7
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++....
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 334578999999999999999999752 367899999999999999999999875432
Q ss_pred --------cccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 --------YMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 --------~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 103 KDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 1111 111235889999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcee--eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 139 VDQTHI--TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 139 ~~~~~~--~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
...... .....||+.|+||| |||||||++|+|++|+.||......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 322211 23357899999999 9999999999999999999654321
Q ss_pred ------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++|||+.|++++-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 12356789999999999999999999999763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=290.95 Aligned_cols=203 Identities=22% Similarity=0.250 Sum_probs=167.6
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceE
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCC 66 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~ 66 (288)
+..+++....++|++.+.||+|+||.||+++++ .+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345666777899999999999999999999753 12378899999999999999999988
Q ss_pred eccccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 67 LETKYMHDQNK--------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 67 ~~~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
.+.++++...+ ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 76643321111 135889999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh------------------hHHHHHHHHHHHHhCCCCCCCCCc------------
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD------------------DVCSFGVVLVELLTGAKPIRFTTF------------ 182 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE------------------DiwSlG~il~elltg~~P~~~~~~------------ 182 (288)
+++.............+||+.|+||| |||||||++|||++|+.||.....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 99876544443344467999999998 999999999999999999965431
Q ss_pred -------cchhHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 044995 183 -------EEDKNITVAKHAKRCLNPSGKKR---PAMKEVASE 214 (288)
Q Consensus 183 -------~~~~~~~~~~li~~cl~~~p~~R---p~~~~i~~~ 214 (288)
....+.++.++|.+||. +|.+| |++.|++++
T Consensus 288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 12356789999999999 99998 589998876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.12 Aligned_cols=197 Identities=17% Similarity=0.228 Sum_probs=160.1
Q ss_pred HhcCCcccCceeeee--CCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQG--GQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G--~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
...++|++.+.||+| +||.||+++++ .+.+.+|++++++++|||||++++++...+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 456889999999999 99999999753 35688899999999999999999998765432
Q ss_pred cc---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 73 HD---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 73 ~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 21 111245889999999999999999999 889999999999999999999999999987643
Q ss_pred CCCCc------eeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------
Q 044995 138 AVDQT------HITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTFE--------------- 183 (288)
Q Consensus 138 ~~~~~------~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~~--------------- 183 (288)
..... .......||+.|+||| |||||||++|||++|+.||......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 22111 1112236888999999 9999999999999999999643211
Q ss_pred ---------------------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ---------------------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ---------------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 1234568899999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=273.77 Aligned_cols=205 Identities=29% Similarity=0.465 Sum_probs=163.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
...+|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||++++++|...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3456888999999999999998731 467899999999999999999999865432
Q ss_pred -----cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 -----YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 -----~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 2211 112345788999999999999999999 8899999999999999999999999999997654
Q ss_pred CCCc---eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHH
Q 044995 139 VDQT---HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNI 188 (288)
Q Consensus 139 ~~~~---~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~ 188 (288)
.... .......+|+.|+||| ||||||+++|+|++ |.+||..... +...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 3221 1122345778899999 99999999999999 5566643221 233477
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
.+.+++.+||+.||++||++.++++.|+.+.....
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 89999999999999999999999999998876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.01 Aligned_cols=194 Identities=23% Similarity=0.310 Sum_probs=154.4
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++.+.||+|+||.||+|.++ ...+.+|++++++++||||+++++++...+.+...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999753 11355799999999999999999998765432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceee
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT 145 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 145 (288)
.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence 11235788999999999999999999 88999999999999999999999999999875432222 22
Q ss_pred eccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-----------------------------
Q 044995 146 TQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE----------------------------- 184 (288)
Q Consensus 146 ~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~----------------------------- 184 (288)
....||..|+||| |||||||++|+|++|..||......+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 2346899999999 99999999999999999996543111
Q ss_pred ---------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.++.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 1356788999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=272.31 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=162.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ-- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~-- 75 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...+.....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999752 57899999999999999999999998765432211
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccccCCCC
Q 044995 76 -----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 76 -----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 11234789999999999999999999 8889999999999999 778899999999997654322
Q ss_pred ceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------c----hhHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE--------------E----DKNITVAKH 193 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~--------------~----~~~~~~~~l 193 (288)
......||+.|+||| ||||||+++|+|++|..||...... . ..+..+.++
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred --chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 223346999999999 9999999999999999999654321 1 346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.+||+.||++||++.+++++-
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHccCChhhCcCHHHHhcCH
Confidence 9999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.22 Aligned_cols=191 Identities=24% Similarity=0.347 Sum_probs=160.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
+.|++.+.||+|+||.||+|++. .+.|.+|++++++++||||++++++|...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999742 3578899999999999999999999876532
Q ss_pred --ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 72 --MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 72 --l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 211 012346889999999999999999999 888999999999999999999999999999764322
Q ss_pred eeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHH
Q 044995 144 ITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKH 193 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~l 193 (288)
....||+.|+||| |||||||++|||++|..||..... ....+..+.++
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 2346899999999 999999999999999999854321 22346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
+.+||+.||++||++.+++++..
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHcccChhhCcCHHHHhhChh
Confidence 99999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.30 Aligned_cols=205 Identities=21% Similarity=0.362 Sum_probs=157.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++...+....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999998742 4578899999999999999999999876533211
Q ss_pred c-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 75 Q-----------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 75 ~-----------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
. .....+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 0 12345788999999999999999999 889999999999999999999999999998754
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNI 188 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~ 188 (288)
..... ......|+..|+||| ||||||+++|+|++|..||..... ....+.
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 33221 122346899999999 999999999999999999854321 123567
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
++.+++.+||+.||++||++.++++.|+.+......
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 899999999999999999999999999999876544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=283.57 Aligned_cols=197 Identities=20% Similarity=0.244 Sum_probs=152.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++...+.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 356688999999999999999999642 346789999999999999999999987654322
Q ss_pred cc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee-----cCCCceEEecccCccc
Q 044995 74 DQ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL-----DDKYCAKVSNFGTSRS 136 (288)
Q Consensus 74 ~~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~-----~~~~~~kl~DfG~a~~ 136 (288)
.. .....+++..+..++.|++.||.||| +.+|+||||||+|||+ +..+.+||+|||+++.
T Consensus 110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 11 11235889999999999999999999 8899999999999999 4455699999999976
Q ss_pred cCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc--------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE-------------------- 184 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~-------------------- 184 (288)
...... ......||..|+||| |||||||++|||++|..||.......
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 543222 223346899999999 99999999999999999996432110
Q ss_pred ------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 ------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 ------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.++.+++.+||+.||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 135788899999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=278.38 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=159.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
..++|++.+.||+|+||.||+|.++ ...|.+|++++++++||||+++++++...+.+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3467888899999999999998631 34688999999999999999999997654322
Q ss_pred c-------c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 73 H-------D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 73 ~-------~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
. . ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 1 1 112246889999999999999999999 8889999999999999999999999999998654
Q ss_pred CCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHH
Q 044995 139 VDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNIT 189 (288)
Q Consensus 139 ~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~ 189 (288)
..... ......++..|+||| ||||||+++|||++ |..||.... .+...+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence 32211 112234577899999 99999999999999 999985322 22345778
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+.+++.+||+.||++||++.++++.|+.+...
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999988653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=293.29 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=154.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||++.++ ...+.+|++++++++||||++++++|...+.+..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3578999999999999999998752 2457789999999999999999999876543321
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.. ....+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 11 1235789999999999999999999 7 78999999999999999999999999999753322
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAK 195 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~ 195 (288)
. .......||+.|+||| |||||||++|||++|+.||.... ++...+.++.++|.
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 2 2233467999999999 99999999999999999996433 23445788999999
Q ss_pred HhcCCCCCCCC-----CHHHHHHHH
Q 044995 196 RCLNPSGKKRP-----AMKEVASEL 215 (288)
Q Consensus 196 ~cl~~~p~~Rp-----~~~~i~~~l 215 (288)
+||+.||++|| ++.|++++-
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCc
Confidence 99999999999 999988763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=284.19 Aligned_cols=195 Identities=23% Similarity=0.316 Sum_probs=148.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
...++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||++++++|...+.+..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 45677999999999999999999763 3568899999999999999999999876532211
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccCCCCc
Q 044995 75 ---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~~~~~ 142 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 122345789999999999999999999 888999999999999975 789999999999864322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------chhHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-------------------EDKNITVAK 192 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-------------------~~~~~~~~~ 192 (288)
.......||+.|+||| |||||||++|||++|..||...... ...+.++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 1223356899999999 9999999999999999998543211 234678999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++||++.+++++
T Consensus 285 li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999885
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=271.80 Aligned_cols=195 Identities=24% Similarity=0.319 Sum_probs=160.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++.........
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999998652 36788999999999999999999998765432211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecccCccccCC
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAV 139 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG~a~~~~~ 139 (288)
. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 1 1234788999999999999999999 88899999999999997654 499999999976543
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~ 190 (288)
... .....||+.|+||| ||||||+++|+|++|..||...... ...+.++
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 222 23356899999999 9999999999999999998543211 2346789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+++.+||+.||++||++.|++++-
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred HHHHHHHcccChhhCCCHHHHhcCc
Confidence 9999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=277.58 Aligned_cols=204 Identities=23% Similarity=0.334 Sum_probs=164.8
Q ss_pred hcCCc-ccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecc--
Q 044995 16 ATDSF-NVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLET-- 69 (288)
Q Consensus 16 ~~~~y-~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 69 (288)
..++| ++.+.||+|+||.||++..+ .+.|.+|++++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34555 99999999999999876421 45689999999999999999999998763
Q ss_pred c-------cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 K-------YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 ~-------~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
. ++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 1 1111 112235889999999999999999999 888999999999999999999999999999866
Q ss_pred CCCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC------------------------
Q 044995 138 AVDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT------------------------ 180 (288)
Q Consensus 138 ~~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~------------------------ 180 (288)
...... ......++..|+||| ||||||+++|+|++|..||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 443322 122345778899999 9999999999999999998532
Q ss_pred ------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 181 ------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 181 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
..+...+.++.+++.+||+.||++||++.++++.|+.+....
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 122345678999999999999999999999999999886653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=301.01 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=161.8
Q ss_pred cCCcccCc-eeeeeCCeeEEEeEc---------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 17 TDSFNVNR-ILGQGGQDIVYKGMA---------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 17 ~~~y~~~~-~lG~G~~g~Vy~~~~---------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
.+++.+.+ .||+|+||.||+|.+ ..+.|.+|+++|++++|||||+++++|....
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv 413 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 413 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence 34444445 799999999999853 1578999999999999999999999986532
Q ss_pred --cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 --YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 --~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 2211 122346899999999999999999999 8899999999999999999999999999998654332
Q ss_pred ceee--eccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHH
Q 044995 142 THIT--TQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAK 192 (288)
Q Consensus 142 ~~~~--~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~ 192 (288)
.... ....+++.|+||| |||||||++|||++ |+.||.... .+...+.++.+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2111 1234568899999 99999999999998 999996433 23346789999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 193 HAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
+|.+||+.||++||++.+|++.|+.+....
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999886554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.87 Aligned_cols=204 Identities=18% Similarity=0.270 Sum_probs=160.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++...+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45688999999999999999999742 367889999999999999999999987654322
Q ss_pred cc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 DQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
.. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 11 11235889999999999999999999 888999999999999999999999999998765433
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAK 192 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~ 192 (288)
.........|+..|+||| ||||||+++|||++|..||.... .....+.++.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 322333456899999999 99999999999999999996432 12234678999
Q ss_pred HHHHhcCCCCCCCC-CHHHHHHHHHhchhh
Q 044995 193 HAKRCLNPSGKKRP-AMKEVASELAGIKAW 221 (288)
Q Consensus 193 li~~cl~~~p~~Rp-~~~~i~~~l~~~~~~ 221 (288)
++.+||+.||++|| ++.++++.|+.....
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 99999999999999 999999999877554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.49 Aligned_cols=197 Identities=24% Similarity=0.306 Sum_probs=154.8
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
...++|++.+.||+|+||.||++++. ...+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999988641 23577899999999999999999998765
Q ss_pred ccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 70 KYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 70 ~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+.++... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 4332111 1235788899999999999999999 88999999999999999999999999999875
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVA 191 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~ 191 (288)
..... .......||+.|+||| ||||||+++|||++|..||.... .+...+.++.
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 43222 1223457999999999 99999999999999999996543 2334578899
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRP-----AMKEVASEL 215 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp-----~~~~i~~~l 215 (288)
+++.+||+.||++|| ++.+++++-
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 999999999999999 777887763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.31 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=155.8
Q ss_pred CcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
.|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||++++++|...+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3677789999999999998631 467999999999999999999999875432
Q ss_pred --cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 --YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 --~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
|+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 2111 112235788899999999999999999 8899999999999999999999999999998553322
Q ss_pred ce---eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHHH
Q 044995 142 TH---ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITVA 191 (288)
Q Consensus 142 ~~---~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~~ 191 (288)
.. ......+++.|+||| ||||||+++|||++ |..||..... +...+..+.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 112335678899999 99999999999999 6777754321 234577899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
+++.+||+.||++||++.+++++|+.+......
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 999999999999999999999999998765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=287.06 Aligned_cols=196 Identities=22% Similarity=0.292 Sum_probs=155.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
...++|.+.+.||+|+||.||+|.++ ...+.+|+++|++++|||||++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999652 1147899999999999999999998754
Q ss_pred cc------ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecccC
Q 044995 69 TK------YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGT 133 (288)
Q Consensus 69 ~~------~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~DfG~ 133 (288)
.. ++. .......+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 42 221 1223456899999999999999999999 8889999999999999654 4599999999
Q ss_pred ccccCCCCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------
Q 044995 134 SRSRAVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTFE---------------- 183 (288)
Q Consensus 134 a~~~~~~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~~---------------- 183 (288)
++..... .......||+.|+||| |||||||++|+|++|..||......
T Consensus 289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 9865432 2233457999999999 9999999999999999999643221
Q ss_pred ---chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++||++.|++++-
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 12367899999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=290.39 Aligned_cols=205 Identities=19% Similarity=0.248 Sum_probs=162.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeec-ceEeccc-------c
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLI-GCCLETK-------Y 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~-~~~~~~~-------~ 71 (288)
..++|++.++||+|+||.||+|.+. .+.+.+|+++++.|+|++++..+ .++...+ +
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 3578999999999999999999752 34688999999999885544443 3333322 2
Q ss_pred ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccccCCCCc
Q 044995 72 MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 72 l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+.. ......+++..++.++.|++.||.||| .++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 210 011346899999999999999999999 8899999999999999 5788999999999986543322
Q ss_pred e------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 143 H------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 143 ~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
. ......||..|+||| |||||||++|||++|+.||......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 1 122457999999999 9999999999999999999754321
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
...+.++.+++..||+.||++||++.+|++.|+.+....+
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 2235689999999999999999999999999998866543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.56 Aligned_cols=197 Identities=21% Similarity=0.286 Sum_probs=162.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLET---- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 69 (288)
..++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4589999999999999999999752 35688999999999999999999987432
Q ss_pred -----ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 70 -----KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 -----~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+++.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 12111 112346889999999999999999999 889999999999999999999999999999765
Q ss_pred CCC-CceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHH
Q 044995 138 AVD-QTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNIT 189 (288)
Q Consensus 138 ~~~-~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~ 189 (288)
... .........||..|+||| ||||||+++|||++|..||.... .+...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHH
Confidence 322 122223456899999999 99999999999999999997543 23345778
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.+++.+||+.||++||++.+++++-
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCc
Confidence 99999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=272.62 Aligned_cols=207 Identities=24% Similarity=0.401 Sum_probs=161.7
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEeccc-cc
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLETK-YM 72 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~l 72 (288)
|...++....++|++.+.||+|+||.||++.++ .+.|.+|++++++++||||+++++++.+.+ .+
T Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp ----CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred hhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 344445566789999999999999999998752 577999999999999999999999875432 11
Q ss_pred cccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 73 HDQNK---------------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 73 ~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
....+ ...+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 11111 012678889999999999999999 888999999999999999999999999998754
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCCc---------------cchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTTF---------------EEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~~---------------~~~~~~~~ 190 (288)
.... ....++..|+||| ||||||+++|||++ |..||..... +...+..+
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 168 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred cccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 3221 2235788999999 99999999999998 9999864332 23457789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+++.+||+.||++||++.++++.|+.+...
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.79 Aligned_cols=200 Identities=22% Similarity=0.345 Sum_probs=163.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEc-----------------------cHHHHHHHHHHHhcCCCCceeeecceEecc--c-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA-----------------------KVEKFINEVVIQSQINHINVVKLIGCCLET--K- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~- 70 (288)
.+.|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999972 136789999999999999999999988654 2
Q ss_pred ------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 ------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 1111 011235889999999999999999999 889999999999999999999999999999866
Q ss_pred CCCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC------------------------
Q 044995 138 AVDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT------------------------ 180 (288)
Q Consensus 138 ~~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~------------------------ 180 (288)
...... ......||..|+||| ||||||+++|+|++|..|+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 543321 223345788899999 9999999999999998875211
Q ss_pred ------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 181 ------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 181 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
..+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 112344678999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=281.32 Aligned_cols=192 Identities=18% Similarity=0.258 Sum_probs=154.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY---- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 71 (288)
..++|++.+.||+|+||.||+|.++ .+++.+|++++++++||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999752 4578899999999999999999999865421
Q ss_pred ----ccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 ----MHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 ----l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 110 011235788999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
.. .....+|+.|+||| |||||||++|||++|+.||......
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 23356899999999 9999999999999999999654311
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||..||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1235678999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.37 Aligned_cols=203 Identities=19% Similarity=0.282 Sum_probs=161.1
Q ss_pred ceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------------------HHHHHHHHHHHhcCCCCc
Q 044995 7 LFISNELEKATDSFNVNRILGQGGQDIVYKGMAK----------------------------VEKFINEVVIQSQINHIN 58 (288)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------------~~~~~~E~~~l~~l~Hpn 58 (288)
.....++....++|++.+.||+|+||.||+|.+. .+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 4456788999999999999999999999999642 278999999999999999
Q ss_pred eeeecceEecc------------ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee
Q 044995 59 VVKLIGCCLET------------KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL 120 (288)
Q Consensus 59 Iv~l~~~~~~~------------~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~ 120 (288)
|+++++++... +++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 99999987432 22111 122346899999999999999999999 8889999999999999
Q ss_pred cCCCceEEecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----
Q 044995 121 DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----- 183 (288)
Q Consensus 121 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----- 183 (288)
+.++.+||+|||+++...... ......||..|+||| |||||||++|+|++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999997543222 223346889999999 9999999999999999999754311
Q ss_pred -----------------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1124568899999999999999999999876
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=276.91 Aligned_cols=196 Identities=23% Similarity=0.359 Sum_probs=163.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|.+.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++.+.+.++.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999998752 4678899999999999999999999877653322
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 11 1135789999999999999999999 8899999999999999999999999999998654322
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
. ......||..|+||| ||||||+++|+|++|+.||.... .+...+..+.+++.+
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 2 223356899999999 99999999999999999996543 233456789999999
Q ss_pred hcCCCCCCCCCHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l 215 (288)
||+.||++||++.+++++-
T Consensus 275 ~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HccCChhHCcCHHHHhcCc
Confidence 9999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=283.06 Aligned_cols=195 Identities=22% Similarity=0.305 Sum_probs=152.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4588999999999999999999642 356889999999999999999999876543
Q ss_pred --------cccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 --------YMHDQN---KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 --------~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
++.... -...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 111100 0124788899999999999999999 88999999999999999999999999999975432
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------------------ 184 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------------------ 184 (288)
. .......||+.|+||| |||||||++|||++|..||.......
T Consensus 180 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 1223357899999999 99999999999999999996432100
Q ss_pred --------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 --------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 --------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.++.+++.+||..||++|||+.|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 1156789999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=273.38 Aligned_cols=207 Identities=18% Similarity=0.238 Sum_probs=164.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecc--------c
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLET--------K 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~ 70 (288)
...++|++.+.||+|+||.||+|++. .+.+.+|++++++++|+|++..+..+... +
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 35588999999999999999999752 24688999999999999988877765332 2
Q ss_pred cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccccCCCC
Q 044995 71 YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 ~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~~~~~ 141 (288)
++.. ......+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 2210 011346899999999999999999999 8889999999999999 788999999999998654332
Q ss_pred c------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 142 T------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 142 ~------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
. .......||+.|+||| |||||||++|+|++|+.||......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 2 1123456899999999 9999999999999999999753321
Q ss_pred -chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 184 -EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 184 -~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
...+.++.+++.+||+.||++||++.++++.|+.+....+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 12367899999999999999999999999999998776554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.23 Aligned_cols=199 Identities=23% Similarity=0.305 Sum_probs=160.8
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLET 69 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 69 (288)
......++|++.+.||+|+||.||+++++ .+.+..|..++..+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 44567799999999999999999999753 34577899999876 999999999998765
Q ss_pred ccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 70 KYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 70 ~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
+.++... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 4332111 1235789999999999999999999 88999999999999999999999999999985
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHH
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVA 191 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~ 191 (288)
..... ......+||+.|+||| |||||||++|||++|..||.... ++...+.++.
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence 43222 2234467999999999 99999999999999999996543 2334578899
Q ss_pred HHHHHhcCCCCCCCCCHH-HHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMK-EVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~-~i~~~ 214 (288)
+++.+||..||++||++. +++++
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHhcCCHhHcCCChHHHHcC
Confidence 999999999999999987 66543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=276.42 Aligned_cols=202 Identities=23% Similarity=0.302 Sum_probs=163.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEc----c------------------HHHHHHHHHHHhcCCCCceeeecceEecc-----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA----K------------------VEKFINEVVIQSQINHINVVKLIGCCLET----- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~----~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 69 (288)
.++|++.+.||+|+||.||+++. . .+.|.+|++++++++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999972 1 45689999999999999999999987532
Q ss_pred ----cccccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 ----KYMHDQ-------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ----~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+++... .....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 222110 01235889999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCce--eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------------
Q 044995 139 VDQTH--ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------------ 181 (288)
Q Consensus 139 ~~~~~--~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------------ 181 (288)
..... ......||..|+||| ||||||+++|+|++|..||....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 33322 122345788899999 99999999999999999974221
Q ss_pred ------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 ------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1223467899999999999999999999999999988554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.02 Aligned_cols=195 Identities=19% Similarity=0.333 Sum_probs=157.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC--CCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN--HINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||++.+. .+.|.+|+++|++++ |||||++++++...++++...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999998642 467899999999997 599999999887665432211
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce-
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH- 143 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~- 143 (288)
....+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 1235788889999999999999999 88999999999999995 578999999999865433221
Q ss_pred eeeccccCCCCCChh----------------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccc
Q 044995 144 ITTQVHGTFGYLNPD----------------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEE 184 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE----------------------DiwSlG~il~elltg~~P~~~~~-----------------~~~ 184 (288)
......||+.|+||| |||||||++|||++|..||.... .+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 223457999999998 99999999999999999996421 122
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 185 DKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 185 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
..+.++.+++.+||+.||++||++.|++++-.
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 33578999999999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=283.78 Aligned_cols=201 Identities=26% Similarity=0.350 Sum_probs=164.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3468999999999999999999753 467889999999999999999999876532
Q ss_pred ---cccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----cCCCceEEecccCc
Q 044995 71 ---YMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL----DDKYCAKVSNFGTS 134 (288)
Q Consensus 71 ---~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~DfG~a 134 (288)
|+.. ......+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 2211 111123899999999999999999999 8889999999999999 77788999999999
Q ss_pred cccCCCCceeeeccccCCCCCChh-------------------hHHHHHHHHHHHHhCCCCCCCCCc-------------
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-------------------DVCSFGVVLVELLTGAKPIRFTTF------------- 182 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-------------------DiwSlG~il~elltg~~P~~~~~~------------- 182 (288)
+....... .....||..|+||| |||||||++|||++|+.||.....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 86543222 22356999999998 999999999999999999852111
Q ss_pred ------------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 183 ------------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 183 ------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
....+..+.+++.+||+.||++||++.++++.++.+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 123456788999999999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=273.44 Aligned_cols=196 Identities=23% Similarity=0.359 Sum_probs=163.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++...+.+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999998752 4578899999999999999999999876643321
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 11 1135789999999999999999999 8899999999999999999999999999998654322
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
. ......||+.|+||| ||||||+++|+|++|..||.... .+...+..+.+++.+
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 2 223356899999999 99999999999999999996542 233456789999999
Q ss_pred hcCCCCCCCCCHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l 215 (288)
||+.||++||++.+++++-
T Consensus 249 ~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HcccChhhCcCHHHHhhCh
Confidence 9999999999999998864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.17 Aligned_cols=194 Identities=22% Similarity=0.305 Sum_probs=147.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
...++|++.+.||+|+||.||+|.+. .+++.+|++++++++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 34589999999999999999999642 457889999999999999999999875431
Q ss_pred ---------cc----cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 ---------YM----HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ---------~l----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
++ ........+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 11 11112246889999999999999999999 889999999999999999999999999999764
Q ss_pred CCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc---------------------
Q 044995 138 AVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE--------------------- 184 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~--------------------- 184 (288)
... .....||..|+||| |||||||++|||++|+.||.......
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 23356899999999 99999999999999999996543210
Q ss_pred ------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+|+.+||..||++|||+.+++++-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 1245688999999999999999999999763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=279.28 Aligned_cols=197 Identities=22% Similarity=0.278 Sum_probs=160.5
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEecccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKY 71 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 71 (288)
....++|++.+.||+|+||.||+++++ .+.+.+|.+++..+ +||||+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345689999999999999999998753 35678999999988 89999999998776543
Q ss_pred ccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 MHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 32111 1235889999999999999999999 8899999999999999999999999999998533
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKH 193 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~l 193 (288)
... ......+||+.|+||| |||||||++|||++|+.||.... ++...+.++.++
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 222 2233457999999999 99999999999999999996543 234457889999
Q ss_pred HHHhcCCCCCCCCC-----HHHHHHH
Q 044995 194 AKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+.+||..||++||+ +.+++++
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999995 4666654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=288.63 Aligned_cols=193 Identities=21% Similarity=0.274 Sum_probs=158.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhcCCCCceeeecceEecc-------------c
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQINHINVVKLIGCCLET-------------K 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------------~ 70 (288)
..+|++.+.||+|+||.||+|++. .....+|+++++.++||||++++++|... +
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 457999999999999999999763 22345799999999999999999987432 2
Q ss_pred cccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceEEecccCccccCCC
Q 044995 71 YMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~~~~ 140 (288)
|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 2211 112346888999999999999999999 88999999999999998 7899999999999865332
Q ss_pred CceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------- 183 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------- 183 (288)
.. .....||+.|+||| |||||||++|||++|+.||......
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 22 22346899999999 9999999999999999999754311
Q ss_pred ------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++||++.|++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 1245689999999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=282.08 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=157.7
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~- 74 (288)
..++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||++++++|...+.+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4578999999999999999999753 3567899999999999999999999876543221
Q ss_pred ------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 75 ------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 112345889999999999999999999 88999999999999999999999999999976443222
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc--------------------------
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE-------------------------- 184 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~-------------------------- 184 (288)
......||..|+||| |||||||++|+|++|+.||.......
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 222346899999999 99999999999999999996543111
Q ss_pred -------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 185 -------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 185 -------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+..+.+++.+||+.||++||++.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 235778999999999999999999999876
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=270.42 Aligned_cols=196 Identities=26% Similarity=0.416 Sum_probs=151.8
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++.+.||+|+||.||+|++. .+.+.+|++++++++||||+++++++...+...
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 34578999999999999999999752 257889999999999999999999987654321
Q ss_pred c--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 74 D--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 74 ~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
. ......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 1 112246899999999999999999999 88999999999999999999999999999976542
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHA 194 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li 194 (288)
... ......||+.|+||| ||||||+++|||++|..||.... .+...+.++.+++
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 221 122346899999999 99999999999999999996432 1233577899999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+||+.||++||++.+++++
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTS
T ss_pred HHHcccCHhhCCCHHHHhcC
Confidence 99999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.05 Aligned_cols=197 Identities=21% Similarity=0.290 Sum_probs=160.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||+|+++ ...+.+|++++++++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4578999999999999999999752 357889999999999999999999876532
Q ss_pred ----------cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 71 ----------YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 71 ----------~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 2111 112245899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCC---ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc---------------
Q 044995 135 RSRAVDQ---THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE--------------- 184 (288)
Q Consensus 135 ~~~~~~~---~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~--------------- 184 (288)
+...... ........||+.|+||| |||||||++|||++|..||.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7654221 12223356899999999 99999999999999999986433110
Q ss_pred -------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 -------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 -------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 0145688999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=275.42 Aligned_cols=208 Identities=20% Similarity=0.330 Sum_probs=159.6
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHh--cCCCCceeeecceEe-----------
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQS--QINHINVVKLIGCCL----------- 67 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~--~l~HpnIv~l~~~~~----------- 67 (288)
....++|++.+.||+|+||.||+|+.. .+.+..|.+++. .++||||+++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 345689999999999999999999642 455666666644 589999999987432
Q ss_pred -cccccccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeEEeCCCCCCeeecCCCceEEeccc
Q 044995 68 -ETKYMHDQ-----NKELPFTWEMQLRISIEASGTMSYLHLSASV---------PIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 68 -~~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---------~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
..+|+... ......++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 22332211 11224578889999999999999999 77 99999999999999999999999999
Q ss_pred CccccCCCCc-------eeeeccccCCCCCChh------------------hHHHHHHHHHHHHhCCCCCCCCCc-----
Q 044995 133 TSRSRAVDQT-------HITTQVHGTFGYLNPD------------------DVCSFGVVLVELLTGAKPIRFTTF----- 182 (288)
Q Consensus 133 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE------------------DiwSlG~il~elltg~~P~~~~~~----- 182 (288)
+++....... .......||+.|+||| |||||||++|||++|..||.....
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9976543211 1122346999999998 999999999999999776522110
Q ss_pred -----------------------------c------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 183 -----------------------------E------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 183 -----------------------------~------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
+ ...+.++.++|.+||+.||++|||+.|+++.|+.+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 0 01345799999999999999999999999999998754433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.89 Aligned_cols=206 Identities=18% Similarity=0.243 Sum_probs=167.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecc--------cc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLET--------KY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~ 71 (288)
..++|++.+.||+|+||.||+|++. .+.+.+|+.++++++|+|++..+..+... ++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4588999999999999999999852 35789999999999999987777665322 22
Q ss_pred ccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccccCCCCc
Q 044995 72 MHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 72 l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+.. ......+++..++.++.|++.||.||| +++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred cCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 210 112346899999999999999999999 8899999999999999 4788999999999986543322
Q ss_pred e------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Q 044995 143 H------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------- 183 (288)
Q Consensus 143 ~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------- 183 (288)
. ......||+.|+||| ||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 1 123456999999999 9999999999999999999753221
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
...+.++.+++.+||+.||++||++.++++.|+.+....+.
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 22367899999999999999999999999999998766544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=276.77 Aligned_cols=193 Identities=18% Similarity=0.221 Sum_probs=157.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCC-CCceeeecceEecc--ccccccCC-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQIN-HINVVKLIGCCLET--KYMHDQNK- 77 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~l~~~~~- 77 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|++++++++ ||||+++++++... .......+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 477999999999999999999752 578999999999997 99999999998762 21111000
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCCCceeeec
Q 044995 78 ---------ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 78 ---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
...+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 115 ~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 189 (330)
T 3nsz_A 115 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNV 189 (330)
T ss_dssp CCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCS
T ss_pred cCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--ccc
Confidence 124788899999999999999999 88899999999999998766 899999999986543222 223
Q ss_pred cccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc---------------------------------
Q 044995 148 VHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF--------------------------------- 182 (288)
Q Consensus 148 ~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~--------------------------------- 182 (288)
..|+..|+||| |||||||++|||++|..||.....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 46888999999 999999999999999999842211
Q ss_pred -------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01146789999999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=275.51 Aligned_cols=204 Identities=21% Similarity=0.310 Sum_probs=163.4
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc------
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET------ 69 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 69 (288)
....++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345678999999999999999999752 46789999999999999999999988621
Q ss_pred -----ccccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCc
Q 044995 70 -----KYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTS 134 (288)
Q Consensus 70 -----~~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a 134 (288)
+++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 12211 112346899999999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCcee--------eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCC------------
Q 044995 135 RSRAVDQTHI--------TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFT------------ 180 (288)
Q Consensus 135 ~~~~~~~~~~--------~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~------------ 180 (288)
.......... .....||+.|+||| ||||||+++|||++|+.||...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7543211100 01234789999999 9999999999999999998421
Q ss_pred -----CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 181 -----TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 181 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
......+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1122457789999999999999999999999999988754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=293.70 Aligned_cols=195 Identities=25% Similarity=0.320 Sum_probs=162.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++.+.||+|+||.||+++++ .+.+.+|+++|++++|||||++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999752 345789999999999999999999877654322
Q ss_pred c---------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 74 D---------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 74 ~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 1 111234889999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNIT 189 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~~ 189 (288)
.... ....+||+.|+||| |||||||++|||++|..||.... ++...+.+
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 3322 23357999999999 99999999999999999997542 22334678
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp-----~~~~i~~~ 214 (288)
+.++|.+||+.||.+|| ++.|++++
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 99999999999999999 78888876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.44 Aligned_cols=196 Identities=24% Similarity=0.384 Sum_probs=162.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM---- 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l---- 72 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999652 36789999999999999999999987665321
Q ss_pred ---c------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 73 ---H------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 73 ---~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
. .......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 1 1122346889999999999999999999 88999999999999999999999999999875432221
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------chhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-----------------EDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~~~~~~l 193 (288)
.......|+..|+||| ||||||+++|||++|..||...... ...+..+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 1123356899999999 9999999999999999999653321 2346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+||+.||++||++.+++++
T Consensus 242 i~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=279.68 Aligned_cols=193 Identities=20% Similarity=0.312 Sum_probs=158.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM--- 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l--- 72 (288)
..++|.+.+.||+|+||.||+|.++ .+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4589999999999999999999752 46788999999999999999999988654321
Q ss_pred ----------cc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 ----------HD---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ----------~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 10 001234889999999999999999999 88999999999999999999999999999975432
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------ 183 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------ 183 (288)
. .....||+.|+||| |||||||++|+|++|..||......
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 23356899999999 9999999999999999999754311
Q ss_pred ---------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++|||+.|++++-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 12367889999999999999999999998763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=279.96 Aligned_cols=198 Identities=22% Similarity=0.299 Sum_probs=160.5
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
...++|++.+.||+|+||.||++.++ ...+.+|++++.++ +||||+++++++.+.+.++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999999999763 23456899998888 799999999998765433211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC----CceEEecccCccccCCCCc
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK----YCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~----~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||+... +.+||+|||+++.......
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 12345889999999999999999999 8899999999999998432 3599999999986543322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------------cchhHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------------EEDKNITV 190 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------------~~~~~~~~ 190 (288)
.....+||+.|+||| |||||||++|||++|..||..... ....+.++
T Consensus 176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 223457899999999 999999999999999999964211 12347789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+++.+||..||++||++.+++++-.
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 99999999999999999999998744
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=283.13 Aligned_cols=196 Identities=22% Similarity=0.309 Sum_probs=152.6
Q ss_pred hcCCcccC-ceeeeeCCeeEEEeEcc-------------HHHHHHHHHHH-hcCCCCceeeecceEec----c-------
Q 044995 16 ATDSFNVN-RILGQGGQDIVYKGMAK-------------VEKFINEVVIQ-SQINHINVVKLIGCCLE----T------- 69 (288)
Q Consensus 16 ~~~~y~~~-~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~------- 69 (288)
..++|.+. +.||+|+||.||++.++ ...+.+|+.++ +.++||||+++++++.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 34677776 68999999999999763 46788999987 45689999999998653 2
Q ss_pred ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccC
Q 044995 70 KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~ 138 (288)
+|+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 22211 111235899999999999999999999 889999999999999987 7899999999998644
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------ch
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------ED 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~----------------------~~ 185 (288)
... .....+||+.|+||| |||||||++|||++|..||...... ..
T Consensus 216 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 216 SHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred CCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 222 223457899999999 9999999999999999999643211 23
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+.++.++|.+||+.||++|||+.+++++-.
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 5678999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=275.02 Aligned_cols=194 Identities=26% Similarity=0.315 Sum_probs=161.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3477999999999999999999752 4679999999999999999999999876542
Q ss_pred cccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----ceEEecccCc
Q 044995 72 MHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY----CAKVSNFGTS 134 (288)
Q Consensus 72 l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a 134 (288)
+... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 2111 12235788999999999999999999 88999999999999998877 7999999999
Q ss_pred cccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------ch
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------ED 185 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~ 185 (288)
+....... .....||+.|+||| ||||||+++|+|++|..||...... ..
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 86543221 23346899999999 9999999999999999999643311 23
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+..+.+++.+||+.||++||++.|++++
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 46678999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=290.70 Aligned_cols=195 Identities=24% Similarity=0.311 Sum_probs=160.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|++++++++|||||++++++.....++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999752 45789999999999999999999998765433211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceEEecccCccccCC
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~DfG~a~~~~~ 139 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 1 1235789999999999999999999 88999999999999994 456899999999976543
Q ss_pred CCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVA 191 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~ 191 (288)
.. ......||+.|+||| |||||||++|+|++|..||..... ....+.++.
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp C------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CC--ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 22 223456999999999 999999999999999999964331 123467899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++|.+||+.||++|||+.+++++-
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCH
Confidence 999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.59 Aligned_cols=194 Identities=26% Similarity=0.347 Sum_probs=162.4
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++++++.+.+....
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999752 3568899999999999999999999876543221
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.. ....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 11 1235788999999999999999999 8899999999999999999999999999987543221
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~ 196 (288)
.....|+..|+||| ||||||+++|+|++|..||.... .+...+..+.+++.+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 22346899999999 99999999999999999996432 233457789999999
Q ss_pred hcCCCCCCCCCHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l 215 (288)
||+.||++||++.+++++-
T Consensus 246 ~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCH
T ss_pred HhhcCHhhCCCHHHHhhCH
Confidence 9999999999999998763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.83 Aligned_cols=207 Identities=26% Similarity=0.419 Sum_probs=167.1
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEec
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLE 68 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 68 (288)
.+++...++|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||+++++++.+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 344556678999999999999999998641 3679999999999999999999999755
Q ss_pred cc------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 69 TK------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 69 ~~------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.. ++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 32 2211 112335889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNI 188 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~ 188 (288)
..............+++.|+||| ||||||+++|||++ |..||.... .+...+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 66443333333345778899999 99999999999997 999986432 2344568
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+.+++.+||+.||++||++.++++.|+.+..
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=280.65 Aligned_cols=187 Identities=23% Similarity=0.280 Sum_probs=150.3
Q ss_pred CceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------ccc---
Q 044995 23 NRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MHD--- 74 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~~--- 74 (288)
.+.||+|+||.||+|.+. .+.|.+|++++++++||||++++++|...+. +..
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999998752 4678999999999999999999999876542 211
Q ss_pred ----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee--cCCCceEEecccCccccCCCCceeeecc
Q 044995 75 ----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL--DDKYCAKVSNFGTSRSRAVDQTHITTQV 148 (288)
Q Consensus 75 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~--~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 148 (288)
......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 012235889999999999999999999 8889999999999999 5678999999999986543322 2234
Q ss_pred ccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHHHHHHHHhcC
Q 044995 149 HGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITVAKHAKRCLN 199 (288)
Q Consensus 149 ~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~~~li~~cl~ 199 (288)
.||+.|+||| |||||||++|||++|..||...... ...+.++.++|.+||+
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 6999999999 9999999999999999999643311 2346789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.||++||++.|++++
T Consensus 329 ~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 329 KEKSWRISASEALKH 343 (373)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=270.32 Aligned_cols=202 Identities=24% Similarity=0.386 Sum_probs=159.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
..++|++.+.||+|+||.||+|++. .+.|.+|++++++++||||+++++++.....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM 95 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCc
Confidence 3578999999999999999998631 3578899999999999999999999876432
Q ss_pred ------ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 ------MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 ------l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+.. ......+++..+..++.|++.||.||| +++|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 111 001235789999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcee--eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------------ccchhHH
Q 044995 139 VDQTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------------FEEDKNI 188 (288)
Q Consensus 139 ~~~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------------~~~~~~~ 188 (288)
...... .....++..|+||| ||||||+++|+|++ |..||.... .....+.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 333221 12345777899999 99999999999999 999985432 2234578
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+.+++.+||+.||++||++.++++.|+++..
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 89999999999999999999999999987754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=277.76 Aligned_cols=197 Identities=21% Similarity=0.270 Sum_probs=159.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLET------- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 69 (288)
..++|++.+.||+|+||.||+|.++ ...+.+|++++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4689999999999999999999753 35688999999999999999999876543
Q ss_pred -----ccccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 70 -----KYMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 -----~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 11111 011235889999999999999999999 889999999999999999999999999999865422
Q ss_pred Cce---------eeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc----------------
Q 044995 141 QTH---------ITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE---------------- 183 (288)
Q Consensus 141 ~~~---------~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~---------------- 183 (288)
... ......||+.|+||| |||||||++|+|++|..||......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111 112346899999999 9999999999999999999654310
Q ss_pred ------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++|||+.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 13456788999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=271.48 Aligned_cols=197 Identities=22% Similarity=0.286 Sum_probs=154.6
Q ss_pred hcCCcccC-ceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc
Q 044995 16 ATDSFNVN-RILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~-~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..+.|++. +.||+|+||.||++.+. .+.+.+|++++.++ +||||+++++++.+.+.+...
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45778885 78999999999999752 57899999999985 799999999998765432211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc---eEEecccCccccCC
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC---AKVSNFGTSRSRAV 139 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~DfG~a~~~~~ 139 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 1 1235788999999999999999999 889999999999999987765 99999999875432
Q ss_pred CCc------eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------
Q 044995 140 DQT------HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTFE-------------- 183 (288)
Q Consensus 140 ~~~------~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~~-------------- 183 (288)
... .......||+.|+||| |||||||++|||++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 1112345899999998 9999999999999999999654211
Q ss_pred -------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 -------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 -------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++||++.|++++-
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 12356789999999999999999999998863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=277.91 Aligned_cols=193 Identities=24% Similarity=0.317 Sum_probs=142.6
Q ss_pred CCcccC---ceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCC-CCceeeecceEecccccccc---
Q 044995 18 DSFNVN---RILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHDQ--- 75 (288)
Q Consensus 18 ~~y~~~---~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~~--- 75 (288)
++|++. +.||+|+||.||++.++ ...+.+|+.+++++. ||||+++++++.+....+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 345543 78999999999999763 467889999999997 99999999998765432211
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecccCccccCCCCc
Q 044995 76 ----------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 12235889999999999999999999 88999999999999997655 899999999975443222
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc---------------------c----chh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF---------------------E----EDK 186 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~---------------------~----~~~ 186 (288)
......||+.|+||| ||||||+++|+|++|..||..... . ...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 223346899999999 999999999999999999964321 0 124
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.++.+++.+||+.||++||++.+++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 6789999999999999999999998765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=290.29 Aligned_cols=194 Identities=24% Similarity=0.320 Sum_probs=158.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
..++|++.+.||+|+||.||+|+++ .+.+.+|+.++++++|||||+++++|.....++..
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4457999999999999999998753 35789999999999999999999998765433211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccCC
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~~ 139 (288)
. ....+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 1 1235788999999999999999999 889999999999999965 45699999999986543
Q ss_pred CCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITVA 191 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~~ 191 (288)
.. ......||+.|+||| |||||||++|+|++|..||...... ...+..+.
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred Cc--cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 22 223456999999999 9999999999999999999643311 23467899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++.+||+.||.+|||+.+++++
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHCCCChhhCccHHHHhcC
Confidence 99999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=268.06 Aligned_cols=191 Identities=20% Similarity=0.362 Sum_probs=156.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc--------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------- 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 69 (288)
..|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788899999999999999752 45689999999999999999999987542
Q ss_pred ---cccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeec-CCCceEEecccCcccc
Q 044995 70 ---KYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLD-DKYCAKVSNFGTSRSR 137 (288)
Q Consensus 70 ---~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~ 137 (288)
+++... .....+++..+..++.|++.||.||| +.+ |+|+||||+|||++ .++.+||+|||++...
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 222110 11135788999999999999999999 777 99999999999997 7899999999999754
Q ss_pred CCCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~ 190 (288)
.... .....||+.|+||| ||||||+++|+|++|..||..... ....+.++
T Consensus 183 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RASF---AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred cccc---cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 3322 22346899999999 999999999999999999964221 12235789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+.||++||++.+++++
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=288.52 Aligned_cols=196 Identities=29% Similarity=0.329 Sum_probs=161.2
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------------------------HHHHHHHHHHHhcCCCCceeeec
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------------------------VEKFINEVVIQSQINHINVVKLI 63 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------------~~~~~~E~~~l~~l~HpnIv~l~ 63 (288)
...++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999998642 24688999999999999999999
Q ss_pred ceEeccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceE
Q 044995 64 GCCLETKYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAK 127 (288)
Q Consensus 64 ~~~~~~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~k 127 (288)
++|.+...++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9987765332111 1235789999999999999999999 88999999999999998665 699
Q ss_pred EecccCccccCCCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------
Q 044995 128 VSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE-------------- 183 (288)
Q Consensus 128 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~-------------- 183 (288)
|+|||+++...... ......||+.|+||| |||||||++|+|++|..||......
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999998654332 223456999999999 9999999999999999999754321
Q ss_pred ----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ----EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||.+|||+.|++++-
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 23467899999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.89 Aligned_cols=196 Identities=24% Similarity=0.323 Sum_probs=163.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
...++|++.+.||+|+||.||++.++ .+.+.+|+.++++++|||||++++++....+++
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999998752 467999999999999999999999987654332
Q ss_pred cc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCcccc
Q 044995 74 DQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 74 ~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~ 137 (288)
.. .....+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 11 12346889999999999999999999 8899999999999999 46789999999999765
Q ss_pred CCCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNIT 189 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~ 189 (288)
.... ......||+.|+||| |||||||++|+|++|..||..... ....+..
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccc--ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 4322 223356999999999 999999999999999999964431 1234678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
+.++|.+||+.||++|||+.+++++-
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 99999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.16 Aligned_cols=197 Identities=27% Similarity=0.324 Sum_probs=162.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcC-CCCceeeecceEeccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETK 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 70 (288)
.++|++.+.||+|+||.||++++. .+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 478999999999999999998651 24577899999999 6999999999876654
Q ss_pred cccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 YMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 322111 1235788999999999999999999 888999999999999999999999999999865
Q ss_pred CCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchh
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDK 186 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~ 186 (288)
............||+.|+||| |||||||++|||++|..||.... .+...
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 433333334467999999999 99999999999999999996332 22344
Q ss_pred HHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRP-----AMKEVASELA 216 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~l~ 216 (288)
+..+.++|.+||+.||++|| ++.+++++..
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 67889999999999999999 9999988753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.39 Aligned_cols=193 Identities=22% Similarity=0.263 Sum_probs=156.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC------CCCceeeecceEeccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI------NHINVVKLIGCCLETKYM 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~l 72 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|+++++.+ +|+||+++++++.....+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3467999999999999999999653 35678899888877 678999999987654322
Q ss_pred cc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc--eEEecccCccc
Q 044995 73 HD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC--AKVSNFGTSRS 136 (288)
Q Consensus 73 ~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~--~kl~DfG~a~~ 136 (288)
.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++.
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 11 112234889999999999999999999 888999999999999998876 99999999975
Q ss_pred cCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc---------------------
Q 044995 137 RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE--------------------- 184 (288)
Q Consensus 137 ~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~--------------------- 184 (288)
.... .....||+.|+||| |||||||++|||++|..||......+
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 4322 22346899999999 99999999999999999986433110
Q ss_pred ----------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 044995 185 ----------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVA 212 (288)
Q Consensus 185 ----------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 212 (288)
..+..+.++|.+||+.||++|||+.|++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 1146688999999999999999999999
Q ss_pred HHH
Q 044995 213 SEL 215 (288)
Q Consensus 213 ~~l 215 (288)
++-
T Consensus 408 ~Hp 410 (429)
T 3kvw_A 408 RHP 410 (429)
T ss_dssp TST
T ss_pred CCh
Confidence 763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=272.50 Aligned_cols=208 Identities=15% Similarity=0.158 Sum_probs=167.8
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEc--------------------cHHHHHHHHHHHhcCC---CCceeeecceEec
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMA--------------------KVEKFINEVVIQSQIN---HINVVKLIGCCLE 68 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~--------------------~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 68 (288)
++....++|++.+.||+|+||.||+|.+ ....+.+|++++++++ |+||+++++++..
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3345567899999999999999999942 1567889999999887 9999999998765
Q ss_pred cc-------cccc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC--------
Q 044995 69 TK-------YMHD-----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-------- 122 (288)
Q Consensus 69 ~~-------~l~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-------- 122 (288)
.+ |+.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence 43 2221 112346899999999999999999999 889999999999999988
Q ss_pred ---CCceEEecccCccccCC-CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----
Q 044995 123 ---KYCAKVSNFGTSRSRAV-DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----- 182 (288)
Q Consensus 123 ---~~~~kl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----- 182 (288)
++.+||+|||+++.... ..........||+.|+||| |||||||++|||++|+.||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 295 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee
Confidence 89999999999975432 2223344567999999999 999999999999999999842211
Q ss_pred -----cchhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhchhhc
Q 044995 183 -----EEDKNITVAKHAKRCLNPSGKKR-PAMKEVASELAGIKAWN 222 (288)
Q Consensus 183 -----~~~~~~~~~~li~~cl~~~p~~R-p~~~~i~~~l~~~~~~~ 222 (288)
.......+.+++..||+.+|.+| |++.++.+.|+.+....
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 11236788999999999999999 78999999988876553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=278.38 Aligned_cols=205 Identities=14% Similarity=0.205 Sum_probs=165.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeee-------------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKL------------- 62 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l------------- 62 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|++++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 478999999999999999999753 2358899999999999999983
Q ss_pred --cceEec-c-------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-
Q 044995 63 --IGCCLE-T-------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY- 124 (288)
Q Consensus 63 --~~~~~~-~-------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~- 124 (288)
++++.. . +++.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCC
Confidence 444432 1 22210 111246899999999999999999999 88999999999999999888
Q ss_pred -ceEEecccCccccCCCCce------eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---
Q 044995 125 -CAKVSNFGTSRSRAVDQTH------ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--- 183 (288)
Q Consensus 125 -~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--- 183 (288)
.+||+|||+++........ ......||+.|+||| ||||||+++|||++|+.||......
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence 8999999999765432211 113346999999999 9999999999999999999654210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcCC
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNGA 224 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~ 224 (288)
...+.++.+++.+||+.||++||++.++++.|+.+....+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 278 IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 12368899999999999999999999999999998776544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=279.85 Aligned_cols=194 Identities=24% Similarity=0.367 Sum_probs=158.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
.++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++...+.+....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 578999999999999999998753 467899999999999999999999887654322111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
....+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 1125788899999999999999999 64 8999999999999999999999999998654221
Q ss_pred eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------------
Q 044995 144 ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------------- 183 (288)
Q Consensus 144 ~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~----------------------------- 183 (288)
......||+.|+||| |||||||++|+|++|..||......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 122346899999999 9999999999999999998543210
Q ss_pred -----------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 184 -----------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 184 -----------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
...+.++.+++.+||+.||++|||+.+++++-.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 113567899999999999999999999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=270.98 Aligned_cols=199 Identities=23% Similarity=0.349 Sum_probs=161.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------ 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 69 (288)
..++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4578999999999999999998752 45688999999999999999999987532
Q ss_pred ---ccccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEEeCCCCCCeeecCCCceEEecc
Q 044995 70 ---KYMHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVP-----IYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 70 ---~~l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+++.. ......+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 12111 011234889999999999999999999 666 999999999999999999999999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccch
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEED 185 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~ 185 (288)
|+++....... ......|+..|+||| ||||||+++|+|++|..||.... .+..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 99876533221 122346899999999 99999999999999999986432 2234
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
.+.++.+++.+||+.||++||++.++++++...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 578899999999999999999999999877543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=268.75 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=165.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEec-------------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLE------------- 68 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~------------- 68 (288)
..++|++.+.||+|+||.||++.+. .+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 4478999999999999999999763 3578899999999999999999997643
Q ss_pred ----------cccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 69 ----------TKYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 69 ----------~~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
.+++.. ......+++..++.++.|++.||.||| +.+|+|+||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECc
Confidence 122211 012246889999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCC----------CCccchhHHH
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRF----------TTFEEDKNIT 189 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~----------~~~~~~~~~~ 189 (288)
||++........ .....|++.|+||| ||||||+++|||++|..|+.. ...+...+..
T Consensus 166 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T 2a19_B 166 FGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKK 243 (284)
T ss_dssp CTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSCHH
T ss_pred chhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCCHH
Confidence 999876543322 22346899999999 999999999999999988631 1223445778
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+.+++.+||+.||++||++.+++++|+.+...
T Consensus 244 ~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 244 EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 99999999999999999999999999887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=280.57 Aligned_cols=202 Identities=23% Similarity=0.286 Sum_probs=156.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHH-HhcCCCCceeeecceEecccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVI-QSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
..++|++.+.||+|+||.||+++++ .+.+.+|..+ ++.++|||||++++++...+.++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4578999999999999999999753 2345667776 57789999999999987654332
Q ss_pred ccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 74 DQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 74 ~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 111 1235788889999999999999999 889999999999999999999999999999853322
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAK 195 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~ 195 (288)
.......+||+.|+||| |||||||++|||++|..||.... ++...+..+.++|.
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 22234467999999999 99999999999999999996433 23345778999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 196 RCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+||+.||.+||++.+.++.+......
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred HHcccCHHhCCCCCCCHHHHhCCccc
Confidence 99999999999986655555555443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=273.79 Aligned_cols=193 Identities=21% Similarity=0.314 Sum_probs=158.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY---- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 71 (288)
..++|.+.+.||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3578999999999999999999752 3578899999999999999999998765432
Q ss_pred ---------ccc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 ---------MHD---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 ---------l~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 111 011235889999999999999999999 88999999999999999999999999999975432
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------- 182 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------- 182 (288)
. .....||+.|+||| ||||||+++|+|++|..||.....
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2 22346899999999 999999999999999999964331
Q ss_pred --------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 183 --------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 183 --------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
....+..+.+++.+||+.||++||++.+++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 113467899999999999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.45 Aligned_cols=211 Identities=23% Similarity=0.358 Sum_probs=165.6
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
...++++...++|++.+.||+|+||.||+|.++ .+.|.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345677778899999999999999999999752 356789999999999999999999987654
Q ss_pred cccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccc
Q 044995 71 YMHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136 (288)
Q Consensus 71 ~l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~ 136 (288)
.+.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 2211 112235888999999999999999999 88999999999999998 67999999999875
Q ss_pred cCCCC----ceeeeccccCCCCCChh--------------------hHHHHHHHHHHHHhCCCCCCCCCcc---------
Q 044995 137 RAVDQ----THITTQVHGTFGYLNPD--------------------DVCSFGVVLVELLTGAKPIRFTTFE--------- 183 (288)
Q Consensus 137 ~~~~~----~~~~~~~~gt~~y~aPE--------------------DiwSlG~il~elltg~~P~~~~~~~--------- 183 (288)
..... ........|++.|+||| ||||||+++|||++|..||......
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 42211 11112235888999998 9999999999999999999643211
Q ss_pred -------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 184 -------EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 184 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
...+.++.+++.+||+.||++||++.++++.|+.+....
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 124568999999999999999999999999999887653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.43 Aligned_cols=196 Identities=24% Similarity=0.298 Sum_probs=156.0
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
....++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345689999999999999999999753 34688999999999999999999988765432
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
.... ....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 2111 1235788999999999999999999 88899999999999999999999999999976543
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKH 193 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~l 193 (288)
.. ......|++.|+||| ||||||+++|+|++|..||.... .+...+..+.++
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 22 122346899999999 99999999999999999996533 233446789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+||+.||++||++.+++++
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=299.53 Aligned_cols=194 Identities=24% Similarity=0.367 Sum_probs=156.8
Q ss_pred ceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc------ccc-
Q 044995 24 RILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------MHD- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------l~~- 74 (288)
+.||+|+||.||+|.+. .+.|.+|+++|++++|||||+++++|....+ +..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999998431 4689999999999999999999999865432 211
Q ss_pred -----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc--eeeec
Q 044995 75 -----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT--HITTQ 147 (288)
Q Consensus 75 -----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~ 147 (288)
......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 112235889999999999999999999 88999999999999999999999999999986543322 11222
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
..+|+.|+||| |||||||++|||++ |+.||.... .+...+.++.++|.+||+.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34678899999 99999999999998 999996432 2345678999999999999
Q ss_pred CCCCCCCHHHHHHHHHhchh
Q 044995 201 SGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l~~~~~ 220 (288)
||++||++.+|++.|+.+..
T Consensus 612 dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 612 DVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=271.20 Aligned_cols=196 Identities=20% Similarity=0.283 Sum_probs=151.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc--
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-- 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-- 72 (288)
...++|++.+.||+|+||.||++.+. .+.+.++...++.++||||+++++++...+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45688999999999999999999762 22344555568889999999999998765322
Q ss_pred -----cc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 73 -----HD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 73 -----~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.. ......+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 11 112346899999999999999999999 76 8999999999999999999999999999765
Q ss_pred CCCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cch
Q 044995 138 AVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EED 185 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~ 185 (288)
.... ......||+.|+||| ||||||+++|+|++|..||..... ...
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 4322 222346899999998 999999999999999999964221 123
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+.++.+++.+||+.||++|||+.+++++-
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 567899999999999999999999998853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=281.12 Aligned_cols=192 Identities=20% Similarity=0.206 Sum_probs=156.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC--------CCceeeecceEec--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN--------HINVVKLIGCCLE-- 68 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~--------HpnIv~l~~~~~~-- 68 (288)
..++|++.+.||+|+||.||+|.+. .+.+.+|++++++++ |+||+++++++..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3478999999999999999999752 467889999999985 8889999998762
Q ss_pred --c-------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCC-------
Q 044995 69 --T-------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKY------- 124 (288)
Q Consensus 69 --~-------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~------- 124 (288)
. +++.. ......+++..+..++.|++.||.||| ++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 2 22211 112245899999999999999999999 77 899999999999998765
Q ss_pred ------------------------------------------ceEEecccCccccCCCCceeeeccccCCCCCChh----
Q 044995 125 ------------------------------------------CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158 (288)
Q Consensus 125 ------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE---- 158 (288)
.+||+|||+++..... .....||+.|+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999765432 22346899999999
Q ss_pred -------hHHHHHHHHHHHHhCCCCCCCCCc-------------------------------------------------
Q 044995 159 -------DVCSFGVVLVELLTGAKPIRFTTF------------------------------------------------- 182 (288)
Q Consensus 159 -------DiwSlG~il~elltg~~P~~~~~~------------------------------------------------- 182 (288)
|||||||++|||++|..||.....
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999964321
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++|||+.|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 11224568899999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=271.47 Aligned_cols=209 Identities=18% Similarity=0.293 Sum_probs=166.9
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhc--CCCCceeeecceEeccc----cccc
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQ--INHINVVKLIGCCLETK----YMHD 74 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~l~~ 74 (288)
....++|++.+.||+|+||.||+|++. .+.+.+|++++.. ++||||+++++++.... .+..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 345578999999999999999999752 4678899999887 79999999999887653 2111
Q ss_pred c------------CCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 75 Q------------NKELPFTWEMQLRISIEASGTMSYLHLS-----ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 75 ~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
. .....+++..++.++.|++.||.|||.. ++.+|+||||||+|||++.++.+||+|||++...
T Consensus 118 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred EEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 1 1123578899999999999999999932 1467999999999999999999999999999765
Q ss_pred CCCCce---eeeccccCCCCCChh-----------------hHHHHHHHHHHHHhC----------CCCCCCCCc-----
Q 044995 138 AVDQTH---ITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTG----------AKPIRFTTF----- 182 (288)
Q Consensus 138 ~~~~~~---~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg----------~~P~~~~~~----- 182 (288)
...... ......||+.|+||| ||||||+++|||++| ..||.....
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 433322 123346899999998 999999999999999 778753211
Q ss_pred ----------------c-----chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 183 ----------------E-----EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 183 ----------------~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
+ ......+.+++.+||+.||++||++.+++++|+.+....
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 0 123457889999999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.17 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=153.9
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecc----
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLET---- 69 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 69 (288)
.+.....++|++.+.||+|+||.||+|.++ .+.+.+|++.+..++||||++++++|...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 455677899999999999999999999753 34678888899999999999999987542
Q ss_pred ----------ccccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEe
Q 044995 70 ----------KYMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVS 129 (288)
Q Consensus 70 ----------~~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~ 129 (288)
+|+.. ......+++..+..++.|++.||.|||. ++.+|+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 22211 1234467888899999999999999993 3678999999999999986 8999999
Q ss_pred cccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc-------------
Q 044995 130 NFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE------------- 184 (288)
Q Consensus 130 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~------------- 184 (288)
|||+++....... .....||+.|+||| |||||||++|||++|+.||.......
T Consensus 175 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 175 DFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999986543322 23346899999999 99999999999999999996543210
Q ss_pred ---------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ---------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ---------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.++.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 1356889999999999999999999999763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=272.35 Aligned_cols=194 Identities=23% Similarity=0.295 Sum_probs=158.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcCCCCceeeecceEecc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQINHINVVKLIGCCLET 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 69 (288)
..++|++.+.||+|+||.||+|.++ ...+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4478999999999999999999652 12478999999999999999999987654
Q ss_pred c------cccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecccCc
Q 044995 70 K------YMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNFGTS 134 (288)
Q Consensus 70 ~------~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~DfG~a 134 (288)
. ++.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 3 2211 123346889999999999999999999 88999999999999997655 4999999999
Q ss_pred cccCCCCceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------
Q 044995 135 RSRAVDQTHITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTFE----------------- 183 (288)
Q Consensus 135 ~~~~~~~~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~~----------------- 183 (288)
+..... .......||+.|+||| |||||||++|+|++|..||......
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 765322 1122356899999999 9999999999999999999643221
Q ss_pred --chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1236788999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=271.53 Aligned_cols=202 Identities=23% Similarity=0.349 Sum_probs=163.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEc----------------------cHHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMA----------------------KVEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~----------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
.++|++.+.||+|+||.||+++. ..+.|.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45699999999999999999972 1467999999999999999999999875432
Q ss_pred -----cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 71 -----YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 71 -----~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
++.. ......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 2111 011235889999999999999999999 8899999999999999999999999999998664
Q ss_pred CCCcee--eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC-------------------------
Q 044995 139 VDQTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT------------------------- 180 (288)
Q Consensus 139 ~~~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~------------------------- 180 (288)
...... .....++..|+||| ||||||+++|||++|..||...
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 433221 12234677899999 9999999999999998887421
Q ss_pred ------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 181 ------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 181 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
..+...+.++.+++.+||+.||++||++.++++.|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11234467899999999999999999999999999988653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=288.61 Aligned_cols=189 Identities=24% Similarity=0.323 Sum_probs=157.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
..++|++.+.||+|+||.||+++++ .+.+.+|++++++++||||+++++++.....
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999752 3568899999999999999999998766532
Q ss_pred ----ccc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 72 ----MHD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 72 ----l~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 211 011335889999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNI 188 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~ 188 (288)
..... .....+||+.|+||| |||||||++|||++|..||.... ++...+.
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 43322 223357999999999 99999999999999999996542 2234577
Q ss_pred HHHHHHHHhcCCCCCCCCCH
Q 044995 189 TVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~ 208 (288)
.+.++|.+||+.||++||++
T Consensus 419 ~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCC
T ss_pred HHHHHHHHhccCCHhHCCCC
Confidence 89999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=268.46 Aligned_cols=198 Identities=26% Similarity=0.363 Sum_probs=164.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH--- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~--- 73 (288)
..+.|++.+.||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++.....+.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999642 478999999999999999999999876653221
Q ss_pred ----c-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 74 ----D-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 74 ----~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
. ......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........ .
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 1 112346889999999999999999999 88999999999999999999999999999976543221 2
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHHHHHHHHHhc
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~~~~li~~cl 198 (288)
.....|+..|+||| ||||||+++|+|++|..||.... .....+..+.+++.+||
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 23356899999999 99999999999999999986432 22345778999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh
Q 044995 199 NPSGKKRPAMKEVASELAG 217 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~l~~ 217 (288)
+.||++||++.+++++..-
T Consensus 256 ~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHH
T ss_pred CCChhhCcCHHHHhhChhh
Confidence 9999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=273.08 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=147.9
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~ 73 (288)
+....++|++.+.||+|+||.||++.+. .+.+.+|+.++++++||||+++++++...+...
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4566789999999999999999999752 356789999999999999999999876543221
Q ss_pred -------c--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 74 -------D--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 74 -------~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
. ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 1 012345889999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCc----eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------
Q 044995 133 TSRSRAVDQT----HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------- 183 (288)
Q Consensus 133 ~a~~~~~~~~----~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------- 183 (288)
++........ .......||+.|+||| ||||||+++|||++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 9875432211 1122346899999999 9999999999999999998643211
Q ss_pred -----------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1235688999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=264.62 Aligned_cols=193 Identities=26% Similarity=0.435 Sum_probs=155.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc------
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH------ 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~------ 73 (288)
++|.....||+|+||.||+|.+. .+.+.+|+.++++++||||+++++++...+.+.
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44555569999999999999752 467899999999999999999999987654221
Q ss_pred ----------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCccccCCCCc
Q 044995 74 ----------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 ----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~ 142 (288)
.......+++..+..++.|++.||.||| +.+|+|+||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 1112235678888899999999999999 889999999999999987 89999999999976543221
Q ss_pred eeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCC-----------------CccchhHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFT-----------------TFEEDKNITVAK 192 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~-----------------~~~~~~~~~~~~ 192 (288)
......|+..|+||| ||||||+++|+|++|..||... ..+...+.++.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 123346899999999 9999999999999999998532 123345788999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++||++.+++++
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=271.12 Aligned_cols=197 Identities=21% Similarity=0.297 Sum_probs=153.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecc--------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLET-------- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 69 (288)
..++|++.+.||+|+||.||+|.++ .+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999753 46789999999999999999999876321
Q ss_pred -------------ccccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceEEecc
Q 044995 70 -------------KYMHD----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNF 131 (288)
Q Consensus 70 -------------~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~Df 131 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 22211 112346889999999999999999999 88999999999999997 5679999999
Q ss_pred cCccccCCCCc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------
Q 044995 132 GTSRSRAVDQT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------- 183 (288)
Q Consensus 132 G~a~~~~~~~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------- 183 (288)
|+++....... .......++..|+||| ||||||+++|||++|+.||......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99986532211 1123345789999999 9999999999999999999654321
Q ss_pred ------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+.++.+++.+||+.||++||++.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 12467899999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=265.76 Aligned_cols=192 Identities=20% Similarity=0.277 Sum_probs=157.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~ 74 (288)
..++|++.+.||+|+||.||+|.+. ...+.+|+..+.++ +||||+++++++.+.+.+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999752 45788999999999 99999999999876543221
Q ss_pred cC-----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---------------
Q 044995 75 QN-----------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD--------------- 122 (288)
Q Consensus 75 ~~-----------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~--------------- 122 (288)
.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 10 0135789999999999999999999 889999999999999984
Q ss_pred ----CCceEEecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCC------
Q 044995 123 ----KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFT------ 180 (288)
Q Consensus 123 ----~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~------ 180 (288)
...+||+|||++....... ...||..|+||| ||||||+++|+|++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 4479999999988654322 235899999999 9999999999999998775321
Q ss_pred ------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 181 ------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 181 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+...+..+.+++.+||+.||++||++.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 23345678999999999999999999999998763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.82 Aligned_cols=204 Identities=23% Similarity=0.315 Sum_probs=162.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
...++|++.+.||+|+||.||+|++. ..+|.+|+.++++++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45688999999999999999999721 357889999999999999999999976653
Q ss_pred ccc-------c---------c----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceE
Q 044995 71 YMH-------D---------Q----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAK 127 (288)
Q Consensus 71 ~l~-------~---------~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~k 127 (288)
..+ . . .....+++..++.++.|++.||.||| +.+|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 211 0 0 11134888999999999999999999 889999999999999984 45699
Q ss_pred EecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC-------------
Q 044995 128 VSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT------------- 181 (288)
Q Consensus 128 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~------------- 181 (288)
|+|||+++....... .......|++.|+||| ||||||+++|+|++ |..||....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999875432221 1222345788999999 99999999999998 999986432
Q ss_pred --ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 --FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2234567899999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=268.83 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=157.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
...++|++.+.||+|+||.||+|.++ .+.+.+|+.++++++||||+++++++...+.+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 45678999999999999999999753 467999999999999999999999876653221
Q ss_pred --c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 74 --D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 74 --~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
. ......+++..+..++.+++.||.||| ..+|+|+||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 1 012346889999999999999999999 88999999999999999999999999999976543221 2
Q ss_pred eeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKR 196 (288)
Q Consensus 145 ~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~ 196 (288)
.....|+..|+||| ||||||+++|+|++|..||.... .+...+..+.+++.+
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 23346899999999 99999999999999999996432 122346789999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~ 214 (288)
||+.||++||++.+++++
T Consensus 262 ~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 262 CLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.91 Aligned_cols=193 Identities=26% Similarity=0.324 Sum_probs=157.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++.+.||+|+||.||++.++ .+.|.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999642 46799999999999999999999998765432
Q ss_pred ccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----ceEEecccCcc
Q 044995 73 HDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY----CAKVSNFGTSR 135 (288)
Q Consensus 73 ~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a~ 135 (288)
... .....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 111 11235789999999999999999999 88999999999999998776 89999999997
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chh
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDK 186 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~ 186 (288)
....... .....|++.|+||| ||||||+++|+|++|..||...... ...
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 6533221 22346899999999 9999999999999999999643321 123
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+..+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 5678999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=280.49 Aligned_cols=191 Identities=13% Similarity=0.191 Sum_probs=149.0
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHH---HHHhcCCCCceeeec-------c
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEV---VIQSQINHINVVKLI-------G 64 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~---~~l~~l~HpnIv~l~-------~ 64 (288)
..++|++.+.||+|+||.||+|+++ .+.|.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3577999999999999999999752 36789999 556666899999998 3
Q ss_pred eEecc-------------------ccccccC-----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 044995 65 CCLET-------------------KYMHDQN-----------------KELPFTWEMQLRISIEASGTMSYLHLSASVPI 108 (288)
Q Consensus 65 ~~~~~-------------------~~l~~~~-----------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 108 (288)
++... .++.... ....+++..++.++.|++.||.||| +++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 33222 1111000 0012234777889999999999999 8899
Q ss_pred EEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh----------------------hHHHHHHH
Q 044995 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------------------DVCSFGVV 166 (288)
Q Consensus 109 iHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------------DiwSlG~i 166 (288)
+||||||+|||++.++.+||+|||+++.... ......| +.|+||| |||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2334567 9999998 99999999
Q ss_pred HHHHHhCCCCCCCCCc----------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 167 LVELLTGAKPIRFTTF----------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 167 l~elltg~~P~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+|||++|+.||..... ....+.++.+++.+||+.||++||++.+++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999964321 13457899999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=272.81 Aligned_cols=197 Identities=25% Similarity=0.392 Sum_probs=162.2
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecce
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
.....++|++.+.||+|+||.||+|.++ .+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999752 34678999999999 79999999999
Q ss_pred EeccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 66 CLETKYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 66 ~~~~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+.......... ....+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 86654322111 1235788999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCCcc------------
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTTFE------------ 183 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~~~------------ 183 (288)
++....... ......||+.|+||| |||||||++|||++|..||......
T Consensus 246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 987654322 223457999999998 9999999999999999999643211
Q ss_pred ------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+++.+||+.||++||++.+++++
T Consensus 324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1235679999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.39 Aligned_cols=196 Identities=22% Similarity=0.336 Sum_probs=158.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
...++|++.+.||+|+||.||+|.++ .+.|.+|++++++++||||+++++++...+.+...
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 35678999999999999999999753 47899999999999999999999988765322110
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++...... .
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 11245889999999999999999999 889999999999999999999999999987532111 0
Q ss_pred eeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHH
Q 044995 143 HITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNIT 189 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~ 189 (288)
.......|+..|+||| ||||||+++|+|++|..||.... .+...+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 1112346889999998 99999999999999999986432 12344678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+++.+||+.||++||++.+++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=267.09 Aligned_cols=194 Identities=24% Similarity=0.296 Sum_probs=159.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN- 76 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~- 76 (288)
..++|++.+.||+|+||.||+++++ .+.+.+|+.++++++||||+++++++.+.+......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4578999999999999999998752 356889999999999999999999887654322111
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee---cCCCceEEecccCccccCCCC
Q 044995 77 ------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---DDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 77 ------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~DfG~a~~~~~~~ 141 (288)
....+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 1235788999999999999999999 8899999999999999 67889999999998754322
Q ss_pred ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHH
Q 044995 142 THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAK 192 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~ 192 (288)
......|++.|+||| ||||||+++|+|++|..||..... ....+..+.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 122346899999999 999999999999999999854321 1245688999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++.+||+.||++||++.+++++-
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHcCCChhHCcCHHHHhcCc
Confidence 99999999999999999998764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.37 Aligned_cols=207 Identities=19% Similarity=0.320 Sum_probs=161.7
Q ss_pred cceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC--CCceeeecc
Q 044995 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN--HINVVKLIG 64 (288)
Q Consensus 6 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~--HpnIv~l~~ 64 (288)
+.|.++.+....++|++.+.||+|+||.||++.++ .+.+.+|++++++++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34556667777888999999999999999998652 467899999999997 499999999
Q ss_pred eEeccccccccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 65 CCLETKYMHDQN------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 65 ~~~~~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
++...+++.... ....+++..+..++.|++.||.||| +.+|+||||||+|||+++ +.+||+|||
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence 987665432211 1235788899999999999999999 889999999999999964 899999999
Q ss_pred CccccCCCCce-eeeccccCCCCCChh----------------------hHHHHHHHHHHHHhCCCCCCCCC--------
Q 044995 133 TSRSRAVDQTH-ITTQVHGTFGYLNPD----------------------DVCSFGVVLVELLTGAKPIRFTT-------- 181 (288)
Q Consensus 133 ~a~~~~~~~~~-~~~~~~gt~~y~aPE----------------------DiwSlG~il~elltg~~P~~~~~-------- 181 (288)
+++........ ......|++.|+||| ||||||+++|||++|..||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 99865432221 122346899999997 99999999999999999996431
Q ss_pred ---------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 182 ---------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 182 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
.+...+.++.+++.+||+.||++||++.|++++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 22334678999999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=268.02 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=155.0
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC----CCCceeee
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI----NHINVVKL 62 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l----~HpnIv~l 62 (288)
.+.+...++|++.+.||+|+||.||+|.+. ...+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345567789999999999999999999752 12345799999998 89999999
Q ss_pred cceEecccccccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceE
Q 044995 63 IGCCLETKYMHDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAK 127 (288)
Q Consensus 63 ~~~~~~~~~l~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~k 127 (288)
++++...+..... .....+++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 9987654322111 11235889999999999999999999 88899999999999998 789999
Q ss_pred EecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCC--------CccchhH
Q 044995 128 VSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFT--------TFEEDKN 187 (288)
Q Consensus 128 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~--------~~~~~~~ 187 (288)
|+|||+++...... .....|+..|+||| ||||||+++|||++|+.||... ..+...+
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSC
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCC
Confidence 99999998654322 22346899999999 9999999999999999998532 2344567
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+.+++.+||+.||++||++.|++++-
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 8899999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.92 Aligned_cols=194 Identities=22% Similarity=0.319 Sum_probs=163.0
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc-------------------H--------------HHHHHHHHHHhcCCCCceee
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK-------------------V--------------EKFINEVVIQSQINHINVVK 61 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~--------------~~~~~E~~~l~~l~HpnIv~ 61 (288)
...++|++.+.||+|+||.||++.+. . +.|.+|++++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 34589999999999999999999642 0 88999999999999999999
Q ss_pred ecceEeccc-------cccc------------cCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCee
Q 044995 62 LIGCCLETK-------YMHD------------QNK--ELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNIL 119 (288)
Q Consensus 62 l~~~~~~~~-------~l~~------------~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil 119 (288)
+++++.+.+ ++.. ... ...+++..+..++.|++.||.||| + .+|+|+||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 999876543 2211 111 456899999999999999999999 7 88999999999999
Q ss_pred ecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCCc----
Q 044995 120 LDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTTF---- 182 (288)
Q Consensus 120 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~~---- 182 (288)
++.++.+||+|||++...... ......|+..|+||| ||||||+++|||++|..||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999765332 233456899999999 999999999999999999964322
Q ss_pred -----------c-------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -----------E-------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -----------~-------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+ ...+..+.+++.+||+.||.+||++.|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 3356789999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.51 Aligned_cols=201 Identities=21% Similarity=0.264 Sum_probs=161.2
Q ss_pred HHHHHHhcCCcccC-ceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCC-CCceeeecceEe
Q 044995 10 SNELEKATDSFNVN-RILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQIN-HINVVKLIGCCL 67 (288)
Q Consensus 10 ~~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 67 (288)
++..+...+.|.+. +.||+|+||.||++.++ ...+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34556677888887 89999999999998652 468999999999995 699999999976
Q ss_pred cccc-------ccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEe
Q 044995 68 ETKY-------MHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVS 129 (288)
Q Consensus 68 ~~~~-------l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~ 129 (288)
..+. +.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 6532 211 112246889999999999999999999 889999999999999987 7899999
Q ss_pred cccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------
Q 044995 130 NFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------- 183 (288)
Q Consensus 130 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------- 183 (288)
|||+++...... ......||+.|+||| ||||||+++|+|++|..||......
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 999998654322 223356999999999 9999999999999999999643321
Q ss_pred ---chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 184 ---EDKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 184 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
...+..+.+++.+||+.||++||++.+++++-
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 23467899999999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=292.29 Aligned_cols=196 Identities=22% Similarity=0.280 Sum_probs=160.7
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYM 72 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l 72 (288)
...++|++++.||+|+||.||++.++ .+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45678999999999999999999753 35678899999987 799999999987665433
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 2111 1235889999999999999999999 88999999999999999999999999999985432
Q ss_pred CCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHA 194 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li 194 (288)
.. ......+||+.|+||| |||||||++|||++|..||.... ++...+.++.++|
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22 2234567999999999 99999999999999999996543 3345678999999
Q ss_pred HHhcCCCCCCCCCH-----HHHHHH
Q 044995 195 KRCLNPSGKKRPAM-----KEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~-----~~i~~~ 214 (288)
.+||+.||++||++ .||+++
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999997 555543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.73 Aligned_cols=205 Identities=23% Similarity=0.340 Sum_probs=161.2
Q ss_pred cceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcC-CCCceeeecceEe
Q 044995 6 KLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI-NHINVVKLIGCCL 67 (288)
Q Consensus 6 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 67 (288)
..+...++....++|++.+.||+|+||.||+|.+. .+.+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 34555666778899999999999999999999752 46899999999999 8999999999886
Q ss_pred cc-------------ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCce
Q 044995 68 ET-------------KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCA 126 (288)
Q Consensus 68 ~~-------------~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~ 126 (288)
.. +++.. ......+++..+..++.|++.||.||| ..+|+|+||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence 52 11111 111246888999999999999999999 8889999999999999999999
Q ss_pred EEecccCccccCCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc--------
Q 044995 127 KVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF-------- 182 (288)
Q Consensus 127 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~-------- 182 (288)
||+|||++........ ......|+..|+||| |||||||++|+|++|..||.....
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9999999876432211 122346899999998 999999999999999999864321
Q ss_pred --------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||..||++||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12346789999999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.15 Aligned_cols=196 Identities=23% Similarity=0.308 Sum_probs=158.1
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC---CCCceeeecceEec-
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI---NHINVVKLIGCCLE- 68 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~- 68 (288)
....++|++.+.||+|+||.||++.+. ...+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 345689999999999999999999752 13577888887766 89999999998762
Q ss_pred ----c-------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEec
Q 044995 69 ----T-------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130 (288)
Q Consensus 69 ----~-------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~D 130 (288)
. +++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 1 11111 111234889999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------
Q 044995 131 FGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----------------- 182 (288)
Q Consensus 131 fG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----------------- 182 (288)
||+++...... ......||..|+||| ||||||+++|+|++|..||.....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99997654222 223356899999999 999999999999999999964321
Q ss_pred ------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12346678899999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=273.87 Aligned_cols=192 Identities=20% Similarity=0.263 Sum_probs=154.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC-----------CCceeeecceEec
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN-----------HINVVKLIGCCLE 68 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 68 (288)
.++|++.+.||+|+||.||+|.+. .+.+.+|++++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 478999999999999999999752 466889999999886 8999999998764
Q ss_pred cc-----------ccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeec------CC
Q 044995 69 TK-----------YMH-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLD------DK 123 (288)
Q Consensus 69 ~~-----------~l~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~------~~ 123 (288)
.+ ++. .......+++..+..++.|++.||.||| ++ +|+||||||+|||++ ..
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence 32 110 0112345889999999999999999999 77 899999999999994 34
Q ss_pred CceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------
Q 044995 124 YCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------- 181 (288)
Q Consensus 124 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------- 181 (288)
+.+||+|||+++..... .....||+.|+||| |||||||++|||++|..||....
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999765432 22346899999999 99999999999999999996432
Q ss_pred ---------------------------------------------------ccchhHHHHHHHHHHhcCCCCCCCCCHHH
Q 044995 182 ---------------------------------------------------FEEDKNITVAKHAKRCLNPSGKKRPAMKE 210 (288)
Q Consensus 182 ---------------------------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 210 (288)
.+...+.++.++|.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 11234567889999999999999999999
Q ss_pred HHHHH
Q 044995 211 VASEL 215 (288)
Q Consensus 211 i~~~l 215 (288)
++++-
T Consensus 331 ll~hp 335 (373)
T 1q8y_A 331 LVNHP 335 (373)
T ss_dssp HHTCG
T ss_pred HhhCh
Confidence 98763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.89 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=161.7
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC--CCceeeec
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN--HINVVKLI 63 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~--HpnIv~l~ 63 (288)
.++.....++|++.+.||+|+||.||+|.+. .+.+.+|+.++++++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 4555667889999999999999999999752 134678999999996 59999999
Q ss_pred ceEecccccccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec-CCCceEE
Q 044995 64 GCCLETKYMHDQ--------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKV 128 (288)
Q Consensus 64 ~~~~~~~~l~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~-~~~~~kl 128 (288)
+++...+..... .....+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 998765432111 11235788999999999999999999 88999999999999998 7799999
Q ss_pred ecccCccccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCC--------CccchhHH
Q 044995 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFT--------TFEEDKNI 188 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~--------~~~~~~~~ 188 (288)
+|||+++...... .....||+.|+||| ||||||+++|||++|..||... ......+.
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 268 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCH
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCH
Confidence 9999998654322 22346899999999 9999999999999999998532 23345578
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 189 TVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 189 ~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
++.+++.+||+.||++||++.+++++-
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 899999999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=275.65 Aligned_cols=191 Identities=10% Similarity=0.052 Sum_probs=137.6
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHH---HHhcCCCCceeeecc-------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVV---IQSQINHINVVKLIG------- 64 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~---~l~~l~HpnIv~l~~------- 64 (288)
...+|++.+.||+|+||.||+|.+. .+.+.+|+. +|+. +||||++++.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 3445999999999999999999752 355677854 5555 7999887542
Q ss_pred eE------------------------ecccccccc------CCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCCe
Q 044995 65 CC------------------------LETKYMHDQ------NKELPFTWEMQ------LRISIEASGTMSYLHLSASVPI 108 (288)
Q Consensus 65 ~~------------------------~~~~~l~~~------~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~~i 108 (288)
++ ...+|+... .....+.+... ..++.|++.||.||| +++|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i 215 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL 215 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence 22 222222110 00012233334 677799999999999 8899
Q ss_pred EEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCC
Q 044995 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAK 175 (288)
Q Consensus 109 iHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~ 175 (288)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+||| |||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999985432 122345779999999 99999999999999999
Q ss_pred CCCCCCc-----------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 176 PIRFTTF-----------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 176 P~~~~~~-----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
||..... ....+..+.+++.+||+.||++||++.+++++
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9965411 01347899999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.16 Aligned_cols=198 Identities=24% Similarity=0.307 Sum_probs=147.0
Q ss_pred HHhcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHH-HHhcCCCCceeeecceEeccccc-
Q 044995 14 EKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVV-IQSQINHINVVKLIGCCLETKYM- 72 (288)
Q Consensus 14 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~l- 72 (288)
....++|++.+.||+|+||.||++.++ ...+.+|+. +++.++||||+++++++...+..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 345689999999999999999998753 235566666 77889999999999988765322
Q ss_pred ------cc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 73 ------HD----------QNKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 73 ------~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.. ......+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 11 012356889999999999999999999 77 89999999999999999999999999997
Q ss_pred ccCCCCceeeeccccCCCCCChh---------------hHHHHHHHHHHHHhCCCCCCCCCc------------------
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD---------------DVCSFGVVLVELLTGAKPIRFTTF------------------ 182 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE---------------DiwSlG~il~elltg~~P~~~~~~------------------ 182 (288)
...... ......||..|+||| ||||||+++|+|++|..||.....
T Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 175 QLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred eccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 654322 122336899999998 999999999999999999854211
Q ss_pred --cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 183 --EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 183 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
....+..+.+++.+||+.||++||++.+++++-.
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 1135778999999999999999999999988643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.85 Aligned_cols=195 Identities=25% Similarity=0.327 Sum_probs=160.3
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~ 74 (288)
...++|++.+.||+|+||.||++.++ .+.+.+|++++++++||||+++++++...+.+..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45678999999999999999999752 4678999999999999999999999876543221
Q ss_pred cC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC---CceEEecccCccccC
Q 044995 75 QN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK---YCAKVSNFGTSRSRA 138 (288)
Q Consensus 75 ~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~DfG~a~~~~ 138 (288)
.. ....+++..+..++.|++.||.||| +.+|+|+||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 11 1235789999999999999999999 8899999999999999654 479999999987654
Q ss_pred CCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITV 190 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~ 190 (288)
.... .....|+..|+||| ||||||+++|+|++|..||...... ...+.++
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCCc--cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 3221 22345889999999 9999999999999999998643211 2346789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+++.+||+.||++||++.+++++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcccChhhCcCHHHHhcC
Confidence 999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.00 Aligned_cols=197 Identities=27% Similarity=0.372 Sum_probs=161.2
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc---------------------------HHHHHHHHHHHhcCC-CCceeeecc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK---------------------------VEKFINEVVIQSQIN-HINVVKLIG 64 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------------~~~~~~E~~~l~~l~-HpnIv~l~~ 64 (288)
.....++|++.+.||+|+||.||+|.++ .+.+.+|+++++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999998752 246789999999996 999999999
Q ss_pred eEeccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 65 CCLETKYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 65 ~~~~~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
++.......... ....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecc
Confidence 987654322111 1235789999999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCCc------------
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTTF------------ 182 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~~------------ 182 (288)
|++....... ......|++.|+||| ||||||+++|+|++|..||.....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9997654322 223346899999998 999999999999999999854321
Q ss_pred ------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 12356789999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.54 Aligned_cols=193 Identities=20% Similarity=0.309 Sum_probs=157.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCc------eeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHIN------VVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~ 70 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|+++++.++|+| |+++++++...+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 34579999999999999999999651 367889999999987765 899998876553
Q ss_pred cccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC--------------
Q 044995 71 YMHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-------------- 122 (288)
Q Consensus 71 ~l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-------------- 122 (288)
.+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 2211 112236789999999999999999999 889999999999999986
Q ss_pred -----CCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---
Q 044995 123 -----KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--- 183 (288)
Q Consensus 123 -----~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--- 183 (288)
++.+||+|||+++..... .....||+.|+||| |||||||++|||++|..||......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 667999999999764322 22346899999999 9999999999999999999643321
Q ss_pred -------------------------------------------------------chhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 184 -------------------------------------------------------EDKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 184 -------------------------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
...+.++.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1124678899999999999999999
Q ss_pred HHHHHH
Q 044995 209 KEVASE 214 (288)
Q Consensus 209 ~~i~~~ 214 (288)
.|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999876
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=266.22 Aligned_cols=193 Identities=19% Similarity=0.265 Sum_probs=156.4
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCc------eeeecceEeccc
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHIN------VVKLIGCCLETK 70 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~ 70 (288)
...++|++.+.||+|+||.||++.+. .+.+.+|++++++++|+| ++.+++++....
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 35689999999999999999998642 456888999999998776 888887765433
Q ss_pred -------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeee----------------
Q 044995 71 -------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL---------------- 120 (288)
Q Consensus 71 -------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~---------------- 120 (288)
++.. ......+++..+..++.|++.||.||| +++|+||||||+|||+
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 2211 112236889999999999999999999 8899999999999999
Q ss_pred ---cCCCceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc--
Q 044995 121 ---DDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE-- 184 (288)
Q Consensus 121 ---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~-- 184 (288)
+.++.+||+|||+++..... .....||+.|+||| |||||||++|||++|..||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999754322 22346899999999 99999999999999999996543211
Q ss_pred --------------------------------------------------------hhHHHHHHHHHHhcCCCCCCCCCH
Q 044995 185 --------------------------------------------------------DKNITVAKHAKRCLNPSGKKRPAM 208 (288)
Q Consensus 185 --------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 208 (288)
..+.++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 113478899999999999999999
Q ss_pred HHHHHH
Q 044995 209 KEVASE 214 (288)
Q Consensus 209 ~~i~~~ 214 (288)
.|++++
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=259.41 Aligned_cols=193 Identities=25% Similarity=0.431 Sum_probs=150.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecc---------
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLET--------- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 69 (288)
..++|++.+.||+|+||.||+|++. .+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4578999999999999999999752 46788999999999999999999887542
Q ss_pred -----------ccccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 70 -----------KYMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 70 -----------~~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+++.. ......+++..+..++.|++.||.||| +++|+|+||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 12111 012235677888999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCC-------------ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCC-------
Q 044995 132 GTSRSRAVDQ-------------THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRF------- 179 (288)
Q Consensus 132 G~a~~~~~~~-------------~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~------- 179 (288)
|++....... ........|+..|+||| ||||||+++|||++ ||..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9987543211 11122346899999999 99999999999998 4321
Q ss_pred ------------CCccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 180 ------------TTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 180 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.......+..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11223445678999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=271.81 Aligned_cols=202 Identities=21% Similarity=0.264 Sum_probs=158.0
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC-CC-----ceeeecc
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN-HI-----NVVKLIG 64 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~-Hp-----nIv~l~~ 64 (288)
|.........++|++.+.||+|+||.||+|.++ .+.+.+|+++++.++ |+ +|+++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 344455566789999999999999999999753 356778898888875 44 4899988
Q ss_pred eEecccc-------ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec--CCCceEE
Q 044995 65 CCLETKY-------MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD--DKYCAKV 128 (288)
Q Consensus 65 ~~~~~~~-------l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~--~~~~~kl 128 (288)
++...+. +.. ......+++..+..++.|++.||.|||. +..+|+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 8765432 211 1112358899999999999999999993 246899999999999994 4788999
Q ss_pred ecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCccc-------------
Q 044995 129 SNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE------------- 184 (288)
Q Consensus 129 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~~------------- 184 (288)
+|||+++..... .....||+.|+||| |||||||++|||++|+.||.......
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999865322 22356899999999 99999999999999999996432100
Q ss_pred -----------------------------------------------------------------hhHHHHHHHHHHhcC
Q 044995 185 -----------------------------------------------------------------DKNITVAKHAKRCLN 199 (288)
Q Consensus 185 -----------------------------------------------------------------~~~~~~~~li~~cl~ 199 (288)
....++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 011368899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 044995 200 PSGKKRPAMKEVASE 214 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~ 214 (288)
.||++|||+.|++++
T Consensus 359 ~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 359 YDPKTRIQPYYALQH 373 (382)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=262.42 Aligned_cols=198 Identities=22% Similarity=0.342 Sum_probs=147.3
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY 71 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 71 (288)
++....++|++.+.||+|+||.||+|.++ .+.+.++..+++.++||||+++++++...+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34455688999999999999999999752 1234445567888999999999999876543
Q ss_pred ccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 72 MHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 72 l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
+.... ....+++..+..++.|++.||.||| .. +|+|+||||+|||++.++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 22111 1246889999999999999999999 74 8999999999999999999999999998754
Q ss_pred CCCCceeeeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCcc------------------
Q 044995 138 AVDQTHITTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTFE------------------ 183 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~~------------------ 183 (288)
.... ......|++.|+||| ||||||+++|||++|+.||......
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 3322 222346899999998 9999999999999999999642211
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||.+||++.+++++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1246789999999999999999999999876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=254.37 Aligned_cols=183 Identities=11% Similarity=0.063 Sum_probs=149.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||.||+|.+. .+.|.+|+.++++++||||+++++++...+..+..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 478999999999999999999752 26799999999999999999999997665332211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH 143 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 143 (288)
... ......+.+++.|++.||.||| +++|+||||||+|||++.++.+||+++|...
T Consensus 110 ~e~~~g~~L~~~l~~-~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~-------- 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP-------- 177 (286)
T ss_dssp EECCCEEEHHHHHTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT--------
T ss_pred EEecCCCCHHHHHhc-CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC--------
Confidence 111 2355678899999999999999 8899999999999999999999998665431
Q ss_pred eeeccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcc---------------------chhHHHHHHHHHHhcCCCC
Q 044995 144 ITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFE---------------------EDKNITVAKHAKRCLNPSG 202 (288)
Q Consensus 144 ~~~~~~gt~~y~aPEDiwSlG~il~elltg~~P~~~~~~~---------------------~~~~~~~~~li~~cl~~~p 202 (288)
.|....|||||||++|||++|+.||...... ...+.++.+++.+||+.||
T Consensus 178 ---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 248 (286)
T 3uqc_A 178 ---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248 (286)
T ss_dssp ---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTS
T ss_pred ---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCC
Confidence 1222339999999999999999999654321 2346789999999999999
Q ss_pred CCCCCHHHHHHHHHhchhh
Q 044995 203 KKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 203 ~~Rp~~~~i~~~l~~~~~~ 221 (288)
++| |+.|+++.|+.+...
T Consensus 249 ~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 249 GIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SCC-CHHHHHHHHHHHHC-
T ss_pred ccC-CHHHHHHHHHHHhcc
Confidence 999 999999999988654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=273.21 Aligned_cols=192 Identities=13% Similarity=0.181 Sum_probs=147.1
Q ss_pred HhcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCC-Cceeeecce-------
Q 044995 15 KATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINH-INVVKLIGC------- 65 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~H-pnIv~l~~~------- 65 (288)
....+|...+.||+|+||.||+|++. .+.|.+|+.+++.++| .|+..+..+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34455888899999999999999853 4678999999999987 322111111
Q ss_pred --E------------eccc--------------------ccc----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 044995 66 --C------------LETK--------------------YMH----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107 (288)
Q Consensus 66 --~------------~~~~--------------------~l~----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 107 (288)
+ .... ++. .......+++..++.++.|++.||.||| +++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 0 0000 000 0111334667788899999999999999 889
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh---------------------hHHHHHHH
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---------------------DVCSFGVV 166 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE---------------------DiwSlG~i 166 (288)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+||| |||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998754322 334567 9999998 99999999
Q ss_pred HHHHHhCCCCCCCCCcc----------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 167 LVELLTGAKPIRFTTFE----------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 167 l~elltg~~P~~~~~~~----------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+|||++|+.||...... ...+..+.+++.+||+.||++||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999654321 2357899999999999999999998888664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=269.53 Aligned_cols=202 Identities=20% Similarity=0.274 Sum_probs=146.4
Q ss_pred HHHHHHhcCCc-ccCceeeeeCCeeEEEeEc--------------cHHHHHHHHHHHhcC-CCCceeeecceEecccccc
Q 044995 10 SNELEKATDSF-NVNRILGQGGQDIVYKGMA--------------KVEKFINEVVIQSQI-NHINVVKLIGCCLETKYMH 73 (288)
Q Consensus 10 ~~~~~~~~~~y-~~~~~lG~G~~g~Vy~~~~--------------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~ 73 (288)
..+++...+++ .+.+.||+|+||+||.+.. ..+.+.+|+++++++ +|||||++++++...++++
T Consensus 6 ~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp --CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccchhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 33444444444 5568899999999975421 146788999999876 8999999999887665432
Q ss_pred ccCCCC------------C-------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-----------
Q 044995 74 DQNKEL------------P-------FTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK----------- 123 (288)
Q Consensus 74 ~~~~~~------------~-------l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~----------- 123 (288)
...+.. . ..+..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCC
Confidence 211111 0 122234679999999999999 8899999999999999643
Q ss_pred --CceEEecccCccccCCCCce---eeeccccCCCCCChh------------------hHHHHHHHHHHHHh-CCCCCCC
Q 044995 124 --YCAKVSNFGTSRSRAVDQTH---ITTQVHGTFGYLNPD------------------DVCSFGVVLVELLT-GAKPIRF 179 (288)
Q Consensus 124 --~~~kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE------------------DiwSlG~il~ellt-g~~P~~~ 179 (288)
+.+||+|||+++........ ......||+.|+||| |||||||++|||++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 48999999999866443221 122356999999998 99999999999999 9999854
Q ss_pred CCc-------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 180 TTF-------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 180 ~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
... ....+.++.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 321 11235789999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=258.88 Aligned_cols=194 Identities=21% Similarity=0.303 Sum_probs=139.6
Q ss_pred hcCCcccCc-eeeeeCCeeEEEeEcc-------------HHHHHHHH-HHHhcCCCCceeeecceEec----c-------
Q 044995 16 ATDSFNVNR-ILGQGGQDIVYKGMAK-------------VEKFINEV-VIQSQINHINVVKLIGCCLE----T------- 69 (288)
Q Consensus 16 ~~~~y~~~~-~lG~G~~g~Vy~~~~~-------------~~~~~~E~-~~l~~l~HpnIv~l~~~~~~----~------- 69 (288)
..++|++.+ .||+|+||.||+|.++ .....+|+ ..++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 458899855 6999999999999763 23344444 44677899999999998754 1
Q ss_pred ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccC
Q 044995 70 KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~ 138 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 22211 112236899999999999999999999 889999999999999975 4569999999997543
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------ch
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------ED 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~----------------------~~ 185 (288)
.. ......||+.|+||| ||||||+++|+|++|..||...... ..
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 183 QN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred cc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence 22 122346899999999 9999999999999999998432211 23
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
.+.++.+++.+||+.||++|||+.|++++-
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 477899999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=280.77 Aligned_cols=195 Identities=20% Similarity=0.342 Sum_probs=158.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK----- 70 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 70 (288)
..++|++.+.||+|+||.||++.+. .+.|.+|++++++++|||||+++++|...+
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3488999999999999999999752 356889999999999999999999876542
Q ss_pred -------ccccc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 71 -------YMHDQ----NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 71 -------~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
|+... .....+++..++.++.|++.||.||| +++|+||||||+|||++.+ .+||+|||+++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 22110 11126899999999999999999999 8889999999999999875 899999999986543
Q ss_pred CCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCc---cc-----hhHHHHHHHHHHhcCCC
Q 044995 140 DQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTF---EE-----DKNITVAKHAKRCLNPS 201 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~---~~-----~~~~~~~~li~~cl~~~ 201 (288)
. ....||+.|+||| |||||||++|+|++|..||..... +. ..+..+.++|.+||+.|
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 308 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPD 308 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTCSS
T ss_pred C-----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhccCC
Confidence 2 3346999999999 999999999999999888753211 11 12467899999999999
Q ss_pred CCCCCC-HHHHHHHHHhch
Q 044995 202 GKKRPA-MKEVASELAGIK 219 (288)
Q Consensus 202 p~~Rp~-~~~i~~~l~~~~ 219 (288)
|++||+ +.++.+.|..+.
T Consensus 309 P~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 309 PRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp GGGSCSSHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHHH
Confidence 999985 667777776654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.07 Aligned_cols=197 Identities=25% Similarity=0.398 Sum_probs=147.7
Q ss_pred HhcCCcccCceeeeeCCeeE-EEeEcc-------------HHHHHHHHHHHhcC-CCCceeeecceEecccccccc----
Q 044995 15 KATDSFNVNRILGQGGQDIV-YKGMAK-------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ---- 75 (288)
Q Consensus 15 ~~~~~y~~~~~lG~G~~g~V-y~~~~~-------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~---- 75 (288)
....+|++.+.||+|+||.| |++... .+.+.+|+++|+++ +|||||++++++.+..+++..
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 44456999999999999985 444321 23467899999999 799999999988766443211
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-----CCceEEecccCccccCCCC
Q 044995 76 ---------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-----KYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 76 ---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-----~~~~kl~DfG~a~~~~~~~ 141 (288)
.....+....++.++.|++.||.||| +.+|+||||||+|||++. ...+||+|||+++......
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 11223344456789999999999999 888999999999999942 2367899999998654322
Q ss_pred c--eeeeccccCCCCCChh--------------hHHHHHHHHHHHHh-CCCCCCCCCc-----------------cchhH
Q 044995 142 T--HITTQVHGTFGYLNPD--------------DVCSFGVVLVELLT-GAKPIRFTTF-----------------EEDKN 187 (288)
Q Consensus 142 ~--~~~~~~~gt~~y~aPE--------------DiwSlG~il~ellt-g~~P~~~~~~-----------------~~~~~ 187 (288)
. .......||+.|+||| |||||||++|||++ |..||..... ....+
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence 1 1223456999999999 99999999999999 9999853221 11235
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 188 ITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
..+.++|.+||+.||++||++.+++++
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 568899999999999999999999965
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=249.78 Aligned_cols=186 Identities=22% Similarity=0.306 Sum_probs=148.9
Q ss_pred hcCCcccC-ceeeeeCCeeEEEeEcc-------------HHHHHHHHHHH-hcCCCCceeeecceEec----c-------
Q 044995 16 ATDSFNVN-RILGQGGQDIVYKGMAK-------------VEKFINEVVIQ-SQINHINVVKLIGCCLE----T------- 69 (288)
Q Consensus 16 ~~~~y~~~-~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~------- 69 (288)
..++|.+. +.||+|+||.||++.++ ...+.+|+.++ +.++||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 45778887 77999999999999763 46788999988 66799999999998764 2
Q ss_pred ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccC
Q 044995 70 KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~ 138 (288)
+++.. ......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 22211 112235889999999999999999999 888999999999999987 7899999999987543
Q ss_pred CCCceeeeccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc------------------c----chhHHHHHHHHHH
Q 044995 139 VDQTHITTQVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTF------------------E----EDKNITVAKHAKR 196 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPEDiwSlG~il~elltg~~P~~~~~~------------------~----~~~~~~~~~li~~ 196 (288)
. ..|....|||||||++|||++|..||..... + ...+.++.+++.+
T Consensus 172 ~------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (299)
T 3m2w_A 172 G------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 239 (299)
T ss_dssp T------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHH
T ss_pred c------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHH
Confidence 2 1233344999999999999999999953211 1 2347789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHH
Q 044995 197 CLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 197 cl~~~p~~Rp~~~~i~~~l~ 216 (288)
||+.||++||++.|++++-.
T Consensus 240 ~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 240 LLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HTCSSTTTSCCHHHHHTSHH
T ss_pred HcccChhhCCCHHHHhcChh
Confidence 99999999999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=276.51 Aligned_cols=192 Identities=23% Similarity=0.313 Sum_probs=148.9
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEec------c-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLE------T- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~- 69 (288)
..++|++.+.||+|+||.||+|.+. .+.|.+|++++++++||||+++++++.. .
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3488999999999999999998652 4678999999999999999999988644 1
Q ss_pred ------ccccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---ceEEecc
Q 044995 70 ------KYMHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY---CAKVSNF 131 (288)
Q Consensus 70 ------~~l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~Df 131 (288)
+|+.. ......+++..+..++.+++.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 22211 111225788889999999999999999 88899999999999998665 4899999
Q ss_pred cCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC--------------------
Q 044995 132 GTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT-------------------- 180 (288)
Q Consensus 132 G~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~-------------------- 180 (288)
|++....... ......||..|+||| ||||||+++|+|++|..||...
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998654322 223457999999999 9999999999999999998432
Q ss_pred ------------------CccchhHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 044995 181 ------------------TFEEDKNITVAKHAKRCLNPSGKKRPAMKEVA 212 (288)
Q Consensus 181 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 212 (288)
......+..+.+++.+||..||++||++.+++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 01123478899999999999999999998743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=242.66 Aligned_cols=186 Identities=15% Similarity=0.161 Sum_probs=142.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC---------CCceeee
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN---------HINVVKL 62 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~---------HpnIv~l 62 (288)
..++|++.+.||+|+||.||+|++. .+.+.+|+.++++++ |||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3578999999999999999999752 178999999999886 5555555
Q ss_pred cc-----------------eEec-------------c-------ccccc-----cCCCCCCCHHHHHHHHHHHHHHHHHh
Q 044995 63 IG-----------------CCLE-------------T-------KYMHD-----QNKELPFTWEMQLRISIEASGTMSYL 100 (288)
Q Consensus 63 ~~-----------------~~~~-------------~-------~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~l 100 (288)
.+ ++.. . +|+.. ......+++..+..++.|++.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 44 3322 1 22111 11224578999999999999999999
Q ss_pred hcCCCCCeEEeCCCCCCeeecCCC--------------------ceEEecccCccccCCCCceeeeccccCCCCCChh--
Q 044995 101 HLSASVPIYHRDIKSTNILLDDKY--------------------CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-- 158 (288)
Q Consensus 101 H~~~~~~iiHrdlkp~Nil~~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-- 158 (288)
|. +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||
T Consensus 178 H~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 178 EA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 91 24699999999999998776 8999999999864321 246999999999
Q ss_pred --------hHHHHHHH-HHHHHhCCCCCCCC--------------C--------ccchhHHHHHHHHHHhcCCCCCCCCC
Q 044995 159 --------DVCSFGVV-LVELLTGAKPIRFT--------------T--------FEEDKNITVAKHAKRCLNPSGKKRPA 207 (288)
Q Consensus 159 --------DiwSlG~i-l~elltg~~P~~~~--------------~--------~~~~~~~~~~~li~~cl~~~p~~Rp~ 207 (288)
|||||+++ .+++++|..||... . .....+.++.++|.+||+.| |
T Consensus 250 ~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 250 TGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred cCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 99998777 77788899987421 0 01235778999999999976 8
Q ss_pred HHHHH-HH
Q 044995 208 MKEVA-SE 214 (288)
Q Consensus 208 ~~~i~-~~ 214 (288)
+.|++ ++
T Consensus 325 a~e~l~~H 332 (336)
T 2vuw_A 325 ATDLLCQH 332 (336)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhcC
Confidence 98888 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=216.73 Aligned_cols=127 Identities=15% Similarity=0.110 Sum_probs=92.8
Q ss_pred HHHHHHHHHHHhcC-CCCceeeecceEecccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 044995 41 VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASV 106 (288)
Q Consensus 41 ~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 106 (288)
.++|.+|+++|+++ .|+||+++++++.+...++.. ....+++.. +|+.||+.||+|+| ++
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH---~~ 358 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALE---KQ 358 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHH---HC
Confidence 46799999999999 799999999998765433221 123355543 58899999999999 88
Q ss_pred CeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCC
Q 044995 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGA 174 (288)
Q Consensus 107 ~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~ 174 (288)
+||||||||+|||++.+|.+||+|||+|+....... .....+||+.||||| |+||+|++++++.++.
T Consensus 359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 999999999999999999999999999986544332 233467999999999 9999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-23 Score=195.62 Aligned_cols=151 Identities=12% Similarity=0.126 Sum_probs=104.8
Q ss_pred cCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccCC
Q 044995 22 VNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQNK 77 (288)
Q Consensus 22 ~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~~ 77 (288)
..+.||+|+||.||++... .++|.+|++++++++||||+++..++...+..+...+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 3568999999999987431 3458999999999999999955444333222111111
Q ss_pred CCC-CCHHH----HHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee------ee
Q 044995 78 ELP-FTWEM----QLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI------TT 146 (288)
Q Consensus 78 ~~~-l~~~~----~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~~ 146 (288)
... -+... ...++.|++.+|.||| +++|+||||||+|||++. .+||+|||+++......... ..
T Consensus 420 ~~~ggsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~ 494 (540)
T 3en9_A 420 YINGKLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK 494 (540)
T ss_dssp CCCSEEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence 110 01111 5689999999999999 889999999999999998 99999999998764322111 13
Q ss_pred ccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCC
Q 044995 147 QVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPI 177 (288)
Q Consensus 147 ~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~ 177 (288)
...||+.||||| |+||..+-..+.+.++.+|
T Consensus 495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 467999999999 8899888888877777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=156.36 Aligned_cols=115 Identities=12% Similarity=0.137 Sum_probs=86.3
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc-----------------------------------HHHHHHHHHHHhcCCCC
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-----------------------------------VEKFINEVVIQSQINHI 57 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------------------~~~~~~E~~~l~~l~Hp 57 (288)
+......|.+.+.||+|+||.||+|.+. ...|.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3344455666799999999999998641 2357899999999994
Q ss_pred ceeeecceEe------ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 044995 58 NVVKLIGCCL------ETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNF 131 (288)
Q Consensus 58 nIv~l~~~~~------~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~Df 131 (288)
+++.+++. ..+++....-.. +.......++.|++.||.||| +.+|+||||||+|||++ ++.+||+||
T Consensus 164 --~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 164 --LAVPKVYAWEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp --SSSCCEEEEETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred --CCcCeEEeccceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 55555432 234433211111 233446679999999999999 88999999999999999 999999999
Q ss_pred cCcc
Q 044995 132 GTSR 135 (288)
Q Consensus 132 G~a~ 135 (288)
|+++
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.4e-16 Score=130.39 Aligned_cols=114 Identities=13% Similarity=0.074 Sum_probs=82.4
Q ss_pred cccCceeeeeCCeeEEEeEc-----------c--------H-------------------------HHHHHHHHHHhcCC
Q 044995 20 FNVNRILGQGGQDIVYKGMA-----------K--------V-------------------------EKFINEVVIQSQIN 55 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~-----------~--------~-------------------------~~~~~E~~~l~~l~ 55 (288)
|++.+.||+|+||.||+|.+ | . ..+.+|+++|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999865 0 0 15788999999987
Q ss_pred CCce--eeec---ceEeccccccc-c-----CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC
Q 044995 56 HINV--VKLI---GCCLETKYMHD-Q-----NKE--LPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD 122 (288)
Q Consensus 56 HpnI--v~l~---~~~~~~~~l~~-~-----~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~ 122 (288)
|+|| ..++ ..+...+|+.. . ... ...++..+..++.|++.+|.|||. ..+|+||||||+|||++.
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~ 206 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID 206 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC
Confidence 7653 2222 23444555521 0 000 012234677899999999999992 346999999999999987
Q ss_pred CCceEEecccCcccc
Q 044995 123 KYCAKVSNFGTSRSR 137 (288)
Q Consensus 123 ~~~~kl~DfG~a~~~ 137 (288)
.++|+|||+|...
T Consensus 207 --~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 --KVYFIDMGQAVTL 219 (258)
T ss_dssp --SEEECCCTTCEET
T ss_pred --cEEEEECcccccC
Confidence 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.49 E-value=6e-15 Score=131.22 Aligned_cols=116 Identities=12% Similarity=0.092 Sum_probs=77.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-------------------------------HHH--------HHHHHHHHhcCCCCc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-------------------------------VEK--------FINEVVIQSQINHIN 58 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-------------------------------~~~--------~~~E~~~l~~l~Hpn 58 (288)
--|++.+.||+|+||.||+|.+. ... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999998642 111 234556666654333
Q ss_pred ee-----eecceEeccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC---------
Q 044995 59 VV-----KLIGCCLETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY--------- 124 (288)
Q Consensus 59 Iv-----~l~~~~~~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~--------- 124 (288)
+. .+...+..++|+....-...........++.|++.+|.||| ..+||||||||.|||+++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~ 251 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSIT 251 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccc
Confidence 21 11122344555532211111222345678899999999999 78899999999999997665
Q ss_pred -ceEEecccCccc
Q 044995 125 -CAKVSNFGTSRS 136 (288)
Q Consensus 125 -~~kl~DfG~a~~ 136 (288)
.+.|+||+-+..
T Consensus 252 ~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 252 LTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECCCTTCEE
T ss_pred cceEEEEeCCccc
Confidence 388999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-08 Score=86.05 Aligned_cols=124 Identities=15% Similarity=0.124 Sum_probs=86.2
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCC-CCceeeecceEeccccccc
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQIN-HINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~l~~ 74 (288)
.+....+.|++...+|.|+.+.||+.... ...+.+|+++++.+. +.++.++++++...+..+.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 44556678998889999999999987521 235889999999885 6677788877655422111
Q ss_pred cC---CCCCC-----CHHHHHHHHHHHHHHHHHhhcCC------------------------------------------
Q 044995 75 QN---KELPF-----TWEMQLRISIEASGTMSYLHLSA------------------------------------------ 104 (288)
Q Consensus 75 ~~---~~~~l-----~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------ 104 (288)
.. ....+ +......++.+++.+|..||...
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 11 10111 11223467889999999999510
Q ss_pred --------------CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 --------------SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 --------------~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+++.|||+++++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.6e-07 Score=79.58 Aligned_cols=155 Identities=17% Similarity=0.225 Sum_probs=96.5
Q ss_pred CceeeeeCCeeEEEeEcc-----------HHHHHHHHHHHhcCC-CCc--eeeecceEeccc-----c-----ccccCCC
Q 044995 23 NRILGQGGQDIVYKGMAK-----------VEKFINEVVIQSQIN-HIN--VVKLIGCCLETK-----Y-----MHDQNKE 78 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~-----------~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~-----~-----l~~~~~~ 78 (288)
.+.++.|.+..||+...+ ...+.+|+++|+.+. +.. +.+++......+ | +.+..-.
T Consensus 25 i~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~ 104 (304)
T 3sg8_A 25 IEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLT 104 (304)
T ss_dssp CCEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECC
T ss_pred eEecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECC
Confidence 467999999999976321 467889999998874 322 233333322211 2 2211100
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------------
Q 044995 79 ----LPFTWEMQLRISIEASGTMSYLHLSA-------------------------------------------------- 104 (288)
Q Consensus 79 ----~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------------------- 104 (288)
..++......++.+++..|..||...
T Consensus 105 ~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 184 (304)
T 3sg8_A 105 PLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENE 184 (304)
T ss_dssp HHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCG
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhcc
Confidence 12455566778888888888888411
Q ss_pred -----CCCeEEeCCCCCCeeecC--CCceEEecccCccccCCCCc----------ee---eeccccCCCCCC-hh-----
Q 044995 105 -----SVPIYHRDIKSTNILLDD--KYCAKVSNFGTSRSRAVDQT----------HI---TTQVHGTFGYLN-PD----- 158 (288)
Q Consensus 105 -----~~~iiHrdlkp~Nil~~~--~~~~kl~DfG~a~~~~~~~~----------~~---~~~~~gt~~y~a-PE----- 158 (288)
...++|+|+++.||+++. ...+.|+||+.+........ .. .......++... |+
T Consensus 185 ~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~ 264 (304)
T 3sg8_A 185 IYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY 264 (304)
T ss_dssp GGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH
T ss_pred ccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH
Confidence 135799999999999987 45678999998753221000 00 001112223444 55
Q ss_pred ----hHHHHHHHHHHHHhCCCCC
Q 044995 159 ----DVCSFGVVLVELLTGAKPI 177 (288)
Q Consensus 159 ----DiwSlG~il~elltg~~P~ 177 (288)
+.|+++.++|.+.+|..+|
T Consensus 265 ~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 265 RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHcCCHHH
Confidence 8899999999999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.47 E-value=6.2e-08 Score=81.05 Aligned_cols=121 Identities=12% Similarity=0.076 Sum_probs=76.6
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCc--eeeecceEecc-------
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHIN--VVKLIGCCLET------- 69 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~------- 69 (288)
+.....+|.+....+.|..+.||+.... ...+.+|+.+++.+.+.+ +.+++++....
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3344455665443345556899987531 245789999999886544 44566665443
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------------
Q 044995 70 KYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSA--------------------------------------------- 104 (288)
Q Consensus 70 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------------- 104 (288)
+++.+..-. ........++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 95 GEVPGQDLL--SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp ECCSSEETT--TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EecCCcccC--cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 223221111 111122367788888899998432
Q ss_pred ----------CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 ----------SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ----------~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.36 E-value=8.2e-07 Score=78.23 Aligned_cols=114 Identities=13% Similarity=0.175 Sum_probs=81.2
Q ss_pred cCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCC--CCceeeecceEecc----------c
Q 044995 22 VNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQIN--HINVVKLIGCCLET----------K 70 (288)
Q Consensus 22 ~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~----------~ 70 (288)
..+.|+.|.++.||+.... ...+.+|+++++.|. +..+.+++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4567899999999987421 235778999999887 45577777776554 2
Q ss_pred cccccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------
Q 044995 71 YMHDQNK----ELPFTWEMQLRISIEASGTMSYLHLSA------------------------------------------ 104 (288)
Q Consensus 71 ~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------ 104 (288)
++....- ...++......++.+++..|..||...
T Consensus 122 ~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 122 FVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred ecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 2222111 113567778889999999999999521
Q ss_pred -------------CCCeEEeCCCCCCeeecCCC--ceEEecccCcc
Q 044995 105 -------------SVPIYHRDIKSTNILLDDKY--CAKVSNFGTSR 135 (288)
Q Consensus 105 -------------~~~iiHrdlkp~Nil~~~~~--~~kl~DfG~a~ 135 (288)
...++|+|+++.|||++.++ .+.|.||+.+.
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 25699999999999998664 36899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0021 Score=55.13 Aligned_cols=30 Identities=17% Similarity=0.325 Sum_probs=24.7
Q ss_pred CCeEEeCCCCCCeeecC---CCc-eEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDD---KYC-AKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~---~~~-~kl~DfG~a~ 135 (288)
..++|+|+++.|||++. ++. +.|.||+.+.
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 35699999999999987 344 5899999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0094 Score=48.24 Aligned_cols=129 Identities=11% Similarity=0.053 Sum_probs=81.8
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeeeccccCCCCCC-
Q 044995 78 ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN- 156 (288)
Q Consensus 78 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~a- 156 (288)
..++++++++.++.|.+.+|.-+-.. ..+ ..+=+.|..|++..+|.+.+.+ +.+.. . ......+....
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~~----~----~~~~~~pe~~~~ 111 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADDA----G----EPPPVAGKLGYS 111 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------------CCSSS
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-ccccc----c----ccCCCChhhccc
Confidence 35899999999999999998776210 011 1223446889999999888774 22110 0 00011111110
Q ss_pred --hh--hHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHHHhcCC-------------------------CCCCCCC
Q 044995 157 --PD--DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNP-------------------------SGKKRPA 207 (288)
Q Consensus 157 --PE--DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~li~~cl~~-------------------------~p~~Rp~ 207 (288)
-| -|||||+++|.-+--..| .+.+...+..+..||..|... .+..|++
T Consensus 112 ~~te~~~IysLG~tLY~ALDygL~---e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~s 188 (229)
T 2yle_A 112 QCMETEVIESLGIIIYKALDYGLK---ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRS 188 (229)
T ss_dssp SSCHHHHHHHHHHHHHHHHTTTCC---TTEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCS
T ss_pred cchHHHHHHHHHHHHHHHhhcCCC---cccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCC
Confidence 12 799999999999875544 234556788999999988765 2467889
Q ss_pred HHHHHHHHHhchh
Q 044995 208 MKEVASELAGIKA 220 (288)
Q Consensus 208 ~~~i~~~l~~~~~ 220 (288)
+++|++.-+....
T Consensus 189 l~~Vi~~C~~hl~ 201 (229)
T 2yle_A 189 YRDVMKLCAAHLP 201 (229)
T ss_dssp HHHHHHHHHTTSS
T ss_pred HHHHHHHHHhhcc
Confidence 9999887765543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0084 Score=49.90 Aligned_cols=28 Identities=18% Similarity=0.323 Sum_probs=24.9
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
++|+|+.+.|||++..+.+-|.||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 7999999999999887777899999775
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.013 Score=50.35 Aligned_cols=31 Identities=26% Similarity=0.273 Sum_probs=27.7
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999877889999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.046 Score=46.32 Aligned_cols=28 Identities=21% Similarity=0.151 Sum_probs=23.6
Q ss_pred CeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 107 ~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.++|+|+.+.||+ ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3799999999999 556678999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.051 Score=46.67 Aligned_cols=31 Identities=23% Similarity=0.355 Sum_probs=26.9
Q ss_pred CCCeEEeCCCCCCeeecCC----CceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDK----YCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~----~~~kl~DfG~a~ 135 (288)
...++|+|+.+.||+++.+ +.+.|.||+.+.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 5679999999999999764 678999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.038 Score=49.32 Aligned_cols=30 Identities=13% Similarity=0.243 Sum_probs=27.0
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+++.|||++.++ ++|.||+.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 67899999999999998766 9999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.63 E-value=0.056 Score=46.07 Aligned_cols=31 Identities=13% Similarity=0.177 Sum_probs=26.2
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3578999999999999877666899998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=91.45 E-value=0.39 Score=40.17 Aligned_cols=37 Identities=11% Similarity=-0.019 Sum_probs=28.0
Q ss_pred CcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN 55 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~ 55 (288)
...-.+.+|.|..+.||+.+.. ...|..|++.|+.|.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 4555678999999999997631 235788999888774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=91.04 E-value=0.065 Score=46.41 Aligned_cols=31 Identities=16% Similarity=0.143 Sum_probs=25.9
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++++..+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 3568999999999999864457899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.61 E-value=0.24 Score=42.13 Aligned_cols=29 Identities=24% Similarity=0.310 Sum_probs=25.2
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+++.|||++ + .+.|+||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 45689999999999998 4 78999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.81 E-value=0.21 Score=43.45 Aligned_cols=30 Identities=23% Similarity=0.457 Sum_probs=24.5
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++.++ +.|+||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 34689999999999997654 8999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.94 E-value=0.25 Score=43.39 Aligned_cols=30 Identities=17% Similarity=0.225 Sum_probs=25.3
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.||+++.+ .++|.||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 4678999999999999765 48999997764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=86.83 E-value=0.2 Score=43.26 Aligned_cols=31 Identities=16% Similarity=0.336 Sum_probs=27.0
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 3568999999999999877789999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=85.18 E-value=0.28 Score=43.86 Aligned_cols=30 Identities=27% Similarity=0.366 Sum_probs=23.9
Q ss_pred CCeEEeCCCCCCeeecCC----------------------------CceEEecccCcc
Q 044995 106 VPIYHRDIKSTNILLDDK----------------------------YCAKVSNFGTSR 135 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~~~----------------------------~~~kl~DfG~a~ 135 (288)
..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 458999999999999764 678899997764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=84.56 E-value=0.42 Score=43.20 Aligned_cols=16 Identities=31% Similarity=0.503 Sum_probs=14.6
Q ss_pred CCeEEeCCCCCCeeec
Q 044995 106 VPIYHRDIKSTNILLD 121 (288)
Q Consensus 106 ~~iiHrdlkp~Nil~~ 121 (288)
..++|+|+.+.|||++
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 4689999999999998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=82.82 E-value=0.5 Score=41.54 Aligned_cols=31 Identities=32% Similarity=0.384 Sum_probs=26.4
Q ss_pred CCCeEEeCCCCCCeeecCC----CceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDK----YCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~----~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3468999999999999765 689999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 288 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-23 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-21 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-20 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-19 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-40
Identities = 56/274 (20%), Positives = 97/274 (35%), Gaps = 68/274 (24%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQI 54
+ E V + +G G VYKG ++ F NEV + +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 55 NHINVVKLIGCCLE------TKYM-------HDQNKELPFTWEMQLRISIEASGTMSYLH 101
H+N++ +G T++ H E F + I+ + + M YLH
Sbjct: 62 RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-THITTQVHGTFGYLNPD-- 158
I HRD+KS NI L + K+ +FG + ++ +H Q+ G+ ++ P+
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 159 ------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH------------- 193
DV +FG+VL EL+TG P + V +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 194 -------AKRCLNPSGKKRPAMKEVASELAGIKA 220
CL +RP ++ + + +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-37
Identities = 40/255 (15%), Positives = 84/255 (32%), Gaps = 60/255 (23%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVK 61
++ + LG G V+ G + F+ E + Q+ H +V+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 62 LIGCCLETKY--------------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
L + + T L ++ + + M+++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
HRD+++ NIL+ D K+++FG +R ++ + P+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEED--KNIT--------------VAKHAKRCLNP 200
DV SFG++L E++T + + +N+ + + + C
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 201 SGKKRPAMKEVASEL 215
+ RP + S L
Sbjct: 250 RPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-36
Identities = 42/255 (16%), Positives = 81/255 (31%), Gaps = 60/255 (23%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVK 61
+S + LGQG V+ G E F+ E + ++ H +V+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 62 LIGCCLETKY--------------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
L E + ++ + + M+Y+ +
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
HRD+++ NIL+ + KV++FG +R ++ + P+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 159 --DVCSFGVVLVELLTGAKP--------------IRFTTFEEDKNIT--VAKHAKRCLNP 200
DV SFG++L EL T + R + +C
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 253
Query: 201 SGKKRPAMKEVASEL 215
++RP + + + L
Sbjct: 254 EPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (316), Expect = 4e-35
Identities = 51/278 (18%), Positives = 93/278 (33%), Gaps = 62/278 (22%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGM-----------------AKVEKFINEVVIQSQI 54
+ E + LG G VY+G+ +VE+F+ E + +I
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 55 NHINVVKLIGCCLETKYMH---------------DQNKELPFTWEMQLRISIEASGTMSY 99
H N+V+L+G C + + + + L ++ + S M Y
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPDD 159
L HRD+ + N L+ + + KV++FG SR D + P+
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 160 -----------VCSFGVVLVELLTGAKPIRFTT--------------FEEDKNIT--VAK 192
V +FGV+L E+ T E + V +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 193 HAKRCLNPSGKKRPAMKEVASELAGIKAWNGASNVMEE 230
+ C + RP+ E+ + + S+ +E+
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-34
Identities = 49/260 (18%), Positives = 94/260 (36%), Gaps = 66/260 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGM--------------AKVEKFINEVVIQSQINHINVVKLI 63
+ + +G+G V G A + F+ E + +Q+ H N+V+L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 64 GCCLETK-----------------YMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASV 106
G +E K Y+ + + + L+ S++ M YL
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------- 158
HRD+ + N+L+ + AKVS+FG ++ + + + P+
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEED--KNIT--------------VAKHAKRCLN 199
DV SFG++L E+ + + +D + V + K C +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 200 PSGKKRPAMKEVASELAGIK 219
RP+ ++ +L IK
Sbjct: 239 LDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-34
Identities = 50/258 (19%), Positives = 89/258 (34%), Gaps = 60/258 (23%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVK 61
+ +G G +V+ G E FI E + +++H +V+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 62 LIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
L G CLE + + + + F E L + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM---CLDVCEGMAYLEEAC 121
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
+ HRD+ + N L+ + KVS+FG +R DQ +T + +P+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEED--KNIT--------------VAKHAKRCLNP 200
DV SFGV++ E+ + K + ++I+ V + C
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 201 SGKKRPAMKEVASELAGI 218
+ RPA + +LA I
Sbjct: 242 RPEDRPAFSRLLRQLAEI 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-34
Identities = 50/269 (18%), Positives = 90/269 (33%), Gaps = 65/269 (24%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVV 49
+ E + + R +G+G V++G+ EKF+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 50 IQSQINHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGT 96
Q +H ++VKLIG E Q ++ + + + S
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
++YL S HRDI + N+L+ C K+ +FG SR + ++ ++
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH------------ 193
P+ DV FGV + E+L D +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 194 ----AKRCLNPSGKKRPAMKEVASELAGI 218
+C +RP E+ ++L+ I
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 7e-34
Identities = 48/259 (18%), Positives = 88/259 (33%), Gaps = 68/259 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVK 61
+ LG G +V G + ++FI E + ++H +V+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 62 LIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
L G C + + + + + F + L + + M YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
HRD+ + N L++D+ KVS+FG SR D+ + + P+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH--------------------AKR 196
D+ +FGV++ E+ + K +E N A+H
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 197 CLNPSGKKRPAMKEVASEL 215
C + +RP K + S +
Sbjct: 237 CWHEKADERPTFKILLSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-33
Identities = 56/271 (20%), Positives = 96/271 (35%), Gaps = 69/271 (25%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVI 50
E +++G G VYKGM K F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 51 QSQINHINVVKLIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGT 96
Q +H N+++L G + K M + K+ F+ + + +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ--THITTQVHGTFGY 154
M YL ++ HRD+ + NIL++ KVS+FG SR D T+ T+ +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 155 LNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEED--KNIT------------ 189
P+ DV SFG+V+ E++T + + + K I
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 190 --VAKHAKRCLNPSGKKRPAMKEVASELAGI 218
+ + +C +RP ++ S L +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 3e-33
Identities = 49/268 (18%), Positives = 93/268 (34%), Gaps = 48/268 (17%)
Query: 13 LEKATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQ 53
+E D F LG G +V+K K + I E+ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 54 INHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGTMSYL 100
N +V G + K ++ ++SI ++YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-- 158
I HRD+K +NIL++ + K+ +FG S + + + V GT Y++P+
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFV-GTRSYMSPERL 175
Query: 159 ---------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMK 209
D+ S G+ LVE+ G PI +E + + + + R +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 210 EVASELAGIKAWNGASNVMEEGILGRAP 237
++S + +++ + P
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPP 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 4e-33
Identities = 52/297 (17%), Positives = 92/297 (30%), Gaps = 91/297 (30%)
Query: 6 KLFIS----NELEKATDSFN---------VNRILGQGGQDIVYKGMAK------------ 40
K+FI + +A F + +++G G V G K
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60
Query: 41 ----------VEKFINEVVIQSQINHINVVKLIGCCLETKY--------------MHDQN 76
F++E I Q +H NV+ L G ++ +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 77 KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
+ FT + + + M YL + HRD+ + NIL++ KVS+FG SR
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 137 RAVDQTHITT----QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT 181
D + T + P+ DV S+G+V+ E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---- 233
Query: 182 FEEDKNITVAKH--------------------AKRCLNPSGKKRPAMKEVASELAGI 218
+ + N V C RP ++ + L +
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-33
Identities = 54/271 (19%), Positives = 100/271 (36%), Gaps = 78/271 (28%)
Query: 21 NVNRILGQGGQDIVYKGM----------------------AKVEKFINEVVIQSQINHIN 58
+ N ++G+G VY G +V +F+ E +I +H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 59 VVKLIGCCLETK---------------YMHDQNKELPFTWEMQLRISIEASGTMSYLHLS 103
V+ L+G CL ++ +N+ T + + ++ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ---VAKGMKFL 146
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR---SRAVDQTHITTQVHGTFGYLNPD-- 158
AS HRD+ + N +LD+K+ KV++FG +R + D H T ++ +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 159 ---------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH---------------- 193
DV SFGV+L EL+T P + + + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 194 ----AKRCLNPSGKKRPAMKEVASELAGIKA 220
+C +P + RP+ E+ S ++ I +
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-33
Identities = 42/257 (16%), Positives = 92/257 (35%), Gaps = 69/257 (26%)
Query: 20 FNVNRILGQGGQDIVYKGM--------------------AKVEKFINEVVIQSQINHINV 59
+ +G+G VYKG+ ++ ++F E + + H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 60 VKLIGCC-----------LETKYM------HDQNKELPFTWEMQLRISIEASGTMSYLHL 102
V+ L T+ M + ++ + + +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH- 129
Query: 103 SASVPIYHRDIKSTNILLDDKYC-AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--- 158
+ + PI HRD+K NI + K+ + G + + + V GT ++ P+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 159 -------DVCSFGVVLVELLTGAKP-----------------IRFTTFEEDKNITVAKHA 194
DV +FG+ ++E+ T P ++ +F++ V +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 195 KRCLNPSGKKRPAMKEV 211
+ C+ + +R ++K++
Sbjct: 247 EGCIRQNKDERYSIKDL 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-32
Identities = 57/253 (22%), Positives = 88/253 (34%), Gaps = 65/253 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINH 56
+ F + R LG+G VY K + EV IQS + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 57 INVVKLIGCCLETKYMHDQNKELP-------------FTWEMQLRISIEASGTMSYLHLS 103
N+++L G + ++ + P F + E + +SY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S + HRDIK N+LL K+++FG S + + GT YL P+
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGR 179
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH--------------AKRCL 198
D+ S GV+ E L G P T++E R L
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 199 NPSGKKRPAMKEV 211
+ +RP ++EV
Sbjct: 240 KHNPSQRPMLREV 252
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-31
Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 67/257 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHIN 58
+ +++ + LG+G V + + E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 59 VVKLIGCC-------LETKYMHDQN------KELPFTWEMQLRISIEASGTMSYLHLSAS 105
VVK G L +Y ++ R + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 121
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRS-RAVDQTHITTQVHGTFGYLNPD------ 158
+ I HRDIK N+LLD++ K+S+FG + R ++ + ++ GT Y+ P+
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA------------------ 194
DV S G+VL +L G + + + + K
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 195 KRCLNPSGKKRPAMKEV 211
+ L + R + ++
Sbjct: 241 HKILVENPSARITIPDI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-31
Identities = 50/272 (18%), Positives = 90/272 (33%), Gaps = 75/272 (27%)
Query: 12 ELEKATDSFNV-NRILGQGGQDIVYKGMAK---------------------VEKFINEVV 49
+L D+ + + LG G V +G+ + E+ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 50 IQSQINHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGT 96
I Q+++ +V+LIG C M K + + S
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHIT--TQVHGTFGY 154
M YL HRD+ + N+LL +++ AK+S+FG S++ D ++ T + +
Sbjct: 122 MKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 155 LNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH---------- 193
P+ DV S+GV + E L+ + +++ K V
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRMECP 234
Query: 194 ----------AKRCLNPSGKKRPAMKEVASEL 215
C + RP V +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-31
Identities = 41/273 (15%), Positives = 94/273 (34%), Gaps = 76/273 (27%)
Query: 15 KATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQ 51
K T+ F ++LG G VYKG+ ++ ++E +
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 52 SQINHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGTMS 98
+ +++ +V +L+G CL + + + + + L ++ + M+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNP 157
YL + HRD+ + N+L+ K+++FG ++ ++ + ++
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 158 D-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH------------- 193
+ DV S+GV + EL+T ++ ++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPIC 238
Query: 194 -------AKRCLNPSGKKRPAMKEVASELAGIK 219
+C RP +E+ E + +
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-30
Identities = 46/261 (17%), Positives = 85/261 (32%), Gaps = 68/261 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKGM--------------------AKVEKFINEVVIQSQINHI 57
+ + V +G G K A+ + ++EV + ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 58 NVVKLIGCCLE---------TKYM----------HDQNKELPFTWEMQLRISIEASGTMS 98
N+V+ ++ +Y + E LR+ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 99 YLHL--SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
H + HRD+K N+ LD K K+ +FG +R T GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMS 182
Query: 157 PD-----------DVCSFGVVLVELLTGAKPI---------------RFTTFEEDKNITV 190
P+ D+ S G +L EL P +F + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 191 AKHAKRCLNPSGKKRPAMKEV 211
+ R LN RP+++E+
Sbjct: 243 NEIITRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-30
Identities = 48/260 (18%), Positives = 86/260 (33%), Gaps = 74/260 (28%)
Query: 23 NRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVV 60
++ LG G V KG + ++ + E + Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 61 KLIGCCLETKYM------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPI 108
++IG C +M + + + + + S M YL S
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVH--GTFGYLNPD-------- 158
HRD+ + N+LL ++ AK+S+FG S++ D+ + Q H + P+
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH--------------------AK 195
DV SFGV++ E + + + K V
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244
Query: 196 RCLNPSGKKRPAMKEVASEL 215
C + RP V L
Sbjct: 245 LCWTYDVENRPGFAAVELRL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-30
Identities = 48/260 (18%), Positives = 84/260 (32%), Gaps = 69/260 (26%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHIN 58
D + + LG G VYK K +E ++ E+ I + +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 59 VVKLIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSA 104
+VKL+ + E P T + + ++YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD------ 158
I HRD+K+ NIL K+++FG S + + GT ++ P+
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 186
Query: 159 ----------DVCSFGVVLVELLTGAKP-------------IRFTTFEEDKNITVAKHAK 195
DV S G+ L+E+ P + + + + K
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 196 ----RCLNPSGKKRPAMKEV 211
+CL + R ++
Sbjct: 247 DFLKKCLEKNVDARWTTSQL 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-30
Identities = 45/269 (16%), Positives = 80/269 (29%), Gaps = 78/269 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQ 53
+ LG G +V +G ++ FI EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 54 INHINVVKLIGCCLE------TKYM-------HDQNKELPFTWEMQLRISIEASGTMSYL 100
++H N+++L G L T+ + + F R +++ + M YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH--ITTQVHGTFGYLNPD 158
S HRD+ + N+LL + K+ +FG R+ + H + F + P+
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH-------------- 193
D FGV L E+ T + + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP----WIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 194 -------AKRCLNPSGKKRPAMKEVASEL 215
+C + RP + L
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-30
Identities = 53/253 (20%), Positives = 89/253 (35%), Gaps = 62/253 (24%)
Query: 17 TDSFNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQSQINHIN 58
+ +GQG VY K E INE+++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 59 VVKLIGCCLETKYM------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASV 106
+V + L + D E + E + +LH S
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SN 135
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------- 158
+ HRDIKS NILL K+++FG +Q+ +T V GT ++ P+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 159 ---DVCSFGVVLVELLTGAKP-------------IRFTTFEEDKNITVAKHAK----RCL 198
D+ S G++ +E++ G P T E ++ + RCL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 199 NPSGKKRPAMKEV 211
+ +KR + KE+
Sbjct: 255 DMDVEKRGSAKEL 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (282), Expect = 5e-30
Identities = 48/296 (16%), Positives = 91/296 (30%), Gaps = 92/296 (31%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINE 47
LE ++ R +G+G V++ A F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 48 VVIQSQINHINVVKLIGCC-------------------------------------LETK 70
+ ++ ++ N+VKL+G C L T+
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 71 YMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSN 130
P + QL I+ + + M+YL HRD+ + N L+ + K+++
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 131 FGTSRS-RAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPI- 177
FG SR+ + D ++ P+ DV ++GVVL E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 178 ---------------RFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGI 218
E+ + + + C + RP+ + L +
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 2e-29
Identities = 51/271 (18%), Positives = 89/271 (32%), Gaps = 75/271 (27%)
Query: 5 TKLFISNELEKATDSFNVNRILGQGGQDIVYKGM---------------------AKVEK 43
+LF ++ EK F+ R +G G VY K +
Sbjct: 5 AELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 44 FINEVVIQSQINHINVVKLIGCCLETKYMH-------------DQNKELPFTWEMQLRIS 90
I EV ++ H N ++ GC L + + P ++
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 91 IEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHG 150
A ++YLH S + HRD+K+ NILL + K+ +FG++ G
Sbjct: 122 HGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANSFVG 173
Query: 151 TFGYLNPD--------------DVCSFGVVLVELLTGAKP------------IRFTTFEE 184
T ++ P+ DV S G+ +EL P I
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233
Query: 185 DKNITVAKHAK----RCLNPSGKKRPAMKEV 211
++ +++ + CL + RP + +
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-29
Identities = 54/302 (17%), Positives = 96/302 (31%), Gaps = 88/302 (29%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKG------------------------ 37
I T+L ++ E + + + LG G V +
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 38 MAKVEKFINEVVIQSQI-NHINVVKLIGCCLETKYMH----------------------- 73
+ + E ++E+ + S + NH+N+V L+G C
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 74 --------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125
++ EL E L S + + M++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRI 183
Query: 126 AKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG 173
K+ +FG +R D + + ++ P+ DV S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 174 AKPIRFTTFEEDKNITVAKH-----------------AKRCLNPSGKKRPAMKEVASELA 216
+ K + K K C + KRP K++ +
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 217 GI 218
Sbjct: 304 KQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-29
Identities = 46/306 (15%), Positives = 95/306 (31%), Gaps = 95/306 (31%)
Query: 2 IKKTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK--------------------- 40
+ + + E ++ ++LG G V A
Sbjct: 21 VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80
Query: 41 ---VEKFINEVVIQSQI-NHINVVKLIGCCLET----------------KYMHDQNKEL- 79
E ++E+ + +Q+ +H N+V L+G C + Y+ + ++
Sbjct: 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 80 -------------------PFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILL 120
T+E L + + + M +L HRD+ + N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLV 197
Query: 121 DDKYCAKVSNFGTSRSRAVDQTHIT-TQVHGTFGYLNPD-----------DVCSFGVVLV 168
K+ +FG +R D ++ ++ P+ DV S+G++L
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257
Query: 169 ELLTGAKPIRFTTFEEDKNI------------------TVAKHAKRCLNPSGKKRPAMKE 210
E+ + + D N + + C +KRP+
Sbjct: 258 EIFSLGVNP-YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 211 VASELA 216
+ S L
Sbjct: 317 LTSFLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-28
Identities = 39/288 (13%), Positives = 79/288 (27%), Gaps = 92/288 (31%)
Query: 24 RILGQGGQDIVYKGM---------------AKVEKFINEVVIQSQINHINVVKLIGCCLE 68
+G+G V++G + E+ + H N++ I +
Sbjct: 9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 69 -----------TKYM-----HDQNKELPFTWEMQLRISIEASGTMSYLHLSA-----SVP 107
+ Y D T E +++++ + +++LH+
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI---TTQVHGTFGYLNPD------ 158
I HRD+KS NIL+ +++ G + I GT Y+ P+
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188
Query: 159 -----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNIT------------------ 189
D+ + G+V E+ +
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248
Query: 190 ------------------VAKHAKRCLNPSGKKRPAMKEVASELAGIK 219
+AK + C +G R + L+ +
Sbjct: 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 45/279 (16%), Positives = 90/279 (32%), Gaps = 83/279 (29%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-N 55
+ ++G+G V K K F E+ + ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 56 HINVVKLIGCC-----------------------------LETKYMHDQNKELPFTWEMQ 86
H N++ L+G C + + + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
L + + + M YL HRD+ + NIL+ + Y AK+++FG SR + V T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP--------------IRFTT 181
++ + DV S+GV+L E+++ +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 182 FEEDKNIT--VAKHAKRCLNPSGKKRPAMKEVASELAGI 218
E+ N V ++C +RP+ ++ L +
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 3e-26
Identities = 52/286 (18%), Positives = 91/286 (31%), Gaps = 89/286 (31%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQ 53
D + + LG+G V + A ++E+ I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 54 INH-INVVKLIGCCLET-----------------KYMHDQNKEL-------------PFT 82
I H +NVV L+G C + Y+ + E T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 83 WEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142
E + S + + M +L S HRD+ + NILL +K K+ +FG +R D
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 143 HI-TTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNIT- 189
++ ++ P+ DV SFGV+L E+ + + + D+
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR 248
Query: 190 -----------------VAKHAKRCLNPSGKKRPAMKEVASELAGI 218
+ + C + +RP E+ L +
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-25
Identities = 48/258 (18%), Positives = 88/258 (34%), Gaps = 63/258 (24%)
Query: 14 EKATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQS 52
+K + F +ILG+G V V E + S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 53 QINHINVVKLIGCCLETKY-------------MHDQNKELPFTWEMQLRISIEASGTMSY 99
+++H VKL + + + K F + E + Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD-QTHITTQVHGTFGYLNPD 158
LH I HRD+K NILL++ ++++FGT++ + + + GT Y++P+
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 159 -----------DVCSFGVVLVELLTGAKPIR-FTTFEEDKNIT---------VAKHAK-- 195
D+ + G ++ +L+ G P R + + I A+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
Query: 196 --RCLNPSGKKRPAMKEV 211
+ L KR +E+
Sbjct: 241 VEKLLVLDATKRLGCEEM 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 99.4 bits (247), Expect = 3e-25
Identities = 55/277 (19%), Positives = 96/277 (34%), Gaps = 75/277 (27%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQIN 55
+D + + ILG GG V+ +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 56 HINVVKLIGCCLE-----------TKYM------HDQNKELPFTWEMQLRISIEASGTMS 98
H +V + +Y+ + E P T + + + +A ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 99 YLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI--TTQVHGTFGYLN 156
+ H I HRD+K NI++ KV +FG +R+ A + T V GT YL+
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 157 PD-----------DVCSFGVVLVELLTGAKPI--------------RFTTFEEDKNITVA 191
P+ DV S G VL E+LTG P ++ ++
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 192 KHAK----RCLNPSGKKRP-AMKEVASELAGIKAWNG 223
+ L + + R E+ ++L ++ NG
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADL--VRVHNG 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 3e-25
Identities = 53/290 (18%), Positives = 106/290 (36%), Gaps = 78/290 (26%)
Query: 5 TKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------ 40
+++ +E E A + ++R LGQG +VY+G+AK
Sbjct: 7 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66
Query: 41 VEKFINEVVIQSQINHINVVKLIGCCLETKYMH-----------------------DQNK 77
+F+NE + + N +VV+L+G + + +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126
Query: 78 ELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS- 136
P + ++++ E + M+YL+ + HRD+ + N ++ + + K+ +FG +R
Sbjct: 127 LAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183
Query: 137 RAVDQTHITTQVHGTFGYLNP-----------DDVCSFGVVLVELLTGAKPI-------- 177
D + +++P DV SFGVVL E+ T A+
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 178 --------RFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219
++ + + + C + K RP+ E+ S +
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 99.8 bits (248), Expect = 8e-25
Identities = 37/257 (14%), Positives = 77/257 (29%), Gaps = 68/257 (26%)
Query: 18 DSFNVNRILGQGGQDIVYKG------------------MAKVEKFINEVVIQSQINHINV 59
D ++++ LG G +V++ + E E+ S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 60 VKLIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
V L + M ++ + + + + + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 106 VPIYHRDIKSTNILLDDKYC--AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
H D+K NI+ K K+ +FG + +D GT + P+
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAK--- 195
D+ S GV+ LL+G P ++ +++ K
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 196 -RCLNPSGKKRPAMKEV 211
+ L R + +
Sbjct: 261 RKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 98.2 bits (244), Expect = 2e-24
Identities = 43/255 (16%), Positives = 82/255 (32%), Gaps = 64/255 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAKV------------------EKFINEVVIQSQINHINV 59
D +++ LG G +V++ + K NE+ I +Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 60 VKLIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSAS 105
+ L + M ++ + + +A + ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 106 VPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP-------- 157
I H DIK NI+ + K + V + ++ I T + P
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 158 ---DDVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAK----R 196
D+ + GV+ LL+G P F+ED +V+ AK
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 197 CLNPSGKKRPAMKEV 211
L +KR + +
Sbjct: 266 LLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 3e-24
Identities = 38/254 (14%), Positives = 73/254 (28%), Gaps = 63/254 (24%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVV 60
+ + + LG+G IV++ + E+ I + H N++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 61 KLIGCCLETKYM--------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASV 106
L + + + + + +LH S
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SH 121
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-------- 158
I H DI+ NI+ + + + ++R + + Y P+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 159 ---DVCSFGVVLVELLTGAKPIRFT--------------TFEEDKNITVAKHAK----RC 197
D+ S G ++ LL+G P TF+E+ ++ A R
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 198 LNPSGKKRPAMKEV 211
L K R E
Sbjct: 242 LVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.1 bits (241), Expect = 4e-24
Identities = 48/258 (18%), Positives = 91/258 (35%), Gaps = 67/258 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINH 56
F + R LG G V+ ++ VE +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 57 INVVKLIGCCLETKYMHDQNKELP-------------FTWEMQLRISIEASGTMSYLHLS 103
++++ G + + + + F + + E + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-- 121
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S I +RD+K NILLD K+++FG ++ +T + GT Y+ P+
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTK 176
Query: 159 ------DVCSFGVVLVELLTGAKPIR-FTTFEEDKNITVAKHA-------------KRCL 198
D SFG+++ E+L G P T + + I A+ R +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236
Query: 199 NPSGKKRP-AMKEVASEL 215
+R ++ ++
Sbjct: 237 TRDLSQRLGNLQNGTEDV 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.3 bits (234), Expect = 3e-23
Identities = 45/261 (17%), Positives = 77/261 (29%), Gaps = 63/261 (24%)
Query: 12 ELEKATDSFNVNRILGQGGQDIVYKGM-------------------AKVEKFINEVVIQS 52
+ E D ++ +LG G V K NE+ +
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 53 QINHINVVKLIGCCLETK-------YMHDQN------KELPFTWEMQLRISIEASGTMSY 99
+I H N+V L + ++ +T R+ + + Y
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 100 LHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD- 158
LH V + LD+ +S+FG S+ D + + GT GY+ P+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEV 180
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHA 194
D S GV+ LL G P F+ ++ A
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 195 K----RCLNPSGKKRPAMKEV 211
K + +KR ++
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 6e-23
Identities = 51/287 (17%), Positives = 92/287 (32%), Gaps = 87/287 (30%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQ 51
D + + LG+G V A + I+E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 52 SQI-NHINVVKLIGCCLETKYMH-----------------------------DQNKELPF 81
I H N++ L+G C + ++ N E
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 82 TWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141
+ + + + + + M YL S HRD+ + N+L+ + K+++FG +R
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 142 THITTQV-HGTFGYLNPD-----------DVCSFGVVLVELLTGAK-PIRFTTFEEDKNI 188
+ T ++ P+ DV SFGV+L E+ T P EE +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 189 TVAKH---------------AKRCLNPSGKKRPAMKEVASELAGIKA 220
H + C + +RP K++ +L I A
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 92.4 bits (229), Expect = 1e-22
Identities = 55/270 (20%), Positives = 92/270 (34%), Gaps = 81/270 (30%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------------VEKFINEVVI 50
+++ ILG+G +V + + K E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 51 QSQIN-HINVVKLIGCC-------LETKYMHDQN------KELPFTWEMQLRISIEASGT 96
+++ H N+++L L M +++ + + +I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ LH + I HRD+K NILLDD K+++FG S +D +V GT YL
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPSYLA 177
Query: 157 PD-----------------DVCSFGVVLVELLTGAKPIRFTT--------------FEED 185
P+ D+ S GV++ LL G+ P F
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 186 KNITVAKHAK----RCLNPSGKKRPAMKEV 211
+ + K R L +KR +E
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-22
Identities = 48/253 (18%), Positives = 83/253 (32%), Gaps = 64/253 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEV-VIQSQIN 55
+ F ++++LG+G V+ K VE + E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 56 HINVVKLIGCCLETKYM-----HDQNKEL--------PFTWEMQLRISIEASGTMSYLHL 102
H + + + + + +L F + E + +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH- 120
Query: 103 SASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---- 158
S I +RD+K NILLD K+++FG + + T GT Y+ P+
Sbjct: 121 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 159 -------DVCSFGVVLVELLTGAKP------------IRFTTFEEDKNITVAKHA--KRC 197
D SFGV+L E+L G P IR + + +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 198 LNPSGKKRPAMKE 210
+KR ++
Sbjct: 238 FVREPEKRLGVRG 250
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 3e-22
Identities = 45/206 (21%), Positives = 80/206 (38%), Gaps = 50/206 (24%)
Query: 18 DSFNVNRILGQGGQDIVYKG-------------MAKVEKFIN-EVVIQSQINHINVVKLI 63
S+ +++G G +VY+ + + ++F N E+ I +++H N+V+L
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 64 GCC-------------LETKYM---------HDQNKELPFTWEMQLRISIEASGTMSYLH 101
L Y+ H + + +++Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 102 LSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQTHITT----------QVHG 150
S I HRDIK N+LLD D K+ +FG+++ + +++ + G
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 151 TFGYLNPDDVCSFGVVLVELLTGAKP 176
Y + DV S G VL ELL G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.7 bits (227), Expect = 8e-22
Identities = 40/262 (15%), Positives = 81/262 (30%), Gaps = 67/262 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQ 53
+ F+V+RI+G+GG VY + + S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 54 INHINVVKLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGTMSYL 100
+ +V + + + ++ F+ + E + ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 101 HLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT---------QVHGT 151
H + + +RD+K NILLD+ ++S+ G + + + H + +
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 152 FGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA----------------- 194
Y + D S G +L +LL G P R ++ I
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240
Query: 195 KRCLNPSGKKRP-AMKEVASEL 215
+ L +R + A E+
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 9e-22
Identities = 47/258 (18%), Positives = 84/258 (32%), Gaps = 77/258 (29%)
Query: 20 FNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN 55
+ V +LG GG VY G+ + EVV+ +++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 56 --HINVVKLIGCCLETKY--------------MHDQNKELPFTWEMQLRISIEASGTMSY 99
V++L+ + E+ + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 100 LHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP- 157
H + + HRDIK NIL+D ++ K+ +FG+ + + + T GT Y P
Sbjct: 126 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSPPE 179
Query: 158 -----------DDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA------------ 194
V S G++L +++ G P FE D+ I +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFFRQRVSSECQHL 234
Query: 195 -KRCLNPSGKKRPAMKEV 211
+ CL RP +E+
Sbjct: 235 IRWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-21
Identities = 43/247 (17%), Positives = 82/247 (33%), Gaps = 48/247 (19%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHI 57
++F +G+G +VYK K I E+ + ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 58 NVVKLIGCCLETKYMHDQNKELPFTWEMQLRISIE-----------ASGTMSYLHLSASV 106
N+VKL+ ++ + L + + S + L S
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 107 PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNP--------- 157
+ HRD+K N+L++ + K+++FG +R+ V T +V +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 158 --DDVCSFGVVLVELLTGAKPIRFTTFEEDKNI-TVAKHAKRCLNPSGKKRPAMKEVASE 214
D+ S G + E++T F D I + + + P P + +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRAL-----FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 215 LAGIKAW 221
W
Sbjct: 237 KPSFPKW 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-21
Identities = 32/217 (14%), Positives = 67/217 (30%), Gaps = 52/217 (23%)
Query: 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHI 57
+ +G+G +V ++ + E+ I + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 58 NVVKLIGCCLETKYMHDQN----------------KELPFTWEMQLRISIEASGTMSYLH 101
N++ + ++ K + + + + Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT--------------Q 147
S + HRD+K +N+LL+ K+ +FG +R D H
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 148 VHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEE 184
+ + GY D+ S G +L E+L+ + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 2e-21
Identities = 47/258 (18%), Positives = 76/258 (29%), Gaps = 64/258 (24%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINH 56
+ F+ ++LG+G V K V + E + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 57 INVVKLIGCCLETKYMHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLS 103
+ L + ++E FT E E +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI---VSALEYL 121
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S + +RDIK N++LD K+++FG + D GT YL P+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDN 180
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHA--------------KRCL 198
D GVV+ E++ G P E + + + L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 199 NPSGKKRP-AMKEVASEL 215
K+R A E+
Sbjct: 241 KKDPKQRLGGGPSDAKEV 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 9e-21
Identities = 54/264 (20%), Positives = 86/264 (32%), Gaps = 75/264 (28%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQ 53
D ++ LG G +V K K E EV I +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 54 INHINVVKLIGCCLETKY-------------MHDQNKELPFTWEMQLRISIEASGTMSYL 100
I H NV+ L ++ T E ++ +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF---LKQILNGV 126
Query: 101 HLSASVPIYHRDIKSTNILLDD----KYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLN 156
+ S+ I H D+K NI+L D K K+ +FG + +D + + GT ++
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPEFVA 184
Query: 157 PD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVA 191
P+ D+ S GV+ LL+GA P T FE++ +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 192 KHAK----RCLNPSGKKRPAMKEV 211
AK R L KKR +++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.3 bits (218), Expect = 1e-20
Identities = 46/258 (17%), Positives = 85/258 (32%), Gaps = 67/258 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINH 56
D F+ + LG G V K +E +NE I +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 57 INVVKLIGCCLETKYMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLS 103
+VKL + ++ + F+ + + T YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S+ + +RD+K N+L+D + +V++FG ++ T + GT L P+
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILSK 213
Query: 159 ------DVCSFGVVLVELLTGAKP------------IRFTTFEEDKNIT--VAKHAKRCL 198
D + GV++ E+ G P I + + + + L
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 199 NPSGKKR-PAMKEVASEL 215
KR +K +++
Sbjct: 274 QVDLTKRFGNLKNGVNDI 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-20
Identities = 44/235 (18%), Positives = 80/235 (34%), Gaps = 56/235 (23%)
Query: 24 RILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVV 60
LG+G VYK K + E+ + +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 61 KLIGCCLETKYM-------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
L+ + ++ L T + + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
I HRD+K N+LLD+ K+++FG ++S T QV T Y P+
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179
Query: 159 ---DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKE 210
D+ + G +L ELL + + + + + + P+ ++ P M
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWPDMCS 230
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 2e-20
Identities = 41/224 (18%), Positives = 70/224 (31%), Gaps = 59/224 (26%)
Query: 15 KATDSFNVNRILGQGGQDIVYKGM---------------------AKVEKFINEVVIQSQ 53
+A + +G+G V+K I EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 54 I---NHINVVKLIGCCLETKY-------------------MHDQNKELPFTWEMQLRISI 91
+ H NVV+L C ++ D+ E E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 92 EASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGT 151
+ + +LH S + HRD+K NIL+ K+++FG +R T V T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVT 178
Query: 152 FGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFEE 184
Y P+ D+ S G + E+ R ++ +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 85.7 bits (211), Expect = 4e-20
Identities = 36/235 (15%), Positives = 79/235 (33%), Gaps = 44/235 (18%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHIN 58
+ ++ +G+G +VYK I E+ I ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 59 VVKLIGCCLETKYMHDQNKELPFTWEMQLR----------ISIEASGTMSYLHLSASVPI 108
+VKL K + + L + L ++ + +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---------- 158
HRD+K N+L++ + K+++FG +R+ + T ++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 159 -DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEVA 212
D+ S G + E++ G + + + + + P+ K P + E+
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVTELP 232
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 3e-19
Identities = 44/257 (17%), Positives = 78/257 (30%), Gaps = 70/257 (27%)
Query: 22 VNRILGQGGQDIVYKG-------------MAKVEKFINEVVIQSQI-NHINVVKLIGC-- 65
+++LG G V + + K EV + + ++V+++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 66 ---------CLETKYMH--------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPI 108
+ + + + FT I + YLH S+ I
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132
Query: 109 YHRDIKSTNILLDDKYC---AKVSNFGTSRSRAVDQTHITTQ---------VHGTFGYLN 156
HRD+K N+L K K+++FG ++ + T V G Y
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 192
Query: 157 PDDVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNITVAKHAK--- 195
D+ S GV++ LL G P F + V++ K
Sbjct: 193 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 252
Query: 196 -RCLNPSGKKRPAMKEV 211
L +R + E
Sbjct: 253 RNLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (204), Expect = 3e-19
Identities = 34/235 (14%), Positives = 78/235 (33%), Gaps = 44/235 (18%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHI 57
+ +G+G V+K + + E+ + ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 58 NVVKLIGCCLETKYMH----------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVP 107
N+V+L K + + + + + L S
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--------- 158
+ HRD+K N+L++ K++NFG +R+ + + +V +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPAMKEV 211
D+ S G + EL +P+ +D + + + P+ ++ P+M ++
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPSMTKL 233
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 82.9 bits (204), Expect = 5e-19
Identities = 31/248 (12%), Positives = 70/248 (28%), Gaps = 55/248 (22%)
Query: 20 FNVNRILGQGGQDIVYKGM----------------AKVEKFINEVVIQSQINHINVVKLI 63
+ V R +G+G ++++G + + +E + + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 64 GCCLETK--------------YMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIY 109
+ F+ + + + + +H +
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 110 HRDIKSTNILLDDKYC-----AKVSNFGTSR------SRAVDQTHITTQVHGTFGYLNP- 157
+RDIK N L+ V +FG + ++ + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 158 ----------DDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPSGKKRPA 207
DD+ + G V + L G+ P + +K K+ P +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 208 MKEVASEL 215
E +
Sbjct: 244 FPEEFYKY 251
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 5e-19
Identities = 34/218 (15%), Positives = 69/218 (31%), Gaps = 52/218 (23%)
Query: 8 FISNELEKAT----DSFNVNRILGQGGQDIVYKGMAK--------------------VEK 43
F E+ K + + +G G V + ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 44 FINEVVIQSQINHINVVKLIGCC-------------LETKYMHDQNKEL----PFTWEMQ 86
E+ + + H NV+ L+ L +M +L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
+ + + Y+H + I HRD+K N+ +++ K+ +FG +R + T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180
Query: 147 --------QVHGTFGYLNPDDVCSFGVVLVELLTGAKP 176
+ Y D+ S G ++ E++TG
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 81.8 bits (201), Expect = 1e-18
Identities = 40/270 (14%), Positives = 73/270 (27%), Gaps = 75/270 (27%)
Query: 18 DSFNVNRILGQGGQDIVYKGM----------------AKVEKFINEVVIQSQINHINVVK 61
+ + + R +G G +Y G K + E I + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 62 LIGCCLETKYMHDQNKEL--------------PFTWEMQLRISIEASGTMSYLHLSASVP 107
I C + EL F+ + L ++ + + Y+H S
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 108 IYHRDIKSTNILLDDKYCAKV---SNFGTSRSRAVDQTHI------TTQVHGTFGYLNP- 157
HRD+K N L+ + +FG ++ +TH + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 158 ----------DDVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKH-------------- 193
DD+ S G VL+ G+ P + +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 194 --------AKRCLNPSGKKRPAMKEVASEL 215
C + +P +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 6e-18
Identities = 42/249 (16%), Positives = 86/249 (34%), Gaps = 63/249 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHI 57
+ +GQG V+K + + E+ I + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 58 NVVKLIGCCLETKYMHDQ---------------------NKELPFTWEMQLRISIEASGT 96
NVV LI C +++ N + FT R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 97 MSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT---HITTQVHGTFG 153
++ L+ I HRD+K+ N+L+ K+++FG +R+ ++ + + T T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 154 YLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAKRCLNPS 201
Y P+ D+ G ++ E+ T + ++ T + +A ++ C + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSIT 242
Query: 202 GKKRPAMKE 210
+ P +
Sbjct: 243 PEVWPNVDN 251
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 7e-17
Identities = 52/266 (19%), Positives = 81/266 (30%), Gaps = 68/266 (25%)
Query: 18 DSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQS 52
++F + ++LG G V+ E E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 53 QINHINVVKLIGCCLETKYMHDQNKELPFTWEMQLRIS-----------IEASGTMSYLH 101
I + + +T+ + E+ +S I + L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 102 LSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD--- 158
+ I +RDIK NILLD +++FG S+ D+T GT Y+ PD
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 159 ----------DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAKHAK------------- 195
D S GV++ ELLTGA P + + + K
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 196 -----RCLNPSGKKRP-AMKEVASEL 215
R L KKR A E+
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.4 bits (187), Expect = 1e-16
Identities = 37/216 (17%), Positives = 76/216 (35%), Gaps = 46/216 (21%)
Query: 18 DSFNVNRILGQGGQDIVYKGM---------------AKVEKFINEVVIQSQIN-HINVVK 61
D + + R LG+G V++ + K +K E+ I + N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 62 LIGCCLETK-------YMHDQNKEL-----PFTWEMQLRISIEASGTMSYLHLSASVPIY 109
L + + H N + T E + Y H S+ I
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIM 151
Query: 110 HRDIKSTNILLDDKYC-AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD---------- 158
HRD+K N+++D ++ ++ ++G + Q + + + P+
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDY 209
Query: 159 --DVCSFGVVLVELLTGAKPIRFTTFEEDKNITVAK 192
D+ S G +L ++ +P D+ + +AK
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (175), Expect = 6e-15
Identities = 36/212 (16%), Positives = 73/212 (34%), Gaps = 52/212 (24%)
Query: 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINV 59
+ + +G G Q IV ++ E+V+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 60 VKLIGCCLETKYMHD----------------QNKELPFTWEMQLRISIEASGTMSYLHLS 103
+ L+ K + + Q ++ E + + + +LH
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 104 ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD----- 158
S I HRD+K +NI++ K+ +FG +R+ + + T T Y P+
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM 193
Query: 159 ------DVCSFGVVLVELLTGAKPIRFTTFEE 184
D+ S G ++ E++ + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 9e-15
Identities = 39/226 (17%), Positives = 72/226 (31%), Gaps = 52/226 (23%)
Query: 8 FISNELEKA----TDSFNVNRILGQGGQDIVYKGMAK--------------------VEK 43
F EL K + + +G G V ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 44 FINEVVIQSQINHINVVKLIGCCLETKYMHDQN-----------------KELPFTWEMQ 86
E+ + + H NV+ L+ + + + N K T +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 87 LRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146
+ + + Y+H S I HRD+K +N+ +++ K+ +FG +R + T
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 147 --------QVHGTFGYLNPDDVCSFGVVLVELLTGAKPIRFTTFEE 184
+ Y D+ S G ++ ELLTG T +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 59.7 bits (143), Expect = 7e-11
Identities = 30/214 (14%), Positives = 55/214 (25%), Gaps = 57/214 (26%)
Query: 20 FNVNRILGQGGQDIVYKGMAKV-----------------EKFINEVVIQSQINHINVVKL 62
+ + R LG G V+ V E +E+ + ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 63 IGCCLE---------------------------TKYMHDQNKELPFTWEMQLRISIEASG 95
+ K + I
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 96 TMSYLHLSASVPIYHRDIKSTNILLD-DKYCAKVSNFGTSR-SRAVDQTHITTQVHGTFG 153
+ ++ I H DIK N+L++ + + A T T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 154 YLNPD-----------DVCSFGVVLVELLTGAKP 176
Y +P+ D+ S ++ EL+TG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.4 bits (117), Expect = 6e-08
Identities = 19/152 (12%), Positives = 44/152 (28%), Gaps = 41/152 (26%)
Query: 22 VNRILGQGGQDIVYKGMA--------KVEK-------------------FINEVVIQSQI 54
+ +++G+G + V+ + K K F + ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 55 NHINVVKLIGCCLETKYMHDQN----------KELPFTWEMQLRISIEASGTMSYLHLSA 104
+ KL G + Y + N + E + ++ +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY--- 120
Query: 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSRS 136
I H D+ N+L+ + + +F S
Sbjct: 121 HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 87.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 87.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 85.39 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=347.13 Aligned_cols=207 Identities=26% Similarity=0.459 Sum_probs=170.2
Q ss_pred HHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccc----
Q 044995 12 ELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETK---- 70 (288)
Q Consensus 12 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 70 (288)
||+...++|++.+.||+|+||.||+|+.+ .+.|.+|+++|++++|||||++++++.+..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv 81 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV 81 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEE
Confidence 45667789999999999999999999753 578999999999999999999999876542
Q ss_pred --cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 71 --YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 71 --~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
|+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 2211 123346899999999999999999999 8899999999999999999999999999998654322
Q ss_pred -ceeeeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc--------------------cchh
Q 044995 142 -THITTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF--------------------EEDK 186 (288)
Q Consensus 142 -~~~~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~--------------------~~~~ 186 (288)
........||+.||||| |||||||++|||+||+.||..... ....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 22334467999999999 999999999999999999964321 2234
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+.++.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 67899999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=342.31 Aligned_cols=201 Identities=24% Similarity=0.388 Sum_probs=158.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
.++|++.+.||+|+||+||+|.++ .+.|.+|+++|++++|||||+++|+|...+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356778899999999999999752 4579999999999999999999999876532
Q ss_pred ----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 211 122346899999999999999999999 889999999999999999999999999999865432
Q ss_pred Ccee----eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHH
Q 044995 141 QTHI----TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNIT 189 (288)
Q Consensus 141 ~~~~----~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~ 189 (288)
.... .....||+.||||| |||||||++|||+| |+.||.... .+...+.+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 2211 11235788999999 99999999999998 899985432 23355789
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+++.+||+.||++|||+.||++.|+++..
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9999999999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=338.39 Aligned_cols=207 Identities=20% Similarity=0.351 Sum_probs=172.8
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
++|+...++|++.+.||+|+||.||+|+++ .+.|.+|+++|++++|||||+++|+|.+...
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv 85 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYII 85 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEE
Confidence 566677789999999999999999999753 5789999999999999999999998865432
Q ss_pred ---cccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ---MHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ---l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+... .....+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 2111 11124899999999999999999999 889999999999999999999999999999876554
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCC-CCCC---------------CccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKP-IRFT---------------TFEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P-~~~~---------------~~~~~~~~~~~~l 193 (288)
.........||+.||||| |||||||++|||+||..| |... ..+...+.++.++
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 444444567899999999 999999999999996555 4321 1234567899999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+||+.||++|||+++|++.|+.+-.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999987643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=341.94 Aligned_cols=208 Identities=25% Similarity=0.358 Sum_probs=175.6
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
+++|+...++|++.+.||+|+||+||+|+++ .++|.+|+++|++++|||||+++++|.+.+.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 3567777889999999999999999999753 57899999999999999999999998765432
Q ss_pred -------cc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 73 -------HD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 73 -------~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 11 123346899999999999999999999 888999999999999999999999999999876
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCC-CC---------------CccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIR-FT---------------TFEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~-~~---------------~~~~~~~~~~ 190 (288)
............|++.|+||| |||||||++|||++|..||. .. ..+...+.++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 555444444556899999999 99999999999999766652 21 2234567899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+++.+||+.||++|||+.||++.|+.+..
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999987754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=334.87 Aligned_cols=196 Identities=24% Similarity=0.381 Sum_probs=164.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc---
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH--- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~--- 73 (288)
..++|++.+.||+|+||+||+|+++ .+.|.+|+++|++++|||||++++++.+.+.++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3578999999999999999999753 356889999999999999999999977653321
Q ss_pred ----------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc-
Q 044995 74 ----------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT- 142 (288)
Q Consensus 74 ----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~- 142 (288)
.......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 1223456899999999999999999999 88999999999999999999999999999986543322
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------chhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-----------------EDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~~~~~~l 193 (288)
......+||+.||||| |||||||++|||++|+.||...... ...+.++.++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 2234467999999999 9999999999999999999643321 2346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+||+.||++|||+.|++++
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=333.37 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=158.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------cc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKY-------MH 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------l~ 73 (288)
.++|++.+.||+|+||.||+|.++ .++|.+|++++++++|||||+++|+|...+. +.
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468999999999999999999752 5789999999999999999999999876532 21
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 1 123346889999999999999999999 888999999999999999999999999999866544433344
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhC-CCCCCCCC---------------ccchhHHHHHHHHHHhcC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTG-AKPIRFTT---------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg-~~P~~~~~---------------~~~~~~~~~~~li~~cl~ 199 (288)
...||+.|+||| |||||||++|||+|+ .+||.... .+...+.++.+++.+||+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHcc
Confidence 457899999999 999999999999995 55554222 233457889999999999
Q ss_pred CCCCCCCCHHHHHHHHHhchhh
Q 044995 200 PSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.||++|||++||+++|+++.++
T Consensus 241 ~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 241 ERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=330.94 Aligned_cols=192 Identities=30% Similarity=0.431 Sum_probs=164.7
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||+||+|+++ .+.+.+|++++++++|||||++++++.+.+.++..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999763 35688999999999999999999998776433211
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 1 2236899999999999999999999 8899999999999999999999999999998654332
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
.....||+.||||| |||||||++|||++|+.||...+ ++...+.++.+++.+|
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 23457999999999 99999999999999999996543 2344578999999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.||++|||+.|++++
T Consensus 239 L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TCSSGGGSCCHHHHHTC
T ss_pred ccCCHhHCcCHHHHHcC
Confidence 99999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=326.31 Aligned_cols=199 Identities=24% Similarity=0.393 Sum_probs=169.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEeccccc-------c
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM-------H 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l-------~ 73 (288)
.++|++.++||+|+||+||+|+++ .+.|++|++++++++|||||+++|+|.+.+.+ .
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 478999999999999999999853 57899999999999999999999998765322 1
Q ss_pred c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 74 D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 74 ~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
. ......+++..+.+++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 1 123346788999999999999999999 889999999999999999999999999999866554444444
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcC
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLN 199 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~ 199 (288)
...||+.|+||| |||||||++|||+| |+.||...+ .+...+.++.++|.+||+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHcc
Confidence 456899999999 99999999999998 899996433 334457889999999999
Q ss_pred CCCCCCCCHHHHHHHHHhc
Q 044995 200 PSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 200 ~~p~~Rp~~~~i~~~l~~~ 218 (288)
.||++|||+++|+++|.++
T Consensus 240 ~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 240 EKADERPTFKILLSNILDV 258 (258)
T ss_dssp SSGGGSCCHHHHHHHHHCC
T ss_pred CCHhHCcCHHHHHHHhhCC
Confidence 9999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=334.30 Aligned_cols=206 Identities=26% Similarity=0.406 Sum_probs=161.4
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK 70 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 70 (288)
++...++|++.+.||+|+||.||+|++. .+.|.+|+++|++++|||||+++|+|.+..
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 81 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 81 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCe
Confidence 3455689999999999999999999641 467999999999999999999999986542
Q ss_pred ------cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 ------YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ------~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
|+.. ......+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence 1111 123346899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHH
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITV 190 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~ 190 (288)
............||+.|+||| |||||||++|||++ |..||.... .+...+.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 544444444567899999999 99999999999998 899986432 234557899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 191 AKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.++|.+||+.||++|||+.||+++|+.+...
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=332.71 Aligned_cols=194 Identities=25% Similarity=0.375 Sum_probs=164.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN-- 76 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~-- 76 (288)
.++|++.++||+|+||+||+|+++ .+.+.+|+++|++++|||||++++++.+.+.++...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999753 567999999999999999999999987765432211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 77 ----------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 77 ----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~ 174 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence 1235889999999999999999999 88999999999999999999999999999987643332 233
Q ss_pred ccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC-----------------ccchhHHHHHHHHHHhc
Q 044995 147 QVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT-----------------FEEDKNITVAKHAKRCL 198 (288)
Q Consensus 147 ~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~-----------------~~~~~~~~~~~li~~cl 198 (288)
...||+.|+||| |||||||++|||++|..||.... .+...+.++.++|.+||
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 457999999999 99999999999999999995432 22345788999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 044995 199 NPSGKKRPAMKEVASE 214 (288)
Q Consensus 199 ~~~p~~Rp~~~~i~~~ 214 (288)
+.||++|||+.|++++
T Consensus 255 ~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 255 DMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=332.07 Aligned_cols=203 Identities=26% Similarity=0.373 Sum_probs=161.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
..+.|++.+.||+|+||.||+|.++ .+.|++|+++|++++|||||+++|+|.+.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 3567999999999999999998631 35799999999999999999999998765432
Q ss_pred cc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 73 HD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 73 ~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 11 123346899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCc--eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCC----------------CccchhHHH
Q 044995 139 VDQT--HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFT----------------TFEEDKNIT 189 (288)
Q Consensus 139 ~~~~--~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~----------------~~~~~~~~~ 189 (288)
.... .......||+.||||| |||||||++|||++|..|+... ..+...+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 3322 2223346899999999 9999999999999976654321 233456788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
+.+++.+||+.||++||++.||++.|+.+...
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=337.75 Aligned_cols=201 Identities=22% Similarity=0.365 Sum_probs=166.3
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeeecceEe
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKLIGCCL 67 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 67 (288)
|+...++|++.+.||+|+||+||+|++. .+.|.+|+.+|.++ +|||||+++++|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 3455689999999999999999999641 35789999999998 8999999999987
Q ss_pred ccccccccC------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEe
Q 044995 68 ETKYMHDQN------------------------------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHR 111 (288)
Q Consensus 68 ~~~~l~~~~------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr 111 (288)
+.+.++... ....+++..++.++.|++.||.||| +++|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 654321100 1124789999999999999999999 8899999
Q ss_pred CCCCCCeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCC
Q 044995 112 DIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIR 178 (288)
Q Consensus 112 dlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~ 178 (288)
||||+|||++.++.+||+|||+|+........ ......||+.||||| |||||||++|||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865443332 233456899999999 99999999999998 899996
Q ss_pred CCC----------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 044995 179 FTT----------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELA 216 (288)
Q Consensus 179 ~~~----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 216 (288)
... .+...+.++.++|.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 432 23345788999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=328.98 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=167.9
Q ss_pred hcCCcccCce-eeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccc---
Q 044995 16 ATDSFNVNRI-LGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--- 70 (288)
Q Consensus 16 ~~~~y~~~~~-lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 70 (288)
..++|.+.+. ||+|+||.||+|.++ .++|.+|+++|++++|||||+++|+|....
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l 85 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 85 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence 3467777774 999999999999642 467999999999999999999999986542
Q ss_pred ---cccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 ---YMHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ---~l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
|+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 2221 223356899999999999999999999 889999999999999999999999999999876543
Q ss_pred Ccee--eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHH
Q 044995 141 QTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVA 191 (288)
Q Consensus 141 ~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~ 191 (288)
.... .....||+.|+||| |||||||++|||+| |+.||.... .+...+.++.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 3222 22346889999999 99999999999998 899996432 3345678999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
++|.+||+.||++|||+.+|++.|+....
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=331.15 Aligned_cols=194 Identities=25% Similarity=0.341 Sum_probs=163.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD---- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~---- 74 (288)
.+.|++++.||+|+||.||+|+++ .+.|.+|+++|++++|||||++++++.+.+.++.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 467999999999999999999753 4679999999999999999999999876543221
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 112346899999999999999999999 8899999999999999999999999999997543211 12
Q ss_pred eeccccCCCCCChh----------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHH
Q 044995 145 TTQVHGTFGYLNPD----------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVA 191 (288)
Q Consensus 145 ~~~~~gt~~y~aPE----------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~ 191 (288)
.....||+.|+||| |||||||++|||++|+.||..... +...+.++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 23457999999999 999999999999999999964321 234578999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++|.+||+.||++|||+.|++++
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=332.96 Aligned_cols=200 Identities=22% Similarity=0.392 Sum_probs=166.2
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH- 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~- 73 (288)
++|++++.||+|+||+||+|.+. .+.|.+|++++++++|||||+++|+|.+.+...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 57999999999999999999641 467999999999999999999999987764221
Q ss_pred ------------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC
Q 044995 74 ------------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 74 ------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 141 (288)
.......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 1123446899999999999999999999 8899999999999999999999999999998764433
Q ss_pred ce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHH
Q 044995 142 TH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKH 193 (288)
Q Consensus 142 ~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~l 193 (288)
.. ......||+.|+||| |||||||++|||+| |..||.... .+...+.++.++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 22 223346899999999 99999999999998 788986432 233567889999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+.+||+.||++|||+.||+++|+.+..
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=327.46 Aligned_cols=197 Identities=23% Similarity=0.359 Sum_probs=152.2
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 69 (288)
.++|++.+.||+|+||.||+|+++ .+.|.+|+++|++++|||||++++++.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999753 45689999999999999999999987542
Q ss_pred --cccccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 70 --KYMHDQ----------NKELPFTWEMQLRISIEASGTMSYLHLSA--SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 70 --~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
+|+... .....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 222110 12346899999999999999999999432 2459999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC---------------ccchhHHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT---------------FEEDKNIT 189 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~---------------~~~~~~~~ 189 (288)
....... ......||+.||||| |||||||++|||+||+.||...+ .+...+.+
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 7543322 233467999999999 99999999999999999996432 23345789
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+++.+||+.||++|||+.|++++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=322.71 Aligned_cols=189 Identities=21% Similarity=0.371 Sum_probs=156.0
Q ss_pred cccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc----------
Q 044995 20 FNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET---------- 69 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------- 69 (288)
|++.++||+|+||+||+|+++ .+.|.+|+++|++++|||||+++++|...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367788999999999999753 45789999999999999999999987542
Q ss_pred -cccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeCCCCCCeeec-CCCceEEecccCccccCC
Q 044995 70 -KYMHDQ------NKELPFTWEMQLRISIEASGTMSYLHLSASVP--IYHRDIKSTNILLD-DKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 70 -~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlkp~Nil~~-~~~~~kl~DfG~a~~~~~ 139 (288)
+|+... .....+++..+..++.|++.||.||| +++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 222211 12236889999999999999999999 776 99999999999996 578999999999985433
Q ss_pred CCceeeeccccCCCCCChh----------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD----------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITVAK 192 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE----------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~~~ 192 (288)
.. .....||+.||||| |||||||++|||++|+.||..... +...+.++.+
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred Cc---cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 22 23457999999999 999999999999999999964321 2234678999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 044995 193 HAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 193 li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
++.+||+.||++|||+.|++++
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-47 Score=330.81 Aligned_cols=188 Identities=24% Similarity=0.355 Sum_probs=161.1
Q ss_pred CcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
.|++++.||+|+||.||+|+++ .+.|.+|+++|++++|||||++++++.+.+.++.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999752 3578999999999999999999999876643321
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 112346899999999999999999999 889999999999999999999999999999864322
Q ss_pred eeccccCCCCCChh--------------hHHHHHHHHHHHHhCCCCCCCCCc----------------cchhHHHHHHHH
Q 044995 145 TTQVHGTFGYLNPD--------------DVCSFGVVLVELLTGAKPIRFTTF----------------EEDKNITVAKHA 194 (288)
Q Consensus 145 ~~~~~gt~~y~aPE--------------DiwSlG~il~elltg~~P~~~~~~----------------~~~~~~~~~~li 194 (288)
....||+.||||| |||||||++|||++|..||..... ....+.++.++|
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 2357999999999 999999999999999999954321 223478999999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q 044995 195 KRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 195 ~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+||+.||++|||+.|++++
T Consensus 248 ~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTC
T ss_pred HHHCcCChhHCcCHHHHHhC
Confidence 99999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=337.49 Aligned_cols=193 Identities=24% Similarity=0.379 Sum_probs=160.8
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc-
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ- 75 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~- 75 (288)
..++|++.+.||+|+||+||+|+++ .+.+.+|+++|++++|||||+++++|.+.+.++..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4688999999999999999999752 46789999999999999999999998776432211
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 ------------NKELPFTWEMQLRISIEASGTMSYLHLSASV-PIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.+...+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 12235899999999999999999999 64 7999999999999999999999999999864322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------------
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE---------------------------- 183 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~---------------------------- 183 (288)
.....+||+.|+||| |||||||++|||++|+.||......
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 123457999999999 9999999999999999999543211
Q ss_pred ------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0124678999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=328.76 Aligned_cols=207 Identities=21% Similarity=0.326 Sum_probs=165.0
Q ss_pred HHHHHhcCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEecccc---
Q 044995 11 NELEKATDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCLETKY--- 71 (288)
Q Consensus 11 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 71 (288)
++|++..++|++.+.||+|+||.||+|+++ .+.|.+|+.+|++++|||||+++|+|.+.++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv 89 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 89 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEE
Confidence 345556689999999999999999999753 5789999999999999999999999866532
Q ss_pred ---cccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 ---MHDQ--------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 ---l~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+... .....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 2111 11125899999999999999999999 888999999999999999999999999999866444
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCC----------------CCccchhHHHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRF----------------TTFEEDKNITVAKH 193 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~----------------~~~~~~~~~~~~~l 193 (288)
.........||+.|+||| |||||||++|||++|..|+.. ...+...+.++.++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 333344456899999999 999999999999997666521 12344567899999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 194 AKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
|.+||+.||++||++++|++.|+.+..
T Consensus 247 i~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 247 MCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 999999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=322.28 Aligned_cols=192 Identities=24% Similarity=0.373 Sum_probs=159.2
Q ss_pred ceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEecccc------ccc-
Q 044995 24 RILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------MHD- 74 (288)
Q Consensus 24 ~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------l~~- 74 (288)
++||+|+||.||+|.++ .+.|.+|+++|++++|||||+++|+|....+ +..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 47999999999999631 4579999999999999999999999865432 211
Q ss_pred -----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee--eec
Q 044995 75 -----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI--TTQ 147 (288)
Q Consensus 75 -----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--~~~ 147 (288)
......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 112346899999999999999999999 8889999999999999999999999999998664433322 223
Q ss_pred cccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHHHhcCC
Q 044995 148 VHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAKRCLNP 200 (288)
Q Consensus 148 ~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~~cl~~ 200 (288)
..||+.||||| |||||||++|||+| |+.||.... .+...+.++.+++.+||+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 56899999999 99999999999998 899996432 3345678999999999999
Q ss_pred CCCCCCCHHHHHHHHHhc
Q 044995 201 SGKKRPAMKEVASELAGI 218 (288)
Q Consensus 201 ~p~~Rp~~~~i~~~l~~~ 218 (288)
||++|||+++|++.|+..
T Consensus 250 dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNY 267 (277)
T ss_dssp STTTSCCHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCH
Confidence 999999999999988765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=328.10 Aligned_cols=194 Identities=24% Similarity=0.346 Sum_probs=162.0
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccccC
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQN 76 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~~ 76 (288)
++|++.+.||+|+||.||+|+++ .+.+.+|+++|++++|||||++++++.+.+.++...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999752 356899999999999999999999987765432211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCC-c
Q 044995 77 -------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-T 142 (288)
Q Consensus 77 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-~ 142 (288)
....+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 2236889999999999999999999 8899999999999999999999999999998764332 2
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
......+||+.|+||| |||||||++|||++|+.||...+ ++...+.++.++|.+|
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 2233457999999999 99999999999999999996432 3445678999999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 044995 198 LNPSGKKRPAMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~~i~~~ 214 (288)
|+.||++|||++|++++
T Consensus 245 L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SCSSGGGSTTSGGGTCH
T ss_pred ccCCHhHCcCHHHHcCC
Confidence 99999999999997654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-47 Score=328.62 Aligned_cols=207 Identities=23% Similarity=0.361 Sum_probs=168.5
Q ss_pred HHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecce
Q 044995 10 SNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGC 65 (288)
Q Consensus 10 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~ 65 (288)
+.+++...++|++.+.||+|+||.||+|+++ .++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456677889999999999999999999631 4679999999999999999999999
Q ss_pred Eeccccccc-------------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 044995 66 CLETKYMHD-------------------------------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPI 108 (288)
Q Consensus 66 ~~~~~~l~~-------------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 108 (288)
|...+.+.. ......+++..++.++.|++.||+||| +++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 875421110 011224789999999999999999999 8899
Q ss_pred EEeCCCCCCeeecCCCceEEecccCccccCCCC-ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCC-C
Q 044995 109 YHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQ-THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGA-K 175 (288)
Q Consensus 109 iHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~-~ 175 (288)
+||||||+|||++.++.+||+|||+++...... ........|++.|+||| |||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999997553322 22233456889999999 9999999999999986 5
Q ss_pred CCCCCC---------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhch
Q 044995 176 PIRFTT---------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIK 219 (288)
Q Consensus 176 P~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~ 219 (288)
||.... .+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 664322 34456789999999999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-46 Score=326.82 Aligned_cols=193 Identities=18% Similarity=0.259 Sum_probs=163.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY------- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------- 71 (288)
.++|++.+.||+|+||.||+|+++ .+.+.+|+++|++++|||||++++++.+.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 478999999999999999999753 4678999999999999999999999876533
Q ss_pred ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec--CCCceEEecccCccccCCCCc
Q 044995 72 MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD--DKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 72 l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~DfG~a~~~~~~~~ 142 (288)
+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 221 123346899999999999999999999 88999999999999995 457899999999987654332
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~~~~~~~l 193 (288)
.....||+.||||| |||||||++|||++|+.||...+.. ...+.++.++
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23457999999999 9999999999999999999644311 2346789999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|.+||+.||++|||+.|++++
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=320.54 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=159.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY- 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~- 71 (288)
.++|++.+.||+|+||.||+|+.. .+.|.+|+++|++++|||||+++|+|.+..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~ 86 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence 367999999999999999999631 4679999999999999999999999876532
Q ss_pred -----ccc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 72 -----MHD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 72 -----l~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 111 112235899999999999999999999 88999999999999999999999999999987644
Q ss_pred CCcee--eeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC----------------ccchhHHH
Q 044995 140 DQTHI--TTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT----------------FEEDKNIT 189 (288)
Q Consensus 140 ~~~~~--~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~----------------~~~~~~~~ 189 (288)
..... .....|+..|+||| |||||||++|||+| |+.||...+ .+...+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 33222 22345788999999 99999999999998 899995332 23445789
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 044995 190 VAKHAKRCLNPSGKKRPAMKEVASELAGI 218 (288)
Q Consensus 190 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 218 (288)
+.+++.+||+.||++||||.+|++.|++.
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=324.62 Aligned_cols=194 Identities=23% Similarity=0.324 Sum_probs=150.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
..+.|++.+.||+|+||+||+|+++ .+.+.+|+++|++++|||||++++++.+.++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999753 3467899999999999999999999876643321
Q ss_pred -----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceEEecccCccccCCC
Q 044995 75 -----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 75 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~DfG~a~~~~~~ 140 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||+. .++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 113346899999999999999999999 88999999999999994 5789999999999865432
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchhHHHHH
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDKNITVA 191 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~------------------~~~~~~~~~~ 191 (288)
. .....+||+.||||| |||||||++|||++|..||.... .....+.++.
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 2 233457999999999 99999999999999999996432 1124578899
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 044995 192 KHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 192 ~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+++.+||+.||++|||+.|++++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-45 Score=319.49 Aligned_cols=191 Identities=26% Similarity=0.349 Sum_probs=162.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++.+.||+|+||+||+|+++ .+.+.+|+.+|++++|||||++++++.+.+.++..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 467999999999999999999753 46788999999999999999999998776544322
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 1 2235688888899999999999999 899999999999999999999999999999875432
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
....+||+.||||| |||||||++|||++|+.||...+ .+...+.++.+++.+|
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 23457999999999 99999999999999999996443 2344578899999999
Q ss_pred cCCCCCCCC-----CHHHHHHH
Q 044995 198 LNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp-----~~~~i~~~ 214 (288)
|+.||.+|+ +++++++|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccchhhHHHHHcC
Confidence 999999995 88888775
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=322.81 Aligned_cols=194 Identities=25% Similarity=0.304 Sum_probs=165.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++++.||+|+||.||+|+++ .+.+.+|+.+|++++|||||++++++.+.++++..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 578999999999999999999753 46788999999999999999999998877544321
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 1 2235789999999999999999999 8899999999999999999999999999998654322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
......+||+.|+||| |||||||++|||++|+.||...+ ++...+.++.++|.+|
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhh
Confidence 2334467999999999 99999999999999999996543 3445688999999999
Q ss_pred cCCCCCCCCC-----HHHHHHH
Q 044995 198 LNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~-----~~~i~~~ 214 (288)
|+.||++|++ +.|+++|
T Consensus 240 L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCchhhcccccccHHHHHcC
Confidence 9999999995 7888765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=320.96 Aligned_cols=211 Identities=25% Similarity=0.373 Sum_probs=164.4
Q ss_pred eeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCceeee
Q 044995 8 FISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHINVVKL 62 (288)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~HpnIv~l 62 (288)
|..++|+...++|++.+.||+|+||.||+|.+. .+.|.+|+.++.++ +|+|||.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 456778778899999999999999999998631 35678888888776 68999999
Q ss_pred cceEecc--------cccccc----------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeC
Q 044995 63 IGCCLET--------KYMHDQ----------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRD 112 (288)
Q Consensus 63 ~~~~~~~--------~~l~~~----------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd 112 (288)
++++... +|+... .....+++..++.++.|++.||.||| +++|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence 9887543 222110 01234789999999999999999999 88999999
Q ss_pred CCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhC-CCCCCC
Q 044995 113 IKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTG-AKPIRF 179 (288)
Q Consensus 113 lkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg-~~P~~~ 179 (288)
|||+|||+++++.+||+|||+|+....... .......||+.|+||| |||||||++|||+|| ..||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543322 2233457999999999 999999999999997 457754
Q ss_pred CC----------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 180 TT----------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 180 ~~----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.. .+...+.++.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 32 2234578899999999999999999999999999988653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-45 Score=324.75 Aligned_cols=193 Identities=20% Similarity=0.280 Sum_probs=163.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM------ 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l------ 72 (288)
.++|++.+.||+|+||.||+|+++ .+.+.+|+++|++++|||||++++++.+.+.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999753 45788999999999999999999998765332
Q ss_pred -cc-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec--CCCceEEecccCccccCCCCc
Q 044995 73 -HD-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD--DKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 73 -~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.. ......+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 11 122346899999999999999999999 88999999999999997 568999999999987654332
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~~~~~~l 193 (288)
.....||+.|+||| |||||||++|||++|..||..... ....+.++.+|
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 33457999999999 999999999999999999964321 12357889999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
|.+||+.||.+|||+.|++++
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=317.81 Aligned_cols=193 Identities=26% Similarity=0.331 Sum_probs=162.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++.+.||+|+||+||+|+++ .+.|.+|+++|++++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999752 46799999999999999999999998776443
Q ss_pred ccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC----ceEEecccCcc
Q 044995 73 HDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY----CAKVSNFGTSR 135 (288)
Q Consensus 73 ~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~DfG~a~ 135 (288)
+.. .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 211 12236899999999999999999999 88999999999999998765 59999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc------------------chh
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE------------------EDK 186 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~------------------~~~ 186 (288)
...... ......||+.|+||| |||||||++|||++|+.||...+.. ...
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 654332 223456899999999 9999999999999999999654321 134
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.++.++|.+||+.||++|||+.|++++
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6788999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=312.51 Aligned_cols=201 Identities=23% Similarity=0.381 Sum_probs=161.5
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc-ccccccC-
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET-KYMHDQN- 76 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~l~~~~- 76 (288)
|+...++|++.+.||+|+||.||+|.++ .+.|.+|++++++++|||||+++|+|.+. +.+....
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3455678999999999999999999763 57899999999999999999999998653 2111111
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 77 --------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 77 --------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 1124789999999999999999999 889999999999999999999999999999854322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC---------------ccchhHHHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT---------------FEEDKNITVAKHAK 195 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~---------------~~~~~~~~~~~li~ 195 (288)
.....++..|+||| |||||||++|||+| |+.||.... .+...+.++.+++.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 22346889999999 99999999999998 688875432 23345789999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 196 RCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+||+.||++|||+.+++++|+.++.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=319.13 Aligned_cols=214 Identities=25% Similarity=0.383 Sum_probs=175.2
Q ss_pred cccceeHHHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCCCCce
Q 044995 4 KTKLFISNELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQINHINV 59 (288)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~HpnI 59 (288)
..+.|..++|+...++|++.+.||+|+||.||+|.++ ...|.+|++++++++||||
T Consensus 6 ~~~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cccCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE
Confidence 4456666778888899999999999999999998641 3468999999999999999
Q ss_pred eeecceEecccccccc-----------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 60 VKLIGCCLETKYMHDQ-----------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 60 v~l~~~~~~~~~l~~~-----------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
|+++++|...+.+... .....+++..+.+++.|++.||.||| +++|+||||||+
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAAR 162 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGG
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCC
Confidence 9999998754322111 11224688889999999999999999 888999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCC-CCCCCCC--
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGA-KPIRFTT-- 181 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~-~P~~~~~-- 181 (288)
|||++.++.+||+|||+++........ ......||+.|+||| ||||||+++|||+||. .||...+
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865433322 223346899999999 9999999999999984 6774322
Q ss_pred -------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 -------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+...+..+.++|.+||+.||++|||+.+|+++|++...
T Consensus 243 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 234457899999999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-45 Score=322.75 Aligned_cols=191 Identities=24% Similarity=0.280 Sum_probs=162.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
.++|++++.||+|+||.||+|+++ .+.+.+|+++|++++|||||++++++...+.++..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 367999999999999999999753 45688999999999999999999998766433211
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 -------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
.....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 12236899999999999999999999 889999999999999999999999999999875432
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
.....||+.||||| |||||||++|||+||..||...+ .+...+.++.++|.+|
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 23457999999999 99999999999999999996543 2334578999999999
Q ss_pred cCCCCCCCC-----CHHHHHHH
Q 044995 198 LNPSGKKRP-----AMKEVASE 214 (288)
Q Consensus 198 l~~~p~~Rp-----~~~~i~~~ 214 (288)
|+.||.+|+ +++++++|
T Consensus 273 L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccccccHHHHHcC
Confidence 999999994 78887764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=317.72 Aligned_cols=194 Identities=21% Similarity=0.285 Sum_probs=162.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc--
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD-- 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~-- 74 (288)
.|+|+++++||+|+||.||+|++. .+.+.+|+++|++++|||||++++++.+...++.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 379999999999999999999752 4578999999999999999999999876543211
Q ss_pred ------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 75 ------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 75 ------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 123346899999999999999999999 88899999999999999999999999999986543322
Q ss_pred eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------------
Q 044995 143 HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE--------------------------- 183 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~--------------------------- 183 (288)
......||+.|+||| |||||||++|+|++|+.||...+..
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 223346999999999 9999999999999999999643210
Q ss_pred ----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0124678999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=317.94 Aligned_cols=200 Identities=23% Similarity=0.388 Sum_probs=164.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC-CCCceeeecceEeccccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI-NHINVVKLIGCCLETKYMHD 74 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~l~~ 74 (288)
.++|++.++||+|+||.||+|+++ .+.|.+|+++|+++ +|||||+++++|.+.+.+..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 378999999999999999999752 34799999999999 79999999999877543211
Q ss_pred -----------------------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCc
Q 044995 75 -----------------------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYC 125 (288)
Q Consensus 75 -----------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~ 125 (288)
......+++.....++.|++.||.||| +++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence 112346899999999999999999999 889999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCC-CCCCCCC------------
Q 044995 126 AKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGA-KPIRFTT------------ 181 (288)
Q Consensus 126 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~-~P~~~~~------------ 181 (288)
+||+|||+++...... ......||..|+||| |||||||++|||++|. .||...+
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999997543222 122346899999999 9999999999999975 5664322
Q ss_pred ---ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhh
Q 044995 182 ---FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAW 221 (288)
Q Consensus 182 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~ 221 (288)
.+...+.++.++|.+||+.||++|||+.||+++|+++...
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2334578999999999999999999999999999988654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=314.29 Aligned_cols=192 Identities=23% Similarity=0.371 Sum_probs=160.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcCC--CCceeeecceEeccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQIN--HINVVKLIGCCLETK 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~ 70 (288)
.++|++.+.||+|+||.||+|+++ ..++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999753 123678999999987 899999999987764
Q ss_pred cccc--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-CCceEEecccCcc
Q 044995 71 YMHD--------------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-KYCAKVSNFGTSR 135 (288)
Q Consensus 71 ~l~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~DfG~a~ 135 (288)
.++. ......+++..+..++.|++.||.||| +++|+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 3221 112236889999999999999999999 889999999999999985 5799999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCC--------CccchhHHHHHHHHH
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFT--------TFEEDKNITVAKHAK 195 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~--------~~~~~~~~~~~~li~ 195 (288)
..... ......||+.|+||| |||||||++|||++|+.||... .++...+.++.++|.
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~ 236 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 236 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHH
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHH
Confidence 64332 223457999999999 9999999999999999999642 234456889999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 044995 196 RCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~ 214 (288)
+||+.||++|||++|++++
T Consensus 237 ~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTS
T ss_pred HHccCCHhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=313.14 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=162.8
Q ss_pred CceeeeeCCeeEEEeEcc----------------------HHHHHHHHHHHhcCCCCceeeecceEeccc--------cc
Q 044995 23 NRILGQGGQDIVYKGMAK----------------------VEKFINEVVIQSQINHINVVKLIGCCLETK--------YM 72 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------~l 72 (288)
.++||+|+||+||+|++. .++|.+|+++|++++|||||+++|+|...+ |+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 568999999999998641 467999999999999999999999986542 11
Q ss_pred c-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCce--
Q 044995 73 H-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTH-- 143 (288)
Q Consensus 73 ~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-- 143 (288)
. .......+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 1 1122335678889999999999999999 888999999999999999999999999999865433221
Q ss_pred -eeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC----------------ccchhHHHHHHHHH
Q 044995 144 -ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT----------------FEEDKNITVAKHAK 195 (288)
Q Consensus 144 -~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~----------------~~~~~~~~~~~li~ 195 (288)
......||..|+||| ||||||+++|||+||..||.... .+...+.++.++|.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence 122346889999999 99999999999999888774321 22345678999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHhchhhcCCC
Q 044995 196 RCLNPSGKKRPAMKEVASELAGIKAWNGAS 225 (288)
Q Consensus 196 ~cl~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 225 (288)
+||+.||++||++.||+++|+++.......
T Consensus 269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999997654443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=314.05 Aligned_cols=188 Identities=21% Similarity=0.240 Sum_probs=156.5
Q ss_pred CceeeeeCCeeEEEeEcc-----------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc-----
Q 044995 23 NRILGQGGQDIVYKGMAK-----------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD----- 74 (288)
Q Consensus 23 ~~~lG~G~~g~Vy~~~~~-----------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~----- 74 (288)
+++||+|+||+||+|+++ .+.+.+|+++|++++|||||++++++...+.++.
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999763 1358899999999999999999999876643321
Q ss_pred --------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCceeee
Q 044995 75 --------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHITT 146 (288)
Q Consensus 75 --------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 146 (288)
......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc-cc
Confidence 223446888899999999999999999 889999999999999999999999999999865443322 23
Q ss_pred ccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-------------------------------
Q 044995 147 QVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE------------------------------- 183 (288)
Q Consensus 147 ~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~------------------------------- 183 (288)
..+||+.|+||| |||||||++|||++|..||......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 357999999999 9999999999999999998543210
Q ss_pred -----------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+|+.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 1235689999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-44 Score=308.80 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=159.8
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcCCCCceeeecceEecc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQINHINVVKLIGCCLET------ 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 69 (288)
.++|++.+.||+|+||.||+|++. .+.|.+|++++++++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999752 45789999999999999999999987543
Q ss_pred -----ccccc------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 70 -----KYMHD------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 -----~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+|+.. ......+++..++.++.|++.||.||| +++|+||||||+|||++.++..+|+|||.++...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 22221 112336899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCC--ceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------cchhH
Q 044995 139 VDQ--THITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------EEDKN 187 (288)
Q Consensus 139 ~~~--~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~~~~~ 187 (288)
... ........||+.|+||| |||||||++|||+||+.||...+. ....+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 322 12233457999999999 999999999999999999965431 12347
Q ss_pred HHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhch
Q 044995 188 ITVAKHAKRCLNPSGKKRP-AMKEVASELAGIK 219 (288)
Q Consensus 188 ~~~~~li~~cl~~~p~~Rp-~~~~i~~~l~~~~ 219 (288)
.++.++|.+||+.||++|| +++++++.|.++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 8899999999999999998 8999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=315.25 Aligned_cols=213 Identities=25% Similarity=0.394 Sum_probs=171.9
Q ss_pred ccceeH-HHHHHhcCCcccCceeeeeCCeeEEEeEcc------------------------HHHHHHHHHHHhcC-CCCc
Q 044995 5 TKLFIS-NELEKATDSFNVNRILGQGGQDIVYKGMAK------------------------VEKFINEVVIQSQI-NHIN 58 (288)
Q Consensus 5 ~~~~~~-~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------------------------~~~~~~E~~~l~~l-~Hpn 58 (288)
.++|.+ .+|+...++|++.++||+|+||.||+|++. ...|.+|+.+++++ +|||
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence 444553 346667799999999999999999999631 45789999999999 6999
Q ss_pred eeeecceEecccc-------cccc------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 044995 59 VVKLIGCCLETKY-------MHDQ------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVP 107 (288)
Q Consensus 59 Iv~l~~~~~~~~~-------l~~~------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 107 (288)
||+++++|.+.+. +... .....+++..++.++.|++.||.||| +++
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ 165 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKN 165 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 9999999876532 2110 11235889999999999999999999 889
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCccccCCCCc-eeeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CC
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT-HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GA 174 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~ 174 (288)
|+||||||+|||++.++.+|++|||+++....... .......||+.|+||| |||||||++|||+| |.
T Consensus 166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 99999999999999999999999999987654332 3334467899999999 99999999999999 55
Q ss_pred CCCCCCCc----------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 175 KPIRFTTF----------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 175 ~P~~~~~~----------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
+||..... +...+..+.+||.+||+.||++||||.+|++.|+++..
T Consensus 246 p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 55543222 23346889999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-44 Score=318.24 Aligned_cols=192 Identities=22% Similarity=0.270 Sum_probs=158.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHH---HHHHHhcCCCCceeeecceEeccccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFIN---EVVIQSQINHINVVKLIGCCLETKYM 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~---E~~~l~~l~HpnIv~l~~~~~~~~~l 72 (288)
.++|++.+.||+|+||.||+|+++ ...+.+ |+++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999763 122344 46778888999999999998776433
Q ss_pred cccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCC
Q 044995 73 HDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAV 139 (288)
Q Consensus 73 ~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~ 139 (288)
+... ....+++..+..++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 2211 2235788999999999999999999 88999999999999999999999999999986543
Q ss_pred CCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc-----------------cchhHHHH
Q 044995 140 DQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF-----------------EEDKNITV 190 (288)
Q Consensus 140 ~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~-----------------~~~~~~~~ 190 (288)
.. .....||+.|+||| |||||||++|||+||+.||..... +...+.++
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 32 23457999999999 999999999999999999964322 23457899
Q ss_pred HHHHHHhcCCCCCCCCC-----HHHHHHH
Q 044995 191 AKHAKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 191 ~~li~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
.++|.+||+.||++||+ +.|+++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 6777765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-44 Score=309.31 Aligned_cols=193 Identities=27% Similarity=0.393 Sum_probs=163.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------------------HHHHHHHHHHHhcCC-CCceeeecceEec
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------------------VEKFINEVVIQSQIN-HINVVKLIGCCLE 68 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 68 (288)
.++|++.+.||+|+||+||+|+++ .+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999752 246889999999997 9999999999877
Q ss_pred ccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 69 TKYMHDQ-------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 69 ~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
.+.++.. .....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 6433211 12346899999999999999999999 8889999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCCc----------------
Q 044995 136 SRAVDQTHITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTTF---------------- 182 (288)
Q Consensus 136 ~~~~~~~~~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~~---------------- 182 (288)
...... ......||..|+||| ||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 765432 223457999999998 999999999999999999964431
Q ss_pred --cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+.++.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12457789999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=313.64 Aligned_cols=205 Identities=25% Similarity=0.378 Sum_probs=164.1
Q ss_pred HHHhcCCcccCceeeeeCCeeEEEeEcc--------------------------HHHHHHHHHHHhcC-CCCceeeecce
Q 044995 13 LEKATDSFNVNRILGQGGQDIVYKGMAK--------------------------VEKFINEVVIQSQI-NHINVVKLIGC 65 (288)
Q Consensus 13 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------------~~~~~~E~~~l~~l-~HpnIv~l~~~ 65 (288)
|+...++|++.+.||+|+||.||+|+.. ...+.+|+..+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4456789999999999999999998631 46788899999888 79999999999
Q ss_pred Eecccccccc-----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCC
Q 044995 66 CLETKYMHDQ-----------------------------NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKST 116 (288)
Q Consensus 66 ~~~~~~l~~~-----------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~ 116 (288)
|.+...+... .....+++..++.++.|++.||.||| +++|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence 8765322110 11235899999999999999999999 889999999999
Q ss_pred CeeecCCCceEEecccCccccCCCCce-eeeccccCCCCCChh-----------hHHHHHHHHHHHHh-CCCCCCCCC--
Q 044995 117 NILLDDKYCAKVSNFGTSRSRAVDQTH-ITTQVHGTFGYLNPD-----------DVCSFGVVLVELLT-GAKPIRFTT-- 181 (288)
Q Consensus 117 Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE-----------DiwSlG~il~ellt-g~~P~~~~~-- 181 (288)
|||++.++.+||+|||+++........ ......|++.|+||| |||||||++|||++ |..||....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 999999999999999999865433222 223356889999999 99999999999998 688885332
Q ss_pred -------------ccchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 182 -------------FEEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 182 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+...+.++.++|.+||+.||++|||+.||++.|+++..
T Consensus 245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 233457889999999999999999999999999998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=313.07 Aligned_cols=194 Identities=21% Similarity=0.277 Sum_probs=162.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCCCCceeeecceEecccccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH----- 73 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~----- 73 (288)
..++|++++.||+|+||+||+|.++ ...+.+|+++|++++|||||++++++.+.+.++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3578999999999999999999863 346889999999999999999999987654322
Q ss_pred --c-------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC--CCceEEecccCccccCCCCc
Q 044995 74 --D-------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD--KYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 74 --~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ......+++..+..++.|++.||.||| +++|+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 1 112236899999999999999999999 889999999999999974 4589999999998654332
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------c----hhHHHHHHH
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------E----DKNITVAKH 193 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------~----~~~~~~~~l 193 (288)
......||+.|+||| |||||||++|+|++|..||...... . ..+.++.++
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 233456899999999 9999999999999999999654321 1 246788999
Q ss_pred HHHhcCCCCCCCCCHHHHHHH
Q 044995 194 AKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 194 i~~cl~~~p~~Rp~~~~i~~~ 214 (288)
+.+||..||++|||+.|++++
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=308.92 Aligned_cols=194 Identities=21% Similarity=0.281 Sum_probs=159.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccccc----
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMH---- 73 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~---- 73 (288)
.++|++.++||+|+||.||+|+++ .+.|.+|+.+|++++|||||++++++...+.+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 378999999999999999999763 468999999999999999999999987764322
Q ss_pred ---------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 74 ---------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 74 ---------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 1223456899999999999999999999 88999999999999999999999999999976543222 2
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc------------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------ 182 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------ 182 (288)
.....|++.|+||| |||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 23346899999999 999999999999999999953321
Q ss_pred -------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 -------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11235688999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=309.61 Aligned_cols=194 Identities=24% Similarity=0.321 Sum_probs=158.5
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHhcC---CCCceeeecceEecc--
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQSQI---NHINVVKLIGCCLET-- 69 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~-- 69 (288)
..++|++++.||+|+||+||+|++. ...+.+|+.+|+.| +|||||+++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3579999999999999999999752 23567888887665 799999999987532
Q ss_pred ----------cccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 044995 70 ----------KYMH-------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFG 132 (288)
Q Consensus 70 ----------~~l~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG 132 (288)
+++. .......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 1111 1223346889999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-------------------
Q 044995 133 TSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------- 182 (288)
Q Consensus 133 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------- 182 (288)
+++...... ......||+.|+||| |||||||++|||++|+.||...+.
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 987543322 233457999999999 999999999999999999964321
Q ss_pred ----------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 ----------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 ----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11235678999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=309.55 Aligned_cols=207 Identities=18% Similarity=0.317 Sum_probs=160.4
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------HHHHHHHHH--HHhcCCCCceeeecceEeccc-----------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------VEKFINEVV--IQSQINHINVVKLIGCCLETK----------- 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------~~~~~~E~~--~l~~l~HpnIv~l~~~~~~~~----------- 70 (288)
..+|.+.++||+|+||.||+|+.+ .+.+.+|.+ .+.+++|||||+++++|...+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 357889999999999999999753 344555554 456789999999999987542
Q ss_pred cccc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 71 YMHD-----QNKELPFTWEMQLRISIEASGTMSYLHLS-----ASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 71 ~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
|+.. ......+++...+.++.+++.||.|+|.. +.++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 2111 11123588999999999999999999942 2469999999999999999999999999999865443
Q ss_pred Cce---eeeccccCCCCCChh-----------------hHHHHHHHHHHHHhCCCCCCCCC-------------------
Q 044995 141 QTH---ITTQVHGTFGYLNPD-----------------DVCSFGVVLVELLTGAKPIRFTT------------------- 181 (288)
Q Consensus 141 ~~~---~~~~~~gt~~y~aPE-----------------DiwSlG~il~elltg~~P~~~~~------------------- 181 (288)
... ......||+.|+||| |||||||++|||+||..||....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 322 223457999999998 99999999999999987763211
Q ss_pred ------------c-----cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhcC
Q 044995 182 ------------F-----EEDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWNG 223 (288)
Q Consensus 182 ------------~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~~ 223 (288)
. .......+.+++.+||+.||++|||+.||+++|+++....+
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 0 01123468899999999999999999999999998876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=310.06 Aligned_cols=193 Identities=23% Similarity=0.313 Sum_probs=160.8
Q ss_pred CCcccCceeeeeCCeeEEEeEcc---------------------HHHHHHHHHHHh-cCCCCceeeecceEecccccccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK---------------------VEKFINEVVIQS-QINHINVVKLIGCCLETKYMHDQ 75 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~---------------------~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~l~~~ 75 (288)
++|++.+.||+|+||+||+|+++ .+.+.+|..++. .++|||||++++++.+.+.++..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 78999999999999999999763 345777877765 68999999999998876544321
Q ss_pred C-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCc
Q 044995 76 N-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQT 142 (288)
Q Consensus 76 ~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 142 (288)
. ....+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 1 2235789999999999999999999 88999999999999999999999999999986543322
Q ss_pred eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCC--------------ccchhHHHHHHHHHHh
Q 044995 143 HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTT--------------FEEDKNITVAKHAKRC 197 (288)
Q Consensus 143 ~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~--------------~~~~~~~~~~~li~~c 197 (288)
......||+.|+||| |||||||++|||++|+.||...+ .+...+.++.++|.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 233457999999999 99999999999999999996543 2334578999999999
Q ss_pred cCCCCCCCCCHH-HHHHH
Q 044995 198 LNPSGKKRPAMK-EVASE 214 (288)
Q Consensus 198 l~~~p~~Rp~~~-~i~~~ 214 (288)
|..||++||++. ++++|
T Consensus 238 L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCSSGGGSBTTBSCGGGS
T ss_pred cccCCCCCcCHHHHHHhC
Confidence 999999999985 67653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=306.28 Aligned_cols=194 Identities=23% Similarity=0.321 Sum_probs=158.0
Q ss_pred hcCCcccCc-eeeeeCCeeEEEeEcc-------------HHHHHHHHHHHhc-CCCCceeeecceEec-----------c
Q 044995 16 ATDSFNVNR-ILGQGGQDIVYKGMAK-------------VEKFINEVVIQSQ-INHINVVKLIGCCLE-----------T 69 (288)
Q Consensus 16 ~~~~y~~~~-~lG~G~~g~Vy~~~~~-------------~~~~~~E~~~l~~-l~HpnIv~l~~~~~~-----------~ 69 (288)
..++|++.. .||+|+||.||+|+++ .+.+.+|+.++.+ ++|||||+++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 357899875 5999999999999863 5678899998765 589999999998653 2
Q ss_pred ccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC---CCceEEecccCccccC
Q 044995 70 KYMHD--------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD---KYCAKVSNFGTSRSRA 138 (288)
Q Consensus 70 ~~l~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~DfG~a~~~~ 138 (288)
+|+.+ ......+++..+..++.|++.||.||| +++|+||||||+|||++. .+.+||+|||+++...
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeecc
Confidence 33321 112246899999999999999999999 889999999999999975 4679999999998654
Q ss_pred CCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc------------------c----ch
Q 044995 139 VDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF------------------E----ED 185 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~------------------~----~~ 185 (288)
... ......||+.||||| |||||||++|+|+||+.||..... + ..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 166 SHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred CCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 332 223457999999999 999999999999999999953321 1 13
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
.+.++.++|.+||+.||++|||+.|++++
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 46789999999999999999999999886
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=305.75 Aligned_cols=192 Identities=18% Similarity=0.267 Sum_probs=156.1
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY---- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 71 (288)
..++|++++.||+|+||+||+|.++ .+.+.+|+++|++++|||||+++++|...+.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4689999999999999999999753 4578899999999999999999999765431
Q ss_pred ---------cc----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 ---------MH----DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 ---------l~----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+. .......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|++|||+++...
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccC
Confidence 10 0112236899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
... ....||+.|+||| |||||||++|||++|..||...+..
T Consensus 173 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 SEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp SSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred Ccc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 322 3356999999999 9999999999999999999643210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+..+.+||.+||..||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1225678899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=308.68 Aligned_cols=196 Identities=18% Similarity=0.288 Sum_probs=158.2
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc-------------------HHHHHHHHHHHhcCCCCceeeecceEecccc-----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK-------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY----- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 71 (288)
..++|++++.||+|+||+||+|+++ .+.+++|+.+|++++|||||++++++....+
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3568999999999999999999753 4578999999999999999999998865321
Q ss_pred --c----cc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 72 --M----HD-----QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 72 --l----~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+ .. ......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 1 00 112236899999999999999999999 889999999999999999999999999999765332
Q ss_pred Cc--eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 141 QT--HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 141 ~~--~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
.. .......||+.|+||| ||||+||++|||++|+.||......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 1223456899999999 9999999999999999999643310
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1124578899999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=300.57 Aligned_cols=196 Identities=21% Similarity=0.284 Sum_probs=158.5
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccc------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETK------ 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 70 (288)
.++|++++.||+|+||+||+|+++ .+++.+|+++|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 588999999999999999999863 356889999999999999999998874421
Q ss_pred ---------ccc------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 71 ---------YMH------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 71 ---------~l~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
++. .......+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceee
Confidence 111 1123346788999999999999999999 8899999999999999999999999999997
Q ss_pred ccCCCCc---eeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCccc----------------
Q 044995 136 SRAVDQT---HITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFEE---------------- 184 (288)
Q Consensus 136 ~~~~~~~---~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~~---------------- 184 (288)
....... .......||+.|+||| |||||||++|||++|+.||.......
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 6543221 1122346999999999 99999999999999999996422100
Q ss_pred ------------------------------hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 044995 185 ------------------------------DKNITVAKHAKRCLNPSGKKRPAMKEVASEL 215 (288)
Q Consensus 185 ------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 215 (288)
..+..+.+||.+||+.||++|||+.|+++|=
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 0144677899999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=306.98 Aligned_cols=191 Identities=23% Similarity=0.301 Sum_probs=156.9
Q ss_pred CcccCceeeeeCCeeEEEeEcc--------------HHHHHHHHHHHhcCCCCceeeecceEecc-------------cc
Q 044995 19 SFNVNRILGQGGQDIVYKGMAK--------------VEKFINEVVIQSQINHINVVKLIGCCLET-------------KY 71 (288)
Q Consensus 19 ~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------------~~ 71 (288)
+|+..++||+|+||+||+|+++ .+.+.+|+++|++++|||||+++++|... +|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 6888999999999999999864 22356899999999999999999987432 22
Q ss_pred ccc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCC-ceEEecccCccccCCCC
Q 044995 72 MHD---------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKY-CAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 72 l~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~DfG~a~~~~~~~ 141 (288)
+.. ......+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 211 113346899999999999999999999 89999999999999998765 89999999998654332
Q ss_pred ceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------------
Q 044995 142 THITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------------- 183 (288)
Q Consensus 142 ~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------------------- 183 (288)
. .....||..|+||| |||||||++|||++|+.||......
T Consensus 178 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 178 P--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp C--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred c--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 2 23357999999999 9999999999999999999543211
Q ss_pred -----------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 -----------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 -----------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+|+.+||..||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1235678999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=294.13 Aligned_cols=193 Identities=20% Similarity=0.270 Sum_probs=159.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEeccccccc---
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKYMHD--- 74 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~l~~--- 74 (288)
++|+++++||+|+||+||+|+++ .+++.+|+.+|++++|||||+++++|...+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999863 4688999999999999999999999877643321
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCCCcee
Q 044995 75 ----------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVDQTHI 144 (288)
Q Consensus 75 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 144 (288)
......+++..+..++.|++.||+||| .++|+||||||+|||++.++.+||+|||.++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 123346788999999999999999999 889999999999999999999999999999865433222
Q ss_pred eeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCc------------------------------
Q 044995 145 TTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTF------------------------------ 182 (288)
Q Consensus 145 ~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~------------------------------ 182 (288)
.....++..|+||| |||||||++|||++|..||.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 22234677788888 999999999999999998632111
Q ss_pred --------------cchhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 183 --------------EEDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 183 --------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
....+..+.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11225678999999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=294.51 Aligned_cols=200 Identities=19% Similarity=0.240 Sum_probs=159.6
Q ss_pred CCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCCCceeeecceEe-ccc-------ccc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINHINVVKLIGCCL-ETK-------YMH 73 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~-------~l~ 73 (288)
++|++.+.||+|+||.||+|++. .+.+.+|++++++++|+|+|..+..|. +.+ ++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 67999999999999999999753 346889999999999888776655543 222 211
Q ss_pred c------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeec---CCCceEEecccCccccCCCCc--
Q 044995 74 D------QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLD---DKYCAKVSNFGTSRSRAVDQT-- 142 (288)
Q Consensus 74 ~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~DfG~a~~~~~~~~-- 142 (288)
. ......+++..++.++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 1 112346899999999999999999999 88899999999999985 355799999999986543322
Q ss_pred ----eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc----------------------ch
Q 044995 143 ----HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE----------------------ED 185 (288)
Q Consensus 143 ----~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~----------------------~~ 185 (288)
.......||+.||||| |||||||++|||++|+.||...... ..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence 1223457999999999 9999999999999999999643221 12
Q ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchh
Q 044995 186 KNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKA 220 (288)
Q Consensus 186 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~ 220 (288)
.+.++.+++..||+.||++||++.++.+.|+.+..
T Consensus 244 ~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 35778999999999999999999999888887644
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=301.57 Aligned_cols=195 Identities=27% Similarity=0.328 Sum_probs=161.9
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc-------------------------HHHHHHHHHHHhcCCC-CceeeecceEeccc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK-------------------------VEKFINEVVIQSQINH-INVVKLIGCCLETK 70 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~-------------------------~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~ 70 (288)
.++|++.+.||+|+||+||+|.+. .+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999998631 3568899999999977 89999999887664
Q ss_pred cccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCcccc
Q 044995 71 YMHDQN-------------KELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSR 137 (288)
Q Consensus 71 ~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~ 137 (288)
.+.... ....+++..+..++.|++.||.|+| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 432211 2224678888999999999999999 889999999999999999999999999999866
Q ss_pred CCCCceeeeccccCCCCCChh-------------hHHHHHHHHHHHHhCCCCCCCCC------------------ccchh
Q 044995 138 AVDQTHITTQVHGTFGYLNPD-------------DVCSFGVVLVELLTGAKPIRFTT------------------FEEDK 186 (288)
Q Consensus 138 ~~~~~~~~~~~~gt~~y~aPE-------------DiwSlG~il~elltg~~P~~~~~------------------~~~~~ 186 (288)
............|++.|++|| |||||||+||||++|+.||.... .+...
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 544444444567999999998 99999999999999999996443 22345
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 044995 187 NITVAKHAKRCLNPSGKKRPA-----MKEVASE 214 (288)
Q Consensus 187 ~~~~~~li~~cl~~~p~~Rp~-----~~~i~~~ 214 (288)
+.++.+++.+||++||++||+ ++|+++|
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 788999999999999999984 7887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-41 Score=295.38 Aligned_cols=193 Identities=18% Similarity=0.245 Sum_probs=158.1
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc---------------HHHHHHHHHHHhcCC-CCceeeecceEecc---------cc
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK---------------VEKFINEVVIQSQIN-HINVVKLIGCCLET---------KY 71 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~---------~~ 71 (288)
.++|+++++||+|+||+||+|+++ .+++.+|+++|++++ ||||+++++++... ++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 368999999999999999999763 578999999999995 99999999987633 12
Q ss_pred ccc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCC-CceEEecccCccccCCCCceeeec
Q 044995 72 MHD---QNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDK-YCAKVSNFGTSRSRAVDQTHITTQ 147 (288)
Q Consensus 72 l~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 147 (288)
+.. ......+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+|||+|+....... ...
T Consensus 114 ~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~ 188 (328)
T d3bqca1 114 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNV 188 (328)
T ss_dssp CCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCS
T ss_pred cCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc--ccc
Confidence 111 111236899999999999999999999 8899999999999999865 4699999999986543322 234
Q ss_pred cccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------------------
Q 044995 148 VHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE-------------------------------- 183 (288)
Q Consensus 148 ~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~-------------------------------- 183 (288)
..+|+.|+||| ||||+||++|||++|..||......
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 56899999999 9999999999999999998532210
Q ss_pred --------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 --------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 --------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+||.+||..||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1135678999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=298.15 Aligned_cols=192 Identities=21% Similarity=0.289 Sum_probs=156.3
Q ss_pred hcCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecccc----
Q 044995 16 ATDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLETKY---- 71 (288)
Q Consensus 16 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 71 (288)
..++|++.+.||+|+||+||+|+++ .+++.+|+++|++++|||||++++++.....
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4689999999999999999999753 3578899999999999999999998753211
Q ss_pred -------------ccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 72 -------------MHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 72 -------------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+........+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC
Confidence 111112346899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCceeeeccccCCCCCChh------------hHHHHHHHHHHHHhCCCCCCCCCcc-----------------------
Q 044995 139 VDQTHITTQVHGTFGYLNPD------------DVCSFGVVLVELLTGAKPIRFTTFE----------------------- 183 (288)
Q Consensus 139 ~~~~~~~~~~~gt~~y~aPE------------DiwSlG~il~elltg~~P~~~~~~~----------------------- 183 (288)
.. .....|++.|+||| |||||||++|+|++|+.||...+..
T Consensus 173 ~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp GG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 22 22346888999999 9999999999999999999643210
Q ss_pred ----------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ----------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+||.+||..||++|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 1235678899999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-40 Score=283.96 Aligned_cols=203 Identities=15% Similarity=0.156 Sum_probs=164.0
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc----------------HHHHHHHHHHHhcCCC-CceeeecceEecccc-------c
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK----------------VEKFINEVVIQSQINH-INVVKLIGCCLETKY-------M 72 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~-------l 72 (288)
.++|++.+.||+|+||+||+|++. .+.+.+|++.++.|+| +||+.+++++..... +
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 478999999999999999999753 3457889999999976 899999888655432 1
Q ss_pred c------ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecC-----CCceEEecccCccccCCCC
Q 044995 73 H------DQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDD-----KYCAKVSNFGTSRSRAVDQ 141 (288)
Q Consensus 73 ~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~-----~~~~kl~DfG~a~~~~~~~ 141 (288)
. .......+++..+..++.|++.||+||| +++|+||||||+|||++. .+.+||+|||+|+......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 1 0112236889999999999999999999 899999999999999964 5789999999998654321
Q ss_pred c------eeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc---------------------
Q 044995 142 T------HITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE--------------------- 183 (288)
Q Consensus 142 ~------~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~--------------------- 183 (288)
. .......||+.||||| |||||||++|||++|..||......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 1 1223457999999999 9999999999999999999654322
Q ss_pred -chhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhchhhc
Q 044995 184 -EDKNITVAKHAKRCLNPSGKKRPAMKEVASELAGIKAWN 222 (288)
Q Consensus 184 -~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~~~~~ 222 (288)
...+.++.+++..|+..+|++||+++.+.+.|+++....
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 123568999999999999999999999999888776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=292.58 Aligned_cols=193 Identities=20% Similarity=0.289 Sum_probs=150.3
Q ss_pred cCCcccCceeeeeCCeeEEEeEcc--------------------HHHHHHHHHHHhcCCCCceeeecceEecc-------
Q 044995 17 TDSFNVNRILGQGGQDIVYKGMAK--------------------VEKFINEVVIQSQINHINVVKLIGCCLET------- 69 (288)
Q Consensus 17 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 69 (288)
.++|+++++||+|+||+||+|.++ .+++.+|+.+|++++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999763 35688999999999999999999987533
Q ss_pred ------cccccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccCCC
Q 044995 70 ------KYMHDQ---NKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRAVD 140 (288)
Q Consensus 70 ------~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 140 (288)
+|+... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc
Confidence 222110 01235789999999999999999999 889999999999999999999999999998754432
Q ss_pred CceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCcc--------------------------
Q 044995 141 QTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTFE-------------------------- 183 (288)
Q Consensus 141 ~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~~-------------------------- 183 (288)
.......||+.|+||| ||||+||++|||++|+.||...+..
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 2233457999999999 9999999999999999999543210
Q ss_pred ------------------------------chhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 044995 184 ------------------------------EDKNITVAKHAKRCLNPSGKKRPAMKEVASE 214 (288)
Q Consensus 184 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 214 (288)
...+.++.+|+.+||..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0125578899999999999999999999977
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-37 Score=271.36 Aligned_cols=190 Identities=19% Similarity=0.229 Sum_probs=150.5
Q ss_pred CCcccCceeeeeCCeeEEEeEcc-----------------HHHHHHHHHHHhcCC-----------CCceeeecceEecc
Q 044995 18 DSFNVNRILGQGGQDIVYKGMAK-----------------VEKFINEVVIQSQIN-----------HINVVKLIGCCLET 69 (288)
Q Consensus 18 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~ 69 (288)
++|+++++||+|+||+||+|+++ .+.+.+|++++++++ |+|||++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999753 366788999998875 57899998887543
Q ss_pred c--cc----------------cccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeCCCCCCeeecCCC------
Q 044995 70 K--YM----------------HDQNKELPFTWEMQLRISIEASGTMSYLHLSAS-VPIYHRDIKSTNILLDDKY------ 124 (288)
Q Consensus 70 ~--~l----------------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlkp~Nil~~~~~------ 124 (288)
. +. ........+++..+..++.|++.||.||| + .+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccc
Confidence 1 00 11223446788999999999999999999 5 7899999999999997544
Q ss_pred ceEEecccCccccCCCCceeeeccccCCCCCChh-----------hHHHHHHHHHHHHhCCCCCCCCCc-----------
Q 044995 125 CAKVSNFGTSRSRAVDQTHITTQVHGTFGYLNPD-----------DVCSFGVVLVELLTGAKPIRFTTF----------- 182 (288)
Q Consensus 125 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE-----------DiwSlG~il~elltg~~P~~~~~~----------- 182 (288)
.++++|||.+...... .....||+.|+||| ||||+||++++|++|+.||.....
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 4899999998754322 23356999999999 999999999999999999853211
Q ss_pred ---------------------------------------------------cchhHHHHHHHHHHhcCCCCCCCCCHHHH
Q 044995 183 ---------------------------------------------------EEDKNITVAKHAKRCLNPSGKKRPAMKEV 211 (288)
Q Consensus 183 ---------------------------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 211 (288)
....+.++.+|+.+||..||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 01225678999999999999999999999
Q ss_pred HHH
Q 044995 212 ASE 214 (288)
Q Consensus 212 ~~~ 214 (288)
++|
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.3e-21 Score=156.96 Aligned_cols=114 Identities=13% Similarity=0.173 Sum_probs=87.7
Q ss_pred cccCceeeeeCCeeEEEeEcc-----------------------------------HHHHHHHHHHHhcCCCCceeeecc
Q 044995 20 FNVNRILGQGGQDIVYKGMAK-----------------------------------VEKFINEVVIQSQINHINVVKLIG 64 (288)
Q Consensus 20 y~~~~~lG~G~~g~Vy~~~~~-----------------------------------~~~~~~E~~~l~~l~HpnIv~l~~ 64 (288)
+.+.++||+|+||+||+|++. ...+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999742 123456888999999999998876
Q ss_pred eE---eccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeCCCCCCeeecCCCceEEecccCccccC
Q 044995 65 CC---LETKYMHDQNKELPFTWEMQLRISIEASGTMSYLHLSASVPIYHRDIKSTNILLDDKYCAKVSNFGTSRSRA 138 (288)
Q Consensus 65 ~~---~~~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~~~~ 138 (288)
+. ..++++.... ...++......++.|++.+|.||| .++|+||||||+|||++++ .++|+|||+|....
T Consensus 82 ~~~~~lvme~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 82 WEGNAVLMELIDAKE-LYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp EETTEEEEECCCCEE-GGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred ecCCEEEEEeecccc-ccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 53 3334433211 123455567789999999999999 8899999999999999865 48999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.04 E-value=0.00044 Score=55.53 Aligned_cols=28 Identities=25% Similarity=0.432 Sum_probs=24.5
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
++|+|+.+.|||+++++...|.||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 7899999999999877666799998775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.84 E-value=0.0069 Score=49.73 Aligned_cols=31 Identities=13% Similarity=0.177 Sum_probs=27.6
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..++||+|+.++||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999988777899999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.73 E-value=0.026 Score=44.32 Aligned_cols=28 Identities=18% Similarity=0.262 Sum_probs=24.6
Q ss_pred eEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 108 IYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 108 iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
++|+|+.|.|||++.+..+.|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999877667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=87.82 E-value=0.1 Score=44.05 Aligned_cols=30 Identities=17% Similarity=0.228 Sum_probs=25.3
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
...++|+|+.+.|||+++++ ++|.||-.+.
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 34689999999999998664 8999998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=87.24 E-value=0.26 Score=41.34 Aligned_cols=15 Identities=40% Similarity=0.678 Sum_probs=12.9
Q ss_pred eEEeCCCCCCeeecC
Q 044995 108 IYHRDIKSTNILLDD 122 (288)
Q Consensus 108 iiHrdlkp~Nil~~~ 122 (288)
++|.|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 479999999999843
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=85.39 E-value=0.13 Score=41.98 Aligned_cols=29 Identities=28% Similarity=0.368 Sum_probs=23.7
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccCcc
Q 044995 105 SVPIYHRDIKSTNILLDDKYCAKVSNFGTSR 135 (288)
Q Consensus 105 ~~~iiHrdlkp~Nil~~~~~~~kl~DfG~a~ 135 (288)
..+++|+|+.+.|||++++ ..+.||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4578999999999999743 4589998775
|